Medicare Program; Revised Payment System Policies for Services Furnished in Ambulatory Surgical Centers (ASCs) Beginning in CY 2008, 42470-42626 [07-3490]
Download as PDF
42470
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Parts 410 and 416
[CMS–1517–F]
RIN 0938–AO73
Medicare Program; Revised Payment
System Policies for Services
Furnished in Ambulatory Surgical
Centers (ASCs) Beginning in CY 2008
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final rule.
AGENCY:
SUMMARY: This final rule revises the
Medicare ambulatory surgical center
(ASC) payment system to implement
certain related provisions of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA). This final rule establishes
the ASC list of covered surgical
procedures, identifies covered ancillary
services under the revised ASC payment
system, and sets forth the amounts and
factors that will be used to determine
the ASC payment rates for calendar year
(CY) 2008. The changes to the ASC
payment system and ratesetting
methodology in this final rule are
applicable to services furnished on or
after January 1, 2008.
DATES: Effective Date: This final rule is
effective on January 1, 2008.
FOR FURTHER INFORMATION, CONTACT:
Alberta Dwivedi, (410) 786–0378. Dana
Burley, (410) 786–0378.
SUPPLEMENTARY INFORMATION:
mstockstill on PROD1PC66 with RULES2
Electronic Access
This Federal Register document is
also available from the Federal Register
online database through GPO Access, a
service of the U.S. Government Printing
Office. Free public access is available on
a Wide Area Information Server (WAIS)
through the Internet and via
asynchronous dial-in. Internet users can
access the database by using the World
Wide Web; the Superintendent of
Documents’ home page address is
https://www.gpoaccess.gov/,
by using local WAIS client software, or
by telnet to swais.access.gpo.gov, then
login as guest (no password required).
Dial-in users should use
communications software and modem
to call (202) 512–1661; type swais, then
login as guest (no password required).
Alphabetical List of Acronyms
Appearing in This Final Rule
AHA
American Hospital Association
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
AMA American Medical Association
APC Ambulatory payment classification
ASC Ambulatory surgical center
BESS [Medicare] Part B Extract Summary
System
CAH Critical access hospital
CBSA Core-Based Statistical Area
CMS Centers for Medicare & Medicaid
Services
CPI–U Consumer Price Index for All Urban
Consumers
CPT [Physicians’] Current Procedural
Terminology, Fourth Edition, 2007,
copyrighted by the American Medical
Association. CPT is a trademark of the
American Medical Association.
CY Calendar year
DRA Deficit Reduction Act of 2005, Public
Law 109–171
FY Federal fiscal year
GAO Government Accountability Office
HCPCS Healthcare Common Procedure
Coding System
HOPD Hospital outpatient department
HQA Hospital Quality Alliance
IOL Intraocular lens
IPPS [Hospital] Inpatient prospective
payment system
MAC Medicare administrative contractor
MedPAC Medicare Payment Advisory
Commission
MMA Medicare Prescription Drug,
Improvement, and Modernization Act of
2003, Public Law 108–173
MPFS Medicare Physician Fee Schedule
MSA Metropolitan Statistical Area
NTIOL New technology intraocular lens
OCE Outpatient Code Editor
OMB Office of Management and Budget
OPPS [Hospital] Outpatient prospective
payment system
PM Program memorandum
PPAC Practicing Physicians Advisory
Council
PPS Prospective payment system
PRA Paperwork Reduction Act of 1995
RFA Regulatory Flexibility Act
RVU Relative value unit
To assist readers in referencing
sections contained in this document, we
are providing the following table of
contents:
Table of Contents
I. Background
A. Legislative and Regulatory History
B. ASC Payment Method
C. Provisions of Public Law 108–173
(MMA)
D. Issuance of Proposed Rule
E. Changes to the ASC List for CY 2007
II. Revisions to the ASC Payment System
Effective January 1, 2008
A. General
B. Factors Considered in the Development
of the Revised ASC Payment System
C. Rulemaking for the Revised ASC
Payment System in CY 2008
III. Covered Surgical Procedures Paid in
ASCs On or After January 1, 2008
A. Payable Procedures
1. Definition of Surgical Procedure
2. Procedures Excluded From Payment
Under the Revised ASC Payment System
a. Significant Safety Risk
PO 00000
Frm 00002
Fmt 4701
Sfmt 4700
b. Overnight Stay
B. Treatment of Unlisted Procedure Codes
and Procedures That Are Not Paid
Separately Under the OPPS
C. Treatment of Office-Based Procedures
D. Specific Surgical Procedures Excluded
From Payment Under the Revised ASC
Payment System
IV. Ratesetting Methodology for the Revised
ASC Payment System
A. Overview of Current ASC Payment
System
B. ASC Relative Payment Weights Based on
APC Groups and Relative Payment
Weights Established Under the OPPS
C. Packaging Policy
1. General Policy
2. Policies for Specific Items and Services
a. Radiology Services
b. Brachytherapy Sources
c. Drugs and Biologicals
d. Implantable Devices With Pass-Through
Status Under the OPPS
e. Implantable Devices Without PassThrough Status Under the OPPS
D. Payment for Corneal Tissue Under the
Revised ASC Payment System
E. Payment for Office-Based Procedures
F. Payment Policies for Multiple and
Interrupted Procedures
1. Multiple Procedure Discounting Policy
2. Interrupted Procedure Policies
G. Geographic Adjustment
H. Adjustment for Inflation
I. Beneficiary Coinsurance
J. Phase-In of Full Implementation of
Payment Rates Calculated Under the
Revised ASC Payment System
Methodology
V. Calculation of ASC Conversion Factor and
ASC Payment Rates for CY 2008
A. Overview
B. Budget Neutrality Requirement
C. Calculation of the ASC Payment Rates
for CY 2008
1. Proposed Method for Calculation of the
ASC Payment Rates for CY 2008 in the
August 2006 Proposed Rule
a. Estimated Medicare Program Payments
(Excluding Beneficiary Coinsurnace)
Under the Current ASC Payment System
in the August 2006 Proposed Rule
b. Estimated Medicare Program Payments
(Excluding Beneficiary Coinsurance)
Under the Proposed Revised ASC
Payment System in the August 2006
Proposed Rule
c. Calculation of the Proposed CY 2008
Budget Neutrality Adjustment in the
August 2006 Proposed Rule
d. Application of the Budget Neutrality
Adjustment To Determine the Proposed
CY 2008 ASC Conversion Factor in the
August 2006 Proposed Rule
e. Calculation of the Proposed CY 2008
ASC Payment Rates Under the Revised
ASC Payment System in the August 2006
Proposed Rule
f. Calculation of the Proposed CY 2008
ASC Payment Rates Under the Transition
in the August 2006 Proposed Rule
2. Alternative Option for Calculating the
Proposed Budget Neutrality Adjustment
in the August 2006 Proposed Rule
a. Estimated Medicare Program Payments
(Excluding Beneficiary Coinsurance)
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
Under the Existing ASC Payment System
in the August 2006 Proposed Rule
b. Estimated Medicare Program Payments
(Excluding Beneficiary Coinsurance)
Under the Proposed Revised ASC
Payment System in the August 2006
Proposed Rule
c. Calculation of the Proposed CY 2008
Budget Neutrality Adjustment in the
August 2006 Proposed Rule
d. Discussion of the Alternative
Calculation of the Budget Neutrality
Adjustment
3. Calculation of the Estimated CY 2008
Budget Neutrality Adjustment According
to the Final Policy
4. Final Calculation of the Estimated ASC
Payment Rates for CY 2008
a. Estimated CY 2008 Medicare Program
Payments (Excluding Beneficiary
Coinsurance) Under the Existing ASC
Payment System
b. Estimated Medicare Program Payments
(Excluding Beneficiary Coinsurance)
Under the Revised ASC Payment System
c. Calculation of the Final Estimated CY
2008 Budget Neutrality Adjustment
d. Calculation of the Final Estimated CY
2008 ASC Payment Rates
D. Calculation of the ASC Payment Rates
for CY 2009 and Future Years
1. Updating the ASC Relative Payment
Weights
2. Updating the ASC Conversion Factor
E. Annual Updates
VI. Information in Addenda Related to the
Revised CY 2008 ASC Payment System
VII. ASC Regulatory Changes
A. Regulatory Changes That Were
Finalized in the CY 2007 OPPS/ASC
Final Rule With Comment Period
B. Regulatory Changes Included in This
Final Rule
VIII. Files Available to the Public Via the
Internet
IX. Collection of Information Requirements
X. Regulatory Impact Analysis
A. Overall Impact
1. Executive Order 12866
2. Regulatory Flexibility Act
3. Small Rural Hospitals
4. Unfunded Mandates
5. Federalism
B. Effects of the Revisions to the ASC
Payment System for CY 2008
1. Alternatives Considered
2. Limitations of Our Analysis
3. Estimated Effects of This Final Rule on
ASCs
4. Estimated Effects of This Final Rule on
Beneficiaries
5. Conclusion
6. Accounting Statement
C. Executive Order 12866
Regulation Text
Addendum AA.—Illustrative ASC Covered
Surgical Procedures for CY 2008
(Including Surgical Procedures for
Which Payment Is Packaged)
Addendum BB.—Illustrative ASC Covered
Ancillary Services Integral to Covered
Surgical Procedures for CY 2008
(Including Ancillary Services for Which
Payment Is Packaged)
Addendum DD1.—Illustrative ASC Payment
Indicators
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
I. Background
A. Legislative and Regulatory History
Section 1832(a)(2)(F)(i) of the Social
Security Act (the Act) provides that
benefits under the Medicare
Supplementary Medical Insurance
program (Part B) include payment for
facility services furnished in connection
with surgical procedures specified by
the Secretary that are performed in an
ambulatory surgical center (ASC). To
participate in the Medicare program as
an ASC, a facility must meet the
standards specified in section
1832(a)(2)(F)(i) of the Act, which are
implemented in 42 CFR Part 416,
Subpart B and Subpart C of our
regulations. The regulations at 42 CFR
416, Subpart B set forth general
conditions and requirements for ASCs,
and the regulations at Subpart C provide
specific conditions for coverage for
ASCs.
The ASC services benefit was enacted
by Congress through the Omnibus
Reconciliation Act of 1980 (Pub. L. 96–
499). For a detailed discussion of the
legislative history related to ASCs, we
refer readers to the June 12, 1998
proposed rule (63 FR 32291).
Section 1833(i)(1)(A) of the Act
requires the Secretary to specify surgical
procedures that, although appropriately
performed in an inpatient hospital
setting, also can be performed safely on
an ambulatory basis in an ASC, critical
access hospital (CAH), or a hospital
outpatient department (HOPD). The
report accompanying the legislation
explained that Congress intended
procedures currently performed on an
ambulatory basis in a physician’s office
that do not generally require the more
elaborate facilities of an ASC not be
included in the list of ASC covered
procedures (H.R. Rep. No. 96–1167, at
390–91, reprinted in 1980 U.S.C.C.A.N.
5526, 5753–54). In a final rule published
on August 5, 1982, in the Federal
Register (47 FR 34082), we established
regulations that included criteria for
specifying which surgical procedures
were to be included for purposes of
implementing the ASC facility benefit.
Medicare only allows payment to ASCs
for procedures that are specified on the
ASC list.
Section 626(b) of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003, Public Law
108–173, repealed the requirement
formerly found in section 1833(i)(2)(A)
of the Act that the Secretary conduct a
survey of ASC costs for purposes of
updating ASC payment rates and,
instead, requires the Secretary to
implement a revised ASC payment
system, to be effective not later than
PO 00000
Frm 00003
Fmt 4701
Sfmt 4700
42471
January 1, 2008. Section 5103 of the
Deficit Reduction Act of 2005 (DRA),
Public Law 109–171, amended section
1833(i)(2) of the Act by adding a new
subparagraph (E) to place a limitation
on payments for surgical procedures in
ASCs. Section 1833(i)(2) of the Act
provides that if the standard overhead
amount under section 1833(i)(2)(A) of
the Act for a facility service for such
procedure, without application of any
geographic adjustment, exceeds the
Medicare payment amount under the
hospital outpatient prospective payment
system (OPPS) for the service for that
year, without application of any
geographic adjustment, the Secretary
shall substitute the OPPS payment
amount for the ASC standard overhead
amount. This provision applies to
surgical procedures furnished in ASCs
on or after January 1, 2007, and before
the effective date of the revised ASC
payment system implemented in this
final rule.
In the November 24, 2006 final rule
with comment period for the CY 2007
OPPS and ASC payment systems (71 FR
67960), we addressed the changes in
payment to ASCs mandated by section
5103 of Public Law 109–171 and
finalized § 416.1(a)(5) of the regulations
to implement this provision.
(Hereinafter, the November 24, 2006
final rule with comment period is
referred to as the CY 2007 OPPS/ASC
final rule with comment period.) We
also addressed additions to and
deletions from the ASC list of covered
surgical procedures that were
implemented on January 1, 2007. In
addition, we made changes in the
process to review payment adjustments
for insertion of new technology
intraocular lenses (NTIOLs) under
section 1833(i)(2)(A)(iii) of the Act.
Section 416.65(a) of the regulations
specifies general standards for
procedures on the ASC list. ASC
procedures are those surgical and other
medical procedures that are—
• Commonly performed on an
inpatient basis but may be safely
performed in an ASC;
• Not of a type that are commonly
performed or that may be safely
performed in physicians’ offices;
• Limited to procedures requiring a
dedicated operating room or suite and
generally requiring a postoperative
recovery room or short-term (not
overnight) convalescent room; and
• Not otherwise excluded from
Medicare coverage.
Specific standards in § 416.65(b) limit
covered ASC procedures to those that
do not generally exceed 90 minutes
operating time and a total of 4 hours
recovery or convalescent time. If
E:\FR\FM\02AUR2.SGM
02AUR2
42472
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
anesthesia is required, the anesthesia
must be local or regional anesthesia, or
general anesthesia of not more than 90
minutes duration.
Section 416.65(b)(3) of the regulations
excludes from the ASC list procedures
that generally result in extensive blood
loss, that require major or prolonged
invasion of body cavities, that directly
involve major blood vessels, or that are
generally emergency or life-threatening
in nature.
A detailed history of published
changes to the ASC list and ASC
payment rates can be found in the June
12, 1998 proposed rule (63 FR 32291).
Subsequently, in accordance with
§ 416.65(c), we published updates of the
ASC list in the Federal Register on
March 28, 2003 (68 FR 15268), May 4,
2005 (70 FR 23690), and in the CY 2007
OPPS/ASC final rule with comment
period (71 FR 67960).
During years when we have not
updated the ASC list in the Federal
Register, we have revised the list to be
consistent with annual calendar year
changes to the Healthcare Common
Procedure Coding System (HCPCS) and
Current Procedural Terminology (CPT)
codes. These annual coding updates
have been implemented through
program instructions to the carriers that
process ASC claims. (We note that
Medicare Part B carriers are
transitioning to Medicare
Administrative Contractors (MACs)
through 2011, as described in a final
rule with comment period published in
the Federal Register on November 24,
2006 (71 FR 68229).) We last issued
program instructions to update the list
only to conform to CPT and HCPCS
coding changes on December 20, 2006,
via Transmittal 1134, Change Request
5211. This transmittal can be found on
the CMS Web site at: https://
www.cms.hhs.gov/Transmittals/).
B. ASC Payment Method
On August 23, 2006, we proposed in
the Federal Register (71 FR 49635) a
revised payment system for ASCs to be
implemented effective January 1, 2008,
in accordance with section 626(b) of
Public Law 108–173, including
revisions to the ratesetting methodology
and the applicable ASC regulations to
incorporate the requirements and
payments for ASC services under the
revised ASC payment system. We also
proposed a new ‘‘exclusionary’’
approach for revising the ASC list of
covered surgical procedures beginning
CY 2008. We proposed to evaluate
surgical procedures to identify those
that could pose a significant safety risk
or that would be expected to require an
overnight stay when performed in ASCs,
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
and that would, therefore, be excluded
from Medicare payment under the
revised ASC payment system. Using that
exclusionary method, we developed a
list of surgical procedures that we
believed were safe for Medicare
beneficiaries in ASCs and that were
appropriate for Medicare payment. We
proposed to adopt an exclusionary
approach for identifying surgical
procedures that were appropriate for
payment under the revised ASC
payment system, and the result of that
process was a proposed list of surgical
procedures for which separate payment
would be made. We refer to that list of
payable procedures hereinafter as the
ASC ‘‘list of covered surgical
procedures.’’
There are two primary elements in the
total cost of performing a surgical
procedure: (a) The cost of the
physician’s professional services to
perform the procedure; and (b) the cost
of items and services furnished by the
facility where the procedure is
performed (for example, surgical
supplies, equipment, and nursing
services). Payment for the first element
is made under the Medicare Physician
Fee Schedule (MPFS). The August 2006
OPPS/ASC proposed rule addressed the
second element, payment for the cost of
items and services furnished by the
facility.
Under the current ASC payment
system, the ASC payment rate is a
standard overhead amount established
on the basis of our estimate of a fee that
takes into account the costs incurred by
ASCs generally in providing facility
services in connection with performing
a specific procedure. The report of the
Conference Committee accompanying
section 934 of the Omnibus
Reconciliation Act of 1980 states that
this overhead amount is expected to be
calculated on a prospective basis using
sample survey data and similar
techniques to establish reasonable
estimated overhead allowances, which
take into account volume (within
reasonable limits), for each of the listed
procedures (H.R. Rept. No. 96–1479, at
134–35 (1980)).
As stated earlier, to establish those
reasonable estimated allowances for
services furnished prior to
implementation of the revised ASC
payment system, section 626(b)(1) of
Public Law 108–73 amended section
1833(i)(2)(A)(i) of the Act that required
us to take into account the audited costs
incurred by ASCs to perform a
procedure in accordance with a survey.
Further, beginning January 1, 2007, and
prior to implementation of a revised
ASC payment system, in accordance
with section 5103 of Pub. L. 109–171,
PO 00000
Frm 00004
Fmt 4701
Sfmt 4700
no ASC standard overhead amount may
be greater than the OPPS payment rate
for a given service for that year. Except
for screening colonoscopies and flexible
sigmoidoscopies, payment for ASC
services is subject to the usual Medicare
Part B deductible and coinsurance
requirements, and the amounts paid by
Medicare must be 80 percent of the
standard overhead amount. As required
by section 1834(d) of the Act and
implemented in regulations at 42 CFR
410.152(i), the amount paid by Medicare
must be 75 percent of the fee schedule
payment amount for screening
colonoscopies and flexible
sigmoidoscopies.
Section 1833(i)(1) of the Act requires
us to specify, in consultation with
appropriate medical organizations,
surgical procedures that are
appropriately performed on an inpatient
basis in a hospital but that can be safely
performed in an ASC, a CAH, or an
HOPD and to review and update the list
of ASC procedures at least every 2 years.
Section 141(b) of the Social Security
Act Amendments of 1994, Public Law
103–432, requires us to establish a
process for reviewing the
appropriateness of the payment amount
provided under section 1833(i)(2)(A)(iii)
of the Act for intraocular lenses (IOLs)
that belong to a class of NTIOLs. That
process was the subject of a separate
final rule entitled ‘‘Adjustment in
Payment Amounts for New Technology
Intraocular Lenses Furnished by
Ambulatory Surgical Centers,’’
published on June 16, 1999, in the
Federal Register (64 FR 32198). We
proposed changes to the NTIOL request
for review process in the CY 2007
OPPS/ASC proposed rule published in
the Federal Register on August 23, 2006
(71 FR 49631 through 49635) and
finalized changes to that process in the
CY 2007 OPPS/ASC final rule with
comment period (71 FR 68175 through
68181).
C. Provisions of Public Law 108–173
(MMA)
Section 626(a) of Public Law 108–173
(MMA) amended section 1833(i)(2)(C) of
the Act, which requires the Secretary to
update ASC payment rates using the
Consumer Price Index for All Urban
Consumers (CPI–U) (U.S. city average) if
the Secretary has not otherwise updated
the amounts under the revised ASC
payment system. As amended by Pub. L.
108–173, section 1833(i)(2)(C) of the Act
requires that, if the Secretary is required
to apply the CPI–U increase, the CPI–U
percentage increase is to be applied on
a fiscal year (FY) basis beginning with
FY 1986 through FY 2005 and on a
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
calendar year (CY) basis beginning with
CY 2006.
Section 626(a) of Public Law 108–173
further amended section 1833(i)(2)(C) of
the Act to require us in FY 2004,
beginning April 1, 2004, to increase the
ASC payment rates using the CPI–U as
estimated for the 12-month period
ending March 31, 2003, minus 3.0
percentage points. Section 626(a) of
Public Law 108–173 also requires that
the CPI–U adjustment factor equal zero
percent in FY 2005, the last quarter of
CY 2005, and each calendar year from
CY 2006 through CY 2009.
Section 626(b) of Public Law 108–173
repealed the requirement that CMS
conduct a survey of ASC costs upon
which to base a standard overhead
payment amount for surgical services
performed in ASCs, and added section
1833(i)(2)(D) of the Act. Section
1833(i)(2)(D)(iii) of the Act requires us
to implement by no earlier than January
1, 2006, and not later than January 1,
2008, a revised ASC payment system.
The revised payment system under
section 1833(i)(2)(D)(i) of the Act is to
take into account the recommendations
contained in a Report to Congress that
the Government Accountability Office
(GAO) was required to submit by
January 1, 2005. Section 1833(i)(2)(D)(ii)
of the Act requires that the revised ASC
payment system be designed to result in
the same aggregate amount of
expenditures for surgical services
furnished in ASCs the year the system
is implemented as would be made if the
new system did not apply as estimated
by the Secretary. This requirement is to
take into account the limitation in ASC
expenditures resulting from
implementation of section 5103 of
Public Law 109–171 beginning January
1, 2007, as we described in sections
XVII.A.1. and XVII.E. of the preamble to
the CY 2007 OPPS/ASC final rule with
comment period (71 FR 68165 and
68174, respectively).
Section 1833(i)(2)(D)(iv) of the Act
exempts the classification system,
relative weights, payment amounts, and
geographic adjustment factor (if any)
under the revised ASC payment system
from administrative and judicial review.
Section 626(c) of Public Law 108–173
added a conforming amendment to
section 1833(a)(1) of the Act, which
provides that the amounts paid under
the revised ASC payment system shall
equal 80 percent of the lesser of the
actual charge for the services or the
payment amount that we determine
under the revised ASC payment system.
D. Issuance of Proposed Rule
As stated earlier, in the August 23,
2006 Federal Register (71 FR 49635), we
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
proposed to implement revisions to the
ASC payment system so that the revised
system is first effective on January 1,
2008.
In addition, we set forth an analysis
of the impact that the proposed revised
ASC payment system would have on
affected entities and Medicare
beneficiaries.
We received over 8,900 pieces of
correspondence in response to our
August 23, 2006 proposal for the revised
ASC payment system, which included
some comments recommending various
changes to how CMS pays for ASC
services and processes ASC claims that
we did not propose in the August 23,
2006 Federal Register. While we read
those comments with interest, we
generally do not address them, nor have
we made any changes in this final rule
based on them. We summarize the
numerous comments and
recommendations that are pertinent to
what we proposed, and we respond to
them in the appropriate sections of this
final rule.
E. Changes to the ASC List for CY 2007
As part of the CY 2007 OPPS/ASC
final rule with comment period, we
finalized additions to and deletions
from the ASC list of covered surgical
procedures, effective January 1, 2007 (71
FR 68166). We did not change the
criteria for adding or deleting items
from the ASC list effective January 1,
2007. However, in the August 2006
proposed rule (71 FR 49628), we
discussed changes to the criteria in the
context of developing the proposed
revised ASC payment system to be
effective January 1, 2008. The changes
to the criteria that we proposed resulted
in the proposed addition for CY 2008 of
many procedures that do not meet the
current criteria for addition to the list.
II. Revisions to the ASC Payment
System Effective January 1, 2008
A. General
As we discussed earlier, generally,
there are two primary elements in the
total cost of performing a surgical
procedure: (a) The cost of the
physician’s professional services for
performing the procedure; and (b) the
cost of services furnished by the facility
where the procedure is performed (for
example, surgical supplies, equipment,
nursing services, and overhead). The
former is covered by the MPFS. The
latter is covered by a Medicare benefit
enacted in 1980 that authorized
payment of a fee to ASCs for services
furnished in connection with
performing certain surgical procedures.
PO 00000
Frm 00005
Fmt 4701
Sfmt 4700
42473
Section 1833(i)(1) of the Act requires
us to specify surgical procedures that
are appropriately and safely performed
on an ambulatory basis in an ASC.
Moreover, we are required to review and
update the list of these procedures not
less often than every 2 years, in
consultation with appropriate trade and
professional associations. The ASC list
of covered surgical procedures was
limited in 1982 to approximately 100
procedures. Currently, the list consists
of more than 2,500 CPT codes
encompassing a cross-section of surgical
services, although 150 of these codes
account for more than 90 percent of the
approximately 4.5 million procedures
paid for each year under the ASC Part
B benefit. Eye, pain management, and
gastrointestinal endoscopic procedures
are the highest volume ASC surgeries
performed under the present ASC
payment system.
In CY 2007, Medicare only allows
payment to ASCs for procedures on the
ASC list of covered surgical procedures.
Except for screening colonoscopy
services, payment for ASC facility
services is subject to the usual Medicare
Part B deductible and coinsurance
requirements, and the amounts paid by
Medicare must be 80 percent of the
standard overhead amount. As
discussed earlier, under section 626(b)
of Public Law 108–173, Congress
mandated implementation of a revised
payment system for ASC surgical
services by no later than January 1,
2008. Public Law 108–173 set forth
several requirements for the revised
payment system, but did not amend
those provisions of the statute
pertaining to the ASC list.
As we proposed in the August 2006
proposed rule (71 FR 49635), in this
final rule, we address two components
of the ASC payment system that will go
into effect January 1, 2008. First, we are
establishing the ASC list of covered
surgical procedures for which an ASC
may receive Medicare payment for
facility services under the revised ASC
payment system, as well as those
covered ancillary services that may be
separately paid if they are provided
integral to a covered surgical procedure.
Second, we are specifying the method
we will use to set payment rates for ASC
services furnished in association with
covered surgical procedures. In this
final rule, we also specify the regulatory
changes that we are making to 42 CFR
Parts 410 and 416 to incorporate the
rules governing ASC payments that will
be applicable beginning in CY 2008.
E:\FR\FM\02AUR2.SGM
02AUR2
42474
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
B. Factors Considered in the
Development of the Revised ASC
Payment System
On August 2, 2005, we convened a
listening session teleconference on
revising the Medicare ASC payment
system. Over 450 callers participated,
including ASC staff, physicians, and
representatives of industry trade
associations. The listening session
provided an opportunity for participants
to identify the issues and concerns that
they wanted us to address as we
developed the revised ASC payment
system.
Callers encouraged us to foster
beneficiary access to ASCs by creating
incentives for physicians to use ASCs.
The issues raised by participants
included suggestions to expand or
eliminate altogether the ASC list,
recommendations to model payment on
the OPPS, and concerns about how we
would propose to treat the geographic
wage index adjustment and the annual
ASC payment rate update. Several
callers also raised concerns about
ensuring adequate payment for supplies,
ancillary services, and implantable
devices under the revised payment
system, as well as developing a process
to allow special payment for new
technology.
We also met with representatives of
the ASC industry over the past several
years to discuss options for ratesetting
other than conducting a survey, to
discuss timely updates to the ASC list,
and to listen to industry concerns
related to the implementation of a
revised payment system. We appreciate
the thoughtful suggestions that were
presented. We considered the concerns
and issues brought to our attention, the
proposals for revising the ASC list of
covered surgical procedures, and the
suggested methods by which we could
set ASC payment rates in developing the
policies in this final rule.
In the August 23, 2006 Federal
Register (71 FR 49506), we proposed the
policies for the revised ASC payment
system to be effective beginning in CY
2008. In response to those proposed
policies, we received over 8,900 pieces
of correspondence from the public that
we are addressing in this final rule.
Subsequent to publication of the
August 2006 proposed rule for the
revised ASC payment system, the GAO
published the statutorily mandated
report entitled, ‘‘Medicare: Payment for
Ambulatory Surgical Centers Should Be
Based on the Hospital Outpatient
Payment System’’ (GAO–07–86) on
November 30, 2006. We considered the
report’s methodology, findings, and
recommendations in the development of
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
this CY 2008 final rule for the revised
ASC payment system. The GAO
methodology, results, and
recommendations are summarized
below.
The GAO was directed to conduct a
study comparing the relative costs of
procedures furnished in ASCs to those
furnished in HOPDs paid under the
OPPS, including examining the
accuracy of the ambulatory payment
classifications (APC) with respect to
surgical procedures furnished in ASCs.
Section 626(d) of Pub. L. 108–173
indicated that the report should include
recommendations on the following
matters:
1. Appropriateness of using groups of
covered services and relative weights
established for the OPPS as the basis of
payment for ASCs.
2. If the OPPS relative weights are
appropriate for this purpose, whether
the ASC payments should be based on
a uniform percentage of the payment
rates or weights under the OPPS, or
should vary, or the weights should be
revised based on specific procedures or
types of services.
3. Whether a geographic adjustment
should be used for ASC payment and,
if so, the labor and nonlabor shares of
such payment.
To compare the relative costs of
procedures performed in ASCs and
HOPDs, the GAO first compiled
information on ASCs’ costs and the
surgical procedures performed. It
conducted a survey of 600 randomly
selected ASCs from the universe of all
ASCs to obtain their CY 2004 cost and
procedure data. The GAO received 397
responses from facilities and, through
data reliability testing, determined that
data from 290 responding facilities were
sufficiently reliable and geographically
representative of ASCs. Furthermore, to
compare the delivery of surgical
procedures and their relative costs
between ASC and HOPD settings, the
GAO analyzed OPPS claims data from
CY 2003. It also interviewed officials at
CMS, representatives from ASC industry
organizations and physician specialty
societies, and representatives from nine
ASCs.
In order to allocate ASCs’ total costs
among the individual procedures they
performed, the GAO developed a
specific methodology to allocate the
portion of an ASC’s costs accounted for
by each procedure. It constructed a
relative weight scale for Medicare’s
covered ASC procedures that captured
the general variation in resources
associated with performing different
procedures. Primarily, it used data that
CMS collects for the purpose of setting
the practice expense component of
PO 00000
Frm 00006
Fmt 4701
Sfmt 4700
physician payment rates, supplemented
by information from specialty societies
and physicians who work for CMS for
those procedures for which CMS had no
data on the resources used.
To calculate per-procedure costs
based upon data gathered through its
survey of ASCs, the GAO deducted costs
that Medicare considers unallowable,
that is, advertising and entertainment
costs. In addition, it also removed costs
for services that Medicare pays for
separately, such as physician and
nonphysician practitioner services. The
remaining facility costs were then
divided into direct and indirect costs.
The GAO defined direct costs as those
associated with the clinical staff,
equipment, and supplies utilized during
the procedure. Indirect costs included
all remaining costs. Next, to allocate
each facility’s direct costs across the
procedures it performed, the GAO
applied its relative weight scale. It
allocated indirect costs equally across
all procedures performed by the facility.
For each procedure performed by a
responding ASC facility, it summed the
allocated direct and indirect costs to
determine a total cost for the procedure.
To obtain a per-procedure cost across all
ASCs, the GAO arrayed the calculated
costs for all ASCs performing that
procedure and identified the median
cost.
To compare per-procedure costs for
ASCs and HOPDs, the GAO obtained the
list of OPPS APCs and their assigned
procedures, along with the OPPS
median cost of each procedure and its
related APC group. It then calculated a
ratio between each procedure’s ASC
median cost as determined by the
survey and the median cost of the
procedure’s corresponding APC group
under the OPPS, referred to as the ASCto-APC cost ratio. It calculated a
corresponding ratio between each ASC
procedure’s median cost under the
OPPS and the median cost of the
procedure’s APC group using CMS data,
referred to as the OPPS-to-APC cost
ratio. In order to evaluate the difference
in procedure costs between the two
settings, the GAO compared the ASC-toAPC cost ratio to the OPPS-to-APC cost
ratio. Next, to assess how well the
relative costs of procedures in the OPPS,
defined by their assignment to APC
groups, reflect the relative costs of
procedures in the ASC setting, it
evaluated the distribution of both the
ASC-to-APC cost ratios and the OPPSto-APC cost ratios.
The GAO also analyzed Medicare
claims data for the top 20 procedures
with the highest Medicare ASC claims
volume in CY 2004 to examine the
delivery of additional services with
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
surgical procedures in ASCs and
HOPDs. Last, to calculate the percentage
of labor-related costs among the
responding ASCs, for each ASC, the
GAO divided total labor costs by total
costs and then determined the range of
the percentage of labor-related costs
among all of the ASCs between the 25th
and the 75th percentile, as well as the
mean and median percentage of laborrelated costs.
Based on its extensive analyses, the
GAO determined that the APC groups in
the OPPS accurately reflect the relative
costs of the procedures performed in
ASCs. GAO’s analysis of the cost ratios
showed that the ASC-to-APC cost ratios
were more tightly distributed around
their median cost ratio than were the
OPPS-to-APC cost ratios. These patterns
demonstrated that the APC groups
reflect the relative costs of procedures
performed by ASCs and, therefore, that
the APC groups could be used as the
basis for an ASC payment system. The
GAO determined, in fact, that there was
less variation in the ASC setting
between individual procedures’ costs
and the costs of their assigned APC
groups than there is in the HOPD
setting. It concluded that, as a group, the
costs of procedures performed in ASCs
have a relatively consistent relationship
with the costs of the APC groups to
which they would be assigned under the
OPPS. The GAO’s analysis also found
that procedures in the ASC setting had
substantially lower costs than those
same procedures in the HOPD. While
ASC costs for individual procedures
varied, in general, the median costs for
procedures were lower in ASCs, relative
to the median costs of their APC groups,
than the median costs for the same
procedures in the HOPD setting. The
median cost ratio among all ASC
procedures was 0.39 (0.84 when
weighted by Medicare volume based on
CY 2004 claims), whereas the median
cost ratio among all OPPS procedures
was 1.04.
The GAO found many similarities in
the additional items and services
provided by ASCs and HOPDs for the
top 20 ASC procedures. However, of
these additional items and services, few
resulted in additional payment in one
setting but not the other. HOPDs were
paid for some of the related services
separately, while in the ASC setting,
other Part B suppliers billed Medicare
and received payment for many of the
related services.
Finally, in its analysis of labor-related
costs, the GAO determined that the
mean labor-related proportion of costs
was 50 percent. The range of the laborrelated costs for the middle 50 percent
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
of responding ASCs was 43 percent to
57 percent of total costs.
Based on its findings from the study,
the GAO recommended that CMS
implement a payment system for
procedures performed in ASCs based on
the OPPS, taking into account the lower
relative costs of procedures performed
in ASCs compared to HOPDs in
determining ASC payment rates.
Comment: A number of commenters
noted that, by the close of the public
comment period for the August 2006
proposed rule for the revised ASC
payment system, the GAO had not yet
provided recommendations regarding
ASC payment in a report to Congress
that it was required to submit by
January 1, 2005. Some commenters
recommended that, although CMS was
directed to take into account these
recommendations in implementing the
revised ASC payment system, should
the GAO’s recommendations be
provided before publication of the final
rule establishing the policies of the
revised ASC payment system, CMS
should not take them into consideration,
given the public’s inability to provide
input to CMS during the comment
period regarding the GAO’s
methodology, findings, and
recommendations. Other commenters
recommended that, if the GAO Report
was forthcoming shortly, CMS should
provide another opportunity for public
comment prior to finalizing the policies
of the revised ASC payment system in
order to allow the public to provide
CMS with their perspectives on those
recommendations.
Response: As described earlier, the
GAO published its report (GAO–07–86)
on November 30, 2006. In accordance
with section 1833(i)(2)(D)(i) of the Act,
we did take into account the
recommendations made in the GAO
Report in developing the final policies
for the revised ASC payment system.
The GAO’s findings and
recommendations are summarized
above, and its specific recommendations
are further discussed in the particular
sections of this final rule that address
the related topics. We appreciate the
public’s interest in providing us with
detailed input regarding the revised
ASC payment system from a variety of
perspectives. In regard to the
commenters’ recommendation for a
second opportunity for public comment
prior to finalizing the policies of the
revised ASC payment system after the
GAO Report was published, we note
that the GAO’s recommendations are in
complete accord with our August 2006
proposal for the revised ASC payment
system. Therefore, we are not providing
another opportunity for public comment
PO 00000
Frm 00007
Fmt 4701
Sfmt 4700
42475
prior to finalizing the policies of the
revised ASC payment system, because
the proposed revised system is fully
consistent with the recommendations of
the GAO Report and we already
provided a 90-day comment period
regarding our proposal for CY 2008. We
believe that the comment period for the
August 2006 proposed rule provided the
public with ample opportunity to
comment on the policies that were
recommended by the GAO. The
considerable operational changes
required to implement the revised ASC
payment system necessitate significant
lead time that would not be possible if
we were to provide another comment
period prior to finalizing the policies.
We also believe that our consideration
of the recent GAO study, as well as
other available information regarding
HOPD and ASC costs and payments, in
addition to our prior discussions with
stakeholders and the many public
comments on the proposed rule, provide
us with the necessary breadth and depth
of information and viewpoints to
finalize our payment policies for the
revised ASC payment system in this
final rule.
At its December 2006 meeting, the
Practicing Physicians Advisory Council
(PPAC) made two recommendations to
CMS regarding the final rule for the
revised ASC payment system. First, the
PPAC recommended that CMS establish
a process to consult with national
medical specialty societies and the ASC
community to develop and adopt a
systematic and adaptable means of fairly
reimbursing ASCs for all safe and
appropriate services, allowing for
changes in technology and current day
practice. Second, the PPAC
recommended that CMS apply any
payment policies uniformly to both
ASCs and HOPDs, as appropriate.
We have considered the GAO Report,
in addition to the recommendations of
the PPAC, all public comments received
on the proposed rule, and other
concerns and issues brought to our
attention by interested parties over the
past several years, in developing this
final rule for the CY 2008 revised ASC
payment system. Specific policies are
discussed, comments summarized and
responses provided, and policies
finalized in subsequent sections of this
final rule.
C. Rulemaking for the Revised ASC
Payment System in CY 2008
In response to comments submitted
timely regarding the proposals set forth
in the proposed rule for the revised ASC
payment system published on August
23, 2006, this final rule establishes the
final policies and regulations of the
E:\FR\FM\02AUR2.SGM
02AUR2
42476
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
revised ASC payment system for initial
implementation in CY 2008. All tables
included in this final rule listing HCPCS
codes subject to pertinent final policies
of the revised ASC payment system, as
well as estimated payment rates, are
illustrative only, based on CY 2007
HCPCS codes and final CY 2007 OPPS
and MPFS information, with application
of the most current update estimates for
CY 2008. The information in the
Addenda to this final rule is also only
illustrative, to provide examples of the
results of applying the final policies of
the revised ASC payment system, based
on the most recent information available
for CY 2007. As further discussed in
sections V.E. and VI. of this final rule,
we will propose the CY 2008 relative
payment weights, payment amounts,
specific HCPCS codes to which the final
policies of the revised ASC payment
system would apply, and other
pertinent ratesetting information for the
CY 2008 revised ASC payment system
in the proposed OPPS/ASC rule to
update the payment systems for CY
2008 to be issued in mid-summer of CY
2007. We will then publish final relative
payment weights, payment amounts,
specific CY 2008 HCPCS codes to which
the final policies will apply, and other
pertinent ratesetting information for the
CY 2008 revised ASC payment system
in the final OPPS/ASC rule to update
the payment systems for CY 2008. The
ASC payment system treatment of new
CY 2008 HCPCS codes published in the
CY 2008 OPPS/ASC final rule will
provide interim determinations, open to
public comment on that final rule, and
we will respond to comments about
those determinations in the OPPS/ASC
final rule for CY 2009.
mstockstill on PROD1PC66 with RULES2
III. Covered Surgical Procedures Paid
in ASCs On or After January 1, 2008
A. Payable Procedures
In its March 2004 Report to the
Congress, the Medicare Payment
Advisory Commission (MedPAC)
recommended replacing the current
‘‘inclusive’’ list of procedures, which
are the only surgical procedures for
which Medicare allows payment to an
ASC, with an ‘‘exclusionary’’ list. That
is, rather than limiting payment to ASCs
to a list of procedures that CMS
specifies, Medicare would allow
payment to ASCs for any surgical
procedure except those that CMS
explicitly excludes from payment.
MedPAC further recommended that
clinical safety standards and the need
for an overnight stay be the only criteria
for excluding a procedure from
eligibility for Medicare ASC payment.
MedPAC suggested that some of the
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
criteria, such as site-of-service volume
and time limits, which we have used in
the past to identify procedures for the
ASC list of covered surgical procedures,
are probably no longer clinically
relevant.
In the August 2006 proposed rule for
the revised ASC payment system, we
noted that we had given careful
consideration to MedPAC’s
recommendations and participated in
considerable discussion and
consultation with members of ASC trade
associations and physicians, who
represent a variety of surgical
specialties, regarding the criteria that we
would use to identify procedures for
payment under the revised ASC
payment system. We agreed that
adoption of a policy similar to that
recommended by MedPAC would serve
both to protect beneficiary safety and
increase beneficiary access to
procedures in appropriate clinical
settings, recognizing the ASC industry’s
interest in obtaining Medicare payment
for a much wider spectrum of services
than is now allowed. Therefore, in the
August 2006 proposed rule (71 FR
49636), we proposed that, under the
revised ASC payment system for
services furnished on or after January 1,
2008, Medicare would allow payment to
ASCs for any surgical procedure
performed in an ASC, except those
surgical procedures that we determine
are not payable under the ASC benefit.
Further, we proposed to establish
beneficiary safety and the expected need
for an overnight stay as the principal
clinical considerations and decisive
factors in determining whether ASC
payment would be allowed for a
particular surgical procedure. As
discussed in section XVIII.B.2. of the
preamble of the proposed rule, we also
proposed to exclude from separate
payment under the revised ASC
payment system those surgical
procedures that are on the OPPS
inpatient list, that are not eligible for
separate payment under the OPPS, and
that are CPT surgical unlisted procedure
codes.
We discuss below the criteria that we
proposed as the basis for identifying
procedures that would pose a significant
safety risk to a Medicare beneficiary
when performed in an ASC, or
procedures following which we would
expect a Medicare beneficiary to require
overnight care.
1. Definition of Surgical Procedure
In order to delineate the scope of
procedures that constitute ‘‘outpatient
surgical procedures’’ in the August 2006
proposed rule, we first proposed to
clarify what we considered to be a
PO 00000
Frm 00008
Fmt 4701
Sfmt 4700
‘‘surgical’’ procedure. Under the
existing ASC payment system, we
define a surgical procedure as any
procedure described within the range of
Category I CPT codes that the CPT
Editorial Panel of the American Medical
Association (AMA) defines as ‘‘surgery’’
(CPT codes 10000 through 69999).
Under the revised payment system, we
proposed to continue to define surgery
using that standard. The CPT Editorial
Panel is responsible for maintaining the
CPT nomenclature, with authority to
revise, update, or modify the CPT codes.
A larger body of CPT advisors, the CPT
Advisory Committee, supports the work
of the CPT Editorial Panel. Members of
the CPT Editorial Panel include
individuals nominated by physician and
hospital associations and insurers,
providing for diverse specialty input.
In addition, in the August 2006
proposed rule for the revised ASC
payment system, we proposed to
include within the scope of surgical
procedures payable in an ASC those
procedures that are described by Level
II HCPCS codes or by Category III CPT
codes that directly crosswalk to or are
clinically similar to procedures in the
CPT surgical range. We proposed to
include all three types of codes in our
definition of surgical procedures
because they all may be eligible for
separate payment under the OPPS and,
to the extent it is reasonable to do so,
we proposed that the revised ASC
payment system parallel the OPPS in its
policies.
In the August 2006 proposed rule, we
provided an example of a Level II
HCPCS code that we believe represents
a procedure that could be safely and
appropriately performed in an ASC,
specifically HCPCS code G0297
(Insertion of single chamber pacing
cardioverter-defibrillator pulse
generator). We developed this Level II
HCPCS code for use in the OPPS
because CPT code 33240 (Insertion of
single or dual chamber pacing
cardioverter-defibrillator pulse
generator), which describes the surgical
insertion of a cardioverter-defibrillator
pulse generator, does not distinguish
insertion of a single chamber
cardioverter-defibrillator generator from
insertion of a dual chamber
cardioverter-defibrillator generator.
Under the OPPS, we were concerned
that different facility resources could be
required for the insertion of these two
types of cardioverter-defibrillator pulse
generators, so we developed Level II
HCPCS codes to permit HOPDs to more
accurately report the resources required
when these surgical procedures are
performed. In instances such as this,
when a Level II HCPCS code is
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
established as a substitute for a CPT
surgical procedure code which does not
adequately describe, from a facility
perspective, the nature of a surgical
service, we proposed to allow payment
for the Level II HCPCS code under the
proposed revised ASC payment system.
We proposed not to allow ASC payment
for Level II HCPCS codes or Category III
CPT codes that describe services that
fall outside the scope of, that is, that do
not correspond to, surgical procedures
described by CPT codes 10000 through
69999.
We recognized in the proposed rule
that continuing to use this definition of
surgery would exclude from ASC
payment certain invasive, ‘‘surgery-like’’
procedures, such as cardiac
catheterization or certain radiation
treatment services which are assigned
codes outside the CPT surgical range.
However, we believed that continuing to
rely on the CPT definition of surgery
would be administratively
straightforward, logically related to the
categorization of services by physician
experts who both establish the codes
and perform the procedures, and
consistent with our proposal to allow
ASC payment for all outpatient surgical
procedures. Given the number of other
changes that we expected to implement
as part of the revised payment system,
along with the significant expansion of
ASC covered surgical procedures that
we proposed, we explained that we
believed it would be prudent at the
outset to continue to define surgery as
it is defined by the CPT code set, which
is used to report services for payment
under both the MPFS and the OPPS.
During the development of the August
2006 proposed rule, we reviewed
thousands of CPT codes in the surgical
range (CPT codes 10000 through 69999),
and we proposed to not exclude from
payment over 750 surgical procedures
previously excluded, in addition to
providing ASC payment for the more
than 2,500 CPT codes on the CY 2007
ASC list of covered surgical procedures.
However, we are cognizant of the
dynamic nature of ambulatory surgery,
which has resulted in a dramatic shift
of services from the inpatient setting to
the outpatient setting over the past two
decades. Therefore, in the proposed
rule, we solicited comments regarding
other services that are invasive and
‘‘surgery-like,’’ which could safely and
appropriately be performed in an ASC,
and which require the resources typical
of an ASC, even though the procedures
are described by codes that fall outside
the range of CPT surgical codes. In
particular, we were interested in
considering commenters’ views
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
regarding what constitutes a ‘‘surgical’’
procedure.
We received many public comments
about our August 2006 proposal to
define the surgical procedures for which
we would make payment to ASCs as
those falling within the surgical code
range specified by the CPT Editorial
Panel.
Comment: While, in general, hospital
associations and device manufacturers
supported the proposal to maintain the
definition of a surgical procedure used
under the existing ASC payment system,
many ASC industry representatives
provided a broad range of suggestions
about how the definition should be
expanded. Some of the commenters
requested that CMS place no limit on
the procedures that would be payable in
ASCs because there is no such limit on
Medicare payments to HOPDs. Other
commenters suggested a more limited
expansion of procedures eligible for
payment under the revised ASC
payment system. These commenters
specifically recommended that CMS
expand its definition of a surgical
procedure to include:
(a) Medical procedures that are
invasive and require general anesthesia
or that are specifically designated as
intraoperative procedures;
(b) X-ray, fluoroscopy, and ultrasound
procedures that require insertion of a
needle, catheter, tube, or probe via a
natural orifice or through the skin;
(c) Radiology procedures integral to
performance of nonradiologic
procedures, performed either during or
immediately following the surgical
procedure; and
(d) Level II HCPCS and Category III
CPT codes that describe procedures that
crosswalk directly or are clinically
similar to those listed in suggestions (a)
through (c) above.
Response: We have given
consideration to the many
recommendations of the commenters. In
general, we continue to believe it is
appropriate to provide payments to
ASCs for the resources associated with
performing those services that are
surgical procedures as defined by the
CPT Editorial Panel. From the Panel’s
broad experience in regularly
addressing the complex issues
associated with new and emerging
health care technologies, as well as the
difficulties encountered with obsolete
procedures, we believe its members are
well-positioned to maintain and refine
the existing coding taxonomy, which
defines certain procedures as surgery, to
appropriately reflect medical practice in
an evolving health care delivery system.
In addition, we believe that our
proposal to pay for surgical procedures
PO 00000
Frm 00009
Fmt 4701
Sfmt 4700
42477
in ASCs that are reported by Level II
HCPCS and Category III CPT codes that
directly crosswalk or are clinically
similar to procedures in the surgical
range of CPT codes that are payable in
ASCs is consistent with our definition
of surgery according to the CPT surgical
code range, while providing ASC
payment for some procedures that have
not yet been categorized by the CPT
Editorial Panel or for which Medicare
recognizes alternative HCPCS codes for
payment.
Although we are not changing our
definition of surgery as suggested by
commenters, we did review procedures
that are coded by specific Level II
HCPCS or Category III CPT codes that
were identified by commenters as
surgical procedures that should be
payable in ASCs. We assessed those
procedures using the same final criteria
discussed in section III.A.2. of this final
rule that we used to evaluate all surgical
procedures for their safety or the
expected need for an overnight stay in
making decisions about their exclusion
from ASC payment. As we proposed, we
also evaluated the codes in the context
of whether they directly crosswalk or
are clinically similar to procedures in
the CPT surgical range that we have
determined do not pose a significant
safety risk or for which an overnight
stay is not expected when performed in
ASCs. As a result of that review, 14
additional Level II HCPCS codes and 15
Category III CPT codes beyond those we
proposed for CY 2008 payment will be
payable as covered surgical procedures
when performed in ASCs beginning in
CY 2008.
Furthermore, as discussed in section
IV. of this final rule, although we are not
expanding our definition of surgical
procedures, we will provide separate
ASC payment for a number of covered
ancillary services when they are
furnished on the same day as a covered
surgical procedure and are integral to
the performance of that procedure in the
ASC setting. Those services include
certain radiology procedures, such as
some fluoroscopy and ultrasound
services, that some commenters
recommended we define as surgical
procedures for addition to the ASC list
of covered surgical procedures.
Comment: Several commenters
expressed concern regarding CMS’
proposed exclusion from ASC payment
of all procedures described within the
range of Category I CPT codes defined
as ‘‘radiology’’ in accordance with the
CPT Editorial Panel designation. The
commenters asserted that regulations
regarding the Federal physician selfreferral prohibition (section 1877 of the
Act) exclude interventional and
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42478
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
intraoperative radiology services from
the definition of ‘‘radiology’’ services
subject to the law’s self-referral
prohibition, and that CMS should,
therefore, treat those services as surgical
services that are eligible for payment as
covered surgical procedures under the
revised ASC payment system. They
believed that interventional radiology
and intraoperative radiology services
that require insertion of a needle,
catheter, tube, probe, or similar device
are appropriately considered surgical in
nature for purposes of ASC payment.
Response: The commenters’
statements with respect to the treatment
of interventional radiology procedures
under the physician self-referral
regulations seem overly broad. The
physician self-referral regulations
provide that the following services
(which may include some, but not all,
interventional radiology procedures) are
not ‘‘radiology and certain other
imaging services’’ for purposes of
section 1877 of the Act: (i) X-ray,
fluoroscopy, or ultrasound procedures
that require the insertion of a needle,
catheter, tube, or probe through the skin
or into a body orifice; and (ii) radiology
procedures that are integral to the
performance of a nonradiological
medical procedure and performed either
during the nonradiological medical
procedure or immediately following the
nonradiological medical procedure
when necessary to confirm placement of
an item inserted during the
nonradiological medical procedure. We
do not believe that Medicare’s exclusion
of specific services from the definition
of ‘‘radiology and certain other imaging
services’’ for purposes of the physician
self-referral prohibition should result in
such services being considered ‘‘surgical
services’’ for purposes of the revised
ASC payment system.
Further, as we explain above, we
believe that the characterization of
procedures as surgery for purposes of
their performance in ASCs is best left to
the expertise of the CPT Editorial Panel.
We do not believe that services
designated as radiology services by the
CPT Editorial Panel are appropriately
classified as covered surgical
procedures in ASCs, facilities that
specialize in the delivery of ambulatory
surgical services. However, as discussed
further in section IV.C.2. of this final
rule, we do believe that it is appropriate
to provide separate ASC payment for
certain ancillary services that are
integral to the covered surgical
procedures. Thus, we will provide
separate payment to ASCs under the
revised payment system for radiology
services that are integral to the
performance of an ASC covered surgical
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
procedure when that radiology
procedure is one of those for which
separate payment is made under the
OPPS. That is, separate payment will be
made for covered ancillary radiology
services integral to covered surgical
procedures that are provided in the ASC
immediately before, during, or
immediately following the surgical
procedure.
After consideration of the public
comments we received, we are
finalizing our proposal to define surgery
as those procedures described by CPT
codes within the surgical range of 10000
through 69999, without modification. In
addition, we are including within our
definition of a covered surgical
procedure payable in the ASC setting
those Level II HCPCS codes or Category
III CPT codes that directly crosswalk or
are clinically similar to procedures in
the CPT surgical range that we have
determined do not pose a significant
safety risk, that we would not expect to
require an overnight stay when
performed in ASCs, and that are
separately paid under the OPPS. An
illustrative list of covered surgical
procedures under the revised ASC
payment system, including Category I
and Category III CPT codes and Level II
HCPCS codes, can be found in
Addendum AA to this final rule. An
illustrative list of radiology services and
other covered ancillary services that are
eligible for separate ASC payment when
provided integral to an ASC covered
surgical procedure on the same day is
located in Addendum BB to this final
rule.
2. Procedures Excluded From Payment
Under the Revised ASC Payment
System
As stated above, in the August 2006
proposed rule for the revised ASC
payment system, we proposed to allow
payment to ASCs for all procedures
described by CPT codes within the
surgical range of 10000 through 69999,
or by Level II HCPCS codes or Category
III CPT codes that directly crosswalk or
are clinically similar to procedures in
the CPT surgical range, that do not pose
a significant safety risk to Medicare
beneficiaries and that are not expected
to require an overnight stay. Having
established what we consider to be a
‘‘surgical procedure,’’ we next
considered criteria that would enable us
to identify procedures that could pose a
significant safety risk when performed
in an ASC or that we expect would
require an overnight stay within the
bounds of prevailing medical practice.
We discuss in the next section how we
proposed to identify procedures that
could pose a significant safety risk.
PO 00000
Frm 00010
Fmt 4701
Sfmt 4700
a. Significant Safety Risk
First, we proposed to exclude from
ASC payment any procedure that is
included on the current OPPS inpatient
list, that is, those procedures designated
as requiring inpatient care under
§ 419.22(n). (See Addendum E to the CY
2007 OPPS/ASC final rule with
comment period (71 FR 68385 through
68398).) The procedures included on
that list are typically performed in the
hospital inpatient setting due to the
nature of the procedure, the need for at
least 24 hours of postoperative recovery
time or monitoring before the patient
can be safely discharged, or the
underlying physical condition of the
patient. We believed that any procedure
for which we did not allow payment in
the hospital outpatient setting due to
safety concerns would not be safe to
perform in an ASC.
Second, we proposed to exclude from
ASC payment procedures that the CY
2005 Part B Extract Summary System
(BESS) data indicated were performed
80 percent or more of the time in the
hospital inpatient setting, even if those
procedures were not included on the
OPPS inpatient list. We selected an 80percent threshold because we believed
that an 80-percent level of inpatient
performance was a fair indicator that a
procedure is most appropriately
performed on an inpatient basis and, as
such, would pose a significant safety
risk for Medicare beneficiaries if
performed in an ASC. We believed that
procedures with inpatient utilization
frequencies above the proposed
threshold were complex and were likely
to require a longer and more intensive
level of care postoperatively than what
is provided in a typical ASC. We also
believed that performing these
procedures in an ASC, where immediate
access to the full resources of an acute
care hospital is not the norm, would
pose a significant safety risk for
beneficiaries.
Third, we proposed to retain some of
the specific criteria for evaluating safety
risks that are listed in § 416.65(b)(3) of
our existing regulations. Procedures that
involve major blood vessels, major or
prolonged invasion of body cavities,
extensive blood loss, or are emergent or
life-threatening in nature could, by
definition, pose a significant safety risk.
Therefore, we proposed to exclude from
ASC payment surgical procedures that
may be expected to involve any of these
characteristics, based on evaluation by
our medical advisors. We noted that
most of the procedures that our medical
advisors identified as involving any of
the characteristics listed in
§ 416.65(b)(3) also require overnight or
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
inpatient stays, reinforcing our belief
that they should be excluded from ASC
payment.
Finally, we proposed not to continue
applying under the proposed revised
system the current time-based,
prescriptive criteria at §§ 416.65(b)(1)
and (b)(2), which exclude from the ASC
list procedures that exceed 90 minutes
of operating time or 4 hours of recovery
time or 90 minutes of anesthesia. We
believed these criteria were no longer
clinically appropriate for purposes of
defining a significant safety risk for
surgical procedures.
We indicated that, in light of the
proposed changes for evaluating
procedures to identify those that pose a
significant safety risk for beneficiaries
when performed in ASCs, we believed
that it would not be appropriate to
apply the existing standard at
§ 416.65(a)(1), which states that covered
surgical procedures are those that are
commonly performed on an inpatient
basis but may be safely performed in an
ASC, because this standard is no longer
relevant to prevailing medical practice
in the realm of ambulatory or outpatient
surgery. Similarly, we believed that it
would not be appropriate to continue
applying the existing standard at
§ 416.65(a)(2), which states that
procedures performed in an ASC are not
of a type that are commonly performed,
or that may be performed, in a
physician’s office. This standard did not
seem relevant within the context of the
proposal only to exclude from ASC
payment under the revised payment
system those surgical procedures that
pose a safety risk or are expected to
require an overnight stay. We would
expect the types of surgical procedures
that are commonly performed or that
may be performed in a physician’s office
to pose no significant safety risk and to
require no overnight stay.
We proposed to add new Subpart F to
42 CFR Part 416 to reflect coverage,
scope, and payment for ASC services
under the revised payment system.
Included in the changes would be new
§ 416.166 to reflect the changes that we
proposed to our current policy for
evaluating and identifying those
procedures that would pose a significant
safety risk for beneficiaries and would
be excluded from our list of ASC
covered surgical procedures beginning
January 1, 2008. To set the provisions
that are applicable to our existing ASC
payment system apart from those that
would apply to the revised ASC
payment system, as we proposed, in the
CY 2007 OPPS/ASC final rule with
comment period, we revised the section
headings of Subparts D and E of Part
416 to clearly denote the provisions that
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
govern covered surgical procedures
furnished before January 1, 2008. We
also added §§ 416.76 and 416.121 to
clearly denote the effective dates of
Subparts D and E (71 FR 68226).
Comment: Commenters provided
many recommendations regarding the
proposed criteria for evaluating which
procedures should be excluded from the
ASC list of covered surgical procedures
that varied greatly. At one end of the
spectrum, some commenters
recommended that CMS only exclude
from ASC payment those procedures
that are included on the ‘‘inpatient list’’
used under the OPPS. They believed
that all procedures not on the OPPS
inpatient list are safe for performance in
ASCs and that, by the specification of
their payable status under the OPPS,
they do not require an overnight stay.
Some commenters suggested that
CMS create the ASC exclusionary list by
individually reviewing surgical
procedures based upon data that
demonstrate the risks, complications,
and overall safety of a given procedure,
rather than attempting to specifically
apply the standards of the proposed
criteria. They believed that health
outcomes databases, including the
National Surgical Quality Improvement
Project and patient and device registries,
could provide further information to
refine an initial safety assessment based
on the proposed criteria when certain
procedures were identified as needing
further consideration and evaluation.
The commenters recommended this
flexible and specific approach to allow
for full consideration of the surgical
aspects of each procedure, in order to
make an appropriate determination
regarding its safety for ASC
performance. The commenters believed
CMS could work with surgical
professional associations and external
surgical experts to facilitate a smooth
and efficient clinical review process.
In contrast, other commenters
recommended that CMS implement
more stringent review criteria than our
criteria under the existing payment
system for evaluating which procedures
are unsafe for performance in ASCs.
They believed that beneficiary safety
could be better protected if CMS would
adopt review criteria that would
exclude more procedures from ASC
performance than those criteria
currently in place, while maintaining
the existing limitations on operating and
recovery room times.
Response: We believe that both ends
of the spectrum of public comments are
inconsistent with our goal of only
excluding those procedures from ASC
payment that are unsafe for performance
in ASCs or are expected to require an
PO 00000
Frm 00011
Fmt 4701
Sfmt 4700
42479
overnight stay. We agree with the
perspective of most commenters that
procedures on the OPPS inpatient list
should also be excluded from ASC
payment. However, while we strongly
disagree with the contention by some
commenters that all procedures
performed in HOPDs are appropriate for
performance in ASCs, we also believe
that instituting criteria that are more
restrictive than those currently in place
would be inappropriate, because we do
not have safety concerns regarding
procedures that are already included on
the ASC list of covered surgical
procedures.
Typically, HOPDs are able to provide
much higher acuity care than ASCs.
ASCs have neither patient safety
standards consistent with those in place
for hospitals, nor are they required to
have the trained staff and equipment
needed to provide the breadth and
intensity of care that hospitals are
required to maintain. According to
current CMS standards, hospitals must
meet numerous documentation,
infection prevention, and patient
assessment requirements that are not
applied to ASCs. Therefore, there are
some procedures that we believe may be
appropriately provided in the HOPD
setting that are unsafe for performance
in ASCs. Thus, we are not adopting a
final policy to exclude only those
surgical procedures on the OPPS
inpatient list from ASC payment under
the revised payment system.
Nonetheless, as stated in our August
2006 proposal and consistent with
MedPAC recommendations, we are
committed to revising the ASC list of
covered surgical procedures so that it
excludes only those surgical procedures
that pose significant safety risks to
beneficiaries or that are expected to
require an overnight stay. We believe
that adoption of a policy similar to that
recommended by MedPAC would serve
both to protect beneficiary safety and
increase beneficiary access to surgical
procedures in appropriate clinical
settings. We also believe that this
approach is most consistent with the
PPAC’s recommendation that we
provide payment under the revised ASC
payment system for all safe and
appropriate services. Thus, we do not
believe that it would be appropriate to
implement more restrictive criteria for
evaluating procedures for exclusion
from ASC payment or even to maintain
all of the current criteria that we use
under the existing payment system to
evaluate the appropriateness of
including procedures on the ASC list.
We continue to believe the current
limitations on operating room and
recovery room times for ASC procedures
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42480
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
are no longer clinically relevant to
assessing the safety risk of surgical
procedures. Our comprehensive review
of all surgical procedures has convinced
us that there are procedures in addition
to those included on the CY 2007 ASC
list of covered surgical procedures that
may be safely performed in ASCs, and
that increasing the number and types of
procedures for which Medicare provides
ASC payment is appropriate.
Regarding our proposed overall
approach to evaluating procedures for
exclusion from the ASC list of covered
surgical procedures, we believe that our
evaluation process is generally
consistent with the approach advised by
some commenters that we apply the
proposed criteria as part of an initial
safety assessment, and then conduct
procedure-specific analyses of possible
risks and complications of individual
procedures based on available data. In
preparing the proposal for the revised
ASC payment system, we reviewed each
surgical procedure that is separately
payable under the OPPS and not already
on the CY 2007 ASC list and with
inpatient utilization of less than 80
percent against the proposed safety and
overnight stay criteria and identified a
subset of procedures for further
assessment if we had concerns about
their potential safety risk. We then used
all of the information available to us to
arrive at a preliminary determination
regarding each procedure’s suitability
for payment in the ASC setting. These
preliminary determinations constituted
our proposed treatment of the
procedures under the revised ASC
payment system, and the status of the
codes was open to public comment in
the August 2006 proposed rule. We
received detailed information and
recommendations from many
commenters, including hospitals, ASCs,
device manufacturers, and physician
specialty organizations, as well as
physician experts, regarding the
proposed treatment of many surgical
procedure codes. Summaries of these
comments and our responses follow
later in this section of this final rule.
Comment: A number of commenters
expressed concerns about the safety
implications of a greatly expanded list
of surgical procedures to be performed
in ASCs. They advocated
implementation of specific additional
measures for tightening and
strengthening the criteria we proposed
to use to evaluate the potential for
beneficiary risk associated with surgical
procedures. Included in the
commenters’ numerous
recommendations were the following
comments:
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
(1) Make no changes to the current
criteria until the ASC Conditions for
Coverage are revised to ensure that
patient protections comparable to those
in place in hospitals are in place in
ASCs.
(2) Apply the existing and proposed
criterion to exclude procedures from the
ASC list that involve major blood
vessels, by adopting a specific list of
blood vessels that CMS defines as major
blood vessels, in order to provide more
certainty about which procedures would
be excluded. Some commenters
recommended that CMS adopt the
definition of a major blood vessel
advanced in a medical textbook,
Essentials of Anatomy & Physiology, 6th
Edition, by Seeley, Stephens and Tate.
For procedures that involve blood
vessels defined by Seeley, et al., as
major, but that are already being
performed safely in ASCs (for example,
CPT code 36870, Thrombectomy,
percutaneous, arteriovenous fistula,
autogenous or nonautogenous graft
(includes mechanical thrombus
extraction and intra-graft thrombolysis)),
the commenters suggested that CMS
retain them as ASC covered surgical
procedures, thereby allowing their
continued payment when performed in
ASCs.
(3) Apply the existing and proposed
criterion to exclude from ASC payment
those procedures requiring major or
prolonged invasion of body cavities, by
defining ‘‘prolonged’’ invasion as
referring to any procedure in which the
patient is under anesthesia for 90
minutes or longer, and expand the
definition of body cavity to include
major blood vessels.
(4) Exclude from ASC payment
procedures that commonly require
systemic thrombolytic therapy. Some
commenters recommended that CMS
exclude procedures that involve blood
vessels that, if occluded, would require
inpatient lytic therapy, while other
commenters recommended more
generally that CMS exclude procedures
that may result in a patient’s need for
lytic therapy. Lytic or inpatient
thrombolytic therapy as used in this
context both refer to systemic
thrombolytic therapy.
(5) Disallow procedures that require
puncturing of the femoral vessels for
access. Some commenters
recommended that this exclusion be for
procedures accessing either the femoral
artery or the femoral vein, while other
commenters would have limited the
exclusion to only those procedures
requiring femoral arterial access.
(6) Implement a quantitative measure
(greater than or equal to 15 percent of
total blood volume) to define the
PO 00000
Frm 00012
Fmt 4701
Sfmt 4700
existing and proposed criterion to
exclude from the list procedures that
generally result in extensive blood loss.
(7) Use a 50-percent inpatient
threshold for excluding procedures from
the ASC list instead of the proposed 80percent threshold. While some
commenters recommended lowering the
proposed threshold for exclusion of
procedures from the ASC list from 80
percent to 50 percent, several other
commenters suggested that CMS should
not apply a specific numerical threshold
of inpatient utilization at all to its
evaluation of procedure safety. They
noted that this could have the
unintended effect of automatically
excluding some procedures from ASC
payment simply because of limited data
indicating their performance slightly
more than 80 percent of the time in the
inpatient setting, while data for
clinically similar codes reflected
inpatient performance slightly less than
the 80-percent threshold. Instead, these
commenters recommended that we
evaluate each surgical procedure with
respect to the other proposed criteria,
based on the clinical characteristics of
the procedure itself. The group of
commenters recommending
establishment of a lower threshold of 50
percent believed that this modified
standard would better enable us to
identify procedures that are typically
clinically complex and have a higher
risk of complications and extensive
postoperative care. They suggested that
setting the threshold at 50 percent
would ensure that procedures
performed the majority of time in the
inpatient setting would be excluded
from ASC payment.
(8) Require that patients be assessed
for comorbidities and anesthesia risk
using the American Society of
Anesthesiologists’ tool, and those
patients who are high risk, such as
patients over age 85 or with morbid
obesity, should be required to go to
hospital settings for surgical procedures.
(9) Identify and implement outcome
and process measures to assess aspects
of quality across care settings, including
ASCs. To develop those measures, some
commenters suggested that CMS work
closely with the Hospital Quality
Alliance (HQA) and the Ambulatory
Quality Alliance (AQA) (formerly both
organizations were known as the AQA).
The HQA has already begun to include
the measures of care used in the
Surgical Care Improvement Project, and
some commenters believed that the goal
of preventing complications in the care
of surgical patients provides an
appropriate starting point for
determining the correct measures for
assessing important aspects of the safety
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
and quality of all types of ambulatory
surgery.
Response: We appreciate the
commenters’ concerns regarding
beneficiary safety and gave
consideration to each of the individual
recommendations listed above. We
respond to each of these individually as
follows:
(1) Maintain the current procedure
review criteria until after the ASC
Conditions for Coverage are revised.
We do not believe that postponing
revisions to our review criteria until
after the ASC Conditions for Coverage
are revised is warranted. We cannot
predict when those revisions will be
issued, and we are confident that the
criteria we will use to evaluate
procedures for exclusion from the list of
covered surgical procedures under the
revised ASC payment system are
appropriate and serve to protect
beneficiary safety in the current
environment.
(2) Specifically adopt a defined list of
‘‘major blood vessels.’’
As we stated earlier, we believe it is
important to maintain flexibility in our
review of procedures for safe
performance in the ASC setting,
consistent with our past practice
regarding this criterion. As noted by
commenters requesting a specific
definition of this criterion, there are
some procedures already on the ASC list
that are being safely performed in ASCs
and that involve vessels that would be
defined as major according to the
recommendations of some commenters.
We do not agree with these commenters
that it would be logical or clinically
consistent for us to adopt a specific
definition of major blood vessels to
evaluate procedures for exclusion from
ASC payment, yet still continue to
provide ASC payment for procedures
that would otherwise be excluded,
except for their history of safe
performance in ASCs. We believe the
involvement of major blood vessels is
best considered in the context of the
clinical characteristics of individual
procedures, as recommended by other
commenters, and see no need to adopt
a defined list of major blood vessels.
(3) Define prolonged invasion of a
body cavity as any procedure in which
the patient is under anesthesia for 90
minutes or longer, and expand the
definition of body cavity to include
major blood vessels.
We do not believe that considering
major blood vessels to be included in
the definition of a body cavity is
clinically sensible, based on the general
medical understanding of the terms. In
addition, we already have a separate
safety review criterion regarding major
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
blood vessels, and we believe that
evaluation of the safety of procedures
involving major blood vessels will
continue to be appropriately assessed
using that criterion. We also do not
believe that prolonged invasion should
be defined as anesthesia for 90 minutes
or longer. There are surgical procedures
that require more than 90 minutes that
do not invade a major body cavity at all,
and maintaining that time-based
restriction would be contrary to the
recommendations of MedPAC and
current clinical practice. We believe the
criterion regarding major or prolonged
invasion of body cavities is most
appropriately evaluated through a
flexible review approach, consistent
with our past practice, in which we
consider the criterion and its
relationship to each specific surgical
procedure. Therefore, we are not
expanding the current criterion
regarding invasion of a body cavity to
include the length of time the
beneficiary will be under anesthesia or
to incorporate major blood vessels.
(4) Exclude from ASC payment
procedures that commonly require
systemic thrombolytic therapy.
We agree with the commenters that
systemic thrombolytic therapy is unsafe
for performance in ASCs. Systemic
thrombolytic therapy involves
significant clinical risks and is not an
appropriate procedure for initiation in
ASCs if its use is anticipated. We have
historically considered in our clinical
evaluation of the safety of procedures
for performance in ASCs the likely need
for systemic thrombolytic therapy in
association with a surgical procedure,
but we have never previously made that
an explicit safety review criterion. We
agree with the commenters that it
should be a specific criterion for
evaluation of procedure safety.
Therefore, we are making it explicit that
the final criteria used to evaluate the
safety of procedures for performance in
ASCs at § 416.166(c)(5) include the
criterion that covered surgical
procedures may not be of a type where
systemic thrombolytic therapy would
commonly be required.
(5) Exclude procedures that require
use of the femoral vessels for access.
We do not agree with some
commenters’ position that excluding all
procedures that involve the femoral
vessels is reasonable or necessary to
ensure the patient safety of surgical
procedures performed in ASCs. Other
commenters stated that there are
instances in which the performance of
procedures may require use of femoral
vessels due to the beneficiary’s
particular physical condition. For
example, a beneficiary who has
PO 00000
Frm 00013
Fmt 4701
Sfmt 4700
42481
experienced prolonged exposure to
vascular sclerosing agents (such as
chemotherapy) or has been on
hemodialysis for many years may not
have upper body peripheral blood
vessels that are adequate even to
support the basic intravenous access
required during any surgical procedure
performed under general anesthesia. In
such a case, the surgeon may need to
use the femoral vein just to provide
routine intravenous access during
surgery. In other cases, the use of the
femoral vessels may be required for
certain surgical procedures. For
instance, the femoral blood vessels may
be accessed to create an arteriovenous
fistula for hemodialysis using a graft, as
described by CPT code 36825 (Creation
of arteriovenous fistula by other than
direct arteriovenous anastomosis
(separate procedure); autogenous graft)
or CPT code 36830 (Creation of
arteriovenous fistula by other than
direct arteriovenous anastomosis
(separate procedure); nonautogenous
graft (e.g., biological collagen,
thermoplastic graft)). Both of these
procedures that may directly involve the
femoral vessels have been on the list of
covered ASC procedures since before
July 2000, and we have no concerns
about their safe performance in ASCs.
We do not believe that it makes clinical
sense to prohibit use of the femoral
vessels in ASC procedures, knowing
that they may be needed in any number
of situations and that femoral access has
been safely achieved in ASCs for years.
We believe that our process for clinical
review of individual procedures, during
which our medical advisors consider
the specific performance characteristics
of a particular surgical procedure, is the
most appropriate method for ensuring
that procedures that pose a significant
safety risk are excluded from ASC
payment. As evidenced by the history of
safe performance in ASCs of some
procedures that utilize femoral access,
we agree with the commenters who
believe that it is the specific surgical
procedure, rather than the method of
vascular access, that must be fully
evaluated to assess a procedure’s safety
in ASCs.
(6) Adopt a quantitative definition of
‘‘extensive blood loss.’’
We do not believe that the
recommendation by some commenters
that we revise the criteria used to
evaluate procedures for exclusion from
the ASC list by quantifying extensive
blood loss is necessary or advisable. The
existing and proposed criterion related
to blood loss requires exclusion of
procedures that ‘‘generally result in
extensive blood loss’’ (42 CFR
416.65(b)(3)(i) and 42 CFR 416.166(c)(1),
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42482
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
respectively), and we have historically
evaluated this criterion in considering
surgical procedures for ASC payment.
We do not believe that identifying a
specific amount of blood loss that is
considered by some to be ‘‘extensive’’
would improve our clinical review
regarding procedural safety. For most
surgical procedures, specific estimates
of expected blood loss are not available,
and we do not believe that a discussion
of whether or not a procedure generally
results in a loss of 14 percent versus 16
percent of a beneficiary’s blood volume
would be clinically meaningful and
contribute to our ability to evaluate a
surgical procedure’s potential for safe
performance in ASCs.
(7) Adopt a 50-percent inpatient
utilization threshold for exclusion of
procedures from the ASC list.
We reexamined our proposal to
exclude all procedures from ASC
payment that are performed in the
inpatient setting 80 percent or more of
the time. Although the
recommendations of some commenters
advocated using a lower threshold to
exclude more procedures from ASC
payment, we confirmed that using any
relatively arbitrary threshold resulted in
unintended inconsistencies in the
treatment of clinically similar
procedures. There were several
instances in which one procedure in a
clinical family would be excluded from
ASC payment based on its inpatient
utilization of just slightly over 80
percent, whereas our clinical review of
other members of the family indicated
that those procedures were safe for
performance in ASCs, with inpatient
utilization of slightly less than 80
percent. For example, we proposed to
exclude CPT codes 33207 (Insertion or
replacement of permanent pacemaker
with transvenous electrode(s);
ventricular) and 33208 (Insertion or
replacement of permanent pacemaker
with transvenous electrode(s); atrial and
ventricular) from ASC payment under
the revised payment system because the
inpatient utilization for those
procedures was higher than 80 percent
and, therefore, we did not specifically
review the procedures to assess their
clinical safety or need for an overnight
stay before proposing to exclude them.
We did not propose to exclude CPT
code 33206 (Insertion or replacement of
permanent pacemaker with transvenous
electrode(s); atrial), the other procedure
in the same family of codes as CPT
codes 33207 and 33208, because the
inpatient utilization for that procedure
was somewhat lower than 80 percent,
and our clinical review, based on the
other safety and overnight stay criteria
proposed for the revised ASC payment
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
system, led to our belief that it was
appropriate for performance in ASCs.
When we performed a clinical review of
CPT codes 33207 and 33208 in order to
respond to public comments, we
determined that CPT codes 33207 and
33208 do not pose a significant risk to
beneficiary safety and are not expected
to require an overnight stay, so they are
appropriate for performance in ASCs,
along with CPT code 33206. Therefore,
we have removed both CPT codes 33207
and 33208 from the list of excluded
procedures for the revised ASC payment
system. We are also, as proposed, not
excluding CPT code 33206 from
eligibility for ASC payment. This more
flexible approach, without application
of a specific inpatient utilization
threshold, allows us to treat the
individual members of the same family
of procedures consistently as a
clinically coherent group, while
considering them in the context of our
final safety and overnight stay criteria
for the revised ASC payment system.
We also identified a number of
surgical procedures with high Medicare
inpatient utilization because, most of
the time, the procedures are performed
with other surgical procedures for
beneficiaries who are hospital
inpatients. Thus, although the data
reflect high inpatient utilization, the
procedures themselves are not unsafe
for ASC performance, nor do they
typically require an overnight stay.
Specifically, commenters argued that
the high inpatient utilization of CPT
code 64447 (Injection, anesthetic agent;
femoral nerve, single) was due to its
frequent use during inpatient surgical
procedures, whereas the injection may
also be performed safely in ASCs on its
own as an ambulatory pain management
intervention. They believed that using
the inpatient utilization as the basis for
the exclusion of this procedure from
ASC payment was unfair because we
should evaluate the procedure itself
specifically based upon its clinical
characteristics, rather than based upon
utilization data which could be
misleading with respect to the
procedure’s potential for safe
performance in the ASC setting. Our
clinical review of CPT code 64447, in
response to comments, convinced us
that it would clearly not pose a
significant safety risk or be expected to
require an overnight stay when
performed in ASCs and should not be
excluded from the list of covered
surgical procedures under the revised
ASC payment system.
Therefore, we concluded that, in the
cases of CPT codes 33207, 33208, and
64447, the utilization data alone could
not be relied upon to support a decision
PO 00000
Frm 00014
Fmt 4701
Sfmt 4700
to exclude these procedures from ASC
payment and, as evidenced by our
proposed list of excluded procedures,
there were many procedures paid under
the OPPS that were not performed more
than 80 percent of the time on an
inpatient basis but that were proposed
for exclusion from ASC payment
because of their safety risk or expected
need for an overnight stay. Therefore,
for this final rule, we evaluated each of
the procedures that we had proposed for
exclusion from ASC payment based on
inpatient utilization of 80 percent or
more and made separate determinations
about the safety and need for an
overnight stay for each of those
procedures using all available
information, as we did for all other
procedures in the surgical range of the
CPT code set.
Thus, while we proposed an 80percent inpatient utilization threshold
as one criterion for excluding surgical
procedures from ASC payment, we now
believe that we will reach more
appropriate, clinically consistent
decisions regarding procedures for
exclusion from ASC payment by not
adopting any specific numerical
threshold for inpatient utilization that
would automatically exclude surgical
procedures from ASC payment. Rather
than institute a definite threshold for
inpatient utilization, we will examine
all the clinical information regarding a
surgical procedure, including its
inpatient utilization, to determine
whether or not a procedure would pose
a significant risk to beneficiary safety or
would be expected to require an
overnight stay if performed in an ASC.
We will not make final our proposal to
exclude procedures from the ASC list of
covered surgical procedures based
solely on their inpatient utilization of 80
percent or more.
(8) Require beneficiary assessment of
individual surgical risk and do not
permit high risk patients to receive ASC
services.
We do not believe that it would be
appropriate to accept the commenters’
recommendation that patients with
certain specified demographic
characteristics or comorbidities be
automatically excluded from being
considered for surgery within an ASC.
The recommendation would require
ASCs to deny services to individual
beneficiaries who are found, based on
an appraisal through a specific
assessment tool, to have a high level of
risk. Section 416.2 defines an ASC as
providing surgical services to patients
not requiring hospitalization. Thus,
ASCs must ensure that each patient is
assessed for relevant risk factors by the
physician prior to performing the
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
surgical procedure, in order to screen
out patients who are likely to require
hospitalization in connection with the
planned procedure. We require
physicians to make these assessments as
a part of their decisions regarding where
to perform a surgical procedure for
specific Medicare beneficiaries, prior to
referring them to facilities for those
surgical procedures. The ASC
Conditions for Coverage specifically
state in § 416.42(a) that ‘‘a physician
must examine the patient immediately
before surgery to evaluate the risk of
anesthesia and of the procedure to be
performed.’’ In addition, we protect
Medicare beneficiary safety through our
process of excluding procedures from
ASC payment that pose a significant
safety risk for the typical Medicare
patient. In summary, we do not believe
that it is necessary or appropriate for
CMS to mandate that ASCs use a
specific assessment tool in conducting
these required beneficiary assessments.
(9) Identify and implement outcome
and process measures in ASCs to assess
quality of care.
We will take into consideration for
future action the recommendation by
some commenters that we identify and
implement outcome and process
measures to assess aspects of quality of
care across settings, including ASCs,
taking into consideration our final
policy for the CY 2009 OPPS that will
require hospitals to meet quality
reporting standards to receive the full
OPPS update (71 FR 68189). We agree
that this could be an appropriate next
step and is consistent with CMS’’
policies being implemented in other
beneficiary care settings. In fact, section
109(b) of the Medicare Improvements
and Extension Act under Division B of
the Tax Relief and Health Care Act of
2006, Public Law 109–432, enacted on
December 20, 2006, specifies that the
Secretary may require that in order to
receive the full annual payment update,
ASCs must report data on selected
measures of quality. The provisions for
ASC services are to apply in a manner
similar to which they apply to hospital
outpatient services, effective January 1,
2009.
After considering the public
comments received, we are finalizing
our proposal, with modification, to
exclude from ASC payment all surgical
procedures that could pose a significant
safety risk to Medicare beneficiaries or
are expected to require an overnight
stay. The criteria to be used to identify
procedures that could pose a significant
safety risk when performed in an ASC
include those surgical procedures that:
generally result in extensive blood loss;
require major or prolonged invasion of
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
body cavities; directly involve major
blood vessels; are emergent or lifethreatening in nature; commonly require
systemic thrombolytic therapy; are
designated as requiring inpatient care
under § 419.22(n); can only be reported
using a CPT unlisted surgical procedure
code (see section III.B. of this final rule
for further discussion); or are otherwise
excluded under § 411.15. We are not
adopting the specific 80-percent
inpatient utilization threshold that we
proposed for exclusion of surgical
procedures from ASC payment. The
final revised policy regarding covered
surgical procedures is set forth in
§ 416.166 of this final rule, effective
January 1, 2008.
b. Overnight Stay
A longstanding criterion for
determining which procedures are
appropriate for inclusion on the ASC
list of covered surgical procedures has
been that the procedures on the list do
not require an extended recovery time.
Section 416.65(a)(3) of the regulations
provides that ASC procedures ‘‘[a]re
limited to those requiring a dedicated
operating room (or suite), and generally
requiring a postoperative recovery room
or short-term (not overnight)
convalescent room.’’ Under
§ 416.65(b)(1)(ii), we have historically
considered procedures that require more
than 4 hours of recovery or convalescent
time to be inappropriately performed in
the ASC.
We have heard many differing
opinions of what constitutes an
‘‘overnight’’ stay, ranging from ‘‘more
than 24 hours’’ to time spent in recovery
after sunset. After deliberation and
consideration of several options, in the
August 2006 proposed rule for the
revised ASC payment system, we
proposed to exclude from ASC payment
any procedure for which prevailing
medical practice dictates that the
beneficiary would typically be expected
to require active medical monitoring
and care at midnight following the
procedure (hereinafter ‘‘overnight
stay’’). During the development of the
August 2006 proposed rule, our clinical
staff evaluated each surgical procedure
using available claims and physician
pricing data, as well as their clinical
judgment, to determine which
procedures would be expected to
require monitoring at midnight of the
day on which the surgical procedure
was performed.
We proposed to use midnight as the
defining measure of an overnight stay
for several reasons. First, a patient’s
location at midnight is a generally
accepted standard for determining his or
her status as a hospital inpatient or
PO 00000
Frm 00015
Fmt 4701
Sfmt 4700
42483
skilled nursing facility patient and as
such, it seems reasonable to apply the
same standard in the ASC setting.
Second, overnight care is not within the
scope of ASC services for which
Medicare makes payment. The
expectation is that surgical procedures
performed in an ASC are ambulatory in
nature; that is, patients undergoing a
procedure in an ASC will recover from
anesthesia and return home on the same
day that they report to the ASC for a
scheduled procedure. Finally, the
expected need for monitoring at
midnight is a straightforward and easily
understood defining measure of
‘‘overnight stay.’’ We proposed to add
the requirement that procedures will
typically not be expected to require
active medical monitoring and care at
midnight following the procedure to
proposed new § 416.166(c)(5).
Comment: Some commenters
recommended that CMS use ‘‘less than
24 hours’’ as the definition of an
overnight stay. Several of the
commenters stated that the same 24hour postoperative recovery standard
that applies in HOPDs should apply in
ASCs. One commenter stated that CMS’
definition of overnight stay related to
survey and certification for ASCs is a
planned stay of over 24 hours and, that
conversely, when the ‘‘length of stay is
less than 24 hours, it is not considered
an overnight stay.’’ Further, several
commenters noted that a number of
States allow ASCs to perform
procedures that require stays of up to 23
or 24 hours.
One commenter group argued that the
terms ‘‘ambulatory’’ and ‘‘outpatient’’
surgery describe the same kind of care,
and that the same 24-hour postoperative
recovery standard should apply in both
ASC and HOPD settings. Some
commenters suggested that, if CMS
allowed all procedures that are
performed in HOPDs to be performed in
ASCs, no specific definition of
overnight stay would be required
because any procedure paid under the
OPPS would be presumed to require no
overnight stay and that the same
assumption should be applied to ASCs.
A number of other commenters agreed
with our proposal that procedures
requiring an overnight stay should not
be performed in an ASC and specifically
endorsed our definition of overnight
stay. They also believed that the
proposed definition is consistent with
other accepted definitions and
standards of the term.
Several commenters believed that our
proposal, if adopted, would require
ASCs performing and billing covered
surgical procedures to transfer patients
to other facilities if the recovery of
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42484
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
individual patients extended beyond
midnight on the day of the procedure,
in order to receive payment under the
revised ASC payment system. Other
commenters expressed concern that
procedures performed later in the day in
ASCs would be treated differently for
purposes of ASC payment than those
procedures that were performed in the
morning, in terms of allowing for
adequate recovery time.
Response: We want to clarify our
proposal to use the expected need for
medical monitoring at midnight
following the performance of a
procedure as a consideration in
determining whether a surgical
procedure should be excluded from
ASC payment. Our proposal does not
affect the distinct care ASCs may
provide in individual cases at various
times of the day, nor does it alter the
ASC payment for covered surgical
procedures and covered ancillary
services. As we explained in the August
2006 proposed rule, we proposed to
exclude surgical procedures from ASC
payment only based on their expected
need for an overnight stay or the risk
they pose to beneficiary safety. We
identified the need for medical
monitoring at midnight as a clinical
measure that was meaningful to our
clinical staff and advisors in their
assessment, on a procedure-byprocedure basis, of the expected
postoperative needs of the typical
Medicare beneficiary, in order to
determine whether a procedure was
likely to require an overnight stay.
We agree with some commenters that
the criteria currently in place under the
existing ASC payment system that limit
covered surgical services to those that
do not generally exceed a total of 90
minutes operating time and a total of 4
hours of recovery or convalescent time
are both outdated and inconsistent with
the proposed policy to base exclusion
on the need for an overnight stay. We
also agree with the commenters who
recognized that the proposed revised
measure to facilitate identification of
those procedures requiring an overnight
stay is considerably less restrictive than
the current criteria and, at the same
time, the use of midnight as a reference
point is clinically meaningful and
adequate to ensure beneficiary safety.
As stated above, a beneficiary’s
location at midnight is a generally
accepted standard for determining his or
her status as a hospital inpatient or
skilled nursing facility patient and, as
such, it seems reasonable to apply the
same standard in the ASC setting.
Second, as defined at § 416.2, ASC
means ‘‘any distinct entity that operates
exclusively for the purpose of providing
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
surgical services to patients not
requiring hospitalization.’’ Thus, ASCs
are not certified by Medicare to provide
overnight care, and there is
longstanding policy to exclude from
coverage in ASCs those surgical
procedures that require overnight stays,
as evidenced by our existing criterion at
§ 416.65(b)(1)(ii) that requires CMS to
limit covered surgical procedures to
those that do not generally exceed a
total of 4 hours of recovery time
following surgery. The expectation is
that a beneficiary undergoing a
procedure in an ASC will recover from
anesthesia and return home on the same
day that he or she reported to the ASC
for a scheduled procedure. This
expectation is inconsistent with a 24hour postoperative recovery period as
recommended by some commenters.
The commenters’ comparisons of
ASCs to HOPDs are not persuasive for
many reasons. Most importantly among
these is the fact that HOPDs, unlike
ASCs, have medical and nursing staff on
duty 24 hours a day and all of the
resources of the hospital to support the
care requirements of beneficiaries in
that setting.
After consideration of the public
comments we received, we continue to
believe that it is appropriate to exclude
from ASC payment any procedure for
which standard medical practice
dictates that the beneficiary would
typically be expected to require active
medical monitoring and care at
midnight following the procedure.
Therefore, we are finalizing, with
editorial modification to include this
requirement in the general standards for
covered surgical procedures at
§ 416.166(b), our proposal to exclude
these surgical procedures from ASC
payment.
B. Treatment of Unlisted Procedure
Codes and Procedures That Are Not
Paid Separately Under the OPPS
Unlisted procedure CPT codes are
used to report services and procedures
that are not accurately described by any
other, more specific CPT codes. An
example of an unlisted CPT code is
33999 (Unlisted procedure, cardiac
surgery). Within the surgical range of
CPT codes, there are 91 such codes.
None of the unlisted CPT codes in the
surgical range is on the current ASC list
of covered surgical procedures. Under
the OPPS, we assign unlisted CPT codes
to the lowest weighted APC in the
relevant clinical group, regardless of the
median cost for the unlisted procedure
code, and we do not include the highly
variable claims-based cost information
for unlisted services in calculating APC
median costs for purposes of
PO 00000
Frm 00016
Fmt 4701
Sfmt 4700
establishing APC relative payment
weights. Payment for procedures
reported by unlisted CPT codes is made
only at the discretion of the contractor
under the MPFS.
Because of concerns about the
potential for safety risks when
procedures that may only be reported
with unlisted procedure CPT codes are
performed, in the August 2006 proposed
rule for the revised ASC payment
system, we proposed to continue
excluding CPT unlisted surgical
procedure codes from ASC payment.
For example, when CPT code 33999 is
reported on a claim, we know only that
some kind of cardiac surgery was
performed. We have no other
information about the procedure, and
we have no way of knowing whether the
procedure involved major blood vessels,
major or prolonged invasion of body
cavities, or extensive blood loss, or was
emergent or life-threatening in nature.
Prior to our evaluation of surgical
procedure codes for their safety risk, we
decided to propose that we would not
make separate payment under the
revised ASC payment system for CPT
codes in the surgical range whose
payments are packaged under the OPPS.
Packaged CPT codes under the OPPS are
identified by status indicator ‘‘N’’ in
Addendum B of the CY 2007 OPPS/ASC
final rule with comment period (71 FR
68283 through 68384), and their OPPS
payment is provided through payment
for other separately payable services.
We made this proposal for two reasons.
First, we would not be able to establish
an ASC payment rate for packaged
surgical procedures using the same
method we proposed for all other ASC
procedures because packaged surgical
codes have no relative payment weights
under the OPPS upon which to base an
ASC payment rate. Second, ASCs, just
like hospitals, would receive payment
for these packaged surgical procedures
because their costs would already be
included in the APC relative payment
weights upon which the ASC payment
rates would be based.
Comment: A few commenters
recommended that CMS not exclude all
unlisted CPT codes from ASC payment
as proposed. Some commenters believed
that, because Medicare makes facility
payments for unlisted CPT codes under
the OPPS, CMS should provide the
same treatment in ASCs. Other
commenters suggested that, for groups
of related CPT codes in which all codes
but the related unlisted code are
provided payment in ASCs, CMS should
also include the unlisted code on the
ASC list of covered surgical procedures.
For example, all of the specific CPT
codes in the surgical hysteroscopy
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
subsection of CPT (CPT codes 58558
through 58578) are currently on the ASC
list. One commenter contended that
because CMS had already determined
that all of those specific hysteroscopy
procedures are safe for performance in
ASCs, the related unlisted hysteroscopy
procedure (CPT code 58579, Unlisted
hysteroscopy procedure, uterus) should
also be deemed to pose no significant
safety risk or require an overnight stay.
Response: We appreciate the
commenters’ examples of unlisted codes
in families where all of the other
procedures in the CPT subsection are
not excluded from ASC payment, in
support of their recommendation that
the related unlisted procedure code
should be treated comparably. However,
the fact remains that we do not know
what specific procedure would be
represented by an unlisted code. Our
charge requires us to evaluate each
surgical procedure for potential safety
risk and the expected need for overnight
monitoring and to exclude such
procedures from ASC payment. It is not
possible to evaluate procedures that
would be reported by unlisted CPT
codes according to these criteria.
We continue to believe that because
our final policy under the revised ASC
payment system excludes from ASC
payment those procedures that pose a
significant safety risk in ASCs or would
be expected to require an overnight stay,
it would not be appropriate to provide
ASC payment for unlisted CPT codes in
the surgical range, even if payment may
be provided under the OPPS. As
discussed earlier, ASCs do not possess
the breadth and intensity of services
that hospitals must maintain to care for
patients of higher acuity, and we would
have no way of knowing what specific
procedures reported by unlisted CPT
codes were provided to patients, in
order to ensure that they are safe for
ASC performance. Therefore, we are
finalizing in § 416.166(c)(7) our
proposal, without modification, to
exclude from ASC payment under the
revised ASC payment system all
procedures reported by unlisted surgical
procedure codes.
Comment: A few commenters
expressed concern that payments for
certain surgical services that are
packaged under the OPPS are frequently
paid through the OPPS payments for
more comprehensive services that we
had proposed to define as nonsurgical
because they are not classified by CPT
within the surgical range of codes.
Therefore, these packaged surgical
services would not be paid under the
revised ASC payment system. They
pointed out that when ASCs perform
these packaged surgical services as part
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
of providing a more comprehensive
nonsurgical service, the ASC would
receive no payment for the surgical
service. To illustrate the problem,
commenters provided examples of the
surgical codes that typically receive
packaged payment under the OPPS
through payment for radiology services.
The minor packaged surgical procedures
included numerous injection and
catheter placement procedures in the
surgical range of CPT codes that
generally accompany radiology services
for purposes of injecting contrast or
facilitating another nonsurgical
intervention. These commenters
recommended that CMS expand the
definition of surgical procedures to
include invasive radiology services that
have a surgical component, including
those radiology procedures that are
performed in association with a surgical
procedure proposed for packaged
payment under the revised ASC
payment system, to enable ASCs to
receive payment for the comprehensive
service, including both the radiology
service and the minor surgical
procedure. Alternatively, several other
commenters supported our proposal to
package payment under the revised ASC
payment system for the minor surgical
procedures for which payment is also
packaged under the OPPS, rather than
paying for them separately.
Response: We continue to believe that
packaging payment for those surgical
services that are packaged under the
OPPS is appropriate under the revised
ASC payment system. This policy is
aligned with the recommendation of the
PPAC to apply payment policies
uniformly in the ASC and HOPD
settings. It also maintains comparable
payment bundles under the OPPS and
the revised ASC payment system for
these services, consistent with the
recommendation of MedPAC to
maintain consistent payment bundles
under both payment systems.
Packaged surgical services are minor
procedures and are usually reported
with a more comprehensive procedure
that may itself be nonsurgical and,
therefore, excluded from payment under
the revised ASC payment system. See
section III.A.1. of this final rule for a
further discussion of the definition of
surgical procedure under the revised
ASC payment system. We believe that
payment for these minor surgical
procedures would be appropriately
packaged into payment for
comprehensive surgical procedures that
are separately paid in the ASC setting,
when those minor surgical procedures
are provided in support of the
comprehensive surgical procedures. In
the circumstances referred to by the
PO 00000
Frm 00017
Fmt 4701
Sfmt 4700
42485
commenters, the minor surgical
procedures are performed in support of
comprehensive nonsurgical services and
payment for the minor surgical
procedures is packaged into payment for
the nonsurgical services under the
OPPS. Although the packaged
procedures are surgical according to our
definition for the revised ASC payment
system, we do not believe it is
reasonable or appropriate to assign a
different packaging status for these
procedures under the revised ASC
payment system than is assigned under
the OPPS. The minor surgical
procedures are not separately paid in
the OPPS and, thus, are not eligible for
separate payment under the revised
ASC payment system. In addition, if the
procedures are only performed in
conjunction with major services not
payable in ASCs, Medicare also will
make no packaged payment for these
minor surgical procedures. As we
discuss further in section III.A. of this
final rule, Medicare pays ASCs for the
performance of ambulatory surgical
procedures, not for providing
nonsurgical services. We do not agree
that we should define surgical
procedures under the revised ASC
payment system to include other types
of services, such as radiology services,
just because they are provided in
association with a minor surgical
procedure in the CPT surgical range of
codes. Instead, we continue to believe
that the other types of services,
including radiology services, are not
appropriate for performance in ASCs
unless they are integral to covered
surgical procedures. We see no rationale
for considering comprehensive
radiology services to be integral to the
minor surgical procedures.
After considering all public comments
received, we are finalizing, without
modification, our proposal to provide
packaged payment under the revised
ASC payment system for all surgical
procedures packaged under the OPPS
for the same calendar year. Therefore,
we will exclude these surgical
procedures from separate payment in
the ASC setting under the revised
payment system, and they will not be
included on the ASC list of covered
surgical procedures. We believe that this
approach will provide appropriate
packaged payment for minor surgical
procedures provided in association with
significant ASC covered surgical
procedures. When these minor surgical
procedures are performed in support of
comprehensive nonsurgical procedures,
they are not appropriate for ASC
payment because the more
comprehensive service is not a surgical
E:\FR\FM\02AUR2.SGM
02AUR2
42486
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
that are performed most of the time in
the physician’s office setting. Numerous
commenters requested that the payment
rate for those procedures be set at a
percentage of the OPPS amount,
applying the same payment
methodology under the revised ASC
payment system as for all other surgical
procedures not excluded from ASC
C. Treatment of Office-Based Procedures payment. The commenters believed that
the proposed treatment of office-based
According to the general standard in
procedures is unfair because, when any
§ 416.65(a)(2) of the existing regulations, of those procedures would be performed
procedures that ‘‘are commonly
in the ASC setting, that facility site
performed, or that may be safely
would be necessary due to an individual
performed, in physicians’ offices’’ are
beneficiary’s need for the higher acuity
excluded from the ASC list of covered
care setting. Therefore, the commenters
surgical procedures. We did not propose concluded that the same level of
to continue to apply this provision
payment, in relationship to OPPS
under the revised ASC payment system. payment for those procedures, should
Rather, in the August 2006 proposed
be made for office-based procedures as
rule for the revised ASC payment
for other covered ASC procedures that
system, we proposed to allow ASC
are not office-based. Furthermore,
payment for surgical procedures that are commenters contended that there would
commonly and safely performed in the
be very little change in surgical practice
office setting. We reasoned that the
patterns under the revised ASC payment
types of procedures performed in
system, and that procedures currently
physicians’ offices would neither pose a performed predominantly in physicians’
significant safety risk nor require an
offices would not move to ASC settings
overnight stay when performed in an
as a result of our proposal to provide
ASC. However, we expressed concerns
payment for those procedures in ASCs.
that allowing payment for office-based
Response: We appreciate the
procedures under the ASC benefit could
commenters’ support for our proposal to
create an incentive for physicians
not exclude office-based surgical
inappropriately to convert their offices
procedures from ASC payment under
into ASCs or to move all their office
the revised ASC payment system. Based
surgery to an ASC.
To address this concern, we proposed on both our final definition of surgical
procedures and our final safety and
to limit payment for office-based
overnight stay criteria to be used in
procedures to neutralize any such
evaluating procedures for exclusion
incentive (see section IV.E. of this final
from ASC payment, we see no reason to
rule). We also proposed in new
§ 416.171(d) to set forth rules governing exclude surgical procedures that are
currently commonly performed in
the payment of office-based procedures
physicians’ offices from payment under
in ASCs. We specifically invited
the revised ASC payment system. We
comment regarding the effect on the
believe there are a variety of reasons
Medicare program, and on practice
that may contribute to the choice of a
patterns for ambulatory surgery
particular care setting for the treatment
generally, of our proposal to allow ASC
of an individual beneficiary, including
payment for office-based procedures
the patient’s surgical risk, the
that historically have been excluded
geographic location of the beneficiary
from the ASC list of covered surgical
and physician, individual physician
procedures.
practice patterns and preferences, the
As we discussed in the August 2006
availability of specialty ASCs, and
proposed rule, we proposed to limit
others. We do not believe that
payment for office-based procedures in
individuals receiving surgical
ASCs in an attempt to mitigate
procedures in ASCs routinely require
potentially inappropriate migration of
care that is of such greater acuity than
services from the physician office
care provided in the office-based setting
setting to the ASC. Alternatively, we
that the facility resources are
acknowledged that we could entirely
significantly and systematically
exclude office-based procedures or
increased when those procedures that
procedures that require relatively
are primarily office-based are performed
inexpensive resources to perform from
occasionally in ASCs. While it may be
the ASC list of covered surgical
true that some more acute cases are
procedures.
treated in ASCs rather than in
Comment: Many commenters
physicians’ offices, we continue to
supported our proposal to not exclude
believe that the structure of payments
from ASC payment those procedures
mstockstill on PROD1PC66 with RULES2
procedure paid under the revised ASC
payment system. HCPCS codes for
surgical procedures for which payment
will be packaged under the revised ASC
payment system are identified in
Addendum AA to this final rule with
payment indicator ‘‘N1’’ (Packaged
service/item; no separate payment
made).
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00018
Fmt 4701
Sfmt 4700
should not provide a financial incentive
for treatment in the ASC facility setting.
Furthermore, this policy is consistent
with the averaging principle that is
common to all prospective payment
systems; payment is based on the
resources that are required to treat the
typical case, and payment for the
treatment of a specific Medicare
beneficiary may, therefore, be higher
than the costs of treating less severe
cases but lower than the costs of treating
more acute cases.
We believe that including these officebased procedures on the ASC list of
covered surgical procedures will ensure
Medicare beneficiary access to these
services in the most appropriate
ambulatory or outpatient setting. Our
final payment policy for these
procedures, along with public
comments and our responses, is
discussed in section IV.E. of this final
rule, and the related payment rules are
set forth in § 416.171(d).
After considering the public
comments received, we are finalizing
our proposal, without modification, to
provide payment under the revised ASC
payment system for surgical procedures
that are currently performed
predominantly in physicians’ offices
and that may be safety performed in
ASCs, without requiring an overnight
stay.
D. Specific Surgical Procedures
Excluded From Payment under the
Revised ASC Payment System
In Tables 44 and 45 of the August
2006 proposed rule (71 FR 49640
through 49646), we listed the HCPCS
codes and short descriptors for surgical
procedures that, in addition to those
that comprised the OPPS inpatient list
in Addendum E to the August 2006
proposed rule, we proposed to exclude
from ASC payment on or after January
1, 2008, because they pose a significant
safety risk or are expected to require an
overnight stay. Table 44 included those
surgical procedures proposed for
exclusion from payment because at least
80 percent of Medicare cases are
performed on an inpatient basis, while
Table 45 listed those surgical
procedures proposed for exclusion from
payment because they require an
overnight stay. In section III.A.2. of this
final rule, we discuss our final rationale
for excluding surgical procedures from
ASC payment. We note that because our
final policy, as discussed above, for the
revised ASC payment system does not
automatically exclude from payment
those procedures for which at least 80
percent of Medicare cases are performed
on an inpatient basis, all procedures
listed in Table 44 of the August 2006
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
proposed rule were reviewed again for
this final rule as described below, in the
context of our final exclusionary patient
safety and overnight stay criteria.
For many of the procedures listed in
Table 45 of the August 2006 proposed
rule, several disqualifying criteria could
be applicable, such as ‘‘requires
inpatient stay’’ or ‘‘could potentially
cause extensive blood loss’’ or ‘‘is
emergent in nature.’’ Rather than list
multiple disqualifying criteria for
individual codes in Table 45 of the
August 2006 proposed rule, we
defaulted to the one characteristic that
is common to all of the codes listed.
That is, we believed that, at a minimum,
prevailing medical practice would
dictate the provision of overnight care
following each of the procedures listed
in Table 45 of the August 2006 proposed
rule. We acknowledged that we had to
exercise a degree of clinical judgment in
identifying those procedures that we
proposed to exclude from ASC payment.
Therefore, we solicited comments on
the appropriateness of excluding the
procedures in Table 45 from payment
under the revised payment system. We
requested that commenters who
disagreed with a specific procedure’s
proposed exclusion from payment
submit clinical evidence that
demonstrates that the criteria we
proposed in proposed new § 416.166 of
the regulations are not factors when the
procedure is performed in the majority
of cases. We asked that commenters also
provide data to support any assertion
that the preponderance of Medicare
beneficiaries upon whom the procedure
is performed would not be expected to
require overnight care or monitoring
following the surgery. We noted in the
proposed rule that simply asserting that
the procedure could be safely performed
in an ASC, without providing
corroborative evidence and data, would
not furnish us with sufficient
information upon which to make an
informed decision.
Comment: Several commenters
requested that, if CMS decided not to
adopt less than 24 hours as its definition
of an overnight stay, CMS should revise
the list of proposed excluded
procedures that were included in Table
45 of the August 2006 proposed rule on
the basis of their overnight stay
requirement. The commenters disagreed
with CMS’ determinations that all of
those procedures required at least active
medical monitoring at midnight
following the procedure. Many
commenters provided specific
recommendations regarding surgical
services that they believed should not
be excluded from payment under the
revised ASC payment system. In
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
addition, several commenters identified
a number of procedures not on the
OPPS inpatient list that CMS proposed
to exclude from ASC payment but that
were not displayed in Table 44 or Table
45 of the proposed rule and for which
CMS provided no rationale for their
exclusion.
Response: In response to these
procedure-specific comments and to
those comments that reflected the belief
that all procedures not on the OPPS
inpatient list should be payable under
the revised ASC payment system, we
reviewed a subset of all of the surgical
procedures that we proposed to exclude
from payment under the revised ASC
payment system, identified as described
below. This included reassessing the
treatment of those codes that were
proposed to be excluded but were
inadvertently left out of Table 44 or
Table 45 in the August 2006 proposed
rule. To conduct this comprehensive
review, we identified all codes within
the surgical range of CPT codes that met
all of the following criteria: (1) Not
proposed for the CY 2008 list of ASC
covered surgical procedures
(Addendum BB to the August 2006
proposed rule); (2) not included on the
CY 2007 OPPS inpatient list; (3) not
packaged under the OPPS; (4) not CPT
unlisted surgical procedure codes; and
(5) recognized for separate payment
under the OPPS. Elimination of all CPT
codes not meeting these criteria yielded
about 750 procedures designated for a
second review by our medical advisors,
in order to finalize their treatment under
the CY 2008 revised ASC payment
system.
Our clinical staff evaluated each of
those procedures using all available
claims and physician pricing data, as
well as their clinical judgment and the
public comments, to determine which
procedures would be expected to
require monitoring at midnight of the
day on which the surgical procedure
was performed or that otherwise would
pose a significant safety risk to the
typical Medicare beneficiary. Table 2
below, which provides an illustrative
list of all surgical procedures excluded
from ASC payment under the revised
ASC payment system, reflects the final
outcome of that comprehensive review
process. In all, we are not excluding 17
of the procedures that we had initially
proposed for exclusion from payment
under the revised ASC payment system.
The procedures for which we made a
different final determination than our
proposal regarding the appropriateness
of their performance in ASCs include
procedures from virtually all specialty
areas within the surgical range, from
dermatology to gastroenterology to
PO 00000
Frm 00019
Fmt 4701
Sfmt 4700
42487
ophthalmology. In addition, we
reviewed all Category III CPT codes and
Level II HCPCS codes in the context of
the public comments and our final
policy for the revised ASC payment
system and concluded that 29 of these
codes, in addition to those HCPCS codes
on the CY 2007 ASC list of covered
procedures, are appropriate for
performance in ASCs under the revised
payment system.
Comment: A number of commenters
requested that CMS exclude additional
procedures from the ASC list of covered
surgical procedures. Specifically,
several commenters requested that CMS
exclude the procedures listed in Table
1 below, because they believed that they
pose significant safety risks to
beneficiaries when performed in ASCs.
They stated that all of the procedures
listed in Table 1 would violate at least
one of the proposed procedure review
criteria by involving major blood vessels
or prolonged invasion of body cavities.
Further, one commenter suggested that
some of the procedures (as listed, CPT
codes 35473 through 37650) should be
excluded, because they involve femoral
access and could require thrombolytic
therapy.
TABLE 1.—SPECIFIC PROCEDURES
THAT COMMENTERS REQUESTED BE
EXCLUDED FROM ASC PAYMENT
HCPCS
code
21215
32002
33206
33214
33215
33216
33217
33218
33220
33222
33223
33224
33225
33226
33234
35473
35474
35475
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
35476 ...
35492
35761
37205
37206
37250
37251
37650
40700
40701
42200
42205
42210
E:\FR\FM\02AUR2.SGM
...
...
...
...
...
...
...
...
...
...
...
...
Short descriptor
Lower jaw bone graft.
Treatment of collapsed lung.
Insertion of heart pacemaker.
Upgrade of pacemaker system.
Reposition pacing-defib lead.
Insert lead pace-defib, one.
Insert lead pace-defib, dual.
Repair lead pace-defib, once.
Repair lead pace-defib, dual.
Revise pocket, pacemaker.
Revise pocket, pacing-defib.
Insert pacing lead & connect.
L ventric pacing lead add-on.
Reposition L ventric lead.
Removal of pacemaker system.
Repair arterial blockage.
Repair arterial blockage.
Repair arterial blockage (non-dialysis).
Repair venous blockage (non-dialysis).
Artherectomy, perc.
Exploration of artery/vein.
Transcath IV stent, perc.
Transcath IV stent/perc addl.
IV U.S. first vessel add-on.
IV U.S. each add vessel add-on.
Revision of major vein.
Repair cleft lip/nasal.
Repair cleft lip/nasal.
Reconstruct cleft palate.
Reconstruct cleft palate.
Reconstruct cleft palate.
02AUR2
42488
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
TABLE 1.—SPECIFIC PROCEDURES
THAT COMMENTERS REQUESTED BE
EXCLUDED FROM ASC PAYMENT—
Continued
Short descriptor
42215 ...
42220 ...
G0297 ..
mstockstill on PROD1PC66 with RULES2
HCPCS
code
Reconstruct cleft palate.
Reconstruct cleft palate.
Insrt 1 chamb dfib pulse generator.
Response: We appreciate the
commenters’ concerns and conducted a
comprehensive review of each of the
procedures presented. We agree with
the commenters that the procedures
reported by CPT codes 35475
(Transluminal balloon angioplasty,
percutaneous; brachiocephalic trunk or
braches, each vessel); 37205
(Transcatheter placement of an
intravascular stent(s), (except coronary,
carotid, and vertebral vessel),
percutaneous; initial vessel); and 37206
(Transcatheter placement of an
intravascular stent(s), (except coronary,
carotid, and vertebral vessel), each
additional vessel) should be excluded
from the ASC list of covered surgical
procedures because they could pose a
significant safety risk to beneficiaries in
ASCs. We did not include CPT code
35475 in our proposed list of covered
surgical procedures under the revised
ASC payment system because we, like
the commenters, believe that it poses a
safety risk for beneficiaries if performed
in ASCs. Although we did propose to
add CPT codes 37205 and 37206 to the
ASC list for CY 2007, we did not
finalize that proposal for CY 2007 in
response to comments and continue to
agree with commenters that those
procedures would likely require an
overnight stay.
With regard to the remaining
procedures, three of them, specifically
CPT codes 33222 (Revision or relocation
of skin pocket for pacemaker); 33223
(Revision of skin pocket for single or
dual chamber pacing cardioverterdefibrillator); and 37650 (Ligation of
femoral vein), are on the current ASC
list of covered surgical procedures and
have been safely performed in ASCs for
some time. We do not believe that they
represent a significant safety risk or are
likely to require an overnight stay.
We did not propose to exclude any of
the remaining procedures in Table 1
from the list of procedures for which
ASCs may receive payment under the
revised payment system because, based
on our clinical review, we did not find
that the procedures would be expected
to require an overnight stay or pose a
significant risk to beneficiary safety
when performed in ASCs. Our review
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
for this final rule, in consideration of
the comments, did not alter our final
opinion on the appropriate treatment of
these other codes.
Therefore, we are finalizing our
proposal, with modification, regarding
specific surgical procedures that are
excluded from ASC payment under the
revised ASC payment system. Table 2
provides an illustrative list of CPT codes
that are payable under the OPPS but
that are excluded from the ASC list of
covered surgical procedures. This
illustrative list does not include those
procedures that are on the OPPS
inpatient list, packaged under the OPPS,
or only reportable by CPT unlisted
surgical procedure codes. All of the
procedures listed in Table 2 are
excluded from the list of covered
surgical procedures for which Medicare
will provide ASC payment under the
revised ASC payment system because
we believe, based on our review of each
procedure’s clinical characteristics,
utilization data reflected in physician
claims, and prevailing medical practice
as reflected in the valuation of the
services by the AMA/Specialty Society
Relative Value Scale Update Committee
(RUC), and consideration of the
judgment of our medical advisors and
all public comments to the proposed
rule, that these surgical procedures pose
a significant risk to beneficiary safety or
are expected to require an overnight
stay.
In this final rule, we are finalizing the
addition of 793 new surgical procedures
to the ASC list of covered surgical
procedures for CY 2008, while we are
excluding those procedures listed in
Table 2 from ASC payment for CY 2008.
This list will be updated for the CY
2008 revised ASC payment system
through the CY 2008 OPPS/ASC annual
rulemaking cycle.
TABLE 2.—ILLUSTRATIVE LIST OF SURGICAL
PROCEDURES
PAYABLE
UNDER THE OPPS (NOT ON THE
OPPS INPATIENT LIST, NOT PACKAGED UNDER THE OPPS AND NOT
DESIGNATED AS CPT UNLISTED
CODES) THAT ARE EXCLUDED FROM
ASC PAYMENT BECAUSE THEY
POSE A SIGNIFICANT SAFETY RISK
OR ARE EXPECTED TO REQUIRE AN
OVERNIGHT STAY
HCPCS
code
15170
15171
15175
15176
19260
19307
PO 00000
..
..
..
..
..
..
Short descriptor
Acell graft trunk/arms/legs.
Acell graft t/arm/leg add-on.
Acellular graft, f/n/hf/g.
Acell graft, f/n/hf/g add-on.
Removal of chest wall lesion.
Mast, mod rad.
Frm 00020
Fmt 4701
Sfmt 4700
TABLE 2.—ILLUSTRATIVE LIST OF SURGICAL
PROCEDURES
PAYABLE
UNDER THE OPPS (NOT ON THE
OPPS INPATIENT LIST, NOT PACKAGED UNDER THE OPPS AND NOT
DESIGNATED AS CPT UNLISTED
CODES) THAT ARE EXCLUDED FROM
ASC PAYMENT BECAUSE THEY
POSE A SIGNIFICANT SAFETY RISK
OR ARE EXPECTED TO REQUIRE AN
OVERNIGHT STAY—Continued
HCPCS
code
20100 ..
20101 ..
20102 ..
21049 ..
21175 ..
21195 ..
21261 ..
21263 ..
21408 ..
21470 ..
21742 ..
21743 ..
22100.
22101 ..
22222 ..
22526 ..
22527 ..
22612 ..
22614 ..
22851 ..
23470 ..
24150 ..
24151 ..
24935 ..
25170 ..
26037 ..
27216 ..
27235 ..
27412 ..
27415 ..
27446 ..
27475 ..
27524 ..
28360 ..
29866 ..
29867 ..
29868 ..
31292 ..
31293 ..
31294 ..
31600 ..
31601 ..
31610 ..
31785 ..
32005 ..
32020 ..
32201 ..
32601 ..
32602 ..
32603 ..
32604 ..
32605 ..
32606 ..
32998 ..
33244 ..
34101 ..
34111 ..
34201 ..
34203 ..
E:\FR\FM\02AUR2.SGM
Short descriptor
Explore wound, neck.
Explore wound, chest.
Explore wound, abdomen.
Excis uppr jaw cyst w/repair.
Reconstruct orbit/forehead.
Reconst lwr jaw w/o fixation.
Revise eye sockets.
Revise eye sockets.
Treat eye socket fracture.
Treat lower jaw fracture.
Repair stern/nuss w/o scope.
Repair sternum/nuss w/scope.
Remove part of neck vertebra.
Remove part, thorax vertebra.
Revision of thorax spine.
Idet, single level.
Idet, 1 or more levels.
Lumbar spine fusion.
Spine fusion, extra segment.
Apply spine prosth device.
Reconstruct shoulder joint.
Extensive humerus surgery.
Extensive humerus surgery.
Revision of amputation.
Extensive forearm surgery.
Decompress fingers/hand.
Treat pelvic ring fracture.
Treat thigh fracture.
Autochondrocyte implant knee.
Osteochondral knee allograft.
Revision of knee joint.
Surgery to stop leg growth.
Treat kneecap fracture.
Reconstruct cleft foot.
Autgrft implnt, knee w/scope.
Allgrft implnt, knee w/scope.
Meniscal trnspl, knee w/scpe.
Nasal/sinus endoscopy, surg.
Nasal/sinus endoscopy, surg.
Nasal/sinus endoscopy, surg.
Incision of windpipe.
Incision of windpipe.
Incision of windpipe.
Remove windpipe lesion.
Treat lung lining chemically.
Insertion of chest tube.
Drain, percut, lung lesion.
Thoracoscopy, diagnostic.
Thoracoscopy, diagnostic.
Thoracoscopy, diagnostic.
Thoracoscopy, diagnostic.
Thoracoscopy, diagnostic.
Thoracoscopy, diagnostic.
Perq rf ablate tx, pul tumor.
Remove eltrd, transven.
Removal of artery clot.
Removal of arm artery clot.
Removal of artery clot.
Removal of leg artery clot.
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42489
TABLE 2.—ILLUSTRATIVE LIST OF SURGICAL
PROCEDURES
PAYABLE
UNDER THE OPPS (NOT ON THE
OPPS INPATIENT LIST, NOT PACKAGED UNDER THE OPPS AND NOT
DESIGNATED AS CPT UNLISTED
CODES) THAT ARE EXCLUDED FROM
ASC PAYMENT BECAUSE THEY
POSE A SIGNIFICANT SAFETY RISK
OR ARE EXPECTED TO REQUIRE AN
OVERNIGHT STAY—Continued
TABLE 2.—ILLUSTRATIVE LIST OF SURGICAL
PROCEDURES
PAYABLE
UNDER THE OPPS (NOT ON THE
OPPS INPATIENT LIST, NOT PACKAGED UNDER THE OPPS AND NOT
DESIGNATED AS CPT UNLISTED
CODES) THAT ARE EXCLUDED FROM
ASC PAYMENT BECAUSE THEY
POSE A SIGNIFICANT SAFETY RISK
OR ARE EXPECTED TO REQUIRE AN
OVERNIGHT STAY—Continued
HCPCS
code
mstockstill on PROD1PC66 with RULES2
TABLE 2.—ILLUSTRATIVE LIST OF SURGICAL
PROCEDURES
PAYABLE
UNDER THE OPPS (NOT ON THE
OPPS INPATIENT LIST, NOT PACKAGED UNDER THE OPPS AND NOT
DESIGNATED AS CPT UNLISTED
CODES) THAT ARE EXCLUDED FROM
ASC PAYMENT BECAUSE THEY
POSE A SIGNIFICANT SAFETY RISK
OR ARE EXPECTED TO REQUIRE AN
OVERNIGHT STAY—Continued
HCPCS
code
HCPCS
code
34421
34471
34490
34501
34510
34520
34530
35011
35180
35184
35190
35201
35206
35226
35231
35236
35256
35261
35266
35286
35321
35458
35459
35460
35470
35471
35472
35475
35484
35485
35490
35491
35493
35494
35495
35500
35685
35686
35860
35879
35881
35883
35884
35903
36838
37183
37195
37201
37202
37204
37205
37206
37207
37208
37209
37210
37565
37600
37605
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
Short descriptor
Removal of vein clot.
Removal of vein clot.
Removal of vein clot.
Repair valve, femoral vein.
Transposition of vein valve.
Cross-over vein graft.
Leg vein fusion.
Repair defect of artery.
Repair blood vessel lesion.
Repair blood vessel lesion.
Repair blood vessel lesion.
Repair blood vessel lesion.
Repair blood vessel lesion.
Repair blood vessel lesion.
Repair blood vessel lesion.
Repair blood vessel lesion.
Repair blood vessel lesion.
Repair blood vessel lesion.
Repair blood vessel lesion.
Repair blood vessel lesion.
Rechanneling of artery.
Repair arterial blockage.
Repair arterial blockage.
Repair venous blockage.
Repair arterial blockage.
Repair arterial blockage.
Repair arterial blockage.
Repair arterial blockage.
Atherectomy, open.
Atherectomy, open.
Atherectomy, percutaneous.
Atherectomy, percutaneous.
Atherectomy, percutaneous.
Atherectomy, percutaneous.
Atherectomy, percutaneous.
Harvest vein for bypass.
Bypass graft patency/patch.
Bypass graft/av fist patency.
Explore limb vessels.
Revise graft w/vein.
Revise graft w/vein.
Revise graft w/nonauto graft.
Revise graft w/vein.
Excision, graft, extremity.
Dist revas ligation, hemo.
Remove hepatic shunt (tips).
Thrombolytic therapy, stroke.
Transcatheter therapy infuse.
Transcatheter therapy infuse.
Transcatheter occlusion.
Transcath iv stent, precut.
Transcath iv stent/perc addl.
Transcath iv stent, open.
Transcath iv stent/open addl.
Change iv cath at thromb tx.
Embolization uterine fibroid.
Ligation of neck vein.
Ligation of neck artery.
Ligation of neck artery.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
37606
37615
37620
38120
38240
38720
39400
42225
42227
42842
42844
43020
43130
43280
43510
43647
43648
43651
43652
43752
43830
43831
44180
44186
44206
44207
44208
44213
44500
44901
44970
45541
47011
47370
47371
47490
48511
49021
49041
49061
49200
49323
49324
49325
49326
49435
49436
49491
49492
50020
50021
50080
50081
50541
50542
50543
50544
50945
51990
PO 00000
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
Short descriptor
Ligation of neck artery.
Ligation of neck artery.
Revision of major vein.
Laparoscopy, splenectomy.
Bone marrow/stem transplant.
Removal of lymph nodes, neck.
Visualization of chest.
Reconstruct cleft palate.
Lengthening of palate.
Extensive surgery of throat.
Extensive surgery of throat.
Incision of esophagus.
Removal of esophagus pouch.
Laparoscopy, fundoplasty.
Surgical opening of stomach.
Lap impl electrode, antrum.
Lap revise/remv eltrd antrum.
Laparoscopy, vagus nerve
Laparoscopy, vagus nerve.
Nasal/orogastric w/stent.
Place gastrostomy tube.
Place gastrostomy tube.
Lap, enterolysis.
Lap, jejunostomy.
Lap part colectomy w/stoma.
Lcolectomy/coloproctostomy.
Lcolectomy/coloproctostomy.
Lap, mobil splenic fl add-on.
Intro, gastrointestinal tube.
Drain app abscess, precut.
Laparoscopy, appendectomy.
Correct rectal prolapse.
Percut drain, liver lesion.
Laparo ablate liver tumor rf.
Laparo ablate liver cryosurg.
Incision of gallbladder.
Drain pancreatic pseudocyst.
Drain abdominal abscess.
Drain, percut, abdom abscess.
Drain, percut, retroper absc.
Removal of abdominal lesion.
Laparo drain lymphocele.
Lap insertion perm ip cath.
Lap revision perm ip cath.
Lap w/omentopexy add-on.
Insert subq exten to ip cath.
Embedded ip cath exit-site.
Rpr hern preemie reduce.
Rpr ing hern premie, blocked.
Renal abscess, open drain.
Renal abscess, percut drain.
Removal of kidney stone.
Removal of kidney stone.
Laparo ablate renal cyst.
Laparo ablate renal mass.
Laparo partial nephrectomy.
Laparoscopy, pyeloplasty.
Laparoscopy, ureterolithotomy.
Laparo urethral suspension.
Frm 00021
Fmt 4701
Sfmt 4700
53500
57106
57107
57109
57120
57282
57283
57284
57292
57295
57310
57330
57335
57425
57555
58260
58262
58263
58270
58290
58291
58292
58294
58541
58542
58543
58544
58553
58554
58770
58823
58920
58925
59030
59074
59409
59612
60210
60212
60220
60225
60240
60252
60260
60500
60502
60512
60520
61623
61626
61720
62000
62160
62351
63001
63003
63005
63011
63012
E:\FR\FM\02AUR2.SGM
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
Short descriptor
Urethrlys, transvag w/ scope.
Remove vagina wall, partial.
Remove vagina tissue, part.
Vaginectomy partial w/nodes.
Closure of vagina.
Colpopexy, extraperitoneal.
Colpopexy, intraperitoneal.
Repair paravaginal defect.
Construct vagina with graft.
Change vaginal graft.
Repair urethrovaginal lesion.
Repair bladder-vagina lesion.
Repair vagina.
Laparoscopy, surg, colpopexy.
Remove cervix/repair vagina.
Vaginal hysterectomy.
Vag hyst including t/o.
Vag hyst w/t/o & vag repair.
Vag hyst w/enterocele repair.
Vag hyst complex.
Vag hyst incl t/o, complex.
Vag hyst t/o & repair, compl.
Vag hyst w/enterocele, compl.
Lsh, uterus 250 g or less.
Lsh w/t/o ut 250 g or less.
Lsh uterus above 250 g.
Lsh w/t/o uterus above 250 g.
Laparo-vag hyst, complex.
Laparo-vag hyst w/t/o, compl.
Create new tubal opening.
Drain pelvic abscess, precut.
Partial removal of ovary(s).
Removal of ovarian cyst(s).
Fetal scalp blood sample.
Fetal fluid drainage w/us.
Obstetrical care.
Vbac delivery only.
Partial thyroid excision.
Partial thyroid excision.
Partial removal of thyroid.
Partial removal of thyroid.
Removal of thyroid.
Removal of thyroid.
Repeat thyroid surgery.
Explore parathyroid glands.
Re-explore parathyroids.
Autotransplant parathyroid.
Removal of thymus gland.
Endovasc tempory vessel occl.
Transcath occlusion, non-cns.
Incise skull/brain surgery.
Treat skull fracture.
Neuroendoscopy add-on.
Implant spinal canal cath.
Removal of spinal lamina.
Removal of spinal lamina.
Removal of spinal lamina.
Removal of spinal lamina.
Removal of spinal lamina.
02AUR2
42490
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
TABLE 2.—ILLUSTRATIVE LIST OF SURGICAL
PROCEDURES
PAYABLE
UNDER THE OPPS (NOT ON THE
OPPS INPATIENT LIST, NOT PACKAGED UNDER THE OPPS AND NOT
DESIGNATED AS CPT UNLISTED
CODES) THAT ARE EXCLUDED FROM
ASC PAYMENT BECAUSE THEY
POSE A SIGNIFICANT SAFETY RISK
OR ARE EXPECTED TO REQUIRE AN
OVERNIGHT STAY—Continued
HCPCS
code
63015
63016
63017
63020
63030
63035
63040
63042
63045
63046
63047
63048
63055
63056
63057
63064
63066
63075
63741
64448
64449
64804
64910
64911
69725
69955
69960
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
Short descriptor
Removal of spinal lamina.
Removal of spinal lamina.
Removal of spinal lamina.
Neck spine disk surgery.
Low back disk surgery.
Spinal disk surgery add-on.
Laminotomy, single cervical.
Laminotomy, single lumbar.
Removal of spinal lamina.
Removal of spinal lamina.
Removal of spinal lamina.
Remove spinal lamina add-on.
Decompress spinal cord.
Decompress spinal cord.
Decompress spine cord add-on.
Decompress spinal cord.
Decompress spine cord add-on.
Neck spine disk surgery.
Install spinal shunt.
Nblock inj fem, cont inf.
Nblock inj, lumbar plexus.
Remove sympathetic nerves.
Nerve repair w/allograft.
Neurorraphy w/vein autograft.
Release facial nerve.
Release facial nerve.
Release inner ear canal.
mstockstill on PROD1PC66 with RULES2
IV. Ratesetting Methodology for the
Revised ASC Payment System
A. Overview of Current ASC Payment
System
Section 1833(i)(1) of the Act requires
us to specify, in consultation with
appropriate medical organizations,
surgical procedures that are
appropriately performed on an inpatient
basis in a hospital but that also can be
safely performed in an ASC and to
review and update the list of procedures
paid under the ASC payment system at
least every 2 years.
Under the existing ASC payment
system, the ASC payment rate is a
standard overhead amount established
on the basis of our estimate of a fee that
takes into account the costs incurred by
ASCs generally in providing facility
services in connection with performing
a specific procedure. We refer readers to
section I.B. of this final rule for further
history regarding the establishment of
standard overhead amounts for ASC
payment. The standard overhead
amounts under the existing ASC
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
payment system for procedures on the
ASC list of covered surgical procedures
were last rebased in 1990 using data
collected in a 1986 survey of ASC costs.
The process and methodology that we
used to establish the payment system
are explained in the February 8, 1990
Federal Register (55 FR 4526).
The existing ASC payment system
consists of 9 standard overhead amounts
ranging from $333 to $1,339, based on
the data collected in the 1986 survey of
ASC costs. An ASC payment group
currently consists of all the procedures
assigned to a particular standard
overhead amount. ASC payment groups
are heterogeneous in terms of clinical
characteristics, cutting across all body
systems and types of surgery. Medicare
pays a $150 allowance for IOLs that are
inserted during or subsequent to
cataract surgery and an additional $50
for IOLs that are included in active
NTIOL classes. Medicare also makes
separate payment for implantable
prosthetic devices and implantable
durable medical equipment (DME) that
are surgically inserted at an ASC under
the Durable Medical Equipment,
Prosthetics, Orthotics, and Supplies
(DMEPOS) fee schedule. Payment for all
other facility services that are directly
related to performing a surgical
procedure is packaged into the
prospectively determined ASC payment
for the covered surgical procedure.
Section 5103 of Public Law 109–171
requires us to substitute the OPPS
payment amount for the ASC standard
overhead amount for surgical
procedures performed in an ASC on or
after January 1, 2007, but prior to the
revised ASC payment system, when the
ASC standard overhead amount exceeds
the OPPS payment amount for the
procedure in that year. In Addendum
AA to the CY 2007 OPPS/ASC final rule
with comment period (71 FR 68243
through 68283), we identify the HCPCS
codes on the CY 2007 ASC list for
which the CY 2007 ASC payments are
capped at the OPPS payment amounts
in accordance with the provisions of
section 5103 of Public Law 109–171,
based on a comparison of the final CY
2007 OPPS payment rates and the ASC
standard overhead amounts that are
effective in CY 2007.
Except for screening flexible
sigmoidoscopy and screening
colonoscopy services, payment for ASC
services is subject to the usual Medicare
Part B deductible and coinsurance
requirements and the amounts paid by
Medicare must be 80 percent of the
standard fee. As required by section
1834(d) of the Act, the coinsurance for
screening flexible sigmoidoscopies and
colonoscopies is 25 percent and the
PO 00000
Frm 00022
Fmt 4701
Sfmt 4700
amounts paid by Medicare must be 75
percent of the standard fee.
Medicare currently accounts for
geographic wage variations when
calculating individual ASC payments by
applying the relevant inpatient
prospective payment system (IPPS)
wage index values and localities that
were established under the IPPS prior to
implementation of the new Core Based
Statistical Areas (CBSAs) issued by the
Office of Management and Budget
(OMB) in June 2003 to 34.45 percent of
the national ASC standard overhead
amount. The 1986 ASC survey data are
the basis for attributing 34.45 percent of
ASC facility costs to labor costs.
Section 1833(i)(2)(C) of the Act
requires the Secretary to update ASC
payment rates using the CPI–U (U.S.
city average) (CPI–U) if the Secretary
has not otherwise updated the amounts
under the revised ASC payment system.
As amended by Public Law 108–173,
section 1833(i)(2)(C) of the Act provides
that if the Secretary is required to apply
the CPI–U increase, the CPI–U
percentage increase is to be applied on
a fiscal year basis beginning with FY
1986 through FY 2005 and on a calendar
year basis beginning with 2006. Public
Law 108–173 further amended section
1833(i)(2)(C) of the Act to require us in
FY 2004, beginning April 1, 2004, to
increase ASC payment rates using the
CPI–U as estimated for the 12-month
period ending March 31, 2003, minus
3.0 percentage points. Public Law 108–
173 also requires that the CPI–U
adjustment factor equal zero percent in
FY 2005, the last quarter of CY 2005,
and each of CYs 2006 through 2009.
Section 141(b) of the Social Security
Act Amendments of 1994, Public Law
103–432, requires us to establish a
process for considering requests for
review of the appropriateness of the
payment amount provided under
section 1833(i)(2)(A)(iii) of the Act for
IOLs to ensure that the ASC payment for
the insertion procedure is reasonable
and related to the cost of acquiring a
lens that belongs to a class of NTIOLs.
In the CY 2007 OPPS/ASC proposed
rule that was published August 23, 2006
(71 FR 49631 through 49635), we
proposed changes to the process for
recognizing IOLs as belonging to a new
NTIOL class. In the subsequent CY 2007
OPPS/ASC final rule with comment
period (71 FR 68175 through 68181), we
finalized the proposed changes to that
process, beginning with requests for
review for establishing new NTIOL
classes for CY 2008 payment.
The revised ASC payment system that
we are finalizing in this rule will
implement requirements set forth in
section 626 of Public Law 108–173. The
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
revised payment system mandated by
section 626(d) of Public Law 108–173
requires us to take into account
recommendations in a report to
Congress prepared by the GAO. As
mentioned earlier, that report (GAO–07–
86) was published on November 30,
2006. Its methodology, findings, and
recommendations are summarized in
section II.B. of this final rule. Specific
ASC payment system issues considered
in the GAO Report are discussed in the
individual sections below under the
related topic areas.
mstockstill on PROD1PC66 with RULES2
B. ASC Relative Payment Weights Based
on APC Groups and Relative Payment
Weights Established Under the OPPS
As we stated in the August 2006
proposed rule for the revised ASC
payment system (71 FR 49647), we
considered several strategies and
methodologies for setting ASC payment
rates under a revised payment system.
These options included requiring ASCs
to submit modified cost reports as a
basis for establishing ASC costs,
expanding the number and payment
range of the current ASC payment
groups, basing payments to ASCs on the
relative weights for surgical services
established under the MPFS, basing
payments to ASCs on the relative
weights for surgical services established
under the Medicare OPPS, as suggested
in Public Law 108–173, or basing
payments to ASCs on a flat percentage
of the payment for the same services
established under the OPPS, as
advocated by representatives of several
ASC associations.
After reviewing the advantages and
disadvantages of each of these
approaches, in the August 2006
proposed rule we proposed, within the
parameters of section 626 of Public Law
108–173, to use the APC groups and the
relative payment weights for surgical
procedures established under the OPPS
as the basis of the payment groups and
the relative payment weights for
surgical procedures performed in ASCs.
These payment weights would be
multiplied by an ASC conversion factor
in order to calculate the ASC payment
rates. Several factors persuaded us to
advance this proposal over the other
approaches that we considered.
First, in section 626(d) of Public Law
108–173, the Congress explicitly targets
the OPPS for consideration by the GAO
in its study of ASC payments. We
believe it is reasonable to assume that
Congress, by so doing, was highlighting
the relative payment weights under the
OPPS as a theoretical model for ASC
relative payment weights under the
revised payment system.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
Second, the ASC benefit provides
payment for services associated with
performing surgical procedures. The
OPPS has equipped us with nearly a
decade of experience in developing and
refining a relative payment system for
all services furnished in connection
with outpatient surgical procedures.
Third, Public Law 108–173 applies,
for the first time, a budget neutrality
requirement to the ASC benefit. That is,
in the year the revised system is
implemented, the system is to be
designed to result in the same aggregate
amount of expenditures that would be
made if the revised payment system
were not implemented. Because the
OPPS is also a prospective payment
system for facility services that is
subject to budget neutrality
requirements, it provides useful
parallels for a ratesetting methodology
based on relative facility payment
weights for surgical services under the
revised ASC payment system.
Fourth, in our analysis of the APC
groups to which surgical procedures are
assigned for payment under the OPPS,
we found that, of the 150 highest
volume surgical procedures furnished in
HOPDs, more than half (80) are also
among the 150 highest volume
procedures performed in ASCs.
Finally, the ASC industry in
numerous meetings with us over the
past several years has frequently voiced
its preference for a payment system that
parallels the OPPS for the sake of
promoting transparency across sites of
service in the arena of outpatient
surgery and to streamline and
modernize how CMS sets payments and
determines what is payable under the
ASC benefit.
We explained in the August 2006
proposed rule that the OPPS payment
rates are based on relative payment
weights, which are updated annually
based on the most recent year of
hospital outpatient claims data and
hospitals’ latest Medicare cost reports.
APCs to which surgical procedures are
assigned are generally homogeneous
both in terms of clinical characteristics
and resource requirements. The APCs
have been continually refined over the
past 6 years through the work of the
Advisory Panel on Ambulatory Payment
Classification Groups (APC Panel) and
as a result of comments received during
the OPPS annual rulemaking cycles.
Moreover, we believed that the APC
groups had matured with respect to
their clinical and resource homogeneity,
and the relativity in resource utilization
among APCs containing surgical
procedures had stabilized. Thus, we
concluded in the proposed rule that the
APC groups and their relative weights
PO 00000
Frm 00023
Fmt 4701
Sfmt 4700
42491
were reasonable and appropriate models
for grouping outpatient surgical
procedures and determining the
relativity of the ASC payment weights
under the revised payment system. For
example, whether performed in an
HOPD or in an ASC, we believed the
time and facility resources required to
perform a routine laparoscopic hernia
repair described by CPT code 49650
(Laparoscopy, surgical; repair initial
inguinal hernia), with a CY 2007 OPPS
relative payment weight of 43.5488,
were approximately 5 times higher than
those required to perform a diagnostic
colonoscopy described by CPT code
45378 (Colonoscopy, flexible, proximal
to splenic flexure; diagnostic, with or
without collection of specimen(s) by
brushing or washing, with or without
colon decompression (separate
procedure)), with a CY 2007 OPPS
relative payment weight of 8.7686.
Thus, we believed that the relative
payment weights established under the
OPPS for procedures performed in the
hospital outpatient setting reasonably
reflected the relative facility resources
required for such procedures and did so
with sufficient coherence to be
applicable to other ambulatory sites of
service. Taking all these factors into
account, we proposed to use the APCs
as a ‘‘grouper’’ and the APC relative
payment weights as the basis for ASC
relative payment weights and for
calculating ASC payment rates under
the revised payment system.
Accordingly, we proposed to establish
provisions in proposed new Subpart F,
§§ 416.167 and 416.171, to reflect these
proposed changes for calculating the
ASC payment rates beginning January 1,
2008.
As further discussed in section II.B. of
this final rule, on November 30, 2006,
the GAO published the report mandated
by section 626(d) of Public Law 108–173
(GAO–07–86), where it determined that
the APC groups of the OPPS accurately
reflect the relative costs of procedures
performed in ASCs. It concluded that
the APC groups in the OPPS reflect the
relative costs of surgical procedures
performed in ASCs in the same way that
they reflect the relative costs of the same
procedures when they are performed in
HOPDs. Therefore, the GAO
recommended that the APC groups
could be applied to procedures
performed in ASCs, and the OPPS could
be used as the basis for an ASC payment
system, thereby eliminating the need for
ASC surveys and providing for an
annual revision of the ASC payment
groups. At its December 2006 meeting,
the PPAC recommended that CMS apply
any payment policies uniformly to both
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42492
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ASCs and HOPDs as appropriate,
confirming its belief that the OPPS and
the revised ASC payment system could
be closely linked.
We received a number of comments
on our proposal to use the OPPS relative
payment weights as the basis for
establishing relative payment weights
under the revised ASC payment system.
A summary of the comments and our
responses follow.
Comment: Many commenters agreed
that using the OPPS APCs as a
‘‘grouper’’ and the APC relative
payment weights to establish ASC
payment rates for surgical procedures
paid under the revised ASC payment
system is appropriate because a
significant number of surgical
procedures furnished in the hospital
outpatient setting are also performed in
ASCs. Some commenters argued that
because ASCs provide many similar
procedures that are also performed in
HOPDs and often utilize the same
equipment, supplies, and clinical labor
in performing these procedures, the
relative costs of performing the
procedures should be similar, if not
identical, in both settings. Moreover, the
commenters generally agreed that
creating an ASC payment system that
parallels the OPPS would promote
transparency across sites of service in
the area of outpatient surgery and would
also promote greater alignment and
coordination between the OPPS and the
revised ASC payment system, including
providing for the annual updating of
payment weights in the ASC payment
system.
Some commenters requested that
CMS apply different conversion factors
to the OPPS relative payment weights
for specific types of procedures to
calculate their ASC payment rates,
because they suggested that the OPPS
relativity was not correct for some
services provided in single specialty
ASCs (for example, gastroenterology and
pain management procedures). They
believed that the OPPS APC weights,
based on all hospital services rather
than just surgical services, may be
flawed and that additional analyses of
relative hospital and ASC costs are
needed. They recommended that CMS
develop firm data on the differences
between hospital outpatient and ASC
costs and the magnitude of those
differences for numerous services before
finalizing significant changes in ASC
payments for procedures. One
commenter specifically discussed a
study commissioned by MedPAC in
which RAND found that no single
outpatient surgical setting, ASCs or
HOPDs, had consistently higher rates of
patient characteristics that would be
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
expected to increase facility costs.
Analyses by another commenter found
that among a subset of gastrointestinal
(GI) procedures, the majority of surgical
CPT codes describing those procedures
received OPPS payments that were less
than hospitals’ median costs for the
individual procedures.
Response: We appreciate the
commenters’ general support for basing
the revised ASC payment system
relative weights on the OPPS APC
groups and their relative weights. As
discussed in detail in section II.B. of
this final rule, in its November 2006
report on ASC payment, the GAO found
that the APC groups in the OPPS
accurately reflect the relative costs of
procedures performed in ASCs. The
GAO analyses also demonstrated that
there is less variation in the ASC setting
between individual procedures’ costs
and the costs of their assigned APC
groups than there is in the HOPD
setting, and that when compared to the
median cost of the same APC group,
procedures performed in ASCs had
substantially lower costs than those
same procedures performed in HOPDs.
The GAO findings were based upon
data for all procedures performed in
ASCs in CY 2004, as reported by those
ASCs responding to the GAO survey. In
view of the GAO’s confirmation that the
APC groups accurately reflect the
relative costs of these procedures
performed in ASCs in the same way that
they reflect the relative costs of the same
procedures when they are performed in
HOPDs, substantiating a key assumption
underlying our proposal for the revised
ASC payment system, we do not believe
there is a compelling rationale for using
different ASC conversion factors to
develop payment rates for various
procedures under the revised ASC
payment system. Applying more than
one ASC conversion factor to different
procedures would imply that we believe
the OPPS APC payment weight
relativity is not applicable to the ASC
setting, contrary to our proposal and the
GAO study results. APCs currently serve
as a ‘‘grouper’’ for the OPPS and, as
such, the payment for any given
procedure under the OPPS does not
specifically reflect the cost of that
procedure in any one facility. Instead,
the APC relative payment weights under
the OPPS are developed based on the
median cost of all single claims for all
procedures assigned to each APC.
Prospectively established APC payment
rates provide an averaging effect on
OPPS payments for individual services.
With the significant expansion of
covered surgical procedures eligible for
ASC payment that we are finalizing in
this final rule for the revised ASC
PO 00000
Frm 00024
Fmt 4701
Sfmt 4700
payment system as discussed in section
III. of this final rule, in many cases
where one service in an APC is an ASC
procedure, most of the other procedures
assigned to the same APC will also be
paid in the ASC setting. Thus, under the
revised payment system, ASCs generally
will have the potential to provide a mix
of individual services assigned to those
APCs that is similar to the mix of OPPS
procedures attributable to certain APCs
and, in many cases, all of the
procedures assigned to certain APCs
under the OPPS will also be ASC
covered surgical procedures. We believe
this uniform approach under the revised
ASC payment system is fully consistent
with the recommendation of the PPAC
that we apply payment policies
consistently to both ASCs and HOPDs,
as appropriate. It also generally treats
procedures performed in ASCs
consistently for purposes of developing
ASC payment rates under the revised
ASC payment system, in accordance
with the PPAC recommendation that we
adopt a systematic and adaptable means
of fairly reimbursing ASCs for their
services.
While information provided by the
commenters clearly demonstrated that
some specific groups of procedures
would experience a significant decrease
in payment under the revised ASC
payment system as compared with the
existing payment structure, we are not
convinced that the information we
received contradicts the premise of our
proposal and the GAO findings that the
relativity of costs observed in HOPDs
could appropriately be used as the basis
for the relative payment weights in the
revised ASC payment system. We also
continue to see no clinical basis that
would support the differential relativity
of costs for various procedures
performed in the ASC or HOPD settings.
While applying a single conversion
factor to the OPPS relative weights may
result in decreases to ASC payments for
some services commonly provided in
single specialty ASCs, we also believe
that this approach should result in
facilities receiving more appropriate
payments for ASC services in general,
where those payments more accurately
reflect the facility resources required for
their performance. As discussed further
in section IV.J. of this final rule, our
final policy of a 4-year transition to
phase in the revised ASC payment
system should mitigate the potential
disruption in care that could be
associated with significant increases or
decreases in payments for specific
surgical procedures under the revised
payment system. Individual ASCs will
have a longer period of time to evaluate
and potentially modify the breadth of
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
surgical procedures they provide based
on the expanded list of covered surgical
procedures and the final policies of the
revised ASC payment system. Further,
our final ASC policies for payment of
device=intensive procedures and
covered ancillary services that more
closely align the ASC and OPPS systems
may moderate the magnitude of
differences between current ASC
payments and those under the revised
payment system for individual surgical
procedures. We do not believe that it
would be appropriate to modulate
changes in payment under the revised
system by differentially adjusting the
payment weights or the conversion
factor for various types of services
because, consistent with the GAO
recommendation, we believe the OPPS
relative payment weights upon which
the revised ASC payment system is
based appropriately reflect the relativity
in ASC resource costs associated with
different surgical procedures. We
believe that the final payment policies
for the revised payment system result in
appropriate and equitable payments,
and thus, we see no rationale for
applying adjustments that are counter to
the principles of a prospective payment
system.
After considering the public
comments received, we are finalizing
our proposal, without modification, to
establish the relative payment weights
under the revised ASC payment system
for most covered surgical procedures
based on their OPPS APC relative
payment weights for the same calendar
year, with application of a single ASC
conversion factor to determine the
national unadjusted ASC payment rates,
as set forth in §§ 416.167 and 416.171.
Several exceptions to this general policy
are discussed elsewhere in this final
rule, specifically in sections IV.C. and
IV.E. of this preamble.
mstockstill on PROD1PC66 with RULES2
C. Packaging Policy
1. General Policy
Payment for a surgical procedure
under both the current OPPS and ASC
payment systems represents payment
for a package of various items and
services, all of which are directly related
and required in order to perform the
procedure. In both systems, we package
into a single facility payment the
payment for a bundle of direct and
indirect costs incurred by the facility to
perform the surgical procedure. These
costs include, but are not limited to, use
of the facility, including an operating
suite or procedure room and recovery
room; nursing, technician, and related
services; administrative, recordkeeping,
and housekeeping items and services;
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
medical and surgical supplies and
equipment; surgical dressings; and
materials for anesthesia.
CMS currently applies different rules
under the ASC payment system and the
OPPS for determining whether payment
for other items and services directly
related to a surgical procedure is
packaged into the facility payment for
the associated surgical procedure or
paid for separately. These other items
and services include drugs, biologicals,
contrast agents, implantable devices,
and diagnostic services such as imaging.
Currently, CMS packages payment for
the costs for all drugs, biologicals, and
diagnostic services, including imaging,
into the ASC standard overhead amount
for the surgical procedure with which
these items and services are associated.
Under the OPPS, CMS pays separately
for some of these items and services, in
addition to paying for the surgical
procedure.
ASCs currently receive separate
payment for prosthetic implants and
implantable DME, as well as additional
payment for NTIOLs. Laboratory
services, physicians’ services, and x-ray
or diagnostic procedures may also be
paid separately under other Medicare
Part B fee schedules. Conversely, under
the OPPS, payment for prosthetic
implants and implantable DME is
packaged into the OPPS payment for the
surgical procedure performed to insert
the implants. Payments for IOLs,
anesthesia materials, and implantable
surgical supplies, such as stents, mesh,
guidewires, pins, and catheters, are
packaged into the associated surgical
procedure payment under both the
OPPS and the ASC payment system.
In developing the August 2006
proposed rule for the revised ASC
payment system, we considered several
packaging options. First, we considered
making no change to the current policy
regarding items and services for which
payment is packaged into the ASC
payment. That is, we would continue
under the revised ASC payment system
to package into the ASC payment all
services listed at existing § 416.61(a). In
addition, we would continue to pay
separately, sometimes under other fee
schedules, for items and services such
as: NTIOLs; prosthetic implants and
implantable DME surgically inserted at
an ASC (DMEPOS fee schedule);
laboratory services (Clinical Diagnostic
Laboratory Fee Schedule); physician
services (MPFS); and x-ray or diagnostic
procedures other than those directly
related to performance of the surgical
procedure (MPFS).
We also considered proposing to
apply the OPPS packaging rules to the
ASC payment system and to pay under
PO 00000
Frm 00025
Fmt 4701
Sfmt 4700
42493
the revised ASC payment system the
same way we pay under the OPPS for
items and services directly related to a
surgical procedure. If we adopted this
option, payment for certain imaging
procedures, drugs, biologicals, and
contrast agents directly related to
performing a covered surgical procedure
would not be packaged into the ASC
payment for the procedure but would,
instead, be paid separately. Conversely,
payment for most surgically implanted
devices and implantable DME would be
packaged.
Each of the preceding two options has
characteristics that are inconsistent with
a fundamental principle of a prospective
payment system, which is to base
payment on large bundles of items and
services so as to promote the efficient
provision of services. To preserve as
much as possible the elements of a
prospective payment system within the
revised ASC payment system, in the
August 2006 proposed rule for the
revised ASC payment system, we
proposed a third option (71 FR 49648).
That is, we proposed to continue the
current policy of packaging payment for
all direct and indirect costs incurred by
the facility to perform a covered surgical
procedure into the ASC payment for the
procedure. This would include payment
for all drugs, biologicals, contrast
agents, anesthesia materials, and
imaging services, as well as the other
items and services that were proposed
for packaging into the ASC surgical
procedure payment as listed in
proposed § 416.164(a). Proposed
§ 416.164(a) addressed the services for
which payment was proposed to be
included in the ASC payment for the
covered surgical procedures, and
proposed § 416.164(b) addressed those
services that were proposed not to be
included in the ASC payment for the
covered surgical procedures.
In addition, we proposed to cease
making separate payment for
implantable prosthetic devices and
implantable DME inserted surgically in
an ASC. Instead, under the revised
payment system, we proposed to
package payment for implantable
prosthetic devices and implantable DME
when they are surgically inserted into
the ASC payment for the associated
covered surgical procedure, as we do
under the OPPS.
However, we proposed to continue
excluding from ASC payment for
covered surgical procedures the other
services addressed in § 416.164(b). That
is, payment for items and services for
which payment is currently made under
other Part B fee schedules, with the
exception of implantable prosthetic
devices and implantable DME, would
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42494
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
not be included in the ASC payment for
the surgical procedure. Payment for
items and services, such as physicians’
professional services; laboratory, x-ray
or diagnostic procedures (other than
those directly related to performance of
the surgical procedure); nonimplantable
prosthetic devices; ambulance services;
leg, arm, back and neck braces; artificial
limbs; and DME for use in the patient’s
home would not be included in the ASC
payment for the covered surgical
procedure.
We proposed this third option for a
number of reasons. First, in the August
2006 proposed rule, we explained that
this approach to packaging is most
consistent with the principles of a
prospective payment system. Second,
we noted that we believe that ASCs
generally treat a less complex and
severely ill patient case-mix and, as a
result, we believe that ASCs are less
likely to provide, on a regular basis,
many of the separately paid items and
services that patients might receive
more consistently in a hospital
outpatient setting. Thus, in the August
2006 proposed rule, we concluded that
we did not believe there is a need to pay
for these services separately in ASCs,
because that would unbundle some
items and services that are currently
packaged into the ASC facility services
payment under the existing payment
system, reduce incentives for costefficient delivery of services in ASCs,
and increase the complexity of the
revised ASC payment system.
Moreover, after analysis of OPPS
claims for surgical procedures, we were
unable to identify ancillary items and
services that are repeatedly and
consistently reported separately in
association with specific ambulatory
surgical procedures. Rather, the OPPS
claims for surgical procedures were of
two types: one group showed a broad
range of items and services that were
provided on the same day that a surgical
procedure was performed in the HOPD,
only some of which were likely to be
directly related to the surgical
procedure; the second group of claims
revealed that many surgical procedures
are only infrequently associated with
ancillary items and services paid
separately under the OPPS.
We sought comments in the August
2006 proposed rule (71 FR 49648) from
ASC clinical and administrative staff,
and from physicians who perform
surgeries in ASCs, regarding nonsurgical
ancillary services or items that are
directly related to a surgical procedure
that would be paid separately under the
OPPS but that would be packaged under
our proposal for the revised ASC
payment system. We specifically
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
requested that commenters provide data
to indicate the frequency with which
specific items and services are typically
furnished in association with given
procedures, the reasons why one patient
might require the additional items and
services whereas another patient would
not, and the costs of those items and
services relative to the other costs
incurred to perform the associated
surgery.
At its December 2006 meeting, the
PPAC recommended that CMS apply
any payment policies uniformly to ASCs
under the revised ASC payment system
and HOPDs under the OPPS. In the
GAO Report (GAO–07–86) published on
November 30, 2006, based upon its
study of the 20 most frequently
performed ASC procedures in CY 2004,
the GAO found that many additional
services were billed with surgical
procedures in both the ASC and HOPD
settings, but few resulted in an
additional payment in one setting but
not the other. In general, HOPDs were
paid separately for some of the related
additional services they billed with the
procedures and, in the ASC setting,
other Part B suppliers usually billed
Medicare for those services and received
payment for them. Multiple surgical
procedures performed in one session
were typically paid separately in both
settings, occurring in similar
proportions of cases and subject to the
same 50-percent reduction policy for the
procedure with the lower payment rate.
Laboratory services were paid under the
OPPS according to the Clinical
Diagnostic Laboratory Fee Schedule
(CLFS) rates and were billed by another
Medicare Part B supplier when
provided in the context of a surgical
procedure performed in an ASC.
Similarly, some radiology services were
paid separately under the OPPS, but
when those radiology services were
performed with procedures provided in
the ASC setting, those services generally
were furnished and billed by another
Part B supplier. Anesthesia services in
both settings were usually billed by
another Part B supplier. While
individual drugs were billed under the
OPPS for most procedures, the GAO
found that none of those individual
drugs were separately payable in the
HOPD setting, just as their payment was
packaged in ASCs. Thus, the GAO
concluded that there were many
similarities in the additional services
billed in the ASC or HOPD settings with
the top 20 ASC procedures.
Furthermore, the GAO found that, in the
context of the existing ASC payment
system, CMS generally made separate
payment for similar additional services
PO 00000
Frm 00026
Fmt 4701
Sfmt 4700
in both settings, although sometimes to
other Part B suppliers than to the ASCs
themselves.
We also note that we proposed,
consistent with section 141(b) of the
Social Security Act Amendments of
1994, Public Law 103–432, to continue
to provide adjustment to payment
amounts for NTIOLs under the revised
ASC payment system as set forth in
Subpart G that we finalized in the CY
2007 OPPS/ASC final rule with
comment period.
We received numerous comments on
our proposed packaging policies for the
revised ASC payment system. The
commenters submitted many
suggestions regarding the various
approaches that they believed CMS
should follow when finalizing the
packaging policies for certain items and
services under the revised ASC payment
system. A summary of the comments
and our responses follow.
Comment: In general, many of the
commenters agreed with CMS’ proposal
to continue to package under the revised
ASC payment system payment for
various items and services that are
currently packaged under the OPPS and
the existing ASC payment system. They
recommended that CMS adopt its
proposal to provide packaged payment
for the costs of many items and services
that are directly related to the provision
of surgical procedures, such as facility
overhead, operating and recovery room
use, nursing and technician services,
administrative and housekeeping items
and services, appliances and equipment,
materials for anesthesia, IOLs, surgical
dressings, supplies, splints, and casts.
They acknowledged that the statute
requires that payment to ASCs for IOLs
(other than NTIOLs which receive a
supplemental payment) must be
packaged into the ASC payment for IOL
insertion procedures. In addition, the
commenters agreed that CMS should
continue to exclude from payment as
part of the ASC payment for covered
surgical procedures some items and
services that are paid under other Part
B fee schedules, specifically the
professional services of physicians and
nonphysician practitioners paid under
the MFPS and laboratory services paid
under the CLFS. Further, the
commenters agreed that CMS should
continue to provide additional payment
for NTIOLs.
The commenters who supported
continued packaging of the items and
services described above generally
provided those recommendations in the
context of their broader
recommendation to apply the same
packaging policies under the revised
ASC payment system as under the
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
OPPS, because the proposed payment
rates under the revised ASC payment
system were based upon the OPPS
payment groups. They argued that
parallel packaging policies were most
consistent with promoting transparency
between the two systems and
minimizing any payment incentives to
shift sites of service for various
procedures. They also believed that this
approach is the most appropriate, given
the proposal to base the rates in the
revised ASC payment system on the
OPPS relative payment weights, with
application of a single conversion factor.
The commenters asserted that consistent
packaging policies would ensure that
some payment was made for the costs of
all items and services used by facilities
in performing surgical procedures, and
that there was no duplicate payment for
these items under either the OPPS or the
revised ASC payment system.
MedPAC supported the proposal to
expand the ASC payment bundles in the
revised payment system by packaging
payment for implantable prosthetics and
DME, but recommended that CMS make
the payment bundles under the revised
ASC payment system and the OPPS
even more compatible by expanding the
payment bundles in the OPPS. MedPAC
noted that different bundling policies
under the two payment systems may
lead to different relative payment
amounts in each setting, even if the base
payment rates share the same relative
values in both settings.
Response: We appreciate the
commenters’ support for continuing to
package payment under the revised ASC
payment system for those items and
services that also receive packaged
payment under the OPPS. The
commenters’ recommendations are
consistent with the PPAC
recommendation that we apply payment
policies uniformly across the two
systems. We note that any changes to
the OPPS payment bundles are outside
the scope of this final rule for the
revised ASC payment system. Such
changes would have to be proposed and
finalized through the OPPS annual
rulemaking cycle, and we will keep
MedPAC’s recommendations in mind
for future OPPS updates.
As set forth in final § 416.163,
payment is made under the revised ASC
payment system for ASC services
furnished in connection with covered
surgical procedures. As set forth in
revised § 416.2, ASC services include
both facility services, which are defined
as items and services that are furnished
in connection with a covered surgical
procedure performed in an ASC and for
which payment is packaged into the
ASC payment for the covered surgical
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
procedure, and covered ancillary
services, which are defined as those
items and services that are integral to a
covered surgical procedure and for
which separate payment may be made
under the revised ASC payment system.
After considering all public comments
received, we are finalizing, with
modification, our proposal to provide
packaged payment for ASC facility
services into the ASC payment for
covered surgical procedures under the
revised ASC payment system. That is,
we will continue to identify as within
the scope of ASC facility services for
which payment is packaged into the
payment for covered surgical
procedures as set forth in final
§ 416.164(a) the following: nursing,
technician, and related services; use of
the facility where the surgical
procedures are performed; laboratory
testing performed under a Clinical
Laboratory Improvement Amendments
of 1988 (CLIA) certificate of waiver;
drugs and biologicals for which separate
payment is not allowed under the OPPS;
medical and surgical supplies not on
pass-through status under the OPPS;
equipment; surgical dressings;
implanted prosthetic devices and
related accessories and supplies not on
pass-through status under the OPPS,
including IOLs; implanted DME and
related accessories and supplies not on
pass-through status under the OPPS;
splints and casts and related devices;
radiology services for which separate
payment is not allowed under the OPPS
and other diagnostic tests or interpretive
services that are integral to a surgical
procedure; administrative,
recordkeeping, and housekeeping items
and services; materials, including
supplies and equipment for the
administration and monitoring of
anesthesia; and supervision of the
services of an anesthetist by the
operating surgeon. Under the revised
ASC payment system, the above items
and services fall within the scope of
ASC facility services, and we will
package payment for them into the ASC
payment for the covered surgical
procedure in order to promote efficient
use of resources. We will continue to
provide a payment adjustment for
insertion of an IOL approved as
belonging to a class of NTIOLs, for the
5-year period of time established for that
class, as set forth in Subpart G and new
§ 416.172(g) for the revised ASC
payment system.
As a modification to our proposal,
under the final policy of the revised
ASC payment system, covered ancillary
services that are integral to a covered
ASC surgical procedure will be allowed
separate payment. These covered
PO 00000
Frm 00027
Fmt 4701
Sfmt 4700
42495
ancillary services, which are outside of
the scope of ASC facility services
defined at § 416.2 and described at new
§ 416.164(a) for which payment is
packaged into the ASC payment for
covered surgical procedures, are defined
at § 416.2 and described at new
§ 416.164(b) as follows: brachytherapy
sources; certain implantable items that
have pass-through status under the
OPPS; certain items and services that
we designate as contractor-priced
(payment rate is determined by the
Medicare contractor) including, but not
limited to, the procurement of corneal
tissue; certain drugs and biologicals for
which separate payment is allowed
under the OPPS; and certain radiology
services for which separate payment is
allowed under the OPPS. Public
comments on the proposed rule and our
responses regarding these specific items
and services are discussed later in this
section.
We will consider to be outside the
scope of ASC services, as set forth in
§ 416.164(c), the following items and
services, including, but not limited to:
physicians’ services (including surgical
procedures and all preoperative and
postoperative services that are
performed by a physician); anesthetists’
services; radiology services (other than
those integral to performance of a
covered surgical procedure); diagnostic
procedures (other than those directly
related to performance of a covered
surgical procedure); ambulance services;
leg, arm, back, and neck braces other
than those that serve the function of a
cast or splint; artificial limbs; and
nonimplantable prosthetic devices and
DME.
2. Policies for Specific Items and
Services
Although in the August 2006
proposed rule we proposed to package
payment for a broad array of items and
services under the revised ASC payment
system into the ASC payment for a
covered surgical procedure as described
earlier in this section, we solicited and
received many public comments
regarding our proposed treatment of
those items or services that are directly
related to a surgical procedure and that
would be paid separately under the
OPPS but that were proposed for
packaging under the revised ASC
payment system. We address those
specific comments and provide our
responses below.
Comment: A number of commenters
indicated that, if the goal of the revised
ASC payment system is to create a
payment system that is based on OPPS
relative weights and payment rates, then
the packaging policy for ASCs should be
E:\FR\FM\02AUR2.SGM
02AUR2
42496
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
based on the same inclusions as those
found under the OPPS. They suggested
that following the OPPS payment
policies under the revised ASC payment
system would promote parity in
payments between HOPDs and ASCs
and, thereby, eliminate inappropriate
incentives to base care decisions on
payment considerations. Specifically, a
number of commenters were concerned
about payment differences that could
arise between HOPDs and ASCs when
services outside the CPT surgical range
were provided in an ASC in conjunction
with a covered surgical procedure on
the ASC list. They noted that when
HOPDs provide some of these services
and items, they generally receive
separate payment for them.
Response: Because we received
numerous comments on various issues
related to the proposed packaging of
payment for specific items and services
under the revised ASC payment system
where the proposed packaging policy
differs from the OPPS payment policy,
we address them separately in the
following sections:
a. Radiology Services
Under the existing ASC payment
system, we define a surgical procedure
as any procedure described within the
range of Category I CPT codes that the
AMA defines as ‘‘surgery’’ (CPT codes
10000–69999). In the August 2006
proposed rule, we indicated that we
would continue this standard (71 FR
49636). Because the HCPCS codes that
describe radiology services are outside
of the CPT surgical range, payment for
radiology services that are directly
related to surgical procedures has been
packaged into the ASC payment for the
covered surgical procedure under the
existing ASC payment system. The
current regulatory definition of an ASC
does not allow the ASC and another
entity to mix functions and operations
in a common space during concurrent or
overlapping hours of operation. That is,
the two facilities must be separated by
time (different hours of operation) or the
other entity may operate in the ASC’s
space when the ASC is not operating in
that space. Historically, we have made
an exception to this rule when there is
a need for imaging services during the
course of a covered surgical procedure
in progress in an ASC under the existing
ASC payment system. In that case, an
Independent Diagnostic Testing Facility
(IDTF) sharing the space with the ASC
(normally at a different time) may
conduct the required radiology service
outside of its normal business hours, as
needed, and receive Medicare payment
for those services. Specifically, under
the existing ASC payment system if an
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
ASC enrolls in the Medicare program as
an IDTF and bills as that supplier when
furnishing a radiology service that is
reasonable and necessary and directly
related to and furnished in conjunction
with a covered surgical procedure, the
IDTF may bill and receive payment
under the MPFS for imaging and
guidance services, even though they are
being provided during the ASC’s
designated hours.
The GAO Report on ASC payment
released on November 30, 2006
confirmed that separate payment is
commonly made to another Part B
supplier for these radiology services
provided in association with surgical
procedures in ASCs. Currently,
radiology services provided in
association with surgical procedures
paid under the OPPS are either
packaged or paid separately through an
OPPS facility payment. We received a
number of comments regarding our
proposal to package payment for
radiology services into payment for their
associated surgical procedures under
the revised ASC payment system. A
summary of the comments and our
responses follow.
Comment: Numerous commenters
opposed CMS’ proposed policy of
packaging payment for radiology
services directly related to a surgical
procedure into the ASC payment for the
associated covered surgical procedure.
Some commenters requested that CMS
continue to follow the existing practice
regarding separate payment for
radiology services provided in
association with surgical procedures
under the current ASC payment system.
That is, they recommended that CMS
permit continued separate payments for
such radiology services to IDTFs if the
ASCs are enrolled as IDTFs and bill for
the services as that type of supplier. On
the other hand, other commenters
believed that ASC enrollment as an
IDTF supplier was unnecessarily
administratively burdensome for those
ASCs that only are providing radiology
services necessary for the safe provision
of surgical procedures. These
commenters requested that CMS adopt
the OPPS payment policy for radiology
services under the revised ASC payment
system, which either provides separate
payment or packages their payment into
the OPPS payment for the surgical
procedure associated with the radiology
services. They indicated that following
the OPPS payment policy under the
revised ASC payment system would
promote parity in payments between
HOPDs and ASCs, especially because
the relative payment weights used in
both payment systems were linked. In
contrast, MedPAC recommended that
PO 00000
Frm 00028
Fmt 4701
Sfmt 4700
CMS address the potentially
inconsistent payment policies by
creating larger payment bundles under
the OPPS, consistent with CMS’
proposal to package payment for
radiology services directly related to a
surgical procedure under the revised
ASC payment system.
Response: We believe that appropriate
radiology services may be necessary for
the safe performance of covered surgical
procedures that are provided to
Medicare beneficiaries in ASCs, and we
realize that under the current system,
payments for many of these services are
made to other Part B suppliers even
though the radiology services are
integral to the surgical procedures
provided by ASCs. We have come to
believe that the most prudent method
for providing accurate payment for the
ancillary radiology services that are
integral to, and required for the
successful performance of, covered
surgical procedures is to provide
separate payment for certain radiology
services under our final policy for the
revised ASC payment system. Payment
for the costs of radiology services that
are separately paid under the OPPS is
not included in the OPPS payment
weights upon which the revised ASC
payment system is based so, under our
proposal, ASCs may not have received
the most appropriate payment for the
costs of these associated radiology
services. We will, therefore, provide
separate payment to ASCs for certain
ancillary radiology services when they
are integral to the performance of a
covered surgical procedure billed by the
ASC on the same day, provided that
separate payment for the radiology
service would be made under the OPPS.
We specify that a radiology service is
integral to the performance of a covered
surgical procedure if it is required for
the successful performance of the
surgery and is performed in the ASC
immediately preceding, during, or
immediately following the covered
surgical procedure. Based on our
analysis of the OPPS data, we believe
that, in most cases, a radiology service
that is separately payable under the
OPPS that is performed in the ASC on
the same day as a covered surgical
procedure will be provided integral to a
covered surgical procedure, and the
ASC will be able to receive separate
payment for the service as a covered
ancillary service. The separate ASC
payments for these radiology services
will be made at the lower of: (1) The
amount calculated according to the
standard methodology of the revised
ASC payment system; or (2) the MPFS
nonfacility practice expense amount for
the service (specifically, for the
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
technical component (TC) if the
service’s HCPCS code is assigned a TC
under the MPFS). This is similar to our
final payment policy for covered officebased surgical procedures added to the
ASC list in CY 2008 or later years.
Payment for the costs of the facility
resources associated with the radiology
service would have been made to IDTFs
under the existing ASC payment system
at the MPFS nonfacility practice
expense amount. Therefore, we believe
the revised payment system beginning
January 1, 2008, will both ensure
appropriate and equitable payment for
covered ancillary radiology services
integral to covered surgical procedures
and not provide a payment incentive for
migration of services from physicians’
offices or IDTFs to ASCs.
This final policy will not encourage
the proliferation of ASCs enrolling as
IDTF suppliers, a practice which could
lead to even greater future increases in
the volume of diagnostic imaging
services than those recently observed for
such services to Medicare beneficiaries.
CMS defines an IDTF in § 410.33 as an
entity independent of a hospital or
physician’s office in which diagnostic
tests are performed by licensed or
certified nonphysician personnel under
appropriate physician supervision.
ASCs are distinct entities that operate
exclusively for the purpose of providing
surgical services to patients not
requiring hospitalization (§ 416.2). As
discussed earlier, an ASC that is also
enrolled as an IDTF must maintain
separate, exclusive hours of operation
from those of the IDTF, and there may
be no overlap in the hours of operation
of the two entities.
In order to bill for diagnostic tests, the
IDTF must be enrolled as such with
Medicare and meet specific
requirements regarding its structure,
ownership and, operation as set forth in
§ 410.33. As stated in § 416.49, an ASC
is responsible for obtaining radiologic
services from a Medicare approved
facility to meet the needs of its patients
and, as confirmed by the GAO in its
report released on November 30, 2006,
many ASCs currently provide those
radiology services in association with
covered surgical procedures through
other Part B suppliers, specifically
IDTFs.
Under the revised payment system,
there is no incentive for ASCs that
provide only those radiology services
that are integral to the performance of
covered surgical procedures to also
enroll as IDTFs. In contrast to current
policy, under the revised system,
payment will be made to the ASC for
radiology services that are furnished
integral to a covered surgical procedure.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
Payment will no longer be permitted to
IDTFs for covered ancillary radiology
services furnished integral to covered
surgical procedures in ASCs. Because
ASCs are distinct entities that operate
exclusively to provide ambulatory
surgical services, we would not expect
that IDTFs sharing space with ASCs
would be billing for any services for a
patient receiving those services in an
ASC on the date of a covered surgical
procedure because all such services
would be integral to the surgical
procedure.
Under the final policy, only the ASC
can receive payment for the facility
resources required to provide the
ancillary radiology services. IDTFs
would not be able to bill for radiology
services integral to the performance of a
covered surgical procedure, an existing
practice which commenters claimed is
unnecessarily administratively
burdensome because it requires ASCs
that are only providing radiology
services related to the safe performance
of surgical procedures also to enroll as
IDTF suppliers under Medicare. As of
January 1, 2008, we are no longer
permitting the exception that has
allowed billing by IDTFs for required
radiology services provided in ASCs
during the course of covered ASC
surgical procedures. We are also not
allowing any other suppliers to bill for
the technical component of radiology
services provided in ASCs that are
integral to the performance of an ASC
covered surgical procedure. Only ASCs
will receive separate payment for the
technical component of those radiology
services that are separately payable
under the OPPS to ensure that no
duplicate payment is made. This policy
will ensure that packaged or separate
payment is made to ASCs for all
radiology services integral to the
performance of covered surgical
procedures, thereby providing
appropriate payment to ASCs for those
radiology services that are essential to
the delivery of safe, high quality
surgical care.
In summary, under the revised ASC
payment system, we are adopting the
OPPS payment status for radiology
services and will pay separately, at the
lower of the amount developed
according to the standard methodology
of the revised ASC payment system or
the MPFS nonfacility practice expense
amount, for ancillary radiology services
designated as separately payable under
the OPPS when those radiology services
are integral to the performance of a
covered surgical procedure provided on
the same day and billed by the ASC.
Similarly, we will package payment for
those services that are designated as
PO 00000
Frm 00029
Fmt 4701
Sfmt 4700
42497
packaged under the OPPS into the
payment for the covered surgical
procedure. The separate national,
unadjusted ASC payment for a covered
ancillary radiology service would be
based either upon the OPPS payment
weight for the APC group of the
radiology service, with application of
the uniform ASC conversion factor, or
upon the MPFS nonfacility practice
expense relative value units (RVUs) for
the service. Payment under the revised
ASC payment system for these covered
ancillary radiology services would be
subject to geographic adjustment, like
payment for covered surgical
procedures. IDTFs would no longer be
able to receive payment for ancillary
radiology services that are integral to the
performance of a covered surgical
procedure for which the ASC is billing
Medicare. This policy is consistent with
the PPAC’s request for uniform payment
policies across the OPPS and the revised
ASC payment system and is responsive
to MedPAC’s concern about creating
different payment bundles for ASCs and
HOPDs. Because the packaging status of
radiology services under the revised
ASC payment system will parallel their
treatment under the OPPS, any changes
to the packaging of radiology services
under the OPPS that would alter the
OPPS payment bundles would also
occur under the revised ASC payment
system. Therefore, we believe that this
approach is fully consistent with the
recommendations of MedPAC and the
PPAC in applying payment policies
consistently to both ASCs and HOPDs.
Radiology services include all
Category I CPT codes in the radiology
range established by CPT, from 70000 to
79999, and Category III CPT codes and
Level II HCPCS codes that describe
radiology services that crosswalk or are
clinically similar to procedures in the
radiology range established by CPT.
This revised ASC payment system
policy for each calendar year will apply
to all radiology services that are
separately payable under the OPPS in
that same calendar year. An illustrative
listing that includes all radiology
services that are separately payable
under the CY 2007 OPPS, which will be
proposed for updating and then
finalized in the CY 2008 OPPS/ASC
proposed and final rules, respectively,
can be found in Addendum BB to this
final rule. Covered ancillary radiology
services are assigned to payment
indicator ‘‘Z2’’ (Radiology service paid
separately when provided integral to a
surgical procedure on ASC list; payment
based on OPPS relative payment weight)
or ‘‘Z3’’ (Radiology service paid
separately when provided integral to a
E:\FR\FM\02AUR2.SGM
02AUR2
42498
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
surgical procedure on ASC list; payment
based on MPFS nonfacility PE RVUs).
ASC payment rates for these radiology
services will be determined according to
the standard methodology of the revised
ASC payment system as discussed
further in section V. of this final rule, or
according to the MPFS nonfacility
practice expense amount, whichever
payment amount is lower. This final
policy is set forth in §§ 416.171(d) and
416.167(b)(3).
After consideration of all public
comments received, we are finalizing a
policy to provide separate payment
under the revised ASC payment system
for those ancillary radiology services
separately paid under the OPPS that are
integral to the performance of covered
surgical procedures for which the ASC
bills Medicare. This final policy
contrasts with our proposal which
would have provided packaged payment
for all ancillary radiology services.
Instead, under the revised ASC payment
system, we will provide separate
payment for those ancillary radiology
services that are separately paid under
the OPPS when they are provided on
the same day as, and integral to, the
performance of a covered surgical
procedure in an ASC. Payment for
ancillary radiology services that are
packaged under the OPPS will be
packaged under the revised ASC
payment system, and these services are
identified in Addendum BB to this final
rule with payment indicator ‘‘N1’’
(Packaged service/item; no separate
payment made).
Separately paid radiology services are
considered to be covered ancillary
services. ASC payment for these
radiology services will not be subject to
the 4-year transition (see section IV.J. of
this final rule) because the services have
never received separate payment under
the existing ASC payment system. The
4-year transition applies only to those
services that receive separate payment
under the existing CY 2007 ASC
payment system. We also are revising
proposed § 416.164(a) and (b) to reflect
this final policy.
b. Brachytherapy Sources
As we stated in the August 2006
proposed rule, under the existing ASC
payment system, a single payment is
made to an ASC for all facility services
furnished by the ASC in connection
with a covered surgical procedure.
However, a number of services and
related items covered under Medicare
may be furnished in an ASC, where
these items and services are not
considered to be facility services and,
therefore, are not paid through the ASC
payment for the covered surgical
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
procedure. These items and related
services may be covered and paid to
other Part B suppliers, such as
physicians. Such is sometimes the case
with payment for brachytherapy sources
implanted in ASCs, where the needles
and catheters to implant the sources are
implanted during surgical procedures
that are on the ASC list. Under the
existing ASC payment system, while
payment is not made for brachytherapy
sources to ASCs, these sources may be
separately paid at contractor-priced
rates by Medicare contractors under the
MPFS to physicians who may also be
billing the CPT codes for application of
the brachytherapy sources in ASCs.
Contractor-priced rates are those
payment rates for certain items or
services that are individually
established by each Medicare contractor
for payment of claims submitted to
them. Brachytherapy source application
codes, which are included in the
radiology section of the CPT code book,
are not on the existing ASC list because
they do not fall within the CPT surgical
range and, therefore, are not defined as
surgery for purposes of ASC payment.
While we did not explicitly discuss
payment for brachytherapy sources in
the August 2006 proposed rule, we
received a number of comments
regarding payment for brachytherapy
sources under the revised ASC payment
system. A summary of the comments
and our responses follow.
Comment: Several commenters
suggested that CMS pay separately for
brachytherapy sources under the revised
ASC payment system when they are
implanted in ASCs. Other commenters
recommended that CMS continue to pay
separately under the MPFS for
brachytherapy sources provided in
ASCs. The commenters requested that
CMS allow separate payment for
brachytherapy sources to facilitate the
treatment of cancer patients who have
brachytherapy sources implanted in
ASCs. As an example, they described a
closely related sequence of procedures
performed in the ASC setting for the
brachytherapy treatment of patients
with prostate cancer, including the
placement of needles and catheters,
reported with a CPT code on the ASC
list; the application of brachytherapy
sources, reported with a CPT code not
on the ASC list; and the provision of
numerous brachytherapy sources,
reported with specific Level II HCPCS
codes in the OPPS setting. The
commenters noted that it would be
appropriate to implant brachytherapy
sources in ASCs for the treatment of
prostate cancer, because the surgical
procedure to insert the required needles
PO 00000
Frm 00030
Fmt 4701
Sfmt 4700
and catheters is currently on the ASC
list and, in the case of prostate cancer
in particular, patients must have the
sources implanted in the same session
where the needles or catheters are
placed. The commenters pointed out
that each of these related items and
services is separately paid under the
OPPS, so the base OPPS payment
weights for the surgical needle and
catheter placement procedures do not
provide payment for the brachytherapy
source application or the sources
themselves. They noted that all of these
individual procedures and items are
required to provide the full
brachytherapy treatment.
Response: Based on the comments
received and our review of the issue, we
have concluded that the most
appropriate policy under the revised
ASC payment system is to provide
separate payment to ASCs for the
brachytherapy sources as covered
ancillary services implanted in
conjunction with covered surgical
procedures billed by ASCs. Further, as
evidenced by our decisions regarding
payment for other covered ancillary
services under the CY 2008 revised ASC
payment system, our intention is to
maintain consistent payment and
packaging policies across HOPD and
ASC settings for covered ancillary
services that are integral to covered
surgical procedures performed in ASCs.
Therefore, consistent with our policy to
pay separately for some drugs,
biologicals, and radiology services as
covered ancillary services, we also
believe that adopting a payment policy
consistent with the OPPS for payment of
brachytherapy sources is reasonable and
appropriate to ensure that the
comprehensive brachytherapy service
can be provided by ASCs. The
application of the brachytherapy
sources is integrally related to the
surgical procedures for insertion of
brachytherapy needles and catheters,
which are appropriate for performance
in ASCs. There is a statutory
requirement that the OPPS establish
separate payment groups for
brachytherapy sources related to their
number, radioisotope, and radioactive
intensity, as well as for stranded and
non-stranded sources as of July 1, 2007,
OPPS procedure payments do not
include payment for brachytherapy
sources. We agree with both MedPAC
and the PPAC that consistent payment
bundles between the two payment
systems are desirable. Therefore, under
the revised ASC payment system, we
will pay ASCs separately for
brachytherapy sources when they are
provided in association with a surgical
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
procedure not excluded from ASC
payment and billed by the ASC on the
same day. The ASC brachytherapy
source payment rate for a given calendar
year will be the same as the OPPS
payment rate for that year or, if specific
OPPS prospective payment rates are
unavailable, ASC payments for
brachytherapy sources will be
contractor-priced. The ASC
brachytherapy source payment rate will
be established at its OPPS payment rate,
without application of the ASC budget
neutrality adjustment factor to the OPPS
conversion factor. In addition,
consistent with the payment of
brachytherapy sources under the OPPS,
the ASC payment rates for
brachytherapy sources will not be
adjusted for geographic wage
differences. Because brachytherapy
sources are implantable devices with
relatively fixed costs for which we
would not expect efficiencies that
would permit ASCs to acquire them at
lower costs than HOPDs, we believe it
is most appropriate to pay for the
brachytherapy sources at the same rates
as the OPPS if possible. A list of
brachytherapy sources recognized under
the CY 2007 OPPS, for which payment
according to the statute is made at
charges reduced to cost under the CY
2007 OPPS, is included in Table 3
below, as well as in Addendum BB to
this final rule, specifically those codes
assigned to payment indicator ‘‘H7’’
(Brachytherapy source paid separately
when provided integral to a surgical
procedure on ASC list; payment
contractor-priced).
An updated list will be proposed and
finalized for CY 2008 in the CY 2008
42499
OPPS/ASC proposed and final rules,
respectively, as will the CY 2008 OPPS
payment rates for brachytherapy
sources. We also may establish new
brachytherapy source HCPCS codes,
revise the existing HCPCS codes, or
both, for separate payment on a
quarterly basis under the revised ASC
payment system, as we currently do
under the OPPS, in order to keep the
two payment systems aligned. In
addition, we note that the CPT codes for
the application of brachytherapy
sources are radiology services in the
radiology range of Category I CPT codes,
so they would also be separately paid in
ASCs under the revised ASC payment
system if provided in association with a
covered surgical procedure, as described
in section IV.C.2.a. of this final rule.
TABLE 3.—BRACHYTHERAPY SOURCES PAID SEPARATELY UNDER THE CY 2007 OPPS AS OF APRIL 1, 2007
HCPCS code
mstockstill on PROD1PC66 with RULES2
A9527
C1716
C1717
C1718
C1719
C1720
C2616
C2633
C2634
C2635
C2636
C2637
.........................................
........................................
........................................
........................................
........................................
........................................
........................................
........................................
........................................
........................................
........................................
........................................
Long descriptor
Iodine I–125, sodium iodide solution, therapeutic, per millicurie.
Brachytherapy source, Gold-198, per source.
Brachytherapy source, High Dose Rate Iridium-192, per source.
Brachytherapy source, Iodine-125, per source.
Brachytherapy source, Non-High Dose Rate Iridium-192, per source.
Brachytherapy source, Palladium-103, per source.
Brachytherapy source, Yttrium-90, per source.
Brachytherapy source, Cesium-131, per source.
Brachytherapy source, High Activity, Iodine-125, greater than 1.01 mCi (NIST), per source.
Brachytherapy source, High Activity, Palladium-103, greater than 2.2 mCi (NIST), per source.
Brachytherapy linear source, Palladium-103, per 1MM.
Brachytherapy source, Ytterbium-169, per source.
After consideration of all public
comments received, we are finalizing a
policy to provide separate payment
under the revised ASC payment system
for ancillary brachytherapy sources
implanted in association with the
performance of a covered surgical
procedure that is billed by the ASC to
Medicare. Under our proposal, no
payment would have been made to
ASCs for the implantation of
brachytherapy sources in conjunction
with covered surgical procedures,
although payment could have been
made to other Part B suppliers. Under
this final policy, ASC payment for
brachytherapy sources as covered
ancillary services in a calendar year will
be made at the OPPS rates for that same
year, or if OPPS rates are unavailable,
ASC payment will be made at
contractor-priced rates. Payment rates
for brachytherapy sources will not be
developed through application of the
uniform ASC conversion factor, and
they will not be subject to the
geographic adjustment. Accordingly, we
are revising proposed § 416.164(a) and
(b) to reflect this final policy.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
We would also caution that we expect
ASCs to follow all Federal, State, and
local safety requirements regarding the
proper handling and disposal of these
radioactive substances. ASCs that
cannot comply with those guidelines
should not provide brachytherapy
services. ASC policies for the proper
handling and disposal of brachytherapy
sources also should include
accommodations for the appropriate
disposal of sources that were not
implanted.
c. Drugs and Biologicals
In the August 2006 proposed rule, we
indicated that under the existing ASC
payment system, payment for all drugs
and biologicals (whether packaged or
separately payable under the OPPS) is
packaged into the ASC payment for the
covered surgical procedure. We
proposed to continue that policy under
the revised ASC payment system. Under
the OPPS, CMS pays separately for all
pass-through drugs and biologicals,
while nonpass-through drugs and
biologicals are either packaged or paid
separately under the OPPS, depending
PO 00000
Frm 00031
Fmt 4701
Sfmt 4700
on whether or not their cost is equal to
or less than $55 per day or exceeds $55
per day, respectively, for CY 2007. We
received a number of comments on our
proposal to package payment for all
drugs and biologicals into the payment
for their associated surgical procedures
under the revised ASC payment system.
A summary of the comments and our
responses follow.
Comment: While the commenters
generally agreed with CMS’ proposal to
package payment for inexpensive drugs
into the ASC payment for the covered
surgical procedure under the revised
ASC payment system consistent with
current practice, many commenters
objected to CMS’ proposed packaging of
payment for expensive drugs and
biologicals and urged CMS to pay
separately for them. Moreover, several
commenters requested that CMS adopt
the OPPS payment policies for both
pass-through and nonpass-through
drugs and biologicals under the revised
ASC payment system. They indicated
that following the OPPS payment
policies under the revised ASC payment
system would promote parity in
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42500
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
payments between HOPDs and ASCs
and, thereby, eliminate inappropriate
incentives to base care decisions on
payment considerations. Specifically, a
number of commenters were concerned
about payment differences that could
arise between HOPDs and ASCs when
items were provided in an ASC in
conjunction with a covered surgical
procedure on the ASC list. They noted
that when HOPDs provide pass-through
and many nonpass-through drugs and
biologicals, they generally receive
separate payment for these items;
therefore, the base OPPS payment rates
contain no payment for these drugs and
biologicals.
Several commenters expressed
particular concern regarding CMS’
proposal to package payment for
expensive biologicals into the associated
surgical procedure’s ASC payment.
These commenters cited surgical
procedures for the application of skin
substitutes, newly proposed as
additions for ASC payment in CY 2008,
as examples of relatively inexpensive
surgical procedures that require the use
of costly biologicals, for which separate
payment is made under the OPPS. They
argued that the additions of the
procedures to the ASC list would not
provide meaningful access to those
services in ASCs, given that the
relatively low procedure payments
proposed for the revised ASC payment
system included no payment for those
necessary biologicals. The commenters
further added that not paying separately
for expensive drugs and biologicals in
ASCs could result in a shift of services
from ASCs to HOPDs or physicians’
offices, where they are separately paid,
even though ASCs could be the most
appropriate clinical setting for care.
Some commenters suggested that CMS
select specific drugs and biologicals for
separate payment under the revised
ASC payment system based on specific
criteria such as their cost, required use,
or association with specific surgical
procedures not excluded from ASC
payment.
Response: After considering all the
comments related to payment for drugs
and biologicals, we agree with the
commenters that the revised ASC
payment system should provide
separate payment for relatively costly
drugs and biologicals that are integral to
covered surgical procedures that are
billed by ASCs and whose payments are
not packaged into the base OPPS
payment rates. Therefore, effective
January 1, 2008, we will pay separately
for all OPPS pass-through and nonpassthrough drugs and biologicals that are
separately paid under the OPPS, when
they are provided in association with a
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
covered surgical procedure that is billed
by the ASC to Medicare.
Based on the November 30, 2006 GAO
Report on ASC payment, we recognize
that historically common ASC
procedures generally used drugs that are
packaged under the OPPS, but we
believe that the significant expansion of
the procedures eligible for payment
under the revised ASC payment system,
in addition to evolving surgical practice,
may necessitate the use of different
drugs and biologicals in ASCs in the
future. To ensure appropriate access to
all surgical procedures that are safe for
performance in ASCs, we believe it is
prudent under the revised ASC payment
system to provide separate payment in
the ASC setting for drugs and
biologicals that are integral to covered
surgical procedures for which the ASC
is billing, when the costs of those drugs
and biologicals were not included in
developing the base procedure payment
weights under the OPPS. We do not
believe it would be appropriate to select
only a subset of these drugs and
biologicals that are separately payable
under the OPPS because we do not see
a clear rationale for doing so.
We specify that a drug or biological is
integral to the performance of a covered
surgical procedure if it is required for
the successful performance of the
surgery and is provided in the ASC
immediately preceding, during, or
immediately following the covered
surgical procedure. Based on our
analysis of OPPS data, we believe that,
in most cases, a drug or biological that
is separately payable under the OPPS
that is provided in an ASC on the same
day as a covered surgical procedure will
be provided as integral to the covered
surgical procedure, and the ASC will be
able to receive separate payment for the
drug or biological as a covered ancillary
service.
The payments for separately payable
drugs and biologicals under the revised
ASC payment system for a calendar year
will be equal to the payment rates
developed according to the payment
methodology used in the OPPS for that
same year, without the application of
the ASC budget neutrality adjustment to
the OPPS conversion factor. Because
OPPS payment for separately paid drugs
and biologicals is provided at the
average hospital acquisition cost and is
not based upon the application of the
OPPS conversion factor to relative
payment weights, we believe the OPPS
rates should also reflect the typical
acquisition cost of these products in the
ASC facility setting as well. The OPPS
currently relies on the average sales
price (ASP) methodology to establish
payment rates for many separately paid
PO 00000
Frm 00032
Fmt 4701
Sfmt 4700
drugs and biologicals, and ASP data are
based upon manufacturers’ reports of all
drug sales, including those to different
types of facilities and physicians’
offices. The ASP methodology is also
utilized to establish the physician’s
office payment for drugs and
biologicals. Therefore, we believe that
aligning the ASC payment methodology
with the OPPS payment for these
covered ancillary services is a consistent
and logical approach to setting their
ASC payment rates, and we will not
apply the ASC budget neutrality
adjustment to establish the ASC
payment rates. Comparable to their
treatment under the OPPS, the ASC
payment for separately paid drugs and
biologicals will also not be subject to the
geographic wage adjustment. In
addition, ASC payment for drugs and
biologicals that are not separately
payable under the OPPS will be
packaged into the payments for the
covered surgical procedures with which
they are administered, consistent with
the current OPPS payment
methodology.
As noted above, under the CY 2007
OPPS, payment for separately payable
nonpass-through drugs and biologicals
is made according to the ASP
methodology, and is generally equal to
the ASP plus 6 percent in CY 2007, the
same as the physician’s office payment.
Payment for pass-through drugs and
biologicals is set at the rate under the
Competitive Acquisition Program (CAP)
for Part B drugs or, if the drug is not
included in the CAP, at the rate
established by the ASP methodology
and generally equal to the ASP plus 6
percent. A list of the drugs and
biologicals that are separately paid
under the CY 2007 OPPS, along with
their payment rates as of April 1, 2007,
is included in Addendum BB to this
final rule, specifically those codes
assigned to payment indicator ‘‘K2’’
(Drugs and biologicals paid separately
when provided integral to a surgical
procedure on ASC list; payment based
on OPPS rate). Drugs and biologicals for
which payment is packaged under the
CY 2007 OPPS are also listed in
Addendum BB, where they are assigned
to payment indicator ‘‘N1’’ (Packaged
service/item; no separate payment
made).
The CY 2008 payment status and
payment rates for drugs and biologicals
will be proposed and finalized in the CY
2008 OPPS/ASC proposed and final
rules, respectively. We also may
establish new HCPCS codes for
separately payable drugs and plan to
update payment rates for drugs and
biologicals based on new ASP
information on a quarterly basis under
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
the revised ASC payment system, as we
currently do under the OPPS, in order
to keep the two payment systems
aligned. This final policy is consistent
with the recommendation of the PPAC
and the comments of MedPAC to align
the payment bundles under the OPPS
and ASC payment systems.
In summary, after consideration of all
public comments received, we are
finalizing a policy to provide separate
payment under the revised ASC
payment system for drugs and
biologicals that are separately paid
under the OPPS, when those items are
integral to the performance of a covered
surgical procedure for which the ASC is
billing. We proposed to provide
packaged payment for all drugs and
biologicals under the revised ASC
payment system through the ASC
payment for the covered surgical
procedure. In contrast, this final policy
will provide separate payment for those
drugs and biologicals that are separately
paid under the OPPS, when those items
are provided on the same day as and
integral to the performance of a covered
surgical procedure in an ASC. Separate
ASC payment for these drugs and
biologicals will be made at the OPPS
payment rate for the same calendar
quarter. ASC payment for those drugs
and biologicals that are integral to the
performance of a covered surgical
procedure and whose payment is
packaged under the OPPS will receive
packaged payment under the revised
ASC payment system. Payment rates for
drugs and biologicals will not be
developed through application of the
uniform ASC conversion factor, and
they will not be subject to the
geographic adjustment. We also are
revising proposed § 416.164(a) and (b) to
reflect this final policy.
d. Implantable Devices With PassThrough Status Under the OPPS
In the August 2006 proposal for the
revised ASC payment system, we
proposed to pay for all implantable
devices as part of the ASC payment for
the covered surgical procedure, thereby
packaging payment for all devices
except for the additional ASC
adjustment for NTIOLs. Under this
proposal, payment for devices included
in those device categories with passthrough status under the OPPS would
also be packaged. In contrast, passthrough status under the OPPS provides
payment for a device included in the
pass-through device category on a
claim-specific basis at the hospital’s
charges reduced to cost. That is, fiscal
intermediaries apply the hospital’s
overall cost-to-charge ratio from the
hospital’s last submitted cost report to
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
the submitted charges on the claim and
pay the resulting amount on a claimspecific basis. A device offset amount is
applied, if appropriate, to take into
consideration the predecessor device
payment already packaged into the
OPPS payment for the associated
implantation procedure, in order to
ensure no duplicate payment. The
predecessor device is the device that
would have been used in the procedure
if the pass-through device had not been
implanted and for which the historical
cost is packaged into the payment for
the implantation procedure.
Under the existing ASC payment
system, payment for OPPS designated
pass-through devices is either packaged
into the ASC payment for the covered
surgical procedure or, if the device is
implantable DME or an implantable
prosthetic, separately paid under the
DMEPOS fee schedule, independent
from the ASC payment for the
associated surgical procedure. We
received many comments regarding our
proposal to package payment for devices
with OPPS pass-through status into
payment for their associated surgical
procedures under the revised ASC
payment system. A summary of the
comments and our responses follow.
Comment: Many commenters
encouraged us to expand the OPPS passthrough program to the revised ASC
payment system, to provide separate
payment for those devices whose
payments, in whole or in part, were not
packaged into the base OPPS payment
weights upon which the revised ASC
payment system would be based. These
commenters questioned how ASCs
would be paid appropriately for devices
that are paid separately under the OPPS
as pass-through devices at the hospital’s
charges reduced to cost by the hospital’s
overall cost-to-charge ratio. The
commenters did not believe it would be
appropriate to provide payment for
devices with pass-through status under
the OPPS packaged into the ASC
payment for the associated surgical
procedure, when there are either no
costs associated with those devices
packaged into the base OPPS procedure
payment weights or inadequate costs
associated only with predecessor
devices packaged into the base OPPS
weights.
The commenters added that many of
the OPPS designated pass-through
devices that are implanted in ASCs are
expensive, and their cost would not be
adequately reflected in the ASC
payment for the covered surgical
procedure. They believed that the
proposed policy would result in little
access to these new technologies in the
ASC setting, despite the fact that the
PO 00000
Frm 00033
Fmt 4701
Sfmt 4700
42501
associated surgical procedures for their
implantation are appropriate for ASC
payment. They pointed out that only
devices that demonstrate significant
clinical improvement are provided passthrough status under the OPPS; hence,
Medicare beneficiaries would be unable
to receive the most clinically beneficial
procedures in ASCs.
Several commenters requested that
CMS not provide ASC payments for
many surgical procedures that use
implantable devices, generally for
patient safety reasons, whether passthrough devices are used or not.
Response: While the OPPS passthrough program is a statutory
requirement of the OPPS under section
1833(t)(6) of the Act and, therefore, not
specifically applicable to the revised
ASC payment system, we agree with
commenters that similar device
payment policies for these devices
under the OPPS and the revised ASC
payment system are most appropriate to
ensure access to procedures implanting
these clinically beneficial devices in
ASCs. Specifically in the case of OPPS
pass-through devices, the costs of the
devices are not fully packaged into the
OPPS payment weights upon which the
revised ASC payment system is based
because the devices are separately paid
under the OPPS. We agree with
commenters that if payments to ASCs
for the associated surgical implantation
procedures are inadequate to cover the
costs of these beneficial devices, then
ASCs will not offer the procedures
implanting these devices and
beneficiary access to these effective
devices will thereby be limited to other
sites for the services.
When we examined the three device
categories that currently have passthrough status under the CY 2007 OPPS,
specifically C1820 (Generator,
neurostimulator (implantable), with
rechargeable battery and charging
system), C1821 (Interspinous process
distraction device (implantable)), and
L8690 (Auditory osseointegrated device,
includes all internal and external
components), we noted that the surgical
procedures associated with both C1820
and L8690 are currently payable in the
ASC setting. We continue to believe that
the procedures associated with these
pass-through device categories are safe
for ASC performance and, as such, the
procedures will be paid under the
revised ASC payment system. We
remind the public that the list of device
categories with pass-through status
under the OPPS is updated quarterly,
with the addition of new pass-through
device categories, if applicable, and that
the dates for the expiration of passthrough payment for device categories
E:\FR\FM\02AUR2.SGM
02AUR2
42502
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
are proposed and finalized during the
OPPS annual rulemaking cycle. Only
device categories C1821 and L8690 will
continue with pass-through status under
the CY 2008 OPPS, but there may be
additional device categories established
in the future that will have pass-through
status during all or a portion of that
calendar year. Under the OPPS, claimspecific device pass-through payment is
calculated based on the device charge
reduced to cost by application of the
overall hospital cost-to-charge ratio and,
if applicable, the resulting device cost is
further subject to a payment reduction
(device offset) that is equivalent to the
device cost for predecessor devices
already included in the APC median
cost for the associated surgical
procedure. This ensures that the OPPS
does not provide duplicate payment for
any portion of an implanted device with
pass-through status. Of the three device
categories currently with pass-through
status under the OPPS, only one device
category (C1820) has an associated
device offset due to the costs of the
predecessor nonrechargeable
implantable neurostimulators already
packaged into the base APC payment
weights for neurostimulator
implantation procedures.
Commenters have persuaded us that,
under the revised ASC payment system,
it is appropriate to provide separate
payment for devices that are included in
device categories with pass-through
status under the OPPS. A list of the
OPPS pass-through device categories as
of April 1, 2007 is provided in Table 4
below, and their HCPCS codes are also
included in Addendum BB to this final
rule, where they are assigned to
payment indicator ‘‘J7’’ (OPPS passthrough device paid separately when
provided integral to a surgical
procedure on ASC list; payment
contractor-priced). Implantable devices
that received packaged payment because
they do not have OPPS pass-through
status are also listed in Addendum BB
to this final rule, where they are
assigned to payment indicator ‘‘N1’’
(Packaged service/item; no separate
payment made).
TABLE 4.—ACTIVE OPPS PASS-THROUGH DEVICE CATEGORIES UNDER THE CY 2007 OPPS AS OF APRIL 1, 2007
HCPCS code
mstockstill on PROD1PC66 with RULES2
C1820 ........................................
C1821 ........................................
L8690 .........................................
Long descriptor
Generator, neurostimulator (implantable), with rechargeable battery and charging system.
Interspinous process distraction device (implantable).
Auditory osseointegrated device, includes all internal and external components.
It is not possible to pay for these
devices using the specific OPPS
payment methodology, because cost-tocharge ratios are not available for ASCs
to convert ASC charges to cost in order
to establish a claim-specific device
payment. Because these devices are new
technology and the number of device
categories with pass-through status
under the OPPS has been limited over
the past several years, we believe that
contractor-priced rates are the most
appropriate payment methodology for
these devices under the revised ASC
payment system since there would be
little or no OPPS claims data available
to establish prospective payment rates
for these devices. Therefore, we will pay
ASCs separately for devices with passthrough status under the OPPS in that
same quarter of the calendar year at
contractor-priced rates when they are
implanted in ASCs during a covered
surgical procedure that is billed by the
ASC. As under the OPPS, ASC payment
for these devices would not be subject
to the geographic wage adjustment, nor
would the uniform ASC conversion
factor be applied because there is no
OPPS payment weight available for
these devices and there is little clinical
labor associated with the device
acquisition by the ASC. The associated
nondevice facility resources for the
device implantation procedures would
be paid through an ASC surgical
procedure service payment based upon
the payment weight for the nondevice
portion of the related OPPS APC
payment weight, as described further
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
below with respect to ASC payment for
implantable devices without passthrough status under the OPPS. This
policy, similar to the device offset
policy under the OPPS, would ensure
no duplicate device payment by
removing, if applicable, the costs of
related predecessor devices packaged
into the base procedure’s OPPS payment
weight. Under this policy, we will pay
separately in ASCs for new devices that
result in significant clinical
improvement, consistent with the passthrough policy under the OPPS. This
similar treatment of devices included in
device categories with OPPS passthrough status under both the OPPS and
revised ASC payment systems will help
to ensure that beneficiaries have access
to the devices in both settings. We
believe this approach is fully consistent
with the recommendation of the PPAC
to apply payment policies uniformly to
both ASCs and HOPDs, and with the
comments of MedPAC in support of
comparable payment bundles in the two
systems.
As we have stated earlier in this final
rule, we are firmly committed to
ensuring that outpatient procedures are
not limited to certain sites of service
and that all surgical procedures that can
safely be performed in ASCs and that
are not expected to require an overnight
stay are on the ASC list of covered
surgical procedures so that Medicare
beneficiaries have full access to surgical
services in all appropriate settings. We
believe that paying separately for those
devices that are included in device
PO 00000
Frm 00034
Fmt 4701
Sfmt 4700
categories with pass-through status
under the OPPS and that are implanted
during ASC covered surgical procedures
under the revised ASC payment system
will promote efficient resource use and
ensure appropriate access to care.
After considering all public comments
received, we are finalizing a policy to
provide separate payment under the
revised ASC payment system for
ancillary devices included in device
categories with pass-through status
under the OPPS in the same quarter of
the same calendar year that the devices
are implanted during a covered surgical
procedure that is billed by the ASC. In
contrast with our proposal which would
have provided packaged payment for
these devices, but consistent with their
separate payment under the OPPS, this
specific subset of implantable devices
will receive separate payment under the
revised ASC payment system as covered
ancillary services. ASC payment will be
made for the devices at contractorpriced rates and will not be subject to
geographic wage adjustment, and
payment for the associated surgical
procedures will be made according to
our standard methodology for the
revised ASC payment system, based on
only the service (nondevice) portion of
the procedure’s OPPS relative payment
weight. Accordingly, we are revising
proposed § 416.164(a) and (b) to reflect
this final policy.
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
e. Implantable Devices Without PassThrough Status Under the OPPS
Historically, separate payment for
implantable DME and prosthetics
provided in association with procedures
on the ASC list of covered surgical
procedures has been made to ASCs on
the basis of the DMEPOS fee schedule.
Payment for other devices that are not
implantable DME or prosthetics,
including some nonpass-through
devices under the OPPS, has historically
been made as part of the ASC payment
for the covered surgical procedure
because such items have been
considered to be supplies.
In the August 2006 proposed rule for
the revised ASC payment system, we
proposed to pay for nonpass-through
devices as part of the ASC payment that
would be based on the OPPS relative
payment weight of the associated
surgical procedure, thereby packaging
payment for all nonpass-through
devices, consistent with their treatment
under the OPPS. We also proposed to
apply an ASC budget neutrality
adjustment of 62 percent to the OPPS
conversion factor to calculate the ASC
payment rates for all covered surgical
services, regardless of the specific
nature of the surgical procedures.
Therefore, payment for surgical
procedures with high device costs,
referred to as device-intensive
procedures, would be calculated like
payment for all other surgical
procedures not excluded from ASC
payment under the revised payment
system. We received many comments on
our proposed payment policy for
devices without pass-through status
under the OPPS. A summary of the
comments and our responses follow.
Comment: Many commenters objected
to the packaging of payment for all
devices as proposed, principally on the
basis that, where the device cost
exceeds 62 percent of the APC payment
rate, the ASC would not be paid enough
to cover the cost of the device, let alone
the other service costs of the
implantation procedure. Some
commenters suggested that CMS
continue to pay separately for devices
for which it currently pays separately
under the DMEPOS fee schedule and
provide payment through the ASC
payment for only the nondevice portion
of the implantation procedure. They
recommended that CMS apply the ASC
conversion factor only to the nondevice
portion of the APC payment weight to
calculate the ASC service payment for
the implantation procedure. Other
commenters believed that CMS should
not apply the ASC conversion factor to
the device portion of the APC payment,
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
but instead should pass the OPPS
payment amount for the device through
to the ASC payment system directly
because ASCs would be unable to obtain
the devices at lower cost than HOPDs.
They argued that ASCs would see no
efficiencies regarding the fixed device
costs, so it would be inappropriate to
apply the ASC conversion factor to
develop this portion of the ASC
procedure payment. These commenters
suggested that CMS could then apply
the ASC conversion factor to the
nondevice portion of the APC payment
to develop a service payment, and sum
the two partial payments (for the device
and the service) to calculate the full
ASC payment for these device-intensive
procedures under the revised ASC
payment system. They concluded that,
in this manner, the OPPS and the
revised ASC payment system would be
aligned, because both systems would
provide packaged payment for devices
without OPPS pass-through status.
Several commenters requested that
CMS not provide ASC payments for
many procedures that use devices and
that are currently paid under the OPPS,
generally for patient safety reasons.
Response: For purposes of the revised
ASC payment system, we are defining
device-intensive procedures as all those
ASC covered surgical procedures in CY
2008 that are assigned to devicedependent APCs under the OPPS, where
the APC device cost is greater than 50
percent of the median APC cost. There
are 40 such procedures that fall into this
group based on their CY 2007 APC
assignments, 25 of which are on the CY
2007 ASC list and 15 of which will be
newly recognized for ASC payment
beginning in CY 2008. They are listed in
Tables 5 and 6, respectively, below.
These procedures are also identified in
Addendum AA to this final rule.
Specific payment policies have been
applied to device-dependent APCs
under the OPPS over the past several
years (71 FR 68063 through 68070).
There are about 194 OPPS devicedependent procedures, specifically
those procedures that are assigned to the
42 OPPS device-dependent APCs under
the CY 2007 OPPS, and 89 of these
device-dependent procedures are also
paid in ASCs in CY 2007. However,
only 25 of those 89 procedures are
assigned to APCs that have device costs
that exceed 50 percent of the APC
median costs and would be subject to
the payment policy applied to deviceintensive procedures under the revised
ASC payment system. Thus, as noted
above, based on current data, there are
40 device-intensive surgical procedures
for which ASC payment will be made in
CY 2008. ASC payments for these 40
PO 00000
Frm 00035
Fmt 4701
Sfmt 4700
42503
device-intensive procedures will be
made according to the policy described
for device-intensive ASC procedures
based on their assignments to 19 of the
42 device-dependent APCs under the
OPPS for CY 2007.
We do not agree with the commenters
who believe that many device-intensive
procedures are unsafe for performance
in ASCs because most of these deviceintensive procedures have been on the
ASC list of covered surgical procedures
for several years and no safety concerns
have arisen. In the context of developing
this final rule, we have once again
reviewed the clinical characteristics of
all of these device-intensive procedures
based on the public comments and our
final policies regarding surgical
procedures for exclusion from ASC
payment, as discussed in section III.A.2.
of this final rule. We continue to believe
that many device-intensive procedures
are appropriate for performance in ASCs
under the final policies of the revised
ASC payment system.
We also are persuaded that it would
be inappropriate to continue to provide
separate payment for some implantable
prosthetics and DME under the
DMEPOS fee schedule by maintaining
the practice of the existing ASC
payment system. Payment for these
devices is already packaged into the
base OPPS payment weights, and
separate payment for devices under the
ASC payment system could essentially
pay twice for the device. Separate
payment for devices under the revised
ASC payment system would also be
contrary to MedPAC’s support for our
proposal to increase the size of the ASC
payment bundles and to create
comparable payable bundles under the
OPPS and the revised ASC payment
system. Most importantly, separate
payment for certain devices would not
provide the incentives for efficiency that
would occur through packaging device
payment into payment for the associated
surgical implantation procedure,
because increased packaging through
larger payment bundles would
encourage ASCs to provide surgical
services as cost-effectively as possible.
In addition, there are some expensive
implantable devices, such as ICDs,
which are not currently paid under the
DMEPOS fee schedule, but for which we
will provide payment for their
associated surgical implantation
procedures in ASCs beginning in CY
2008. If the separate DMEPOS payment
methodology were to be continued,
ASCs would be significantly underpaid
for such procedures because the device
would not be separately paid if it were
neither implantable DME nor an
implantable prosthetic device. The
E:\FR\FM\02AUR2.SGM
02AUR2
42504
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
commenters who recommended
continued separate payment for some
devices under the DMEPOS fee
schedule provided no suggestions for
developing the appropriate ASC
payment for expensive implantable
devices that are neither implantable
DME nor implantable prosthetics.
We agree with the commenters who
are concerned that our standard
methodology for the revised ASC
payment system that applies a uniform
ASC conversion factor to the OPPS
relative payment weights could provide
inadequate payment for deviceintensive procedures under the revised
ASC payment system. The estimated
budget neutrality adjustment for the
revised ASC payment system was 62
percent of the OPPS conversion factor in
the proposed rule, and it is currently 67
percent as discussed in section V. of this
final rule (the final CY 2008 ASC budget
neutrality adjustment will be proposed
and finalized through the CY 2008
OPPS/ASC rulemaking cycle). Because
of the expected magnitude of the
difference between the estimated ASC
procedure payments, calculated by
application of the ASC conversion factor
to the OPPS payment weights under the
revised ASC payment system, and the
OPPS payment rates for those same
procedures, we are particularly
concerned that under the revised ASC
payment system device-intensive
procedures would be underpaid if we
paid for them as proposed.
We would not expect that ASCs’
device costs for expensive devices
would differ significantly from the
device costs of HOPDs because we do
not believe that ASCs would realize
more substantial efficiencies in their
acquisition of devices in comparison
with HOPDs. On the other hand, we
believe that ASCs would experience
significant efficiencies in comparison
with HOPDs when performing the
implantation procedures themselves,
consistent with the findings of the GAO
Report regarding the lower cost of
procedures in ASCs in comparison with
HOPDs. These lower ASC costs may be
attributable to a variety of factors,
including lower facility overhead costs
due to ASCs’ limited operating hours,
lack of emergency departments,
specialization of ASCs contributing to
efficient delivery of services, and the
characteristics of different patient
populations treated in ASCs versus
HOPDs. Therefore, we believe it would
be most appropriate under the revised
ASC payment system to apply a
modified payment methodology to this
group of device-intensive services.
Accordingly, in developing the ASC
payment rates under the revised
payment system for device-intensive
procedures, we will calculate the device
portion of the ASC procedure payment
separately from the service portion, in
order to provide special consideration
for the packaged device costs that are
unlikely to vary significantly across
different facility settings.
Our final payment methodology for
device-intensive procedures under the
revised ASC payment system is as
follows. We will apply the OPPS device
offset percentage to the OPPS national
unadjusted payment to acquire the
device cost included in the OPPS
payment rate for a device-intensive ASC
covered surgical procedure, which we
will then set as equal to the device
portion of the national unadjusted ASC
payment rate for the procedure. The
device offset percentage, which is used
under the OPPS to remove the
predecessor device cost from the device
pass-through payment when a passthrough device is paid at charges
reduced to cost, so that the pass-through
payment for the device only represents
the incremental payment for the new
device over the payment for predecessor
devices already packaged into the APC
payment is our best estimate of the
amount of device cost included in an
APC payment under the OPPS. We
believe that use of the OPPS device
offset percentage is appropriate to
establish the device amount of payment
when device-intensive procedures are
furnished in an ASC under the revised
ASC payment system. The OPPS device
offset percentage is calculated for each
OPPS device-dependent APC based
upon the most recent year of hospital
outpatient claims data available and
represents the relative amount of device
payment that we believe exists in the
total APC payment. The device offset
percentage is also applied to reduce the
APC payment when a typically
expensive device is provided to the
hospital without cost or with full credit
for the device being replaced and,
therefore, the hospital incurs no device
cost for implanting the replacement
device. For more background on the
calculation and use of the device offset
percentage, we refer readers to the CY
2007 OPPS/ASC final rule with
comment period (71 FR 68077 through
68079).
We will then calculate the service
portion of the ASC payment for deviceintensive procedures by applying the
uniform ASC conversion factor as
specified in new § 416.171 to the service
(nondevice) portion of the OPPS relative
payment weight for the device-intensive
procedure. Finally, we will sum the
ASC device portion and ASC service
portion to establish the full payment for
the device-intensive procedure under
the revised ASC payment system.
Tables 5 and 6 include the most
current device-intensive procedures that
would be subject to this modified
payment methodology under the revised
ASC payment system. The deviceintensive procedure lists for the CY
2008 revised ASC payment system will
be proposed and finalized in
conjunction with the OPPS treatment of
these procedures in the CY 2008 OPPS/
ASC proposed and final rules,
respectively. The device-intensive
procedures in Tables 5 and 6 are listed
in Addendum AA to this final rule,
where they are assigned to payment
indicators ‘‘H8’’ (Device-intensive
procedure on ASC list in CY 2007; paid
at adjusted rate) and ‘‘J8’’ (Deviceintensive procedure added to ASC list
in CY 2008 or later; paid at adjusted
rate), respectively.
TABLE 5.—ILLUSTRATIVE LIST OF DEVICE-INTENSIVE PROCEDURES ON THE CY 2007 ASC LIST SUBJECT TO THE
MODIFIED PAYMENT METHODOLOGY UNDER THE REVISED ASC PAYMENT SYSTEM BEGINNING IN CY 2008
mstockstill on PROD1PC66 with RULES2
HCPCS code
33212
33213
36566
53445
53447
54401
54405
54410
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
VerDate Aug<31>2005
16:08 Aug 01, 2007
CY 2007
OPPS APC
Short descriptor
Insertion of pulse generator .................................................................
Insertion of pulse generator .................................................................
Insert tunneled cv cath ........................................................................
Insert uro/ves nck sphincter .................................................................
Remove/replace ur sphincter ...............................................................
Insert self-contd prosthesis ..................................................................
Insert multi-comp penis pros ...............................................................
Remove/replace penis prosth ..............................................................
Jkt 211001
PO 00000
Frm 00036
Fmt 4701
Sfmt 4700
E:\FR\FM\02AUR2.SGM
0090
0654
0625
0386
0386
0386
0386
0386
02AUR2
CY 2007
device-dependent
APC offset percent
74.74
77.35
57.56
61.16
61.16
61.16
61.16
61.16
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42505
TABLE 5.—ILLUSTRATIVE LIST OF DEVICE-INTENSIVE PROCEDURES ON THE CY 2007 ASC LIST SUBJECT TO THE
MODIFIED PAYMENT METHODOLOGY UNDER THE REVISED ASC PAYMENT SYSTEM BEGINNING IN CY 2008—Continued
HCPCS code
54416
55873
61885
61886
62361
62362
63650
63685
64553
64561
64573
64575
64577
64580
64581
64590
69930
CY 2007
OPPS APC
Short descriptor
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
Remv/repl penis contain pros ..............................................................
Cryoablate prostate ..............................................................................
Insrt/redo neurostim 1 array ................................................................
Implant neurostim arrays .....................................................................
Implant spine infusion pump ................................................................
Implant spine infusion pump ................................................................
Implant neuroelectrodes ......................................................................
Insrt/redo spine n generator ................................................................
Implant neuroelectrodes ......................................................................
Implant neuroelectrodes ......................................................................
Implant neuroelectrodes ......................................................................
Implant neuroelectrodes ......................................................................
Implant neuroelectrodes ......................................................................
Implant neuroelectrodes ......................................................................
Implant neuroelectrodes ......................................................................
Insrt/redo pn/gastr stimul .....................................................................
Implant cochlear device .......................................................................
0386
0674
0039
0315
0227
0227
0040
0222
0225
0040
0225
0061
0061
0061
0061
0222
0259
CY 2007
device-dependent
APC offset percent
61.16
53.78
78.85
83.19
80.27
80.27
54.06
77.65
79.04
54.06
79.04
60.06
60.06
60.06
60.06
77.65
84.61
TABLE 6.—ILLUSTRATIVE LIST OF DEVICE-INTENSIVE PROCEDURES NEW TO THE CY 2008 ASC LIST SUBJECT TO THE
MODIFIED PAYMENT METHODOLOGY UNDER THE REVISED ASC PAYMENT SYSTEM BEGINNING IN CY 2008
HCPCS code
33206
33207
33208
33214
33224
33225
33282
63655
64555
64560
64565
G0297
G0298
G0299
G0300
CY 2007
OPPS APC
Short descriptor
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
............................................
Insertion of heart pacemaker ...............................................................
Insertion of heart pacemaker ...............................................................
Insertion of heart pacemaker ...............................................................
Upgrade of pacemaker system ............................................................
Insert pacing lead & connect ...............................................................
Lventric pacing lead add-on ................................................................
Implant pat-active ht record .................................................................
Implant neuroelectrodes ......................................................................
Implant neuroelectrodes ......................................................................
Implant neuroelectrodes ......................................................................
Implant neuroelectrodes ......................................................................
Insert single chamber/cd ......................................................................
Insert dual chamber/cd ........................................................................
Inser/repos single icd+leads ................................................................
Insert reposit lead dual+gen ................................................................
Table 7 provides an example of how
we will calculate the ASC payment for
a device-intensive procedure. We use
the example of insertion of a cochlear
implant, CPT code 69930 (Cochlear
device implantation, with or without
mastoidectomy), that is included in
Table 5 above. For purposes of this
illustration, we are using the CY 2007
OPPS/ASC final rule with comment
period device offset percentage and
payment rate for APC 0259 (Level VI
ENT Procedures), the APC to which CPT
code 69930 is assigned under the CY
2007 OPPS. We also assume that the
ASC budget neutrality adjustment
remains at 0.67 under both the first
transition year and full implementation
0089
0089
0655
0655
0418
0418
0680
0061
0040
0040
0040
0107
0107
0108
0108
CY 2007
device-dependent
APC offset percent
77.11
77.11
76.59
76.59
87.32
87.32
76.40
60.06
54.06
54.06
54.06
90.44
90.44
89.40
89.40
scenarios, yielding an ASC conversion
factor of $42.543 based on our current
estimate of the CY 2008 OPPS
conversion factor. The example includes
the estimated ASC payment in the first
year of the 4-year transition and the
estimated payment under full
implementation of the revised ASC
payment system.
TABLE 7.—EXAMPLE OF CALCULATION OF ASC PAYMENT FOR A DEVICE-INTENSIVE COVERED SURGICAL PROCEDURE
ACCORDING TO THE MODIFIED PAYMENT METHODOLOGY OF THE REVISED ASC PAYMENT SYSTEM
mstockstill on PROD1PC66 with RULES2
First year of 4-year transition
OPPS CY 2007 national unadjusted payment rate .........................
OPPS CY 2007 device offset percent .............................................
OPPS/ASC device portion ...............................................................
$25,499.72
84.61%
$21,575.31
($25,499.72 × 0.8461)
$3,924.41
OPPS service portion ......................................................................
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00037
Fmt 4701
Full implementation of revised
system
Sfmt 4700
E:\FR\FM\02AUR2.SGM
$25,499.72
84.61%
$21,575.31
($25,499.72 × 0.8461)
$3,924.41
02AUR2
42506
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
TABLE 7.—EXAMPLE OF CALCULATION OF ASC PAYMENT FOR A DEVICE-INTENSIVE COVERED SURGICAL PROCEDURE
ACCORDING TO THE MODIFIED PAYMENT METHODOLOGY OF THE REVISED ASC PAYMENT SYSTEM—Continued
First year of 4-year transition
OPPS relative payment weight attributable to service (OPPS
service portion divided by estimated CY 2008 OPPS conversion factor) ...................................................................................
ASC service portion (OPPS relative payment weight for service
portion multiplied by estimated CY 2008 ASC conversion factor) ................................................................................................
CY 2007 ASC payment (without device payment) ..........................
ASC service payment (see following paragraph) ............................
61.8047
($3,924.41/63.497)
61.8047
($3,924.41/63.497)
$2,629.36
(61.8047 × $42.543)
$995
$1,403.59
(0.25 × $2,629.36) + (0.75 × $995)
$2,629.36
(61.8047 × $42.543)
N/A
$2,629.36
$22,978.90
($1,403.59 + $21,575.31)
$24,204.67
($2,629.36 + $21,575.31)
mstockstill on PROD1PC66 with RULES2
Estimated CY 2008 ASC total payment (sum of service payment
and device payment) ....................................................................
As discussed further in section IV.J. of
this final rule and as shown in the
example above, we will apply the
transitional blend only to the service
portion of the ASC procedure payment.
Consistent with their treatment under
the OPPS, we will apply the ASC
geographic wage adjustment to payment
for device-intensive procedures under
the revised ASC payment system.
Comment: Several commenters
encouraged CMS to pay the same
amount and apply the same payment
policies regarding implantable devices
in both ASCs and HOPDs. In particular,
they recommended that ASCs be paid
100 percent of the portion of the OPPS
procedure payment that is devicerelated, when ASCs perform deviceintensive procedures.
Response: We agree with commenters
that providing the same device payment
amount for expensive devices under the
revised ASC payment system as under
the OPPS is appropriate, and our final
payment methodology accomplishes
that. As we discuss above, we will
specifically calculate the amount of
OPPS device payment in APCs that
contain devices for which the device
cost exceeds 50 percent of the APC
median cost. We will then add the OPPS
device payment amount to the ASC
service payment for each deviceintensive procedure that is a covered
ASC surgical procedure, in order to
determine the total payment for the
device-intensive procedure when it is
performed in an ASC.
We also agree that the same payment
policies that exist with regard to
payment for costly devices under the
OPPS should also apply to payment for
devices implanted in ASCs. In
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
particular, under the OPPS, beginning
on January 1, 2007, when a device is
replaced without cost to the hospital or
with full credit for the cost of the device
being replaced, CMS reduces the APC
payment to the hospital by the amount
that we estimate represents the cost of
the device. The application of this same
policy to ASC payment for certain
device-intensive procedures is fully
consistent with the comments that CMS
should pay ASCs for expensive devices
in the same manner that they are paid
under the OPPS, and with the
recommendation of the PPAC that CMS
should apply payment policies
uniformly under the OPPS and revised
ASC payment systems. Therefore, in
accordance with the OPPS policy
implemented in CY 2007, beginning in
CY 2008, we will reduce the amount of
payment made to ASCs for deviceintensive procedures assigned to certain
OPPS APCs in those cases in which the
necessary device is furnished without
cost to the ASC or the beneficiary, or
with a full credit for the cost of the
device being replaced. We will provide
the same amount of payment reduction
that would apply under the OPPS for
performance of those procedures under
the same circumstances. Specifically,
when an ASC performs a procedure that
is listed in Table 8 below and the case
involves implantation of a no cost or
full credit device listed in Table 9, the
ASC must report the HCPCS ‘‘FB’’
modifier on the line with the covered
surgical procedure code to indicate that
a major implantable device in Table 9
was furnished without cost. We expect
that this scenario will occur most often
in cases in which there is a recall, field
action, or other activity that results in
PO 00000
Frm 00038
Full implementation of revised
system
Fmt 4701
Sfmt 4700
the ASC receiving a device from a
device manufacturer, for which the
facility has no obligation to pay. In these
cases, this policy is necessary to be
consistent with section 1862(a)(2) of the
Act, which excludes from Medicare
coverage items and services for which
neither the beneficiary nor anyone on
the beneficiary’s behalf has an
obligation to pay. This reduction policy
is consistent with the modified payment
methodology for device-intensive
procedures under the revised ASC
payment system that would generally
provide the same device-related
payment amount in HOPD and ASC
settings, both in those cases where the
facility bears the cost of the device and
those situations where it does not.
Tables 8 and 9 list those specific
procedures and implantable devices to
which the reduction policy applies
under the CY 2007 OPPS. The list of
device-dependent APCs and their
associated procedures and implantable
devices to which this policy will apply
in CY 2008 will be proposed and
finalized in the CY 2008 OPPS/ASC
proposed and final rules, respectively.
See the CY 2007 OPPS/ASC final rule
with comment period (71 FR 68071
through 68077) for further discussion of
this policy.
When the ‘‘FB’’ modifier is reported
with a procedure code that is listed in
Table 8, the contractor will reduce the
ASC payment for the procedure by the
amount of payment that CMS attributed
to the device when the ASC payment
rate was calculated. The reduction of
ASC payment in this circumstance is
necessary to pay appropriately for the
covered surgical procedure being
furnished by the ASC.
E:\FR\FM\02AUR2.SGM
02AUR2
42507
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
TABLE 8.—ILLUSTRATIVE LIST OF ADJUSTMENTS TO PAYMENTS FOR ASC COVERED SURGICAL PROCEDURES IN CY 2008
IN CASES OF DEVICES REPORTED WITHOUT COST OR FOR WHICH FULL CREDIT IS RECEIVED
HCPCS code
61885
63650
64555
64560
64561
64565
63655
64575
64577
64580
64581
33206
33207
33212
CY 2007
OPPS APC
Short descriptor
CY 2007
OPPS offset
percent
APC group title
...........
...........
...........
...........
...........
...........
...........
...........
...........
...........
...........
...........
...........
...........
Insrt/redo neurostim 1 array ............................
Implant neuroelectrodes ..................................
Implant neuroelectrodes.
Implant neuroelectrodes.
Implant neuroelectrodes.
Implant neuroelectrodes.
Implant neuroelectrodes ..................................
Implant neuroelectrodes.
Implant neuroelectrodes.
Implant neuroelectrodes.
Implant neuroelectrodes.
Insertion of heart pacemaker ..........................
Insertion of heart pacemaker.
Insertion of pulse generator ............................
0039
0040
Level I Implantation of Neurostimulator ..........
Percutaneous Implantation of Neurostimulator
Electrodes, Excluding Cranial Nerve.
78.85
54.06
0061
Laminectomy or Incision for Implantation of
Neurostimulator Electrodes, Excluding Cranial Nerve.
60.06
089
77.11
33210 ...........
33211 ...........
33216 ...........
33217 ...........
G0297 ..........
G0298 ..........
G0299 ..........
G0300 ..........
63685 ...........
64590 ...........
64553 ...........
64573 ...........
62361 ...........
62362 ...........
69930 ...........
61886 ...........
53440 ...........
53444 ...........
54400 ...........
53445 ...........
53447 ...........
54401 ...........
54405 ...........
54410 ...........
54416 ...........
33224 ...........
33225 ...........
33213 ...........
Insertion of heart electrode .............................
Insertion of heart electrode.
Insert lead pace-defib, one.
Insert lead pace-defib, dual.
Insert single chamber/cd .................................
Insert dual chamber/cd.
Inser/repos single icd+leads ............................
Insert reposit lead dual+gen.
Insrt/redo spine n generator ............................
Insrt/redo perph n generator.
Implant neuroelectrodes ..................................
Implant neuroelectrodes.
Implant spine infusion pump ...........................
Implant spine infusion pump.
Implant cochlear device ...................................
Implant neurostim arrays .................................
Male sling procedure .......................................
Insert tandem cuff.
Insert semi-rigid prosthesis.
Insert uro/ves nck sphincter ............................
Remove/replace ur sphincter.
Insert self-contd prosthesis.
Insert multi-comp penis pros.
Remove/replace penis prosth.
Remv/repl penis contain pros.
Insert pacing lead & connect ...........................
L ventric pacing lead add-on.
Insertion of pulse generator ............................
0106
Insertion/Replacement of Permanent Pacemaker and Electrodes.
Insertion/Replacement of Pacemaker Pulse
Generator.
Insertion/Replacement/Repair of Pacemaker
and/or Electrodes.
0107
Insertion of Cardioverter-Defibrillator ..............
90.44
0108
Insertion/Replacement/Repair of CardioverterDefibrillator Leads.
Implantation of Neurological Device ................
89.40
79.04
0227
Implantation of Neurostimulator Electrodes,
Cranial Nerve.
Implantation of Drug Infusion Device ..............
0259
0315
0385
Level VI ENT Procedures ................................
Level II Implantation of Neurostimulator .........
Level I Prosthetic Urological Procedures ........
84.61
83.19
46.86
0386
Level II Prosthetic Urological Procedures .......
61.16
0418
Insertion of Left Ventricular Pacing Elect ........
87.32
0654
77.35
33214 ...........
33208 ...........
33282 ...........
Upgrade of pacemaker system .......................
Insertion of heart pacemaker.
Implant pat-active ht record .............................
0655
Insertion/Replacement of a permanent dual
chamber pacemaker.
Insertion/Replacement/Conversion of a permanent dual chamber pacemaker.
Insertion of Patient Activated Event Recorders.
TABLE 9.—ILLUSTRATIVE LIST OF DEVICES FOR WHICH THE ‘‘FB’’ MODIFIER MUST BE REPORTED WITH THE
PROCEDURE CODE WHEN FURNISHED WITHOUT COST OR FOR
WHICH FULL CREDIT IS RECEIVED
mstockstill on PROD1PC66 with RULES2
Device
C1721
C1722
C1764
C1767
C1771
C1772
C1776
C1777
..
..
..
..
..
..
..
..
0090
0222
0225
0680
74.74
41.88
77.65
80.27
76.59
76.40
TABLE 9.—ILLUSTRATIVE LIST OF DEVICES FOR WHICH THE ‘‘FB’’ MODIFIER MUST BE REPORTED WITH THE
PROCEDURE CODE WHEN FURNISHED WITHOUT COST OR FOR
WHICH FULL CREDIT IS RECEIVED—
Continued
TABLE 9.—ILLUSTRATIVE LIST OF DEVICES FOR WHICH THE ‘‘FB’’ MODIFIER MUST BE REPORTED WITH THE
PROCEDURE CODE WHEN FURNISHED WITHOUT COST OR FOR
WHICH FULL CREDIT IS RECEIVED—
Continued
Device
Device
Short descriptor
AICD, dual chamber.
AICD, single chamber.
Event recorder, cardiac.
Generator, neurostim, imp.
Rep dev, urinary, w/sling.
Infusion pump, programmable.
Joint device (implantable.
Lead, AICD, endo single coil.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
C1778
C1779
C1785
C1786
C1813
C1815
C1820
PO 00000
..
..
..
..
..
..
..
Short descriptor
Lead, neurostimulator.
Lead, pmkr, transvenous VDD.
Pmkr, dual, rate-resp.
Pmkr, single, rate-resp.
Prosthesis, penile, inflatab.
Pros, urinary sph, imp.
Generator, neuro rechg bat sys.
Frm 00039
Fmt 4701
Sfmt 4700
C1882
C1891
C1895
C1896
C1897
C1898
C1899
E:\FR\FM\02AUR2.SGM
..
..
..
..
..
..
..
Short descriptor
AICD, other than sing/dual.
Infusion pump, non-prog, perm.
Lead, AICD, endo dual coil.
Lead, AICD, non sing/dual.
Lead, neurostim, test kit.
Lead, pmkr, other than trans.
Lead, pmkr/AICD combination.
02AUR2
42508
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
TABLE 9.—ILLUSTRATIVE LIST OF DEVICES FOR WHICH THE ‘‘FB’’ MODIFIER MUST BE REPORTED WITH THE
PROCEDURE CODE WHEN FURNISHED WITHOUT COST OR FOR
WHICH FULL CREDIT IS RECEIVED—
Continued
replaced is provided to the ASC, by the
same amount as the OPPS payment
reduction for the same calendar year
because neither the HOPD nor the ASC
incur a device cost for the replaced
device in such situations. Accordingly,
we are adding new § 416.179 to reflect
this payment reduction policy.
Device
D. Payment for Corneal Tissue Under
the Revised ASC Payment System
mstockstill on PROD1PC66 with RULES2
C1900
C2619
C2620
C2621
C2622
C2626
C2631
L8614
..
..
..
..
..
..
..
...
Short descriptor
Lead coronary venous.
Pmkr, dual, non rate-resp.
Pmkr, single, non rate-resp.
Pmkr, other than sing/dual.
Prosthesis, penile, non-inf.
Infusion pump, non-prog, temp.
Rep dev, urinary, w/o sling.
Cochlear device/system.
After considering all public comments
received, while we are finalizing our
proposed policy to package payment
under the revised ASC payment system
for all implantable devices without
pass-through status under the OPPS into
the ASC payment for the associated
surgical implantation procedure, we are
adopting a modified methodology to
calculate the payment rates for deviceintensive procedures under the revised
ASC payment system. We proposed to
pay for these devices and their
associated implantation procedures
according to the standard revised ASC
payment system methodology, with
application of the uniform ASC
conversion factor to the applicable
OPPS payment weight for the
procedure. However, our final payment
policy will apply a modified payment
methodology to develop the ASC
payment rates for device-intensive
covered surgical procedures, in order to
provide the same payment amount to
ASCs for the implantable devices as is
made under the OPPS. This
methodology will apply to ASC covered
surgical procedures that are assigned to
device-dependent APCs under the OPPS
for the same calendar year, where those
APCs have a device cost of greater than
50 percent of the APC cost (device offset
percentage greater than 50). While lists
of device-intensive procedures under
the revised ASC payment system to
which this policy would apply based on
their CY 2007 OPPS status are included
in Tables 5 and 6 of this final rule, the
list of ASC procedures subject to this
modified payment methodology will be
proposed and finalized in the CY 2008
OPPS/ASC proposed and final rules,
respectively.
We will also reduce the ASC
procedure payment for certain deviceintensive procedures when the
necessary device is furnished to the
ASC or the beneficiary at no cost or
when a full credit for the device being
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
In a memorandum dated May 21,
1992, CMS (known at the time as the
Health Care Financing Administration
or ‘‘HCFA’’) notified Regional
Administrators that carriers could pay
corneal tissue acquisition costs when
HCPCS code V2785 (Processing,
preserving and transporting corneal
tissue) is reported with corneal
transplant procedures performed in an
ASC. The memorandum indicated that
payment for corneal tissue acquisition
costs is subject to the usual coinsurance
and deductible requirements, and could
be paid as an add-on to either the ASC
payment or the physician’s fee for
corneal transplant surgery performed at
an ASC. In the June 12, 1998 proposed
rule to revise the ASC ratesetting
methodology and payment rates, we
proposed to package the costs incurred
by an ASC to procure corneal tissue into
the payment for the associated corneal
transplant procedure, rather than
continue making separate payment for
those costs (63 FR 32312 and 32313).
We also proposed to package corneal
tissue acquisition costs into the APC
payment for corneal transplant
procedures in the September 8, 1998
proposed rule to implement the OPPS
(63 FR 47760).
We received numerous comments
from physicians, eye banks, and health
care associations opposing both
proposals. In the April 7, 2000 final rule
with comment period, which
implemented the OPPS, we summarized
the comments that we received in
response to the September 8, 1998
proposal, and we determined that we
would not implement our proposal to
package payment under the OPPS for
corneal tissue acquisition costs but
would, instead, make separate payment
based on hospitals’ reasonable costs to
procure corneal tissue (65 FR 18448 and
18449). Because we never made final
the changes in the ASC payment rates
and ratesetting methodology that we
proposed in the June 12, 1998 Federal
Register, the policy issued in the June
1992 memorandum remains in effect,
which allows carriers (now MACs) to
make separate payment for the costs
incurred to procure corneal tissue for
transplant at an ASC.
PO 00000
Frm 00040
Fmt 4701
Sfmt 4700
In the August 2006 proposed rule to
revise the ASC ratesetting methodology
and payment rates beginning in CY
2008, we proposed to continue to pay
ASCs separately, based on their
invoiced costs, for the procurement of
corneal tissue (71 FR 49648). We had no
evidence to suggest that costs incurred
to procure corneal tissue are any less
variable now than they were in 1992, in
1998, or in 2000. We noted that, if we
were to package payment for the
procurement of corneal tissue into the
APC payment for corneal transplant
procedures, we believed the resulting
payment rate would overpay those
facilities that are able to acquire corneal
tissue at little or no cost through
philanthropic organizations and
underpay those facilities that must pay
for corneal tissue processing, testing,
preservation, and transportation costs.
We further proposed in the August 2006
proposed rule to exclude, through
proposed new § 416.164(b), the costs of
procurement of corneal tissue furnished
in an ASC on or after January 1, 2008
from the scope of ASC facility services.
We invited comments and submission
of data that supported or challenged this
proposal to continue paying ASCs
separately for corneal tissue on an
acquisition cost basis.
Comment: Several commenters agreed
with our proposal to continue to pay
separately for the acquisition costs of
corneal tissue under the revised ASC
payment system, rather than package
payment for corneal tissue costs into the
payment for the associated corneal
transplant procedure. The commenters
indicated that this proposed
methodology is consistent with the way
physicians and HOPDs are currently
paid for corneal tissue procurement.
They believed that this policy of paying
separately for the procurement of
corneal tissue has been, and continues
to be, the most appropriate payment
policy for these services provided in
ASC settings, because of the continuing
significant variability in the costs of
corneal tissue procurement. The
commenters further reiterated that
packaging these costs should not be
considered, because such an option
would result in overpayments to certain
facilities that have been able to acquire
corneal tissue at little or no cost through
philanthropic organizations and would
undoubtedly result in underpayments to
other facilities that paid for the corneal
tissue processing, testing, preservation,
and transportation costs.
Response: After consideration of the
public comments we received, we are
finalizing our proposed CY 2008 ASC
corneal tissue procurement payment
policy, with modification to clarify that
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
corneal tissue is a covered ancillary
service within the scope of ASC
services, but not within the scope of
ASC facility services. Corneal tissue
procurement will be included in the
scope of ASC services as a covered
ancillary service when it is integral to
the performance of an ASC covered
surgical procedure, but its payment will
not be packaged into the ASC payment
for the associated covered surgical
procedure. Specifically, under the
revised ASC payment system, we will
continue to pay ASCs separately, based
on their invoiced costs, for the
acquisition costs of corneal tissue for
transplant in an ASC. The HCPCS code
for corneal tissue processing, V2785, is
listed in Addendum BB to this final
rule, where it is assigned to payment
indicator ‘‘F4’’ (Corneal tissue
processing; paid at reasonable cost).
Accordingly, we are reflecting this final
policy in revised proposed
§§ 416.164(b)(3) and 416.171(b).
E. Payment for Office-Based Procedures
Since the inception of the ASC
benefit, procedures that are commonly
performed or that can be safely
performed in a physician’s office have
generally been excluded from the ASC
list of covered surgical procedures. We
refer to these procedures as ‘‘officebased’’ in this preamble discussion.
Over the past 15 years, physicians and
ASC associations have urged CMS to
add office-based procedures to the ASC
list of covered surgical procedures or to
retain on the ASC list procedures that
were originally performed most
commonly in an institutional setting,
but that have subsequently moved to an
office setting as surgical techniques and
technology have advanced.
Representatives of the ASC industry
have argued that although, for most
patients, the office is an appropriate
setting for most high volume office
procedures, there are some patients for
whom an ASC or another more
resource-intensive setting is required.
The physician may decide that a facility
setting is necessary for individual
patients for various clinical reasons,
such as the need for more nursing staff,
a sterile operating room, or a piece of
equipment not typically available in the
office setting. CPT code 52000
(Cystourethroscopy (separate
procedure)) is a prime example of a high
volume procedure that is performed
more than 80 percent of the time in an
office setting, but for which a small
number of patients require resources
usually available only in an ASC or a
hospital. Representatives of the ASC
industry have contended that unless we
made an exception to the criteria that
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
historically governed which procedures
comprised the ASC list and allowed an
office-based procedure to remain on the
ASC list, as we have done with CPT
code 52000, the hospital would be the
only facility setting available as an
alternative to the office setting. ASC
industry commenters asserted in the
past that this limitation was
burdensome both to physicians and to
beneficiaries and could, in some cases,
limit beneficiary access to needed
surgery.
We generally interpret ‘‘office-based’’
or ‘‘commonly performed in a
physician’s office’’ to mean a surgical
procedure that the most recent BESS
data available indicate is performed
more than 50 percent of the time in the
physician’s office setting. In the August
2006 proposed rule for the revised ASC
payment system and as discussed in
section III.A.2. of this final rule, we
proposed to expand the ASC list of
covered surgical procedures to allow
payment for all surgical procedures,
except those procedures that pose a
significant safety risk or would be
expected to require an overnight stay.
Because office-based surgical
procedures typically do not pose a
significant safety risk and do not require
an overnight stay, we proposed not to
exclude them from ASC payment under
the revised ASC payment system.
However, we were concerned that
allowing payment to ASCs for officebased procedures based on OPPS
relative payment weights could have a
significant impact on Medicare program
costs. Approximately two-thirds of the
additional procedures which we
proposed not to exclude from ASC
payment beginning in CY 2008 are
office-based, that is, they are performed
in the physician’s office more than 50
percent of the time. The practice
expense payment for many of these
procedures under the MPFS, when they
are performed in the physician’s office,
would be lower than the payment for
the same procedures under the OPPS or
under the standard methodology of the
revised ASC payment system as
proposed. Therefore, we indicated that
the proposed ASC payment rates based
on the OPPS relative payment weights
could result in a significant program
cost if these high volume procedures
were to shift from the office-based
setting to the ASC setting.
One reason why we were concerned
about the possibility of a sizable shift of
office-based procedures to ASCs is the
impact that such a shift might have on
ASC payments in light of the statutory
requirements that the revised ASC
payment system be designed to result in
the same aggregate amount of
PO 00000
Frm 00041
Fmt 4701
Sfmt 4700
42509
expenditures that would be made if the
revised payment system were not
implemented. In the August 2006
proposed rule, we explained that,
depending on the methodology for
determining the requisite budget
neutrality adjustment (71 FR 49657), an
influx of high-volume, relatively low
cost office-based surgical procedures
into the ASC setting under the revised
payment system could lower the
payment amounts for other procedures
made to ASCs due to the constraints of
budget neutrality. In other words, we
might have had to scale the ASC
conversion factor downward in order for
estimated aggregate expenditures under
the revised system to not exceed what
they would have been if the revised
payment system were not implemented.
Payment for procedures with relatively
high payments would have to be
reduced in order to offset increased
aggregate costs resulting from an influx
of relatively low cost, high volume
office-based procedures shifting to
ASCs. (See section V. of this final rule
for a detailed discussion of our
proposed and final policies regarding
calculation of an ASC conversion
factor.)
In the August 2006 proposed rule, we
explained that we are committed to
refining Medicare payment systems
wherever possible to prevent payment
incentives from inappropriately driving
decisions about where to perform a
surgical procedure, when those
decisions should properly be based on
clinical considerations. Towards that
end, we proposed to cap payment for
office-based surgical procedures for
which ASC payment would be newly
allowed under the revised payment
system as of January 1, 2008, at the
lesser of the MPFS nonfacility practice
expense amount or the ASC rate
developed according to the standard
methodology of the revised ASC
payment system. We also proposed to
exempt procedures that are on the ASC
list as of January 1, 2007, and that meet
our criterion for designation as officebased, from the payment limitation
proposed for office-based procedures for
which ASC payment would be allowed
for the first time beginning January 1,
2008. Accordingly, we proposed to
incorporate in proposed new
§ 416.171(e) the payment basis for these
office-based procedures beginning
January 1, 2008.
When we started to identify the codes
that we would propose to classify as
office-based surgical procedures
beginning in CY 2008, we encountered
some anomalous cases that required
further refinement of our office-based
criterion beyond strict application of a
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42510
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
50-percent utilization threshold. For
example, we identified some CPT codes
that met the 50-percent office utilization
threshold but for which a nonfacility
practice expense amount had not been
developed under the MPFS. We
proposed to classify as office-based any
surgical codes that our physicians’
claims data indicated are performed
more than 50 percent of the time in an
office setting, even if the codes currently
lack a nonfacility practice expense value
under the MPFS. We further proposed
to cap payment for these procedures, as
appropriate, once a nonfacility practice
expense amount is established. Until
that time, we proposed to calculate
payment for these office-based surgical
CPT codes using the methodology we
proposed for other surgical procedures
under the revised ASC payment system.
Similarly, until a national nonfacility
practice expense amount is established
for office-based surgical CPT codes that
are contractor-priced (that is, carriers
typically determine the payment for a
procedure for which there is no
calculated national payment) under the
MPFS, we proposed to calculate the
ASC payment using the same
methodology that we proposed for
surgical procedures that are not officebased. Application of the cap to codes
designated as office-based would be
updated through rulemaking as part of
the annual OPPS/ASC payment update.
In applying the 50-percent threshold,
we discovered some apparent
contradictions in the BESS data that
required us to further refine our
definition of office-based procedures.
For example, we noted instances in
which seemingly similar procedures
had inconsistent site-of-service
utilization data. The BESS data showed
high levels of office utilization for some
complex procedures that we expected to
be performed relatively infrequently in
an office setting, whereas simpler but
related procedures showed lower levels
of office utilization.
Therefore, we undertook another,
more detailed level of review and
identified groups of surgical CPT codes
related to procedures that are performed
50 percent or more of the time in the
office setting to determine if there was
a logical correlation between procedure
complexity within a group of related
procedures and the frequency with
which those procedures were performed
in the office setting. For example,
according to CPT coding, the following
three codes are related:
• 13120, Repair, complex, scalp arms
and/or legs; 1.1 cm to 2.5 cm.
• 13121, Repair, complex, scalp arms
and/or legs; 2.6 cm to 7.5 cm.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
• 13122, Repair, complex, scalp arms
and/or legs; each additional 5 cm or
less.
As is often the case for groups of
related codes in the CPT coding system,
the first of these codes is the least
complex clinically and, in this example,
the complexity of the procedure
increases in proportion to the increase
in the size of the area to be repaired. If
utilization data indicated that CPT code
13122 was performed in the office 67
percent of the time in CY 2005, we
would expect to find that both CPT
codes 13120 and 13121 were also
performed in the physician’s office more
than 50 percent of the time during that
year. Because the most complex
procedure was provided in the office
most of the time, logically, it would
seem that the less complex procedures
would also have been performed
frequently in that site of service.
However, the BESS data showed that
this was not always the case.
Although our expectation was that the
less complex procedures within a group
of related procedure codes would
typically be performed most often in the
office and the more complex procedures
less often in the office, there were
instances in which the less complex
procedures within the code group were
billed more commonly in an ASC or
HOPD, while the more complex
procedures within the code group were
billed more frequently in the office
setting. Therefore, we believed it was
prudent to consider the clinical
characteristics and utilization data of
related CPT codes in determining the
codes to be proposed as office-based, to
supplement our consideration of data
specific to the codes under review.
In our analysis of the BESS site-ofservice data, we also took into
consideration the volume of cases
represented in the data. There were a
few instances in which we initially
identified a procedure as office-based
because the data indicated that 100
percent of the cases were performed in
the physician’s office. However, closer
inspection revealed that there was only
one case reported for the procedure with
a physician’s office as the site of service.
We were concerned about using such a
low volume of procedure claims as the
basis for identifying a procedure as
office-based. Therefore, we also believed
it was wise to consider the volume of
claims for procedures in the context of
our assessment of their utilization data,
to determine those codes to propose as
office-based for the revised ASC
payment system.
Because of the occasional unevenness
and inconsistency of the data associated
with some of the codes we initially
PO 00000
Frm 00042
Fmt 4701
Sfmt 4700
classified as office-based, we conducted
a code-by-code analysis to buttress
inconclusive data with the clinical
judgment of our medical advisors. As a
result, in our proposed rule, there were
some procedures that met the 50percent office performance threshold
when evaluated in isolation from other
closely related codes, but that we did
not propose to designate as office-based
after more specific review.
In the August 2006 proposed rule for
the revised ASC payment system, we
proposed to assess each year, based on
the most recent available BESS and
other data available to us and detailed
clinical review, whether there are
additional procedures that we would
propose to newly classify as officebased, beginning in the update year. We
would solicit comments on the
proposed classification of additional
codes as office-based as part of the
annual OPPS/ASC rulemaking cycle. In
addition, we proposed that once we
identify a procedure as office-based, that
classification could not change in future
updates of the ASC payment system. We
reasoned that once a procedure becomes
safe enough to be performed in more
than 50 percent of cases in the office
setting, it would be improbable for it to
revert to an institutional setting.
To summarize, the list of codes that
we proposed as office-based took into
account the most recent available
volume and utilization data for each
individual procedure code and/or, if
appropriate, the clinical characteristics,
utilization, and volume of related codes.
We proposed to apply the office-based
designation only to procedures that
would no longer be excluded from ASC
payment beginning in CY 2008 or later
years. Moreover, we proposed to exempt
all procedures on the CY 2007 ASC list
from application of the office-based
classification. We believed that the
resulting list accurately reflected
Medicare practice patterns and was
clinically coherent. The procedures that
we proposed to designate as subject to
the office-based payment limit were
identified in Addendum BB to the
proposed rule (71 FR 49845 through
49948). Those procedures for which the
CY 2008 payment would be based on
the MPFS nonfacility practice expense
RVUs according to our analysis for the
August 2006 proposed rule were flagged
in Addendum BB to that rule. The ASC
relative payment weights shown for
procedures in Addendum BB to the
proposed rule that would be capped by
the MPFS nonfacility practice expense
RVUs were adjusted to reflect the
capped payment amounts. We reminded
readers in the August 2006 proposed
rule that the ASC payment rates in
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
Addendum BB to that rule were based
on the proposed CY 2007 OPPS relative
payment weights and the proposed CY
2007 MPFS nonfacility practice expense
RVUs. Similarly, the information in
Addenda AA and BB to this final rule
is also only illustrative, meaning that
the Addenda provide examples of the
results of applying the final policies of
the revised ASC payment system, based
on the final information available for CY
2007 and projected CY 2008 updates. As
further discussed in sections V.E. and
VI. of this final rule, we will propose the
CY 2008 relative payment weights,
payment amounts, specific HCPCS
codes to which the final policies of the
revised ASC payment system would
apply, and other pertinent ratesetting
information for the CY 2008 revised
ASC payment system in the proposed
OPPS/ASC rule to update the payment
systems for CY 2008 to be issued in
mid-summer of CY 2007. We will then
publish final relative payment weights,
payment amounts, specific CY 2008
HCPCS codes to which the final policies
will apply, and other pertinent
ratesetting information for the CY 2008
revised ASC payment system in the
final OPPS/ASC rule to update the
payment systems for CY 2008.
Comment: Several commenters
suggested that instituting a cap on
payment for office-based surgical
procedures would result in payment
levels that would make it economically
infeasible for many ASCs to perform
certain surgical procedures, forcing
patients who could be treated safely and
more cost effectively in an ASC to go to
an HOPD for surgery. Other commenters
suggested that there is no empirical
evidence that payment of office-based
procedures in ASCs would lead to
overutilization of ASCs or result in
physicians converting their offices into
ASCs. The commenters pointed out that,
in historical cases where CMS has made
exceptions to allow ASC payment for
procedures primarily performed in the
office, there have not been significant
shifts in the sites of service for these
procedures. Several commenters
suggested that imposing a cap on
payment for these procedures would be
tantamount to a penalty and an
affirmative policy intended to
discourage these procedures from
performance in the ASC setting. The
commenters strongly recommended that
the best policy would be to allow
physicians to select the site of service
they believe is the most clinically
appropriate for their patients, especially
because sicker patients may require the
additional infrastructure and safeguards
of an ASC or a HOPD. Other
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
commenters pointed out that CMS’
proposal for the revised ASC payment
system depends on the use of the
relative payment weights for the OPPS
that CMS argued in the proposed rule
would be expected to reasonably reflect
the relativity of ASC resources for
surgical procedures. They stated that
CMS has no evidence to suggest that the
OPPS relativity of payment weights for
office-based procedures does not reflect
the relative resource use for the
performance of these procedures in
ASCs and, therefore, application of a
payment limitation for these procedures
is unwarranted.
The commenters also expressed
concern that the establishment of a
payment cap for office-based procedures
would be problematic and detrimental
to CMS’ desire to create a setting-neutral
payment system. The commenters
recommended that CMS exclude this
provision from the final rule and pay all
procedures using a single ASC
conversion factor applied to the
applicable OPPS relative payment
weight. Several commenters suggested
that CMS could follow trends in the
sites of service for office-based
procedures, and should CMS find
significant and unwarranted migration
of certain procedures to ASCs,
implement the proposed policy at a later
date.
Response: We acknowledge the
commenters’ concerns regarding our
proposal to cap payments for officebased surgical procedures performed in
ASCs. Nevertheless, we continue to
believe that capping the payment for
office-based surgical procedures
performed in ASCs would be the best
approach to eliminating differential
payment as a factor in site-of-service
decisions regarding minor surgical
procedures. The combined ASC and
physician payment exceeds the single
payment the physician would receive
for services performed in the office,
even with the application of the
proposed payment limitation for officebased procedures. Therefore, we are
concerned that allowing payment for
office-based procedures under the ASC
benefit may create an incentive for
physicians inappropriately to convert
their offices into ASCs or to move all
their office surgery to an ASC. As
discussed further in section V. of this
final rule, the final policy for the budget
neutrality adjustment for the revised
ASC payment system which would cap
payment for office-based surgical
procedures as we proposed takes into
account the expected migration of 15
percent of the current office utilization
of office-based procedures that will be
newly paid in CY 2008 under the
PO 00000
Frm 00043
Fmt 4701
Sfmt 4700
42511
revised ASC payment system over the
first 4 years of the revised payment
system. As commenters observed, a
setting-neutral payment system is most
consistent with the principle that
physicians should be free to make siteof-service decisions on the basis of
clinical and quality of care
considerations alone. We strongly agree
that the health of the patient should be
the primary consideration. The
proposed cap significantly reduces the
payment differential that would
otherwise exist when office-based
surgical procedures are performed in
ASCs and is, thus, more consistent with
the principle of site-neutral payment.
After consideration of the public
comments we received, we are
finalizing our proposal under
§ 416.167(b)(3) and § 416.171(d),
without modification, to cap payment
for office-based surgical procedures for
which ASC payment would first be
allowed under the revised payment
system beginning in January 1, 2008, or
later years at the lesser of the MPFS
nonfacility practice expense amount or
the ASC rate developed according to the
standard methodology of the revised
ASC payment system. For those officebased procedures for which there is no
available MPFS nonfacility practice
expense amount, we will implement the
cap, as appropriate, once a MPFS
nonfacility practice expense amount is
available. Until that time, those
procedures that are office-based but for
which there is no available MPFS
nonfacility practice expense amount
available for the comparison will be
paid using the standard methodology for
calculating ASC payment under the
revised ASC payment system.
The procedures that we are finalizing
as office-based for CY 2008 are
identified in Addendum AA to this final
rule, assigned to payment indicators of
‘‘P2’’ (Office-based surgical procedure
added to ASC list in CY 2008 or later
with MPFS nonfacility PE RVUs;
payment based on OPPS relative
payment weight); ‘‘P3’’ (Office-based
surgical procedure added to ASC list in
CY 2008 or later with MPFS nonfacility
PE RVUs; payment based on MPFS
nonfacility PE RVUs); and ‘‘R2’’ (Officebased surgical procedure added to ASC
list in CY 2008 or later without MPFS
nonfacility PE RVUs; payment based on
OPPS relative payment weight). These
payment indicators identify the officebased procedures’ estimated payment
status under the CY 2008 revised ASC
payment system, based on the final CY
2007 information for the OPPS and the
MPFS as discussed above, and their
illustrative CY 2008 relative payment
weights and payment rates reflect
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42512
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
application of the capped payment
amounts for those procedures with a
payment status indicator of ‘‘P3.’’ We
note that the actual proposed and final
ASC relative payment weights and
payment amounts for CY 2008 will be
proposed and finalized through the CY
2008 OPPS/ASC proposed and final
rules, respectively. We will continue to
monitor the appropriateness of the
payment cap for office-based surgical
procedures performed in ASCs and
explore other opportunities to promote
site-neutral payments as we gain
experience under the revised ASC
payment system.
Comment: Several commenters
expressed concern about the ‘‘50percent rule’’ we proposed to use to
designate which procedures would be
considered office-based. One
commenter indicated that if a procedure
is performed in an office 50 percent of
the time, that means half the time the
physician has determined that the office
is not the appropriate setting for specific
patients. Commenters further indicated
that clinical circumstances dictate the
site of service and not the physician’s
personal preference, as suggested by the
policy proposed for the revised payment
system. One commenter stated that
surgeons often perform a procedure in
the office when anesthesia is not
required and perform the same
procedure in an ASC when anesthesia is
required due to the complexity of
individual patient factors.
The commenters offered several
suggestions for modifying the specific
proposal for designating procedures as
office-based. In particular, one
commenter requested that there be a
reasonable, fair, and efficient
mechanism for removing a procedure
from the office-based list if the typical
site of service for a procedure does
change for a legitimate clinical reason.
Other commenters recommended that
CMS consider raising the threshold
above 50 percent to a number that
shows the clear majority of cases are
performed in the physician’s office or
allow an exemption to the cap for
procedures that are performed in ASCs
because of the need for anesthesia.
Another commenter suggested that CMS
could implement this policy through the
use of a modifier that indicates the
surgeon selected the ASC over the
physician’s office as the site of service
because of the necessity of anesthesia or
patient factors, whereupon the payment
limitation would not be applied.
Response: As indicated in our
proposed rule, office-based procedures
are surgical procedures that the most
recent BESS data available indicate are
performed more than 50 percent of the
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
time in the physician’s office setting.
We believe our ‘‘50-percent rule’’
proposed policy is the best option at
this point in time. It is our current
practice to consider procedures that are
performed more than 50 percent of the
time in the physician’s office setting as
office-based procedures, and we will
continue to monitor whether the 50percent threshold is appropriate for this
categorization. These office-based
procedures, as categorized through
application of the ‘‘50-percent rule,’’ are
typically procedures that have
transitioned from low volume in the
office setting and high volume in the
facility setting to higher volume in the
office setting and lower volume in the
facility setting. The 50-percent
threshold marks the point in that
transition at which a procedure comes
to be performed more often in the office.
Typically, procedures that come to be
performed more frequently in offices
than in the facility setting remain
primarily office-based once that
transition has taken place. Therefore, we
continue to believe that the 50-percent
threshold is an appropriate, objective
measure for determining which
procedures ought to be considered
office-based. Moreover, a rigorous
review of procedures that met the
aforementioned threshold took into
account the most recent available
volume and utilization data for each
individual procedure code and, if
appropriate, the utilization and volume
of related codes. In addition, we
conducted a code-by-code analysis to
bolster inconclusive data with the
clinical judgment of our medical
advisors.
We will continue to assess each year,
based on the most recent available BESS
and other data available to us, whether
there are additional procedures that we
would propose to classify as officebased. However, we note that we
proposed that once we identify a
procedure as office-based, that
classification would not change in
future updates of the ASC payment
system, except in cases of new codes,
where those initial determinations are
temporary, as explained further in
section V.E. of this final rule. As we
have explained above, once a procedure
becomes safe enough to be performed in
more than 50 percent of cases in the
office setting, it is unlikely to revert to
a facility setting.
The vast majority of procedures
designated as office-based under the
revised ASC payment system would
require only either local anesthesia or at
most moderate or ‘‘conscious’’ sedation,
that is, sedation to achieve a medically
controlled state of depressed
PO 00000
Frm 00044
Fmt 4701
Sfmt 4700
consciousness while maintaining the
patient’s airway, protective reflexes, and
ability to respond to stimulation or
verbal commands. The use of general
anesthesia for the performance of these
office-based procedures would be
expected to be highly unusual. In those
cases where local anesthesia or
‘‘conscious’’ sedation are the typical
types of anesthesia used in the
performance of certain procedures, the
procedure’s MPFS nonfacility practice
expense amount would have already
been valued to include payment for the
anesthesia typically used, so
appropriate payment would be provided
in the ASC setting if the procedure were
subject to the office-based payment
limitation. However, even when general
anesthesia may be required because of
uncommon patient-specific
considerations, basing a surgical
procedure’s prospective payment rate
on the typical case when anesthesia is
not required and the procedure can be
performed safely in the office is
consistent with the averaging principle
that is the basis for all our prospective
payment systems, including the revised
ASC payment system.
Therefore, after considering all
comments received, we are finalizing
our proposal, without modification, to
identify office-based surgical procedures
for the revised ASC payment system as
those surgical procedures no longer
excluded from ASC payment beginning
in CY 2008 or later years that are
performed more than 50 percent of the
time in physicians’ offices, taking into
account the most recent available
volume and utilization data for each
individual procedure code and/or, if
appropriate, the clinical characteristics,
utilization, and volume of related codes.
We will annually assess whether there
are additional procedures that we would
propose to classify as office-based as
part of the annual OPPS/ASC
rulemaking cycle. With the exception of
new codes for which our determinations
would remain preliminary until there
are adequate physicians’ claims data
available to assess their predominant
sites of service as discussed further in
section V.E. of this final rule, the
classification of a procedure as officebased would not change in future
updates of the ASC payment system.
Those procedures whose office-based
designation for CY 2008 is temporary
because they are new codes for which
there is not yet adequate physicians’
claims data are flagged with an asterisk
(*) in Addendum AA to this final rule.
Comment: One commenter indicated
that code CPT 64555 (Percutaneous
implantation of neurostimulator
electrodes; peripheral nerve (excludes
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
sacral nerve)), should not be designated
as an office-based procedure under the
revised ASC payment system because
not all of the procedures described by
the code can be done in the physician’s
office. The commenter further stated
that payment accuracy should be
included as a goal of any new payment
system, to avoid site-of-service
decisions that are based on financial
factors rather than clinical
appropriateness. The commenter
reasoned that the proposed payment
method for procedures similarly
identified as office-based would
inappropriately impact site-of-service
decisions, because it would not be
possible to provide the procedures in
the ASC setting.
Another commenter suggested that
CPT code 15340 (Tissue cultured
allogeneic skin substitute, first 25 sq cm
or less) be removed from the proposed
list of office-based procedures so as to
ensure appropriate payment for the
procedure in the ASC setting and
thereby provide Medicare beneficiaries
with increased access to the procedure.
The commenter noted that this CPT
code was new for CY 2006 and,
therefore, there were no CY 2005
utilization data available for our review.
They also explained that the
predecessor CPT code was not
performed in the physician’s office more
than 50 percent of the time, and they
did not believe this new code would be
determined to be office-based based on
the 50-percent threshold when CY 2006
data were available.
Response: We have identified CPT
code 64555, newly proposed for ASC
payment beginning in CY 2008, as a
device-intensive procedure that is
clinically similar to other CPT codes for
implantation of neuroelectrodes that are
not office-based procedures, although
some of the other procedures are ASC
covered surgical procedures prior to
January 2008. The code is assigned to
APC 0040 (Percutaneous Implantation
of Neurostimulator Electrodes,
Excluding Cranial Nerve) under the CY
2007 OPPS, where other
neurostimatulor electrode implantation
procedures reside. Therefore, we believe
it is most appropriate to remove CPT
code 64555 from the list of office-based
procedures under the revised ASC
payment system, so that it will be paid
in the ASC setting according to the
modified payment methodology we are
adopting for device-intensive
procedures. We refer readers to section
IV.C.2.e. of this final rule for a detailed
discussion of our proposed and final
policies regarding ASC payment for
procedures with significant device
costs. In addition, we note that, while
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
we had also proposed an office-based
designation for CPT code 64565
(Percutaneous implantation of
neurostimulator electrodes;
neuromuscular) beginning with its
initial ASC payment in CY 2008, under
the OPPS this code is assigned to the
same clinical APC as CPT code 64555,
which it resembles from both clinical
and facility resource perspectives.
Therefore, we will also remove CPT
code 64565 from the list of office-based
procedures for the CY 2008 revised ASC
payment system. Following the removal
of these two codes from the list of officebased procedures, there are no ASC
covered surgical procedures that are
both device-intensive and office-based
for the CY 2008 revised ASC payment
system.
With respect to CPT code 15340, as
the commenter pointed out, we have no
utilization data from CY 2005 available
for this procedure to review in
developing this final rule. We note that
we did not propose to designate the CPT
add-on code for an additional area of
application, 15341 (Tissue cultured
allogeneic skin substitute, each
additional 25 sq cm) as office-based
under the revised ASC payment system.
The proposed ASC treatment of CPT
code 15340 was a temporary designation
for the new code, subject to change in
response to public comments and our
examination of utilization data when
available. At this time, we have decided
to remove this CPT code from the officebased list because, after further review,
we believe it is not likely to be
performed more than 50 percent of the
time in the physician’s office setting.
However, we will continue to evaluate
the appropriateness of this action as
new data become available and will
annually reassess whether this code, or
other procedures newly paid in ASCs in
CY 2008 or later years that are not
already designated as office-based or for
which that classification is temporary,
should be proposed as office-based for
ASC payment, in the context of each
year’s OPPS/ASC annual update. We
note, specifically, that our treatment of
CPT code 15340 in this CY 2008 ASC
final rule is not a final determination for
CY 2008, because we expect to have CY
2006 utilization data available for the
CY 2008 OPPS/ASC proposed rule,
where we may propose that additional
codes be classified as office-based for
the CY 2008 revised ASC payment
system.
After considering all public comments
received, we are finalizing our proposal,
with modification, of the office-based
list of covered surgical procedures
under the CY 2008 revised ASC
payment system. At this point, we are
PO 00000
Frm 00045
Fmt 4701
Sfmt 4700
42513
removing CPT codes 64555, 64565, and
15340 from the office-based list for the
CY 2008 revised ASC payment system.
As new data become available, we may
propose that additional HCPCS codes
newly paid in ASCs in CY 2008 be
classified as office-based in the CY 2008
OPPS/ASC proposed rule, and the final
CY 2008 ASC list of covered officebased surgical procedures will be
published in the CY 2008 OPPS/ASC
final rule.
F. Payment Policies for Multiple and
Interrupted Procedures
1. Multiple Procedure Discounting
Policy
In the August 2006 proposed rule for
the revised ASC payment system, we
proposed to mirror the OPPS policy for
discounting when a beneficiary has
more than one surgical procedure
performed on the same day at an ASC
facility (71 FR 49651). The current
policy for multiple procedure
discounting in the ASC, as specified in
§ 416.120(c)(2)(ii) of our regulations, is
based on a simple count of procedures
performed on the same day. The most
costly procedure is paid the full amount
and all other procedures are discounted
by half.
Under the OPPS, certain surgical
procedures are not subject to the
discounting policy. Generally, the
procedures that are exempted are those
performed to implant costly devices.
They are not discounted even when
performed in association with other
surgical procedures because the cost of
the implantable device does not change;
therefore, resource savings due to
efficiencies would be minimal.
Until now, there has been no reason
to exempt any procedure from the
multiple procedure discounting policy
in ASCs because separate payments
have been made for implantable
devices. Although the ASC payment for
the procedure may have been
discounted, the cost of the device was
paid outside of that rate and was
unaffected by the multiple procedure
discount methodology.
Under the revised ASC payment
system in the August 2006 proposed
rule, we proposed to package payment
for implantable devices into the
procedure payment made to the ASC, as
under the OPPS. Because we are trying
wherever possible to implement parallel
payment policies across both systems,
we proposed to adopt the OPPS
discounting policy that is applied to
surgical procedures so that the costs of
performing multiple procedures for the
implantation of costly devices are taken
into account. Thus, payment for the
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42514
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
same set of multiple procedures under
the OPPS and the ASC payment system
would be made using similar packaging
and payment rules.
For the revised ASC payment system,
we proposed in Table 46 of the August
2006 proposed rule (71 FR 49652) a
listing of the covered surgical
procedures that would be exempt from
multiple procedure discounting based
on CY 2007 OPPS proposed procedurespecific discounting designations (71 FR
49652 through 49654). These exempt
procedures were those surgical
procedures proposed for ASC payment
in CY 2008 that were also proposed for
assignment to a status indicator other
than ‘‘T’’ under the CY 2007 OPPS,
indicating that a multiple surgical
procedure reduction would not apply.
We proposed to update this list
annually in the OPPS/ASC proposed
and final rules, and solicited comments
on the list.
We also proposed to incorporate our
proposed policy on multiple procedure
discounting in proposed new
§ 416.172(e).
Comment: Several commenters
supported our proposal to apply the
multiple procedure discounting policy
of the OPPS to procedures provided
under the revised ASC payment system.
The commenters noted that this policy
would ensure that payments for ASC
covered surgical procedures with high
fixed costs are not discounted, and that
the full costs of procedures to implant
expensive devices are taken into
account when these device-intensive
procedures are performed in
conjunction with other surgical
procedures. The commenters also
suggested that adopting the OPPS
multiple procedure discounting policy
would provide parity in payments to
both HOPDs and ASCs, as well as
minimize any payment incentive to shift
services between the two settings
because of different policies. They
believed that this consistency would
result in appropriate and parallel
policies for payment of multiple
surgical procedures performed in a
single operative session in both of these
delivery settings where outpatient
surgery is commonly performed.
Response: We appreciate the
commenters’ support for the proposed
ASC multiple procedure discounting
policy. Specifically, when more than
one covered surgical procedure is
provided by an ASC in a single
operative session to a Medicare
beneficiary, the procedure with the
highest ASC payment rate would be
paid 100 percent of the ASC payment
amount, and ASC payments for any
other surgical procedures not expressly
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
exempt from the discounting policy
would be reduced by half. Certain ASC
covered surgical procedures with
relatively high fixed costs would be
specifically exempt from the ASC
multiple procedure discounting policy,
consistent with the current OPPS
multiple procedure discounting policy
for those surgical procedures assigned to
a status indicator other than ‘‘T’’ under
the OPPS. We agree with the
commenters’ general reasoning and
further believe that adopting an ASC
policy that parallels the OPPS
discounting policy would assist in
timely and coordinated updates to the
multiple procedure discounting status
of services payable under both payment
systems.
Comment: Several commenters
indicated that CMS inappropriately
included only one of three similar CPT
codes for the placement of breast
brachytherapy catheters (specifically
CPT code 19298 (Placement of
radiotherapy after loading
brachytherapy catheters (multiple tube
and button type) into the breast for
interstitial radioelement application
following (at the time of or subsequent
to) partial mastectomy, includes
imaging guidance)) on the list of
procedures proposed for exemption
from multiple procedure discounting,
which was provided as Table 46 in the
CY 2008 ASC proposed rule (and which
has been updated as Table 10 below
based on the CY 2007 OPPS final
procedure-specific discounting
designations). These commenters
explained that the general surgical
approach and devices required to
perform CPT code 19298 are similar to
those used to provide CPT code 19296
(Placement of radiotherapy after loading
balloon catheter into the breast for
interstitial radioelement application
following partial mastectomy, includes
imaging guidance; on date separate from
partial mastectomy) and CPT code
19297 (Placement of radiotherapy after
loading balloon catheter into the breast
for interstitial radioelement application
following partial mastectomy, includes
imaging guidance; concurrent with
partial mastectomy). Moreover, the
commenters believed that, because all
three CPT codes are assigned to status
indicator ‘‘S’’ under the OPPS,
indicating that multiple procedure
discounting does not apply to payment
for their performance in the hospital
outpatient setting, all of these codes
should also be exempt from multiple
procedure discounting under the
revised ASC payment system.
Response: While CPT code 19298 is
assigned to status indicator ‘‘S’’ under
the CY 2007 OPPS, CPT codes 19296
PO 00000
Frm 00046
Fmt 4701
Sfmt 4700
and 19297 are assigned to status
indicator ‘‘T’’ under the OPPS effective
January 1, 2007. As discussed in the CY
2007 OPPS final rule with comment
period (71 FR 68028), CPT codes 19296
and 19297 were reassigned from New
Technology APCs to a clinical APC
effective January 1, 2007. Along with
their APC reassignments, CPT codes
19296 and 19297 were also reassigned
from status indicator ‘‘S’’ to ‘‘T’’
effective January 1, 2007. During the CY
2007 OPPS rulemaking cycle, in
considering the public comments and
finalizing the new assignments of CPT
codes 19296 and 19297 to a clinical
APC with status indicator ‘‘T,’’ the
implications of the multiple procedure
reduction to payment for CPT codes
19296 and 19297 in various clinical
scenarios were taken into consideration.
Therefore, consistent with our proposed
multiple procedure discounting policy
for the revised ASC payment system,
these two procedures were not included
on the proposed list of procedures for
exemption from multiple procedure
discounting under the revised ASC
payment system. Their OPPS payment
status of ‘‘T’’ implies that the multiple
procedure payment reduction would be
appropriate, and the possibility of a 50percent payment reduction has already
specifically been evaluated with respect
to the hospital outpatient resources
required to perform the procedures.
However, because CPT code 19298 is
assigned to status indicator ‘‘S’’ under
the CY 2007 OPPS, where it remains in
its original New Technology APC while
additional hospital cost data are being
collected, we believe that CPT code
19298 would be appropriately exempted
from multiple procedure discounting in
both the ASC and HOPD settings,
consistent with our overall proposal for
discounting under the revised ASC
payment system.
After considering the public
comments we received, we are
finalizing our proposed payment policy
for multiple surgical procedure
discounting under the revised ASC
payment system under § 416.172(e) with
only editorial modification. We will
mirror the OPPS payment policy for
discounting when a beneficiary has
more than one covered surgical
procedure performed in a single
operative session in an ASC in CY 2008,
by exempting those surgical procedures
on the ASC list of covered surgical
procedures that are assigned to a status
indicator other than ‘‘T’’ under the CY
2008 OPPS from multiple procedure
discounting under the revised ASC
payment system. The discounting policy
of the revised ASC payment system, like
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
the policy of the existing ASC payment
system, will apply the multiple
procedure reduction if the same
procedure is performed bilaterally,
consistent with the general discounting
policy of the OPPS for payment of
surgical procedures that are performed
bilaterally. A procedure performed
bilaterally in one operative session
would be paid at 150 percent of the
single procedure payment under the
revised ASC payment system. The
multiple procedure discounting policy
will only apply to ASC payment for
covered surgical procedures. ASC
payment for covered ancillary services,
as discussed further in section IV.C.2. of
this final rule, will not be subject to the
multiple procedure discount.
The specific multiple procedure
discounting policy that applies to each
ASC covered surgical procedure is
identified in Addendum AA to this final
rule. Table 10 provides an illustrative
summary list of the CY 2007 HCPCS
codes on the ASC list of covered
surgical procedures for CY 2008, and
their respective APCs as of January 1,
2007 under the OPPS, which will be
exempt from multiple procedure
discounting in ASCs effective January 1,
2008, if no changes are made to their
OPPS discounting designation for CY
2008. We will update this list annually
in the OPPS/ASC proposed and final
rulemaking process, which includes the
solicitation of public comments. The CY
2008 list of exemptions will be
proposed and finalized for the CY 2008
revised ASC payment system through
the OPPS/ASC rulemaking cycle for CY
2008.
TABLE 10.—ILLUSTRATIVE LIST OF
PROCEDURES EXEMPT FROM MULTIPLE
PROCEDURE DISCOUNTING
UNDER THE REVISED ASC PAYMENT
SYSTEM IN CY 2008
Short descriptor
11980 .....
Implant hormone pellet(s).
Insert drug implant device.
Remove drug implant
device.
Remove/insert drug implant.
Dressing change not for
burn.
Test for blood flow in
graft.
Place breast clip, percut
Place breast rad tube/
caths.
Removal of fixation device.
11982 .....
11983 .....
mstockstill on PROD1PC66 with RULES2
15852 .....
15860 .....
19295 .....
19298 .....
20665 .....
HCPCS
code
Short descriptor
20975 .....
Electrical bone stimulation.
Us bone stimulation ......
Application of body cast
Application of body cast
Application of body cast
Application of body cast
Application of body cast
Application of body cast
Application of body cast
Application of figure
eight.
Application of shoulder
cast.
Application of shoulder
cast.
Application of long arm
cast.
Application of forearm
cast.
Apply hand/wrist cast ...
Apply finger cast ...........
Apply long arm splint ....
Apply forearm splint .....
Apply forearm splint .....
Application of finger
splint.
Application of finger
splint.
Strapping of chest ........
Strapping of low back ...
Strapping of shoulder ...
Strapping of elbow or
wrist.
Strapping of hand or
finger.
Application of hip cast ..
Application of hip casts
Application of long leg
cast.
Application of long leg
cast.
Apply long leg cast
brace.
Application of long leg
cast.
Apply short leg cast ......
Apply short leg cast ......
Apply short leg cast ......
Addition of walker to
cast.
Apply rigid leg cast .......
Application of leg cast ..
Application, long leg
splint.
Application lower leg
splint.
Strapping of hip ............
Strapping of knee .........
Strapping of ankle and/
or ft.
Strapping of toes ..........
Application of paste
boot.
Application of foot splint
20979
29010
29015
29020
29025
29035
29040
29044
29049
.....
.....
.....
.....
.....
.....
.....
.....
.....
29055 .....
29058 .....
29065 .....
29075 .....
29085
29086
29105
29125
29126
29130
.....
.....
.....
.....
.....
.....
29131 .....
29200
29220
29240
29260
.....
.....
.....
.....
29280 .....
29305 .....
29325 .....
29345 .....
29355 .....
29358 .....
29365 .....
HCPCS
code
11981 .....
TABLE 10.—ILLUSTRATIVE LIST OF
PROCEDURES EXEMPT FROM MULTIPLE
PROCEDURE DISCOUNTING
UNDER THE REVISED ASC PAYMENT
SYSTEM IN CY 2008—Continued
VerDate Aug<31>2005
16:08 Aug 01, 2007
APC
0340
0340
0340
0340
29405
29425
29435
29440
.....
.....
.....
.....
29445 .....
29450 .....
29505 .....
29515 .....
0340
0340
0657
1524
29520 .....
29530 .....
29540 .....
29550 .....
29580 .....
0340
Jkt 211001
29590 .....
PO 00000
Frm 00047
Fmt 4701
Sfmt 4700
TABLE 10.—ILLUSTRATIVE LIST OF
PROCEDURES EXEMPT FROM MULTIPLE
PROCEDURE DISCOUNTING
UNDER THE REVISED ASC PAYMENT
SYSTEM IN CY 2008—Continued
HCPCS
code
Short descriptor
0340
29700 .....
0340
0426
0426
0058
0058
0426
0058
0426
0058
29705 .....
Removal/revision of
cast.
Removal/revision of
cast.
Removal/revision of
cast.
Removal/revision of
cast.
Repair of body cast ......
Windowing of cast ........
Wedging of cast ...........
Wedging of clubfoot
cast.
Remove nasal foreign
body.
Insert emergency airway.
Endobronchial us addon.
Implant pat-active ht
record.
Pseudoaneurysm injection trt.
Blood transfusion service.
Bl push transfuse, 2 yr
or <.
Bl exchange/transfuse,
nb.
Apheresis wbc ..............
Apheresis rbc ...............
Apheresis platelets .......
Apheresis plasma .........
Apheresis, adsorp/reinfuse.
Apheresis, selective .....
Photopheresis ...............
Inj w/fluor, eval cv device.
Iv us first vessel add-on
Iv us each add vessel
add-on.
Harvest allogenic stem
cells.
Harvest auto stem cells
Bone marrow collection
Bone marrow/stem
transplant.
Lymphocyte infuse
transplant.
Removal, foreign body,
mouth.
Remove pharynx foreign body.
Diagnostic anoscopy ....
Insert bladder catheter
Insert temp bladder
cath.
Us urine capacity measure.
Male sling procedure ....
Insert tandem cuff ........
Insert uro/ves nck
sphincter.
Remove/replace ur
sphincter.
APC
0426
0058
0426
0426
0058
0058
0058
0058
0058
0058
0058
0058
0058
0058
0058
0058
0426
0426
0426
0426
29710 .....
29715 .....
29720
29730
29740
29750
.....
.....
.....
.....
30300 .....
31500 .....
31620 .....
33282 .....
36002 .....
36430 .....
36440 .....
36450 .....
36511
36512
36513
36514
36515
.....
.....
.....
.....
.....
36516 .....
36522 .....
36598 .....
37250 .....
37251 .....
38205 .....
0426
0426
38206 .....
38230 .....
38241 .....
0426
0426
0426
0058
38242 .....
0426
0058
0058
0058
0058
0058
0058
0058
0058
42515
40804 .....
42809 .....
46600 .....
51701 .....
51702 .....
51798 .....
53440 .....
53444 .....
53445 .....
53447 .....
0058
E:\FR\FM\02AUR2.SGM
02AUR2
APC
0058
0058
0426
0058
0058
0058
0058
0058
0340
0094
0670
0680
0267
0110
0110
0110
0111
0111
0111
0111
0112
0112
0112
0340
0416
0416
0111
0111
0123
0123
0111
0340
0340
0340
0340
0340
0340
0385
0385
0386
0386
42516
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
TABLE 10.—ILLUSTRATIVE LIST OF
PROCEDURES EXEMPT FROM MULTIPLE
PROCEDURE DISCOUNTING
UNDER THE REVISED ASC PAYMENT
SYSTEM IN CY 2008—Continued
HCPCS
code
Short descriptor
54400 .....
Insert semi-rigid prosthesis.
Insert self-contd prosthesis.
Insert multi-comp penis
pros.
Remove/replace penis
prosth.
Remv/repl penis contain
pros.
Brain surgery using
computer.
Insrt/redo neurostim 1
array.
Csf shunt reprogram ....
Analyze spine infusion
pump.
Analyze spine infusion
pump.
Implant neuroelectrodes
Implant neuroelectrodes
Implant neuroelectrodes
Implant neuroelectrodes
Implant neuroelectrodes
Implant neuroelectrodes
Implant neuroelectrodes
Implant neuroelectrodes
Implant neuroelectrodes
Implant neuroelectrodes
Implant neuroelectrodes
Implant neuroelectrodes
Remove foreign body
from eye.
Remove foreign body
from eye.
Remove foreign body
from eye.
Remove foreign body
from eye.
Corneal smear ..............
Treatment of corneal lesion.
Inject/treat eye socket ..
Revise eyelashes .........
Remove eyelid foreign
body.
Treatment of eyelid lesions.
Treat eyelid by injection
Close tear duct opening
Close tear duct opening
Dilate tear duct opening
Probe nasolacrimal duct
Explore/irrigate tear
ducts.
Clear outer ear canal ...
Remove impacted ear
wax.
Place endorectal app ...
Rxt breast appl place/
remov.
Insert palate implants ...
CA screen; flexi
sigmoidscope.
54401 .....
54405 .....
54410 .....
54416 .....
61795 .....
61885 .....
62252 .....
62367 .....
62368 .....
63650
63655
64553
64555
64560
64561
64565
64573
64575
64577
64580
64581
65205
.....
.....
.....
.....
.....
.....
.....
.....
.....
.....
.....
.....
.....
65210 .....
65220 .....
65222 .....
65430 .....
65450 .....
67500 .....
67820 .....
67938 .....
68040 .....
68200
68760
68761
68801
68810
68840
.....
.....
.....
.....
.....
.....
mstockstill on PROD1PC66 with RULES2
69200 .....
69210 .....
C9725 ....
C9726 ....
C9727 ....
G0104 ....
VerDate Aug<31>2005
16:08 Aug 01, 2007
APC
0385
0386
0386
0386
0386
0302
0039
0691
0691
0691
0040
0061
0225
0040
0040
0040
0040
0225
0061
0061
0061
0061
0698
0698
0698
0698
0698
0231
0231
0698
0698
0698
0230
0231
0231
0698
0231
0698
0340
0340
1507
1508
1510
0159
Jkt 211001
2. Interrupted Procedure Policies
When a procedure requiring
anesthesia is discontinued after the
beneficiary is prepared for the
procedure and taken to the room where
it is to be performed, but before the
administration of anesthesia, ASCs
currently report modifier 73
(Discontinued outpatient procedure
prior to anesthesia administration)
appended to the discontinued
procedure and receive 50 percent of the
ASC payment for the planned surgical
procedure. We believe that ASCs, like
hospital outpatient facilities, realize
significant savings when procedures for
which anesthesia is to be used are
discontinued prior to their initiation but
after the beneficiary is taken to the
procedure room. We believe that savings
are recognized for the costs associated
with a variety of facility resources,
including treatment/operating room
time, single use devices, drugs,
equipment, supplies, and recovery room
time. When a procedure is interrupted
after its initiation or the administration
of anesthesia, ASCs currently report
these cases using modifier 74
(Discontinued outpatient procedure
after anesthesia administration)
appended to the interrupted procedure,
and the full ASC payment for the
covered surgical procedure is made.
Similar to hospital outpatient
procedures that are discontinued after
the administration of anesthesia or the
initiation of the procedure, in cases
where modifier 74 is reported by ASCs,
we believe that the facility costs
incurred for these discontinued
procedures that were initiated to some
degree are generally as significant to the
ASC as those for a completed procedure,
including resources for patient
preparation, operating room use, and
recovery room care. In the August 2006
proposed rule, we proposed no change
to the existing ASC payment policy for
procedures reported with modifier 73 or
74 under the revised ASC payment
system, and note that the policy under
the existing ASC payment system is the
same as the OPPS policy in these
circumstances.
Under the existing ASC payment
system, ASCs do not report modifier 52
(Reduced services) for interrupted
procedures, because most interrupted
covered surgical procedures paid in
ASCs would be appropriately reported
with modifier 73 or 74 because they
generally require anesthesia. Modifier
52 is appended to a service under the
OPPS to signify that a service that did
not require anesthesia was partially
reduced or discontinued at the
physician’s discretion. Modifier 52 is
PO 00000
Frm 00048
Fmt 4701
Sfmt 4700
reported under the OPPS for a variety of
types of interrupted services, such as
radiology services, and we believe that
there are considerable resource savings
to the facility under the circumstances
where it is reported. Therefore, under
the OPPS, we apply a 50 percent
reduction to the facility payment for
interrupted procedures and services
reported with modifier 52.
The PPAC recommended that we
apply payment policies consistently
under the revised ASC payment system
and the OPPS. We received a number of
public comments recommending
consistency of payment policies
between the two payment systems.
Although not discussed in our proposed
rule for the revised ASC payment
system, we received comments on the
application of the current interrupted
procedure policies to the revised ASC
payment system and respond to these
comments below.
Comment: Many commenters
recommended that we establish
consistent payment policies under the
OPPS and the revised ASC payment
system, because the hospital and ASC
facilities provide many of the same
services to similar patients. In
particular, several commenters
compared current payment policies that
were similar between the existing ASC
payment system and the OPPS,
including the payment policy that
reduces the payment for interrupted
procedures reported with modifier 73 by
50 percent in both payment systems.
Response: We agree with commenters
that consistent policies between the
revised ASC payment system and the
OPPS are desirable whenever possible,
because the revised ASC payment
system will be based upon the OPPS
relative payment weights. We also note
that, with the significant expansion of
procedures eligible for ASC payment
under the revised ASC payment system,
it is possible that some of the additional
procedures payable in the ASC setting
beginning in CY 2008 may not always
require anesthesia. In addition, as
further discussed in section IV.C.2. of
this final rule, we will be providing
separate payment for some ancillary
radiology services that are integral to the
performance of covered surgical
procedures under the revised ASC
payment system. Therefore, we believe
that the revised ASC payment system
should also allow ASCs to report
interrupted services not requiring
anesthesia with modifier 52, consistent
with the OPPS reporting of these
services. Because we expect ASCs to
utilize fewer facility resources in such
situations, similar to ASC procedures
where modifier 73 is reported and to
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
HOPDs where modifier 73 or 52 is
reported, we believe that it is
appropriate to provide the same
payment reduction of 50 percent under
the revised ASC payment system as
under the OPPS when modifier 52 is
reported.
After considering the public
comments received, we are clarifying
here the payment policies for
interrupted procedures in ASCs. First,
procedures requiring anesthesia that are
terminated after the patient has been
prepared for surgery and taken to the
operating room but before the
administration of anesthesia will be
reported with modifier 73, and the ASC
payment for the covered surgical
procedure will be reduced by 50
percent. Second, procedures and
services not requiring anesthesia that
are partially reduced or discontinued at
the physician’s discretion will be
reported with modifier 52, and the ASC
payment for the covered surgical
procedure or covered ancillary service
will be reduced by 50 percent. Third,
procedures requiring anesthesia that are
terminated after the administration of
anesthesia or the initiation of the
procedure will be reported with
modifier 74, and the full ASC payment
for the covered surgical procedure will
be provided. We are adding new
§ 416.172(f) to reflect this final policy.
G. Geographic Adjustment
Currently, Medicare adjusts 34.45
percent of the national ASC payment
rates using wage index values and
localities that were established under
the hospital IPPS prior to
implementation of the new CBSAs
issued by OMB in June 2003. Medicare
currently adjusts 60 percent of national
OPPS payment rates by the IPPS wage
index value assigned to hospitals using
the June 2003 OMB definitions for
geographical statistical areas and wage
adjustments required under Public Law
108–173.
Since 1990, ASC payments have been
adjusted for regional wage variations
using the IPPS wage index values. As
we discussed in the August 2006
proposed rule, we believe that
standardization continues to be
appropriate in recognition of widely
varying labor market costs tied to
geographic localities. We also explained
in the proposed rule that we believe it
is advisable to maintain consistency in
locality designations between ASCs and
hospitals and acknowledge parity of
labor costs between ASCs and HOPDs
that are competing for staff in the same
locality. Therefore, we proposed to
apply to ASCs the IPPS prereclassification wage index values
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
associated with the June 2003 OMB
geographic localities, as recognized
under the IPPS and OPPS, to adjust
national ASC payment rates for
geographic wage differences under the
revised payment system.
Although we had not collected new
data to identify whether the current
labor-related share is correct, the results
of a 1994 survey of ASC costs generally
supported the current 34.45-percent
labor adjustment factor, and we had
received no complaints from the ASC
community, prior to our proposal, about
our continued use of the 34.45/65.55
ratio of labor to nonlabor costs for
purposes of adjusting payments for
regional wage differences. Moreover, in
the proposed rule, we stated our belief
that it is reasonable to expect ASCs to
have a lower labor adjustment factor
than that of hospitals. For example,
most OPPS HOPDs are staffed 24 hours
per day to provide emergency
department services and observation
care, and these patterns of operation
could lead to relatively higher labor
costs for hospital services overall.
Therefore, we proposed to continue
using 34.45 percent as the labor
adjustment factor for regional wage
differences under the revised ASC
payment system, beginning in CY 2008.
We proposed to establish rules
governing this proposal in new
§ 416.172(c).
Subsequent to the publication of the
August 2006 proposed rule for the
revised ASC payment system, the GAO
issued the report, ‘‘Medicare: Payment
for Ambulatory Surgical Centers Should
Be Based on the Hospital Outpatient
Payment System,’’ (GAO–07–86), which
is discussed in further detail in section
II.B. of this final rule. In this report, the
GAO determined that based upon the
2004 ASC cost data from a
geographically representative group of
ASCs received in response to its ASC
survey, the mean labor-related
proportion of ASC costs was 50 percent.
Comment: Several commenters agreed
with CMS’ proposal to use the IPPS prereclassification wage index values
associated with the June 2003 OMB
geographic localities. However, many
commenters indicated that the current
34.45-percent labor factor is based on
old data and is too low, leading to their
recommendation that the 60-percent
OPPS labor factor would be more
appropriate. Some commenters
explained that it was difficult to assess
the appropriateness of CMS’ proposal in
the absence of the GAO Report on the
ASC payment system that was directed
to address whether a geographic
adjustment should be provided for
payment of procedures furnished in
PO 00000
Frm 00049
Fmt 4701
Sfmt 4700
42517
ASCs and, if so, the labor and nonlabor
shares of ASC payment. Other
commenters recommended that CMS
collect more recent data on the costs of
delivering services in the ASC setting or
suggested that ASCs be asked to submit
cost reports to inform the development
of an appropriate, contemporary labor
factor reflecting current ASC costs.
Response: For the reasons stated in
the proposed rule and reiterated above,
we agree with the commenters that we
should use the IPPS pre-reclassification
wage index values associated with the
June 2003 OMB geographic localities.
While we share the concerns of
commenters about the age of the survey
data used for the current 34.45-percent
labor factor, we disagree that it would
be appropriate to use the same 60percent labor factor used under the
OPPS. The commenters who indicated a
preference for the OPPS labor factor did
not address the fact that most OPPS
HOPDs are staffed 24 hours per day to
provide emergency department services
and observation care. Other than their
request for parity with the OPPS labor
adjustment, they provided no specific
data to support the appropriateness of a
60-percent labor factor based on current
ASC costs for performing procedures.
However, we agree with commenters
that the 34.45 labor-related share that
we proposed for the revised payment
system is likely too low to accurately
reflect the current proportion of ASCs’
labor costs. The data used to develop
the 34.45 labor-related share are 20
years old, and 1994 ASC survey cost
data, which have never been used for
ASC payment, showed a slightly higher
labor-related share of 37.66 percent that
we believe was likely reflective of a
generally increasing proportion of ASC
labor costs. ASCs and HOPDs operate in
some of the same communities, using
similar clinical staff to perform certain
procedures, and ASC staff wages may be
comparable to those of hospital staff.
However, we have no data to indicate
that ASCs and HOPDs have equivalent
ratios of labor to nonlabor costs, on
average, for all the services each type of
facility provides. As discussed above,
because ASCs only provide a subset of
surgical procedures compared with the
wide variety of OPPS services that we
expect could be, overall, relatively more
labor-intensive than ambulatory surgical
procedures specifically, we believe that
the most appropriate ASC labor-related
share would be lower than the 60
percent used to adjust HOPD payment.
The GAO Report determined, on the
basis of the 2004 ASC cost data received
from a geographically representative
group of ASCs in response to its ASC
survey, that the mean labor-related
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42518
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
proportion of costs was 50 percent. In
addition, the GAO found that the range
of the labor-related costs for the middle
50 percent of ASCs responding to the
survey was relatively narrow, at 43
percent to 57 percent of total costs.
Therefore, in response to comments
about the age of the historical data used
for the existing and proposed revised
ASC payment system labor factor, in
addition to consideration of the GAO’s
determination based on the most recent
ASC survey findings, we reviewed the
labor-related share indicated by the
1994 ASC survey cost data and assessed
the clinical labor required to provide
both ASC and OPPS services, in the
context of the full facility resource costs
associated with those services. Based on
all of those considerations, we believe
that it is not necessary to collect
additional ASC cost data in order to
determine the appropriate labor-related
factor for use under the revised ASC
payment system and that a 50-percent
labor factor for the revised ASC
payment system is most appropriate.
Fifty percent is significantly higher than
the current labor-related share (34.45
percent) that we proposed to maintain
but is also lower than the OPPS laborrelated share of 60 percent, a differential
we believe is appropriate given the
broader range of labor-intensive services
provided in the HOPD setting. A 50percent labor-related share is fully
consistent with the GAO findings that
we believe provide a more accurate
representation of the present-day laborrelated proportion of ASC costs than the
data upon which we currently rely. In
the future, if we believe that the
collection of additional ASC cost data is
important to providing appropriate
payment to ASCs and such an activity
is administratively feasible, we may
consider gathering such information
from ASCs.
After considering the public
comments received, we are finalizing
our proposal to apply to ASC payments
under the revised ASC payment system
the IPPS pre-reclassification wage index
values associated with the June 2003
OMB geographic localities, as
recognized under the IPPS and OPPS, in
order to adjust national ASC payment
rates for geographic wage differences
under the revised payment system.
However, rather than adopting 34.45
percent as the labor adjustment factor as
we proposed, we are adopting 50
percent as the labor-related proportion
under the revised ASC payment system.
The geographic adjustment policy of the
revised ASC payment system is set forth
in § 416.172(c).
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
H. Adjustment for Inflation
As noted above, section
1833(i)(2)(C)(iv) of the Act, as amended
by section 626(a) of Public Law 108–
173, requires the adjustment of ASC
payment amounts for inflation for FY
2005, the last quarter of CY 2005, and
each of CYs 2006 through 2009 to equal
zero percent. Otherwise, section
1833(i)(2)(C)(i) of the Act provides that
ASC payment amounts are to be
adjusted by the percentage increase in
the CPI–U during years when the ASC
payment amounts are not updated.
Although we are only required to
increase the ASC payment rates by the
percentage increase in the CPI–U during
years in which we have not updated the
ASC payment amounts, we proposed to
update the ASC conversion factor
annually using the CPI–U. For CY 2008
and CY 2009, the statute requires a zero
percent CPI–U increase for ASC
services. Beginning in CY 2010, in the
August 2006 proposed rule for the
revised ASC payment system, we
proposed to update the ASC conversion
factor by the percentage increase in the
CPI–U (U.S. city average) as estimated
for the 12-month period ending with the
midpoint of the year involved.
Accordingly, we proposed to establish
rules in proposed new §§ 416.171 and
416.172 to reflect our proposed policy
for applying an inflation adjustment
under the proposed revised payment
system beginning January 1, 2008.
(These sections of the proposed
regulations also included our proposed
policies for calculating a conversion
factor and standardizing labor-related
costs, respectively, under the proposed
revised payment system.)
Comment: A number of commenters
recommended that CMS use the hospital
market basket as an update for inflation
in the revised ASC payment system. The
commenters generally indicated that the
hospital market basket more
appropriately reflects inflation in the
costs of providing surgical services.
These commenters pointed out that the
CPI–U is a measure of consumer
inflation rather than health care
provider inflation, and that the hospital
market basket was specifically designed
to measure the cost of hospital inflation.
They concluded that the hospital market
basket is, thus, a better proxy for the
inflationary pressures faced by ASCs.
One commenter presented data
indicating that the cost of operating an
ASC rose by an average of 13.4 percent
between 2003 and 2005 and that, during
that same period, the CPI–U fell 36
percent short of meeting these increased
costs.
PO 00000
Frm 00050
Fmt 4701
Sfmt 4700
Some commenters expressed concern
that the use of two different factors to
update payments for ASCs and HOPDs
would further increase the
discrepancies between payments in the
two settings. They further suggested that
alignment with hospital updates and
policies in general would achieve parity
and transparency in the market and
ensure that facility decisions are made
based upon what is best for the patient.
Other commenters suggested that CMS
develop another method that would
more closely approximate the rising cost
of operating an ASC if the proposal to
base the annual update of the ASC
conversion factor on the CPI–U is
finalized.
Response: As we explained in the CY
2007 OPPS/ASC final rule with
comment period (71 FR 68003), the
OPPS conversion factor is updated
annually using the hospital inpatient
market basket percentage increase. The
statute specifically required us to take
into account the recommendations of a
GAO Report studying the
appropriateness of aligning a revised
ASC payment system with the payment
rates and relative weights established
under the OPPS. However, the statute
gives the Secretary broad authority in
designing the specific features of the
revised system. In particular, the statute
gives the Secretary considerable
discretion in determining an
appropriate update mechanism for the
revised ASC payment system. Section
1833(i)(2)(C)(i) of the Act requires that
the Secretary update the payment
amounts established under the revised
system ‘‘by the percentage increase in
the Consumer Price Index for all urban
consumers,’’ but only if the Secretary
has not otherwise ‘‘updated amounts
established’’ under the revised system
for that year. The statute, therefore, does
not mandate the adoption of any
particular update mechanism, but it
does establish the CPI–U as the default
update mechanism in the absence of any
other update. In addition, section
1833(i)(2)(C)(iv) of the Act mandates a
zero CPI–U adjustment in CY 2008 and
CY 2009 for ASCs, the first 2 years
under the revised payment system,
suggesting that maintaining continuity
in the update mechanism under the
revised system may be appropriate.
Therefore, we proposed, under the
revised system beginning in CY 2010, to
apply the CPI–U adjustment to update
the ASC conversion factor for inflation
on an annual basis. While we
understand the arguments of
commenters in favor of adopting the
hospital market basket as the update
mechanism under the revised ASC
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
payment system, we continue to believe
that it is appropriate to adopt the default
update mechanism designated by
Congress for the revised system.
Therefore, we are finalizing our
proposal, beginning in CY 2010, to
update the conversion factor by the
percentage increase in the CPI–U (U.S.
city average) as estimated for the 12month period ending with the midpoint
of the year involved. At the same time,
we recognize that we continue to have
flexibility under the statute to employ a
different update mechanism under the
revised ASC payment system. As one
example, we do not intend for the
revised ASC payment system to result in
additional Medicare expenditures over
time. We will be monitoring this issue
closely in the coming years.
Consequently, we will reconsider the
ASC update if expenditures increase
inappropriately in future years.
Therefore, after consideration of all
public comments received, we are
finalizing our proposal under
§ 416.171(a)(2), without modification, to
apply the CPI–U to update the ASC
conversion factor for inflation on an
annual basis under the revised ASC
payment system.
I. Beneficiary Coinsurance
Payment for ASC services is subject to
the Medicare Part B deductible and
coinsurance requirements. Currently,
Medicare pays participating ASCs 80
percent of a prospectively determined
standard overhead amount, adjusted for
regional wage variations for ASC
covered surgical procedures, except for
screening colonoscopies. The
beneficiary deductible and coinsurance
make up the other 20 percent of
payment for ASC services, except for
screening colonoscopies for which there
is no deductible and for which the
coinsurance is equal to 25 percent.
Section 1834(d) of the Act requires this
higher coinsurance for screening
colonoscopies and screening flexible
sigmoidoscopies. However, only
screening colonoscopies are on the CY
2007 ASC list of covered surgical
procedures. In addition, effective
January 1, 2007, a deductible is no
longer applied for colorectal cancer
screening tests, including screening
flexible sigmoidoscopy and screening
colonoscopy procedures performed in
ASCs or other settings, as specified in
section 1833(b)(8) of the Act (as added
by section 5113 of Public Law 109–171).
Section 626(c) of Public Law 108–173
amended section 1833(a)(1) of the Act to
provide that, beginning with the
implementation date of the revised
payment system, the Medicare program
payment to ASCs shall equal 80 percent
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
of the lesser of the actual charge for the
services or the payment amount that we
determine under the revised payment
system for the services. This
amendment, however, did not affect
section 1834(d) of the Act. Therefore,
we proposed to make this change and to
continue to maintain the beneficiary
deductible and coinsurance at 20
percent under the revised ASC payment
system, except for screening
colonoscopies and screening flexible
sigmoidoscopies (which are both ASC
covered surgical procedures in CY 2008)
for which the statute requires 25 percent
beneficiary coinsurance. In the August
2006 proposed rule for the revised ASC
payment system, we proposed to reflect
the 20 percent beneficiary coinsurance
in proposed new §§ 416.172(b) and (d);
however, the proposed regulation text
did not address the statutory
requirement of 25 percent coinsurance
for screening flexible sigmoidoscopies
and screening colonoscopies. Consistent
with the provisions of section 1834(d) of
the Act, we implemented the 25 percent
coinsurance requirement for screening
colonoscopies (screening flexible
sigmoidoscopies are not on the CY 2007
ASC list of covered surgical procedures)
in ASCs, effective January 1, 2007, as
finalized in § 410.152(i) and discussed
in the preamble to the CY 2007 OPPS/
ASC final rule with comment period (71
FR 68174).
Comment: Many commenters
supported our proposal to continue to
apply the 20 percent coinsurance
provision to payment for covered
surgical procedures performed in ASCs
and paid under the revised ASC
payment system.
Response: We appreciate the
comments. The statute requires
Medicare to pay 80 percent of the lesser
of the actual charge for the service or the
amount we determine under the revised
payment system, other than for
screening colonoscopy and screening
flexible sigmoidoscopy procedures.
Beneficiary coinsurance will remain at
20 percent for ASC services under the
revised ASC payment system, except for
screening flexible sigmoidoscopy and
screening colonoscopy procedures. The
coinsurance for screening colonoscopies
and screening flexible sigmoidoscopies
will be 25 percent, as required by
section 1834(d) of the Act, with no
deductible for those services under the
revised ASC payment system. This
requirement is reflected in our
regulations at §§ 416.172(b) and (d).
PO 00000
Frm 00051
Fmt 4701
Sfmt 4700
42519
J. Phase-In of Full Implementation of
Payment Rates Calculated Under the
Revised ASC Payment System
Methodology
We discussed in section XXVII.D. of
the preamble to the August 2006
proposed rule for the revised ASC
payment system (71 FR 49690 through
49695), our analysis of the impact that
the revised ASC payment system and
estimated payment rates for
implementation in CY 2008 could have
on certain ASCs that specialize in or
perform high volumes of procedures for
which payment under the new system
would decrease. We wanted to ensure
that the revised payment system does
not cause a sudden, unwarranted
migration of services from ASCs to other
ambulatory settings, or the reverse; that
ASCs would have an opportunity to
balance their Medicare caseπmix
between procedures whose rates
decrease and procedures whose rates
increase; and that beneficiaries and their
physicians would continue to have a
robust choice of sites where important
preventive and other surgical services
are paid under Medicare.
In the August 2006 proposed rule, we
proposed to implement the revised ASC
payment system in CY 2008 using
transitional payment rates that would be
based upon a 50/50 blend of the CY
2007 ASC payment rate for a procedure
on the CY 2007 ASC list of covered
surgical procedures and the final
payment rate for that same procedure
calculated under the revised payment
system methodology described in the
proposed rule and reflected in proposed
new § 416.171(c). We further proposed
that, in CY 2009, we would fully
implement the ASC payment rates
calculated under the proposed payment
methodology, discontinuing the blended
transitional payment rates for services
furnished beginning January 1, 2009.
This was proposed in new § 416.171(d).
Comment: Several commenters
expressed concern that the proposed 2year transition period would threaten
the viability of many ASCs. The
commenters indicated that given the
size of the payment cuts contemplated
under the proposed rule for certain
procedures and specialties, especially
gastrointestinal, pain management, and
ophthalmology services, 1 year would
not provide adequate time for ASCs to
adjust to the changes and that a 4-year
phase-in would allow a more gradual
and less disruptive transition to the new
payment system. Many commenters
urged CMS to implement policies to
further address the decrease in
payments for procedures whose rates
would fall significantly during a
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42520
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
transition to the new payment system.
One commenter suggested that CMS
hold harmless procedures that were on
the ASC list of covered surgical
procedures prior to CY 2008 to prevent
significant changes in payments during
the transition. Some commenters
expressed concern that if CMS revises
both the payment system and the
geographic localities used for wage
adjustment at the same time, providers
in certain areas could experience
dramatic shifts in payment as a result of
the cumulative effect of the wage index
and other policy changes that were
described in the proposed rule. These
commenters encouraged CMS to
consider the cumulative effects of the
wage index and other policy changes on
payments to ASCs under the revised
ASC payment system and develop a
transitional approach that protects
providers from significant reductions in
payment.
A number of commenters supported
the proposed 2-year phase-in of the ASC
payment rates based on the final
methodology of the revised ASC
payment system. The commenters
generally believed that the transition
period as proposed would provide
sufficient notice and time for ASCs to
adapt to the revised payment system.
Some commenters stated that the
proposed transition does not
appropriately address payment for
device-intensive procedures that
implant devices that are paid separately
according to the DMEPOS fee schedule
under the existing payment system
during the transitional year of CY 2008.
Some of these commenters urged CMS
to devise a strategy that would
accelerate full implementation of
payment for device-intensive
procedures according to the proposed
methodology for the revised ASC
payment system. Alternatively, other
commenters suggested that CMS
develop a final transitional policy that
does not exclude the payments for
implanted devices now paid separately
under the DMEPOS fee schedule in
calculating the CY 2007 ASC payment
contributions to the blended payment
rates for device-intensive procedures for
CY 2008.
Response: After consideration of all of
these public comments, we agree with
the majority of the commenters who
indicated that a 2-year transition may
provide some ASCs with insufficient
time to adapt to the revised payment
system. During the transition to the
revised system, we believe it is
important to maintain appropriate
Medicare beneficiary access to ASC
services. In addition, we do not believe
that the transition should be
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
asymmetrical, meaning that procedures
with decreasing payments under the
revised payment system should be
transitioned differently from those with
increasing payments. We also do not
believe that the transition should lead to
increases or decreases in overall
Medicare ASC expenditures.
Therefore, in order to provide
additional time for ASCs to adapt to the
revised payment system and to facilitate
Medicare beneficiary access to
ambulatory surgical procedures at those
ASCs that may not adjust as quickly as
others to the revised payment system,
we are extending the transition from our
proposed 2 years to 4 years for all
services on the CY 2007 ASC list of
covered surgical procedures, as reflected
in § 416.171(c). We believe a transition
period of 4 years, comparable to
transition periods provided under other
payment systems (for example, the
recent practice expense changes to the
MPFS) and as suggested in comments
concerning this issue, will provide a
reasonable and balanced approach to
implementation that addresses two
important objectives, in particular
offering sufficient notice and time for
ASCs to adapt to the revised payment
system and providing more accurate and
appropriate ASC payments for covered
surgical procedures. The contribution of
CY 2007 ASC payment rates to the
blended transitional rates will decrease
by 25 percentage point increments each
year of transitional payment, until CY
2011, when we will fully implement the
ASC payment rates calculated under the
final methodology of the revised
payment system. Procedures new to
ASC payment for CY 2008 or later
calendar years will receive payments
determined according to the final
methodology of the revised ASC
payment system, as reflected in
§ 416.171(a), without the need for a
transition. ASC covered surgical
procedures listed in Addendum AA to
this final rule that are subject to the
transition are assigned to payment
indicators ‘‘A2’’ (Surgical procedure on
ASC list in CY 2007; payment based on
OPPS relative payment weight) and
‘‘H8’’ (Device-intensive procedure on
ASC list in CY 2007; paid at adjusted
rate). ASC covered surgical procedures
listed in Addendum AA to this final
rule that are not subject to the transition
are assigned to payment indicators ‘‘G2’’
(Non office-based surgical procedure
added to ASC list in CY 2008 or later;
payment based on OPPS relative
payment weight); ‘‘J8’’ (Device-intensive
procedure added to ASC list in CY 2008
or later; paid at adjusted rate); ‘‘P2’’
(Office-based surgical procedure added
PO 00000
Frm 00052
Fmt 4701
Sfmt 4700
to ASC list in CY 2008 or later with
MPFS nonfacility PE RVUs; payment
based on OPPS relative payment
weight); ‘‘P3’’ (Office-based surgical
procedure added to ASC list in CY 2008
or later with MPFS nonfacility PE RVUs;
payment based on MPFS nonfacility PE
RVUs); and ‘‘R2’’ (Office-based surgical
procedure added to ASC list in CY 2008
or later without MPFS nonfacility PE
RVUs; payment based on OPPS relative
payment weight).
In addition, we agree with
commenters who indicated that an
adjustment should be made during the
transition period for certain procedures
that implant devices that are separately
payable under the existing ASC
payment system. For device-intensive
procedures utilizing separately payable
devices of significant cost, ideally, we
would adjust the CY 2007 base rates for
the procedures to appropriately reflect
the fact that associated devices may
have been separately paid to ASCs in
CY 2007 under the DMEPOS fee
schedule, but beginning in CY 2008
implantable device payment will be
packaged into the ASC payment for the
covered surgical procedure under the
revised ASC payment system. This
would require associating the current
separately provided implantable device
payments with specific covered surgical
procedures, in order to determine an
appropriate CY 2007 base payment rate
for the transition for each procedure.
However, due to the challenges in
making these associations, including the
common historical practice of payment
at contractor-priced rates for some
implantable devices that have been
reported only under Level II HCPCS
unlisted codes under the existing
payment system, we cannot accurately
allocate those device payments to
covered surgical procedures using the
ASC data.
Under the final methodology of the
revised ASC payment system for
calculating payment for procedures with
significant device costs as discussed in
section IV.C.2.e. of this final rule, for
device-intensive procedures on the CY
2007 ASC list of covered surgical
procedures, we will separately
determine both the device payment and
service payment portions of the total
ASC payment under the revised
payment system. We will apply the ASC
conversion factor only to the specially
calculated OPPS relative payment
weight for the service portion, while
providing the same packaged payment
for the device portion as would be made
under the OPPS. That is, we will
determine the payment amount
attributable to the device, as currently
determined under the OPPS, and
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
combine that payment amount with the
adjusted ASC service payment, resulting
in a total ‘‘bundled’’ ASC payment for
the device-intensive procedure under
the revised ASC payment system.
Consistent with that approach, we
also will apply our transition policy
differentially to those portions of the
total ASC payment. While we will not
subject the device payment portion of
the total ASC payment for the procedure
under the revised ASC payment system
to the transition policy, we will
transition the service payment portion
of the total ASC payment for the
procedure over the 4-year phase-in
period. Device-intensive procedures that
are new to the ASC list of covered
surgical procedures for CY 2008 or later
years will be exempted from any
transition period and will be paid at the
fully implemented revised ASC
payment system rates beginning in CY
2008 or the applicable update year, just
like all other new ASC surgical
procedures. During each of the
transition years, when the CY 2007 ASC
payment rate for a device-intensive
procedure that did not previously
include packaged ASC payment for the
implantable device itself is blended
with the payment developed under the
methodology of the revised ASC
payment system that would otherwise
package the device payment, the full
device payment amount will be paid to
ASCs in the transition year, with
blended payment determined only for
the service portion of the ASC payment,
for which a corresponding CY 2007 ASC
payment rate exists. This methodology
achieves an appropriate payment for
costly, implantable devices, because it
recognizes that, in general, the device
costs are similar for ASCs and HOPDs.
This specific transition approach for
device-intensive procedures ensures
that ASCs receive appropriate packaged
payment for implantable devices during
the transition years, even though
payment for such devices is generally
not included in their base CY 2007 ASC
payment rates under the existing ASC
payment system.
A full discussion of the calculation of
the payment rates for these deviceintensive procedures can be found in
section IV.C.2.e. of this final rule, in the
context of establishing payment weights
for device-intensive procedures under
the revised ASC payment system. Tables
5 and 6 above are illustrative of the
device-intensive procedures likely to be
subject to this special transitional policy
for device-intensive procedures under
the revised ASC payment system,
pending updating of their OPPS status
in CY 2008 and future years.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
After considering the public
comments received, we are finalizing a
policy to phase in implementation of
the payment rates calculated under the
revised ASC payment system over 4
years. For CYs 2008, 2009, and 2010,
payment will be made for each
procedure on the CY 2007 ASC list of
covered surgical procedures based on a
25/75, 50/50, and 75/25 blend,
respectively, of the CY 2007 payment
rate for the procedure and the payment
rate for that procedure calculated under
the standard revised payment system
methodology set forth in § 416.171(a).
Procedures that are newly approved for
ASC payment in CY 2008 or later years
are not subject to the transition policy.
In CY 2011, we will fully implement the
ASC payment rates calculated under the
standard payment methodology of the
revised ASC payment system. This final
transition policy is set forth in
§ 416.171(c).
The service payment portion of the
total ASC payment for device-intensive
procedures that are on the ASC list of
covered surgical procedures in CY 2007
will be subject to the transition. The
service payment portion calculated
under the fully implemented revised
ASC payment system methodology will
be blended with the ASC payment for
the procedure under the existing
payment system. In contrast, the device
payment portion of the total ASC
payment for these procedures, where
the device would generally have been
paid separately according to the
DMEPOS fee schedule under the
existing ASC payment system, will not
be subject to the transition. Rather, the
contribution of the device payment
portion to the total ASC payment during
the transitional years will be calculated
according to the methodology of the
fully implemented revised ASC
payment system. During the years of
phase-in of the revised ASC payment
system, the device payment portion will
be summed with the blended service
payment portion (that is, the 25/75, 50/
50, or 75/25 blend, as appropriate) to
establish the total ASC payment for
these device-intensive procedures for
each year of the transition. Deviceintensive procedures new to the ASC
list of covered surgical procedures for
CY 2008 or later years will be paid the
fully implemented revised payment
system rates.
V. Calculation of ASC Conversion
Factor and ASC Payment Rates for CY
2008
A. Overview
As discussed in section IV.B. of this
final rule, in the August 2006 proposed
PO 00000
Frm 00053
Fmt 4701
Sfmt 4700
42521
rule, we proposed to base ASC relative
payment weights and payment rates
under the revised ASC payment system
on APC groups and relative payment
weights established under the OPPS. We
also proposed to set the ASC relative
payment weight for certain office-based
surgical procedures so that the national
ASC payment rate does not exceed the
MPFS unadjusted nonfacility practice
expense amount. We explained that the
proposed ASC payment weights would
be multiplied by an ASC conversion
factor to calculate the ASC payment
rates. In the August 2006 proposed rule,
our estimate for the CY 2008 budget
neutral ASC conversion factor was
$39.688. In this final rule, we estimate
that the ASC conversion factor for CY
2008 will be approximately $42.543.
This new estimate of the ASC
conversion factor differs from the
estimate in the August 2006 proposed
rule for a number of reasons, including:
(1) Use of the final OPPS relative
payment weights for CY 2007; (2) use of
the final MPFS nonfacility practice
expense payment amounts for CY 2007;
(3) use of updated utilization data for
the full year of CY 2005; (4) a 4-year
instead of 2-year transition to the
revised payment system rates, with a
modified transition for device-intensive
procedures; (5) more recent estimates of
the hospital market basket update and
the MPFS conversion factor update for
CY 2008; and (6) adoption of the withmigration approach to calculation of the
budget neutrality adjustment using
different time periods for the assumed
migration of procedures from
physicians’ offices and HOPDs to ASCs
under the revised ASC payment system.
Specific details regarding our final
methodology for estimating the revised
ASC payment system conversion factor
are discussed later in this section.
We are not able to provide the final
CY 2008 ASC conversion factor in this
final rule for the revised ASC payment
system because the final conversion
factor will be based on the final OPPS
relative payment weights for CY 2008,
the final MPFS nonfacility practice
expense payment amounts for CY 2008,
and updated and complete CY 2006
utilization data, all of which are
unavailable at this time but will be
available for the CY 2008 OPPS/ASC
final rule. Therefore, in this final rule,
we are finalizing the methodology for
calculating the ASC conversion factor
for the revised ASC payment system.
When the necessary data are available,
they will be used in the methodology
described in this final rule, and we will
provide the final CY 2008 ASC
conversion factor and ASC relative
E:\FR\FM\02AUR2.SGM
02AUR2
42522
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
payment weights and rates in the CY
2008 OPPS/ASC final rule.
B. Budget Neutrality Requirement
Section 626(b) of Public Law 108–173
amended section 1833(i)(2) of the Act by
adding subparagraph (D) to require that
in the year the revised ASC system is
implemented:
‘‘* * * [S]uch system shall be
designed to result in the same aggregate
amount of expenditures for such
services as would be made if this
subparagraph did not apply, as
estimated by the Secretary. * * *’’
As discussed in the August 2006
proposed rule for the revised ASC
payment system, the ASC conversion
factor is calculated so that estimated
total Medicare payments under the
revised ASC payment system would be
budget neutral to estimated total
Medicare payments under the current
ASC payment system as required by the
statute. That is, application of the ASC
conversion factor would be designed to
result in aggregate expenditures under
the revised ASC payment system in CY
2008 equal to aggregate expenditures
that would have occurred in CY 2008 in
the absence of the revised system, taking
into consideration the cap on payments
in CY 2007 as required under section
5103 of Public Law 109–171, which we
discuss further in section IV.A. of this
final rule.
We note that, in the August 2006
proposed rule (71 FR 49656), we
considered the term ‘‘expenditures’’ in
the context of section 626(b) of the
Public Law 108–173 budget neutrality
requirement to mean expenditures from
the Medicare Part B Trust Fund. We did
not consider expenditures to include
beneficiary coinsurance and
copayments.
mstockstill on PROD1PC66 with RULES2
C. Calculation of the ASC Payment
Rates for CY 2008
1. Proposed Method for Calculation of
the ASC Payment Rates for CY 2008 in
the August 2006 Proposed Rule
In the August 2006 proposed rule, we
proposed to calculate the ASC payment
rates for CY 2008 as follows:
a. Estimated Medicare Program
Payments (Excluding Beneficiary
Coinsurance) Under the Current ASC
Payment System in the August 2006
Proposed Rule
Step 1: To estimate the aggregate
amount of expenditures that would be
made in CY 2008 under the current ASC
payment system, we first multiplied the
estimated CY 2008 ASC volume for each
HCPCS code on the CY 2007 ASC list
of covered surgical procedures by the
estimated CY 2008 ASC payment rate
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
for the HCPCS code under the existing
ASC system, and then subtracted
beneficiary coinsurance. In the August
2006 proposed rule, the estimated CY
2008 ASC payment rates were based on
the proposed CY 2007 ASC payment
rates, which were listed in Addendum
AA to the rule, taking into account the
OPPS cap on ASC services at the OPPS
rate as required by section 5103 of
Public Law 109–171 and reflecting the
zero percent CY 2008 update for ASC
services mandated by section
1833(i)(2)(C)(iv) of the Act. Although we
did not specify in the August 2006
proposed rule that we did so, we also
estimated the amount the Medicare
program would pay in CY 2008 for
implantable prosthetic devices and
implantable DME for which ASCs
currently receive separate payment
under the DMEPOS fee schedule. We
then summed the estimated DMEPOS
fee schedule total amount and all of the
estimated procedure payment amounts
for services on the CY 2007 ASC list of
covered surgical procedures to estimate
the aggregate amount of expenditures
that would be made in CY 2008 under
the policies of the current ASC payment
system.
b. Estimated Medicare Program
Payments (Excluding Beneficiary
Coinsurance) Under the Proposed
Revised ASC Payment System in the
August 2006 Proposed Rule
Step 2: To estimate the aggregate
amount of expenditures that would be
made in CY 2008, we used estimated CY
2008 OPPS payment amounts instead of
estimated CY 2008 ASC payment
amounts under the current system, and
we multiplied the estimated CY 2008
ASC volume for each HCPCS code on
the CY 2007 ASC list of covered surgical
procedures by the estimated CY 2008
OPPS payment rate for the HCPCS code,
and then subtracted beneficiary
coinsurance. We summed the results for
all services on that ASC list of covered
surgical procedures.
c. Calculation of the Proposed CY 2008
Budget Neutrality Adjustment in the
August 2006 Proposed Rule
Step 3: To calculate the proposed CY
2008 ASC budget neutrality adjustment,
we divided the total expenditures
calculated in Step 1 by the total
expenditures calculated in Step 2. We
calibrated this estimate of the budget
neutrality adjustment to take into
account that, in CY 2008, the payment
rate for procedures on the CY 2007 ASC
list of covered surgical procedures was
proposed to be 50 percent of the CY
2007 ASC payment amount and 50
percent of the CY 2008 ASC payment
PO 00000
Frm 00054
Fmt 4701
Sfmt 4700
rate calculated according to the
proposed revised payment system
methodology without the transition. The
result of these calculations was a budget
neutrality adjustment of 0.62.
d. Application of the Budget Neutrality
Adjustment To Determine the Proposed
CY 2008 ASC Conversion Factor in the
August 2006 Proposed Rule
Step 4: To determine the proposed CY
2008 ASC conversion factor, we
multiplied the estimated CY 2008 OPPS
conversion factor by the result of Step
3. The proposed estimated CY 2008
OPPS conversion factor was $64.013.
Multiplying the estimated CY 2008
OPPS conversion factor by the 0.62
budget neutrality adjustment yielded
our proposed CY 2008 ASC conversion
factor of $39.688.
e. Calculation of the Proposed CY 2008
ASC Payment Rates Under the Revised
ASC Payment System in the August
2006 Proposed Rule
Step 5: To determine the proposed
national ASC payment rates for covered
surgical procedures under the revised
payment system (including beneficiary
coinsurance), we multiplied the ASC
conversion factor from Step 4 by the
ASC relative payment weight.
The proposed ASC relative payment
weights for covered surgical procedures
were based on the relative payment
weights for the APC groups established
under the OPPS as described in section
IV.B. of this final rule. However, as
further discussed in section IV.E. of this
final rule, the ASC relative payment
weights for certain office-based surgical
procedures were set so that the national
ASC payment rate did not exceed the
MPFS unadjusted nonfacility practice
expense amount.
f. Calculation of the Proposed CY 2008
ASC Payment Rates Under the
Transition in the August 2006 Proposed
Rule
Step 6: We proposed to fully
implement the revised ASC payment
rates through a 2-year transition to 100
percent implementation of the revised
ASC payment rates for procedures
included on the CY 2007 ASC list of
covered surgical procedures. In the first
year of the transition, the payment rate
would be based on 50 percent of the
final CY 2007 ASC payment rate under
the existing ASC payment system and
50 percent of the final CY 2008 ASC
payment rate calculated under the
proposed revised payment
methodology. The CY 2008 payment for
procedures not on the CY 2007 ASC list
of covered surgical procedures, but for
which we proposed to make payment
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
under the revised payment system
beginning in CY 2008, would be made
at the fully implemented revised ASC
payment rates.
2. Alternative Option for Calculating the
Proposed Budget Neutrality Adjustment
in the August 2006 Proposed Rule
In the August 2006 proposed rule, we
presented an alternative approach to
calculating the budget neutrality
adjustment under the revised ASC
payment system, which would take into
account the effects of migration of
procedures across ASCs, physicians’
offices, and HOPDs that might be
attributable to the revised ASC payment
system (71 FR 49657 through 49658). In
the following discussion, the phrase
‘‘new ASC procedure’’ refers to a
surgical procedure not on the CY 2007
ASC list of covered surgical procedures
but for which we proposed to make
payment under the revised ASC
payment system beginning in CY 2008.
Under this alternative, we assumed
that 25 percent of the HOPD utilization
for new ASC procedures would migrate
to ASCs, and we also assumed that 15
percent of the physician’s office
utilization for new ASC procedures
would migrate to ASCs in the first year
of the revised ASC payment system. In
the August 2006 proposed rule, we also
noted our belief that our assumptions of
25 percent and 15 percent migration
from HOPDs and physicians’ offices to
ASCs, respectively, were reasonable,
given the general utilization
relationships between those settings for
services on the CY 2007 ASC list of
covered surgical procedures. Services
on the ASC list of covered surgical
procedures that are predominantly
performed in ASC and HOPD settings
are, on average, performed 30 percent of
the time in the ASC setting.
Furthermore, services on the existing
ASC list of covered surgical procedures
that are mainly performed in ASC and
physician’s office settings are, on
average, performed 17 percent of the
time in the ASC setting. We assumed
that new ASC procedures would migrate
at slightly lower rates in the first year of
the revised ASC payment system,
yielding our migration assumptions to
ASCs of 25 percent for the HOPD
services and 15 percent for the
physician’s office services.
We also assumed that the net impact
of migration of services on the existing
CY 2007 ASC list of covered surgical
procedures would be negligible. We
noted that payment rates for the current
highest volume ASC procedures would
generally decrease under the proposed
revised ASC payment system, and the
lower volume ASC procedures would
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
experience significant payment
increases. We believed it was reasonable
to assume that some of the higher
volume services would migrate from
ASCs to other settings, and some of the
current lower volume procedures would
migrate to the ASC setting as a result of
the payment changes.
In order to calculate the budget
neutrality adjustment under this
alternative option in the August 2006
proposed rule, first we estimated
expenditures that would occur if we did
not revise the ASC payment system. We
estimated CY 2008 expenditures if the
ASC payment rates were not revised and
the ASC list of covered surgical
procedures was not expanded, as
described below.
a. Estimated Medicare Program
Payments (Excluding Beneficiary
Coinsurance) Under the Existing ASC
Payment System in the August 2006
Proposed Rule
Step 1: Migration from HOPDs to
ASCs was valued using estimated CY
2008 OPPS payment rates.
(a) We multiplied the estimated CY
2008 HOPD utilization for each new
ASC procedure by 0.25, consistent with
our assumption that 25 percent of the
HOPD utilization for new ASC
procedures would migrate to the ASC.
(b) For each new ASC procedure, we
multiplied the results of Step 1(a) by the
estimated CY 2008 OPPS payment rate
for the procedure, and then subtracted
beneficiary coinsurance for the
procedure.
(c) We summed the results of Step
1(b) across all new ASC procedures.
Step 2: Migration of procedures from
physicians’ offices to ASCs was valued
using estimated CY 2008 MPFS
physician in-office payment rates.
‘‘Physician in-office payment rate’’ was
equal to the MPFS nonfacility practice
expense RVUs multiplied by the
estimated CY 2008 MPFS conversion
factor.
(a) To estimate the payment
associated with our assumption that 15
percent of the physicians’ office
utilization for new ASC procedures
would migrate to the ASC, we
multiplied the projected CY 2008
physicians’ office utilization for each
new ASC procedure by 0.15.
(b) For each new ASC procedure, we
multiplied the results of Step 2(a) by the
estimated CY 2008 physician in-office
payment rate for the procedure, and
then subtracted beneficiary coinsurance
for the procedure.
(c) We summed the results of Step
2(b) across all new ASC procedures.
Step 3: CY 2007 ASC services valued
using the estimated CY 2008 ASC
PO 00000
Frm 00055
Fmt 4701
Sfmt 4700
42523
payment rates under the current ASC
system.
This is described under Step 1 in the
Estimated Payments under the Current
ASC Payment System section,
specifically section V.C.1.a. above.
Step 4: The results of Steps 1–3 were
summed.
b. Estimated Medicare Program
Payments (Excluding Beneficiary
Coinsurance) Under the Proposed
Revised ASC Payment System in the
August 2006 Proposed Rule
Step 5: HOPD migration was valued
using estimated CY 2008 OPPS payment
rates.
This step is the same as Step 1 in
section V.C.2.a. above.
Step 6: We identified new ASC
procedures that were office-based (as
discussed in section III.C. of this final
rule).
Step 7: Migration of new ASC officebased procedures from physicians’
offices to ASCs was valued based on
estimated CY 2008 OPPS payment rates
capped at the estimated CY 2008
physician in-office payment rates, if
appropriate.
(a) For each new ASC procedure
determined to be office-based, we
multiplied the results of Step 2(a) from
section V.C.2.a. above by the lesser of—
(1) The estimated CY 2008 OPPS
payment rate for the procedure; or
(2) The estimated CY 2008 physician
in-office payment rate for the procedure,
and then subtracted beneficiary
coinsurance for the procedure. (As
noted in subsequent discussion in
section V.C.3. of this final rule, we
applied this adjustment for the capped
office-based procedures after
publication of the proposed rule and
posted the results on our Web site.)
(b) The results of Step 7(a) were
summed across all new ASC procedures
considered to be office-based.
Step 8: Migration of new ASC
procedures that were not determined to
be office-based from physicians’ offices
to ASCs was valued using the estimated
CY 2008 OPPS rates.
(a) For each new ASC procedure not
considered to be office-based, we
multiplied the results of Step 2(a) from
section V.C.2.a. above by the estimated
CY 2008 OPPS rate for the procedure,
and then subtracted beneficiary
coinsurance for the procedure.
(b) The results of Step 8(a) were
summed across all new ASC procedures
not considered to be office-based.
Step 9: Migration of new ASC
procedures from physicians’ offices to
ASCs was valued using the estimated
CY 2008 MPFS physician out-of-office
payment rates. ‘‘Physician out-of-office
E:\FR\FM\02AUR2.SGM
02AUR2
42524
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
payment rate’’ was equal to the facility
practice expense RVUs multiplied by
the estimated CY 2008 MPFS
conversion factor.
(a) For each new ASC procedure, we
multiplied the results of Step 2(a) from
section V.C.2.a. above by the estimated
CY 2008 physician out-of-office
payment rate for the procedure, and
then subtracted beneficiary coinsurance
for the procedure.
(b) The results of Step 9(a) were
summed across all new ASC
procedures.
Step 10: Current ASC services were
valued using the estimated CY 2008
OPPS payment rates.
This is described under Step 2 in
section V.C.1.b. above.
Step 11: The results of Steps 5 and 7–
10 were summed.
mstockstill on PROD1PC66 with RULES2
c. Calculation of the Proposed CY 2008
Budget Neutrality Adjustment in the
August 2006 Proposed Rule
Step 12: The result of Step 4 was
divided by the result of Step 11.
Step 13: The calculation of the budget
neutrality adjustment in Step 12 was
calibrated in a number of ways. The
application of the cap at the estimated
CY 2008 MPFS nonfacility practice
expense amount that occurred in Step 7
was dependent on the ASC conversion
factor. The ASC budget neutrality
adjustment resulting from Step 12 was
calibrated to take into account the
effects of the physician’s office payment
cap on the ASC conversion factor. The
ASC budget neutrality calculation was
also calibrated to take into account the
fact that the additional physician out-ofoffice payments under the revised ASC
payment system calculated in Step 9
must be fully offset by the budget
neutrality adjustment to ASC services
under the revised payment system.
Furthermore, the budget neutrality
calculation was calibrated to take into
account the CY 2008 transitional
payment rates for procedures on the CY
2007 ASC list of covered surgical
procedures.
As reported in the August 2006
proposed rule (71 FR 49658), the budget
neutrality adjustment calculated using
this alternative option that incorporated
CMS’ migration assumptions was 0.62,
indicating that under the migration
assumptions described above there was
no difference, rounded to the nearest
hundredth, between our proposed
budget neutrality adjustment without
migration (0.62) and the alternative
budget neutrality adjustment with
migration (0.62).
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
d. Discussion of the Alternative
Calculation of the Budget Neutrality
Adjustment
We chose to propose calculation of
the budget neutrality adjustment based
on the CY 2007 final ASC list of covered
surgical procedures and the most recent
available ASC utilization data because
we believed this was the most
appropriate approach to estimating
expenditures to result in a budget
neutral payment system in CY 2008. We
believed that the data available to us did
not enable us to precisely estimate the
net potential migration of services
between the ASC, outpatient hospital,
and physician’s office settings that
might result from implementation of the
revised ASC payment system. Moreover,
basing our estimate of expenditures on
current ASC utilization without
including migration from other sites of
service was consistent with how we
estimate expenditures for purposes of
establishing budget neutrality in other
Medicare payment systems. However,
we recognized, that significant service
migration would not generally be
expected to occur under these other
payment systems and acknowledged
that the potential for migration could be
significantly greater under the revised
ASC payment system, with a possible
effect on Medicare expenditures. Our
recognition of the uniqueness of the
revised ASC payment system was the
reason we presented the alternative
with-migration budget neutrality
adjustment calculation in the August
2006 proposed rule, so commenters
would have the opportunity to fully
examine this model, in addition to the
traditional without-migration
methodology that we proposed to use.
Given that the revised ASC payment
system includes a significant expansion
of procedures for which ASC payment
would be allowed, in addition to the
expected service mix changes that result
from the changes in payment incentives
that accompany the introduction of any
revised payment system, we expected
that some commenters might believe
that it would be more appropriate to
estimate the ASC budget neutrality
adjustment taking into account the
potential migration of services between
the ASC, hospital outpatient, and
physician’s office settings, consistent
with the alternative with-migration
model discussed in the August 2006
proposed rule. In that proposed rule, we
explained that we would welcome data
supporting the use of specific migration
assumptions in the calculation of the
ASC budget neutrality adjustment. We
described the budget neutrality
calculation under the alternative
PO 00000
Frm 00056
Fmt 4701
Sfmt 4700
approach based on our best estimate of
the potential migration of services
between the different settings, hoping to
facilitate and stimulate comment on
migration that could occur and
specifically to encourage the submission
of pertinent quantitative evidence of
service migration resulting from changes
in payment rates. We welcomed data on
all of the migration assumptions
presented in the proposed rule
discussion of the alternative approach.
We noted that there was no difference
between our proposed budget neutrality
calculation without migration (0.62) and
the alternative budget neutrality
adjustment with migration (0.62), when
rounded to the nearest hundredth.
Comment: Many commenters
recommended different interpretations
of section 626(b) of Public Law 108–173.
The commenters believed that CMS’
interpretation of the law’s requirement
that CMS ensure the budget neutrality of
the revised system was overly restrictive
and that consequently, the proposed
budget neutrality factor was not
adequate to make fair ASC payments.
According to the commenters’
interpretations of the law, they believed
that CMS has the clear legal authority to
make assumptions regarding the
migration of procedures between
different sites of service, and that
expenditures for all services covered by
the ASC payment system, including
beneficiary coinsurance, should be
considered in the calculation of budget
neutrality. Most of the commenters
recommended that CMS include
projected case migration across ASC,
HOPD, and physician’s office settings in
its budget neutrality model and use total
expenditures across all Medicare Part B
sites of service, rather than limit the
base solely to estimated CY 2008
aggregate expenditures under the ASC
payment system. Several commenters
supported the use of the alternative
option for calculating budget neutrality
that incorporated the case migration
assumptions as they were presented in
the August 2006 proposed rule, with the
stipulation that several technical
corrections to fully account for the
Medicare expenditures for all
procedures that were assumed to
migrate to the ASC would be made and
that the resulting conversion factor
would be 64.6 percent. Most other
commenters believed that case
migration would certainly be one result
of implementation of the revised ASC
payment system, and that CMS’ budget
neutrality adjustment model should
include recognition of those changes in
sites of service and the related Medicare
expenditures. They recommended that
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
CMS use a model like the alternative
option for calculating budget neutrality
presented in the August 2006 proposed
rule and discussed above in this final
rule, but that the specific assumptions
CMS used should be revised as
indicated in their comments.
Response: As discussed in the August
2006 proposed rule, we were interested
in comments from the public about our
interpretation of budget neutrality and
our proposed methodology for
developing the budget neutrality
adjustment factor for the revised ASC
payment system. We will fully address
each of the specific technical
corrections (for example, that we
account for differences in beneficiary
coinsurance amounts in HOPD and ASC
settings) and migration assumption
modifications that were recommended
by commenters in section V.C.3. of this
final rule. At the more general level, we
noted the strong preference among
commenters for CMS to use the
alternative, with-migration methodology
that would take into account the effects
of assumed migration of cases across
ambulatory sites of service that could
result from the payment changes
associated with the revised ASC
payment system. The August 2006
proposal reflected our belief that
adoption of the without-migration
model was more appropriate than the
alternative with-migration model that
was also discussed. In the proposal, we
explained that basing our estimate of
expenditures on current utilization
without including migration from other
sites of services was consistent with
how we estimate expenditures for
purposes of maintaining budget
neutrality in other Medicare payment
systems. We realized that the influx of
newly covered procedures was unique
to our proposal for the revised ASC
payment system, but because the budget
neutrality adjustment that resulted from
both models in the August 2006
proposed rule was the same and data to
determine estimates of potential case
migration were limited, we adopted the
without-migration model in our
proposal, consistent with our previous
modeling to ensure that our payment
systems are budget neutral.
We agree with commenters that the
flexibility to include migration
assumptions in our calculation of
budget neutrality for the revised ASC
payment system is provided by the
statute. Furthermore, our review of the
extensive comments on the August 2006
proposed rule led to our conclusion in
this final rule that the significant
expansion of ASC covered surgical
procedures proposed as part of the
revised system is not only a unique
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
aspect of the revised ASC payment
system, but that its effects on ASC
expenditures may be substantial. An
influx of new covered services has not
been a factor in developing the budget
neutrality adjustment factors for our
other prospective payment systems. The
scope of services in other payment
systems does not change significantly
from one year to the next, as does the
ASC scope of services between CYs
2007 and 2008 in the context of our
final policies for the revised ASC
payment system, as discussed in
sections III. and IV. of this final rule.
In view of our belief that the revised
ASC payment system is unique because
of the significant expansion of covered
surgical procedures and covered
ancillary services to be paid under the
revised ASC payment system, we
conclude that including estimates of
case migration of the new procedures, as
well as the existing ASC covered
surgical procedures, is the most accurate
method for developing the budget
neutrality adjustment in this case. After
reviewing all of the public comments
and reexamining the available data, we
believe that there is sufficient evidence
to indicate that adoption of a withmigration methodology for calculating
the budget neutrality adjustment for the
revised ASC payment system is
appropriate. Thus, we have determined
that it would be prudent, and more
accurate, to adopt a with-migration
budget neutrality estimation
methodology, in order to take into
account the effects of the migration of
procedures between ASCs, physicians’
offices, and HOPDs that might be
attributable to the revised ASC payment
system. While the budget neutrality
estimation methodology that takes into
account migration increases the
complexity associated with establishing
the budget neutrality adjustment, we
believe that its application provides us
with the most reasonable approach to
establishing payment rates under the
revised ASC payment system in order to
assist in ensuring continued access to
current ASC procedures and expanded
access to new surgical procedures for
Medicare beneficiaries in ASCs.
Although we are convinced that the
with-migration model is more
appropriate for calculating the final
budget neutrality adjustment factor for
the revised ASC payment system, we
calculated the budget neutrality
adjustment for this final rule using both
with-migration and without-migration
models, as we had for the August 2006
proposed rule. However, in contrast to
the results of our work for that proposed
rule, where application of either model
resulted in the same adjustment factor,
PO 00000
Frm 00057
Fmt 4701
Sfmt 4700
42525
the budget neutrality factors that
resulted from application of the two
methods for this final rule were
different. The adjustment factor that
resulted from application of our
proposed model that did not consider
migration was 0.64, while the withmigration model resulted in a 0.67
budget neutrality adjustment factor. For
a full discussion of the calculation of
the final budget neutrality adjustment
factor, we refer readers to section V.C.3.
of this final rule.
Comment: Several commenters agreed
with the use of a blended rate for CY
2008 to calculate budget neutrality for
the revised ASC payment system, based
on the proposal for a 2-year transition to
the fully implemented revised payment
system. They believed this use of
discretion was an appropriate
interpretation of the legislation and
produced the most reasonable result.
They believed that, because the
proposed CY 2008 rates were a 50/50
blend of the CY 2007 ASC rate and the
estimated CY 2008 ASC rate calculated
according to the methodology of the
proposed revised ASC payment system,
the ASC payment system would have
increased expenditures in CY 2009
unless migration patterns differed from
the assumptions discussed in the
proposed rule regarding the alternative
calculation of the budget neutrality
adjustment. These commenters
concluded that the increased
expenditures that would result from our
adoption of their recommendation to
utilize a modification of the alternative
calculation of the proposed budget
neutrality adjustment were expected,
appropriate, and consistent with the
budget neutrality provision of section
626(b) of Public Law 108–173 for the
revised ASC payment system.
Response: We agree with commenters
that the migration assumptions
influence the relationship between
estimated expenditures under the
current ASC system and the revised
ASC payment system over time. As
noted elsewhere in sections IV.J. and
V.C.4 of this final rule, we have
extended the transition period for
payment of services on the CY 2007
ASC list of covered surgical procedures
and have also modified our migration
assumptions to reflect migration over a
more extended time period than was
reflected in our discussion of the
alternative option for calculating the
budget neutrality adjustment in the
August 2006 proposed rule. As
described in section X. of this final rule,
we estimate that, over time, the
expenditures under the revised ASC
system using our final migration
assumptions would be slightly less than
E:\FR\FM\02AUR2.SGM
02AUR2
42526
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
the expenditures that would occur if we
did not revise the system.
3. Calculation of the Estimated CY 2008
Budget Neutrality Adjustment
According to the Final Policy
In the August 2006 proposed rule, and
as discussed earlier in this section of the
final rule, we described two
methodologies for determining the
budget neutrality adjustment under the
revised ASC payment system that could
then be used to establish the ASC
conversion factor for CY 2008 (71 FR
49656 through 49658). We proposed
that, under the standard methodology of
the revised ASC payment system, the
ASC conversion factor would be
multiplied by the ASC payment weight
for each covered surgical procedure to
determine the procedure’s CY 2008 ASC
payment rate. As discussed in detail in
section IV.C. of this final rule, our final
policy will also provide separate
payment for covered ancillary services
under the revised ASC payment system.
While the payment rates for separately
payable drugs and biologicals,
brachytherapy sources, corneal tissue
acquisition, and implantable devices
with OPPS pass-through status that are
covered ancillary services, along with
the device portion of ASC payment for
device-intensive covered surgical
procedures, will be determined without
application of the ASC conversion
factor, the final standard methodology
of the revised ASC payment system will
apply the ASC conversion factor to ASC
payment weights to calculate the fully
implemented payment rates for covered
surgical procedures and covered
ancillary radiology services. We
received a number of general and
specific comments on our proposal for
calculating the CY 2008 ASC payment
rates under the revised ASC payment
system.
Comment: There was general
agreement among the commenters that,
in the absence of cost data for surgical
procedures performed in ASCs, CMS’
proposal to base the revised ASC
payment system on the OPPS APC
groups and their relative payment
weights was sound policy that could
reasonably be expected to result in
accurate ASC payments for most
procedures. Further, the commenters
generally agreed that ASC facility costs
are lower than the HOPD costs for
providing the same surgical services.
The commenters gave specific examples
of the reasons why higher costs are
incurred by hospitals, including the
requirement that HOPDs satisfy quality
and safety standards that are not applied
to ASCs; the fact that hospitals’
resources are available 24 hours a day,
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
7 days a week; Emergency Medical
Treatment and Labor Act of 1986-related
(EMTALA-related) requirements;
treatment of a more acutely ill
population with greater comorbidities;
and higher uncompensated care rates.
Moreover, those commenters cited
MedPAC’s findings reported in 2003
and 2004 that hospitals probably incur
higher costs than ASCs for providing
similar procedures, because HOPDs are
subject to additional regulatory
requirements which are likely to
increase their overhead costs, and
HOPDs also treat patients who are more
medically complex.
Beyond these points, the commenters
diverged on their opinions about the
accuracy and appropriateness of the
proposed conversion factor, as
discussed in detail below.
Response: We appreciate the
commenters’ general support of our
proposal to base payment under the
revised ASC payment system on the
OPPS relative payment weights and the
APC groups. These comments were
consistent with the recommendation of
the GAO (GAO–07–86) that CMS should
implement a payment system for
procedures performed in ASCs based on
the OPPS, taking into account the lower
relative costs of procedures performed
in ASCs compared to HOPDs. For
further discussion of this subject, as
well as a summary of additional public
comments and our responses, we refer
readers to section IV.B. of this final rule.
Comment: Several commenters
specifically recommended that CMS
adopt 75 percent as the multiplier to the
OPPS conversion factor, so that
payment rates under the revised ASC
payment system would be 75 percent of
the OPPS rates. They cited legislation
that was introduced in the U.S. Senate
in 2003 in which payments to ASCs
were to have been provided at 75
percent of the OPPS rates. The
proponents of that proposed legislation
believed that, by using a 75 percent
factor to reduce OPPS rates in order to
provide payment for ASCs to perform
procedures, Medicare would save 25
cents for every dollar spent for
procedures performed in the ASC
setting instead of the HOPD.
Several commenters also believed
that, because ASC rates have been
frozen since 2003 while OPPS rates
have been increased annually for
inflation, an unfair differential in
payments between the two payment
systems has grown over the past several
years. These commenters argued that by
calculating budget neutrality for the
revised ASC payment system using the
static ASC rates in comparison with
annually updated OPPS rates, CMS
PO 00000
Frm 00058
Fmt 4701
Sfmt 4700
proposed an inappropriately low budget
neutrality adjustment factor. They were
convinced that, if CMS had
implemented the revised ASC payment
system immediately after Congress
passed Public Law 108–173 in 2003,
before the differential between the
payment rates for the two systems
increased due to the continued freeze on
ASC rates, the budget neutrality
adjustment for the revised payment
system would have been close to 85
percent, rather than 62 percent as CMS
proposed for the revised payment
system to be implemented in CY 2008.
Other commenters, noting that Congress
gave CMS the authority to implement
the revised payment system between CY
2006 and CY 2008, expressed their
belief that, had CMS implemented the
revised ASC payment system in an
earlier year, the budget neutrality
adjustment would have been at least 8
percent higher than the 62 percent that
was proposed.
Response: We see no rationale for
estimating the budget neutrality
adjustment by comparing existing ASC
payment system rates with OPPS rates
from an earlier calendar year, prior to
implementation of the revised ASC
payment system. Congress provided
CMS with the latitude to implement the
revised ASC payment system beginning
on or after January 1, 2006, and not later
than January 1, 2008. We believe that
the statute provides direction that the
revised ASC payment system is to be
budget neutral in its design in order to
result in the same aggregate
expenditures for services as would be
made if the provisions of the revised
ASC payment system did not apply, that
the ASC conversion factor is not to be
updated before CY 2010, and that
implementation of the revised system by
January 1, 2008 is timely. There is no
evidence that Congress intended for
CMS to attempt to maintain the
relationship between OPPS payment
rates and ASC payments that existed at
the time of enactment of Public Law
108–173 (CY 2003) in the development
of the revised ASC payment system. We
also see no rationale for adopting an
arbitrary multiplier, such as 75 percent
of OPPS payment rates, that is not
founded on explicit consideration of
budget neutrality as required by the
statute.
We received many public comments
in response to our proposed budget
neutrality adjustment factor. A number
of commenters included seven specific
recommendations, three of which were
related to the migration assumptions
discussed as an alternative option for
calculating the budget neutrality
adjustment in the proposed rule. The
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
other four were technical in nature and
related to our proposed budget
neutrality model. A summary of the
comments and our responses follow,
beginning with the four recommended
technical modifications to our proposed
methodology, followed by the three
migration assumption
recommendations.
Comment: One of the recommended
technical modifications was that,
instead of basing ASC payments on CY
2007 rates for all procedures on the CY
2007 ASC list of covered surgical
procedures, CMS should use the
payment amounts that would be made
in CY 2008 in the absence of the revised
payment system for those ASC
procedures whose payments are capped
in CY 2007 due to section 5103 of
Public Law 109–171. The commenters
believed that using the lower CY 2007
rates for ASC procedures capped by
section 5103 of Public Law 109–171 was
an unfair representation of estimated
ASC payments under the existing
payment system in CY 2008. Their
rationale was that, if the revised ASC
system were not implemented in CY
2008, the payments for those services
under the policy of the existing ASC
payment system would increase in CY
2008, consistent with the overall
projected increase in OPPS rates of 4
percent. The commenters expected that
incorporation of this adjustment would
result in a 0.11 percentage point
increase to the budget neutrality
adjustment.
Response: We do not agree that the
ASC rates for these specific services
would necessarily increase consistent
with an overall increase in OPPS rates
for CY 2008. Through the annual update
of the OPPS, while the aggregate
spending is generally projected to
increase in the update, the specific
payments for individual services may
rise or fall from year to year based on
a variety of factors, including APC
recalibration. Because the ASC
procedures that are capped at the OPPS
rates in CY 2007 are a small subset of
all OPPS services, we are unable to
project that their rates would be subject
to a 4 percent increase, or indeed any
increase, as suggested by the
commenters. In addition, we believe
that Congress intended for the revised
ASC payment system rates and budget
neutrality to be related to the estimated
aggregate expenditures for ASC services
based on ASC payment rates from the
year prior to implementation of the
revised system. Congress mandated that
the revised ASC system be budget
neutral and be implemented by CY
2008. It also set ASC updates to zero
percent for the calendar years through
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
2009. We believe all of those actions, in
combination, provide clear indication
that Congress did not intend for
estimates of aggregate expenditures
under the existing ASC payment system
to take into account updated ASC
payment rates for CY 2008. The
limitations on ASC payments prior to
implementation of the revised ASC
payment system, specifically both
section 626 of Public Law 108–173 that
specifies that ASC rates would not be
updated before CY 2010 and, further,
the limit on ASC payment at the lesser
of the OPPS or ASC rate, as required in
section 5103 of Public Law 109–171 that
extends until implementation of the
revised ASC payment system, provide
clear evidence that the CY 2007 ASC
rates for covered procedures are to be
used in developing the budget neutrality
adjustment for the revised payment
system. We continue to believe, for the
purposes of this final rule, that the most
appropriate course for calculation of the
budget neutrality adjustment, consistent
with our proposal, is to estimate that the
CY 2008 rates for the ASC procedures
subject to the cap set forth in section
5103 of Public Law 109–171 in CY 2007
will be the same as their CY 2007 rates.
Comment: Some commenters stated
that, in CMS’ calculation of estimated
ASC payments under the existing ASC
payment system for comparison to
payments under the proposed
methodology for the revised ASC
payment system, CMS did not include
payments for the costs of implantable
prosthetic devices that are currently
separately paid to ASCs under the
DMEPOS fee schedule. The commenters
recommended that CMS include the
amount paid to ASCs to cover the costs
of separately payable implantable
prosthetics and DME under the
DMEPOS fee schedule to avoid
understating Medicare’s current full cost
related to the surgical implantation
procedures. The commenters believed
that inclusion of those payments would
increase the budget neutrality
adjustment by 0.41 percentage points.
Response: We agree with the
commenters that the payments to ASCs
for the implantable prosthetic devices
and DME should be included in
estimating total ASC payments for CY
2008 under the policies of the existing
ASC payment system. In fact, we did
include those payments in our proposed
budget neutrality adjustment
calculation, but we failed to explicitly
state that in our explanation in the
August 2006 proposed rule. Therefore,
the effect of including those payments
was reflected in the budget neutrality
adjustment that we proposed. We have
also included these payments in our
PO 00000
Frm 00059
Fmt 4701
Sfmt 4700
42527
calculation of the budget neutrality
adjustment for this final rule.
Comment: Several commenters
believed that, although CMS accounted
for the 20 percent beneficiary
coinsurance in ASCs by discounting by
20 percent all of the payment rates used
to estimate the CY 2008 payments under
the existing ASC system and under the
proposed methodology of the revised
ASC payment system, CMS did not
appropriately account for beneficiary
coinsurance associated with the new
ASC office-based procedures for which
payment was proposed to be limited to
the MPFS unadjusted nonfacility
practice expense amount. They believed
that CMS should apply the 20 percent
discount to those procedures because
that approach would more accurately
and consistently reflect the Medicare
program costs, and they concluded that
this change would increase the budget
neutrality adjustment by 0.43
percentage points.
Response: While we did not apply
this discount to payment rates for the
capped office-based procedures newly
proposed for ASC payment in CY 2008
in our calculation of the proposed
budget neutrality adjustment, we agree
with this recommendation. Recognizing
those lower costs to the Medicare
program, consistent with our calculation
of program costs under the existing ASC
payment system and the standard
methodology of the revised ASC
payment system, would be more
accurate. Soon after publication of the
August 2006 proposed rule, we
discovered this oversight, made the
appropriate adjustments to the data, and
posted the revised data on our Web site
(https://www.cms.hhs.gov/ASCPayment).
Comment: Commenters noted that
CMS did not account for the variable
copayment amounts associated with
procedures under the OPPS for
purposes of establishing the budget
neutrality adjustment under the revised
ASC payment system. The beneficiary
copayment under the OPPS varies from
20 to 40 percent of the payment rate,
depending on the procedure, whereas
the coinsurance under the ASC payment
system is 20 percent for all procedures.
The commenters believed that as a
result of not considering the sometimes
much higher copayments under the
OPPS, CMS artificially inflated
Medicare’s estimated payments under
the proposed methodology of the
revised ASC payment system. They
believed that accurately accounting for
the OPPS copayments would increase
the budget neutrality adjustment by 1.04
percentage points.
Response: We agree with the
commenters regarding this
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42528
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
recommendation. We did not apply the
variable OPPS copayment amounts in
the model that was proposed. However,
soon after publication of the August
2006 proposed rule, we discovered this
oversight, made the appropriate
adjustments to the data, and posted the
revised data on our Web site (https://
www.cms.hhs.gov/ASCPayment).
After considering the first four
technical recommendations of many
commenters and making the two
technical adjustments as described
above, the resulting increase in the
proposed budget neutrality adjustment
was approximately 2.6 percentage
points. We have applied these same two
technical adjustments in our calculation
of the budget neutrality adjustment for
this final rule. In addition, we made
another technical change in this final
rule by taking the multiple procedure
discount into account in our estimates
of ASC, OPPS, and MPFS expenditures
both before and after implementation of
the revised ASC payment system. We
factored the multiple procedure
discount into our estimates of ASC,
OPPS, and MPFS spending under the
existing and revised ASC payment
systems. We assumed that the pattern of
multiple surgical procedures furnished
in ASCs and physicians’ offices would
be similar to the pattern in HOPDs.
Based on claims data indicating the
prevalence of multiple procedures in
HOPDs, we estimated the percentage of
discounted units to total units for each
procedure and then reduced the volume
for those procedures prior to estimating
expenditures in each year. We
incorporated this reduction into our
estimates of Medicare expenditures
under the ASC, OPPS, and MPFS
payment systems both before and after
implementation of the revised ASC
payment system. We had not factored
the multiple procedure discount into
the August 2006 proposed rule
estimates.
The final three recommendations by
commenters that were related to the
migration assumptions used in the
alternative option for calculating the
budget neutrality adjustment presented
in the August 2006 proposed rule are
discussed below.
Comment: Many commenters believed
that the alternative method for
calculating the budget neutrality
adjustment that CMS discussed in the
August 2006 proposed rule described a
preferable and superior method for
developing the budget neutrality
adjustment for the revised ASC payment
system. They believed that developing
and applying some assumptions to
account for the migration of services
and their payment across Medicare Part
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
B sites of care would be the most
appropriate method for ensuring budget
neutrality. However, they recommended
that CMS revise some of the
assumptions regarding migration that
were described in that proposed rule.
The first of their recommendations in
this regard was that CMS use a much
lower migration assumption of 2 percent
for new ASC procedures migrating from
physicians’ offices to ASCs. They were
convinced that CMS’ assumption in the
proposed rule that 15 percent of the
current office utilization of new ASC
procedures would migrate to ASCs was
far greater than would be possible. They
stated that ASCs do not have the
capacity to absorb that level of services.
Furthermore, they explained that ASCs
have found that, once physicians
acquire the equipment and resources to
provide a procedure in their offices,
they prefer to perform it there. The
commenters believed that physicians
only typically perform procedures in an
ASC or HOPD setting when there is a
particular patient need that requires the
facility setting. They argued that by
allowing the new ASC procedures to
receive payment in ASCs, CMS would
realize savings because cases could be
moved from the office to an ASC instead
of to the more costly HOPD setting
when the physician determines that
relocation of the service is preferable for
a particular beneficiary.
Furthermore, the commenters stated
that ASCs would not only be
overwhelmed by the volume of cases
CMS assumed would migrate to that
setting, but that ASCs would not
welcome the influx of low paying,
minor procedures that could generally
be performed in physicians’ offices over
the more complex, higher paying
procedures that ASCs are accustomed to
providing in the more efficient and
intensive facility setting. The
commenters believed that adjusting the
assumption for migration of new ASC
procedures from physicians’ offices to
ASCs to 2 percent of the cases would be
more appropriate and would result in a
3.11 percentage point increase in the
budget neutrality adjustment.
In addition, the commenters believed
that CMS did not accurately adjust for
the likely negative migration of cases
involving procedures paid under the
existing ASC payment system out of
ASCs and into more costly HOPDs
under the proposal for the revised
payment system. They developed a
model that they believed would more
correctly predict the migration of
procedures out of ASCs and into HOPDs
based on the magnitude of the
procedure’s proposed payment rate
decrease. In that model, the commenters
PO 00000
Frm 00060
Fmt 4701
Sfmt 4700
assumed that for every 10 percent
decrease in a procedure’s ASC payment
rate from the existing to the revised
payment system, 1.5 percent of the ASC
volume would migrate to HOPDs. They
believed that CMS’ application of this
adjustment would result in a 0.51
percentage point decrease to the budget
neutrality adjustment.
They also recommended that CMS
account for the positive migration of
existing ASC covered procedures from
HOPDs to ASCs by assuming that for
every 10 percent increase in a
procedure’s ASC payment rate under
the proposal for the revised ASC
payment system, 1.5 percent of the
HOPD volume would migrate to ASCs,
up to a maximum of 25 percent of the
procedure’s current HOPD volume.
Furthermore, commenters suggested
that ASC capacity would limit
movement of these procedures to no
more than 25 percent of each
procedure’s existing ASC volume. The
commenters believed that, although
ASCs have significant excess capacity,
as confirmed by a CY 2006 industry
study that showed that only about one
quarter of ASCs were operating above 60
percent operating room capacity, they
could not absorb more than 25 percent
of the HOPD volume for all ASC
procedures for which payment was
expected to increase under the proposed
revised payment system. They
explained that application of their
assumption would result in a 5.57
percentage point increase in the budget
neutrality adjustment.
Response: We appreciate the
extensive comments we received
regarding the appropriate migration
assumptions to be applied in
determining the budget neutrality
adjustment for the revised ASC payment
system. While commenters provided a
number of suggestions regarding
migration assumptions for both the
procedures on the CY 2007 ASC list of
covered surgical procedures and new
ASC procedures, they did not provide
data supporting all of the specific
assumptions regarding the relationship
between expected service migration and
changes in payment rates that they
recommended we adopt along with their
other migration assumptions. However,
as stated above, we are adopting a withmigration model for calculation of the
final budget neutrality adjustment factor
because we believe that it is more
accurate than the without-migration
model that we proposed that does not
consider the migration of new
procedures across sites of service, but
we did not adopt the assumptions
recommended by some commenters.
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
The CMS Office of the Actuary
(OACT) developed the assumptions
utilized in the final budget neutrality
model. With respect to current ASC
covered surgical procedures paid under
the existing ASC payment system, we
did not accept the recommendation by
commenters that we should assume that
negative migration, that is, movement of
existing ASC covered procedures out of
ASCs and into the higher cost HOPD
setting, would have an effect on our
budget neutrality adjustment that is not
equal to the effect of positive migration
of cases from other settings into ASCs.
Rather, in this final rule, after reviewing
information provided by commenters
and reevaluating current site-of-service
utilization patterns for exiting and new
ASC procedures, we are assuming that
the effect on budget neutrality due to
movement of cases involving existing
ASC procedures out of ASCs will be
balanced by movement of additional
cases involving existing ASC procedures
into ASCs. We believe that it is
reasonable to assume that the payment
increases for many currently low
volume ASC procedures will result in
higher ASC volumes for those
procedures under the revised ASC
payment system. Moreover, we believe
that this anticipated positive migration
of those procedures will balance the
estimated negative migration of the high
volume ASC procedures for which
payment will decrease. Our actuaries
project that the net budgetary effect of
migration into and out of ASCs for
procedures currently on the ASC list of
covered surgical procedures will be
negligible.
Consistent with our assumption for
the alternative budget neutrality
adjustment model discussed in the
August 2006 proposed rule, under the
final methodology for the revised ASC
payment system, we assume that 25
percent of the current HOPD volume of
new ASC procedures would ultimately
migrate from HOPDs to ASCs. However,
taking into consideration the final,
longer 4-year transition period to the
fully implemented payment weights of
the revised ASC payment system and
the final modifications to several
aspects of the proposed payment policy
as discussed in this preamble, for this
final rule, we assume that the 25 percent
case migration would occur more
gradually, over the first 2 years of the
transition, instead of all in the first year.
We believe the migration would occur
over the first 2 years of the 4-year
transition, as the ASC industry adapts to
the revised ASC payment system and
the significant expansion of covered
surgical procedures described in this
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
final rule. We agree with commenters
that the level of migration in a single
year, as discussed in our presentation of
the with-migration budget neutrality
adjustment model in the August 2006
proposed rule, would be difficult for
ASCs to accommodate in a single year,
but we believe, based on current ASC
and HOPD utilization and ASC industry
information, that the 25 percent case
migration over 2 years is most likely.
We believe that our assumption of 25
percent migration of current HOPD
volume for new ASC procedures is
reasonable, given the general utilization
relationships between ASCs and HOPDs
for services as discussed in section
V.C.2. above. We also note that
commenters generally did not disagree
with our proposed HOPD migration
assumption for the new ASC
procedures. As discussed in the August
2006 proposed rule (71 FR 49657),
services on the ASC list of covered
surgical procedures that are
predominantly performed in ASC and
HOPD settings are, on average,
performed 30 percent of the time in the
ASC setting. Thus, for calculation of the
budget neutrality adjustment according
to the final policy of this final rule, we
assume that new ASC procedures would
migrate at the slightly slower rate of 25
percent over the first 2 years of the 4year transition, reflecting their
movement toward the general 30percent site-of-service utilization
pattern currently observed for ASC
covered surgical procedures as ASCs
transition to the revised ASC payment
system.
Our assumed 25 percent migration of
new ASC procedures from HOPDs to
ASCs differs considerably from the
commenters’ recommended positive
migration assumptions, because the
commenters’ model included all current
ASC procedures and applied a formula
linking the magnitude of ASC payment
changes under the revised ASC payment
system to the expected volume of
migration. Given that the commenters
based their estimate for this assumption
on existing ASC procedures, they used
25 percent of current HOPD volume as
the upper limit for migration from
HOPDs to ASCs, the same assumption
we used for the migration of new ASC
procedures in CY 2008. However,
because they believed that ASC capacity
would ultimately limit procedure
movement, they also limited the
movement to 25 percent of the existing
ASC volume for those procedures. Our
actuaries determined migration
assumptions separately for existing ASC
covered procedures and new ASC
procedures. As mentioned earlier, the
net effect of migration of existing
PO 00000
Frm 00061
Fmt 4701
Sfmt 4700
42529
procedures into and out of ASCs is
assumed to be negligible. For the new
ASC procedures, it is assumed that 25
percent of the current HOPD volume
will migrate to ASCs during the first 2
years of the revised ASC payment
system.
The commenters assumed some
negative migration of existing ASC
covered procedures from ASCs to
HOPDs in response to price changes
under the revised ASC payment system,
based on a relationship between a
procedure’s decrease in ASC payment
and its volume of migration. However,
as discussed above, we also believe that
we have adequately accounted for the
expected migration of procedures
currently covered in ASCs from the ASC
to the HOPD setting under the revised
ASC payment system.
Finally, the commenters’
recommendation that we assume much
less migration from physicians’ offices
to ASCs for new ASC procedures due to
ASC capacity limitations led us to
reconsider our earlier assumption
articulated in the August 2006 proposed
rule for the alternative model to
calculate the budget neutrality
adjustment. Thus, for this final rule,
although the actuaries’ assumption is
that 15 percent of the physicians’ office
volume of new ASC procedures may
eventually be expected to move into
ASCs, they did take into consideration
the commenters’ argument that such a
level of migration could not be fully
accommodated by ASCs in CY 2008.
Therefore, in our final policy we assume
that the migration of these currently
office-based cases would occur more
gradually, with an additional one
quarter of the total migration occurring
in each year of the full 4-year transition
period. Thus, we expect that only 3.75
percent of the office utilization of new
ASC procedures would migrate to ASCs
in CY 2008, followed by an additional
quarter of new cases in each subsequent
year, reaching the full 15 percent by the
end of the transition period to the fully
implemented revised ASC payment
rates. Given the current 17 percent ASC
utilization of procedures that are
predominantly performed in physicians’
offices and ASCs that are on the existing
ASC list of covered surgical procedures,
we see no reason to assume that only 2
percent of the current office volume for
new ASC procedures would migrate to
ASCs, as suggested by some
commenters. Instead, we believe the
eventual utilization data for those
procedures would most likely resemble
the site-of-service utilization for
procedures predominantly performed in
ASC and physician’s office settings that
are currently paid in ASCs. Our
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42530
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
assumption of 15 percent is slightly
lower than the current pattern of 17
percent ASC utilization, consistent with
our expectation that migration of the
broad array of new ASC procedures
would result in slightly lower ASC
utilization in 4 years than the currently
observed pattern for procedures on the
CY 2007 ASC list of covered surgical
procedures that are predominantly
performed in physicians’ offices and
ASCs.
In addition, in the context of
developing the budget neutrality
adjustment for the revised ASC payment
system under the with-migration model,
the actuaries took into consideration the
final payment policies of the revised
ASC payment system. These include the
final changes to the payment rate
calculations for device-intensive
procedures, as well as the separate
payment for covered ancillary services.
While specific current and projected
ASC utilization of covered ancillary
services is difficult to estimate, in
establishing the final budget neutrality
adjustment, the actuaries took into
account the findings of the GAO that
payment for many of these ancillary
services is currently provided to other
Medicare Part B suppliers under the
existing ASC payment system, and that
most drugs and biologicals utilized with
current ASC procedures do not receive
separate payment under the OPPS.
In summary, since our discussion of
the alternative model for calculating the
budget neutrality adjustment presented
in the August 2006 proposed rule for the
revised ASC payment system, the
actuaries have continued to refine the
assumptions and estimates related to the
with-migration budget neutrality model
to take into account policy decisions
made in this final rule, additional
research, information from industry
experts, and public comments.
Application of our final revised
migration assumptions, along with
changes to the OPPS rates, MPFS rates,
and updated utilization data, as well as
the final payment policies for the
revised ASC payment system, taken
together result in an estimated budget
neutrality adjustment of 0.67. The
estimated budget neutrality adjustment
of 0.67 in this July 2007 final rule for
the revised ASC payment system is
based on the CY 2007 OPPS relative
payment weights, with an estimated
update factor for CY 2008, the CY 2007
MPFS PE RVUs trended forward to CY
2008, and CY 2005 utilization data
projected forward to CY 2008. It is
important to note that the budget
neutrality estimate in this final rule is
illustrative only. The CY 2008 ASC
budget neutrality adjustment will be
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
proposed in the CY 2008 OPPS/ASC
proposed rule based on the
methodology for calculating budget
neutrality established in this final rule
and incorporating the proposed CY 2008
OPPS relative payment weights, the
proposed CY 2008 MPFS PE RVUs, and
CY 2006 utilization information
projected forward to CY 2008. The final
CY 2008 ASC budget neutrality
adjustment will be established in the CY
2008 OPPS/ASC final rule with
comment period. The final CY 2008
ASC budget neutrality factor will be
calculated in that rule in accord with
the methodology for calculating budget
neutrality established in this July 2007
final rule and based on the final CY
2008 OPPS relative payment weights,
the final CY 2008 MPFS PE RVUs, and
updated CY 2006 utilization data
projected forward to CY 2008.
4. Final Calculation of the Estimated
ASC Payment Rates for CY 2008
The following is a step-by-step
illustration of the final budget neutrality
adjustment calculation.
a. Estimated CY 2008 Medicare Program
Payments (Excluding Beneficiary
Coinsurance) Under the Existing ASC
Payment System
Step 1: Migration from HOPDs to
ASCs is valued using estimated CY 2008
OPPS payment rates.
(a) We multiply the estimated CY
2008 HOPD utilization for each new
ASC procedure by 0.125, consistent
with our assumption that 25 percent of
the HOPD utilization for new ASC
procedures will migrate to the ASC over
the first 2 years of the revised ASC
payment system, only half of which
would be in CY 2008. In estimating
HOPD utilization for CY 2008, we take
into account the impact of the multiple
procedure discount (as discussed in
more detail in section V.C.3. of this final
rule).
(b) For each new ASC procedure, we
multiply the results of Step 1(a) by the
estimated CY 2008 OPPS payment rate
for the procedure, and then subtract
beneficiary coinsurance for the
procedure.
(c) We sum the results of Step 1(b)
across all new ASC procedures.
Step 2: Migration of procedures from
physicians’ offices to ASCs is valued
using estimated CY 2008 physician inoffice payment rates. ‘‘Physician inoffice payment rate’’ is equal to the
MPFS nonfacility practice expense
RVUs multiplied by the estimated CY
2008 MPFS conversion factor.
(a) We multiply the estimated
physician office utilization for CY 2008
for each new ASC procedure by 0.0375,
PO 00000
Frm 00062
Fmt 4701
Sfmt 4700
consistent with our assumption that 15
percent of the physician’s office
utilization for new ASC procedures will
migrate to the ASC over the full 4-year
transition period.
(b) For each new ASC procedure, we
multiply the results of Step 2(a) by the
estimated CY 2008 physician in-office
payment rate for the procedure, and
then subtract beneficiary coinsurance
for the procedure.
(c) We sum the results of Step 2(b)
across all new ASC procedures.
Step 3: CY 2007 ASC services are
valued using the estimated CY 2008
ASC payment rates under the current
ASC system.
To estimate the aggregate
expenditures that would be made in CY
2008 under the existing ASC payment
system:
(a) We multiply the estimated CY
2008 ASC utilization for each HCPCS
code on the CY 2007 ASC list by the
estimated CY 2008 ASC payment rate
for the HCPCS code under the existing
ASC payment system, and then subtract
beneficiary coinsurance for the
procedure. The estimated CY 2008 ASC
payment rates are based on the CY 2007
ASC payment rates, which were listed
in Addendum AA to the CY 2007 OPPS/
ASC final rule with comment period
and take into account the OPPS cap on
payment for ASC services as required by
section 5103 of Public Law 109–171 and
reflect the zero percent CY 2008 update
for ASC services mandated by section
1833(i)(2)(C) of the Act. In estimating
ASC utilization for CY 2008, we take
into account the impact of the multiple
procedure discount (as discussed in
section V.C.3. of this final rule).
(b) We estimate the amount the
Medicare program would pay in CY
2008 for implantable prosthetic devices
and implantable DME for which ASCs
currently receive separate payment
under the DMEPOS fee schedule.
(c) We sum the results of Steps 3(a)
and 3(b) to estimate the aggregate
amount of expenditures that would be
made in CY 2008 for current covered
surgical procedures under the existing
ASC payment system.
Step 4: Sum the results of Steps 1–3.
b. Estimated Medicare Program
Payments (Excluding Beneficiary
Coinsurance) Under the Revised ASC
Payment System
Step 5: HOPD migration is valued
using estimated CY 2008 OPPS payment
rates.
This step is the same as Step 1, above.
Step 6: We identify new ASC
procedures that are office-based (as
discussed in section III.C. of this final
rule).
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
Step 7: Migration of new ASC officebased procedures from physicians’
offices to ASCs is valued based on
estimated CY 2008 OPPS payment rates
capped at the estimated CY 2008
physician in-office payment rates, if
appropriate.
(a) For each new ASC procedure
determined to be office-based, we
multiply the results of Step 2(a) above
by the lesser of—
(1) The estimated CY 2008 OPPS rate
for the procedure; or
(2) The estimated CY 2008 physician
in-office payment rate for the procedure,
and then subtract beneficiary
coinsurance for the procedure.
(b) The results of Step 7(a) are
summed across all new ASC procedures
considered to be office-based.
Step 8: Migration of new ASC
procedures not determined to be officebased from physicians’ offices to ASCs
is valued using the estimated CY 2008
OPPS rates.
(a) For each new ASC procedure not
considered to be office-based, we
multiply the results of Step 2(a) above
by the estimated CY 2008 OPPS rate for
the procedure, and then subtract
beneficiary coinsurance for the
procedure.
(b) The results of Step 8(a) are
summed across all new ASC procedures
not considered to be office-based.
Step 9: Migration of new ASC
procedures from physicians’ offices to
ASCs is valued using the estimated CY
2008 MPFS physician out-of-office
payment rate. ‘‘Physician out-of-office
payment rate’’ is equal to the facility
practice expense RVUs multiplied by
the estimated CY 2008 MFPS
conversion factor.
(a) For each new ASC procedure, we
multiply the results of Step 2(a) from
above by the estimated CY 2008
physician out-of-office payment rate for
the procedure, and then subtract
beneficiary coinsurance for the
procedure.
(b) The results of Step 9(a) are
summed across all new ASC
procedures.
Step 10: Current ASC services are
valued using the estimated CY 2008
OPPS payment rates.
To estimate the aggregate amount of
expenditures that would be made in CY
2008, we use estimated CY 2008 OPPS
payment amounts instead of estimated
CY 2008 ASC payment amounts under
the current system, and we multiply the
estimated CY 2008 ASC volume for each
HCPCS code on the CY 2007 ASC list
by the estimated CY 2008 OPPS
payment rate for the HCPCS code, and
then subtract beneficiary coinsurance
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
for the procedure. We sum the results
over all services on that ASC list.
Step 11: The results of Steps 5 and 7–
10 are summed.
c. Calculation of the Final Estimated CY
2008 Budget Neutrality Adjustment
Step 12: The result of Step 4 is
divided by the result of Step 11.
Step 13: The application of the cap at
the estimated CY 2008 physician inoffice payment rates that occurs in Step
7 is dependent on the ASC conversion
factor. The ASC budget neutrality
adjustment resulting from Step 12 is
calibrated to take into account the
interactive nature of the ASC conversion
factor and the physician’s office
payment cap. The ASC budget
neutrality calculation is also calibrated
to take into account the fact that the
additional physician out-of-office
payment rates under the revised ASC
payment system calculated in Step 9
must be fully offset by the budget
neutrality adjustment to ASC services
under the revised payment system.
Furthermore, the budget neutrality
calculation is calibrated to take into
account the CY 2008 transitional
payment rates for procedures on the CY
2007 ASC list of covered surgical
procedures.
d. Calculation of the Final Estimated CY
2008 ASC Payment Rates
As described earlier, the application
of the methodology to the data available
for this final rule results in an estimated
budget neutrality adjustment of 0.67.
The CY 2008 budget neutrality
adjustment for the revised ASC payment
system, based on the methodology
outlined above, will be proposed in the
CY 2008 OPPS/ASC proposed rule and
finalized in the CY 2008 OPPS/ASC
final rule with comment period, based
on the methodology for calculating
budget neutrality established in this July
2007 final rule.
After developing the estimated CY
2008 budget neutrality adjustment of
0.67 according to the policies
established in this final rule, in order to
determine the estimated CY 2008 ASC
conversion factor we multiply the
estimated CY 2008 OPPS conversion
factor by the budget neutrality
adjustment. At this time, our estimate of
the CY 2008 OPPS conversion factor is
$63.497. Multiplying the estimated CY
2008 OPPS conversion factor by the 0.67
budget neutrality adjustment yields our
estimated CY 2008 ASC conversion
factor of $42.543 for this final rule. To
determine the fully implemented ASC
payment rates for this final rule,
including beneficiary coinsurance,
according to the final payment
PO 00000
Frm 00063
Fmt 4701
Sfmt 4700
42531
methodology that applies to covered
surgical procedures and covered
ancillary radiology services under the
revised ASC payment system, we
multiply the ASC conversion factor by
the ASC relative payment weight for
each procedure or service. As further
discussed in sections IV.C. and IV.E. of
this final rule, the ASC relative payment
weights for certain office-based surgical
procedures and covered ancillary
radiology services are set so that the
national unadjusted ASC payment rate
does not exceed the MPFS unadjusted
nonfacility practice expense amount. In
addition, as discussed in section IV.C of
this final rule, the ASC relative payment
weights for device-intensive covered
surgical procedures are set according to
a modified payment methodology to
ensure the same device payment under
the revised ASC payment system as
under the OPPS. We then calculate the
estimated CY 2008 payment rate for
procedures on the CY 2007 ASC list of
covered surgical procedures using a
blend of 75 percent of the final CY 2007
ASC payment rate and 25 percent of the
estimated revised ASC payment rate
developed according to methodology of
the revised ASC payment system,
applying the special transition treatment
to device-intensive procedures as
discussed in section IV.J. of this final
rule. See Addenda AA and BB to this
final rule for the illustrative estimated
CY 2008 ASC payment weights and
payment rates for covered surgical
procedures and covered ancillary
services that are expected to be paid
separately under the CY 2008 revised
ASC payment system.
D. Calculation of the ASC Payment
Rates for CY 2009 and Future Years
1. Updating the ASC Relative Payment
Weights
In the August 2006 proposed rule, we
proposed to update the ASC relative
payment weights each year using the
national OPPS relative payment weights
for that calendar year, as well as the
practice expense payment amounts
under the MPFS schedule for that
calendar year because some covered
office-based surgical procedures and
covered ancillary services will be paid
according to MPFS amounts if those are
less than the rates calculated under the
standard methodology of the revised
ASC payment system. We further
proposed to uniformly scale the ASC
relative payment weights for each
update year so that estimated aggregate
expenditures using updated ASC
relative payment weights would be the
same as estimated aggregate
expenditures using the current year ASC
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42532
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
relative payment weights. That is, we
proposed to make the relative payment
weights budget neutral to ensure that
changes in the relative payment weights
from year to year would not cause the
estimated amount of expenditures to
ASCs to increase or decrease as a
function of those changes. For example,
we proposed to uniformly scale the ASC
relative payment weights for CY 2009 so
that estimated expenditures for CY 2009
using the updated CY 2009 ASC relative
payment weights would be the same as
they would be using the CY 2008 ASC
relative payment weights. Similarly, we
proposed to uniformly scale the ASC
relative payment weights for CY 2010 so
that estimated expenditures for CY 2010
using the updated CY 2010 ASC relative
payment weights would be the same as
they would be using the CY 2009 ASC
relative payment weights.
We proposed to scale the relative
payment weights annually because we
believed that the purpose of using
relative payment weights as part of the
ratesetting methodology under the
proposed revised ASC payment system
was only to establish appropriate
relativity among surgical procedures
paid in ASCs. Changes in weights
should not, in and of themselves,
change aggregate payment levels under
a prospective payment system. Scaling
the relative payment weights each year
would also serve as a buffer to protect
ASCs from sudden changes that could
occur under the OPPS. For example, by
making the relative payment weights
budget neutral under the revised ASC
payment system, the ASC relative
weights would not drop were there to be
a sudden upsurge in costs associated
with outpatient hospital emergency or
clinic visits relative to outpatient
hospital surgical costs. Moreover,
making the ASC relative weights budget
neutral would shield the ASC payment
system from the inadvertent impact of
unrelated aggregate changes in OPPS
expenditures. We proposed to continue
this methodology to update the revised
ASC payment system in future years.
Comment: Several commenters
supported the proposal to annually
update ASC relative payment weights
using the national OPPS payment
weights for the corresponding year;
conversely, some commenters also
expressed concern regarding our
proposed policy of rescaling ASC
relative weights. They were concerned
that annual rescaling would cause
divergence of the relative weights
between the OPPS and the revised ASC
payment system for individual
procedures.
Response: We appreciate commenters’
support for annually updating ASC
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
relative payment weights in
coordination with the OPPS update,
consistent with the proposed
relationship between the two payment
systems. We believe this process would
provide more appropriate payments for
surgical services under the revised ASC
payment system that would reflect
ongoing changes in the facility costs
associated with different surgical
procedures. We also acknowledge
commenters’ concerns about our
proposed policy of rescaling ASC
relative weights. However, we note that
rescaling the relative payment weights
in the ASC payment system would not
cause divergence in the relativity of the
weights of various services under the
two payment systems. Rescaling of the
weights would equally increase or
decrease the relative payment weights of
services under the revised ASC payment
system in comparison to the relative
weights of the same services under the
OPPS, but only to the extent necessary
to ensure that changes in the relative
weights do not, in and of themselves,
change aggregate payments to ASCs.
Rescaling of relative weights or the
application of a budget neutrality
adjustment is a common feature of
Medicare payment systems, designed to
ensure that the estimated aggregate
payments under a payment system for
an upcoming year would be neither
greater than nor less than the aggregate
payments that would be made in the
prior year, taking into consideration any
changes or recalibrations for the
upcoming year. For example, in CY
2006, as required by section
1833(t)(9)(B) of the Act, we scaled
relative weights under the OPPS by
applying a budget neutrality adjustment
to ensure that changes due to APC
reclassification and recalibration
changes, wage index changes, and other
adjustments were made in a manner that
ensured that estimated aggregate OPPS
payments for CY 2006 would not exceed
aggregate payments for CY 2005 (70 FR
68542). We continue to believe that this
principle should apply as well in the
revised ASC payment system. We note
that while we do not currently have a
provider-level dataset of ASC utilization
that accurately identifies unique ASCs
and their geographic information that
would allow us to compare changes in
geographic adjustment over time for
budget neutrality purposes, we intend to
take these changes into account in
maintaining budget neutrality for the
revised ASC payment system as soon as
our provider-level ASC data permit.
In addition to considerations that are
common to many payment systems,
there is another reason for adopting
annual rescaling of the relative weights
PO 00000
Frm 00064
Fmt 4701
Sfmt 4700
in the revised ASC payment system.
Because we are finalizing our proposal
to generally employ the relative
payment weights developed under the
OPPS in the revised ASC payment
system as discussed earlier in section
IV.B. of this final rule, aggregate
payments to ASCs could, in the absence
of rescaling, be affected by changes in
the cost structure of HOPDs that ought
to be relevant only under the OPPS. We
provided an example of such a scenario
in the August 2006 proposed rule. A
sudden increase in the costs of hospital
outpatient emergency or clinic visits
due, for instance, to an increase in the
volume of cases, would have the effect
of increasing the weights for these
services relative to the weights for
surgical procedures in the hospital
outpatient setting. In the absence of
rescaling, this change in the relative
weights under the OPPS would result in
a decrease in the relative weights for
surgical procedures under the ASC
payment system and, therefore, a
decrease in aggregate ASC payments for
these same procedures. Because ASCs
principally receive payment for surgical
procedures, aggregate payments to ASCs
could decline; ASCs would receive
lower payments for surgical procedures
without realizing the benefits of the
higher payments provided to HOPDs for
emergency or clinic visits. As we
explained in the August 2006 proposed
rule (71 FR 49657), we believe that
changes in relative weights each year
under the OPPS should not, in and of
themselves, cause aggregate payments
under the revised ASC payment system
to increase or decrease. In fact, scaling
the relative weights each year under the
revised ASC payment system would
serve as a buffer to protect ASCs from
sudden changes that could occur under
the OPPS.
Rescaling of relative payment weights
in a budget neutral manner under the
revised ASC payment system would
thus shield the ASC payment system
from the inadvertent impact of
unrelated aggregate changes in OPPS
expenditures. It is important to note that
the specific adjustment factor applied in
the scaling process could be positive or
negative in any particular year. Annual
scaling would prevent both sudden
decreases in aggregate payments to
ASCs and sudden windfall payments
due solely to changes in HOPD costs for
nonsurgical services. In the example
given above, the scaling adjustment
would be positive, that is, scaling would
increase the relative weights of all
surgical procedures under the ASC
payment system in order to maintain
aggregate ASC payments for the
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
procedures at the same level, in the
absence of other factors affecting the
relative payment weights of hospital
outpatient emergency or clinic visits
and surgical procedures under the
OPPS.
After considering the public
comments we received, we are
finalizing our proposal, without
modification, to update the ASC relative
payment weights in the revised ASC
payment system each year using the
national OPPS relative payment weights
for that same calendar year and to
uniformly scale the ASC relative
payment weights for each update year to
make them budget neutral. For example,
holding ASC utilization and the mix of
services constant, for CY 2009, we will
compare the total weight using the CY
2008 ASC relative payment weights
under the 75/25 blend (of the CY 2007
payment rate and the revised payment
rate) with the total weight using CY
2009 relative payment weights under
the 50/50 blend (of the CY 2007
payment rate and the revised payment
rate), taking into account the changes in
the OPPS relative payment weights
between CY 2008 and CY 2009. We will
use the ratio of CY 2008 to CY 2009 total
weight to scale the ASC relative
payment weights for CY 2009. Scaling of
ASC relative payment weights would
apply to covered surgical procedures
and covered ancillary radiology services
whose payment rates are related to
OPPS relative payment weights. Scaling
would not apply in the case of ASC
payment for other separately payable
covered ancillary services that have a
predetermined national payment
amount (that is, their national payment
amounts are not based on OPPS relative
payment weights) such as drugs and
biologicals that are separately paid
under the OPPS. Any service with a
predetermined national payment
amount would be included in the
budget neutrality comparison, but
scaling of the relative payment weights
would not apply to those services that
have a predetermined payment amount.
The ASC payment weights for those
services without predetermined national
payment amounts (that is, their national
payment amounts would be based on
OPPS relative payment weights if a
payment limitation did not apply)
would be scaled to eliminate any
difference in the total payment weight
between the current year and the update
year.
2. Updating the ASC Conversion Factor
Section 1833(i)(2)(C) of the Act
requires that, if the Secretary has not
updated the ASC payment amounts in a
calendar year after CY 2009, the
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
payment amounts shall be increased by
the percentage increase in the CPI–U as
estimated by the Secretary for the 12month period ending with the midpoint
of the year involved. Therefore, in the
August 2006 proposed rule for the
revised ASC payment system we
proposed to update the ASC conversion
factor using the CPI–U in order to adjust
ASC payment rates for inflation.
We received a number of comments
regarding our proposal to use the CPI–
U to adjust payments to ASCs for
inflation, and these comments and our
responses are discussed in section IV.H.
of this final rule, which addresses the
adjustment for inflation under the
revised ASC payment system. We did
not receive any public comments
regarding our proposal to adjust ASC
payments for inflation by applying the
inflation adjustment to the conversion
factor under the revised ASC payment
system.
As explained in section IV.H. of this
final rule, after consideration of the
public comments we received, we are
finalizing our proposal under
§§ 416.171(a) and (b), without
modification, to apply the CPI–U to
adjust payments to ASCs for inflation.
We will implement the annual update
through an adjustment to the conversion
factor under the revised ASC payment
system, beginning in CY 2010 when the
statutory requirement for a zero update
no longer applies.
E. Annual Updates
Currently, under the existing ASC
payment system, we update the ASC list
of covered surgical procedures every 2
years through the notice and comment
regulation process. We make additions
to and deletions from the ASC list of
covered surgical procedures based on
clinical judgment and data that are
available regarding utilization of care
settings. We last published an updated
list of the ASC covered surgical
procedures in the CY 2007 OPPS/ASC
final rule with comment period (71 FR
67960).
Under the revised ASC payment
system, which will be implemented
effective January 1, 2008, we proposed
in the August 2006 proposed rule to
update on an annual calendar year basis
the ASC conversion factor, the relative
payment weights and APC assignments,
the ASC payment rates, and the list of
procedures for which Medicare would
not make payment of an ASC payment
rate. To the extent possible under the
rules and policies of the revised ASC
payment system, we proposed to
maintain consistency between the OPPS
and the ASC payment system in the way
we treat new and revised HCPCS and
PO 00000
Frm 00065
Fmt 4701
Sfmt 4700
42533
CPT codes for payment under the ASC
payment system. We also proposed to
invite comment as part of the annual
update cycle to determine if there are
procedures that we exclude from
payment in the ASC setting that merit
reconsideration as a result of changes in
clinical practice or innovations in
technology.
We proposed to update the ASC list
of covered surgical procedures and
payment system as part of the annual
proposed and final rulemaking cycle
updating the hospital OPPS. We
believed that including the ASC update
as part of the OPPS rulemaking cycle
would ensure that updates of the ASC
payment rates and the list of covered
surgical procedures for which Medicare
makes payment to ASCs would be
issued in a regular, predictable, and
timely manner. Moreover, the ASC
payment system would be updated
concurrent with changes in the APC
groups and the OPPS inpatient list,
making it easier to predict changes in
payment for particular services from
year to year.
In the August 2006 proposed rule for
the revised ASC payment system, we
proposed to issue a final rule in the first
part of CY 2007 in which we would
respond to comments submitted timely
regarding the proposals set forth in that
proposed rule and make final the policy
and regulations for the revised ASC
payment system for implementation
effective January 1, 2008. We also
proposed to include the CY 2008 ASC
payment rates for surgical procedures
payable in an ASC as part of the
proposed and final rules for the CY 2008
OPPS update.
In addition, in the August 2006
proposed rule we proposed to evaluate
each year all new HCPCS codes that
describe surgical procedures to make
preliminary determinations regarding
whether or not they should be payable
in the ASC setting and, if so, whether
they are office-based procedures. In the
absence of claims data that would
indicate where procedures described by
new codes are being performed and
identify the facility resources required
to perform them, we proposed to use
other available information, including
our clinical advisors’ judgment,
predecessor CPT and Level II HCPCS
codes, information submitted by
representatives of specialty societies
and professional associations, and
information submitted by commenters
during the public comment period
following publication of the final rule
with comment period in the Federal
Register. We would publish in the
annual OPPS/ASC payment update final
rule those interim determinations for
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
42534
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
the new codes to be active January 1 of
the update year. The ASC payment
system treatment of those procedures
would be open to comment on that final
rule, and we would respond to
comments about our interim
determinations in the final rule for the
following year, just as we currently
respond to comments about our APC
assignments for new codes in the OPPS
final rule for the following year. After
our review of public comments and in
the absence of physicians’ claims data,
if our determination regarding a new
code was that it should reside on the
ASC list of covered surgical procedures
as an office-based procedure subject to
the payment limitation, this
determination would remain
preliminary until we were able to
consider more recent volume and
utilization data for each individual
procedure code and/or, if appropriate,
the clinical characteristics, utilization,
and volume of related codes. Using that
information, if we confirmed our
determination that the new code was
appropriately assigned to an officebased payment indicator, it would then
be permanently assigned to the list of
office-based procedures subject to the
payment limitation.
Accordingly, we proposed to reflect
this annual rulemaking and publication
of revised payment methodologies and
payment rates in new § 416.173 in
proposed new Subpart F.
Comment: Several commenters
recommended that CMS continue to
consider the input of interested parties
submitting comments regarding the
assignment of HCPCS codes to
appropriate APCs, additions to and
deletions from the ASC list of covered
surgical procedures, and creation of
payment mechanisms to account for
new technology.
Response: As stated in our August
2006 proposal for the annual update
process, we intend to invite comments
from interested parties as part of the
consolidated annual update cycle for
updating the hospital OPPS and revised
ASC payment system. As always, the
OPPS treatment, including APC
assignments, of all HCPCS codes would
be open to comment, and we proposed
also to invite comment regarding
whether there are procedures that we
exclude from payment in the ASC
setting that merit reconsideration as a
result of changes in clinical practice or
innovations in technology. This
approach is consistent with the
recommendation of the PPAC that we
utilize a process for the revised ASC
payment system to obtain input from
national medical specialty societies and
the ASC community in order to provide
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
payment to ASCs for all safe and
appropriate procedures and to allow for
changes in technology and evolution in
medical practice. Annual updating will
provide for the adaptable methodology
that the PPAC recommends for the
revised ASC payment system.
Comment: Some commenters
supported our proposal for the annual
updates, indicating that the proposed
alignment of annual updates to the
revised ASC payment system with the
OPPS updates is appropriate and allows
the industry to review and contemplate
the changes in both payment systems
simultaneously.
Response: We appreciate the
commenters’ support and continue to
believe that including the ASC update
as part of the OPPS rulemaking cycle
would ensure that updates of the ASC
payment rates and the list of surgical
procedures for which Medicare pays
ASCs would be issued in a regular,
predictable, and timely manner.
Moreover, the ASC payment system
would be updated concurrent with
changes in the APC groups and the
OPPS inpatient list, making it easier to
predict changes in payment for
particular services from year to year. We
believe this approach is especially
appropriate, given the final policy of the
revised ASC payment system as
discussed further in section IV.B. of this
final rule, to use the APC groups and
relative payment weights for surgical
procedures established under the OPPS
as the basis of the payment groups and
the relative payment weights for
surgical procedures paid in ASCs
beginning in CY 2008. The annually
updated OPPS device offset percents
will be used to establish ASC payment
rates for device-intensive procedures. In
addition, according to the final policies
established in this final rule, the OPPS
relative payment weights and rates will
be used as the basis for the payment of
most covered ancillary services under
the revised ASC payment system, so
coordinated annual updating of the
OPPS and the revised ASC payment
system is particularly important.
Comment: A number of commenters
indicated that many ASCs were
interested in submitting bills to
Medicare using the same claim form
that is used by HOPDs, the CMS UB–92
(soon to be the UB–04), so that CMS
would have additional information
available for the annual ASC update
under the revised ASC payment system.
The commenters stated that the CMS–
1500 billing form currently used by
most Medicare Part B providers and
suppliers, including ASCs, limits the
amount of information that ASCs can
report on claims. The commenters
PO 00000
Frm 00066
Fmt 4701
Sfmt 4700
expressed concern that, as a result of
having to use the CMS–1500, the true
costs incurred by ASCs to provide
services are not available to CMS and
that, consequently, CMS cannot include
actual ASC costs in its analyses to
develop and update the revised
payment system. They recommended
that ASCs be allowed to report to CMS
the same level of detail about the
services they provide as do HOPDs.
Further, the commenters stated that it
would be less burdensome than the
current Medicare billing policy because
ASCs already use the UB–92 to submit
bills to commercial payors. Thus, they
concluded that allowing ASCs to use the
UB–92 for Medicare Part B billing
would be advantageous for both CMS
and ASCs, because ASCs could provide
more detailed cost information to CMS
and this change would reduce the
administrative burden on ASCs that
currently are maintaining billing
capabilities for both the CMS–1500 and
UB–92 formats.
Response: For future ASC update
years, we will explore the feasibility of
adopting the ASC billing change
recommended by commenters, but this
is not a change that we can make by
January 2008. We understand the
commenters’ concerns in this regard and
investigated the possibility of
implementing this recommendation as
part of the revised payment system,
effective January 2008. A policy change
that requires ASCs to use a different
billing format would have to incorporate
adequate time for CMS and ASCs to
make the necessary systems changes
and for CMS to provide training for
contractors and ASCs prior to
implementing the new format. Although
we will continue to explore this
recommendation, not only is there
insufficient time to make systems
changes and provide training before
implementation of the revised ASC
payment system, but CMS is in the
midst of a comprehensive
reorganization of its contracting
functions, making adoption of any
significant billing change at this time
even more challenging. During the next
few years, Medicare Part A and B claims
will be processed by reconfigured
contracting entities, and we believe that
allowing ASCs to bill using the same
format as HOPDs should be explored as
part of that larger contractor reform. We
plan to pursue the feasibility of this
option and to coordinate any possible
change to ASC billing requirements
with CMS’ overall contracting
transition. We welcome additional
information from the public regarding
recommendations for ASC billing
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
modifications or improvements that we
should consider once the revised
payment system is implemented. We
note that, under our final annual update
methodology for the revised ASC
payment system, we would not require
ASC information beyond that currently
available to us through the CMS–1500
in order to annually update the ASC
payment system.
After consideration of the public
comments we received, we are
finalizing our proposal as reflected in
§ 416.173, without modification, to
annually update the ASC conversion
factor, the relative payment weights and
OPPS APC assignments of covered
surgical procedures paid in ASCs, the
ASC payment rates, and the list of
surgical procedures for which Medicare
would not make payment to ASCs as
part of the annual proposed and final
rulemaking cycle updating the hospital
OPPS. In addition, we will annually
update the list of covered ancillary
services and their ASC payment rates.
We also are finalizing our proposal,
without modification, to evaluate each
year all new HCPCS codes that describe
surgical procedures to make preliminary
determinations regarding whether they
should be payable in the ASC setting
and, if so, whether they are office-based
procedures. The ASC treatment of these
procedures would be open to comment
in the final rule, and we would provide
responses in the final rule for the
following calendar year. Designations of
new surgical procedure codes as officebased would remain preliminary until
there are adequate physicians’ claims
data to assess their predominant sites of
services, whereupon if we confirm their
office-based nature, the codes would be
permanently assigned to the list of
office-based procedures subject to the
ASC payment limitation.
VI. Information in Addenda Related to
the Revised CY 2008 ASC Payment
System
We include addenda to the preamble
of proposed and final rules updating the
ASC payment system to present national
ASC unadjusted payment rates, by
HCPCS code, and other factors that
affect ratesetting. For example, in
Addendum BB to the August 2006
proposed rule for the revised ASC
payment system, we listed the HCPCS
codes of surgical procedures for which
we proposed to allow payment to ASCs
in CY 2008, the short descriptors for
those codes, and whether or not the
code was proposed to be newly added
to the list of covered surgical
procedures. We also indicated for each
HCPCS code: (1) Whether or not we
proposed to designate it as office-based;
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
(2) whether or not we proposed to cap
it at the MPFS nonfacility practice
expense rate; (3) the estimated proposed
CY 2008 ASC relative payment weight;
(4) the estimated proposed CY 2008 full
payment and coinsurance amounts; and
(5) the estimated proposed CY 2008
transitional payment and coinsurance
amounts using a 50/50 blend of the
current and proposed new rates.
Addendum CC to the August 2006
proposed rule listed the specific subset
of HCPCS codes and their short
descriptors for procedures proposed for
payment limitation at the MPFS
nonfacility practice expense amount
under the revised ASC payment system.
We will continue to use addenda to
summarize, as part of the annual
proposed and final OPPS/ASC rules
updating both payment systems, the
annual update of the relative payment
weights of ASC covered surgical
procedures, the national unadjusted
ASC payment amounts for those
procedures, the procedures designated
as office-based that are subject to
payment limitation at the MPFS
nonfacility practice expense amount,
and other pertinent information that
bears on the determination of the
payment status and payment rates for
services under the revised ASC payment
system for the update year. We will also
summarize in the addenda the covered
ancillary services that will be separately
paid under the revised ASC payment
system if they are integral to the
performance of a covered surgical
procedure, including their updated
relative payment weights as appropriate,
the national unadjusted ASC payment
amounts for those services, and other
pertinent information.
Although we are including addenda
to this final rule, we emphasize that the
information presented in these addenda
is intended solely to demonstrate the
payment rates that result from
application of the revised ASC payment
system methodology that we are
finalizing in this final rule based on the
most current data available. We caution
readers that the illustrative relative
payment weights, national payment
amounts, and other information shown
in the addenda to this final rule are
neither the proposed nor final ASC rates
for the CY 2008 revised ASC payment
system. The information in the addenda
to this final rule exemplifies the results
of applying the revised ASC payment
system methodology implemented in
this final rule to the final or most
recently updated CY 2007 OPPS
information, with application of the
estimated CY 2008 OPPS update,
including the CY 2007 APC groupings
and relative payment weights, the CY
PO 00000
Frm 00067
Fmt 4701
Sfmt 4700
42535
2007 second quarter OPPS payment
rates for drugs and biologicals, the CY
2007 OPPS payment methodology for
brachytherapy sources, the specification
of surgical procedures as subject to
OPPS multiple procedure discounting,
the designation of surgical procedures
as inpatient only under the OPPS, the
identification of surgical procedures for
which payment is packaged under the
OPPS rather than separately paid, and
the CY 2007 OPPS device-dependent
APCs and their respective device offset
percents. The information is also based
on the most recently available Part B
utilization data derived from the full
year of CY 2005 ASC and physicians’
claims, and the CY 2008 estimated
transitional nonfacility practice expense
payment amounts for the CY 2008
MPFS, with application of the projected
CY 2008 MPFS update.
We reiterate that the information in
the addenda to this final rule does not
represent the rates that we will be
proposing for implementation in CY
2008 under the revised ASC payment
system, but merely serves to illustrate
application of the final ratesetting
methodology under the revised ASC
payment system. All information
included in Addendum AA and
Addendum BB to this final rule is
subject to change in the annual cycle of
notice and comment rulemaking to
update the OPPS/ASC payment rates for
CY 2008, with the exception of the
office-based designation of procedures
whose designation is not marked as
temporary. We note that we have also
included in Addenda AA and BB to this
final rule HCPCS codes for those
surgical procedures, radiology services,
implantable devices, and drugs and
biologicals whose payment is packaged
under the OPPS and which, therefore,
would not be eligible for separate ASC
payment as covered surgical procedures
or covered ancillary services, in order to
facilitate review of the ASC payment
policies for these groups of services.
Payment to ASCs under the revised ASC
payment system for these services
would also be packaged. We will
propose the relative payment weights,
payments rates, and other pertinent
ratesetting information for the CY 2008
revised ASC payment system in the
OPPS/ASC proposed rule to update both
payment systems for CY 2008. This
proposed rule will be issued in midsummer of CY 2007. The relative
payment weights and payment rates and
other pertinent ratesetting information
proposed for the revised ASC payment
system in CY 2008 will be based on
proposed CY 2008 OPPS payment
weights and APC groups, proposed CY
E:\FR\FM\02AUR2.SGM
02AUR2
42536
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
2008 MPFS nonfacility practice expense
payment amounts, CY 2007 second
quarter OPPS payment rates for drugs
and biologicals as established based on
the ASP information for that quarter,
and the most recent Part B utilization
data available to us from CY 2006
claims.
CMS will publish final relative
payment weights and final payment
rates and other pertinent ratesetting
information for the CY 2008 revised
ASC payment system in the final OPPS/
ASC rule that updates both payment
systems for CY 2008.
Changes in CY 2008 payments for
physicians’ services under the MPFS, in
first quarter CY 2008 prices for drugs
and biologicals based on the most recent
available ASP data, and in CY 2008
HCPCS codes and pricing of OPPS
services that may occur and that would
affect the CY 2008 revised ASC payment
system between publication of the CY
2008 OPPS/ASC final rule and release of
the January 2008 OPPS PRICER and the
ASC payment files will be reflected in
updated addenda that we will post on
the CMS Web site.
We have created Addendum DD1 to
this final rule to define ASC payment
indicators that we will use in Addenda
AA and BB to provide payment
information regarding covered surgical
procedures and covered ancillary
services, respectively, under the revised
ASC payment system. Analogous to the
OPPS payment status indicators that we
publish in Addendum D1 as part of the
annual OPPS rulemaking cycle, the ASC
payment indicators in Addendum DD1
are intended to capture policy-relevant
characteristics of HCPCS codes that may
receive packaged or separate payment in
ASCs, including their ASC payment
status prior to CY 2008; their
designation as device-intensive; their
designation as office-based and the
corresponding ASC payment
methodology; and their classification as
a separately payable radiology service,
brachytherapy source, OPPS passthrough device, corneal tissue
acquisition service, drug or biological,
or NTIOL.
mstockstill on PROD1PC66 with RULES2
VII. ASC Regulatory Changes
In the August 23, 2006 proposed rule,
we proposed to modify applicable ASC
regulations under 42 CFR Parts 410,
414, and 416 to incorporate the
requirements and conditions for
payments for ASC facility services
under the revised payment system that
was proposed for implementation
beginning January 1, 2008.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
A. Regulatory Changes That Were
Finalized in the CY 2007 OPPS/ASC
Final Rule With Comment Period
In the August 23, 2006 proposed rule
(71 FR 49631), we proposed the
following regulatory changes which we
finalized in the CY 2007 OPPS/ASC
final rule with comment period (71 FR
68174).
• We proposed to revise the current
regulations at Part 416, Subparts D and
E, to ensure that the rules governing the
current ASC payment system are clearly
distinguishable from those that would
apply to the revised system beginning
January 1, 2008.
• We proposed to revise Subparts D
and E to Part 416 to reflect the rules
governing the ASC payment system
prior to January 1, 2008.
• We proposed to redesignate existing
Subpart F as Subpart G under Part 416
to codify the rules governing the ASC
payment adjustment for NTIOLs (71 FR
49631).
• We proposed several technical
changes to Part 416 (71 FR 49659).
• We proposed to revise existing
§ 416.1 (Basis and scope) to remove the
obsolete reference to ‘‘a hospital
outpatient department,’’ and to add
provisions of section 5103 of Public Law
109–171 and applicable provisions of
Public Law 108–173.
• We proposed to revise existing
§ 416.65 (Covered surgical procedures)
to modify the introductory text to
clearly denote the section’s application
to covered surgical procedures
furnished before January 1, 2008. In
addition, we proposed to remove the
obsolete cross-reference in paragraph
(a)(4) to § 405.310 and replace it with
the correct cross-reference to § 411.15.
• We proposed to revise § 416.125
(ASC facility services payment rate) to
incorporate the limitation on payment
imposed by section 5103 of Public Law
109–171.
• We proposed to revise § 488.1
(Definitions) to add ambulatory surgical
centers to the definition of a supplier in
conformance with section 1861(d) of the
Act.
• We proposed to add new § 416.76
and new § 416.121 to Subparts D and E,
respectively, to clearly state that the
provisions of Subparts D and E apply to
services furnished before January 1,
2008.
The bases for these proposed
regulatory changes were discussed in
detail throughout the preamble of the
August 23, 2006 proposed rule. We did
not receive any public comments on
these proposed revisions. In the CY
2007 OPPS/ASC final rule with
comment period, we made these
PO 00000
Frm 00068
Fmt 4701
Sfmt 4700
provisions final as proposed, without
modification (71 FR 68174).
B. Regulatory Changes Included in This
Final Rule
In the August 23, 2006 proposed rule
(71 FR 49699), we proposed to add a
new Subpart F to Part 416 entitled
‘‘Subpart—Coverage, Scope of ASC
Facility Services, and Prospective
Payment System for Facility Services
Furnished On or After January 1, 2008,’’
which would include the following new
sections:
§ 416.160 Basis and scope.
§ 416.161 Applicability.
§ 416.163 General rules.
§ 416.164 Scope of ASC facility
services.
§ 416.166 Covered surgical procedures.
§ 416.167 Basis of payment.
§ 416.171 Calculation of prospective
payment rates for ASC services.
§ 416.172 Adjustments to national
payment rates.
§ 416.173 Publication of revised
payment methodologies and
payment rates.
§ 416.178 Limitations on
administrative and judicial review.
We also proposed a technical change
to 42 CFR Part 414 to conform with
changes we were proposing under Part
416, new Subpart F (71 FR 49659), and
we likewise proposed to revise
§ 410.152(i) to make it consistent with
provisions of the revised ASC payment
system. The numerous public comments
that we received regarding the revised
ASC payment system we proposed to
implement January 1, 2008, are
addressed in detail throughout the
preamble of this final rule.
As a result of our review of the public
comments, in this final rule, we have
made a number of modifications to our
proposals for the revised ASC payment
system. These modifications, which are
also discussed in detail in other sections
of this final rule, have necessitated
corresponding changes in the
regulations that we proposed for the
revised ASC payment system. The
following is a summary of changes to 42
CFR 410 and 416 that reflect those
modifications, which we are finalizing
in this final rule.
• We added a new paragraph (i)(2)
under § 410.152 to specify the amount
of payment the Medicare program
makes for ASC services beginning
January 1, 2008.
• We decided not to finalize the
proposed revision of § 414.22(b)(5)(i)(B)
in this final rule.
• In § 416.2, we revised the
definitions of ‘‘ASC services,’’ ‘‘Covered
surgical procedures,’’ and ‘‘Facility
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
services,’’ and we added a definition of
‘‘Covered ancillary services.’’
• We added new Subpart F, as
proposed, but modified the title to read
‘‘Coverage, Scope of ASC Services, and
Prospective Payment System for ASC
Services Furnished on or after January
1, 2008.’’ We also modified certain
proposed sections under Subpart F and
added other provisions as outlined
below.
• We revised the section headings of
§§ 416.161 and 416.164 to read
‘‘Applicability of this subpart’’ and
‘‘Scope of ASC services,’’ respectively.
We also revised the section heading of
§ 416.171 to read ‘‘Determination of
payment rates for ASC services.’’ In
addition, we added new § 416.179 with
a new section heading.
• We added § 416.160(a)(4), which
addresses payment rules for screening
flexible sigmoidoscopy and screening
colonoscopy services. Also, we
reordered the paragraphs of § 416.160.
• We revised § 416.160(b) to conform
the text with the changes to the
definitions in § 416.2.
• We made a technical change to
§§ 416.163(b) and (c) to specify that
payment for anesthetists’ services is
made in accordance with 42 CFR part
414, in addition to editorial changes to
§ 416.163(a) to reference ASC services
rather than ASC facility services.
• We revised § 416.164(a), ‘‘Included
facility services,’’ and we renamed and
revised § 416.164(b) as ‘‘Covered
ancillary services,’’ to reflect the policy
regarding the packaging of services
which is made final in section IV.C. of
this final rule. Proposed § 416.164(b)
becomes final § 416.164(c), ‘‘Excluded
services,’’ where we revised
anesthetists’ services, which are paid
under 42 CFR part 414 and where we
changed x-ray procedures to radiology
services and separated diagnostic
procedures and radiology services into
separate items. Also, ‘‘Excluded
services’’ no longer includes costs
incurred to procure corneal tissue.
• In § 416.166(c), ‘‘General
exclusions,’’ we deleted the phrase
‘‘other medical procedures’’ from the
introductory sentence to conform with
the definition of the type of procedures
covered under the ASC benefit as
discussed in section III. of this final
rule. We moved the criterion proposed
as paragraph (c)(5) (regarding the
expected requirement for active medical
monitoring and care at midnight
following the procedure) to § 416.166(b)
as an element of the ‘‘General
standards.’’ We also added the following
as new criteria for exclusion of a
procedure from coverage when
performed in an ASC: (1) Commonly
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
require systemic thrombolytic therapy;
(2) are designated as requiring inpatient
care under § 419.22(n); and (3) can only
be reported using a CPT unlisted
surgical procedure code.
• We made technical and editorial
changes to § 416.167(a) and (b) to
reference payment for ASC services and
covered ancillary services.
• We revised § 416.171 to reflect the
modifications that we are making final
in this final rule regarding separate
payment for certain covered ancillary
services and the extension of
transitional payment rates from 1 to 3
years, as discussed in section IV. J. of
this final rule.
• We revised § 416.172 as follows: (1)
Made minor changes to paragraphs (a),
(b), (d), and (e) to reference ASC
services and to clarify that the
comparison for purposes of assessing
the lesser of the actual charge or the
prospective rate is to the geographically
adjusted payment rate; and (2) revised
paragraph (c) to exclude application of
a geographic adjustment to payment
rates for certain drugs, devices, and
brachytherapy sources, as discussed in
section IV. C. of this final rule. In
addition, we added new paragraph (f) to
reflect the payment adjustment when
ASC services are interrupted due to
circumstances that threaten the wellbeing of the beneficiary. We also added
new paragraph (g) to reflect the payment
adjustment for the insertion of NTIOLs.
• We made editorial changes to
§ 416.173 and § 416.178.
• We added new § 416.179, ‘‘Payment
and coinsurance reduction for devices
replaced without cost or when full
credit is received,’’ as discussed in
section IV.C. of this final rule.
VIII. Files Available to the Public Via
the Internet
Addenda AA, BB, and DD1 to this
final rule provide various data
pertaining to the CY 2008 ASC list of
covered procedures and the covered
ancillary services that will be separately
paid to ASCs beginning in CY 2008
when provided by an ASC as integral to
a covered surgical procedure on the
same day as the procedure. All relative
payment weights and payment rates are
illustrative only, demonstrating the
payment rates that result from
application of the revised ASC payment
system methodology that we are
finalizing in this final rule based on the
most current data available. They
exemplify the results of applying the
revised ASC payment system
methodology implemented in this final
rule to the final or most recently
updated CY 2007 OPPS information as
updated by the currently estimated CY
PO 00000
Frm 00069
Fmt 4701
Sfmt 4700
42537
2008 OPPS update factor and to the CY
2008 estimated transitional nonfacility
practice expense amounts for the CY
2008 MPFS, with application of the
projected CY 2008 MPFS update.
As further discussed in section VI. of
this final rule, Addendum DD1 defines
the payment indicators that are used in
Addenda AA and BB of this final rule,
while Addenda AA and BB provide
payment information regarding covered
surgical procedures and covered
ancillary services under the revised ASC
payment system.
These addenda, as well as the final
rule preamble tables and other
supporting data files, are included on
the CMS Web site at: https://
www.cms.hhs.gov/ASCPayment/ in a
format that can easily be downloaded
and manipulated. Proposed and final
ASC relative weights and payment rates
for CY 2008 will be published in the
proposed and final CY 2008 OPPS/ASC
rules, respectively, and related data files
will be included on the CMS Web site
as noted above. The OPPS data files are
available to the public on the CMS Web
site at: https://www.cms.hhs.gov/
HospitalOutpatientPPS, and the MPFS
data files are located at: https://
www.cms.hhs.gov/PhysicianFeeSched.
We are not including as addenda to
this final rule reprints of the final FY
2007 IPPS wage indexes that were
included in a notice published in the
Federal Register on October 11, 2006
(71 FR 59886). Rather, we are providing
a link on the CMS Web site at: https://
www.cms.hhs.gov/AcuteInpatientPPS/
WIFN to all of the final FY 2007 IPPS
wage index related tables. The final CY
2008 ASC payment system will utilize
the FY 2008 IPPS wage index related
tables that will be proposed and
finalized in the FY 2008 IPPS
rulemaking cycle, and we will provide
a link on the CMS Web site to those
proposed and final wage index related
tables in the CY 2008 OPPS/ASC
proposed and final rules, respectively.
For additional assistance, contact Gift
Tee, (410) 786–0378.
IX. Collection of Information
Requirements
This document does not impose any
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
E:\FR\FM\02AUR2.SGM
02AUR2
42538
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
X. Regulatory Impact Analysis
mstockstill on PROD1PC66 with RULES2
A. Overall Impact
We have examined the impacts of this
final rule as required by Executive
Order 12866 (September 1993,
Regulatory Planning and Review), the
Regulatory Flexibility Act (RFA)
(September 19, 1980, Pub. L. 96–354),
section 1102(b) of the Social Security
Act, the Unfunded Mandates Reform
Act of 1995 (Pub. L. 104–4), and
Executive Order 13132.
1. Executive Order 12866
Executive Order 12866 (as amended
by Executive Order 13258, which
merely reassigns responsibility of
duties) directs agencies to assess all
costs and benefits of available regulatory
alternatives and, if regulation is
necessary, to select regulatory
approaches that maximize net benefits
(including potential economic,
environmental, public health and safety
effects, distributive impacts, and
equity). A regulatory impact analysis
(RIA) must be prepared for major rules
with economically significant effects
($100 million or more in any 1 year).
We estimate that the revised ASC
payment system and the expanded ASC
list of covered surgical procedures that
we are implementing in CY 2008 will
have no net effect on Medicare
expenditures compared to the level of
Medicare expenditures that would have
occurred in CY 2008 in the absence of
the revised payment system. A more
detailed discussion of the effects of the
changes to the ASC list of covered
surgical procedures and the effects of
the revisions to the ASC payment
system in CY 2008 is provided in
section X.B. below.
While we estimate that there will be
no net change in Medicare expenditures
in CY 2008 as a result of the revised
ASC payment system, we estimate that
the revised system will result in savings
of $240 million over 5 years due to
migration of new ASC covered surgical
procedures from HOPDs and physicians’
offices to ASCs over time. In addition,
we note there will be a total increase in
Medicare payments to ASCs for CY 2008
of approximately $270 million
compared to Medicare expenditures that
would have occurred in CY 2008 in the
absence of the revised payment system.
These additional payments to ASCs of
approximately $270 million in CY 2008
will be fully offset by savings from
reduced Medicare spending in HOPDs
and physicians’ offices on services that
migrate from these settings to ASCs in
CY 2008 (as discussed in detail in
section V.C. of this final rule).
Therefore, this final rule is an
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
economically significant rule under
Executive Order 12866 and a major rule
under 5 U.S.C. 804(2).
2. Regulatory Flexibility Act
The RFA requires agencies to
determine whether a rule would have a
significant economic impact on a
substantial number of small entities. For
purposes of the RFA, small entities
include small businesses, nonprofit
organizations, and small governmental
jurisdictions. Most hospitals and most
other providers and suppliers are small
entities, either by nonprofit status or by
having revenues of $9 million to $31.5
million in any 1 year (65 FR 69432).
For purposes of the RFA, we have
determined that approximately 73
percent of ASCs would be considered
small businesses according to the Small
Business Administration (SBA) size
standards. Individuals and States are
not included in the definition of a small
entity. We anticipate that this final rule
will have a significant impact on a
substantial number of small entities.
3. Small Rural Hospitals
In addition, section 1102(b) of the Act
requires us to prepare a regulatory
impact analysis if a rule may have a
significant impact on the operations of
a substantial number of small rural
hospitals. This analysis must conform to
the provisions of section 604 of the
RFA. For purposes of section 1102(b) of
the Act, we define a small rural hospital
as a hospital with fewer than 100 beds
that is located outside of a Metropolitan
Statistical Area (MSA). The Secretary
certifies that this final rule will not have
a significant impact on the operations of
a substantial number of small rural
hospitals.
4. Unfunded Mandates
Section 202 of the Unfunded
Mandates Reform Act of 1995 (Pub. L.
104–4) also requires that agencies assess
anticipated costs and benefits before
issuing any rule whose mandates
require spending in any 1 year of $100
million in 1995 dollars, updated
annually for inflation. That threshold
level is currently approximately $120
million. This final rule will not mandate
any requirements for State, local, or
tribal government, nor will it affect
private sector costs.
5. Federalism
Executive Order 13132 establishes
certain requirements that an agency
must meet when it publishes any rule
(proposed or final) that imposes
substantial direct costs on State and
local governments, preempts State law,
PO 00000
Frm 00070
Fmt 4701
Sfmt 4700
or otherwise has Federalism
implications.
We have examined this final rule in
accordance with Executive Order 13132,
Federalism, and have determined that it
would not have an impact on the rights,
roles, and responsibilities of State, local
or tribal governments. The changes
related to payments to ASCs in CY 2008
will not affect payments to government
hospitals.
B. Effects of Revisions to the ASC
Payment System for CY 2008
In CY 2008, we are implementing a
revised Medicare ASC payment system
that could have a far-reaching effect on
the provision of outpatient surgical
services for a number of years to come.
First, we are greatly expanding the list
of procedures that will be eligible for
payment under the revised ASC
payment system. Second, we are moving
from a limited fee schedule based on
nine disparate payment groups to a
payment system incorporating relative
payment weights for groups of
procedures with similar clinical and
resource characteristics, based on the
APCs that are key elements of the OPPS.
Implementation by January 1, 2008 of
a revised ASC payment system designed
to result in budget neutrality is
mandated by section 626 of Public Law
108–173. To set ASC payment rates for
CY 2008 under the revised payment
system, we are multiplying ASC relative
payment weights for surgical procedures
by an ASC conversion factor that we
calculate to result in the same amount
of aggregate Medicare expenditures for
those services in CY 2008 as we
estimate would have been made if the
revised payment system were not
implemented.
The effects of the expanded numbers
and types of procedures for which an
ASC payment may be made and other
policy changes that affect the revised
payment system, combined with
significant changes in payment rates for
covered surgical procedures, will vary
across ASCs, depending on whether or
not the ASC limits its services to those
in a particular surgical specialty area,
the volume of specific services provided
by the ASC, the extent to which ASCs
will offer different services, and the
percentage of its patients that are
Medicare beneficiaries.
In this July 2007 final rule for the
revised ASC payment system, we have
estimated the CY 2008 ASC payment
rates, budget neutrality factor, and
impacts using the CY 2007 OPPS
relative payment weights with an
estimated update factor for CY 2008, the
CY 2007 MPFS PE RVUs trended
forward to CY 2008, and CY 2005
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
utilization data projected forward to CY
2008. We emphasize that the impact
estimates in this final rule are
illustrative only. The CY 2008 ASC
payment rates and budget neutrality
factor will be proposed in the CY 2008
OPPS/ASC proposed rule based on the
methodology for calculating budget
neutrality established in this final rule
and incorporating the proposed CY 2008
OPPS relative payment weights, the
proposed CY 2008 MPFS PE RVUs, and
CY 2006 utilization information
projected forward to CY 2008. The final
CY 2008 ASC payment rates and budget
neutrality factor will be established in
the CY 2008 OPPS/ASC final rule with
comment period, in accordance with the
methodology for calculating budget
neutrality established in this final rule
and based on the final CY 2008 OPPS
payment weights, the final CY 2008
MPFS RVUs, and updated CY 2006
utilization data projected forward to CY
2008.
As discussed fully in section V.C. of
this final rule, our final methodology for
calculating the budget neutrality factor
considers not only the effects of the new
payment rates to be implemented under
the revised payment system, but also the
estimated net effect of migration of new
ASC procedures across ambulatory care
settings. The methodology for
calculating the budget neutrality
adjustment factor finalized in this rule
assumes that over the first 2 years of the
revised payment system, approximately
25 percent of the HOPD volume of new
ASC procedures would migrate from the
HOPD service setting to ASCs, and that
over the 4-year transition period,
approximately 15 percent of the
physicians’ office volume of new ASC
procedures would migrate to ASCs.
We estimate that the revised ASC
payment system established in this final
rule will result in neither savings nor
costs to the Medicare program in CY
2008. That is, because it is designed to
be budget neutral, in CY 2008, the
revised ASC payment system will
neither increase nor decrease
expenditures under Part B of Medicare.
We further estimate that beneficiaries
will save approximately $20 million
under the revised ASC payment system
in CY 2008, because ASC payment rates
will, in most cases, be lower than OPPS
payment rates for the same services and,
because, except for screening flexible
sigmoidoscopy and screening
colonoscopy procedures, beneficiary
coinsurance for ASC services is 20
percent rather than 20 to 40 percent as
is the case under the OPPS. (The only
possible instance in which an ASC
coinsurance amount could exceed the
OPPS copayment amount would be
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
when the coinsurance amount for a
procedure under the revised ASC
payment system exceeds the hospital
inpatient deductible. Section
1833(t)(8)(C)(i) of the Act provides that
the copayment amount for a procedure
paid under the OPPS cannot exceed the
inpatient deductible established for the
year in which the procedure is
performed, but there is no such
requirement related to the ASC
coinsurance amount.) Beneficiary
coinsurance for services migrating from
physicians’ offices to ASCs may
decrease or increase under the revised
ASC payment system, depending on the
particular service and whether the
Medicare payment to the physician for
providing that service in his or her
office is higher or lower than the sum
of the Medicare payment to the ASC for
providing the facility portion of that
service and the Medicare payment to the
physician for providing that service in
a facility (nonoffice) setting. As noted
previously, the net effect of the revised
ASC payment system on beneficiary
coinsurance, taking into account the
migration of services from HOPDs and
physicians’ offices, is estimated to be
$20 million in beneficiary savings in CY
2008.
1. Alternatives Considered
We are issuing this final rule to meet
a statutory requirement to implement,
no later than January 1, 2008, a revised
payment system for ASCs. We are
implementing the revised ASC payment
system through rulemaking in the
Federal Register. Through the August
2006 proposed rule, we have afforded
interested parties an opportunity to
comment on revisions we proposed to
make to the policies and rules for
identifying surgical procedures that
would be excluded from payment in
ASCs, to the ASC ratesetting
methodology and payment policies, and
to the regulations for the revised ASC
payment system.
Throughout the preamble of this final
rule, we discuss the various options we
considered as we developed policies to
redesign the ASC payment system in
broad terms, and specific policies, such
as those affecting payment for covered
ancillary services integral to covered
surgical procedures, the definition of a
covered surgical procedure, criteria for
identifying procedures that are not
safely or appropriately performed in an
ASC, and the payment methodology for
device-intensive procedures, among
others.
Although we proposed to phase in the
new ASC payment rates under the
revised payment system over a 2-year
period, we are finalizing a policy to
PO 00000
Frm 00071
Fmt 4701
Sfmt 4700
42539
phase in the ASC payment rates under
the revised payment system over a 4year period. As we discuss in section
X.B.3. of this final rule, we believe that
allowing a longer transition period is
appropriate in light of the adverse
financial impact that some ASCs could
potentially experience if they perform a
high volume of procedures whose rates
would decrease significantly under the
revised payment system. We believe the
4-year transition will give ASCs time to
reconfigure their mix of services and
make other needed adjustments so they
can focus on achieving more efficient
delivery of a broader range of surgical
procedures.
2. Limitations of Our Analysis
Presented here are the projected
effects of the policy and statutory
changes that will be effective for CY
2008 on aggregate ASC utilization and
Medicare payments. One limitation of
this analysis is that we could only infer
the effects of the revised payment
system on different types of ASCs, for
example, single or multispecialty, high
or low volume, and urban or nonurban
ASCs, based on an overall comparison
of procedure volumes and facility
payments between the current and the
revised payment system. At this time,
we do not have a provider-level dataset
of CY 2005 ASC utilization that
accurately identifies unique ASCs and
their geographic information that would
allow us to compare estimated
payments and geographic adjustment
among classes of ASCs based on a
provider-level analysis.
A second limitation is our lack of
information on ASC resource use. ASCs
are not required to file Medicare cost
reports and, therefore, we do not have
cost information to evaluate whether or
not the payments for ASC services
coincide with the resources required by
ASCs to provide those services.
A third limitation is our inability to
predict changes in service mix between
CY 2005 and CY 2008. The aggregated
impact tables below are based upon a
methodology that assumes no changes
in service-mix with respect to the CY
2005 ASC data used for this final rule.
We believe that the net effect on
Medicare expenditures of changes in
service-mix for current ASC covered
surgical procedures will be negligible,
in the aggregate. Such changes may have
differential effects across surgical
specialty procedure groups as ASCs
adjust to the revised payment system.
However, we are unable to accurately
project such changes at a disaggregated
level. Clearly, individual ASCs will
experience changes in payment that
E:\FR\FM\02AUR2.SGM
02AUR2
42540
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
differ from the aggregated estimated
changes presented in the tables below.
Because we do not have experience
with ASC payment under the revised
payment system, we have relied on
comments and information from
stakeholders in response to our August
2006 proposed rule for the revised ASC
payment system to mitigate the
limitations in the data available to us for
analysis of the impact of the changes on
specific procedures, on classes of
specialty ASCs, and on beneficiaries.
3. Estimated Effect of This Final Rule on
ASCs
Some ASCs are multispecialty
facilities that perform the gamut of
surgical procedures, from excision of
lesions to hernia repair to cataract
extraction; others focus on a single
specialty and perform only a limited
range of surgical procedures, such as
eye procedures, gastrointestinal
procedures, or orthopedic surgery. The
combined effect on an individual ASC
of the CY 2008 revised payment system
and the expanded ASC list of covered
surgical procedures will depend on a
number of factors, including, but not
limited to, the mix of services the ASC
provides, the volume of specific services
provided by the ASC, the percentage of
its patients who are Medicare
beneficiaries, and the extent to which an
ASC will choose to provide different
services under the revised payment
system. The following discussion
presents two tables that provide
estimates of the impact of the revised
ASC payment system on Medicare
payments to ASCs for current ASC
services, assuming the same mix of
services as offered by ASCs in our CY
2005 claims data. The first table depicts
aggregate percent change in payment by
surgical specialty group and the other
compares payment for procedures
estimated to receive the most payment
in CY 2008 under the current payment
system.
In section IV.J. of this final rule, we
finalize our policy of a transition of 4
years for the revised payment rates,
rather than the proposed 2-year
transition, where payments will
generally be made using a blend of the
rates based on the CY 2007 ASC
payment rate and the revised ASC
payment rate. In comparing estimated
payment rates for CY 2008 under the
existing system with the estimated
payment rates for CY 2008 under the
revised system, we noted the negative
effect the estimated proposed payment
rates would have on Medicare payments
to ASCs for certain surgical procedures
that currently are performed frequently
in ASCs. We were concerned about the
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
impact of the revised payment rates on
ASCs that specialize in a limited
number of surgical procedures for
which payment would decrease under
the revised system and wanted to
encourage ASCs to continue to provide
access to the high volume procedures
that are currently performed there
because, in all likelihood, the ASC has
become an extremely efficient setting for
those procedures, such as cataract
extractions and colonoscopies.
Moreover, we believe that a positive
outcome of the revised ASC payment
system could be to expand beneficiary
and physician choice in selection of an
appropriate site for ambulatory surgical
services, as a consequence of the
expansion of surgical procedures for
which Medicare will make an ASC
payment and the revised rates that will
pay more appropriately for those
services. We believe a 4-year transition
will give ASCs additional time to
reconfigure their mix of surgical
services and make other needed
adjustments so that they can focus on
achieving more efficient delivery of a
broader range of surgical procedures.
In CY 2008, we will pay ASCs using
a 75/25 blend, in which payment will be
calculated by adding 75 percent of the
CY 2007 ASC rate for a surgical
procedure on the CY 2007 ASC list of
covered surgical procedures and 25
percent of the revised CY 2008 ASC rate
for the same procedure. For CYs 2009
and 2010, the blend will be transitioned
first to 50/50 and then to a 25/75 blend
of the CY 2007 ASC rate and the revised
ASC payment rate. Beginning in CY
2011, payments will be made to ASCs
for covered surgical procedures on the
CY 2007 ASC list at the fully
implemented revised ASC payment
rates. Procedures that were not included
on the ASC list of covered surgical
procedures in CY 2007 will not be paid
at the transitional rates for CYs 2008
through 2010 because they have no CY
2007 ASC payment rate. Those
procedures will be paid at the fully
implemented ASC rate, beginning in CY
2008.
Table 11 shows the impact of the
revised payment system at the surgical
specialty group level. We have
aggregated the surgical HCPCS codes by
specialty group and estimated the effect
on aggregated payment for surgical
specialty groups, considering separately
the CY 2008 transitional rate and the
fully implemented revised payment
rate. The groups are sorted for display
in descending order by estimated
Medicare program payment to ASCs for
CY 2008 in the absence of the revised
ASC payment system. The following is
PO 00000
Frm 00072
Fmt 4701
Sfmt 4700
an explanation of the information
presented in Table 11:
• Column 1—Surgical Specialty
Group indicates the surgical specialties
into which ASC procedures are
grouped. We used the CPT code range
definitions and added the related Level
II HCPCS codes and Category III CPT
codes, as appropriate, to account for all
surgical procedures to which the
Medicare program payments are
attributed.
• Column 2—Estimated CY 2008 ASC
Payments in the absence of the revised
ASC payment system were calculated by
multiplying the CY 2007 ASC payment
rate by CY 2008 ASC utilization (which
is based on CY 2005 ASC utilization
multiplied by a factor of 1.305 to take
into account expected volume growth
with volume adjustment, as appropriate,
for the multiple procedure discount).
The resulting amount was then
multiplied by 0.8 to estimate the
Medicare program’s share of the total
payments to the ASC. The payment
amounts are expressed in millions of
dollars.
• Column 3—Estimated CY 2008
Percent Change with Transition (75/25
Blend) is the aggregate percentage
increase or decrease in Medicare
program payment to ASCs for each
surgical specialty group that is
attributable to changes in the ASC
payment rates for CY 2008 under the 75/
25 blend of the CY 2007 ASC payment
rate and the revised ASC payment rate.
• Column 4—Estimated CY 2008
Percent Change without Transition
(Fully Implemented) is the aggregate
percentage increase or decrease in
Medicare program payment to ASCs for
each surgical specialty group that is
attributable to changes in the ASC
payment rates for CY 2008 if there were
no transition period to the revised
payment rates. The percentages
appearing in column 4 are presented as
a comparison for the transition policy in
column 3 and do not depict the impact
of the fully implemented proposal in CY
2011.
Table 11 reflects the changes for ASCs
at the surgical specialty level and shows
that for all but gastrointestinal
procedures, if an ASC offers the same
mix of services in CY 2008 that is
reflected in our national CY 2005 claims
data, Medicare payments to the ASC for
services in that surgical specialty area
would be estimated to increase under
the revised payment system. If the
revised payment system were fully
implemented in CY 2008, we would
expect all but gastrointestinal
procedures and nervous system
procedures to receive greater Medicare
payment. In addition to the impacts on
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
Medicare payments for current ASC
procedures shown in Table 11, it is
important to note that overall CY 2008
payments to ASCs are estimated to
increase by about $270 million as a
result of the revised payment system.
This increased spending in ASCs is
projected to be fully offset by savings
42541
from reduced spending in HOPDs and
physicians’ offices due to service
migration.
TABLE 11.—ESTIMATED CY 2008 IMPACT OF THE REVISED ASC PAYMENT SYSTEM ON ESTIMATED AGGREGATE CY 2008
MEDICARE PROGRAM PAYMENTS UNDER THE 75/25 TRANSITION BLEND AND WITHOUT A TRANSITION, BY SURGICAL
SPECIALTY GROUP
Surgical specialty group
Estimated
CY 2008
ASC payments
(in millions)
Estimated
CY 2008
percent
change with
transition
(75/25 blend)
Estimated
CY 2008 percent change
without
transition
(fully implemented)
(1)
(2)
(3)
(4)
Eye and ocular adnexa ................................................................................................................
Digestive system ..........................................................................................................................
Nervous system ...........................................................................................................................
Musculoskeletal system ...............................................................................................................
Integumentary system .................................................................................................................
Genitourinary system ...................................................................................................................
Respiratory system ......................................................................................................................
Cardiovascular system ................................................................................................................
Auditory system ...........................................................................................................................
Hemic and lymphatic systems .....................................................................................................
Other systems ..............................................................................................................................
Table 12 below shows the estimated
impact of the revised payment system
on aggregate ASC payments for selected
procedures during the first year of
implementation (CY 2008) with and
without the transitional blended rate.
The table displays 30 of the procedures
receiving the highest estimated CY 2008
ASC payments under the existing
Medicare payment system. The HCPCS
codes are sorted in descending order by
estimated CY 2008 ASC program
payments in the absence of the revised
ASC payment system.
• Column 1—HCPCS code.
• Column 2—Short Descriptor of the
HCPCS code.
• Column 3—Estimated CY 2008 ASC
Payments in the absence of the revised
payment system were calculated by
$1,365
721
274
167
85
76
23
8
4
2
0.1
multiplying the CY 2007 ASC payment
rate by CY 2008 ASC utilization (which
is based on CY 2005 ASC utilization
multiplied by a factor of 1.305 to take
into account expected volume growth
with volume adjustment, as appropriate,
for the multiple procedure discount).
The resulting amount was then
multiplied by 0.8 to estimate the
Medicare program’s share of the total
payments to the ASC. The payment
amounts are expressed in millions of
dollars.
• Column 4—CY 2008 Percent
Change with Transition (75/25 Blend)
reflects the percent differences between
the estimated ASC payment rates for CY
2008 under the current system and the
estimated payment rates for CY 2008
1
¥4
2
24
4
10
16
25
30
28
19
5
¥15
¥5
97
15
38
65
95
85
110
75
under the revised system, incorporating
a 75/25 blend of the estimated ASC
payment using the CY 2007 ASC
payment rate and the revised ASC
payment rate.
• Column 5—CY 2008 Percent
Change without Transition (Fully
Implemented) reflects the percent
differences between the estimated ASC
payment rates for CY 2008 under the
current system and the estimated
payment rates for CY 2008 under the
revised payment system if there were no
transition period to the revised payment
rates. The percentages appearing in
column 5 are presented as a comparison
for the transition policy in column 4
and do not depict the impact of the fully
implemented proposal in CY 2011.
TABLE 12.—ESTIMATED CY 2008 IMPACT OF REVISED ASC PAYMENT SYSTEM ON AGGREGATE PAYMENTS FOR
PROCEDURES WITH THE HIGHEST ESTIMATED CY 2008 PAYMENTS UNDER THE CURRENT SYSTEM
(1)
mstockstill on PROD1PC66 with RULES2
Short descriptor
(2)
(3)
66984
45378
43239
45380
66821
45385
62311
45384
.......
.......
.......
.......
.......
.......
.......
.......
VerDate Aug<31>2005
Cataract surg w/iol, 1 stage ..................................................................................
Diagnostic colonoscopy .........................................................................................
Upper GI endoscopy, biopsy .................................................................................
Colonoscopy and biopsy .......................................................................................
After cataract laser surgery ...................................................................................
Lesion removal colonoscopy .................................................................................
Inject spine l/s (cd) ................................................................................................
Lesion remove colonoscopy ..................................................................................
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00073
Fmt 4701
Sfmt 4700
$1,112
153
148
114
102
96
81
44
E:\FR\FM\02AUR2.SGM
02AUR2
Estimated
CY 2008
percent
change
(75/25 blend)
Estimated
CY 2008 percent changes
without
transition
(fully implemented)
(4)
HCPCS
code
Estimated
CY 2008
ASC payments
(in millions)
(5)
1
¥4
¥5
¥4
¥8
¥4
¥5
¥4
3
¥16
¥21
¥16
¥31
¥16
¥19
¥16
42542
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
TABLE 12.—ESTIMATED CY 2008 IMPACT OF REVISED ASC PAYMENT SYSTEM ON AGGREGATE PAYMENTS FOR
PROCEDURES WITH THE HIGHEST ESTIMATED CY 2008 PAYMENTS UNDER THE CURRENT SYSTEM—Continued
(1)
(2)
(3)
64483 .......
G0121 ......
15823 .......
66982 .......
64476 .......
G0105 ......
43235 .......
52000 .......
64475 .......
67904 .......
64721 .......
29881 .......
43248 .......
62310 .......
29880 .......
64484 .......
28285 .......
67038 .......
29848 .......
64623 .......
45383 .......
26055 .......
mstockstill on PROD1PC66 with RULES2
Short descriptor
Inj foramen epidural l/s ..........................................................................................
Colon ca scrn not hi rsk ind ..................................................................................
Revision of upper eyelid ........................................................................................
Cataract surgery, complex ....................................................................................
Inj paravertebral l/s add-on ...................................................................................
Colorectal scrn; hi risk ind .....................................................................................
Uppr gi endoscopy, diagnosis ...............................................................................
Cystoscopy ............................................................................................................
Inj paravertebral l/s ................................................................................................
Repair eyelid defect ..............................................................................................
Carpal tunnel surgery ............................................................................................
Knee arthroscopy/surgery .....................................................................................
Uppr gi endoscopy/guide wire ...............................................................................
Inject spine c/t .......................................................................................................
Knee arthroscopy/surgery .....................................................................................
Inj foramen epidural add-on ..................................................................................
Repair of hammertoe ............................................................................................
Strip retinal membrane ..........................................................................................
Wrist endoscopy/surgery .......................................................................................
Destr paravertebral n add-on ................................................................................
Lesion removal colonoscopy .................................................................................
Incise finger tendon sheath ...................................................................................
Over time, we believe that the current
ASC payment system has served as an
incentive to ASCs to focus on providing
procedures for which they determine
Medicare payments are adequate to
support the ASC’s continued operation.
We would expect that, under the
existing payment system, the ASC
payment rates for many of the most
frequently performed procedures in
ASCs are similar to the OPPS payment
rates for the same procedures.
Conversely, we would expect that
procedures with existing ASC payment
rates that are substantially lower than
the OPPS rates would be performed less
often in ASCs. We believe the revised
ASC payment system represents a major
stride towards encouraging greater
efficiency in ASCs and promoting a
significant increase in the breadth of
surgical procedures performed in ASCs,
because it more appropriately
distributes payments across the entire
spectrum of covered surgical
procedures, based on a coherent system
of relative payment weights that are
related to the clinical and facility
resource characteristics of those
procedures.
Table 12 identifies a number of ASC
procedures receiving the highest
estimated CY 2008 payments under the
current system and shows that most of
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
them will experience payment decreases
in CY 2008 under the revised ASC
payment system. This contrasts with the
estimated aggregate payment increases
at the surgical specialty group level
displayed in Table 11. In fact, Table 11
shows only one surgical specialty group
of procedures for which the payments
are expected to see a small decrease in
the first year under the revised ASC
payment system, and only two groups
for which a decrease would be expected
if there were no transition period to the
revised payment rates. The increased
payments at the full group level are due
to the moderating effect of the payment
increases for the less frequently
performed procedures within the
surgical specialty group. The exception
to this is the surgical specialty group of
eye and ocular adnexa where the
aggregate increase in CY 2008 is driven
by a small increase in payment for the
highest volume procedure (CPT code
66984, Extracapsular cataract removal
with insertion of intraocular lens
prosthesis (one stage procedures),
manual or mechanical technique (e.g.,
irrigation and aspiration or
phacoemulsification)).
As a result of the redistribution of
payments across the expanded breadth
of surgical procedures for which
Medicare will provide an ASC payment,
PO 00000
Frm 00074
Fmt 4701
Sfmt 4700
44
37
35
33
29
27
25
24
24
22
17
16
15
14
11
11
10
10
9
9
9
9
Estimated
CY 2008
percent
change
(75/25 blend)
Estimated
CY 2008 percent changes
without
transition
(fully implemented)
(4)
HCPCS
code
Estimated
CY 2008
ASC payments
(in millions)
(5)
¥5
¥6
¥4
1
¥7
¥6
2
¥4
¥5
4
18
23
¥5
¥5
23
¥5
18
31
¥2
¥5
¥4
14
¥19
¥25
¥17
3
¥27
¥25
6
¥17
¥19
16
70
93
¥21
¥19
93
¥19
70
122
¥9
¥19
¥16
54
we believe that ASCs may change the
mix of services they provide over the
next several years. The revised ASC
payment system should encourage ASCs
to expand their service mix beyond the
handful of the highest paying
procedures which comprise the majority
of ASC utilization under the existing
ASC payment system. For example,
although cystoscopy (CPT code 52000),
the highest volume ASC genitourinary
procedure, is expected to experience a
4 percent payment rate decrease in CY
2008, overall payment to ASCs for the
group of genitourinary procedures
currently performed in ASCs is
expected to increase by 10 percent.
Although a urology specialty ASC may
currently perform far more cystoscopy
procedures than any other genitourinary
procedure, we believe that under the
revised ASC payment system, the ASC
has the opportunity to adapt to the
payment decrease for its most frequently
performed procedures by offering an
increased breadth of procedures, still
within the clinical specialty area, and
receive payments that are adequate to
support continued operations.
Similarly, payments for all of the
highest volume pain management
injection procedures are expected to
decrease in CY 2008, although payments
for nervous system procedures overall
E:\FR\FM\02AUR2.SGM
02AUR2
mstockstill on PROD1PC66 with RULES2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
are expected to increase. However, if
there were no transition for CY 2008,
payments would also decrease slightly
for the nervous system surgical specialty
group.
For those procedures that will be paid
a significantly lower amount under the
revised payment system than they are
currently paid, we believe that their
current payment rates, which are closer
to the OPPS payment rates than other
ASC procedures, are likely to be
generous relative to ASC costs, so ASCs
would in all likelihood continue
performing those procedures under the
revised payment system. We also note
that the majority of the most frequently
performed ASC procedures specifically
studied by the GAO, as described in the
section II.B. of this final rule for the
revised ASC payment system, appear in
Table 12 with estimated payment
decreases under the revised ASC
payment system. The GAO concluded
that, for these procedures, the OPPS
APC groups accurately reflect the
relative costs of procedures performed
at ASCs and that ASCs have
substantially lower costs.
Generally, the payment changes for
individual surgical procedures are
relatively small in the first year under
the transition to the revised payment
system. As displayed in Table 12, a 1
percent increase in payment for the
most common cataract surgery, CPT
code 66984, is expected and mirrors the
effect of the revised payment system on
payment for the eye and ocular adnexa
surgical specialty group (Table 11), even
though payment for another relatively
high volume eye procedure, CPT code
66821 (Discission of secondary
membranous cataract (opacified
posterior lens capsule and/or anterior
hyaloid); laser surgery (e.g., YAG laser)
(one or more stages)), is expected to
decrease by 8 percent.
For some procedures the estimated
payment amounts in CY 2008 under the
revised ASC payment system are much
higher than the CY 2007 rates currently
paid to ASCs. For example, payment for
CPT code 67038 (Vitrectomy,
mechanical, pars plana approach; with
epiretinal membrane stripping)
increases by 31 percent compared to
estimated CY 2008 payments under the
current system. Similarly, the estimated
CY 2008 ASC payment for CPT code
29880 (Arthroscopy, knee, surgical; with
meniscetomy (medial and lateral,
including any meniscal shaving))
increases by 23 percent. For these two
procedures and the other procedures
with estimated payment increases
greater than 10 percent, the increases
are due to the comparatively higher
OPPS rates which, when adjusted by the
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
ASC budget neutrality factor and
blended with the CY 2007 ASC payment
amounts, generate CY 2008 ASC
payment rates that are substantially
above the current CY 2007 ASC
payment rates.
We estimate that payments for most of
the highest volume colonoscopy and
upper gastrointestinal endoscopy
procedures will decrease under the
revised payment system. In fact,
payment decreases also are expected for
the gastrointestinal surgical specialty
group overall. We believe that decreased
payments for so many of the
gastrointestinal procedures are because
current ASC payment rates are close to
the OPPS rates. Procedures with current
payment rates that are nearly as high as
their OPPS rates are affected more
negatively under the revised payment
system than procedures for which ASC
rates have historically been much lower
than the comparable OPPS rates. The
payment decreases expected in the first
year under the revised ASC payment
system for some of the high volume
gastrointestinal procedures are not large
(all less than 7 percent). We believe that
ASCs can generally continue to cover
their costs for these procedures, and that
ASCs specializing in providing those
services will be able to adapt their
business practices and case-mix to
manage declines for individual
procedures.
In CY 2008, we also are adding
hundreds of surgical procedures to the
already extensive list of procedures for
which Medicare allows payment to
ASCs, creating new opportunities for
ASCs to expand their range of covered
surgical procedures. For the first time,
ASCs will be paid separately for covered
ancillary services that are integral to
covered surgical procedures, including
certain radiology procedures, costly
drugs and biologicals, devices with
pass-through status under the OPPS,
and brachytherapy sources. While
separately paid radiology services will
be paid based on their ASC relative
payment weight calculated according to
the standard ratesetting methodology of
the revised ASC payment system or to
the MPFS nonfacility practice expense
amount, whichever is lower, the other
items newly eligible for separate
payment in ASCs will be paid
comparably to their OPPS rates because
we would not expect ASCs to
experience efficiencies in providing
them. Lastly, this final rule establishes
a specific payment methodology for
device-intensive procedures that
provides the same packaged payment
for the device as under the OPPS, while
providing a reduced service payment
that is subject to the 4-year transition if
PO 00000
Frm 00075
Fmt 4701
Sfmt 4700
42543
the device-intensive procedure is on the
CY 2007 ASC list of covered surgical
procedures. This final methodology
should allow ASCs to continue to
expand their provision of deviceintensive services and to begin
performing new device-intensive ASC
procedures.
4. Estimated Effects of This Final Rule
on Beneficiaries
We estimate that the changes for CY
2008 will be positive for beneficiaries in
at least two respects. Except for
screening colonoscopy and flexible
sigmoidoscopy procedures, the ASC
coinsurance rate for all procedures is 20
percent. This contrasts with procedures
performed in HOPDs where the
beneficiary is responsible for
copayments that range from 20 percent
to 40 percent. In addition, ASC payment
rates under the revised payment system
are lower than payment rates for the
same procedures under the OPPS, so the
beneficiary coinsurance amount under
the ASC payment system almost always
will be less than the OPPS copayment
amount for the same services. (The only
exceptions will be when the ASC
coinsurance amount exceeds the
inpatient deductible. The statute
requires that copayment amounts under
the OPPS not exceed the inpatient
deductible.) Beneficiary coinsurance for
services migrating from physicians’
offices to ASCs may decrease or increase
under the revised ASC payment system,
depending on the particular service and
the relative payment amounts for that
service in the physician’s office
compared with the ASC. As noted
previously, the net effect of the revised
ASC payment system on beneficiary
coinsurance, taking into account the
migration of services from HOPDs and
physicians’ offices, is estimated to be
$20 million in beneficiary savings in CY
2008.
In addition to the lower out-of-pocket
expenses, we believe that beneficiaries
also will have access to more services in
ASCs as a result of the addition of 793
surgical procedures to the ASC list of
covered surgical services eligible for
Medicare payment. We expect that
ASCs will provide a broader range of
surgical services under the revised
payment system and that beneficiaries
will benefit from having access to a
greater variety of surgical procedures in
ASCs.
5. Conclusion
The changes to the ASC payment
system for CY 2008 will affect each of
the more than 4,600 ASCs currently
approved for participation in the
Medicare program. The effect on an
E:\FR\FM\02AUR2.SGM
02AUR2
42544
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
individual ASC will depend on the
ASC’s mix of patients, the proportion of
the ASC’s patients that are Medicare
beneficiaries, the degree to which the
payments for the procedures offered by
the ASC are changed under the revised
payment system, and the degree to
which the ASC chooses to provide a
different set of procedures. The revised
ASC payment system is designed to
result in the same aggregate amount of
Medicare expenditures in CY 2008 that
would be made in the absence of the
revised ASC payment system. As
mentioned previously, we estimate that
the revised ASC payment system and
the expanded ASC list of covered
surgical procedures that we are
implementing in CY 2008 will have no
net effect on Medicare expenditures
compared to the level of Medicare
expenditures that would have occurred
in CY 2008 in the absence of the revised
payment system. However, there will be
a total increase in Medicare payments to
ASCs for CY 2008 of approximately
$270 million as a result of the revised
ASC payment system, which will be
fully offset by savings from reduced
Medicare spending in HOPDs and
physicians’ offices on services that
migrate from these settings to ASCs (as
discussed in detail in section V.C. of
this final rule). Furthermore, we
estimate that the revised ASC payment
system will result in Medicare savings
of $240 million over 5 years due to
migration of new ASC services from
HOPDs and physicians’ offices to ASCs
over time. We anticipate that this final
rule will have a significant economic
impact on a substantial number of small
entities.
6. Accounting Statement
As required by OMB Circular A–4
(available at https://www.whitehousegov/
omb/circulars/a004/a-4.pdf), in Table
13 below, we have prepared an
accounting statement showing the
classification of the expenditures
associated with the implementation of
the CY 2008 revised ASC payment
system, based on the provisions of this
final rule. As explained above, we
estimate that Medicare payments to
ASCs in CY 2008 will be about $270
million higher than they would
otherwise be in the absence of the
revised ASC payment system. This $270
million in additional payments to ASCs
in CY 2008 will be fully offset by
savings from reduced spending in
HOPDs and physicians’ offices on
services that migrate from these settings
to ASCs. This table provides our best
estimate of Medicare payments to
providers and suppliers as a result of
the CY 2008 revised ASC payment
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
system, as presented in this final rule.
All expenditures are classified as
transfers.
section, Medicare Part B pays the lesser
of 80 percent of the actual charge or 80
percent of the prospective payment
amount, geographically adjusted, if
TABLE 13.—ACCOUNTING STATEMENT: applicable, as determined under
CLASSIFICATION OF ESTIMATED EX- Subpart F of Part 416 of this subchapter.
PENDITURES FROM CY 2007 TO CY Part B coinsurance is 20 percent of the
2008 AS A RESULT OF THE CY 2008 actual charge or 20 percent of the
prospective payment amount,
REVISED ASC PAYMENT SYSTEM
geographically adjusted, if applicable.
(i) If the limitation described in
Category
Transfers
§ 416.167(b)(3) of this subchapter
applies, Medicare pays 80 percent of the
Annualized Monetized $0 Million.
amount determined under Subpart B of
Transfers.
From Whom to Whom Federal Government
Part 414 of this subchapter and Part B
to Medicare Procoinsurance is 20 percent of the
viders and Supapplicable payment amount.
pliers.
(ii) Medicare Part B pays 75 percent
Annualized Monetized $0 Million.
of the applicable payment amount for
Transfer.
screening flexible sigmoidoscopies and
From Whom to Whom Premium Payments
screening colonoscopies, and Part B
from Beneficiaries
coinsurance is 25 percent of the
to Federal Governapplicable payment amount.
ment.
*
*
*
*
*
Total ...................
$0 Million.
C. Executive Order 12866
In accordance with the provisions of
Executive Order 12866, this final rule
was reviewed by the OMB.
List of Subjects
42 CFR Part 410
Health facilities, Health professions,
Laboratories, Medicare, Rural areas, Xrays.
42 CFR Part 416
Health facilities, Kidney diseases,
Medicare, Reporting and recordkeeping
requirements.
I For reasons stated in the preamble of
this final rule, the Centers for Medicare
& Medicaid Services is amending 42
CFR Chapter IV as set forth below:
PART 410—SUPPLEMENTARY
MEDICAL INSURANCE (SMI)
BENEFITS
1. The authority citation for part 410
continues to read as follows:
I
Authority: Secs. 1102 and 1871 of the
Social Security Act (42 U.S.C. 1302 and
1395hh).
2. Section 410.152 is amended by
adding a new paragraph (i)(2) to read as
follows:
I
§ 410.152
Amounts of payment.
*
*
*
*
*
(i) * * *
(2) For ASC services furnished on or
after January 1, 2008, in connection
with the covered surgical procedures
specified in § 416.166 of this
subchapter, except as provided in
paragraphs (i)(2)(i) and (i)(2)(ii) of this
PO 00000
Frm 00076
Fmt 4701
Sfmt 4700
PART 416—AMBULATORY SURGICAL
SERVICES
3. The authority citation for part 416
continues to read as follows:
I
Authority: Secs. 1102 and 1871 of the
Social Security Act (42 U.S.C. 1302 and
1395hh).
4. Section 416.2 is amended by—
a. Revising the definition of ‘‘ASC
services.’’
I b. Adding a definition of ‘‘Covered
ancillary services’’ in alphabetical order.
I c. Revising the definition of ‘‘Covered
surgical procedures.’’
I d. Revising the definition of ‘‘Facility
services.’’
The revisions and addition read as
follows:
I
I
§ 416.2
Definitions.
*
*
*
*
*
ASC services means, for the period
before January 1, 2008, facility services
that are furnished in an ASC, and
beginning January 1, 2008, means the
combined facility services and covered
ancillary services that are furnished in
an ASC in connection with covered
surgical procedures.
Covered ancillary services means
items and services that are integral to a
covered surgical procedure performed
in an ASC as provided in § 416.164(b),
for which payment may be made under
§ 416.171 in addition to the payment for
the facility services.
Covered surgical procedures means
those surgical procedures furnished
before January 1, 2008, that meet the
criteria specified in § 416.65 and those
surgical procedures furnished on or
after January 1, 2008, that meet the
criteria specified in § 416.166.
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
Facility services means for the period
before January 1, 2008, services that are
furnished in connection with covered
surgical procedures performed in an
ASC, and beginning January 1, 2008,
means services that are furnished in
connection with covered surgical
procedures performed in an ASC as
provided in § 416.164(a) for which
payment is included in the ASC
payment established under § 416.171 for
the covered surgical procedure.
I 5. A new Subpart F is added to read
as follows:
Subpart F—Coverage, Scope of ASC
Services, and Prospective Payment System
for ASC Services Furnished on or After
January 1, 2008
Sec.
416.160 Basis and scope
416.161 Applicability of this subpart
416.163 General rules
416.164 Scope of ASC services
416.166 Covered surgical procedures
416.167 Basis of payment
416.171 Determination of payment rates for
ASC services
416.172 Adjustments to national payment
rates
416.173 Publication of revised payment
methodologies and payment rates
416.178 Limitations on administrative and
judicial review
416.179 Payment and coinsurance
reduction for devices replaced without
cost or when full credit is received
Subpart F—Coverage, Scope of ASC
Services, and Prospective Payment
System for ASC Services Furnished on
or After January 1, 2008
mstockstill on PROD1PC66 with RULES2
§ 416.160
Basis and scope.
(a) Statutory basis. (1) Section
1833(i)(2)(D) of the Act requires the
Secretary to implement a revised
payment system for payment of surgical
services furnished in ASCs. The statute
requires that, in the year such system is
implemented, the system shall be
designed to result in the same amount
of aggregate expenditures for such
services as would be made if there was
no requirement for a revised payment
system. The revised payment system
shall be implemented no earlier than
January 1, 2006, and no later than
January 1, 2008. There shall be no
administrative or judicial review under
section 1869 of the Act, section 1878 of
the Act, or otherwise of the
classification system, the relative
weights, payment amounts, and the
geographic adjustment factor, if any, of
the revised payment system.
(2) Section 1833(a)(1)(G) of the Act
provides that, beginning with the
implementation date of a revised
payment system for ASC facility
services furnished in connection with a
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
surgical procedure pursuant to section
1833(i)(1)(A) of the Act, the amount
paid shall be 80 percent of the lesser of
the actual charge for such services or the
amount determined by the Secretary
under the revised payment system.
(3) Section 1833(i)(1)(A) of the Act
requires the Secretary to specify the
surgical procedures that can be
performed safely on an ambulatory basis
in an ASC.
(4) Section 1834(d) of the Act
specifies that, when screening
colonoscopies or screening flexible
sigmoidoscopies are performed in an
ASC or hospital outpatient department,
payment shall be based on the lesser of
the amount under the fee schedule that
would apply to such services if they
were performed in a hospital outpatient
department in an area or the amount
under the fee schedule that would apply
to such services if they were performed
in an ambulatory surgical center in the
same area. Section 1834(d) of the Act
further specifies that the coinsurance for
screening flexible sigmoidoscopy and
screening colonoscopy procedures is 25
percent of the payment amount. Section
1834(d) of the Act also specifies that, in
the case of screening flexible
sigmoidoscopy and screening
colonoscopy services, their payment
amounts must not exceed the payment
rates established for the related
diagnostic services. Section 1833(b)(8)
of the Act specifies that the Part B
deductible shall not apply with respect
to colorectal screening tests as described
in section 1861(pp)(1) of the Act, which
include screening colonoscopies and
screening flexible sigmoidoscopies.
(b) Scope. This subpart sets forth—
(1) The scope of ASC services and the
criteria for determining the covered
surgical procedures for which Medicare
provides payment for the associated
facility services and covered ancillary
services;
(2) The basis of payment for facility
services and for covered ancillary
services furnished in an ASC in
connection with a covered surgical
procedure;
(3) The methodologies by which
Medicare determines payment amounts
for ASC services.
§ 416.161
Applicability of this subpart.
The provisions of this subpart apply
to ASC services furnished on or after
January 1, 2008.
§ 416.163
General rules.
(a) Payment is made under this
subpart for ASC services specified in
§§ 416.164(a) and (b) furnished to
Medicare beneficiaries by a
participating ASC in connection with
PO 00000
Frm 00077
Fmt 4701
Sfmt 4700
42545
covered surgical procedures as
determined by the Secretary in
accordance with § 416.166.
(b) Payment for physicians’ services
and payment for anesthetists’ services
are made in accordance with Part 414 of
this subchapter.
(c) Payment for items and services
other than physicians’ and anesthetists’
services, as specified in § 416.164(c), is
made in accordance with § 410.152 of
this subchapter.
§ 416.164
Scope of ASC services.
(a) Included facility services. ASC
services for which payment is packaged
into the ASC payment for a covered
surgical procedure under § 416.166
include, but are not limited to—
(1) Nursing, technician, and related
services;
(2) Use of the facility where the
surgical procedures are performed;
(3) Any laboratory testing performed
under a Clinical Laboratory
Improvement Amendments of 1988
(CLIA) certificate of waiver;
(4) Drugs and biologicals for which
separate payment is not allowed under
the hospital outpatient prospective
payment system (OPPS);
(5) Medical and surgical supplies not
on pass-through status under Subpart G
of Part 419 of this subchapter;
(6) Equipment;
(7) Surgical dressings;
(8) Implanted prosthetic devices,
including intraocular lenses (IOLs), and
related accessories and supplies not on
pass-through status under Subpart G of
Part 419 of this subchapter;
(9) Implanted DME and related
accessories and supplies not on passthrough status under Subpart G of Part
419 of this subchapter;
(10) Splints and casts and related
devices;
(11) Radiology services for which
separate payment is not allowed under
the OPPS, and other diagnostic tests or
interpretive services that are integral to
a surgical procedure;
(12) Administrative, recordkeeping
and housekeeping items and services;
(13) Materials, including supplies and
equipment for the administration and
monitoring of anesthesia; and
(14) Supervision of the services of an
anesthetist by the operating surgeon.
(b) Covered ancillary services.
Ancillary items and services that are
integral to a covered surgical procedure,
as defined in § 416.166, and for which
separate payment is allowed include:
(1) Brachytherapy sources;
(2) Certain implantable items that
have pass-through status under the
OPPS;
(3) Certain items and services that
CMS designates as contractor-priced,
E:\FR\FM\02AUR2.SGM
02AUR2
42546
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
including, but not limited to, the
procurement of corneal tissue;
(4) Certain drugs and biologicals for
which separate payment is allowed
under the OPPS;
(5) Certain radiology services for
which separate payment is allowed
under the OPPS.
(c) Excluded services. ASC services do
not include items and services outside
the scope of ASC services for which
payment may be made under Part 414
of this subchapter in accordance with
§ 410.152, including, but not limited
to—
(1) Physicians’ services (including
surgical procedures and all preoperative
and postoperative services that are
performed by a physician);
(2) Anesthetists’ services;
(3) Radiology services (other than
those integral to performance of a
covered surgical procedure);
(4) Diagnostic procedures (other than
those directly related to performance of
a covered surgical procedure);
(5) Ambulance services;
(6) Leg, arm, back, and neck braces
other than those that serve the function
of a cast or splint;
(7) Artificial limbs;
(8) Nonimplantable prosthetic devices
and DME.
mstockstill on PROD1PC66 with RULES2
§ 416.166
Covered surgical procedures.
(a) Covered surgical procedures.
Effective for services furnished on or
after January 1, 2008, covered surgical
procedures are those procedures that
meet the general standards described in
paragraph (b) of this section (whether
commonly furnished in an ASC or a
physician’s office) and are not excluded
under paragraph (c) of this section.
(b) General standards. Subject to the
exclusions in paragraph (c) of this
section, covered surgical procedures are
surgical procedures specified by the
Secretary and published in the Federal
Register that are separately paid under
the OPPS, that would not be expected
to pose a significant safety risk to a
Medicare beneficiary when performed
in an ASC, and for which standard
medical practice dictates that the
beneficiary would not typically be
expected to require active medical
monitoring and care at midnight
following the procedure.
(c) General exclusions.
Notwithstanding paragraph (b) of this
section, covered surgical procedures do
not include those surgical procedures
that—
(1) Generally result in extensive blood
loss;
(2) Require major or prolonged
invasion of body cavities;
(3) Directly involve major blood
vessels;
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
(4) Are generally emergent or lifethreatening in nature;
(5) Commonly require systemic
thrombolytic therapy;
(6) Are designated as requiring
inpatient care under § 419.22(n) of this
subchapter;
(7) Can only be reported using a CPT
unlisted surgical procedure code; or
(8) Are otherwise excluded under
§ 411.15 of this subchapter.
§ 416.167
Basis of payment.
(a) Unit of payment. Under the ASC
payment system, prospectively
determined amounts are paid for ASC
services furnished to Medicare
beneficiaries in connection with
covered surgical procedures. Covered
surgical procedures and covered
ancillary services are identified by
codes established under the Healthcare
Common Procedure Coding System
(HCPCS). The unadjusted national
payment rate is determined according to
the methodology described in § 416.171.
The manner in which the Medicare
payment amount and the beneficiary
coinsurance amount for each ASC
service is determined is described in
§ 416.172.
(b) Ambulatory payment classification
(APC) groups and payment weights.
(1) ASC covered surgical procedures
are classified using the APC groups
described in § 419.31 of this subchapter.
(2) For purposes of calculating ASC
national payment rates under the
methodology described in § 416.171,
except as specified in paragraph (b)(3) of
this section, an ASC relative payment
weight is determined based on the APC
relative payment weight for each
covered surgical procedure and covered
ancillary service that has an applicable
APC relative payment weight described
in § 419.31 of this subchapter.
(3) Notwithstanding paragraph (b)(2)
of this section, the relative payment
weights for services paid in accordance
with § 416.171(d) are determined so that
the national ASC payment rate does not
exceed the unadjusted nonfacility
practice expense amount paid under the
Medicare physician fee schedule for
such procedures under Subpart B of Part
414 of this subchapter.
§ 416.171 Determination of payment rates
for ASC services.
(a) Standard methodology. The
standard methodology for determining
the national unadjusted payment rate
for ASC services is to calculate the
product of the applicable conversion
factor and the relative payment weight
established under § 416.167(b), unless
otherwise indicated in this section.
(1) Conversion factor for CY 2008.
CMS calculates a conversion factor so
PO 00000
Frm 00078
Fmt 4701
Sfmt 4700
that payment for ASC services furnished
in CY 2008 would result in the same
aggregate amount of expenditures as
would be made if the provisions in this
Subpart F did not apply, as estimated by
CMS.
(2) Conversion factor for CY 2009 and
subsequent calendar years. The
conversion factor for a calendar year is
equal to the conversion factor calculated
for the previous year, updated as
follows:
(i) For CY 2009, the update is equal
to zero percent.
(ii) For CY 2010 and subsequent
calendar years, the update is the
Consumer Price Index for All Urban
Consumers (U.S. city average) as
estimated by the Secretary for the 12month period ending with the midpoint
of the year involved.
(b) Exception. The national ASC
payment rates for the following items
and services are not determined in
accordance with paragraph (a) of this
section but are paid an amount derived
from the payment rate for the equivalent
item or service set under the payment
system established in Part 419 of this
subchapter as updated annually in the
Federal Register. If a payment rate is
not available, the following items and
services are designated as contractorpriced:
(1) Covered ancillary services
specified in § 416.164(b), with the
exception of radiology services as
provided in § 416.164(b)(5);
(2) Device-intensive procedures
assigned to device-dependent APCs
under the OPPS with device costs
greater than 50 percent of the APC cost;
(3) Procedures using certain
separately paid implantable devices that
are approved for transitional passthrough payment in accordance with
§ 419.66 of this subchapter.
(c) Transitional payment rates. (1)
ASC payment rates for CY 2008 are a
transitional blend of 75 percent of the
CY 2007 ASC payment rate for a
covered surgical procedure on the CY
2007 ASC list of surgical procedures
and 25 percent of the payment rate for
the procedure calculated under the
methodology described in paragraph (a)
of this section.
(2) ASC payment rates for CY 2009 are
a transitional blend of 50 percent of the
CY 2007 ASC payment rate for a
covered surgical procedure on the CY
2007 ASC list of surgical procedures
and 50 percent of the payment rate for
the procedure calculated under the
methodology described in paragraph (a)
of this section.
(3) ASC payment rates for CY 2010 are
a transitional blend of 25 percent of the
CY 2007 ASC payment rate for a
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
covered surgical procedure on the CY
2007 ASC list of surgical procedures
and 75 percent of the payment rate for
the procedure calculated under the
methodology described in paragraph (a)
of this section.
(4) The national ASC payment rate for
CY 2011 and subsequent calendar years
for a covered surgical procedure
designated in accordance with § 416.166
is the payment rates for the procedure
calculated under the methodology
described in paragraph (a) of this
section.
(5) Covered ancillary services
described in § 416.164(b) and surgical
procedures identified as covered when
performed in an ASC under § 416.166
for the first time beginning on or after
January 1, 2008, are not subject to the
transitional payment rates applicable in
CYs 2008 through 2010 for ASC facility
services.
(d) Limitation on payment rates for
office-based surgical procedures and
covered ancillary radiology services.
Notwithstanding the provisions of
paragraph (a) of this section, for any
covered surgical procedure under
§ 416.166 that CMS determines is
commonly performed in physicians’
offices or for any covered ancillary
radiology service, the national
unadjusted ASC payment rates for these
procedures and services will be the
lesser of the amount determined under
paragraph (a) of this section or the
amount calculated at the nonfacility
practice expense relative value units
under § 414.22(b)(5)(i)(B) of this
subchapter multiplied by the conversion
factor described in § 414.20(a)(3) of this
subchapter.
(e) Budget neutrality. (1) For CY 2008,
CMS establishes the conversion factor to
result in budget neutrality as estimated
by CMS in accordance with paragraph
(a)(1) of this section.
(2) For CY 2009 and subsequent
calendar years, CMS adjusts the ASC
relative payment weights under
§ 416.167(b)(2) as needed so that any
updates and adjustments made under
§ 419.50(a) of this subchapter are budget
neutral as estimated by CMS.
mstockstill on PROD1PC66 with RULES2
§ 416.172 Adjustments to national
payment rates.
(a) General rule. Contractors adjust
the payment rates established for ASC
services to determine Medicare program
payment and beneficiary coinsurance
amounts in accordance with paragraphs
(b) through (g) of this section.
(b) Lesser of actual charge or
geographically adjusted payment rate.
Payments to ASCs equal 80 percent of
the lesser of—
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
(1) The actual charge for the service;
or
(2) The geographically adjusted
payment rate determined under this
subpart.
(c) Geographic adjustment.—(1)
General rule. Except as provided in
paragraph (c)(2) of this section, the
national ASC payment rates established
under § 416.171 for covered surgical
procedures are adjusted for variations in
ASC labor costs across geographic areas
using wage index values, labor and
nonlabor percentages, and localities
specified by the Secretary.
(2) Exception. The geographic
adjustment is not applied to the
payment rates set for drugs, biologicals,
devices with OPPS transitional passthrough payment status, and
brachytherapy sources.
(d) Deductibles and coinsurance. Part
B deductible and coinsurance amounts
apply as specified in §§ 410.152(a) and
(i)(2) of this subchapter.
(e) Payment reductions for multiple
surgical procedures.—(1) General rule.
Except as provided in paragraph (e)(2)
of this section, when more than one
covered surgical procedure for which
payment is made under the ASC
payment system is performed during an
operative session, the Medicare program
payment amount and the beneficiary
coinsurance amount are based on—
(i) 100 percent of the applicable ASC
payment amount for the procedure with
the highest national unadjusted ASC
payment rate; and
(ii) 50 percent of the applicable ASC
payment amount for all other covered
surgical procedures.
(2) Exception: Procedures not subject
to multiple procedure discounting. CMS
may apply any policies or procedures
used with respect to multiple
procedures under the prospective
payment system for hospital outpatient
department services under Part 419 of
this subchapter as may be consistent
with the equitable and efficient
administration of this part.
(f) Interrupted procedures. When a
covered surgical procedure or covered
ancillary service is terminated prior to
completion due to extenuating
circumstances or circumstances that
threaten the well-being of the patient,
the Medicare program payment amount
and the beneficiary coinsurance amount
are based on one of the following—
(1) The full program and beneficiary
coinsurance amounts if the procedure
for which anesthesia is planned is
discontinued after the induction of
anesthesia or after the procedure is
started;
(2) One-half of the full program and
beneficiary coinsurance amounts if the
PO 00000
Frm 00079
Fmt 4701
Sfmt 4700
42547
procedure for which anesthesia is
planned is discontinued after the
patient is prepared for surgery and taken
to the room where the procedure is to
be performed but before the anesthesia
is induced; or
(3) One-half of the full program and
beneficiary coinsurance amounts if a
covered surgical procedure or covered
ancillary service for which anesthesia is
not planned is discontinued after the
patient is prepared and taken to the
room where the service is to be
provided.
(g) Payment adjustment for new
technology intraocular lenses (NTIOLs).
A payment adjustment will be made for
insertion of an IOL approved as
belonging to a class of NTIOLs as
defined in Subpart G.
§ 416.173 Publication of revised payment
methodologies and payment rates.
CMS publishes annually, through
notice and comment rulemaking in the
Federal Register, the payment
methodologies and payment rates for
ASC services and designates the covered
surgical procedures and covered
ancillary services for which CMS will
make an ASC payment and other
revisions as appropriate.
§ 416.178 Limitations on administrative
and judicial review.
There is no administrative or judicial
review under section 1869 of the Act,
section 1878 of the Act, or otherwise of
the following:
(a) The classification system;
(b) Relative weights;
(c) Payment amounts; and
(d) Geographic adjustment factors.
§ 416.179 Payment and coinsurance
reduction for devices replaced without cost
or when full credit is received.
(a) General rule. CMS reduces the
amount of payment for a covered
surgical procedure for which CMS
determines that a significant portion of
the payment is attributable to the cost of
an implanted device not on passthrough status under Subpart G of Part
419 of this subchapter when one of the
following situations occur:
(1) The device is replaced without
cost to the ASC or the beneficiary; or
(2) The ASC receives full credit for
the cost of a replaced device.
(b) Amount of reduction to the ASC
payment for the covered surgical
procedure. The amount of the reduction
to the ASC payment made under
paragraph (a) of this section is
calculated in the same manner as the
device payment reduction that would be
applied to the ASC payment for the
covered surgical procedure in order to
remove predecessor device costs so that
E:\FR\FM\02AUR2.SGM
02AUR2
42548
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
mstockstill on PROD1PC66 with RULES2
the ASC payment amount for a device
with pass-through status under § 419.66
of this subchapter represents the full
cost of the device, and no packaged
device payment is provided through the
ASC payment for the covered surgical
procedure.
(c) Amount of beneficiary
coinsurance. The beneficiary
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
coinsurance is calculated based on the
ASC payment for the covered surgical
procedure after application of the
reduction under paragraph (b) of this
section.
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
PO 00000
Frm 00080
Fmt 4701
Sfmt 4700
Medicare—Supplementary Medical
Insurance Program)
Dated: April 24, 2007.
Leslie Norwalk,
Acting Administrator, Centers for Medicare
& Medicaid Services.
Dated: May 31, 2007.
Michael O. Leavitt,
Secretary.
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42549
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
Short descriptor
Subject to
multiple
procedure
discounting
0016T .......
0017T .......
0027T .......
0031T .......
0032T .......
0046T .......
0047T .......
0062T .......
0063T .......
0084T .......
0099T * .....
0100T .......
0101T .......
0102T .......
0123T .......
0124T * .....
0133T .......
0176T .......
0177T .......
10021 .......
10022 .......
10040 .......
10060 .......
10061 .......
10080 .......
10081 .......
10120 .......
10121 .......
10140 .......
10160 .......
10180 .......
11000 .......
11001 .......
11010 .......
11011 .......
11012 .......
11040 .......
11041 .......
11042 .......
11043 .......
11044 .......
11055 .......
11056 .......
11057 .......
11100 .......
11101 .......
11200 .......
11201 .......
11300 .......
11301 .......
11302 .......
11303 .......
11305 .......
11306 .......
11307 .......
11308 .......
11310 .......
11311 .......
11312 .......
11313 .......
11400 .......
11401 .......
11402 .......
Thermotx choroids vasc lesion ......................
Photocoagulat macular drusen ......................
Endoscopic epidural lysis ..............................
Speculoscopy .................................................
Speculoscopy w/direct sample ......................
Cath lavage, mammary duct(s) .....................
Cath lavage, mammary duct(s) .....................
Rep intradisc annulus;1 lev ...........................
Rep intradisc annulus;>1lev ..........................
Temp prostate urethral stent .........................
Implant corneal ring .......................................
Prosth retina receive&gen .............................
Extracorp shockwv tx,hi enrg ........................
Extracorp shockwv tx,anesth .........................
Scleral fistulization .........................................
Conjunctival drug placement .........................
Esophageal implant injexn .............................
Aqu canal dilat w/o retent ..............................
Aqu canal dilat w retent .................................
Fna w/o image ...............................................
Fna w/image ..................................................
Acne surgery ..................................................
Drainage of skin abscess ..............................
Drainage of skin abscess ..............................
Drainage of pilonidal cyst ..............................
Drainage of pilonidal cyst ..............................
Remove foreign body ....................................
Remove foreign body ....................................
Drainage of hematoma/fluid ..........................
Puncture drainage of lesion ...........................
Complex drainage, wound .............................
Debride infected skin .....................................
Debride infected skin add-on .........................
Debride skin, fx ..............................................
Debride skin/muscle, fx .................................
Debride skin/muscle/bone, fx ........................
Debride skin, partial .......................................
Debride skin, full ............................................
Debride skin/tissue ........................................
Debride tissue/muscle ...................................
Debride tissue/muscle/bone ..........................
Trim skin lesion ..............................................
Trim skin lesions, 2 to 4 ................................
Trim skin lesions, over 4 ...............................
Biopsy, skin lesion .........................................
Biopsy, skin add-on .......................................
Removal of skin tags .....................................
Remove skin tags add-on ..............................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Shave skin lesion ...........................................
Exc tr-ext b9+marg 0.5 2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00081
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42550
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
11403
11404
11406
11420
11421
11422
11423
11424
11426
11440
11441
11442
11443
11444
11446
11450
11451
11462
11463
11470
11471
11600
11601
11602
11603
11604
11606
11620
11621
11622
11623
11624
11626
11640
11641
11642
11643
11644
11646
11719
11720
11721
11730
11732
11740
11750
11752
11755
11760
11762
11765
11770
11771
11772
11900
11901
11920
11921
11922
11950
11951
11952
11954
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Exc tr-ext b9+marg 2.1–3 cm ........................
Exc tr-ext b9+marg 3.1–4 cm ........................
Exc tr-ext b9+marg > 4.0 cm .........................
Exc h-f-nk-sp b9+marg 0.5< ..........................
Exc h-f-nk-sp b9+marg 0.6–1 ........................
Exc h-f-nk-sp b9+marg 1.1–2 ........................
Exc h-f-nk-sp b9+marg 2.1–3 ........................
Exc h-f-nk-sp b9+marg 3.1–4 ........................
Exc h-f-nk-sp b9+marg > 4 cm ......................
Exc face-mm b9+marg 0.5 < cm ...................
Exc face-mm b9+marg 0.6–1 cm ..................
Exc face-mm b9+marg 1.1–2 cm ..................
Exc face-mm b9+marg 2.1-3 cm ...................
Exc face-mm b9+marg 3.1–4 cm ..................
Exc face-mm b9+marg > 4 cm ......................
Removal, sweat gland lesion .........................
Removal, sweat gland lesion .........................
Removal, sweat gland lesion .........................
Removal, sweat gland lesion .........................
Removal, sweat gland lesion .........................
Removal, sweat gland lesion .........................
Exc tr-ext mlg+marg 0.5 < cm .......................
Exc tr-ext mlg+marg 0.6–1 cm ......................
Exc tr-ext mlg+marg 1.1-2 cm .......................
Exc tr-ext mlg+marg 2.1–3 cm ......................
Exc tr-ext mlg+marg 3.1–4 cm ......................
Exc tr-ext mlg+marg > 4 cm ..........................
Exc h-f-nk-sp mlg+marg 0.5 ..........................
Exc h-f-nk-sp mlg+marg 0.6–1 ......................
Exc h-f-nk-sp mlg+marg 1.1–2 ......................
Exc h-f-nk-sp mlg+marg 2.1–3 ......................
Exc h-f-nk-sp mlg+marg 3.1–4 ......................
Exc h-f-nk-sp mlg+mar > 4 cm ......................
Exc face-mm malig+marg 0.5< .....................
Exc face-mm malig+marg 0.6–1 ...................
Exc face-mm malig+marg 1.1–2 ...................
Exc face-mm malig+marg 2.1–3 ...................
Exc face-mm malig+marg 3.1–4 ...................
Exc face-mm mlg+marg > 4 cm ....................
Trim nail(s) .....................................................
Debride nail, 1–5 ...........................................
Debride nail, 6 or more ..................................
Removal of nail plate .....................................
Remove nail plate, add-on ............................
Drain blood from under nail ...........................
Removal of nail bed .......................................
Remove nail bed/finger tip .............................
Biopsy, nail unit .............................................
Repair of nail bed ..........................................
Reconstruction of nail bed .............................
Excision of nail fold, toe ................................
Removal of pilonidal lesion ............................
Removal of pilonidal lesion ............................
Removal of pilonidal lesion ............................
Injection into skin lesions ...............................
Added skin lesions injection ..........................
Correct skin color defects ..............................
Correct skin color defects ..............................
Correct skin color defects ..............................
Therapy for contour defects ..........................
Therapy for contour defects ..........................
Therapy for contour defects ..........................
Therapy for contour defects ..........................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
P3
A2
A2
P3
P3
P3
P3
A2
A2
P3
P3
P3
P3
A2
A2
A2
A2
A2
A2
A2
A2
P3
P3
P3
P3
A2
A2
P3
P3
P3
P3
A2
A2
P3
P3
P3
P3
A2
A2
P3
P3
P3
P3
P3
P3
P3
P3
P3
G2
P2
P2
A2
A2
A2
P3
P3
P2
P2
P3
P3
P3
P3
P2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
....................
$333.00
$446.00
....................
....................
....................
....................
$446.00
$446.00
....................
....................
....................
....................
$333.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
....................
....................
....................
....................
$418.49
$446.00
....................
....................
....................
....................
$446.00
$446.00
....................
....................
....................
....................
$446.00
$446.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$510.00
$510.00
$510.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
1.9876
15.1024
15.1024
1.4484
1.7220
1.8750
2.1085
15.1024
20.0656
1.6898
1.8993
2.0763
2.3256
6.8083
20.0656
20.0656
20.0656
20.0656
20.0656
20.0656
20.0656
2.1646
2.4787
2.6879
2.8729
6.8083
15.1024
2.1888
2.4947
2.7683
3.0017
15.1024
20.0656
2.2934
2.6796
2.9937
3.2511
15.1024
20.0656
0.2494
0.3218
0.4024
0.9576
0.4024
0.5392
2.0763
2.8729
1.4566
1.4843
1.4843
1.6241
20.0656
20.0656
20.0656
0.6358
0.6760
1.4843
1.4843
0.8368
0.8048
1.0784
1.4484
1.4843
Estimated
CY 2008
fully implemented
payment
$84.56
$642.50
$642.50
$61.62
$73.26
$79.77
$89.70
$642.50
$853.65
$71.89
$80.80
$88.33
$98.94
$289.65
$853.65
$853.65
$853.65
$853.65
$853.65
$853.65
$853.65
$92.09
$105.45
$114.35
$122.22
$289.65
$642.50
$93.12
$106.13
$117.77
$127.70
$642.50
$853.65
$97.57
$114.00
$127.36
$138.31
$642.50
$853.65
$10.61
$13.69
$17.12
$40.74
$17.12
$22.94
$88.33
$122.22
$61.97
$63.15
$63.15
$69.09
$853.65
$853.65
$853.65
$27.05
$28.76
$63.15
$63.15
$35.60
$34.24
$45.88
$61.62
$63.15
Estimated
CY 2008
first transition year
payment
$84.56
$410.38
$495.13
$61.62
$73.26
$79.77
$89.70
$495.13
$547.91
$71.89
$80.80
$88.33
$98.94
$322.16
$547.91
$547.91
$547.91
$547.91
$547.91
$547.91
$547.91
$92.09
$105.45
$114.35
$122.22
$386.28
$495.13
$93.12
$106.13
$117.77
$127.70
$495.13
$547.91
$97.57
$114.00
$127.36
$138.31
$495.13
$547.91
$10.61
$13.69
$17.12
$40.74
$17.12
$22.94
$88.33
$122.22
$61.97
$63.15
$63.15
$69.09
$595.91
$595.91
$595.91
$27.05
$28.76
$63.15
$63.15
$35.60
$34.24
$45.88
$61.62
$63.15
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00082
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42551
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
11960
11970
11971
11976
11980
11981
11982
11983
12001
12002
12004
12005
12006
12007
12011
12013
12014
12015
12016
12017
12018
12020
12021
12031
12032
12034
12035
12036
12037
12041
12042
12044
12045
12046
12047
12051
12052
12053
12054
12055
12056
12057
13100
13101
13102
13120
13121
13122
13131
13132
13133
13150
13151
13152
13153
13160
14000
14001
14020
14021
14040
14041
14060
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Insert tissue expander(s) ...............................
Replace tissue expander ...............................
Remove tissue expander(s) ...........................
Removal of contraceptive cap .......................
Implant hormone pellet(s) ..............................
Insert drug implant device .............................
Remove drug implant device .........................
Remove/insert drug implant ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Repair superficial wound(s) ...........................
Closure of split wound ...................................
Closure of split wound ...................................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Layer closure of wound(s) .............................
Repair of wound or lesion .............................
Repair of wound or lesion .............................
Repair wound/lesion add-on ..........................
Repair of wound or lesion .............................
Repair of wound or lesion .............................
Repair wound/lesion add-on ..........................
Repair of wound or lesion .............................
Repair of wound or lesion .............................
Repair wound/lesion add-on ..........................
Repair of wound or lesion .............................
Repair of wound or lesion .............................
Repair of wound or lesion .............................
Repair wound/lesion add-on ..........................
Late closure of wound ...................................
Skin tissue rearrangement .............................
Skin tissue rearrangement .............................
Skin tissue rearrangement .............................
Skin tissue rearrangement .............................
Skin tissue rearrangement .............................
Skin tissue rearrangement .............................
Skin tissue rearrangement .............................
Y
Y
Y
Y
N
N
N
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
P3
P2
P2
P2
P2
P2
P2
P2
A2
A2
A2
P2
P2
P2
G2
A2
A2
A2
A2
A2
P2
P2
A2
A2
A2
A2
P2
P2
A2
A2
A2
A2
P2
P2
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$446.00
$510.00
$333.00
....................
....................
....................
....................
....................
....................
....................
....................
$91.24
$91.24
$91.24
....................
....................
....................
....................
$91.24
$91.24
$91.24
$91.24
$91.24
....................
....................
$91.24
$91.24
$91.24
$323.28
....................
....................
$91.24
$91.24
$91.24
$323.28
....................
....................
....................
$91.24
$91.24
$91.24
$323.28
$323.28
$323.28
$91.24
$91.24
$91.24
$91.24
$91.24
$91.24
$91.24
$323.28
$323.28
$323.28
$91.24
$446.00
$446.00
$510.00
$510.00
$510.00
$446.00
$510.00
$510.00
21.4302
41.0893
20.0656
1.3760
0.6102
0.6102
0.6102
0.6102
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
5.2594
1.4843
1.4843
1.4843
1.4843
1.4843
5.2594
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
5.2594
5.2594
5.2594
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
1.4843
5.2594
5.2594
5.2594
1.4843
21.4302
14.0346
21.4302
14.0346
14.0346
14.0346
14.0346
14.0346
Estimated
CY 2008
fully implemented
payment
$911.71
$1,748.06
$853.65
$58.54
$25.96
$25.96
$25.96
$25.96
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$223.75
$63.15
$63.15
$63.15
$63.15
$63.15
$223.75
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$223.75
$223.75
$223.75
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$63.15
$223.75
$223.75
$223.75
$63.15
$911.71
$597.07
$911.71
$597.07
$597.07
$597.07
$597.07
$597.07
Estimated
CY 2008
first transition year
payment
$562.43
$819.52
$463.16
$58.54
$25.96
$25.96
$25.96
$25.96
$63.15
$63.15
$63.15
$84.22
$84.22
$84.22
$63.15
$63.15
$63.15
$63.15
$84.22
$84.22
$84.22
$84.22
$84.22
$63.15
$63.15
$84.22
$84.22
$84.22
$298.40
$63.15
$63.15
$84.22
$84.22
$84.22
$298.40
$63.15
$63.15
$63.15
$84.22
$84.22
$84.22
$298.40
$298.40
$298.40
$84.22
$84.22
$84.22
$84.22
$84.22
$84.22
$84.22
$298.40
$298.40
$298.40
$84.22
$562.43
$483.77
$610.43
$531.77
$531.77
$483.77
$531.77
$531.77
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00083
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42552
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
14061
14300
14350
15002
15003
15004
15005
15040
15050
15100
15101
15110
15111
15115
15116
15120
15121
15130
15131
15135
15136
15150
15151
15152
15155
15156
15157
15200
15201
15220
15221
15240
15241
15260
15261
15300
15301
15320
15321
15330
15331
15335
15336
15340
15341
15360
15361
15365
15366
15400
15401
15420
15421
15430
15431
15570
15572
15574
15576
15600
15610
15620
15630
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Skin tissue rearrangement .............................
Skin tissue rearrangement .............................
Skin tissue rearrangement .............................
Wnd prep, ch/inf, trk/arm/lg ...........................
Wnd prep, ch/inf addl 100 cm .......................
Wnd prep ch/inf, f/n/hf/g ................................
Wnd prep, f/n/hf/g, addl cm ...........................
Harvest cultured skin graft .............................
Skin pinch graft ..............................................
Skin splt grft, trnk/arm/leg ..............................
Skin splt grft t/a/l, add-on ..............................
Epidrm autogrft trnk/arm/leg ..........................
Epidrm autogrft t/a/l add-on ...........................
Epidrm a-grft face/nck/hf/g ............................
Epidrm a-grft f/n/hf/g addl ..............................
Skn splt a-grft fac/nck/hf/g .............................
Skn splt a-grft f/n/hf/g add .............................
Derm autograft, trnk/arm/leg ..........................
Derm autograft t/a/l add-on ...........................
Derm autograft face/nck/hf/g .........................
Derm autograft, f/n/hf/g add ..........................
Cult epiderm grft t/arm/leg .............................
Cult epiderm grft t/a/l addl .............................
Cult epiderm graft t/a/l +% ............................
Cult epiderm graft, f/n/hf/g .............................
Cult epidrm grft f/n/hfg add ............................
Cult epiderm grft f/n/hfg +% ..........................
Skin full graft, trunk ........................................
Skin full graft trunk add-on ............................
Skin full graft sclp/arm/leg .............................
Skin full graft add-on .....................................
Skin full grft face/genit/hf ...............................
Skin full graft add-on .....................................
Skin full graft een & lips ................................
Skin full graft add-on .....................................
Apply skinallogrft, t/arm/lg .............................
Apply sknallogrft t/a/l addl .............................
Apply skin allogrft f/n/hf/g ..............................
Aply sknallogrft f/n/hfg add ............................
Aply acell alogrft t/arm/leg .............................
Aply acell grft t/a/l add-on ..............................
Apply acell graft, f/n/hf/g ................................
Aply acell grft f/n/hf/g add ..............................
Apply cult skin substitute ...............................
Apply cult skin sub add-on ............................
Apply cult derm sub, t/a/l ...............................
Aply cult derm sub t/a/l add ...........................
Apply cult derm sub f/n/hf/g ...........................
Apply cult derm f/hf/g add .............................
Apply skin xenograft, t/a/l ..............................
Apply skn xenogrft t/a/l add ...........................
Apply skin xgraft, f/n/hf/g ...............................
Apply skn xgrft f/n/hf/g add ............................
Apply acellular xenograft ...............................
Apply acellular xgraft add ..............................
Form skin pedicle flap ...................................
Form skin pedicle flap ...................................
Form skin pedicle flap ...................................
Form skin pedicle flap ...................................
Skin graft ........................................................
Skin graft ........................................................
Skin graft ........................................................
Skin graft ........................................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
G2
G2
G2
G2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$510.00
$630.00
$510.00
$323.28
$323.28
$323.28
$323.28
$91.24
$323.28
$446.00
$510.00
$446.00
$333.00
$446.00
$333.00
$446.00
$510.00
$446.00
$333.00
$446.00
$333.00
$446.00
$333.00
$333.00
$446.00
$333.00
$333.00
$510.00
$323.28
$446.00
$323.28
$510.00
$323.28
$446.00
$323.28
$323.28
$323.28
$323.28
$323.28
$323.28
$323.28
$323.28
$323.28
....................
....................
....................
....................
....................
....................
$323.28
$323.28
$323.28
$323.28
$323.28
$323.28
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$510.00
14.0346
21.4302
21.4302
5.2594
5.2594
5.2594
5.2594
1.4843
5.2594
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
21.4302
14.0346
5.2594
14.0346
5.2594
14.0346
5.2594
14.0346
5.2594
5.2594
5.2594
5.2594
5.2594
5.2594
5.2594
5.2594
5.2594
3.1385
5.2594
5.2594
5.2594
5.2594
5.2594
5.2594
5.2594
5.2594
5.2594
5.2594
5.2594
21.4302
21.4302
21.4302
14.0346
21.4302
21.4302
21.4302
21.4302
Estimated
CY 2008
fully implemented
payment
$597.07
$911.71
$911.71
$223.75
$223.75
$223.75
$223.75
$63.15
$223.75
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$911.71
$597.07
$223.75
$597.07
$223.75
$597.07
$223.75
$597.07
$223.75
$223.75
$223.75
$223.75
$223.75
$223.75
$223.75
$223.75
$223.75
$133.52
$223.75
$223.75
$223.75
$223.75
$223.75
$223.75
$223.75
$223.75
$223.75
$223.75
$223.75
$911.71
$911.71
$911.71
$597.07
$911.71
$911.71
$911.71
$911.71
Estimated
CY 2008
first transition year
payment
$531.77
$700.43
$610.43
$298.40
$298.40
$298.40
$298.40
$84.22
$298.40
$562.43
$610.43
$562.43
$477.68
$562.43
$477.68
$562.43
$610.43
$562.43
$477.68
$562.43
$477.68
$562.43
$477.68
$477.68
$562.43
$477.68
$477.68
$531.77
$298.40
$483.77
$298.40
$531.77
$298.40
$483.77
$298.40
$298.40
$298.40
$298.40
$298.40
$298.40
$298.40
$298.40
$298.40
$133.52
$223.75
$223.75
$223.75
$223.75
$223.75
$298.40
$298.40
$298.40
$298.40
$298.40
$298.40
$610.43
$610.43
$610.43
$531.77
$610.43
$610.43
$700.43
$610.43
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00084
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42553
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
15650
15731
15732
15734
15736
15738
15740
15750
15760
15770
15775
15776
15780
15781
15782
15783
15786
15787
15788
15789
15792
15793
15819
15820
15821
15822
15823
15824
15825
15826
15828
15829
15830
15832
15833
15834
15835
15836
15837
15838
15839
15840
15841
15842
15845
15847
15850
15851
15852
15860
15876
15877
15878
15879
15920
15922
15931
15933
15934
15935
15936
15937
15940
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Transfer skin pedicle flap ..............................
Forehead flap w/vasc pedicle ........................
Muscle-skin graft, head/neck .........................
Muscle-skin graft, trunk .................................
Muscle-skin graft, arm ...................................
Muscle-skin graft, leg .....................................
Island pedicle flap graft .................................
Neurovascular pedicle graft ...........................
Composite skin graft ......................................
Derma-fat-fascia graft ....................................
Hair transplant punch grafts ..........................
Hair transplant punch grafts ..........................
Abrasion treatment of skin .............................
Abrasion treatment of skin .............................
Abrasion treatment of skin .............................
Abrasion treatment of skin .............................
Abrasion, lesion, single ..................................
Abrasion, lesions, add-on ..............................
Chemical peel, face, epiderm ........................
Chemical peel, face, dermal ..........................
Chemical peel, nonfacial ...............................
Chemical peel, nonfacial ...............................
Plastic surgery, neck .....................................
Revision of lower eyelid .................................
Revision of lower eyelid .................................
Revision of upper eyelid ................................
Revision of upper eyelid ................................
Removal of forehead wrinkles .......................
Removal of neck wrinkles ..............................
Removal of brow wrinkles .............................
Removal of face wrinkles ..............................
Removal of skin wrinkles ...............................
Exc skin abd ..................................................
Excise excessive skin tissue .........................
Excise excessive skin tissue .........................
Excise excessive skin tissue .........................
Excise excessive skin tissue .........................
Excise excessive skin tissue .........................
Excise excessive skin tissue .........................
Excise excessive skin tissue .........................
Excise excessive skin tissue .........................
Graft for face nerve palsy ..............................
Graft for face nerve palsy ..............................
Flap for face nerve palsy ...............................
Skin and muscle repair, face .........................
Exc skin abd add-on ......................................
Removal of sutures ........................................
Removal of sutures ........................................
Dressing change not for burn ........................
Test for blood flow in graft .............................
Suction assisted lipectomy ............................
Suction assisted lipectomy ............................
Suction assisted lipectomy ............................
Suction assisted lipectomy ............................
Removal of tail bone ulcer .............................
Removal of tail bone ulcer .............................
Remove sacrum pressure sore .....................
Remove sacrum pressure sore .....................
Remove sacrum pressure sore .....................
Remove sacrum pressure sore .....................
Remove sacrum pressure sore .....................
Remove sacrum pressure sore .....................
Remove hip pressure sore ............................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
P2
P2
P2
P2
P3
P2
P2
P2
P2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
A2
A2
A2
G2
A2
A2
G2
P3
G2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$717.00
$510.00
$510.00
$510.00
$510.00
$510.00
$446.00
$446.00
$446.00
$510.00
$323.28
$323.28
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$510.00
$510.00
$510.00
$717.00
$510.00
$510.00
$510.00
$510.00
$717.00
$510.00
$510.00
$510.00
$510.00
$323.28
$510.00
....................
....................
$510.00
$630.00
$630.00
....................
$630.00
$510.00
....................
....................
....................
....................
$510.00
$510.00
$510.00
$510.00
$251.52
$630.00
$510.00
$510.00
$510.00
$630.00
$630.00
$630.00
$510.00
21.4302
14.0346
21.4302
21.4302
21.4302
21.4302
14.0346
21.4302
21.4302
21.4302
5.2594
5.2594
9.3992
4.0919
4.0919
2.6749
1.0918
0.7726
0.8432
1.6241
1.0918
0.8432
5.2594
21.4302
21.4302
21.4302
14.0346
21.4302
21.4302
21.4302
21.4302
21.4302
20.0656
20.0656
20.0656
20.0656
5.2594
15.1024
15.1024
15.1024
15.1024
21.4302
21.4302
14.0346
21.4302
20.0656
2.6749
1.2070
0.6102
0.6102
21.4302
21.4302
14.0346
21.4302
4.0919
21.4302
20.0656
20.0656
21.4302
21.4302
21.4302
21.4302
20.0656
Estimated
CY 2008
fully implemented
payment
$911.71
$597.07
$911.71
$911.71
$911.71
$911.71
$597.07
$911.71
$911.71
$911.71
$223.75
$223.75
$399.87
$174.08
$174.08
$113.80
$46.45
$32.87
$35.87
$69.09
$46.45
$35.87
$223.75
$911.71
$911.71
$911.71
$597.07
$911.71
$911.71
$911.71
$911.71
$911.71
$853.65
$853.65
$853.65
$853.65
$223.75
$642.50
$642.50
$642.50
$642.50
$911.71
$911.71
$597.07
$911.71
$853.65
$113.80
$51.35
$25.96
$25.96
$911.71
$911.71
$597.07
$911.71
$174.08
$911.71
$853.65
$853.65
$911.71
$911.71
$911.71
$911.71
$853.65
Estimated
CY 2008
first transition year
payment
$765.68
$531.77
$610.43
$610.43
$610.43
$610.43
$483.77
$562.43
$562.43
$610.43
$298.40
$298.40
$399.87
$174.08
$174.08
$113.80
$46.45
$32.87
$35.87
$69.09
$46.45
$35.87
$223.75
$610.43
$610.43
$610.43
$687.02
$610.43
$610.43
$610.43
$610.43
$765.68
$595.91
$595.91
$595.91
$595.91
$298.40
$543.13
$642.50
$642.50
$543.13
$700.43
$700.43
$597.07
$700.43
$595.91
$113.80
$51.35
$25.96
$25.96
$610.43
$610.43
$531.77
$610.43
$232.16
$700.43
$595.91
$595.91
$610.43
$700.43
$700.43
$700.43
$595.91
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00085
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42554
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Remove hip pressure sore ............................
Remove hip pressure sore ............................
Remove hip pressure sore ............................
Remove hip pressure sore ............................
Remove thigh pressure sore .........................
Remove thigh pressure sore .........................
Remove thigh pressure sore .........................
Remove thigh pressure sore .........................
Remove thigh pressure sore .........................
Remove thigh pressure sore .........................
Initial treatment of burn(s) .............................
Dress/debrid p-thick burn, s ..........................
Dress/debrid p-thick burn, m .........................
Dress/debrid p-thick burn, l ...........................
Incision of burn scab, initi ..............................
Destruct premalg lesion .................................
Destruct premalg les, 2–14 ...........................
Destroy premlg lesions 15+ ...........................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruct b9 lesion, 1–14 ................................
Destruct lesion, 15 or more ...........................
Chemical cautery, tissue ...............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Destruction of skin lesions .............................
Mohs, 1 stage, h/n/hf/g ..................................
Mohs addl stage ............................................
Mohs, 1 stage, t/a/l ........................................
Mohs, addl stage, t/a/l ...................................
Mohs surg, addl block ...................................
Cryotherapy of skin ........................................
Skin peel therapy ...........................................
Hair removal by electrolysis ..........................
Drainage of breast lesion ..............................
Drain breast lesion add-on ............................
Incision of breast lesion .................................
Injection for breast x-ray ................................
Bx breast percut w/o image ...........................
Biopsy of breast, open ...................................
Bx breast percut w/image ..............................
Bx breast percut w/device .............................
Cryosurg ablate fa, each ...............................
Nipple exploration ..........................................
Excise breast duct fistula ...............................
Removal of breast lesion ...............................
Excision, breast lesion ...................................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
15941
15944
15945
15946
15950
15951
15952
15953
15956
15958
16000
16020
16025
16030
16035
17000
17003
17004
17106
17107
17108
17110
17111
17250
17260
17261
17262
17263
17264
17266
17270
17271
17272
17273
17274
17276
17280
17281
17282
17283
17284
17286
17311
17312
17313
17314
17315
17340
17360
17380
19000
19001
19020
19030
19100
19101
19102
19103
19105
19110
19112
19120
19125
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
P3
A2
A2
G2
P2
P3
P3
P2
P2
P2
P2
P2
P3
P3
P2
P2
P2
P2
P3
P2
P2
P2
P2
P3
P2
P3
P2
P2
P2
P2
P2
P2
P2
P2
P2
P3
P3
P2
R2
P3
P3
A2
N1
A2
A2
A2
A2
G2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
$510.00
$630.00
$630.00
$510.00
$630.00
$510.00
$630.00
$510.00
$630.00
....................
....................
$67.11
$99.83
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$446.00
....................
$240.00
$446.00
$240.00
$395.77
....................
$446.00
$510.00
$510.00
$510.00
20.0656
21.4302
21.4302
21.4302
20.0656
20.0656
21.4302
21.4302
21.4302
21.4302
0.6438
0.9656
1.0918
1.6241
2.6749
0.4760
0.0886
1.8993
2.5665
2.5665
2.5665
0.8432
1.0918
1.0220
1.0944
1.6241
1.6241
1.6241
1.6241
2.4382
1.6241
1.0918
1.6241
1.6241
2.5026
2.6749
1.6014
1.6241
1.6241
1.6241
2.6749
1.6241
3.7292
3.7292
3.7292
3.7292
0.9254
0.2816
1.0918
1.0918
1.5290
0.1932
17.5086
....................
3.9045
19.2788
3.9045
6.4387
28.0166
19.2788
19.2788
19.2788
19.2788
$853.65
$911.71
$911.71
$911.71
$853.65
$853.65
$911.71
$911.71
$911.71
$911.71
$27.39
$41.08
$46.45
$69.09
$113.80
$20.25
$3.77
$80.80
$109.19
$109.19
$109.19
$35.87
$46.45
$43.48
$46.56
$69.09
$69.09
$69.09
$69.09
$103.73
$69.09
$46.45
$69.09
$69.09
$106.47
$113.80
$68.13
$69.09
$69.09
$69.09
$113.80
$69.09
$158.65
$158.65
$158.65
$158.65
$39.37
$11.98
$46.45
$46.45
$65.05
$8.22
$744.87
....................
$166.11
$820.18
$166.11
$273.92
$1,191.91
$820.18
$820.18
$820.18
$820.18
$595.91
$610.43
$700.43
$700.43
$595.91
$685.91
$610.43
$700.43
$610.43
$700.43
$27.39
$41.08
$61.95
$92.15
$113.80
$20.25
$3.77
$80.80
$109.19
$109.19
$109.19
$35.87
$46.45
$43.48
$46.56
$69.09
$69.09
$69.09
$69.09
$103.73
$69.09
$46.45
$69.09
$69.09
$106.47
$113.80
$68.13
$69.09
$69.09
$69.09
$113.80
$69.09
$158.65
$158.65
$158.65
$158.65
$39.37
$11.98
$46.45
$46.45
$65.05
$8.22
$520.72
....................
$221.53
$539.55
$221.53
$365.31
$1,191.91
$539.55
$587.55
$587.55
$587.55
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00086
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42555
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Excision, addl breast lesion ...........................
Place needle wire, breast ..............................
Place needle wire, breast ..............................
Place breast clip, percut ................................
Place po breast cath for rad ..........................
Place breast cath for rad ...............................
Place breast rad tube/caths ...........................
Removal of breast tissue ...............................
Partical mastectomy ......................................
P-mastectomy w/ln removal ..........................
Mast, simple, complete ..................................
Mast, subq .....................................................
Suspension of breast .....................................
Reduction of large breast ..............................
Enlarge breast ...............................................
Enlarge breast with implant ...........................
Removal of breast implant .............................
Removal of implant material ..........................
Immediate breast prosthesis .........................
Delayed breast prosthesis .............................
Breast reconstruction .....................................
Correct inverted nipple(s) ..............................
Breast reconstruction .....................................
Breast reconstruction .....................................
Surgery of breast capsule .............................
Removal of breast capsule ............................
Revise breast reconstruction .........................
Design custom breast implant .......................
Incision of abscess ........................................
Incision of deep abscess ...............................
Explore wound, extremity ..............................
Excise epiphyseal bar ....................................
Muscle biopsy ................................................
Deep muscle biopsy ......................................
Needle biopsy, muscle ..................................
Bone biopsy, trocar/needle ............................
Bone biopsy, trocar/needle ............................
Bone biopsy, excisional .................................
Bone biopsy, excisional .................................
Open bone biopsy .........................................
Open bone biopsy .........................................
Injection of sinus tract ....................................
Inject sinus tract for x-ray ..............................
Removal of foreign body ...............................
Removal of foreign body ...............................
Ther injection, carp tunnel .............................
Inj tendon sheath/ligament ............................
Inj tendon origin/insertion ..............................
Inj trigger point, 1/2 muscl .............................
Inject trigger points, =/> 3 ..............................
Drain/inject, joint/bursa ..................................
Drain/inject, joint/bursa ..................................
Drain/inject, joint/bursa ..................................
Aspirate/inj ganglion cyst ...............................
Treatment of bone cyst ..................................
Insert and remove bone pin ..........................
Application of pelvis brace .............................
Application of thigh brace ..............................
Removal of fixation device ............................
Removal of support implant ...........................
Removal of support implant ...........................
Apply bone fixation device .............................
Apply bone fixation device .............................
Y ..............
..................
..................
N ..............
Y ..............
Y ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
19126
19290
19291
19295
19296
19297
19298
19300
19301
19302
19303
19304
19316
19318
19324
19325
19328
19330
19340
19342
19350
19355
19357
19366
19370
19371
19380
19396
20000
20005
20103
20150
20200
20205
20206
20220
20225
20240
20245
20250
20251
20500
20501
20520
20525
20526
20550
20551
20552
20553
20600
20605
20610
20612
20615
20650
20662
20663
20665
20670
20680
20690
20692
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
N1
N1
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
P2
A2
G2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
N1
P3
A2
P3
P3
P3
P3
P3
P3
P3
P3
P3
P2
A2
R2
R2
G2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
$333.00
$333.00
$106.76
$1,339.00
$1,339.00
$1,339.00
$630.00
$510.00
$995.00
$630.00
$630.00
$630.00
$630.00
$630.00
$1,339.00
$333.00
$333.00
$446.00
$510.00
$630.00
$630.00
$717.00
$717.00
$630.00
$630.00
$717.00
....................
....................
$446.00
....................
....................
$446.00
$510.00
$240.00
$251.52
$418.49
$446.00
$510.00
$510.00
$510.00
....................
....................
....................
$510.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$510.00
....................
....................
....................
$333.00
$510.00
$446.00
$510.00
19.2788
....................
....................
1.7369
51.2269
51.2269
52.8730
19.2788
19.2788
36.9988
28.0166
28.0166
28.0166
36.9988
36.9988
51.2269
28.0166
28.0166
37.8692
51.2269
19.2788
28.0166
51.2269
28.0166
28.0166
28.0166
37.8692
28.0166
1.4392
20.8706
4.2212
41.0893
15.1024
15.1024
3.9045
4.0919
6.8083
20.0656
20.0656
20.8706
20.8706
1.4162
....................
2.2131
20.0656
0.7162
0.5392
0.5312
0.5230
0.5874
0.5312
0.6036
0.8128
0.5714
2.0687
20.8706
20.8706
20.8706
0.6102
15.1024
20.0656
25.1296
25.1296
$820.18
....................
....................
$73.89
$2,179.35
$2,179.35
$2,249.38
$820.18
$820.18
$1,574.04
$1,191.91
$1,191.91
$1,191.91
$1,574.04
$1,574.04
$2,179.35
$1,191.91
$1,191.91
$1,611.07
$2,179.35
$820.18
$1,191.91
$2,179.35
$1,191.91
$1,191.91
$1,191.91
$1,611.07
$1,191.91
$61.23
$887.90
$179.58
$1,748.06
$642.50
$642.50
$166.11
$174.08
$289.65
$853.65
$853.65
$887.90
$887.90
$60.25
....................
$94.15
$853.65
$30.47
$22.94
$22.60
$22.25
$24.99
$22.60
$25.68
$34.58
$24.31
$88.01
$887.90
$887.90
$887.90
$25.96
$642.50
$853.65
$1,069.09
$1,069.09
$587.55
....................
....................
$98.54
$1,549.09
$1,549.09
$1,566.60
$677.55
$587.55
$1,139.76
$770.48
$770.48
$770.48
$866.01
$866.01
$1,549.09
$547.73
$547.73
$737.27
$927.34
$677.55
$770.48
$1,082.59
$835.73
$770.48
$770.48
$940.52
$1,191.91
$61.23
$556.48
$179.58
$1,748.06
$495.13
$543.13
$221.53
$232.16
$386.28
$547.91
$595.91
$604.48
$604.48
$60.25
....................
$94.15
$595.91
$30.47
$22.94
$22.60
$22.25
$24.99
$22.60
$25.68
$34.58
$24.31
$88.01
$604.48
$887.90
$887.90
$25.96
$410.38
$595.91
$601.77
$649.77
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00087
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42556
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Adjust bone fixation device ............................
Remove bone fixation device ........................
Replantation digit, complete ..........................
Removal of bone for graft ..............................
Removal of bone for graft ..............................
Remove cartilage for graft .............................
Remove cartilage for graft .............................
Removal of fascia for graft ............................
Removal of fascia for graft ............................
Removal of tendon for graft ...........................
Removal of tissue for graft ............................
Fluid pressure, muscle ..................................
Bone/skin graft, metatarsal ............................
Bone/skin graft, great toe ..............................
Electrical bone stimulation .............................
Us bone stimulation .......................................
Ablate, bone tumor(s) perq ............................
Incision of jaw joint ........................................
Resection of facial tumor ...............................
Excision of bone, lower jaw ...........................
Excision of facial bone(s) ..............................
Contour of face bone lesion ..........................
Excise max/zygoma b9 tumor .......................
Remove exostosis, mandible .........................
Remove exostosis, maxilla ............................
Excise max/zygoma mlg tumor .....................
Excise mandible lesion ..................................
Removal of jaw bone lesion ..........................
Remove mandible cyst complex ....................
Excise lwr jaw cyst w/repair ..........................
Remove maxilla cyst complex .......................
Removal of jaw joint ......................................
Remove jaw joint cartilage ............................
Remove coronoid process .............................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Prepare face/oral prosthesis ..........................
Maxillofacial fixation .......................................
Interdental fixation .........................................
Injection, jaw joint x-ray .................................
Reconstruction of chin ...................................
Reconstruction of chin ...................................
Reconstruction of chin ...................................
Reconstruction of chin ...................................
Augmentation, lower jaw bone ......................
Augmentation, lower jaw bone ......................
Reduction of forehead ...................................
Reduction of forehead ...................................
Reduction of forehead ...................................
Reconstruct midface, lefort ............................
Contour cranial bone lesion ...........................
Reconstr lwr jaw segment .............................
Reconstr lwr jaw w/advance ..........................
Reconstruct upper jaw bone ..........................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
20693
20694
20822
20900
20902
20910
20912
20920
20922
20924
20926
20950
20972
20973
20975
20979
20982
21010
21015
21025
21026
21029
21030
21031
21032
21034
21040
21044
21046
21047
21048
21050
21060
21070
21076
21077
21079
21080
21081
21082
21083
21084
21085
21086
21087
21088
21100
21110
21116
21120
21121
21122
21123
21125
21127
21137
21138
21139
21150
21181
21198
21199
21206
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
R2
A2
P3
G2
A2
A2
A2
A2
A2
P3
P3
P3
A2
A2
A2
A2
A2
R2
A2
A2
A2
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
R2
A2
P2
N1
A2
A2
A2
A2
A2
A2
G2
G2
G2
G2
A2
G2
G2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
$333.00
....................
$510.00
$630.00
$510.00
$510.00
$630.00
$510.00
$630.00
$630.00
....................
....................
....................
$37.51
....................
....................
$446.00
$510.00
$446.00
$446.00
$446.00
....................
....................
....................
$510.00
$446.00
$446.00
$446.00
$446.00
....................
$510.00
$446.00
$510.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$446.00
....................
....................
$995.00
$995.00
$995.00
$995.00
$995.00
$1,339.00
....................
....................
....................
....................
$995.00
....................
....................
$717.00
20.8706
20.8706
25.8758
25.1296
25.1296
21.4302
21.4302
14.0346
21.4302
25.1296
14.0346
1.4392
40.8559
40.8559
0.6102
0.5552
41.0893
23.3299
16.4266
38.1991
38.1991
38.1991
5.4479
4.4823
4.5869
38.1991
23.3299
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
8.1760
20.1504
14.2437
16.3280
14.9437
13.8253
13.5113
15.6117
6.1079
14.7587
14.6621
38.1991
38.1991
7.5511
....................
23.3299
23.3299
23.3299
23.3299
23.3299
38.1991
23.3299
38.1991
38.1991
38.1991
23.3299
38.1991
38.1991
38.1991
$887.90
$887.90
$1,100.83
$1,069.09
$1,069.09
$911.71
$911.71
$597.07
$911.71
$1,069.09
$597.07
$61.23
$1,738.13
$1,738.13
$25.96
$23.62
$1,748.06
$992.52
$698.84
$1,625.10
$1,625.10
$1,625.10
$231.77
$190.69
$195.14
$1,625.10
$992.52
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$347.83
$857.26
$605.97
$694.64
$635.75
$588.17
$574.81
$664.17
$259.85
$627.88
$623.77
$1,625.10
$1,625.10
$321.25
....................
$992.52
$992.52
$992.52
$992.52
$992.52
$1,625.10
$992.52
$1,625.10
$1,625.10
$1,625.10
$992.52
$1,625.10
$1,625.10
$1,625.10
$604.48
$471.73
$1,100.83
$649.77
$739.77
$610.43
$610.43
$621.77
$610.43
$739.77
$621.77
$61.23
$1,738.13
$1,738.13
$34.62
$23.62
$1,748.06
$582.63
$557.21
$740.78
$740.78
$740.78
$231.77
$190.69
$195.14
$788.78
$582.63
$740.78
$740.78
$740.78
$1,625.10
$788.78
$740.78
$788.78
$347.83
$857.26
$605.97
$694.64
$635.75
$588.17
$574.81
$664.17
$259.85
$627.88
$623.77
$1,625.10
$740.78
$321.25
....................
$994.38
$994.38
$994.38
$994.38
$994.38
$1,410.53
$992.52
$1,625.10
$1,625.10
$1,625.10
$994.38
$1,625.10
$1,625.10
$944.03
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00088
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42557
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
21208
21209
21210
21215
21230
21235
21240
21242
21243
21244
21245
21246
21248
21249
21260
21267
21270
21275
21280
21282
21295
21296
21310
21315
21320
21325
21330
21335
21336
21337
21338
21339
21340
21345
21355
21356
21390
21400
21401
21406
21407
21421
21440
21445
21450
21451
21452
21453
21454
21461
21462
21465
21480
21485
21490
21495
21497
21501
21502
21550
21555
21556
21557
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Augmentation of facial bones ........................
Reduction of facial bones ..............................
Face bone graft .............................................
Lower jaw bone graft .....................................
Rib cartilage graft ..........................................
Ear cartilage graft ..........................................
Reconstruction of jaw joint ............................
Reconstruction of jaw joint ............................
Reconstruction of jaw joint ............................
Reconstruction of lower jaw ..........................
Reconstruction of jaw ....................................
Reconstruction of jaw ....................................
Reconstruction of jaw ....................................
Reconstruction of jaw ....................................
Revise eye sockets ........................................
Revise eye sockets ........................................
Augmentation, cheek bone ............................
Revision, orbitofacial bones ...........................
Revision of eyelid ..........................................
Revision of eyelid ..........................................
Revision of jaw muscle/bone .........................
Revision of jaw muscle/bone .........................
Treatment of nose fracture ............................
Treatment of nose fracture ............................
Treatment of nose fracture ............................
Treatment of nose fracture ............................
Treatment of nose fracture ............................
Treatment of nose fracture ............................
Treat nasal septal fracture .............................
Treat nasal septal fracture .............................
Treat nasoethmoid fracture ...........................
Treat nasoethmoid fracture ...........................
Treatment of nose fracture ............................
Treat nose/jaw fracture ..................................
Treat cheek bone fracture .............................
Treat cheek bone fracture .............................
Treat eye socket fracture ...............................
Treat eye socket fracture ...............................
Treat eye socket fracture ...............................
Treat eye socket fracture ...............................
Treat eye socket fracture ...............................
Treat mouth roof fracture ...............................
Treat dental ridge fracture .............................
Treat dental ridge fracture .............................
Treat lower jaw fracture .................................
Treat lower jaw fracture .................................
Treat lower jaw fracture .................................
Treat lower jaw fracture .................................
Treat lower jaw fracture .................................
Treat lower jaw fracture .................................
Treat lower jaw fracture .................................
Treat lower jaw fracture .................................
Reset dislocated jaw ......................................
Reset dislocated jaw ......................................
Repair dislocated jaw ....................................
Treat hyoid bone fracture ..............................
Interdental wiring ...........................................
Drain neck/chest lesion .................................
Drain chest lesion ..........................................
Biopsy of neck/chest ......................................
Remove lesion, neck/chest ............................
Remove lesion, neck/chest ............................
Remove tumor, neck/chest ............................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
G2
G2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
G2
A2
A2
G2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$995.00
$717.00
$995.00
$995.00
$995.00
$995.00
$630.00
$717.00
$717.00
$995.00
$995.00
$995.00
$995.00
$995.00
....................
$995.00
$717.00
$995.00
$717.00
$717.00
$333.00
$333.00
$150.72
$150.72
$446.00
$630.00
$717.00
$995.00
$630.00
$446.00
$630.00
$717.00
$630.00
$995.00
$510.00
$510.00
....................
$446.00
$510.00
....................
....................
$630.00
....................
$630.00
$150.72
$464.15
$446.00
$510.00
$717.00
$630.00
$717.00
$630.00
$150.72
$446.00
$510.00
....................
$446.00
$446.00
$446.00
....................
$446.00
$446.00
....................
38.1991
38.1991
38.1991
38.1991
38.1991
23.3299
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
16.4266
7.5511
23.3299
2.4520
2.4520
7.5511
23.3299
23.3299
23.3299
37.5382
16.4266
23.3299
23.3299
38.1991
23.3299
38.1991
23.3299
38.1991
7.5511
16.4266
38.1991
38.1991
23.3299
7.0012
23.3299
2.4520
7.5511
16.4266
38.1991
23.3299
38.1991
38.1991
38.1991
2.4520
16.4266
38.1991
16.4266
16.4266
17.5086
20.8706
6.8083
20.0656
20.0656
20.0656
Estimated
CY 2008
fully implemented
payment
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$992.52
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$698.84
$321.25
$992.52
$104.32
$104.32
$321.25
$992.52
$992.52
$992.52
$1,596.99
$698.84
$992.52
$992.52
$1,625.10
$992.52
$1,625.10
$992.52
$1,625.10
$321.25
$698.84
$1,625.10
$1,625.10
$992.52
$297.85
$992.52
$104.32
$321.25
$698.84
$1,625.10
$992.52
$1,625.10
$1,625.10
$1,625.10
$104.32
$698.84
$1,625.10
$698.84
$698.84
$744.87
$887.90
$289.65
$853.65
$853.65
$853.65
Estimated
CY 2008
first transition year
payment
$1,152.53
$944.03
$1,152.53
$1,152.53
$1,152.53
$994.38
$878.78
$944.03
$944.03
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$1,625.10
$1,152.53
$944.03
$1,152.53
$944.03
$712.46
$330.06
$497.88
$139.12
$139.12
$414.81
$720.63
$785.88
$994.38
$871.75
$509.21
$720.63
$785.88
$878.78
$994.38
$788.78
$630.63
$1,625.10
$414.81
$557.21
$1,625.10
$1,625.10
$720.63
$297.85
$720.63
$139.12
$428.43
$509.21
$788.78
$785.88
$878.78
$944.03
$878.78
$139.12
$509.21
$788.78
$698.84
$509.21
$520.72
$556.48
$289.65
$547.91
$547.91
$853.65
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00089
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42558
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Partial removal of rib .....................................
Partial removal of rib .....................................
Hyoid myotomy & suspension .......................
Revision of neck muscle ................................
Revision of neck muscle ................................
Revision of neck muscle ................................
Treatment of rib fracture ................................
Treatment of rib fracture ................................
Treat sternum fracture ...................................
Biopsy soft tissue of back ..............................
Biopsy soft tissue of back ..............................
Remove lesion, back or flank ........................
Remove tumor, back .....................................
Remove part, lumbar vertebra .......................
Remove extra spine segment ........................
Treat spine process fracture ..........................
Treat spine fracture .......................................
Treat spine fracture .......................................
Manipulation of spine .....................................
Percut vertebroplasty thor .............................
Percut vertebroplasty lumb ............................
Percut vertebroplasty add-on ........................
Percut kyphoplasty, thor ................................
Percut kyphoplasty, lumbar ...........................
Percut kyphoplasty, add-on ...........................
Remove abdominal wall lesion ......................
Removal of calcium deposits .........................
Release shoulder joint ...................................
Drain shoulder lesion .....................................
Drain shoulder bursa .....................................
Drain shoulder bone lesion ............................
Exploratory shoulder surgery .........................
Exploratory shoulder surgery .........................
Biopsy shoulder tissues .................................
Biopsy shoulder tissues .................................
Removal of shoulder lesion ...........................
Removal of shoulder lesion ...........................
Remove tumor of shoulder ............................
Biopsy of shoulder joint .................................
Shoulder joint surgery ....................................
Remove shoulder joint lining .........................
Incision of collarbone joint .............................
Explore treat shoulder joint ............................
Partial removal, collar bone ...........................
Removal of collar bone ..................................
Remove shoulder bone, part .........................
Removal of bone lesion .................................
Removal of bone lesion .................................
Removal of bone lesion .................................
Removal of humerus lesion ...........................
Removal of humerus lesion ...........................
Removal of humerus lesion ...........................
Remove collar bone lesion ............................
Remove shoulder blade lesion ......................
Remove humerus lesion ................................
Remove collar bone lesion ............................
Remove shoulder blade lesion ......................
Remove humerus lesion ................................
Partial removal of scapula .............................
Removal of head of humerus ........................
Remove shoulder foreign body .....................
Remove shoulder foreign body .....................
Injection for shoulder x-ray ............................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
mstockstill on PROD1PC66 with RULES2
HCPCS
code
21600
21610
21685
21700
21720
21725
21800
21805
21820
21920
21925
21930
21935
22102
22103
22305
22310
22315
22505
22520
22521
22522
22523
22524
22525
22900
23000
23020
23030
23031
23035
23040
23044
23065
23066
23075
23076
23077
23100
23101
23105
23106
23107
23120
23125
23130
23140
23145
23146
23150
23155
23156
23170
23172
23174
23180
23182
23184
23190
23195
23330
23331
23350
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
G2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
G2
G2
A2
A2
A2
A2
A2
A2
A2
G2
G2
G2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
N1
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$446.00
$446.00
....................
$446.00
$510.00
$88.46
$103.62
$446.00
$103.62
....................
$446.00
$446.00
$510.00
....................
....................
$103.62
$103.62
$103.62
$446.00
$1,339.00
$1,339.00
$1,339.00
....................
....................
....................
$630.00
$446.00
$446.00
$333.00
$510.00
$510.00
$510.00
$630.00
....................
$446.00
$446.00
$446.00
$510.00
$446.00
$995.00
$630.00
$630.00
$630.00
$717.00
$717.00
$717.00
$630.00
$717.00
$717.00
$630.00
$717.00
$717.00
$446.00
$446.00
$446.00
$630.00
$630.00
$630.00
$630.00
$717.00
$333.00
$333.00
....................
25.1296
25.1296
7.5511
20.8706
20.8706
1.4392
1.6857
25.5264
1.6857
3.0983
20.0656
20.0656
20.0656
44.1489
44.1489
1.6857
1.6857
1.6857
14.5947
25.1296
25.1296
25.1296
66.5800
66.5800
66.5800
20.0656
15.1024
41.0893
17.5086
17.5086
20.8706
25.1296
25.1296
2.1888
20.0656
15.1024
20.0656
20.0656
20.8706
25.1296
25.1296
25.1296
25.1296
41.0893
41.0893
41.0893
20.8706
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
6.8083
20.0656
....................
$1,069.09
$1,069.09
$321.25
$887.90
$887.90
$61.23
$71.71
$1,085.97
$71.71
$131.81
$853.65
$853.65
$853.65
$1,878.23
$1,878.23
$71.71
$71.71
$71.71
$620.90
$1,069.09
$1,069.09
$1,069.09
$2,832.51
$2,832.51
$2,832.51
$853.65
$642.50
$1,748.06
$744.87
$744.87
$887.90
$1,069.09
$1,069.09
$93.12
$853.65
$642.50
$853.65
$853.65
$887.90
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,748.06
$1,748.06
$1,748.06
$887.90
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$289.65
$853.65
....................
$601.77
$601.77
$321.25
$556.48
$604.48
$81.65
$95.64
$605.99
$95.64
$131.81
$547.91
$547.91
$595.91
$1,878.23
$1,878.23
$95.64
$95.64
$95.64
$489.73
$1,271.52
$1,271.52
$1,271.52
$2,832.51
$2,832.51
$2,832.51
$685.91
$495.13
$771.52
$435.97
$568.72
$604.48
$649.77
$739.77
$93.12
$547.91
$495.13
$547.91
$595.91
$556.48
$1,013.52
$739.77
$739.77
$739.77
$974.77
$974.77
$974.77
$694.48
$805.02
$805.02
$739.77
$805.02
$805.02
$601.77
$601.77
$601.77
$739.77
$739.77
$739.77
$739.77
$805.02
$322.16
$463.16
....................
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00090
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42559
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
23395
23397
23400
23405
23406
23410
23412
23415
23420
23430
23440
23450
23455
23460
23462
23465
23466
23480
23485
23490
23491
23500
23505
23515
23520
23525
23530
23532
23540
23545
23550
23552
23570
23575
23585
23600
23605
23615
23616
23620
23625
23630
23650
23655
23660
23665
23670
23675
23680
23700
23800
23802
23921
23930
23931
23935
24000
24006
24065
24066
24075
24076
24077
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Muscle transfer,shoulder/arm ........................
Muscle transfers ............................................
Fixation of shoulder blade .............................
Incision of tendon & muscle ..........................
Incise tendon(s) & muscle(s) .........................
Repair rotator cuff, acute ...............................
Repair rotator cuff, chronic ............................
Release of shoulder ligament ........................
Repair of shoulder .........................................
Repair biceps tendon .....................................
Remove/transplant tendon .............................
Repair shoulder capsule ................................
Repair shoulder capsule ................................
Repair shoulder capsule ................................
Repair shoulder capsule ................................
Repair shoulder capsule ................................
Repair shoulder capsule ................................
Revision of collar bone ..................................
Revision of collar bone ..................................
Reinforce clavicle ...........................................
Reinforce shoulder bones ..............................
Treat clavicle fracture ....................................
Treat clavicle fracture ....................................
Treat clavicle fracture ....................................
Treat clavicle dislocation ...............................
Treat clavicle dislocation ...............................
Treat clavicle dislocation ...............................
Treat clavicle dislocation ...............................
Treat clavicle dislocation ...............................
Treat clavicle dislocation ...............................
Treat clavicle dislocation ...............................
Treat clavicle dislocation ...............................
Treat shoulder blade fx ..................................
Treat shoulder blade fx ..................................
Treat scapula fracture ....................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat shoulder dislocation .............................
Treat shoulder dislocation .............................
Treat shoulder dislocation .............................
Treat dislocation/fracture ...............................
Treat dislocation/fracture ...............................
Treat dislocation/fracture ...............................
Treat dislocation/fracture ...............................
Fixation of shoulder .......................................
Fusion of shoulder joint .................................
Fusion of shoulder joint .................................
Amputation follow-up surgery ........................
Drainage of arm lesion ..................................
Drainage of arm bursa ...................................
Drain arm/elbow bone lesion .........................
Exploratory elbow surgery .............................
Release elbow joint .......................................
Biopsy arm/elbow soft tissue .........................
Biopsy arm/elbow soft tissue .........................
Remove arm/elbow lesion .............................
Remove arm/elbow lesion .............................
Remove tumor of arm/elbow .........................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P2
A2
A2
A2
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$717.00
$995.00
$995.00
$446.00
$446.00
$717.00
$995.00
$717.00
$995.00
$630.00
$630.00
$717.00
$995.00
$717.00
$995.00
$717.00
$995.00
$630.00
$995.00
$510.00
$510.00
$103.62
$103.62
$510.00
$103.62
$103.62
$510.00
$630.00
$103.62
$103.62
$510.00
$630.00
$103.62
$103.62
$510.00
....................
$103.62
$630.00
$630.00
....................
$103.62
$717.00
$103.62
$333.00
$510.00
$103.62
$510.00
$103.62
$510.00
$333.00
$630.00
$995.00
$323.28
$333.00
$446.00
$446.00
$630.00
$630.00
....................
$446.00
$446.00
$446.00
$510.00
41.0893
66.5800
25.1296
25.1296
25.1296
41.0893
41.0893
41.0893
41.0893
41.0893
41.0893
66.5800
66.5800
66.5800
41.0893
66.5800
41.0893
41.0893
66.5800
41.0893
66.5800
1.6857
1.6857
57.2172
1.6857
1.6857
37.5382
25.5264
1.6857
1.6857
37.5382
37.5382
1.6857
1.6857
57.2172
1.6857
1.6857
57.2172
57.2172
1.6857
1.6857
57.2172
1.6857
14.5947
37.5382
1.6857
57.2172
1.6857
37.5382
14.5947
66.5800
41.0893
5.2594
17.5086
17.5086
20.8706
25.1296
25.1296
2.9695
15.1024
15.1024
20.0656
20.0656
Estimated
CY 2008
fully implemented
payment
$1,748.06
$2,832.51
$1,069.09
$1,069.09
$1,069.09
$1,748.06
$1,748.06
$1,748.06
$1,748.06
$1,748.06
$1,748.06
$2,832.51
$2,832.51
$2,832.51
$1,748.06
$2,832.51
$1,748.06
$1,748.06
$2,832.51
$1,748.06
$2,832.51
$71.71
$71.71
$2,434.19
$71.71
$71.71
$1,596.99
$1,085.97
$71.71
$71.71
$1,596.99
$1,596.99
$71.71
$71.71
$2,434.19
$71.71
$71.71
$2,434.19
$2,434.19
$71.71
$71.71
$2,434.19
$71.71
$620.90
$1,596.99
$71.71
$2,434.19
$71.71
$1,596.99
$620.90
$2,832.51
$1,748.06
$223.75
$744.87
$744.87
$887.90
$1,069.09
$1,069.09
$126.33
$642.50
$642.50
$853.65
$853.65
Estimated
CY 2008
first transition year
payment
$974.77
$1,454.38
$1,013.52
$601.77
$601.77
$974.77
$1,183.27
$974.77
$1,183.27
$909.52
$909.52
$1,245.88
$1,454.38
$1,245.88
$1,183.27
$1,245.88
$1,183.27
$909.52
$1,454.38
$819.52
$1,090.63
$95.64
$95.64
$991.05
$95.64
$95.64
$781.75
$743.99
$95.64
$95.64
$781.75
$871.75
$95.64
$95.64
$991.05
$71.71
$95.64
$1,081.05
$1,081.05
$71.71
$95.64
$1,146.30
$95.64
$404.98
$781.75
$95.64
$991.05
$95.64
$781.75
$404.98
$1,180.63
$1,183.27
$298.40
$435.97
$520.72
$556.48
$739.77
$739.77
$126.33
$495.13
$495.13
$547.91
$595.91
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00091
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42560
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Biopsy elbow joint lining ................................
Explore/treat elbow joint ................................
Remove elbow joint lining ..............................
Removal of elbow bursa ................................
Remove humerus lesion ................................
Remove/graft bone lesion ..............................
Remove/graft bone lesion ..............................
Remove elbow lesion ....................................
Remove/graft bone lesion ..............................
Remove/graft bone lesion ..............................
Removal of head of radius ............................
Removal of arm bone lesion .........................
Remove radius bone lesion ...........................
Remove elbow bone lesion ...........................
Partial removal of arm bone ..........................
Partial removal of radius ................................
Partial removal of elbow ................................
Radical resection of elbow ............................
Extensive radius surgery ...............................
Extensive radius surgery ...............................
Removal of elbow joint ..................................
Remove elbow joint implant ..........................
Remove radius head implant .........................
Removal of arm foreign body ........................
Removal of arm foreign body ........................
Injection for elbow x-ray ................................
Manipulate elbow w/anesth ...........................
Muscle/tendon transfer ..................................
Arm tendon lengthening ................................
Revision of arm tendon .................................
Repair of arm tendon .....................................
Revision of arm muscles ...............................
Revision of arm muscles ...............................
Tenolysis, triceps ...........................................
Repair of biceps tendon ................................
Repair arm tendon/muscle ............................
Repair of ruptured tendon .............................
Repr elbow lat ligmnt w/tiss ...........................
Reconstruct elbow lat ligmnt .........................
Repr elbw med ligmnt w/tissu .......................
Reconstruct elbow med ligmnt ......................
Repair of tennis elbow ...................................
Repair of tennis elbow ...................................
Repair of tennis elbow ...................................
Repair of tennis elbow ...................................
Revision of tennis elbow ................................
Reconstruct elbow joint .................................
Reconstruct elbow joint .................................
Reconstruct elbow joint .................................
Replace elbow joint .......................................
Reconstruct head of radius ...........................
Reconstruct head of radius ...........................
Revision of humerus ......................................
Revision of humerus ......................................
Revision of humerus ......................................
Repair of humerus .........................................
Repair humerus with graft .............................
Revision of elbow joint ...................................
Decompression of forearm ............................
Reinforce humerus ........................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
24100
24101
24102
24105
24110
24115
24116
24120
24125
24126
24130
24134
24136
24138
24140
24145
24147
24149
24152
24153
24155
24160
24164
24200
24201
24220
24300
24301
24305
24310
24320
24330
24331
24332
24340
24341
24342
24343
24344
24345
24346
24350
24351
24352
24354
24356
24360
24361
24362
24363
24365
24366
24400
24410
24420
24430
24435
24470
24495
24498
24500
24505
24515
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
G2
A2
A2
A2
P3
A2
N1
G2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
G2
G2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$333.00
$630.00
$630.00
$510.00
$446.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$446.00
$446.00
$446.00
$510.00
$510.00
$446.00
....................
....................
....................
$510.00
$446.00
$510.00
....................
$446.00
....................
....................
$630.00
$630.00
$510.00
$510.00
$510.00
$510.00
....................
$510.00
$510.00
$510.00
....................
....................
$446.00
....................
$510.00
$510.00
$510.00
$510.00
$510.00
$717.00
$717.00
$717.00
$995.00
$717.00
$717.00
$630.00
$630.00
$510.00
$510.00
$630.00
$510.00
$446.00
$510.00
$103.62
$103.62
$630.00
20.8706
25.1296
25.1296
20.8706
20.8706
25.1296
25.1296
20.8706
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
41.0893
66.5800
41.0893
25.1296
25.1296
2.4867
15.1024
....................
14.5947
25.1296
25.1296
20.8706
41.0893
66.5800
41.0893
20.8706
41.0893
41.0893
41.0893
25.1296
66.5800
25.1296
41.0893
25.1296
25.1296
25.1296
25.1296
25.1296
33.4505
107.1942
47.4378
107.1942
33.4505
107.1942
25.1296
25.1296
41.0893
66.5800
66.5800
41.0893
25.1296
66.5800
1.6857
1.6857
57.2172
$887.90
$1,069.09
$1,069.09
$887.90
$887.90
$1,069.09
$1,069.09
$887.90
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,748.06
$2,832.51
$1,748.06
$1,069.09
$1,069.09
$105.79
$642.50
....................
$620.90
$1,069.09
$1,069.09
$887.90
$1,748.06
$2,832.51
$1,748.06
$887.90
$1,748.06
$1,748.06
$1,748.06
$1,069.09
$2,832.51
$1,069.09
$1,748.06
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,423.08
$4,560.36
$2,018.15
$4,560.36
$1,423.08
$4,560.36
$1,069.09
$1,069.09
$1,748.06
$2,832.51
$2,832.51
$1,748.06
$1,069.09
$2,832.51
$71.71
$71.71
$2,434.19
$471.73
$739.77
$739.77
$604.48
$556.48
$649.77
$649.77
$604.48
$649.77
$649.77
$649.77
$601.77
$601.77
$601.77
$649.77
$649.77
$601.77
$1,069.09
$1,748.06
$2,832.51
$819.52
$601.77
$649.77
$105.79
$495.13
....................
$620.90
$739.77
$739.77
$604.48
$819.52
$1,090.63
$819.52
$887.90
$819.52
$819.52
$819.52
$1,069.09
$2,832.51
$601.77
$1,748.06
$649.77
$649.77
$649.77
$649.77
$649.77
$893.52
$1,677.84
$1,042.29
$1,886.34
$893.52
$1,677.84
$739.77
$739.77
$819.52
$1,090.63
$1,180.63
$819.52
$601.77
$1,090.63
$95.64
$95.64
$1,081.05
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00092
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42561
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
24516
24530
24535
24538
24545
24546
24560
24565
24566
24575
24576
24577
24579
24582
24586
24587
24600
24605
24615
24620
24635
24640
24650
24655
24665
24666
24670
24675
24685
24800
24802
24925
25000
25001
25020
25023
25024
25025
25028
25031
25035
25040
25065
25066
25075
25076
25077
25085
25100
25101
25105
25107
25109
25110
25111
25112
25115
25116
25118
25119
25120
25125
25126
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat humerus fracture ..................................
Treat elbow fracture .......................................
Treat elbow fracture .......................................
Treat elbow dislocation ..................................
Treat elbow dislocation ..................................
Treat elbow dislocation ..................................
Treat elbow fracture .......................................
Treat elbow fracture .......................................
Treat elbow dislocation ..................................
Treat radius fracture ......................................
Treat radius fracture ......................................
Treat radius fracture ......................................
Treat radius fracture ......................................
Treat ulnar fracture ........................................
Treat ulnar fracture ........................................
Treat ulnar fracture ........................................
Fusion of elbow joint ......................................
Fusion/graft of elbow joint .............................
Amputation follow-up surgery ........................
Incision of tendon sheath ..............................
Incise flexor carpi radialis ..............................
Decompress forearm 1 space .......................
Decompress forearm 1 space .......................
Decompress forearm 2 spaces .....................
Decompress forearm 2 spaces .....................
Drainage of forearm lesion ............................
Drainage of forearm bursa ............................
Treat forearm bone lesion .............................
Explore/treat wrist joint ..................................
Biopsy forearm soft tissues ...........................
Biopsy forearm soft tissues ...........................
Removal forearm lesion subcu ......................
Removal forearm lesion deep .......................
Remove tumor, forearm/wrist ........................
Incision of wrist capsule ................................
Biopsy of wrist joint ........................................
Explore/treat wrist joint ..................................
Remove wrist joint lining ................................
Remove wrist joint cartilage ..........................
Excise tendon forearm/wrist ..........................
Remove wrist tendon lesion ..........................
Remove wrist tendon lesion ..........................
Reremove wrist tendon lesion .......................
Remove wrist/forearm lesion .........................
Remove wrist/forearm lesion .........................
Excise wrist tendon sheath ............................
Partial removal of ulna ...................................
Removal of forearm lesion ............................
Remove/graft forearm lesion .........................
Remove/graft forearm lesion .........................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$630.00
$103.62
$103.62
$446.00
$630.00
$717.00
$103.62
$103.62
$446.00
$510.00
$103.62
$103.62
$510.00
$446.00
$630.00
$717.00
$103.62
$446.00
$510.00
$103.62
$510.00
....................
....................
$103.62
$630.00
$630.00
$103.62
$103.62
$510.00
$630.00
$717.00
$510.00
$510.00
....................
$510.00
$510.00
$510.00
$510.00
$333.00
$446.00
$446.00
$717.00
....................
$446.00
$446.00
$510.00
$510.00
$510.00
$446.00
$510.00
$630.00
$510.00
....................
$510.00
$510.00
$630.00
$630.00
$630.00
$446.00
$510.00
$510.00
$510.00
$510.00
57.2172
1.6857
1.6857
25.5264
57.2172
57.2172
1.6857
1.6857
25.5264
57.2172
1.6857
1.6857
57.2172
25.5264
57.2172
57.2172
1.6857
14.5947
57.2172
1.6857
57.2172
1.6857
1.6857
1.6857
37.5382
57.2172
1.6857
1.6857
37.5382
41.0893
41.0893
20.8706
20.8706
20.8706
20.8706
25.1296
25.1296
25.1296
20.8706
20.8706
20.8706
25.1296
3.0259
20.0656
15.1024
20.0656
20.0656
20.8706
20.8706
25.1296
25.1296
25.1296
20.8706
20.8706
16.1540
16.1540
20.8706
20.8706
25.1296
25.1296
25.1296
25.1296
25.1296
Estimated
CY 2008
fully implemented
payment
$2,434.19
$71.71
$71.71
$1,085.97
$2,434.19
$2,434.19
$71.71
$71.71
$1,085.97
$2,434.19
$71.71
$71.71
$2,434.19
$1,085.97
$2,434.19
$2,434.19
$71.71
$620.90
$2,434.19
$71.71
$2,434.19
$71.71
$71.71
$71.71
$1,596.99
$2,434.19
$71.71
$71.71
$1,596.99
$1,748.06
$1,748.06
$887.90
$887.90
$887.90
$887.90
$1,069.09
$1,069.09
$1,069.09
$887.90
$887.90
$887.90
$1,069.09
$128.73
$853.65
$642.50
$853.65
$853.65
$887.90
$887.90
$1,069.09
$1,069.09
$1,069.09
$887.90
$887.90
$687.24
$687.24
$887.90
$887.90
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
Estimated
CY 2008
first transition year
payment
$1,081.05
$95.64
$95.64
$605.99
$1,081.05
$1,146.30
$95.64
$95.64
$605.99
$991.05
$95.64
$95.64
$991.05
$605.99
$1,081.05
$1,146.30
$95.64
$489.73
$991.05
$95.64
$991.05
$71.71
$71.71
$95.64
$871.75
$1,081.05
$95.64
$95.64
$781.75
$909.52
$974.77
$604.48
$604.48
$887.90
$604.48
$649.77
$649.77
$649.77
$471.73
$556.48
$556.48
$805.02
$128.73
$547.91
$495.13
$595.91
$595.91
$604.48
$556.48
$649.77
$739.77
$649.77
$887.90
$604.48
$554.31
$644.31
$694.48
$694.48
$601.77
$649.77
$649.77
$649.77
$649.77
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00093
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42562
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Removal of wrist lesion .................................
Remove & graft wrist lesion ..........................
Remove & graft wrist lesion ..........................
Remove forearm bone lesion ........................
Partial removal of ulna ...................................
Partial removal of radius ................................
Removal of wrist bone ...................................
Removal of wrist bones .................................
Partial removal of radius ................................
Partial removal of ulna ...................................
Injection for wrist x-ray ..................................
Remove forearm foreign body .......................
Removal of wrist prosthesis ..........................
Removal of wrist prosthesis ..........................
Manipulate wrist w/anesthes .........................
Repair forearm tendon/muscle ......................
Repair forearm tendon/muscle ......................
Repair forearm tendon/muscle ......................
Repair forearm tendon/muscle ......................
Repair forearm tendon/muscle ......................
Repair forearm tendon/muscle ......................
Repair forearm tendon sheath .......................
Revise wrist/forearm tendon ..........................
Incise wrist/forearm tendon ...........................
Release wrist/forearm tendon ........................
Fusion of tendons at wrist .............................
Fusion of tendons at wrist .............................
Transplant forearm tendon ............................
Transplant forearm tendon ............................
Revise palsy hand tendon(s) .........................
Revise palsy hand tendon(s) .........................
Repair/revise wrist joint .................................
Revise wrist joint ............................................
Realignment of hand .....................................
Reconstruct ulna/radioulnar ...........................
Revision of radius ..........................................
Revision of radius ..........................................
Revision of ulna .............................................
Revise radius & ulna .....................................
Revise radius or ulna .....................................
Revise radius & ulna .....................................
Shorten radius or ulna ...................................
Lengthen radius or ulna .................................
Shorten radius & ulna ....................................
Lengthen radius & ulna .................................
Repair carpal bone, shorten ..........................
Repair radius or ulna .....................................
Repair/graft radius or ulna .............................
Repair radius & ulna ......................................
Repair/graft radius & ulna ..............................
Repair/graft radius or ulna .............................
Repair/graft radius & ulna ..............................
Vasc graft into carpal bone ...........................
Repair nonunion carpal bone ........................
Repair/graft wrist bone ..................................
Reconstruct wrist joint ...................................
Reconstruct wrist joint ...................................
Reconstruct wrist joint ...................................
Reconstruct wrist joint ...................................
Reconstruct wrist joint ...................................
Wrist replacement ..........................................
Repair wrist joint(s) ........................................
Remove wrist joint implant ............................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
25130
25135
25136
25145
25150
25151
25210
25215
25230
25240
25246
25248
25250
25251
25259
25260
25263
25265
25270
25272
25274
25275
25280
25290
25295
25300
25301
25310
25312
25315
25316
25320
25332
25335
25337
25350
25355
25360
25365
25370
25375
25390
25391
25392
25393
25394
25400
25405
25415
25420
25425
25426
25430
25431
25440
25441
25442
25443
25444
25445
25446
25447
25449
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
N1
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
G2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
$510.00
$510.00
$446.00
$446.00
$446.00
$510.00
$630.00
$630.00
$630.00
....................
$446.00
$333.00
$333.00
....................
$630.00
$446.00
$510.00
$630.00
$510.00
$630.00
$630.00
$630.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$510.00
$510.00
$510.00
$717.00
$510.00
$717.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$510.00
$630.00
$510.00
$630.00
....................
$510.00
$630.00
$510.00
$630.00
$510.00
$630.00
....................
....................
$630.00
$717.00
$717.00
$717.00
$717.00
$717.00
$995.00
$717.00
$717.00
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.8758
25.8758
25.1296
25.1296
....................
20.8706
25.1296
25.1296
1.6857
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
20.8706
25.1296
25.1296
41.0893
41.0893
41.0893
66.5800
41.0893
33.4505
41.0893
41.0893
66.5800
41.0893
25.1296
25.1296
41.0893
41.0893
25.1296
41.0893
25.1296
41.0893
16.1540
25.1296
25.1296
25.1296
66.5800
41.0893
41.0893
25.8758
25.8758
66.5800
107.1942
107.1942
47.4378
47.4378
47.4378
107.1942
33.4505
33.4505
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,100.83
$1,100.83
$1,069.09
$1,069.09
....................
$887.90
$1,069.09
$1,069.09
$71.71
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$887.90
$1,069.09
$1,069.09
$1,748.06
$1,748.06
$1,748.06
$2,832.51
$1,748.06
$1,423.08
$1,748.06
$1,748.06
$2,832.51
$1,748.06
$1,069.09
$1,069.09
$1,748.06
$1,748.06
$1,069.09
$1,748.06
$1,069.09
$1,748.06
$687.24
$1,069.09
$1,069.09
$1,069.09
$2,832.51
$1,748.06
$1,748.06
$1,100.83
$1,100.83
$2,832.51
$4,560.36
$4,560.36
$2,018.15
$2,018.15
$2,018.15
$4,560.36
$1,423.08
$1,423.08
$649.77
$649.77
$649.77
$601.77
$601.77
$601.77
$657.71
$747.71
$739.77
$739.77
....................
$556.48
$517.02
$517.02
$71.71
$739.77
$601.77
$649.77
$739.77
$649.77
$739.77
$739.77
$739.77
$649.77
$604.48
$649.77
$649.77
$819.52
$909.52
$819.52
$1,090.63
$819.52
$893.52
$819.52
$974.77
$1,090.63
$819.52
$649.77
$649.77
$819.52
$909.52
$649.77
$909.52
$649.77
$909.52
$687.24
$649.77
$739.77
$649.77
$1,180.63
$819.52
$909.52
$1,100.83
$1,100.83
$1,180.63
$1,677.84
$1,677.84
$1,042.29
$1,042.29
$1,042.29
$1,886.34
$893.52
$893.52
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00094
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42563
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
25450
25455
25490
25491
25492
25500
25505
25515
25520
25525
25526
25530
25535
25545
25560
25565
25574
25575
25600
25605
25606
25607
25608
25609
25622
25624
25628
25630
25635
25645
25650
25651
25652
25660
25670
25671
25675
25676
25680
25685
25690
25695
25800
25805
25810
25820
25825
25830
25907
25922
25929
26010
26011
26020
26025
26030
26034
26035
26040
26045
26055
26060
26070
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Revision of wrist joint .....................................
Revision of wrist joint .....................................
Reinforce radius .............................................
Reinforce ulna ................................................
Reinforce radius and ulna .............................
Treat fracture of radius ..................................
Treat fracture of radius ..................................
Treat fracture of radius ..................................
Treat fracture of radius ..................................
Treat fracture of radius ..................................
Treat fracture of radius ..................................
Treat fracture of ulna .....................................
Treat fracture of ulna .....................................
Treat fracture of ulna .....................................
Treat fracture radius & ulna ...........................
Treat fracture radius & ulna ...........................
Treat fracture radius & ulna ...........................
Treat fracture radius/ulna ..............................
Treat fracture radius/ulna ..............................
Treat fracture radius/ulna ..............................
Treat fx distal radial .......................................
Treat fx rad extra-articul ................................
Treat fx rad intra-articul .................................
Treat fx radial 3+ frag ....................................
Treat wrist bone fracture ...............................
Treat wrist bone fracture ...............................
Treat wrist bone fracture ...............................
Treat wrist bone fracture ...............................
Treat wrist bone fracture ...............................
Treat wrist bone fracture ...............................
Treat wrist bone fracture ...............................
Pin ulnar styloid fracture ................................
Treat fracture ulnar styloid .............................
Treat wrist dislocation ....................................
Treat wrist dislocation ....................................
Pin radioulnar dislocation ..............................
Treat wrist dislocation ....................................
Treat wrist dislocation ....................................
Treat wrist fracture .........................................
Treat wrist fracture .........................................
Treat wrist dislocation ....................................
Treat wrist dislocation ....................................
Fusion of wrist joint ........................................
Fusion/graft of wrist joint ...............................
Fusion/graft of wrist joint ...............................
Fusion of hand bones ....................................
Fuse hand bones with graft ...........................
Fusion, radioulnar jnt/ulna .............................
Amputation follow-up surgery ........................
Amputate hand at wrist ..................................
Amputation follow-up surgery ........................
Drainage of finger abscess ............................
Drainage of finger abscess ............................
Drain hand tendon sheath .............................
Drainage of palm bursa .................................
Drainage of palm bursa(s) .............................
Treat hand bone lesion ..................................
Decompress fingers/hand ..............................
Release palm contracture ..............................
Release palm contracture ..............................
Incise finger tendon sheath ...........................
Incision of finger tendon ................................
Explore/treat hand joint ..................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
P2
A2
A2
A2
A2
A2
P2
A2
A2
P2
A2
A2
A2
P2
A2
A2
A2
A2
A2
P2
A2
A2
P2
A2
A2
P2
G2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$510.00
$510.00
$510.00
$510.00
$510.00
....................
$103.62
$510.00
$103.62
$630.00
$717.00
....................
$103.62
$510.00
....................
$103.62
$510.00
$510.00
....................
$103.62
$510.00
$717.00
$717.00
$717.00
....................
$103.62
$510.00
....................
$103.62
$510.00
....................
....................
....................
$103.62
$510.00
$333.00
$103.62
$446.00
$103.62
$510.00
$103.62
$446.00
$630.00
$717.00
$717.00
$630.00
$717.00
$717.00
$510.00
$510.00
$510.00
....................
$333.00
$446.00
$333.00
$446.00
$446.00
....................
$630.00
$510.00
$446.00
$446.00
$446.00
41.0893
41.0893
41.0893
41.0893
41.0893
1.6857
1.6857
37.5382
1.6857
37.5382
37.5382
1.6857
1.6857
37.5382
1.6857
1.6857
57.2172
57.2172
1.6857
1.6857
25.5264
57.2172
57.2172
57.2172
1.6857
1.6857
37.5382
1.6857
1.6857
37.5382
1.6857
25.5264
37.5382
1.6857
25.5264
25.5264
1.6857
25.5264
1.6857
25.5264
1.6857
25.5264
66.5800
41.0893
66.5800
16.1540
25.8758
66.5800
20.8706
20.8706
14.0346
1.4392
11.1535
16.1540
16.1540
16.1540
16.1540
16.1540
25.8758
25.8758
16.1540
16.1540
16.1540
Estimated
CY 2008
fully implemented
payment
$1,748.06
$1,748.06
$1,748.06
$1,748.06
$1,748.06
$71.71
$71.71
$1,596.99
$71.71
$1,596.99
$1,596.99
$71.71
$71.71
$1,596.99
$71.71
$71.71
$2,434.19
$2,434.19
$71.71
$71.71
$1,085.97
$2,434.19
$2,434.19
$2,434.19
$71.71
$71.71
$1,596.99
$71.71
$71.71
$1,596.99
$71.71
$1,085.97
$1,596.99
$71.71
$1,085.97
$1,085.97
$71.71
$1,085.97
$71.71
$1,085.97
$71.71
$1,085.97
$2,832.51
$1,748.06
$2,832.51
$687.24
$1,100.83
$2,832.51
$887.90
$887.90
$597.07
$61.23
$474.50
$687.24
$687.24
$687.24
$687.24
$687.24
$1,100.83
$1,100.83
$687.24
$687.24
$687.24
Estimated
CY 2008
first transition year
payment
$819.52
$819.52
$819.52
$819.52
$819.52
$71.71
$95.64
$781.75
$95.64
$871.75
$937.00
$71.71
$95.64
$781.75
$71.71
$95.64
$991.05
$991.05
$71.71
$95.64
$653.99
$1,146.30
$1,146.30
$1,146.30
$71.71
$95.64
$781.75
$71.71
$95.64
$781.75
$71.71
$1,085.97
$1,596.99
$95.64
$653.99
$521.24
$95.64
$605.99
$95.64
$653.99
$95.64
$605.99
$1,180.63
$974.77
$1,245.88
$644.31
$812.96
$1,245.88
$604.48
$604.48
$531.77
$61.23
$368.38
$506.31
$421.56
$506.31
$506.31
$687.24
$747.71
$657.71
$506.31
$506.31
$506.31
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00095
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42564
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
26075
26080
26100
26105
26110
26115
26116
26117
26121
26123
26125
26130
26135
26140
26145
26160
26170
26180
26185
26200
26205
26210
26215
26230
26235
26236
26250
26255
26260
26261
26262
26320
26340
26350
26352
26356
26357
26358
26370
26372
26373
26390
26392
26410
26412
26415
26416
26418
26420
26426
26428
26432
26433
26434
26437
26440
26442
26445
26449
26450
26455
26460
26471
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Explore/treat finger joint .................................
Explore/treat finger joint .................................
Biopsy hand joint lining ..................................
Biopsy finger joint lining .................................
Biopsy finger joint lining .................................
Removal hand lesion subcut .........................
Removal hand lesion, deep ...........................
Remove tumor, hand/finger ...........................
Release palm contracture ..............................
Release palm contracture ..............................
Release palm contracture ..............................
Remove wrist joint lining ................................
Revise finger joint, each ................................
Revise finger joint, each ................................
Tendon excision, palm/finger .........................
Remove tendon sheath lesion .......................
Removal of palm tendon, each .....................
Removal of finger tendon ..............................
Remove finger bone ......................................
Remove hand bone lesion .............................
Remove/graft bone lesion ..............................
Removal of finger lesion ................................
Remove/graft finger lesion .............................
Partial removal of hand bone ........................
Partial removal, finger bone ..........................
Partial removal, finger bone ..........................
Extensive hand surgery .................................
Extensive hand surgery .................................
Extensive finger surgery ................................
Extensive finger surgery ................................
Partial removal of finger ................................
Removal of implant from hand ......................
Manipulate finger w/anesth ............................
Repair finger/hand tendon .............................
Repair/graft hand tendon ...............................
Repair finger/hand tendon .............................
Repair finger/hand tendon .............................
Repair/graft hand tendon ...............................
Repair finger/hand tendon .............................
Repair/graft hand tendon ...............................
Repair finger/hand tendon .............................
Revise hand/finger tendon .............................
Repair/graft hand tendon ...............................
Repair hand tendon .......................................
Repair/graft hand tendon ...............................
Excision, hand/finger tendon .........................
Graft hand or finger tendon ...........................
Repair finger tendon ......................................
Repair/graft finger tendon ..............................
Repair finger/hand tendon .............................
Repair/graft finger tendon ..............................
Repair finger tendon ......................................
Repair finger tendon ......................................
Repair/graft finger tendon ..............................
Realignment of tendons .................................
Release palm/finger tendon ...........................
Release palm & finger tendon .......................
Release hand/finger tendon ..........................
Release forearm/hand tendon .......................
Incision of palm tendon .................................
Incision of finger tendon ................................
Incise hand/finger tendon ..............................
Fusion of finger tendons ................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$630.00
$630.00
$446.00
$333.00
$333.00
$446.00
$446.00
$510.00
$630.00
$630.00
$630.00
$510.00
$630.00
$446.00
$510.00
$510.00
$510.00
$510.00
$630.00
$446.00
$510.00
$446.00
$510.00
$992.95
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$446.00
$446.00
....................
$333.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$510.00
$630.00
$510.00
$510.00
$510.00
$630.00
$510.00
$630.00
$630.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$446.00
16.1540
16.1540
16.1540
16.1540
16.1540
20.0656
20.0656
20.0656
25.8758
25.8758
16.1540
16.1540
25.8758
16.1540
16.1540
16.1540
16.1540
16.1540
16.1540
16.1540
25.8758
16.1540
16.1540
16.1540
16.1540
16.1540
16.1540
25.8758
16.1540
16.1540
16.1540
15.1024
1.6857
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
16.1540
25.8758
25.8758
25.8758
16.1540
25.8758
25.8758
25.8758
16.1540
16.1540
25.8758
16.1540
16.1540
25.8758
16.1540
25.8758
16.1540
16.1540
16.1540
16.1540
Estimated
CY 2008
fully implemented
payment
$687.24
$687.24
$687.24
$687.24
$687.24
$853.65
$853.65
$853.65
$1,100.83
$1,100.83
$687.24
$687.24
$1,100.83
$687.24
$687.24
$687.24
$687.24
$687.24
$687.24
$687.24
$1,100.83
$687.24
$687.24
$687.24
$687.24
$687.24
$687.24
$1,100.83
$687.24
$687.24
$687.24
$642.50
$71.71
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$687.24
$1,100.83
$1,100.83
$1,100.83
$687.24
$1,100.83
$1,100.83
$1,100.83
$687.24
$687.24
$1,100.83
$687.24
$687.24
$1,100.83
$687.24
$1,100.83
$687.24
$687.24
$687.24
$687.24
Estimated
CY 2008
first transition year
payment
$644.31
$644.31
$506.31
$421.56
$421.56
$547.91
$547.91
$595.91
$747.71
$747.71
$644.31
$554.31
$747.71
$506.31
$554.31
$554.31
$554.31
$554.31
$644.31
$506.31
$657.71
$506.31
$554.31
$916.52
$554.31
$554.31
$554.31
$657.71
$554.31
$554.31
$506.31
$495.13
$71.71
$524.96
$747.71
$747.71
$747.71
$747.71
$747.71
$747.71
$657.71
$747.71
$657.71
$554.31
$657.71
$747.71
$657.71
$644.31
$747.71
$657.71
$657.71
$554.31
$554.31
$657.71
$554.31
$554.31
$657.71
$554.31
$657.71
$554.31
$554.31
$554.31
$506.31
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00096
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42565
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
26474
26476
26477
26478
26479
26480
26483
26485
26489
26490
26492
26494
26496
26497
26498
26499
26500
26502
26508
26510
26516
26517
26518
26520
26525
26530
26531
26535
26536
26540
26541
26542
26545
26546
26548
26550
26555
26560
26561
26562
26565
26567
26568
26580
26587
26590
26591
26593
26596
26600
26605
26607
26608
26615
26641
26645
26650
26665
26670
26675
26676
26685
26686
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Fusion of finger tendons ................................
Tendon lengthening .......................................
Tendon shortening .........................................
Lengthening of hand tendon ..........................
Shortening of hand tendon ............................
Transplant hand tendon .................................
Transplant/graft hand tendon ........................
Transplant palm tendon .................................
Transplant/graft palm tendon .........................
Revise thumb tendon .....................................
Tendon transfer with graft .............................
Hand tendon/muscle transfer ........................
Revise thumb tendon .....................................
Finger tendon transfer ...................................
Finger tendon transfer ...................................
Revision of finger ...........................................
Hand tendon reconstruction ..........................
Hand tendon reconstruction ..........................
Release thumb contracture ...........................
Thumb tendon transfer ..................................
Fusion of knuckle joint ...................................
Fusion of knuckle joints .................................
Fusion of knuckle joints .................................
Release knuckle contracture .........................
Release finger contracture ............................
Revise knuckle joint .......................................
Revise knuckle with implant ..........................
Revise finger joint ..........................................
Revise/implant finger joint .............................
Repair hand joint ...........................................
Repair hand joint with graft ...........................
Repair hand joint with graft ...........................
Reconstruct finger joint ..................................
Repair nonunion hand ...................................
Reconstruct finger joint ..................................
Construct thumb replacement .......................
Positional change of finger ............................
Repair of web finger ......................................
Repair of web finger ......................................
Repair of web finger ......................................
Correct metacarpal flaw .................................
Correct finger deformity .................................
Lengthen metacarpal/finger ...........................
Repair hand deformity ...................................
Reconstruct extra finger ................................
Repair finger deformity ..................................
Repair muscles of hand .................................
Release muscles of hand ..............................
Excision constricting tissue ............................
Treat metacarpal fracture ..............................
Treat metacarpal fracture ..............................
Treat metacarpal fracture ..............................
Treat metacarpal fracture ..............................
Treat metacarpal fracture ..............................
Treat thumb dislocation .................................
Treat thumb fracture ......................................
Treat thumb fracture ......................................
Treat thumb fracture ......................................
Treat hand dislocation ...................................
Treat hand dislocation ...................................
Pin hand dislocation ......................................
Treat hand dislocation ...................................
Treat hand dislocation ...................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P2
A2
A2
A2
A2
G2
A2
A2
A2
G2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$446.00
$333.00
$333.00
$333.00
$333.00
$510.00
$510.00
$446.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$510.00
$630.00
$630.00
$510.00
$510.00
$333.00
$510.00
$510.00
$510.00
$510.00
$510.00
$995.00
$717.00
$717.00
$630.00
$995.00
$630.00
$630.00
$630.00
$630.00
$446.00
$510.00
$446.00
$510.00
$630.00
$717.00
$717.00
$510.00
$717.00
$717.00
$717.00
$510.00
$510.00
$446.00
....................
$103.62
$103.62
$630.00
$630.00
....................
$103.62
$446.00
$630.00
....................
$103.62
$446.00
$510.00
$510.00
16.1540
16.1540
16.1540
16.1540
16.1540
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
16.1540
25.8758
16.1540
25.8758
25.8758
25.8758
25.8758
16.1540
16.1540
33.4505
47.4378
33.4505
47.4378
16.1540
25.8758
16.1540
25.8758
25.8758
25.8758
25.8758
25.8758
16.1540
25.8758
25.8758
25.8758
25.8758
25.8758
16.1540
16.1540
16.1540
25.8758
16.1540
16.1540
1.6857
1.6857
1.6857
25.5264
37.5382
1.6857
1.6857
25.5264
37.5382
1.6857
1.6857
25.5264
37.5382
57.2172
Estimated
CY 2008
fully implemented
payment
$687.24
$687.24
$687.24
$687.24
$687.24
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$687.24
$1,100.83
$687.24
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$687.24
$687.24
$1,423.08
$2,018.15
$1,423.08
$2,018.15
$687.24
$1,100.83
$687.24
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$687.24
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$687.24
$687.24
$687.24
$1,100.83
$687.24
$687.24
$71.71
$71.71
$71.71
$1,085.97
$1,596.99
$71.71
$71.71
$1,085.97
$1,596.99
$71.71
$71.71
$1,085.97
$1,596.99
$2,434.19
Estimated
CY 2008
first transition year
payment
$506.31
$421.56
$421.56
$421.56
$421.56
$657.71
$657.71
$609.71
$657.71
$657.71
$657.71
$657.71
$657.71
$657.71
$747.71
$657.71
$644.31
$747.71
$554.31
$657.71
$524.96
$657.71
$657.71
$554.31
$554.31
$738.27
$1,250.79
$893.52
$1,042.29
$644.31
$1,021.46
$644.31
$747.71
$747.71
$747.71
$609.71
$657.71
$506.31
$657.71
$747.71
$812.96
$812.96
$657.71
$709.56
$709.56
$709.56
$657.71
$554.31
$506.31
$71.71
$95.64
$95.64
$743.99
$871.75
$71.71
$95.64
$605.99
$871.75
$71.71
$95.64
$605.99
$781.75
$991.05
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00097
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42566
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Treat knuckle dislocation ...............................
Treat knuckle dislocation ...............................
Pin knuckle dislocation ..................................
Treat knuckle dislocation ...............................
Treat finger fracture, each .............................
Treat finger fracture, each .............................
Treat finger fracture, each .............................
Treat finger fracture, each .............................
Treat finger fracture, each .............................
Treat finger fracture, each .............................
Treat finger fracture, each .............................
Treat finger fracture, each .............................
Treat finger fracture, each .............................
Pin finger fracture, each ................................
Treat finger fracture, each .............................
Treat finger dislocation ..................................
Treat finger dislocation ..................................
Pin finger dislocation .....................................
Treat finger dislocation ..................................
Thumb fusion with graft .................................
Fusion of thumb .............................................
Thumb fusion with graft .................................
Fusion of hand joint .......................................
Fusion/graft of hand joint ...............................
Fusion of knuckle ...........................................
Fusion of knuckle with graft ...........................
Fusion of finger joint ......................................
Fusion of finger jnt, add-on ...........................
Fusion/graft of finger joint ..............................
Fuse/graft added joint ....................................
Amputate metacarpal bone ...........................
Amputation of finger/thumb ...........................
Amputation of finger/thumb ...........................
Drainage of pelvis lesion ...............................
Drainage of pelvis bursa ................................
Incision of hip tendon ....................................
Incision of hip tendon ....................................
Incision of hip tendon ....................................
Exploration of hip joint ...................................
Denervation of hip joint ..................................
Biopsy of soft tissues .....................................
Biopsy of soft tissues .....................................
Remove hip/pelvis lesion ...............................
Remove hip/pelvis lesion ...............................
Remove tumor, hip/pelvis ..............................
Biopsy of sacroiliac joint ................................
Biopsy of hip joint ..........................................
Removal of ischial bursa ...............................
Remove femur lesion/bursa ...........................
Removal of hip bone lesion ...........................
Removal of hip bone lesion ...........................
Remove/graft hip bone lesion ........................
Removal of tail bone ......................................
Remove hip foreign body ..............................
Remove hip foreign body ..............................
Injection for hip x-ray .....................................
Injection for hip x-ray .....................................
Revision of hip tendon ...................................
Transfer tendon to pelvis ...............................
Transfer of abdominal muscle .......................
Transfer of spinal muscle ..............................
Transfer of iliopsoas muscle ..........................
Transfer of iliopsoas muscle ..........................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
26700
26705
26706
26715
26720
26725
26727
26735
26740
26742
26746
26750
26755
26756
26765
26770
26775
26776
26785
26820
26841
26842
26843
26844
26850
26852
26860
26861
26862
26863
26910
26951
26952
26990
26991
27000
27001
27003
27033
27035
27040
27041
27047
27048
27049
27050
27052
27060
27062
27065
27066
27067
27080
27086
27087
27093
27095
27097
27098
27100
27105
27110
27111
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
G2
A2
A2
A2
P2
P2
A2
A2
P2
A2
A2
P2
G2
A2
A2
G2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
N1
N1
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
....................
$103.62
$103.62
$630.00
....................
....................
$995.00
$630.00
....................
$103.62
$717.00
....................
....................
$446.00
$630.00
....................
....................
$446.00
$446.00
$717.00
$630.00
$630.00
$510.00
$510.00
$630.00
$630.00
$510.00
$446.00
$630.00
$510.00
$510.00
$446.00
$630.00
$333.00
$333.00
$446.00
$510.00
$510.00
$510.00
$630.00
$333.00
$418.49
$446.00
$510.00
$510.00
$510.00
$510.00
$717.00
$717.00
$717.00
$717.00
$717.00
$446.00
$333.00
$510.00
....................
....................
$510.00
$510.00
$630.00
$630.00
$630.00
$630.00
1.6857
1.6857
1.6857
37.5382
1.6857
1.6857
25.5264
37.5382
1.6857
1.6857
37.5382
1.6857
1.6857
25.5264
37.5382
1.6857
14.5947
25.5264
25.5264
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
25.8758
16.1540
16.1540
20.8706
20.8706
20.8706
25.1296
25.1296
41.0893
41.0893
6.8083
6.8083
20.0656
20.0656
20.0656
20.8706
20.8706
20.8706
20.8706
20.8706
25.1296
25.1296
25.1296
6.8083
20.8706
....................
....................
25.1296
25.1296
41.0893
41.0893
41.0893
41.0893
$71.71
$71.71
$71.71
$1,596.99
$71.71
$71.71
$1,085.97
$1,596.99
$71.71
$71.71
$1,596.99
$71.71
$71.71
$1,085.97
$1,596.99
$71.71
$620.90
$1,085.97
$1,085.97
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$1,100.83
$687.24
$687.24
$887.90
$887.90
$887.90
$1,069.09
$1,069.09
$1,748.06
$1,748.06
$289.65
$289.65
$853.65
$853.65
$853.65
$887.90
$887.90
$887.90
$887.90
$887.90
$1,069.09
$1,069.09
$1,069.09
$289.65
$887.90
....................
....................
$1,069.09
$1,069.09
$1,748.06
$1,748.06
$1,748.06
$1,748.06
$71.71
$95.64
$95.64
$871.75
$71.71
$71.71
$1,017.74
$871.75
$71.71
$95.64
$937.00
$71.71
$71.71
$605.99
$871.75
$71.71
$620.90
$605.99
$605.99
$812.96
$747.71
$747.71
$657.71
$657.71
$747.71
$747.71
$657.71
$609.71
$747.71
$657.71
$657.71
$506.31
$644.31
$471.73
$471.73
$556.48
$649.77
$649.77
$819.52
$909.52
$322.16
$386.28
$547.91
$595.91
$595.91
$604.48
$604.48
$759.73
$759.73
$759.73
$805.02
$805.02
$601.77
$322.16
$604.48
....................
....................
$649.77
$649.77
$909.52
$909.52
$909.52
$909.52
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00098
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42567
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Treat pelvic ring fracture ................................
Treat pelvic ring fracture ................................
Treat tail bone fracture ..................................
Treat tail bone fracture ..................................
Treat hip socket fracture ................................
Treat thigh fracture ........................................
Treat thigh fracture ........................................
Treat thigh fracture ........................................
Treat hip dislocation ......................................
Treat hip dislocation ......................................
Treat hip dislocation ......................................
Treat hip dislocation ......................................
Treat hip dislocation ......................................
Treat hip dislocation ......................................
Manipulation of hip joint .................................
Drain thigh/knee lesion ..................................
Incise thigh tendon & fascia ..........................
Incision of thigh tendon .................................
Incision of thigh tendons ................................
Exploration of knee joint ................................
Biopsy, thigh soft tissues ...............................
Biopsy, thigh soft tissues ...............................
Neurectomy, hamstring ..................................
Neurectomy, popliteal ....................................
Removal of thigh lesion .................................
Removal of thigh lesion .................................
Remove tumor, thigh/knee ............................
Biopsy, knee joint lining .................................
Explore/treat knee joint ..................................
Removal of knee cartilage .............................
Removal of knee cartilage .............................
Remove knee joint lining ...............................
Remove knee joint lining ...............................
Removal of kneecap bursa ............................
Removal of knee cyst ....................................
Remove knee cyst .........................................
Removal of kneecap ......................................
Remove femur lesion .....................................
Remove femur lesion/graft ............................
Remove femur lesion/graft ............................
Remove femur lesion/fixation ........................
Partial removal, leg bone(s) ..........................
Injection for knee x-ray ..................................
Removal of foreign body ...............................
Repair of kneecap tendon .............................
Repair/graft kneecap tendon .........................
Repair of thigh muscle ...................................
Repair/graft of thigh muscle ..........................
Incision of thigh tendon .................................
Incision of thigh tendons ................................
Incision of thigh tendons ................................
Lengthening of thigh tendon ..........................
Lengthening of thigh tendons ........................
Lengthening of thigh tendons ........................
Transplant of thigh tendon .............................
Transplants of thigh tendons .........................
Revise thigh muscles/tendons .......................
Repair of knee cartilage ................................
Repair of knee ligament ................................
Repair of knee ligament ................................
Repair of knee ligaments ...............................
Repair degenerated kneecap ........................
Revision of unstable kneecap .......................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
27193
27194
27200
27202
27220
27230
27238
27246
27250
27252
27256
27257
27265
27266
27275
27301
27305
27306
27307
27310
27323
27324
27325
27326
27327
27328
27329
27330
27331
27332
27333
27334
27335
27340
27345
27347
27350
27355
27356
27357
27358
27360
27370
27372
27380
27381
27385
27386
27390
27391
27392
27393
27394
27395
27396
27397
27400
27403
27405
27407
27409
27418
27420
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
P2
A2
G2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
N1
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$103.62
$446.00
....................
$446.00
....................
$103.62
$103.62
$103.62
$103.62
$446.00
....................
$510.00
$103.62
$446.00
$446.00
$510.00
$446.00
$510.00
$510.00
$630.00
$333.00
$333.00
$446.00
$446.00
$446.00
$510.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$510.00
$630.00
$630.00
$630.00
$510.00
$630.00
$717.00
$717.00
$717.00
....................
$995.00
$333.00
$510.00
$510.00
$510.00
$333.00
$446.00
$510.00
$446.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$630.00
$630.00
$630.00
$510.00
$510.00
1.6857
14.5947
1.6857
37.5382
1.6857
1.6857
1.6857
1.6857
1.6857
14.5947
1.6857
14.5947
1.6857
14.5947
14.5947
17.5086
20.8706
20.8706
20.8706
25.1296
6.8083
20.0656
17.8499
17.8499
20.0656
20.0656
20.0656
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
20.8706
20.8706
20.8706
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
....................
20.0656
20.8706
20.8706
20.8706
20.8706
20.8706
20.8706
20.8706
25.1296
25.1296
41.0893
25.1296
41.0893
41.0893
25.1296
41.0893
66.5800
41.0893
41.0893
41.0893
$71.71
$620.90
$71.71
$1,596.99
$71.71
$71.71
$71.71
$71.71
$71.71
$620.90
$71.71
$620.90
$71.71
$620.90
$620.90
$744.87
$887.90
$887.90
$887.90
$1,069.09
$289.65
$853.65
$759.39
$759.39
$853.65
$853.65
$853.65
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$887.90
$887.90
$887.90
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
....................
$853.65
$887.90
$887.90
$887.90
$887.90
$887.90
$887.90
$887.90
$1,069.09
$1,069.09
$1,748.06
$1,069.09
$1,748.06
$1,748.06
$1,069.09
$1,748.06
$2,832.51
$1,748.06
$1,748.06
$1,748.06
$95.64
$489.73
$71.71
$733.75
$71.71
$95.64
$95.64
$95.64
$95.64
$489.73
$71.71
$537.73
$95.64
$489.73
$489.73
$568.72
$556.48
$604.48
$604.48
$739.77
$322.16
$463.16
$524.35
$524.35
$547.91
$595.91
$685.91
$739.77
$739.77
$739.77
$739.77
$739.77
$739.77
$604.48
$694.48
$694.48
$739.77
$649.77
$739.77
$805.02
$805.02
$805.02
....................
$959.66
$471.73
$604.48
$604.48
$604.48
$471.73
$556.48
$604.48
$601.77
$649.77
$819.52
$649.77
$819.52
$819.52
$739.77
$909.52
$1,180.63
$909.52
$819.52
$819.52
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00099
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42568
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
27422
27424
27425
27427
27428
27429
27430
27435
27437
27438
27440
27441
27442
27443
27446
27496
27497
27498
27499
27500
27501
27502
27503
27508
27509
27510
27516
27517
27520
27530
27532
27538
27550
27552
27560
27562
27566
27570
27594
27600
27601
27602
27603
27604
27605
27606
27607
27610
27612
27613
27614
27615
27618
27619
27620
27625
27626
27630
27635
27637
27638
27640
27641
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Revision of unstable kneecap .......................
Revision/removal of kneecap ........................
Lat retinacular release open ..........................
Reconstruction, knee .....................................
Reconstruction, knee .....................................
Reconstruction, knee .....................................
Revision of thigh muscles ..............................
Incision of knee joint ......................................
Revise kneecap .............................................
Revise kneecap with implant .........................
Revision of knee joint ....................................
Revision of knee joint ....................................
Revision of knee joint ....................................
Revision of knee joint ....................................
Revision of knee joint ....................................
Decompression of thigh/knee ........................
Decompression of thigh/knee ........................
Decompression of thigh/knee ........................
Decompression of thigh/knee ........................
Treatment of thigh fracture ............................
Treatment of thigh fracture ............................
Treatment of thigh fracture ............................
Treatment of thigh fracture ............................
Treatment of thigh fracture ............................
Treatment of thigh fracture ............................
Treatment of thigh fracture ............................
Treat thigh fx growth plate .............................
Treat thigh fx growth plate .............................
Treat kneecap fracture ..................................
Treat knee fracture ........................................
Treat knee fracture ........................................
Treat knee fracture(s) ....................................
Treat knee dislocation ...................................
Treat knee dislocation ...................................
Treat kneecap dislocation ..............................
Treat kneecap dislocation ..............................
Treat kneecap dislocation ..............................
Fixation of knee joint .....................................
Amputation follow-up surgery ........................
Decompression of lower leg ..........................
Decompression of lower leg ..........................
Decompression of lower leg ..........................
Drain lower leg lesion ....................................
Drain lower leg bursa ....................................
Incision of achilles tendon .............................
Incision of achilles tendon .............................
Treat lower leg bone lesion ...........................
Explore/treat ankle joint .................................
Exploration of ankle joint ...............................
Biopsy lower leg soft tissue ...........................
Biopsy lower leg soft tissue ...........................
Remove tumor, lower leg ..............................
Remove lower leg lesion ...............................
Remove lower leg lesion ...............................
Explore/treat ankle joint .................................
Remove ankle joint lining ..............................
Remove ankle joint lining ..............................
Removal of tendon lesion ..............................
Remove lower leg bone lesion ......................
Remove/graft leg bone lesion ........................
Remove/graft leg bone lesion ........................
Partial removal of tibia ...................................
Partial removal of fibula .................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$995.00
$510.00
$995.00
$510.00
$630.00
$630.00
$630.00
$630.00
$630.00
$717.00
....................
$717.00
$717.00
$717.00
....................
$717.00
$510.00
$510.00
$510.00
$103.62
$103.62
$103.62
$103.62
$103.62
$510.00
$103.62
$103.62
$103.62
$103.62
$103.62
$103.62
$103.62
$103.62
$333.00
$103.62
$333.00
$446.00
$333.00
$510.00
$510.00
$510.00
$510.00
$446.00
$446.00
$333.00
$333.00
$446.00
$446.00
$510.00
....................
$446.00
$510.00
$446.00
$510.00
$630.00
$630.00
$630.00
$510.00
$510.00
$510.00
$510.00
$446.00
$446.00
41.0893
41.0893
25.1296
41.0893
66.5800
66.5800
41.0893
41.0893
33.4505
47.4378
33.4505
33.4505
33.4505
33.4505
205.6815
20.8706
20.8706
20.8706
20.8706
1.6857
1.6857
1.6857
1.6857
1.6857
25.5264
1.6857
1.6857
1.6857
1.6857
1.6857
1.6857
1.6857
1.6857
14.5947
1.6857
14.5947
37.5382
14.5947
20.8706
20.8706
20.8706
20.8706
17.5086
20.8706
20.4263
20.8706
20.8706
25.1296
25.1296
2.8569
20.0656
25.1296
15.1024
20.0656
25.1296
25.1296
25.1296
20.8706
25.1296
25.1296
25.1296
41.0893
25.1296
Estimated
CY 2008
fully implemented
payment
$1,748.06
$1,748.06
$1,069.09
$1,748.06
$2,832.51
$2,832.51
$1,748.06
$1,748.06
$1,423.08
$2,018.15
$1,423.08
$1,423.08
$1,423.08
$1,423.08
$8,750.31
$887.90
$887.90
$887.90
$887.90
$71.71
$71.71
$71.71
$71.71
$71.71
$1,085.97
$71.71
$71.71
$71.71
$71.71
$71.71
$71.71
$71.71
$71.71
$620.90
$71.71
$620.90
$1,596.99
$620.90
$887.90
$887.90
$887.90
$887.90
$744.87
$887.90
$869.00
$887.90
$887.90
$1,069.09
$1,069.09
$121.54
$853.65
$1,069.09
$642.50
$853.65
$1,069.09
$1,069.09
$1,069.09
$887.90
$1,069.09
$1,069.09
$1,069.09
$1,748.06
$1,069.09
Estimated
CY 2008
first transition year
payment
$1,183.27
$819.52
$1,013.52
$819.52
$1,180.63
$1,180.63
$909.52
$909.52
$828.27
$1,042.29
$1,423.08
$893.52
$893.52
$893.52
$8,750.31
$759.73
$604.48
$604.48
$604.48
$95.64
$95.64
$95.64
$95.64
$95.64
$653.99
$95.64
$95.64
$95.64
$95.64
$95.64
$95.64
$95.64
$95.64
$404.98
$95.64
$404.98
$733.75
$404.98
$604.48
$604.48
$604.48
$604.48
$520.72
$556.48
$467.00
$471.73
$556.48
$601.77
$649.77
$121.54
$547.91
$649.77
$495.13
$595.91
$739.77
$739.77
$739.77
$604.48
$649.77
$649.77
$649.77
$771.52
$601.77
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00100
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42569
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Extensive ankle/heel surgery .........................
Injection for ankle x-ray .................................
Repair achilles tendon ...................................
Repair/graft achilles tendon ...........................
Repair of achilles tendon ...............................
Repair leg fascia defect .................................
Repair of leg tendon, each ............................
Repair of leg tendon, each ............................
Repair of leg tendon, each ............................
Repair of leg tendon, each ............................
Repair lower leg tendons ...............................
Repair lower leg tendons ...............................
Release of lower leg tendon ..........................
Release of lower leg tendons ........................
Revision of lower leg tendon .........................
Revise lower leg tendons ..............................
Revision of calf tendon ..................................
Revise lower leg tendon ................................
Revise lower leg tendon ................................
Revise additional leg tendon .........................
Repair of ankle ligament ................................
Repair of ankle ligaments ..............................
Repair of ankle ligament ................................
Revision of ankle joint ...................................
Removal of ankle implant ..............................
Incision of tibia ...............................................
Incision of fibula .............................................
Incision of tibia & fibula .................................
Repair of tibia epiphysis ................................
Repair of fibula epiphysis ..............................
Repair lower leg epiphyses ...........................
Repair of leg epiphyses .................................
Repair of leg epiphyses .................................
Reinforce tibia ................................................
Treatment of tibia fracture .............................
Treatment of tibia fracture .............................
Treatment of tibia fracture .............................
Treatment of tibia fracture .............................
Treatment of tibia fracture .............................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of fibula fracture ...........................
Treatment of fibula fracture ...........................
Treatment of fibula fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treat lower leg fracture .................................
Treat lower leg fracture .................................
Treat lower leg fracture .................................
Treat lower leg fracture .................................
Treat lower leg fracture .................................
Treat lower leg joint .......................................
Treat lower leg dislocation .............................
Treat lower leg dislocation .............................
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
27647
27648
27650
27652
27654
27656
27658
27659
27664
27665
27675
27676
27680
27681
27685
27686
27687
27690
27691
27692
27695
27696
27698
27700
27704
27705
27707
27709
27730
27732
27734
27740
27742
27745
27750
27752
27756
27758
27759
27760
27762
27766
27780
27781
27784
27786
27788
27792
27808
27810
27814
27816
27818
27822
27823
27824
27825
27826
27827
27828
27829
27830
27831
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
N1
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
....................
$510.00
$510.00
$510.00
$446.00
$333.00
$446.00
$446.00
$446.00
$446.00
$510.00
$510.00
$446.00
$510.00
$510.00
$510.00
$630.00
$630.00
$510.00
$446.00
$446.00
$446.00
$717.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$510.00
$103.62
$103.62
$510.00
$630.00
$630.00
$103.62
$103.62
$510.00
$103.62
$103.62
$510.00
$103.62
$103.62
$510.00
$103.62
$103.62
$510.00
$103.62
$103.62
$510.00
$510.00
$103.62
$103.62
$510.00
$510.00
$630.00
$446.00
$103.62
$103.62
41.0893
....................
41.0893
66.5800
41.0893
20.8706
20.8706
20.8706
20.8706
25.1296
20.8706
25.1296
25.1296
25.1296
25.1296
25.1296
25.1296
41.0893
41.0893
41.0893
25.1296
25.1296
25.1296
33.4505
20.8706
41.0893
20.8706
25.1296
25.1296
25.1296
25.1296
25.1296
41.0893
66.5800
1.6857
1.6857
25.5264
37.5382
57.2172
1.6857
1.6857
37.5382
1.6857
1.6857
37.5382
1.6857
1.6857
37.5382
1.6857
1.6857
37.5382
1.6857
1.6857
37.5382
57.2172
1.6857
1.6857
37.5382
57.2172
57.2172
37.5382
1.6857
1.6857
$1,748.06
....................
$1,748.06
$2,832.51
$1,748.06
$887.90
$887.90
$887.90
$887.90
$1,069.09
$887.90
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,748.06
$1,748.06
$1,748.06
$1,069.09
$1,069.09
$1,069.09
$1,423.08
$887.90
$1,748.06
$887.90
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,069.09
$1,748.06
$2,832.51
$71.71
$71.71
$1,085.97
$1,596.99
$2,434.19
$71.71
$71.71
$1,596.99
$71.71
$71.71
$1,596.99
$71.71
$71.71
$1,596.99
$71.71
$71.71
$1,596.99
$71.71
$71.71
$1,596.99
$2,434.19
$71.71
$71.71
$1,596.99
$2,434.19
$2,434.19
$1,596.99
$71.71
$71.71
$819.52
....................
$819.52
$1,090.63
$819.52
$556.48
$471.73
$556.48
$556.48
$601.77
$556.48
$649.77
$649.77
$601.77
$649.77
$649.77
$649.77
$909.52
$909.52
$819.52
$601.77
$601.77
$601.77
$893.52
$556.48
$771.52
$556.48
$601.77
$601.77
$601.77
$601.77
$601.77
$771.52
$1,090.63
$95.64
$95.64
$653.99
$871.75
$1,081.05
$95.64
$95.64
$781.75
$95.64
$95.64
$781.75
$95.64
$95.64
$781.75
$95.64
$95.64
$781.75
$95.64
$95.64
$781.75
$991.05
$95.64
$95.64
$781.75
$991.05
$1,081.05
$733.75
$95.64
$95.64
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00101
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42570
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
27832
27840
27842
27846
27848
27860
27870
27871
27884
27889
27892
27893
27894
28001
28002
28003
28005
28008
28010
28011
28020
28022
28024
28035
28043
28045
28046
28050
28052
28054
28055
28060
28062
28070
28072
28080
28086
28088
28090
28092
28100
28102
28103
28104
28106
28107
28108
28110
28111
28112
28113
28114
28116
28118
28119
28120
28122
28124
28126
28130
28140
28150
28153
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Treat lower leg dislocation .............................
Treat ankle dislocation ...................................
Treat ankle dislocation ...................................
Treat ankle dislocation ...................................
Treat ankle dislocation ...................................
Fixation of ankle joint .....................................
Fusion of ankle joint, open ............................
Fusion of tibiofibular joint ...............................
Amputation follow-up surgery ........................
Amputation of foot at ankle ...........................
Decompression of leg ....................................
Decompression of leg ....................................
Decompression of leg ....................................
Drainage of bursa of foot ...............................
Treatment of foot infection .............................
Treatment of foot infection .............................
Treat foot bone lesion ....................................
Incision of foot fascia .....................................
Incision of toe tendon ....................................
Incision of toe tendons ..................................
Exploration of foot joint ..................................
Exploration of foot joint ..................................
Exploration of toe joint ...................................
Decompression of tibia nerve ........................
Excision of foot lesion ....................................
Excision of foot lesion ....................................
Resection of tumor, foot ................................
Biopsy of foot joint lining ...............................
Biopsy of foot joint lining ...............................
Biopsy of toe joint lining ................................
Neurectomy, foot ...........................................
Partial removal, foot fascia ............................
Removal of foot fascia ...................................
Removal of foot joint lining ............................
Removal of foot joint lining ............................
Removal of foot lesion ...................................
Excise foot tendon sheath .............................
Excise foot tendon sheath .............................
Removal of foot lesion ...................................
Removal of toe lesions ..................................
Removal of ankle/heel lesion ........................
Remove/graft foot lesion ................................
Remove/graft foot lesion ................................
Removal of foot lesion ...................................
Remove/graft foot lesion ................................
Remove/graft foot lesion ................................
Removal of toe lesions ..................................
Part removal of metatarsal ............................
Part removal of metatarsal ............................
Part removal of metatarsal ............................
Part removal of metatarsal ............................
Removal of metatarsal heads ........................
Revision of foot ..............................................
Removal of heel bone ...................................
Removal of heel spur ....................................
Part removal of ankle/heel .............................
Partial removal of foot bone ..........................
Partial removal of toe ....................................
Partial removal of toe ....................................
Removal of ankle bone ..................................
Removal of metatarsal ...................................
Removal of toe ..............................................
Partial removal of toe ....................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$446.00
$103.62
$333.00
$510.00
$510.00
$333.00
$630.00
$630.00
$510.00
$510.00
$510.00
$510.00
$510.00
....................
$510.00
$510.00
$510.00
$510.00
....................
$510.00
$446.00
$446.00
$446.00
$630.00
$446.00
$510.00
$510.00
$446.00
$446.00
$446.00
$630.00
$446.00
$510.00
$510.00
$510.00
$510.00
$446.00
$446.00
$510.00
$510.00
$446.00
$510.00
$510.00
$446.00
$510.00
$510.00
$446.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$630.00
$995.00
$510.00
....................
$510.00
$510.00
$510.00
$510.00
$510.00
37.5382
1.6857
14.5947
37.5382
37.5382
14.5947
66.5800
66.5800
20.8706
25.1296
20.8706
20.8706
20.8706
2.8327
20.8706
20.8706
20.4263
20.4263
2.1164
20.4263
20.4263
20.4263
20.4263
17.8499
20.0656
20.4263
20.4263
20.4263
20.4263
20.4263
17.8499
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
40.8559
40.8559
20.4263
40.8559
40.8559
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
20.4263
4.7639
20.4263
20.4263
20.4263
20.4263
20.4263
Estimated
CY 2008
fully implemented
payment
$1,596.99
$71.71
$620.90
$1,596.99
$1,596.99
$620.90
$2,832.51
$2,832.51
$887.90
$1,069.09
$887.90
$887.90
$887.90
$120.51
$887.90
$887.90
$869.00
$869.00
$90.04
$869.00
$869.00
$869.00
$869.00
$759.39
$853.65
$869.00
$869.00
$869.00
$869.00
$869.00
$759.39
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$1,738.13
$1,738.13
$869.00
$1,738.13
$1,738.13
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$869.00
$202.67
$869.00
$869.00
$869.00
$869.00
$869.00
Estimated
CY 2008
first transition year
payment
$733.75
$95.64
$404.98
$781.75
$781.75
$404.98
$1,180.63
$1,180.63
$604.48
$649.77
$604.48
$604.48
$604.48
$120.51
$604.48
$604.48
$599.75
$599.75
$90.04
$599.75
$551.75
$551.75
$551.75
$662.35
$547.91
$599.75
$599.75
$551.75
$551.75
$551.75
$662.35
$551.75
$599.75
$599.75
$599.75
$599.75
$551.75
$551.75
$599.75
$599.75
$551.75
$817.03
$817.03
$551.75
$817.03
$817.03
$551.75
$599.75
$599.75
$599.75
$599.75
$599.75
$599.75
$689.75
$689.75
$963.50
$599.75
$202.67
$599.75
$599.75
$599.75
$599.75
$599.75
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00102
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42571
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
28160
28171
28173
28175
28190
28192
28193
28200
28202
28208
28210
28220
28222
28225
28226
28230
28232
28234
28238
28240
28250
28260
28261
28262
28264
28270
28272
28280
28285
28286
28288
28289
28290
28292
28293
28294
28296
28297
28298
28299
28300
28302
28304
28305
28306
28307
28308
28309
28310
28312
28313
28315
28320
28322
28340
28341
28344
28345
28400
28405
28406
28415
28420
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Partial removal of toe ....................................
Extensive foot surgery ...................................
Extensive foot surgery ...................................
Extensive foot surgery ...................................
Removal of foot foreign body ........................
Removal of foot foreign body ........................
Removal of foot foreign body ........................
Repair of foot tendon .....................................
Repair/graft of foot tendon .............................
Repair of foot tendon .....................................
Repair/graft of foot tendon .............................
Release of foot tendon ..................................
Release of foot tendons ................................
Release of foot tendon ..................................
Release of foot tendons ................................
Incision of foot tendon(s) ...............................
Incision of toe tendon ....................................
Incision of foot tendon ...................................
Revision of foot tendon ..................................
Release of big toe .........................................
Revision of foot fascia ...................................
Release of midfoot joint .................................
Revision of foot tendon ..................................
Revision of foot and ankle .............................
Release of midfoot joint .................................
Release of foot contracture ...........................
Release of toe joint, each ..............................
Fusion of toes ................................................
Repair of hammertoe .....................................
Repair of hammertoe .....................................
Partial removal of foot bone ..........................
Repair hallux rigidus ......................................
Correction of bunion ......................................
Correction of bunion ......................................
Correction of bunion ......................................
Correction of bunion ......................................
Correction of bunion ......................................
Correction of bunion ......................................
Correction of bunion ......................................
Correction of bunion ......................................
Incision of heel bone .....................................
Incision of ankle bone ....................................
Incision of midfoot bones ...............................
Incise/graft midfoot bones .............................
Incision of metatarsal .....................................
Incision of metatarsal .....................................
Incision of metatarsal .....................................
Incision of metatarsals ...................................
Revision of big toe .........................................
Revision of toe ...............................................
Repair deformity of toe ..................................
Removal of sesamoid bone ...........................
Repair of foot bones ......................................
Repair of metatarsals ....................................
Resect enlarged toe tissue ............................
Resect enlarged toe ......................................
Repair extra toe(s) .........................................
Repair webbed toe(s) ....................................
Treatment of heel fracture .............................
Treatment of heel fracture .............................
Treatment of heel fracture .............................
Treat heel fracture .........................................
Treat/graft heel fracture .................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
P3
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$510.00
$510.00
$510.00
$510.00
....................
$446.00
$418.49
$510.00
$510.00
$510.00
$510.00
....................
$333.00
$333.00
$333.00
....................
....................
$446.00
$510.00
$446.00
$510.00
$510.00
$510.00
$630.00
$333.00
$510.00
....................
$446.00
$510.00
$630.00
$510.00
$510.00
$446.00
$446.00
$510.00
$510.00
$510.00
$510.00
$510.00
$717.00
$446.00
$446.00
$446.00
$510.00
$630.00
$630.00
$446.00
$630.00
$510.00
$510.00
$446.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$103.62
$103.62
$446.00
$510.00
$630.00
20.4263
20.4263
20.4263
20.4263
2.9855
15.1024
6.8083
20.4263
20.4263
20.4263
40.8559
4.4823
20.4263
20.4263
20.4263
4.4341
4.2329
20.4263
40.8559
20.4263
20.4263
20.4263
20.4263
20.4263
40.8559
20.4263
4.0559
20.4263
20.4263
20.4263
20.4263
20.4263
28.2349
28.2349
28.2349
28.2349
28.2349
28.2349
28.2349
28.2349
40.8559
20.4263
40.8559
40.8559
20.4263
20.4263
20.4263
40.8559
20.4263
20.4263
20.4263
20.4263
40.8559
40.8559
20.4263
20.4263
20.4263
20.4263
1.6857
1.6857
25.5264
37.5382
37.5382
Estimated
CY 2008
fully implemented
payment
$869.00
$869.00
$869.00
$869.00
$127.01
$642.50
$289.65
$869.00
$869.00
$869.00
$1,738.13
$190.69
$869.00
$869.00
$869.00
$188.64
$180.08
$869.00
$1,738.13
$869.00
$869.00
$869.00
$869.00
$869.00
$1,738.13
$869.00
$172.55
$869.00
$869.00
$869.00
$869.00
$869.00
$1,201.20
$1,201.20
$1,201.20
$1,201.20
$1,201.20
$1,201.20
$1,201.20
$1,201.20
$1,738.13
$869.00
$1,738.13
$1,738.13
$869.00
$869.00
$869.00
$1,738.13
$869.00
$869.00
$869.00
$869.00
$1,738.13
$1,738.13
$869.00
$869.00
$869.00
$869.00
$71.71
$71.71
$1,085.97
$1,596.99
$1,596.99
Estimated
CY 2008
first transition year
payment
$599.75
$599.75
$599.75
$599.75
$127.01
$495.13
$386.28
$599.75
$599.75
$599.75
$817.03
$190.69
$467.00
$467.00
$467.00
$188.64
$180.08
$551.75
$817.03
$551.75
$599.75
$599.75
$599.75
$689.75
$684.28
$599.75
$172.55
$551.75
$599.75
$689.75
$599.75
$599.75
$634.80
$634.80
$682.80
$682.80
$682.80
$682.80
$682.80
$838.05
$769.03
$551.75
$769.03
$817.03
$689.75
$689.75
$551.75
$907.03
$599.75
$599.75
$551.75
$689.75
$907.03
$907.03
$689.75
$689.75
$689.75
$689.75
$95.64
$95.64
$605.99
$781.75
$871.75
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00103
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42572
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
28430
28435
28436
28445
28450
28455
28456
28465
28470
28475
28476
28485
28490
28495
28496
28505
28510
28515
28525
28530
28531
28540
28545
28546
28555
28570
28575
28576
28585
28600
28605
28606
28615
28630
28635
28636
28645
28660
28665
28666
28675
28705
28715
28725
28730
28735
28737
28740
28750
28755
28760
28810
28820
28825
28890
29000
29010
29015
29020
29025
29035
29040
29044
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treatment of ankle fracture ...........................
Treat ankle fracture .......................................
Treat midfoot fracture, each ..........................
Treat midfoot fracture, each ..........................
Treat midfoot fracture ....................................
Treat midfoot fracture, each ..........................
Treat metatarsal fracture ...............................
Treat metatarsal fracture ...............................
Treat metatarsal fracture ...............................
Treat metatarsal fracture ...............................
Treat big toe fracture .....................................
Treat big toe fracture .....................................
Treat big toe fracture .....................................
Treat big toe fracture .....................................
Treatment of toe fracture ...............................
Treatment of toe fracture ...............................
Treat toe fracture ...........................................
Treat sesamoid bone fracture .......................
Treat sesamoid bone fracture .......................
Treat foot dislocation .....................................
Treat foot dislocation .....................................
Treat foot dislocation .....................................
Repair foot dislocation ...................................
Treat foot dislocation .....................................
Treat foot dislocation .....................................
Treat foot dislocation .....................................
Repair foot dislocation ...................................
Treat foot dislocation .....................................
Treat foot dislocation .....................................
Treat foot dislocation .....................................
Repair foot dislocation ...................................
Treat toe dislocation ......................................
Treat toe dislocation ......................................
Treat toe dislocation ......................................
Repair toe dislocation ....................................
Treat toe dislocation ......................................
Treat toe dislocation ......................................
Treat toe dislocation ......................................
Repair of toe dislocation ................................
Fusion of foot bones ......................................
Fusion of foot bones ......................................
Fusion of foot bones ......................................
Fusion of foot bones ......................................
Fusion of foot bones ......................................
Revision of foot bones ...................................
Fusion of foot bones ......................................
Fusion of big toe joint ....................................
Fusion of big toe joint ....................................
Fusion of big toe joint ....................................
Amputation toe & metatarsal .........................
Amputation of toe ..........................................
Partial amputation of toe ...............................
High energy eswt, plantar f ...........................
Application of body cast ................................
Application of body cast ................................
Application of body cast ................................
Application of body cast ................................
Application of body cast ................................
Application of body cast ................................
Application of body cast ................................
Application of body cast ................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
N
N
N
N
N
N
N
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
P2
A2
A2
A2
P2
P2
A2
A2
P2
P2
A2
A2
P3
P2
A2
A2
P3
P3
A2
P3
A2
P2
A2
A2
A2
P2
A2
A2
A2
P2
A2
A2
A2
G2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
P2
P2
G2
P2
G2
G2
P2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
....................
$103.62
$446.00
$510.00
....................
....................
$446.00
$510.00
....................
....................
$446.00
$630.00
....................
....................
$446.00
$510.00
....................
....................
$510.00
....................
$510.00
....................
$333.00
$446.00
$446.00
....................
$103.62
$510.00
$510.00
....................
$103.62
$446.00
$510.00
....................
$333.00
$510.00
$510.00
....................
$333.00
$510.00
$510.00
$630.00
$630.00
$630.00
$630.00
$630.00
$717.00
$630.00
$630.00
$630.00
$630.00
$446.00
$446.00
$446.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
1.6857
1.6857
25.5264
37.5382
1.6857
1.6857
25.5264
37.5382
1.6857
1.6857
25.5264
37.5382
1.6579
1.6857
25.5264
37.5382
1.2956
1.6658
37.5382
1.2392
37.5382
1.6857
25.5264
25.5264
37.5382
1.6857
1.6857
25.5264
37.5382
1.6857
1.6857
25.5264
37.5382
1.6857
14.5947
25.5264
37.5382
1.6857
14.5947
25.5264
37.5382
40.8559
40.8559
40.8559
40.8559
40.8559
40.8559
40.8559
40.8559
20.4263
40.8559
20.4263
20.4263
20.4263
25.1296
1.0607
2.2777
2.2777
1.0607
1.0607
2.2777
1.0607
2.2777
Estimated
CY 2008
fully implemented
payment
$71.71
$71.71
$1,085.97
$1,596.99
$71.71
$71.71
$1,085.97
$1,596.99
$71.71
$71.71
$1,085.97
$1,596.99
$70.53
$71.71
$1,085.97
$1,596.99
$55.12
$70.87
$1,596.99
$52.72
$1,596.99
$71.71
$1,085.97
$1,085.97
$1,596.99
$71.71
$71.71
$1,085.97
$1,596.99
$71.71
$71.71
$1,085.97
$1,596.99
$71.71
$620.90
$1,085.97
$1,596.99
$71.71
$620.90
$1,085.97
$1,596.99
$1,738.13
$1,738.13
$1,738.13
$1,738.13
$1,738.13
$1,738.13
$1,738.13
$1,738.13
$869.00
$1,738.13
$869.00
$869.00
$869.00
$1,069.09
$45.13
$96.90
$96.90
$45.13
$45.13
$96.90
$45.13
$96.90
Estimated
CY 2008
first transition year
payment
$71.71
$95.64
$605.99
$781.75
$71.71
$71.71
$605.99
$781.75
$71.71
$71.71
$605.99
$871.75
$70.53
$71.71
$605.99
$781.75
$55.12
$70.87
$781.75
$52.72
$781.75
$71.71
$521.24
$605.99
$733.75
$71.71
$95.64
$653.99
$781.75
$71.71
$95.64
$605.99
$781.75
$71.71
$404.98
$653.99
$781.75
$71.71
$404.98
$653.99
$781.75
$907.03
$907.03
$907.03
$907.03
$907.03
$972.28
$907.03
$907.03
$689.75
$907.03
$551.75
$551.75
$551.75
$1,069.09
$45.13
$96.90
$96.90
$45.13
$45.13
$96.90
$45.13
$96.90
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00104
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42573
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
29046
29049
29055
29058
29065
29075
29085
29086
29105
29125
29126
29130
29131
29200
29220
29240
29260
29280
29305
29325
29345
29355
29358
29365
29405
29425
29435
29440
29445
29450
29505
29515
29520
29530
29540
29550
29580
29590
29700
29705
29710
29715
29720
29730
29740
29750
29800
29804
29805
29806
29807
29819
29820
29821
29822
29823
29824
29825
29826
29827
29830
29834
29835
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Application of body cast ................................
Application of figure eight ..............................
Application of shoulder cast ..........................
Application of shoulder cast ..........................
Application of long arm cast ..........................
Application of forearm cast ............................
Apply hand/wrist cast .....................................
Apply finger cast ............................................
Apply long arm splint .....................................
Apply forearm splint .......................................
Apply forearm splint .......................................
Application of finger splint .............................
Application of finger splint .............................
Strapping of chest ..........................................
Strapping of low back ....................................
Strapping of shoulder ....................................
Strapping of elbow or wrist ............................
Strapping of hand or finger ............................
Application of hip cast ...................................
Application of hip casts ..................................
Application of long leg cast ...........................
Application of long leg cast ...........................
Apply long leg cast brace ..............................
Application of long leg cast ...........................
Apply short leg cast .......................................
Apply short leg cast .......................................
Apply short leg cast .......................................
Addition of walker to cast ..............................
Apply rigid leg cast ........................................
Application of leg cast ...................................
Application, long leg splint .............................
Application lower leg splint ............................
Strapping of hip .............................................
Strapping of knee ..........................................
Strapping of ankle and/or ft ...........................
Strapping of toes ...........................................
Application of paste boot ...............................
Application of foot splint ................................
Removal/revision of cast ...............................
Removal/revision of cast ...............................
Removal/revision of cast ...............................
Removal/revision of cast ...............................
Repair of body cast .......................................
Windowing of cast .........................................
Wedging of cast .............................................
Wedging of clubfoot cast ...............................
Jaw arthroscopy/surgery ................................
Jaw arthroscopy/surgery ................................
Shoulder arthroscopy, dx ...............................
Shoulder arthroscopy/surgery ........................
Shoulder arthroscopy/surgery ........................
Shoulder arthroscopy/surgery ........................
Shoulder arthroscopy/surgery ........................
Shoulder arthroscopy/surgery ........................
Shoulder arthroscopy/surgery ........................
Shoulder arthroscopy/surgery ........................
Shoulder arthroscopy/surgery ........................
Shoulder arthroscopy/surgery ........................
Shoulder arthroscopy/surgery ........................
Arthroscop rotator cuff repr ...........................
Elbow arthroscopy .........................................
Elbow arthroscopy/surgery ............................
Elbow arthroscopy/surgery ............................
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
G2
P3
P2
P2
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
G2
G2
P3
P3
P3
P3
P3
P3
P3
P3
P3
P2
G2
G2
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$717.00
$510.00
$510.00
$717.00
$510.00
$510.00
$510.00
2.2777
0.9736
2.2777
1.0607
1.0462
0.9978
1.0220
0.8048
0.9334
0.7966
0.8932
0.3622
0.5472
0.5312
0.5312
0.6116
0.5632
0.5874
2.2777
2.2777
1.3760
1.3438
1.6496
1.3036
0.9736
0.9898
1.2392
0.5230
1.3760
1.0607
1.0607
1.0607
0.6116
0.5714
0.3862
0.4024
0.5552
0.4506
0.7484
0.6438
1.1990
0.9254
0.9254
0.6276
0.8852
0.7966
28.6245
28.6245
28.6245
45.5027
45.5027
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
45.5027
45.5027
28.6245
28.6245
28.6245
Estimated
CY 2008
fully implemented
payment
$96.90
$41.42
$96.90
$45.13
$44.51
$42.45
$43.48
$34.24
$39.71
$33.89
$38.00
$15.41
$23.28
$22.60
$22.60
$26.02
$23.96
$24.99
$96.90
$96.90
$58.54
$57.17
$70.18
$55.46
$41.42
$42.11
$52.72
$22.25
$58.54
$45.13
$45.13
$45.13
$26.02
$24.31
$16.43
$17.12
$23.62
$19.17
$31.84
$27.39
$51.01
$39.37
$39.37
$26.70
$37.66
$33.89
$1,217.77
$1,217.77
$1,217.77
$1,935.82
$1,935.82
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,935.82
$1,935.82
$1,217.77
$1,217.77
$1,217.77
Estimated
CY 2008
first transition year
payment
$96.90
$41.42
$96.90
$45.13
$44.51
$42.45
$43.48
$34.24
$39.71
$33.89
$38.00
$15.41
$23.28
$22.60
$22.60
$26.02
$23.96
$24.99
$96.90
$96.90
$58.54
$57.17
$70.18
$55.46
$41.42
$42.11
$52.72
$22.25
$58.54
$45.13
$45.13
$45.13
$26.02
$24.31
$16.43
$17.12
$23.62
$19.17
$31.84
$27.39
$51.01
$39.37
$39.37
$26.70
$37.66
$33.89
$686.94
$686.94
$686.94
$866.46
$866.46
$686.94
$686.94
$686.94
$686.94
$686.94
$842.19
$686.94
$866.46
$1,021.71
$686.94
$686.94
$686.94
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00105
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42574
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
29836
29837
29838
29840
29843
29844
29845
29846
29847
29848
29850
29851
29855
29856
29860
29861
29862
29863
29870
29871
29873
29874
29875
29876
29877
29879
29880
29881
29882
29883
29884
29885
29886
29887
29888
29889
29891
29892
29893
29894
29895
29897
29898
29899
29900
29901
29902
30000
30020
30100
30110
30115
30117
30118
30120
30124
30125
30130
30140
30150
30160
30200
30210
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Elbow arthroscopy/surgery ............................
Elbow arthroscopy/surgery ............................
Elbow arthroscopy/surgery ............................
Wrist arthroscopy ...........................................
Wrist arthroscopy/surgery ..............................
Wrist arthroscopy/surgery ..............................
Wrist arthroscopy/surgery ..............................
Wrist arthroscopy/surgery ..............................
Wrist arthroscopy/surgery ..............................
Wrist endoscopy/surgery ...............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Tibial arthroscopy/surgery .............................
Tibial arthroscopy/surgery .............................
Hip arthroscopy, dx ........................................
Hip arthroscopy/surgery .................................
Hip arthroscopy/surgery .................................
Hip arthroscopy/surgery .................................
Knee arthroscopy, dx .....................................
Knee arthroscopy/drainage ............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Knee arthroscopy/surgery ..............................
Ankle arthroscopy/surgery .............................
Ankle arthroscopy/surgery .............................
Scope, plantar fasciotomy .............................
Ankle arthroscopy/surgery .............................
Ankle arthroscopy/surgery .............................
Ankle arthroscopy/surgery .............................
Ankle arthroscopy/surgery .............................
Ankle arthroscopy/surgery .............................
Mcp joint arthroscopy, dx ..............................
Mcp joint arthroscopy, surg ...........................
Mcp joint arthroscopy, surg ...........................
Drainage of nose lesion .................................
Drainage of nose lesion .................................
Intranasal biopsy ............................................
Removal of nose polyp(s) ..............................
Removal of nose polyp(s) ..............................
Removal of intranasal lesion .........................
Removal of intranasal lesion .........................
Revision of nose ............................................
Removal of nose lesion .................................
Removal of nose lesion .................................
Excise inferior turbinate .................................
Resect inferior turbinate ................................
Partial removal of nose ..................................
Removal of nose ............................................
Injection treatment of nose ............................
Nasal sinus therapy .......................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P2
P2
P3
P3
A2
A2
A2
A2
R2
A2
A2
A2
A2
A2
P3
P3
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$1,339.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$1,339.00
$630.00
$510.00
$510.00
$510.00
$510.00
$630.00
$630.00
$630.00
$510.00
$630.00
$630.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$1,255.56
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
....................
....................
....................
....................
$446.00
$510.00
$510.00
$333.00
....................
$446.00
$510.00
$446.00
$510.00
$630.00
....................
....................
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
45.5027
45.5027
28.6245
28.6245
28.6245
45.5027
45.5027
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
28.6245
45.5027
28.6245
28.6245
45.5027
45.5027
28.6245
28.6245
20.4263
28.6245
28.6245
28.6245
28.6245
45.5027
16.1540
16.1540
16.1540
2.4520
2.4520
1.7625
2.7683
16.4266
16.4266
23.3299
16.4266
7.5511
38.1991
16.4266
23.3299
38.1991
38.1991
1.4082
1.7784
Estimated
CY 2008
fully implemented
payment
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,935.82
$1,935.82
$1,217.77
$1,217.77
$1,217.77
$1,935.82
$1,935.82
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,935.82
$1,217.77
$1,217.77
$1,935.82
$1,935.82
$1,217.77
$1,217.77
$869.00
$1,217.77
$1,217.77
$1,217.77
$1,217.77
$1,935.82
$687.24
$687.24
$687.24
$104.32
$104.32
$74.98
$117.77
$698.84
$698.84
$992.52
$698.84
$321.25
$1,625.10
$698.84
$992.52
$1,625.10
$1,625.10
$59.91
$75.66
Estimated
CY 2008
first transition year
payment
$686.94
$686.94
$686.94
$686.94
$686.94
$686.94
$686.94
$686.94
$686.94
$1,308.69
$776.94
$956.46
$956.46
$776.94
$776.94
$776.94
$1,488.21
$956.46
$686.94
$686.94
$686.94
$686.94
$776.94
$776.94
$776.94
$686.94
$776.94
$776.94
$686.94
$686.94
$686.94
$866.46
$686.94
$686.94
$866.46
$866.46
$686.94
$686.94
$1,158.92
$686.94
$686.94
$686.94
$686.94
$866.46
$554.31
$554.31
$554.31
$104.32
$104.32
$74.98
$117.77
$509.21
$557.21
$630.63
$424.46
$321.25
$740.78
$557.21
$582.63
$788.78
$878.78
$59.91
$75.66
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00106
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42575
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
30220
30300
30310
30320
30400
30410
30420
30430
30435
30450
30460
30462
30465
30520
30540
30545
30560
30580
30600
30620
30630
30801
30802
30901
30903
30905
30906
30915
30920
30930
31000
31002
31020
31030
31032
31040
31050
31051
31070
31075
31080
31081
31084
31085
31086
31087
31090
31200
31201
31205
31231
31233
31235
31237
31238
31239
31240
31254
31255
31256
31267
31276
31287
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Insert nasal septal button ..............................
Remove nasal foreign body ...........................
Remove nasal foreign body ...........................
Remove nasal foreign body ...........................
Reconstruction of nose ..................................
Reconstruction of nose ..................................
Reconstruction of nose ..................................
Revision of nose ............................................
Revision of nose ............................................
Revision of nose ............................................
Revision of nose ............................................
Revision of nose ............................................
Repair nasal stenosis ....................................
Repair of nasal septum .................................
Repair nasal defect ........................................
Repair nasal defect ........................................
Release of nasal adhesions ..........................
Repair upper jaw fistula .................................
Repair mouth/nose fistula ..............................
Intranasal reconstruction ...............................
Repair nasal septum defect ...........................
Ablate inf turbinate, superf ............................
Cauterization, inner nose ...............................
Control of nosebleed .....................................
Control of nosebleed .....................................
Control of nosebleed .....................................
Repeat control of nosebleed .........................
Ligation, nasal sinus artery ............................
Ligation, upper jaw artery ..............................
Ther fx, nasal inf turbinate .............................
Irrigation, maxillary sinus ...............................
Irrigation, sphenoid sinus ...............................
Exploration, maxillary sinus ...........................
Exploration, maxillary sinus ...........................
Explore sinus, remove polyps .......................
Exploration behind upper jaw ........................
Exploration, sphenoid sinus ...........................
Sphenoid sinus surgery .................................
Exploration of frontal sinus ............................
Exploration of frontal sinus ............................
Removal of frontal sinus ................................
Removal of frontal sinus ................................
Removal of frontal sinus ................................
Removal of frontal sinus ................................
Removal of frontal sinus ................................
Removal of frontal sinus ................................
Exploration of sinuses ...................................
Removal of ethmoid sinus .............................
Removal of ethmoid sinus .............................
Removal of ethmoid sinus .............................
Nasal endoscopy, dx .....................................
Nasal/sinus endoscopy, dx ............................
Nasal/sinus endoscopy, dx ............................
Nasal/sinus endoscopy, surg .........................
Nasal/sinus endoscopy, surg .........................
Nasal/sinus endoscopy, surg .........................
Nasal/sinus endoscopy, surg .........................
Revision of ethmoid sinus .............................
Removal of ethmoid sinus .............................
Exploration maxillary sinus ............................
Endoscopy, maxillary sinus ...........................
Sinus endoscopy, surgical .............................
Nasal/sinus endoscopy, surg .........................
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
P3
R2
A2
A2
A2
R2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$464.15
....................
$333.00
$446.00
$630.00
$717.00
$717.00
$510.00
$717.00
$995.00
$995.00
$1,339.00
$1,339.00
$630.00
$717.00
$717.00
$150.72
$630.00
$630.00
$995.00
$995.00
$333.00
$333.00
....................
$72.48
$72.48
$72.48
$446.00
$510.00
$630.00
....................
....................
$446.00
$510.00
$630.00
....................
$446.00
$630.00
$446.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$717.00
$446.00
$717.00
$510.00
....................
$86.39
$333.00
$446.00
$333.00
$630.00
$446.00
$510.00
$717.00
$510.00
$510.00
$510.00
$510.00
7.5511
0.6102
16.4266
16.4266
38.1991
38.1991
38.1991
23.3299
38.1991
38.1991
38.1991
38.1991
38.1991
23.3299
38.1991
38.1991
2.4520
38.1991
38.1991
38.1991
23.3299
7.5511
7.5511
1.0300
1.1791
1.1791
1.1791
24.8809
24.8809
16.4266
2.3499
7.5511
23.3299
38.1991
38.1991
23.3299
38.1991
38.1991
23.3299
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
1.4054
1.4054
14.7928
14.7928
14.7928
21.9512
14.7928
21.9512
21.9512
21.9512
21.9512
21.9512
21.9512
Estimated
CY 2008
fully implemented
payment
$321.25
$25.96
$698.84
$698.84
$1,625.10
$1,625.10
$1,625.10
$992.52
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$992.52
$1,625.10
$1,625.10
$104.32
$1,625.10
$1,625.10
$1,625.10
$992.52
$321.25
$321.25
$43.82
$50.16
$50.16
$50.16
$1,058.51
$1,058.51
$698.84
$99.97
$321.25
$992.52
$1,625.10
$1,625.10
$992.52
$1,625.10
$1,625.10
$992.52
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$59.79
$59.79
$629.33
$629.33
$629.33
$933.87
$629.33
$933.87
$933.87
$933.87
$933.87
$933.87
$933.87
Estimated
CY 2008
first transition year
payment
$428.43
$25.96
$424.46
$509.21
$878.78
$944.03
$944.03
$630.63
$944.03
$1,152.53
$1,152.53
$1,410.53
$1,410.53
$720.63
$944.03
$944.03
$139.12
$878.78
$878.78
$1,152.53
$994.38
$330.06
$330.06
$43.82
$66.90
$66.90
$66.90
$599.13
$647.13
$647.21
$99.97
$321.25
$582.63
$788.78
$878.78
$992.52
$740.78
$878.78
$582.63
$878.78
$878.78
$878.78
$878.78
$878.78
$878.78
$878.78
$944.03
$740.78
$944.03
$788.78
$59.79
$79.74
$407.08
$491.83
$407.08
$705.97
$491.83
$615.97
$771.22
$615.97
$615.97
$615.97
$615.97
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00107
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42576
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
31288
31300
31320
31400
31420
31500
31502
31505
31510
31511
31512
31513
31515
31520
31525
31526
31527
31528
31529
31530
31531
31535
31536
31540
31541
31545
31546
31560
31561
31570
31571
31575
31576
31577
31578
31579
31580
31582
31588
31590
31595
31603
31605
31611
31612
31613
31614
31615
31620
31622
31623
31624
31625
31628
31629
31630
31631
31632
31633
31635
31636
31637
31638
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Nasal/sinus endoscopy, surg .........................
Removal of larynx lesion ...............................
Diagnostic incision, larynx .............................
Revision of larynx ..........................................
Removal of epiglottis .....................................
Insert emergency airway ...............................
Change of windpipe airway ...........................
Diagnostic laryngoscopy ................................
Laryngoscopy with biopsy .............................
Remove foreign body, larynx .........................
Removal of larynx lesion ...............................
Injection into vocal cord .................................
Laryngoscopy for aspiration ..........................
Dx laryngoscopy, newborn ............................
Dx laryngoscopy excl nb ...............................
Dx laryngoscopy w/oper scope .....................
Laryngoscopy for treatment ...........................
Laryngoscopy and dilation .............................
Laryngoscopy and dilation .............................
Laryngoscopy w/fb removal ...........................
Laryngoscopy w/fb & op scope .....................
Laryngoscopy w/biopsy .................................
Laryngoscopy w/bx & op scope ....................
Laryngoscopy w/exc of tumor ........................
Larynscop w/tumr exc + scope .....................
Remove vc lesion w/scope ............................
Remove vc lesion scope/graft .......................
Laryngoscop w/arytenoidectom .....................
Larynscop, remve cart + scop .......................
Laryngoscope w/vc inj ...................................
Laryngoscop w/vc inj + scope .......................
Diagnostic laryngoscopy ................................
Laryngoscopy with biopsy .............................
Remove foreign body, larynx .........................
Removal of larynx lesion ...............................
Diagnostic laryngoscopy ................................
Revision of larynx ..........................................
Revision of larynx ..........................................
Revision of larynx ..........................................
Reinnervate larynx .........................................
Larynx nerve surgery .....................................
Incision of windpipe .......................................
Incision of windpipe .......................................
Surgery/speech prosthesis ............................
Puncture/clear windpipe ................................
Repair windpipe opening ...............................
Repair windpipe opening ...............................
Visualization of windpipe ...............................
Endobronchial us add-on ...............................
Dx bronchoscope/wash .................................
Dx bronchoscope/brush .................................
Dx bronchoscope/lavage ...............................
Bronchoscopy w/biopsy(s) .............................
Bronchoscopy/lung bx, each .........................
Bronchoscopy/needle bx, each .....................
Bronchoscopy dilate/fx repr ...........................
Bronchoscopy, dilate w/stent .........................
Bronchoscopy/lung bx, add’l ..........................
Bronchoscopy/needle bx add’l .......................
Bronchoscopy w/fb removal ..........................
Bronchoscopy, bronch stents ........................
Bronchoscopy, stent add-on ..........................
Bronchoscopy, revise stent ...........................
Y
Y
Y
Y
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
G2
G2
P2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$510.00
$717.00
$446.00
$446.00
$446.00
....................
....................
....................
$446.00
$86.39
$446.00
$86.39
$333.00
....................
$333.00
$446.00
$333.00
$446.00
$446.00
$446.00
$510.00
$446.00
$510.00
$510.00
$630.00
$630.00
$630.00
$717.00
$717.00
$446.00
$446.00
....................
$446.00
$236.42
$446.00
....................
$717.00
$717.00
$717.00
$717.00
$446.00
$333.00
....................
$510.00
$333.00
$446.00
$446.00
$333.00
$333.00
$333.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
....................
....................
$446.00
$446.00
$333.00
$446.00
21.9512
23.3299
38.1991
38.1991
38.1991
2.4233
2.3587
0.7698
14.7928
1.4054
14.7928
1.4054
14.7928
1.4054
14.7928
21.9512
21.9512
14.7928
14.7928
21.9512
21.9512
21.9512
21.9512
21.9512
21.9512
21.9512
21.9512
21.9512
21.9512
14.7928
21.9512
1.4002
21.9512
3.8463
21.9512
2.5833
38.1991
38.1991
38.1991
38.1991
38.1991
7.5511
7.5511
23.3299
23.3299
23.3299
38.1991
9.5228
32.2854
9.5228
9.5228
9.5228
9.5228
9.5228
9.5228
22.0099
22.0099
9.5228
9.5228
9.5228
22.0099
9.5228
22.0099
Estimated
CY 2008
fully implemented
payment
$933.87
$992.52
$1,625.10
$1,625.10
$1,625.10
$103.09
$100.35
$32.75
$629.33
$59.79
$629.33
$59.79
$629.33
$59.79
$629.33
$933.87
$933.87
$629.33
$629.33
$933.87
$933.87
$933.87
$933.87
$933.87
$933.87
$933.87
$933.87
$933.87
$933.87
$629.33
$933.87
$59.57
$933.87
$163.63
$933.87
$109.90
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$321.25
$321.25
$992.52
$992.52
$992.52
$1,625.10
$405.13
$1,373.52
$405.13
$405.13
$405.13
$405.13
$405.13
$405.13
$936.37
$936.37
$405.13
$405.13
$405.13
$936.37
$405.13
$936.37
Estimated
CY 2008
first transition year
payment
$615.97
$785.88
$740.78
$740.78
$740.78
$103.09
$100.35
$32.75
$491.83
$79.74
$491.83
$79.74
$407.08
$59.79
$407.08
$567.97
$483.22
$491.83
$491.83
$567.97
$615.97
$567.97
$615.97
$615.97
$705.97
$705.97
$705.97
$771.22
$771.22
$491.83
$567.97
$59.57
$567.97
$218.22
$567.97
$109.90
$944.03
$944.03
$944.03
$944.03
$740.78
$330.06
$321.25
$630.63
$497.88
$582.63
$740.78
$351.03
$593.13
$351.03
$435.78
$435.78
$435.78
$435.78
$435.78
$568.59
$568.59
$405.13
$405.13
$435.78
$568.59
$351.03
$568.59
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00108
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42577
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Payment
indicator
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
Bronchoscopy w/tumor excise .......................
Bronchoscopy, treat blockage .......................
Diag bronchoscope/catheter ..........................
Bronchoscopy, clear airways .........................
Bronchoscopy, reclear airway .......................
Bronchoscopy, inj for x-ray ............................
Injection for bronchus x-ray ...........................
Bronchial brush biopsy ..................................
Clearance of airways .....................................
Intro, windpipe wire/tube ................................
Repair of windpipe .........................................
Repair of windpipe .........................................
Closure of windpipe lesion ............................
Repair of windpipe defect ..............................
Revise windpipe scar .....................................
Drainage of chest ..........................................
Treatment of collapsed lung ..........................
Insert pleural catheter ....................................
Needle biopsy chest lining .............................
Biopsy, lung or mediastinum .........................
Puncture/clear lung ........................................
Therapeutic pneumothorax ............................
Drainage of heart sac ....................................
Repeat drainage of heart sac ........................
Insertion of heart pacemaker .........................
Insertion of heart pacemaker .........................
Insertion of heart pacemaker .........................
Insertion of heart electrode ............................
Insertion of heart electrode ............................
Insertion of pulse generator ...........................
Insertion of pulse generator ...........................
Upgrade of pacemaker system .....................
Reposition pacing-defib lead .........................
Insert lead pace-defib, one ............................
Insert lead pace-defib, dual ...........................
Repair lead pace-defib, one ..........................
Repair lead pace-defib, dual .........................
Revise pocket, pacemaker ............................
Revise pocket, pacing-defib ..........................
Insert pacing lead & connect .........................
Lventric pacing lead add-on ..........................
Reposition 1 ventric lead ...............................
Removal of pacemaker system .....................
Removal of pacemaker system .....................
Removal pacemaker electrode ......................
Remove pulse generator ...............................
Implant pat-active ht record ...........................
Remove pat-active ht record .........................
Endoscopic vein harvest ................................
Repair blood vessel lesion ............................
Repair blood vessel lesion ............................
Repair arterial blockage .................................
Repair arterial blockage .................................
Repair venous blockage ................................
Atherectomy, percutaneous ...........................
Harvest femoropopliteal vein .........................
Exploration of artery/vein ...............................
Removal of clot in graft .................................
Removal of clot in graft .................................
Place needle in vein ......................................
Pseudoaneurysm injection trt ........................
Injection ext venography ................................
Place catheter in vein ....................................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
..................
N ..............
..................
..................
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
N1 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
G2 ............
G2 ............
A2 ............
A2 ............
A2 ............
G2 ............
A2 ............
A2 ............
J8 .............
J8 .............
J8 .............
G2 ............
G2 ............
H8 ............
H8 ............
J8 .............
G2 ............
G2 ............
G2 ............
G2 ............
G2 ............
A2 ............
A2 ............
J8 .............
J8 .............
G2 ............
A2 ............
G2 ............
G2 ............
G2 ............
J8 .............
G2 ............
N1 ............
A2 ............
A2 ............
G2 ............
G2 ............
G2 ............
G2 ............
N1 ............
G2 ............
A2 ............
A2 ............
N1 ............
G2 ............
N1 ............
N1 ............
$446.00
$446.00
$446.00
$333.00
$333.00
$333.00
....................
$236.42
$47.32
$236.42
$717.00
$446.00
$333.00
$446.00
$446.00
$222.78
....................
....................
$333.00
$333.00
$222.78
....................
$222.78
$222.78
....................
....................
....................
....................
....................
$510.00
$510.00
....................
....................
....................
....................
....................
....................
$446.00
$446.00
....................
....................
....................
$446.00
....................
....................
....................
....................
....................
....................
$630.00
$630.00
....................
....................
....................
....................
....................
....................
$1,339.00
$1,339.00
....................
....................
....................
....................
22.0099
22.0099
9.5228
9.5228
9.5228
9.5228
....................
3.8463
0.7698
3.8463
38.1991
38.1991
16.4266
23.3299
23.3299
3.6244
3.6244
29.5416
6.1384
6.1384
3.6244
3.6244
3.6244
3.6244
170.6370
170.6370
210.2184
58.8594
58.8594
134.4886
155.7342
210.2184
25.6142
58.8594
58.8594
25.6142
25.6142
21.4302
21.4302
439.4366
439.4366
25.6142
25.6142
25.6142
25.6142
25.6142
99.9215
10.9918
....................
37.7391
37.7391
42.9360
42.9360
42.9360
42.9360
....................
29.2133
37.7391
37.7391
....................
2.4606
....................
....................
$936.37
$936.37
$405.13
$405.13
$405.13
$405.13
....................
$163.63
$32.75
$163.63
$1,625.10
$1,625.10
$698.84
$992.52
$992.52
$154.19
$154.19
$1,256.79
$261.15
$261.15
$154.19
$154.19
$154.19
$154.19
$7,259.41
$7,259.41
$8,943.32
$2,504.06
$2,504.06
$5,721.55
$6,625.40
$8,943.32
$1,089.70
$2,504.06
$2,504.06
$1,089.70
$1,089.70
$911.71
$911.71
$18,694.95
$18,694.95
$1,089.70
$1,089.70
$1,089.70
$1,089.70
$1,089.70
$4,250.96
$467.62
....................
$1,605.53
$1,605.53
$1,826.63
$1,826.63
$1,826.63
$1,826.63
....................
$1,242.82
$1,605.53
$1,605.53
....................
$104.68
....................
....................
$568.59
$568.59
$435.78
$351.03
$351.03
$351.03
....................
$218.22
$43.68
$218.22
$944.03
$740.78
$424.46
$582.63
$582.63
$205.63
$154.19
$1,256.79
$315.04
$315.04
$205.63
$154.19
$205.63
$205.63
$7,259.41
$7,259.41
$8,943.32
$2,504.06
$2,504.06
$5,311.76
$6,192.90
$8,943.32
$1,089.70
$2,504.06
$2,504.06
$1,089.70
$1,089.70
$562.43
$562.43
$18,694.95
$18,694.95
$1,089.70
$606.93
$1,089.70
$1,089.70
$1,089.70
$4,250.96
$467.62
....................
$873.88
$873.88
$1,826.63
$1,826.63
$1,826.63
$1,826.63
....................
$1,242.82
$1,405.63
$1,405.63
....................
$104.68
....................
....................
mstockstill on PROD1PC66 with RULES2
HCPCS
code
31640
31641
31643
31645
31646
31656
31715
31717
31720
31730
31750
31755
31820
31825
31830
32000
32002
32019
32400
32405
32420
32960
33010
33011
33206
33207
33208
33210
33211
33212
33213
33214
33215
33216
33217
33218
33220
33222
33223
33224
33225
33226
33233
33234
33235
33241
33282
33284
33508
35188
35207
35473
35474
35476
35492
35572
35761
35875
35876
36000
36002
36005
36010
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00109
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42578
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Place catheter in vein ....................................
Place catheter in vein ....................................
Place catheter in artery .................................
Place catheter in artery .................................
Place catheter in artery .................................
Establish access to artery .............................
Establish access to artery .............................
Establish access to artery .............................
Artery to vein shunt .......................................
Establish access to aorta ..............................
Place catheter in aorta ..................................
Place catheter in artery .................................
Place catheter in artery .................................
Place catheter in artery .................................
Place catheter in artery .................................
Place catheter in artery .................................
Place catheter in artery .................................
Place catheter in artery .................................
Place catheter in artery .................................
Insertion of infusion pump .............................
Revision of infusion pump .............................
Removal of infusion pump .............................
Bl draw <3 yrs fem/jugular ............................
Bl draw <3 yrs scalp vein ..............................
Bl draw <3 yrs other vein ..............................
Non-routine bl draw >3 yrs ............................
Capillary blood draw ......................................
Vein access cutdown <1 yr ...........................
Vein access cutdown >1 yr ...........................
Blood transfusion service ..............................
Bl push transfuse, 2 yr or < ...........................
Bl exchange/transfuse, nb .............................
Injection(s), spider veins ................................
Injection(s), spider veins ................................
Injection therapy of vein ................................
Injection therapy of veins ...............................
Endovenous rf, 1st vein .................................
Endovenous rf, vein add-on ..........................
Endovenous laser, 1st vein ...........................
Endovenous laser vein addon .......................
Insertion of catheter, vein ..............................
Insertion of catheter, vein ..............................
Insertion of catheter, vein ..............................
Apheresis wbc ...............................................
Apheresis rbc .................................................
Apheresis platelets ........................................
Apheresis plasma ..........................................
Apheresis, adsorp/reinfuse ............................
Apheresis, selective .......................................
Photopheresis ................................................
Collect blood venous device ..........................
Declot vascular device ...................................
Insert non-tunnel cv cath ...............................
Insert non-tunnel cv cath ...............................
Insert tunneled cv cath ..................................
Insert tunneled cv cath ..................................
Insert tunneled cv cath ..................................
Insert tunneled cv cath ..................................
Insert tunneled cv cath ..................................
Insert tunneled cv cath ..................................
Insert tunneled cv cath ..................................
Insert picc cath ..............................................
Insert picc cath ..............................................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
Y ..............
Y ..............
Y ..............
..................
..................
..................
..................
..................
Y ..............
Y ..............
N ..............
N ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
..................
..................
N ..............
N ..............
N ..............
N ..............
N ..............
N ..............
N ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
36011
36012
36013
36014
36015
36100
36120
36140
36145
36160
36200
36215
36216
36217
36218
36245
36246
36247
36248
36260
36261
36262
36400
36405
36406
36410
36416
36420
36425
36430
36440
36450
36468
36469
36470
36471
36475
36476
36478
36479
36481
36500
36510
36511
36512
36513
36514
36515
36516
36522
36540
36550
36555
36556
36557
36558
36560
36561
36563
36565
36566
36568
36569
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
A2
A2
A2
N1
N1
N1
N1
N1
G2
R2
P3
R2
R2
R2
G2
P2
P2
A2
A2
A2
A2
N1
N1
N1
G2
G2
G2
G2
G2
G2
G2
N1
P3
A2
A2
A2
A2
A2
A2
A2
A2
H8
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$510.00
$446.00
$333.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$1,339.00
$1,339.00
$1,339.00
$1,339.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$333.00
$333.00
$446.00
$446.00
$510.00
$510.00
$510.00
$510.00
$510.00
$333.00
$333.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
28.5032
28.5032
22.6665
....................
....................
....................
....................
....................
0.1999
0.1999
0.7806
3.4584
3.4584
1.0798
1.0798
1.0798
1.0798
34.7288
34.7288
24.8809
24.8809
....................
....................
....................
11.7134
11.7134
11.7134
11.7134
30.2231
30.2231
30.2231
....................
0.2816
8.7846
8.7846
22.6665
22.6665
28.5032
28.5032
28.5032
28.5032
107.1217
8.7846
8.7846
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$1,212.61
$1,212.61
$964.30
....................
....................
....................
....................
....................
$8.50
$8.50
$33.21
$147.13
$147.13
$45.94
$45.94
$45.94
$45.94
$1,477.47
$1,477.47
$1,058.51
$1,058.51
....................
....................
....................
$498.32
$498.32
$498.32
$498.32
$1,285.78
$1,285.78
$1,285.78
....................
$11.98
$373.72
$373.72
$964.30
$964.30
$1,212.61
$1,212.61
$1,212.61
$1,212.61
$4,557.28
$373.72
$373.72
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$685.65
$637.65
$490.83
....................
....................
....................
....................
....................
$8.50
$8.50
$33.21
$147.13
$147.13
$45.94
$45.94
$45.94
$45.94
$1,373.62
$1,373.62
$1,268.88
$1,268.88
....................
....................
....................
$498.32
$498.32
$498.32
$498.32
$1,285.78
$1,285.78
$1,285.78
....................
$11.98
$343.18
$343.18
$575.58
$575.58
$685.65
$685.65
$685.65
$685.65
$3,809.60
$343.18
$343.18
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00110
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42579
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
Short descriptor
Subject to
multiple
procedure
discounting
36570 .......
36571 .......
36575 .......
36576 .......
36578 .......
36580 .......
36581 .......
36582 .......
36583 .......
36584 .......
36585 .......
36589 .......
36590 .......
36595 .......
36596 .......
36597 .......
36598 * .....
36600 .......
36620 .......
36625 .......
36640 .......
36680 .......
36800 .......
36810 .......
36815 .......
36818 .......
36819 .......
36820 .......
36821 .......
36825 .......
36830 .......
36831 .......
36832 .......
36833 .......
36834 .......
36835 .......
36860 .......
36861 .......
36870 .......
37184 .......
37185 .......
37186 .......
37187 .......
37188 .......
37200 .......
37203 .......
37250 .......
37251 .......
37500 .......
37607 .......
37609 .......
37650 .......
37700 .......
37718 .......
37722 .......
37735 .......
37760 .......
37765 .......
37766 .......
37780 .......
37785 .......
37790 .......
38200 .......
Insert picvad cath ..........................................
Insert picvad cath ..........................................
Repair tunneled cv cath .................................
Repair tunneled cv cath .................................
Replace tunneled cv cath ..............................
Replace cvad cath .........................................
Replace tunneled cv cath ..............................
Replace tunneled cv cath ..............................
Replace tunneled cv cath ..............................
Replace picc cath ..........................................
Replace picvad cath ......................................
Removal tunneled cv cath .............................
Removal tunneled cv cath .............................
Mech remov tunneled cv cath .......................
Mech remov tunneled cv cath .......................
Reposition venous catheter ...........................
Inj w/fluor, eval cv device ..............................
Withdrawal of arterial blood ...........................
Insertion catheter, artery ................................
Insertion catheter, artery ................................
Insertion catheter, artery ................................
Insert needle, bone cavity .............................
Insertion of cannula .......................................
Insertion of cannula .......................................
Insertion of cannula .......................................
Av fuse, uppr arm, cephalic ...........................
Av fuse, uppr arm, basilic ..............................
Av fusion/forearm vein ...................................
Av fusion direct any site ................................
Artery-vein autograft ......................................
Artery-vein nonautograft ................................
Open thrombect av fistula .............................
Av fistula revision, open ................................
Av fistula revision ...........................................
Repair A-V aneurysm ....................................
Artery to vein shunt .......................................
External cannula declotting ...........................
Cannula declotting .........................................
Percut thrombect av fistula ............................
Prim art mech thrombectomy ........................
Prim art m-thrombect add-on ........................
Sec art m-thrombect add-on ..........................
Venous mech thrombectomy .........................
Venous m-thrombectomy add-on ..................
Transcatheter biopsy .....................................
Transcatheter retrieval ...................................
Iv us first vessel add-on ................................
Iv us each add vessel add-on .......................
Endoscopy ligate perf veins ..........................
Ligation of a-v fistula .....................................
Temporal artery procedure ............................
Revision of major vein ...................................
Revise leg vein ..............................................
Ligate/strip short leg vein ..............................
Ligate/strip long leg vein ................................
Removal of leg veins/lesion ...........................
Ligation, leg veins, open ................................
Phleb veins - extrem - to 20 ..........................
Phleb veins - extrem 20+ ..............................
Revision of leg vein .......................................
Ligate/divide/excise vein ................................
Penile venous occlusion ................................
Injection for spleen x-ray ...............................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
..................
..................
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
G2
P2
N1
N1
N1
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
G2
G2
G2
G2
G2
G2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
R2
R2
A2
A2
A2
N1
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
$510.00
$446.00
$446.00
$446.00
$333.00
$446.00
$510.00
$510.00
$333.00
$510.00
$333.00
$333.00
....................
....................
....................
....................
....................
....................
....................
$333.00
....................
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$630.00
$1,339.00
$630.00
$630.00
$510.00
$630.00
$127.40
$510.00
$1,339.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
$510.00
$510.00
$446.00
$446.00
$446.00
$510.00
$510.00
$510.00
$510.00
....................
....................
$510.00
$510.00
$510.00
....................
22.6665
22.6665
8.7846
8.7846
22.6665
8.7846
22.6665
28.5032
28.5032
8.7846
22.6665
8.7846
8.7846
22.6665
8.7846
8.7846
0.6102
....................
....................
....................
28.5032
1.0995
29.2133
29.2133
29.2133
37.7391
37.7391
37.7391
37.7391
37.7391
37.7391
37.7391
37.7391
37.7391
37.7391
29.2133
2.0726
29.2133
32.3818
37.7391
37.7391
37.7391
37.7391
37.7391
6.1384
16.2375
32.5472
32.5472
34.7288
24.8809
15.1024
24.8809
34.7288
34.7288
34.7288
34.7288
24.8809
24.8809
24.8809
24.8809
24.8809
32.9873
....................
$964.30
$964.30
$373.72
$373.72
$964.30
$373.72
$964.30
$1,212.61
$1,212.61
$373.72
$964.30
$373.72
$373.72
$964.30
$373.72
$373.72
$25.96
....................
....................
....................
$1,212.61
$46.78
$1,242.82
$1,242.82
$1,242.82
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$1,242.82
$88.17
$1,242.82
$1,377.62
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$261.15
$690.79
$1,384.66
$1,384.66
$1,477.47
$1,058.51
$642.50
$1,058.51
$1,477.47
$1,477.47
$1,477.47
$1,477.47
$1,058.51
$1,058.51
$1,058.51
$1,058.51
$1,058.51
$1,403.38
....................
$623.58
$623.58
$427.93
$427.93
$575.58
$343.18
$575.58
$685.65
$685.65
$343.18
$623.58
$343.18
$343.18
$964.30
$373.72
$373.72
$25.96
....................
....................
....................
$552.90
$46.78
$693.21
$693.21
$693.21
$783.88
$783.88
$783.88
$783.88
$873.88
$873.88
$1,405.63
$873.88
$873.88
$783.88
$783.21
$117.59
$693.21
$1,348.66
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$1,605.53
$261.15
$690.79
$1,384.66
$1,384.66
$751.87
$647.13
$495.13
$599.13
$703.87
$751.87
$751.87
$751.87
$647.13
$1,058.51
$1,058.51
$647.13
$647.13
$733.35
....................
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00111
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42580
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Bl donor search management .......................
Harvest allogenic stem cells ..........................
Harvest auto stem cells .................................
Bone marrow aspiration .................................
Bone marrow biopsy ......................................
Bone marrow collection .................................
Bone marrow/stem transplant ........................
Lymphocyte infuse transplant ........................
Drainage, lymph node lesion .........................
Drainage, lymph node lesion .........................
Incision of lymph channels ............................
Biopsy/removal, lymph nodes ........................
Needle biopsy, lymph nodes .........................
Biopsy/removal, lymph nodes ........................
Biopsy/removal, lymph nodes ........................
Biopsy/removal, lymph nodes ........................
Biopsy/removal, lymph nodes ........................
Explore deep node(s), neck ..........................
Removal, neck/armpit lesion .........................
Removal, neck/armpit lesion .........................
Laparoscopy, lymph node biop .....................
Laparoscopy, lymphadenectomy ...................
Laparoscopy, lymphadenectomy ...................
Removal of lymph nodes, neck .....................
Remove armpit lymph nodes .........................
Remove armpit lymph nodes .........................
Remove groin lymph nodes ...........................
Inject for lymphatic x-ray ...............................
Identify sentinel node .....................................
Access thoracic lymph duct ...........................
Biopsy of lip ...................................................
Partial excision of lip ......................................
Partial excision of lip ......................................
Partial excision of lip ......................................
Reconstruct lip with flap ................................
Reconstruct lip with flap ................................
Partial removal of lip ......................................
Repair lip ........................................................
Repair lip ........................................................
Repair lip ........................................................
Repair cleft lip/nasal ......................................
Repair cleft lip/nasal ......................................
Repair cleft lip/nasal ......................................
Repair cleft lip/nasal ......................................
Repair cleft lip/nasal ......................................
Drainage of mouth lesion ..............................
Drainage of mouth lesion ..............................
Removal, foreign body, mouth ......................
Removal, foreign body, mouth ......................
Incision of lip fold ...........................................
Biopsy of mouth lesion ..................................
Excision of mouth lesion ................................
Excise/repair mouth lesion ............................
Excise/repair mouth lesion ............................
Excision of mouth lesion ................................
Excise oral mucosa for graft ..........................
Excise lip or cheek fold .................................
Treatment of mouth lesion .............................
Repair mouth laceration ................................
Repair mouth laceration ................................
Reconstruction of mouth ................................
Reconstruction of mouth ................................
Reconstruction of mouth ................................
..................
N ..............
N ..............
Y ..............
Y ..............
N ..............
N ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
..................
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
38204
38205
38206
38220
38221
38230
38241
38242
38300
38305
38308
38500
38505
38510
38520
38525
38530
38542
38550
38555
38570
38571
38572
38700
38740
38745
38760
38790
38792
38794
40490
40500
40510
40520
40525
40527
40530
40650
40652
40654
40700
40701
40702
40720
40761
40800
40801
40804
40805
40806
40808
40810
40812
40814
40816
40818
40819
40820
40830
40831
40840
40842
40843
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
N1
G2
G2
P2
P2
G2
G2
R2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
N1
N1
N1
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
R2
A2
A2
P2
A2
P2
P3
P3
P2
P3
P3
A2
A2
A2
A2
P3
G2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
....................
....................
....................
....................
....................
....................
....................
....................
$333.00
$446.00
$446.00
$446.00
$240.00
$446.00
$446.00
$446.00
$446.00
$446.00
$510.00
$630.00
$1,339.00
$1,339.00
$1,339.00
....................
$446.00
$630.00
$446.00
....................
....................
....................
....................
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$464.15
$464.15
$464.15
$995.00
$995.00
....................
$995.00
$510.00
....................
$446.00
....................
....................
....................
....................
....................
....................
$446.00
$446.00
$150.72
$333.00
....................
....................
$333.00
$446.00
$510.00
$510.00
....................
11.7134
11.7134
2.4011
2.4011
20.3582
20.3582
11.7134
11.1535
17.5086
21.2621
21.2621
3.9045
21.2621
21.2621
21.2621
21.2621
37.7224
21.2621
21.2621
43.5488
70.5066
43.5488
21.2621
37.7224
37.7224
21.2621
....................
....................
....................
1.4968
16.4266
23.3299
16.4266
23.3299
23.3299
23.3299
7.5511
7.5511
7.5511
38.1991
38.1991
38.1991
38.1991
38.1991
1.4392
7.5511
0.6102
3.8385
1.6898
2.4520
2.5913
3.3155
16.4266
23.3299
2.4520
7.5511
3.6455
2.4520
7.5511
23.3299
23.3299
23.3299
....................
$498.32
$498.32
$102.15
$102.15
$866.10
$866.10
$498.32
$474.50
$744.87
$904.55
$904.55
$166.11
$904.55
$904.55
$904.55
$904.55
$1,604.82
$904.55
$904.55
$1,852.70
$2,999.56
$1,852.70
$904.55
$1,604.82
$1,604.82
$904.55
....................
....................
....................
$63.68
$698.84
$992.52
$698.84
$992.52
$992.52
$992.52
$321.25
$321.25
$321.25
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$61.23
$321.25
$25.96
$163.30
$71.89
$104.32
$110.24
$141.05
$698.84
$992.52
$104.32
$321.25
$155.09
$104.32
$321.25
$992.52
$992.52
$992.52
....................
$498.32
$498.32
$102.15
$102.15
$866.10
$866.10
$498.32
$368.38
$520.72
$560.64
$560.64
$221.53
$560.64
$560.64
$560.64
$560.64
$735.71
$608.64
$698.64
$1,467.43
$1,754.14
$1,467.43
$904.55
$735.71
$873.71
$560.64
....................
....................
....................
$63.68
$509.21
$582.63
$509.21
$582.63
$582.63
$582.63
$428.43
$428.43
$428.43
$1,152.53
$1,152.53
$1,625.10
$1,152.53
$788.78
$61.23
$414.81
$25.96
$163.30
$71.89
$104.32
$110.24
$141.05
$509.21
$582.63
$139.12
$330.06
$155.09
$104.32
$330.06
$582.63
$630.63
$630.63
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00112
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42581
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
40844
40845
41000
41005
41006
41007
41008
41009
41010
41015
41016
41017
41018
41100
41105
41108
41110
41112
41113
41114
41115
41116
41120
41250
41251
41252
41500
41510
41520
41800
41805
41806
41820
41821
41822
41823
41825
41826
41827
41828
41830
41850
41870
41872
41874
42000
42100
42104
42106
42107
42120
42140
42145
42160
42180
42182
42200
42205
42210
42215
42220
42226
42235
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Reconstruction of mouth ................................
Reconstruction of mouth ................................
Drainage of mouth lesion ..............................
Drainage of mouth lesion ..............................
Drainage of mouth lesion ..............................
Drainage of mouth lesion ..............................
Drainage of mouth lesion ..............................
Drainage of mouth lesion ..............................
Incision of tongue fold ...................................
Drainage of mouth lesion ..............................
Drainage of mouth lesion ..............................
Drainage of mouth lesion ..............................
Drainage of mouth lesion ..............................
Biopsy of tongue ............................................
Biopsy of tongue ............................................
Biopsy of floor of mouth ................................
Excision of tongue lesion ...............................
Excision of tongue lesion ...............................
Excision of tongue lesion ...............................
Excision of tongue lesion ...............................
Excision of tongue fold ..................................
Excision of mouth lesion ................................
Partial removal of tongue ..............................
Repair tongue laceration ...............................
Repair tongue laceration ...............................
Repair tongue laceration ...............................
Fixation of tongue ..........................................
Tongue to lip surgery .....................................
Reconstruction, tongue fold ...........................
Drainage of gum lesion .................................
Removal of foreign body, gum ......................
Removal of foreign body, jawbone ................
Excision, gum, each quadrant .......................
Excision of gum flap ......................................
Excision of gum lesion ...................................
Excision of gum lesion ...................................
Excision of gum lesion ...................................
Excision of gum lesion ...................................
Excision of gum lesion ...................................
Excision of gum lesion ...................................
Removal of gum tissue ..................................
Treatment of gum lesion ................................
Gum graft .......................................................
Repair gum ....................................................
Repair tooth socket ........................................
Drainage mouth roof lesion ...........................
Biopsy roof of mouth .....................................
Excision lesion, mouth roof ...........................
Excision lesion, mouth roof ...........................
Excision lesion, mouth roof ...........................
Remove palate/lesion ....................................
Excision of uvula ............................................
Repair palate, pharynx/uvula .........................
Treatment mouth roof lesion .........................
Repair palate .................................................
Repair palate .................................................
Reconstruct cleft palate .................................
Reconstruct cleft palate .................................
Reconstruct cleft palate .................................
Reconstruct cleft palate .................................
Reconstruct cleft palate .................................
Lengthening of palate ....................................
Repair palate .................................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
P3
P3
P3
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
P3
R2
G2
P3
P3
P3
P3
A2
P3
P3
R2
G2
P3
P3
A2
P3
P3
P3
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$717.00
$717.00
....................
$150.72
$333.00
$333.00
$333.00
$150.72
$333.00
$150.72
$333.00
$333.00
$333.00
....................
....................
....................
....................
$446.00
$446.00
$446.00
....................
$333.00
$717.00
$150.72
$150.72
$446.00
$333.00
$333.00
$446.00
$88.46
....................
....................
....................
....................
....................
....................
....................
....................
$446.00
....................
....................
....................
....................
....................
....................
$150.72
....................
....................
....................
$446.00
$630.00
$446.00
$717.00
....................
$150.72
$446.00
$717.00
$717.00
$717.00
$995.00
$717.00
$717.00
$717.00
38.1991
38.1991
1.9394
2.4520
23.3299
16.4266
16.4266
2.4520
7.5511
2.4520
7.5511
7.5511
7.5511
2.0118
1.9634
1.7947
2.5913
16.4266
16.4266
23.3299
3.0339
16.4266
23.3299
2.4520
2.4520
7.5511
23.3299
16.4266
7.5511
1.4392
2.9695
3.8145
7.5511
7.5511
3.4363
4.8525
2.6879
3.0339
23.3299
3.1867
4.4261
16.4266
23.3299
4.3939
4.2651
2.4520
1.7220
2.3980
3.0741
23.3299
38.1991
7.5511
23.3299
3.1707
2.4520
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
16.4266
Estimated
CY 2008
fully implemented
payment
$1,625.10
$1,625.10
$82.51
$104.32
$992.52
$698.84
$698.84
$104.32
$321.25
$104.32
$321.25
$321.25
$321.25
$85.59
$83.53
$76.35
$110.24
$698.84
$698.84
$992.52
$129.07
$698.84
$992.52
$104.32
$104.32
$321.25
$992.52
$698.84
$321.25
$61.23
$126.33
$162.28
$321.25
$321.25
$146.19
$206.44
$114.35
$129.07
$992.52
$135.57
$188.30
$698.84
$992.52
$186.93
$181.45
$104.32
$73.26
$102.02
$130.78
$992.52
$1,625.10
$321.25
$992.52
$134.89
$104.32
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$698.84
Estimated
CY 2008
first transition year
payment
$944.03
$944.03
$82.51
$139.12
$497.88
$424.46
$424.46
$139.12
$330.06
$139.12
$330.06
$330.06
$330.06
$85.59
$83.53
$76.35
$110.24
$509.21
$509.21
$582.63
$129.07
$424.46
$785.88
$139.12
$139.12
$414.81
$497.88
$424.46
$414.81
$81.65
$126.33
$162.28
$321.25
$321.25
$146.19
$206.44
$114.35
$129.07
$582.63
$135.57
$188.30
$698.84
$992.52
$186.93
$181.45
$139.12
$73.26
$102.02
$130.78
$582.63
$878.78
$414.81
$785.88
$134.89
$139.12
$740.78
$944.03
$944.03
$944.03
$1,152.53
$944.03
$944.03
$712.46
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00113
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42582
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Repair nose to lip fistula ................................
Preparation, palate mold ...............................
Insertion, palate prosthesis ............................
Drainage of salivary gland .............................
Drainage of salivary gland .............................
Drainage of salivary gland .............................
Drainage of salivary gland .............................
Removal of salivary stone .............................
Removal of salivary stone .............................
Removal of salivary stone .............................
Biopsy of salivary gland .................................
Biopsy of salivary gland .................................
Excision of salivary cyst ................................
Drainage of salivary cyst ...............................
Excise parotid gland/lesion ............................
Excise parotid gland/lesion ............................
Excise parotid gland/lesion ............................
Excise parotid gland/lesion ............................
Excise submaxillary gland .............................
Excise sublingual gland .................................
Repair salivary duct .......................................
Repair salivary duct .......................................
Parotid duct diversion ....................................
Parotid duct diversion ....................................
Parotid duct diversion ....................................
Parotid duct diversion ....................................
Injection for salivary x-ray ..............................
Closure of salivary fistula ..............................
Dilation of salivary duct .................................
Dilation of salivary duct .................................
Ligation of salivary duct .................................
Drainage of tonsil abscess ............................
Drainage of throat abscess ...........................
Drainage of throat abscess ...........................
Biopsy of throat ..............................................
Biopsy of throat ..............................................
Biopsy of upper nose/throat ..........................
Biopsy of upper nose/throat ..........................
Excise pharynx lesion ....................................
Remove pharynx foreign body ......................
Excision of neck cyst .....................................
Excision of neck cyst .....................................
Remove tonsils and adenoids .......................
Remove tonsils and adenoids .......................
Removal of tonsils .........................................
Removal of tonsils .........................................
Removal of adenoids .....................................
Removal of adenoids .....................................
Removal of adenoids .....................................
Removal of adenoids .....................................
Excision of tonsil tags ....................................
Excision of lingual tonsil ................................
Partial removal of pharynx .............................
Revision of pharyngeal walls .........................
Repair throat wound ......................................
Reconstruction of throat ................................
Surgical opening of throat .............................
Control throat bleeding ..................................
Control throat bleeding ..................................
Control nose/throat bleeding .........................
Control nose/throat bleeding .........................
Throat muscle surgery ...................................
Esophagus endoscopy ..................................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
42260
42280
42281
42300
42305
42310
42320
42330
42335
42340
42400
42405
42408
42409
42410
42415
42420
42425
42440
42450
42500
42505
42507
42508
42509
42510
42550
42600
42650
42660
42665
42700
42720
42725
42800
42802
42804
42806
42808
42809
42810
42815
42820
42821
42825
42826
42830
42831
42835
42836
42860
42870
42890
42892
42900
42950
42955
42960
42962
42970
42972
43030
43200
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
P3
G2
A2
A2
A2
A2
P3
P3
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
N1
A2
P3
P3
A2
A2
A2
A2
P3
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
R2
A2
G2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$630.00
....................
....................
$333.00
$446.00
$150.72
$150.72
....................
....................
$446.00
....................
$446.00
$510.00
$510.00
$510.00
$995.00
$995.00
$995.00
$510.00
$446.00
$510.00
$630.00
$510.00
$630.00
$630.00
$630.00
....................
$333.00
....................
....................
$995.00
$150.72
$333.00
$446.00
....................
$333.00
$333.00
$446.00
$446.00
....................
$510.00
$717.00
$510.00
$717.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$510.00
$510.00
$995.00
$995.00
$333.00
$446.00
$446.00
$72.48
$446.00
....................
$510.00
....................
$333.00
23.3299
1.6898
16.4266
16.4266
16.4266
2.4520
2.4520
2.5511
4.1685
16.4266
1.4244
16.4266
16.4266
16.4266
38.1991
38.1991
38.1991
38.1991
38.1991
23.3299
23.3299
38.1991
38.1991
38.1991
38.1991
38.1991
....................
16.4266
0.9254
1.1186
23.3299
2.4520
16.4266
38.1991
1.7947
16.4266
16.4266
23.3299
16.4266
0.6102
23.3299
38.1991
22.1165
22.1165
22.1165
22.1165
22.1165
22.1165
22.1165
22.1165
22.1165
22.1165
38.1991
38.1991
7.5511
23.3299
23.3299
1.1791
38.1991
1.1791
16.4266
16.4266
8.3175
$992.52
$71.89
$698.84
$698.84
$698.84
$104.32
$104.32
$108.53
$177.34
$698.84
$60.60
$698.84
$698.84
$698.84
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$992.52
$992.52
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
....................
$698.84
$39.37
$47.59
$992.52
$104.32
$698.84
$1,625.10
$76.35
$698.84
$698.84
$992.52
$698.84
$25.96
$992.52
$1,625.10
$940.90
$940.90
$940.90
$940.90
$940.90
$940.90
$940.90
$940.90
$940.90
$940.90
$1,625.10
$1,625.10
$321.25
$992.52
$992.52
$50.16
$1,625.10
$50.16
$698.84
$698.84
$353.85
$720.63
$71.89
$698.84
$424.46
$509.21
$139.12
$139.12
$108.53
$177.34
$509.21
$60.60
$509.21
$557.21
$557.21
$788.78
$1,152.53
$1,152.53
$1,152.53
$788.78
$582.63
$630.63
$878.78
$788.78
$878.78
$878.78
$878.78
....................
$424.46
$39.37
$47.59
$994.38
$139.12
$424.46
$740.78
$76.35
$424.46
$424.46
$582.63
$509.21
$25.96
$630.63
$944.03
$617.73
$772.98
$707.73
$707.73
$707.73
$707.73
$707.73
$707.73
$617.73
$617.73
$1,152.53
$1,152.53
$330.06
$582.63
$582.63
$66.90
$740.78
$50.16
$557.21
$698.84
$338.21
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00114
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42583
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
43201
43202
43204
43205
43215
43216
43217
43219
43220
43226
43227
43228
43231
43232
43234
43235
43236
43237
43238
43239
43240
43241
43242
43243
43244
43245
43246
43247
43248
43249
43250
43251
43255
43256
43257
43258
43259
43260
43261
43262
43263
43264
43265
43267
43268
43269
43271
43272
43450
43453
43456
43458
43600
43653
43750
43760
43761
43870
43886
43887
43888
44100
44312
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Esoph scope w/submucous inj ......................
Esophagus endoscopy, biopsy ......................
Esoph scope w/sclerosis inj ..........................
Esophagus endoscopy/ligation ......................
Esophagus endoscopy ..................................
Esophagus endoscopy/lesion ........................
Esophagus endoscopy ..................................
Esophagus endoscopy ..................................
Esoph endoscopy, dilation .............................
Esoph endoscopy, dilation .............................
Esoph endoscopy, repair ...............................
Esoph endoscopy, ablation ...........................
Esoph endoscopy w/us exam ........................
Esoph endoscopy w/us fn bx ........................
Upper GI endoscopy, exam ...........................
Uppr gi endoscopy, diagnosis .......................
Uppr gi scope w/submuc inj ..........................
Endoscopic us exam, esoph .........................
Uppr gi endoscopy w/us fn bx .......................
Upper GI endoscopy, biopsy .........................
Esoph endoscope w/drain cyst ......................
Upper GI endoscopy with tube ......................
Uppr gi endoscopy w/us fn bx .......................
Upper gi endoscopy & inject .........................
Upper GI endoscopy/ligation .........................
Uppr gi scope dilate strictr .............................
Place gastrostomy tube .................................
Operative upper GI endoscopy .....................
Uppr gi endoscopy/guide wire .......................
Esoph endoscopy, dilation .............................
Upper GI endoscopy/tumor ...........................
Operative upper GI endoscopy .....................
Operative upper GI endoscopy .....................
Uppr gi endoscopy w/stent ............................
Uppr gi scope w/thrml txmnt ..........................
Operative upper GI endoscopy .....................
Endoscopic ultrasound exam ........................
Endo cholangiopancreatograph .....................
Endo cholangiopancreatograph .....................
Endo cholangiopancreatograph .....................
Endo cholangiopancreatograph .....................
Endo cholangiopancreatograph .....................
Endo cholangiopancreatograph .....................
Endo cholangiopancreatograph .....................
Endo cholangiopancreatograph .....................
Endo cholangiopancreatograph .....................
Endo cholangiopancreatograph .....................
Endo cholangiopancreatograph .....................
Dilate esophagus ...........................................
Dilate esophagus ...........................................
Dilate esophagus ...........................................
Dilate esophagus ...........................................
Biopsy of stomach .........................................
Laparoscopy, gastrostomy .............................
Place gastrostomy tube .................................
Change gastrostomy tube .............................
Reposition gastrostomy tube .........................
Repair stomach opening ................................
Revise gastric port, open ...............................
Remove gastric port, open ............................
Change gastric port, open .............................
Biopsy of bowel .............................................
Revision of ileostomy .....................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
G2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$446.00
$446.00
$446.00
$446.00
$333.00
$333.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$510.00
$510.00
$510.00
$510.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$333.00
$333.00
$335.41
$335.41
$333.00
$1,339.00
$446.00
$144.98
$333.00
$333.00
....................
....................
....................
$333.00
$333.00
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
22.9475
8.3175
8.3175
8.3175
25.7552
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
8.3175
22.9475
25.7552
8.3175
8.3175
19.8381
19.8381
19.8381
19.8381
19.8381
19.8381
19.8381
22.9475
22.9475
19.8381
19.8381
5.4566
5.4566
5.4566
5.4566
8.3175
43.5488
8.3175
2.3587
7.4800
8.3175
5.2594
5.2594
14.0346
8.3175
21.4302
Estimated
CY 2008
fully implemented
payment
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$976.26
$353.85
$353.85
$353.85
$1,095.70
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$353.85
$976.26
$1,095.70
$353.85
$353.85
$843.97
$843.97
$843.97
$843.97
$843.97
$843.97
$843.97
$976.26
$976.26
$843.97
$843.97
$232.14
$232.14
$232.14
$232.14
$353.85
$1,852.70
$353.85
$100.35
$318.22
$353.85
$223.75
$223.75
$597.07
$353.85
$911.71
Estimated
CY 2008
first transition year
payment
$338.21
$338.21
$338.21
$338.21
$338.21
$338.21
$338.21
$493.82
$338.21
$338.21
$422.96
$608.43
$422.96
$422.96
$338.21
$338.21
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$422.96
$626.57
$656.43
$470.96
$470.96
$545.49
$545.49
$545.49
$545.49
$545.49
$545.49
$545.49
$578.57
$578.57
$545.49
$545.49
$307.79
$307.79
$309.59
$309.59
$338.21
$1,467.43
$422.96
$133.82
$329.31
$338.21
$223.75
$223.75
$597.07
$338.21
$477.68
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00115
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42584
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Revision of colostomy ....................................
Small bowel endoscopy .................................
Small bowel endoscopy/biopsy .....................
Small bowel endoscopy .................................
Small bowel endoscopy .................................
Small bowel endoscopy .................................
Small bowel endoscopy .................................
Small bowel endoscopy .................................
Small bowel endoscopy/stent ........................
Small bowel endoscopy .................................
Small bowel endoscopy .................................
Small bowel endoscopy .................................
Small bowel endoscopy/biopsy .....................
Small bowel endoscopy .................................
Sbowel endoscope w/stent ............................
Small bowel endoscopy .................................
Small bowel endoscopy .................................
Ileoscopy w/stent ...........................................
Endoscopy of bowel pouch ...........................
Endoscopy, bowel pouch/biop .......................
Colonoscopy ..................................................
Colonoscopy with biopsy ...............................
Colonoscopy for foreign body ........................
Colonoscopy for bleeding ..............................
Colonoscopy & polypectomy .........................
Colonoscopy, lesion removal .........................
Colonoscopy w/snare ....................................
Colonoscopy w/stent ......................................
Intraop colon lavage add-on ..........................
Drainage of pelvic abscess ...........................
Drainage of rectal abscess ............................
Drainage of rectal abscess ............................
Biopsy of rectum ............................................
Removal of anorectal lesion ..........................
Excision of rectal stricture .............................
Excision of rectal lesion .................................
Excision of rectal lesion .................................
Destruction, rectal tumor ...............................
Proctosigmoidoscopy dx ................................
Proctosigmoidoscopy dilate ...........................
Proctosigmoidoscopy w/bx ............................
Proctosigmoidoscopy fb .................................
Proctosigmoidoscopy removal .......................
Proctosigmoidoscopy removal .......................
Proctosigmoidoscopy removal .......................
Proctosigmoidoscopy bleed ...........................
Proctosigmoidoscopy ablate ..........................
Proctosigmoidoscopy volvul ..........................
Proctosigmoidoscopy w/stent ........................
Diagnostic sigmoidoscopy .............................
Sigmoidoscopy and biopsy ............................
Sigmoidoscopy w/fb removal .........................
Sigmoidoscopy & polypectomy ......................
Sigmoidoscopy for bleeding ..........................
Sigmoidoscopy w/submuc inj ........................
Sigmoidoscopy & decompress ......................
Sigmoidoscopy w/tumr remove .....................
Sigmoidoscopy w/ablate tumr ........................
Sig w/balloon dilation .....................................
Sigmoidoscopy w/ultrasound .........................
Sigmoidoscopy w/us guide bx .......................
Sigmoidoscopy w/stent ..................................
Surgical colonoscopy .....................................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
44340
44360
44361
44363
44364
44365
44366
44369
44370
44372
44373
44376
44377
44378
44379
44380
44382
44383
44385
44386
44388
44389
44390
44391
44392
44393
44394
44397
44701
45000
45005
45020
45100
45108
45150
45160
45170
45190
45300
45303
45305
45307
45308
45309
45315
45317
45320
45321
45327
45330
45331
45332
45333
45334
45335
45337
45338
45339
45340
45341
45342
45345
45355
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
N1
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$1,339.00
$446.00
$446.00
$446.00
$446.00
$446.00
$1,339.00
$333.00
$333.00
$1,339.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
....................
$312.07
$446.00
$446.00
$333.00
$446.00
$446.00
$446.00
$446.00
$1,339.00
....................
....................
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
....................
$299.24
$299.24
$333.00
$333.00
$299.24
$299.24
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
21.4302
9.4946
9.4946
9.4946
9.4946
9.4946
9.4946
9.4946
22.9475
9.4946
9.4946
9.4946
9.4946
9.4946
22.9475
9.4946
9.4946
22.9475
8.7686
8.7686
8.7686
8.7686
8.7686
8.7686
8.7686
8.7686
8.7686
22.9475
....................
5.0770
12.7389
12.7389
22.2682
22.2682
22.2682
22.2682
22.2682
22.2682
1.3922
8.5477
8.5477
20.6375
8.5477
8.5477
8.5477
8.5477
20.6375
20.6375
22.9475
1.9152
4.8683
4.8683
8.5477
8.5477
4.8683
4.8683
8.5477
8.5477
8.5477
8.5477
8.5477
22.9475
8.7686
$911.71
$403.93
$403.93
$403.93
$403.93
$403.93
$403.93
$403.93
$976.26
$403.93
$403.93
$403.93
$403.93
$403.93
$976.26
$403.93
$403.93
$976.26
$373.04
$373.04
$373.04
$373.04
$373.04
$373.04
$373.04
$373.04
$373.04
$976.26
....................
$215.99
$541.95
$541.95
$947.36
$947.36
$947.36
$947.36
$947.36
$947.36
$59.23
$363.64
$363.64
$877.98
$363.64
$363.64
$363.64
$363.64
$877.98
$877.98
$976.26
$81.48
$207.11
$207.11
$363.64
$363.64
$207.11
$207.11
$363.64
$363.64
$363.64
$363.64
$363.64
$976.26
$373.04
$610.43
$435.48
$435.48
$435.48
$435.48
$435.48
$435.48
$435.48
$1,248.32
$435.48
$435.48
$435.48
$435.48
$435.48
$1,248.32
$350.73
$350.73
$1,248.32
$343.01
$343.01
$343.01
$343.01
$343.01
$343.01
$343.01
$343.01
$343.01
$493.82
....................
$288.05
$469.99
$469.99
$486.59
$571.34
$571.34
$571.34
$571.34
$1,241.09
$59.23
$363.64
$340.66
$469.25
$340.66
$340.66
$340.66
$340.66
$469.25
$469.25
$493.82
$81.48
$276.21
$276.21
$340.66
$340.66
$276.21
$276.21
$340.66
$340.66
$340.66
$340.66
$340.66
$493.82
$343.01
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00116
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42585
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
45378
45379
45380
45381
45382
45383
45384
45385
45386
45387
45391
45392
45500
45505
45520
45560
45900
45905
45910
45915
45990
46020
46030
46040
46045
46050
46060
46070
46080
46083
46200
46210
46211
46220
46221
46230
46250
46255
46257
46258
46260
46261
46262
46270
46275
46280
46285
46288
46320
46500
46505
46600
46604
46606
46608
46610
46611
46612
46614
46615
46700
46706
46750
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Diagnostic colonoscopy .................................
Colonoscopy w/fb removal ............................
Colonoscopy and biopsy ...............................
Colonoscopy, submucous inj .........................
Colonoscopy/control bleeding ........................
Lesion removal colonoscopy .........................
Lesion remove colonoscopy ..........................
Lesion removal colonoscopy .........................
Colonoscopy dilate stricture ..........................
Colonoscopy w/stent ......................................
Colonoscopy w/endoscope us .......................
Colonoscopy w/endoscopic fnb .....................
Repair of rectum ............................................
Repair of rectum ............................................
Treatment of rectal prolapse .........................
Repair of rectocele ........................................
Reduction of rectal prolapse ..........................
Dilation of anal sphincter ...............................
Dilation of rectal narrowing ............................
Remove rectal obstruction .............................
Surg dx exam, anorectal ...............................
Placement of seton ........................................
Removal of rectal marker ..............................
Incision of rectal abscess ..............................
Incision of rectal abscess ..............................
Incision of anal abscess ................................
Incision of rectal abscess ..............................
Incision of anal septum ..................................
Incision of anal sphincter ...............................
Incise external hemorrhoid ............................
Removal of anal fissure .................................
Removal of anal crypt ....................................
Removal of anal crypts ..................................
Removal of anal tag ......................................
Ligation of hemorrhoid(s) ...............................
Removal of anal tags .....................................
Hemorrhoidectomy .........................................
Hemorrhoidectomy .........................................
Remove hemorrhoids & fissure .....................
Remove hemorrhoids & fistula ......................
Hemorrhoidectomy .........................................
Remove hemorrhoids & fissure .....................
Remove hemorrhoids & fistula ......................
Removal of anal fistula ..................................
Removal of anal fistula ..................................
Removal of anal fistula ..................................
Removal of anal fistula ..................................
Repair anal fistula ..........................................
Removal of hemorrhoid clot ..........................
Injection into hemorrhoid(s) ...........................
Chemodenervation anal musc .......................
Diagnostic anoscopy ......................................
Anoscopy and dilation ...................................
Anoscopy and biopsy ....................................
Anoscopy, remove for body ...........................
Anoscopy, remove lesion ..............................
Anoscopy .......................................................
Anoscopy, remove lesions .............................
Anoscopy, control bleeding ...........................
Anoscopy .......................................................
Repair of anal stricture ..................................
Repr of anal fistula w/glue .............................
Repair of anal sphincter ................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
P3
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
P3
G2
P2
P2
P3
A2
A2
A2
A2
P3
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$333.00
$446.00
$446.00
$446.00
$446.00
....................
$446.00
$312.07
$333.00
$333.00
$312.07
$312.07
$510.00
$312.07
$510.00
$446.00
$312.07
$446.00
....................
$510.00
....................
$446.00
$446.00
$446.00
$333.00
....................
$333.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$630.00
$510.00
$510.00
$630.00
$333.00
$630.00
....................
....................
....................
....................
....................
....................
$333.00
$333.00
$333.00
$333.00
....................
$446.00
$510.00
$333.00
$510.00
8.7686
8.7686
8.7686
8.7686
8.7686
8.7686
8.7686
8.7686
8.7686
22.9475
8.7686
8.7686
22.2682
29.6189
1.0798
29.6189
5.0770
22.2682
22.2682
5.0770
5.0770
22.2682
5.0770
22.2682
22.2682
5.0770
22.2682
12.7389
22.2682
1.9554
22.2682
22.2682
22.2682
22.2682
2.5591
22.2682
22.2682
22.2682
22.2682
22.2682
22.2682
22.2682
22.2682
22.2682
22.2682
22.2682
22.2682
22.2682
1.8186
2.2934
5.0770
0.6102
8.5477
3.0821
8.5477
20.6375
8.5477
20.6375
1.9634
20.6375
22.2682
29.6189
37.8991
Estimated
CY 2008
fully implemented
payment
$373.04
$373.04
$373.04
$373.04
$373.04
$373.04
$373.04
$373.04
$373.04
$976.26
$373.04
$373.04
$947.36
$1,260.08
$45.94
$1,260.08
$215.99
$947.36
$947.36
$215.99
$215.99
$947.36
$215.99
$947.36
$947.36
$215.99
$947.36
$541.95
$947.36
$83.19
$947.36
$947.36
$947.36
$947.36
$108.87
$947.36
$947.36
$947.36
$947.36
$947.36
$947.36
$947.36
$947.36
$947.36
$947.36
$947.36
$947.36
$947.36
$77.37
$97.57
$215.99
$25.96
$363.64
$131.12
$363.64
$877.98
$363.64
$877.98
$83.53
$877.98
$947.36
$1,260.08
$1,612.34
Estimated
CY 2008
first transition year
payment
$427.76
$427.76
$427.76
$427.76
$427.76
$427.76
$427.76
$427.76
$427.76
$493.82
$427.76
$427.76
$571.34
$649.52
$45.94
$649.52
$288.05
$486.59
$486.59
$288.05
$288.05
$619.34
$288.05
$619.34
$571.34
$288.05
$571.34
$541.95
$619.34
$83.19
$571.34
$571.34
$571.34
$486.59
$108.87
$486.59
$619.34
$619.34
$619.34
$619.34
$619.34
$709.34
$709.34
$619.34
$619.34
$709.34
$486.59
$709.34
$77.37
$97.57
$215.99
$25.96
$363.64
$131.12
$340.66
$469.25
$340.66
$469.25
$83.53
$554.00
$619.34
$564.77
$785.59
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00117
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42586
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Reconstruction of anus ..................................
Removal of suture from anus ........................
Repair of anal sphincter ................................
Repair of anal sphincter ................................
Implant artificial sphincter ..............................
Destruction, anal lesion(s) .............................
Destruction, anal lesion(s) .............................
Cryosurgery, anal lesion(s) ............................
Laser surgery, anal lesions ...........................
Excision of anal lesion(s) ...............................
Destruction, anal lesion(s) .............................
Destruction of hemorrhoids ...........................
Destruction of hemorrhoids ...........................
Destruction of hemorrhoids ...........................
Cryotherapy of rectal lesion ...........................
Cryotherapy of rectal lesion ...........................
Treatment of anal fissure ...............................
Treatment of anal fissure ...............................
Ligation of hemorrhoids .................................
Ligation of hemorrhoids .................................
Hemorrhoidopexy by stapling ........................
Needle biopsy of liver ....................................
Needle biopsy, liver add-on ...........................
Percut ablate liver rf ......................................
Injection for liver x-rays .................................
Injection for liver x-rays .................................
Insert catheter, bile duct ................................
Insert bile duct drain ......................................
Change bile duct catheter .............................
Revise/reinsert bile tube ................................
Biliary endoscopy thru skin ............................
Biliary endoscopy thru skin ............................
Biliary endoscopy thru skin ............................
Biliary endoscopy thru skin ............................
Biliary endoscopy thru skin ............................
Laparoscopy w/cholangio ..............................
Laparo w/cholangio/biopsy ............................
Laparoscopic cholecystectomy ......................
Laparo cholecystectomy/graph ......................
Laparo cholecystectomy/explr .......................
Remove bile duct stone .................................
Needle biopsy, pancreas ...............................
Puncture, peritoneal cavity ............................
Removal of abdominal fluid ...........................
Biopsy, abdominal mass ................................
Excision of umbilicus .....................................
Diag laparo separate proc .............................
Laparoscopy, biopsy ......................................
Laparoscopy, aspiration .................................
Air injection into abdomen .............................
Remove foreign body, adbomen ...................
Insrt abdom cath for chemotx ........................
Insert abdom drain, temp ..............................
Insert abdom drain, perm ..............................
Remove perm cannula/catheter ....................
Exchange drainage catheter ..........................
Assess cyst, contrast inject ...........................
Revise abdomen-venous shunt .....................
Injection, abdominal shunt .............................
Removal of shunt ...........................................
Rpr ing hernia baby, reduc ............................
Rpr ing hernia baby, blocked ........................
Rpr ing hernia, init, reduce ............................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
..................
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
46753
46754
46760
46761
46762
46900
46910
46916
46917
46922
46924
46934
46935
46936
46937
46938
46940
46942
46945
46946
46947
47000
47001
47382
47500
47505
47510
47511
47525
47530
47552
47553
47554
47555
47556
47560
47561
47562
47563
47564
47630
48102
49080
49081
49180
49250
49320
49321
49322
49400
49402
49419
49420
49421
49422
49423
49424
49426
49427
49429
49495
49496
49500
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
A2
A2
A2
P3
P3
P2
A2
A2
A2
P3
P3
P3
A2
A2
P3
P3
P3
A2
A2
A2
N1
G2
N1
N1
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
N1
A2
A2
A2
A2
A2
G2
N1
A2
N1
G2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
$446.00
$446.00
$510.00
$995.00
....................
....................
....................
$333.00
$333.00
$333.00
....................
....................
....................
$446.00
$446.00
....................
....................
....................
$333.00
$995.00
$333.00
....................
....................
....................
....................
$446.00
$1,245.85
$333.00
$333.00
$446.00
$510.00
$510.00
$510.00
$1,245.85
$510.00
$510.00
....................
....................
....................
$510.00
$333.00
$222.78
$222.78
$333.00
$630.00
$510.00
$630.00
$630.00
....................
$446.00
$333.00
$333.00
$333.00
$333.00
....................
....................
$446.00
....................
....................
$630.00
$630.00
$630.00
22.2682
22.2682
37.8991
37.8991
37.8991
2.4947
2.7281
1.0918
20.4276
20.4276
20.4276
4.2087
2.8729
4.4341
22.2682
29.6189
1.9394
1.8588
3.2511
12.7389
29.6189
6.1384
....................
37.3604
....................
....................
20.2682
20.2682
11.6575
11.6575
20.2682
20.2682
20.2682
20.2682
20.2682
32.1241
32.1241
43.5488
43.5488
43.5488
20.2682
6.1384
3.6244
3.6244
6.1384
22.0832
32.1241
32.1241
32.1241
....................
22.0832
29.2133
29.5416
29.5416
25.6142
11.6575
....................
22.0832
....................
25.6142
29.2182
29.2182
29.2182
$947.36
$947.36
$1,612.34
$1,612.34
$1,612.34
$106.13
$116.06
$46.45
$869.05
$869.05
$869.05
$179.05
$122.22
$188.64
$947.36
$1,260.08
$82.51
$79.08
$138.31
$541.95
$1,260.08
$261.15
....................
$1,589.42
....................
....................
$862.27
$862.27
$495.95
$495.95
$862.27
$862.27
$862.27
$862.27
$862.27
$1,366.66
$1,366.66
$1,852.70
$1,852.70
$1,852.70
$862.27
$261.15
$154.19
$154.19
$261.15
$939.49
$1,366.66
$1,366.66
$1,366.66
....................
$939.49
$1,242.82
$1,256.79
$1,256.79
$1,089.70
$495.95
....................
$939.49
....................
$1,089.70
$1,243.03
$1,243.03
$1,243.03
$619.34
$571.34
$737.59
$785.59
$1,149.34
$106.13
$116.06
$46.45
$467.01
$467.01
$467.01
$179.05
$122.22
$188.64
$571.34
$649.52
$82.51
$79.08
$138.31
$385.24
$1,061.27
$315.04
....................
$1,589.42
....................
....................
$550.07
$1,149.96
$373.74
$373.74
$550.07
$598.07
$598.07
$598.07
$1,149.96
$724.17
$724.17
$1,852.70
$1,852.70
$1,852.70
$598.07
$315.04
$205.63
$205.63
$315.04
$707.37
$724.17
$814.17
$814.17
....................
$569.37
$560.46
$563.95
$563.95
$522.18
$495.95
....................
$569.37
....................
$1,089.70
$783.26
$783.26
$783.26
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00118
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42587
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Rpr ing hernia, init blocked ............................
Prp i/hern init reduc > 5 yr ............................
Prp i/hern init block > 5 yr .............................
Rerepair ing hernia, reduce ...........................
Rerepair ing hernia, blocked .........................
Repair ing hernia, sliding ...............................
Repair lumbar hernia .....................................
Rpr rem hernia, init, reduce ...........................
Rpr fem hernia, init blocked ..........................
Rerepair fem hernia, reduce ..........................
Rerepair fem hernia, blocked ........................
Rpr ventral hern init, reduc ............................
Rpr ventral hern init, block ............................
Rerepair ventrl hern, reduce ..........................
Rerepair ventrl hern, block ............................
Hernia repair w/mesh ....................................
Rpr epigastric hern, reduce ...........................
Rpr epigastric hern, blocked ..........................
Rpr umbil hern, reduc < 5 yr .........................
Rpr umbil hern, block < 5 yr ..........................
Rpr umbil hern, reduc > 5 yr .........................
Rpr umbil hern, block > 5 yr ..........................
Repair spigelian hernia ..................................
Repair umbilical lesion ...................................
Laparo hernia repair initial .............................
Laparo hernia repair recur .............................
Biopsy of kidney ............................................
Change ureter stent, percut ...........................
Remove ureter stent, percut ..........................
Change ext/int ureter stent ............................
Remove renal tube w/fluoro ..........................
Drainage of kidney lesion ..............................
Instll rx agnt into rnal tub ...............................
Insert kidney drain .........................................
Insert ureteral tube ........................................
Injection for kidney x-ray ...............................
Create passage to kidney ..............................
Measure kidney pressure ..............................
Change kidney tube .......................................
Kidney endoscopy .........................................
Kidney endoscopy .........................................
Kidney endoscopy & biopsy ..........................
Kidney endoscopy & treatment .....................
Kidney endoscopy & treatment .....................
Renal scope w/tumor resect ..........................
Kidney endoscopy .........................................
Kidney endoscopy .........................................
Kidney endoscopy & biopsy ..........................
Kidney endoscopy .........................................
Kidney endoscopy & treatment .....................
Fragmenting of kidney stone .........................
Perc rf ablate renal tumor ..............................
Injection for ureter x-ray ................................
Measure ureter pressure ...............................
Change of ureter tube/stent ...........................
Injection for ureter x-ray ................................
Laparo new ureter/bladder ............................
Laparo new ureter/bladder ............................
Endoscopy of ureter ......................................
Endoscopy of ureter ......................................
Ureter endoscopy & biopsy ...........................
Ureter endoscopy & treatment ......................
Ureter endoscopy & treatment ......................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
49501
49505
49507
49520
49521
49525
49540
49550
49553
49555
49557
49560
49561
49565
49566
49568
49570
49572
49580
49582
49585
49587
49590
49600
49650
49651
50200
50382
50384
50387
50389
50390
50391
50392
50393
50394
50395
50396
50398
50551
50553
50555
50557
50561
50562
50570
50572
50574
50575
50576
50590
50592
50684
50686
50688
50690
50947
50948
50951
50953
50955
50957
50961
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
G2
G2
A2
P2
A2
A2
N1
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
G2
G2
G2
G2
G2
G2
N1
P2
A2
N1
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$1,339.00
$630.00
$1,339.00
$995.00
$1,339.00
$630.00
$446.00
$717.00
$1,339.00
$717.00
$1,339.00
$630.00
$1,339.00
$630.00
$1,339.00
$995.00
$630.00
$1,339.00
$630.00
$1,339.00
$630.00
$1,339.00
$510.00
$630.00
$630.00
$995.00
$333.00
....................
....................
....................
....................
$333.00
....................
$333.00
$333.00
....................
$333.00
$131.50
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$333.00
....................
$1,339.00
$1,339.00
$333.00
$333.00
$333.00
$333.00
$333.00
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
29.2182
43.5488
43.5488
6.1384
19.2251
19.2251
7.4800
3.4079
6.1384
1.0887
19.2251
19.2251
....................
19.2251
2.1393
7.4800
6.4951
19.2251
6.4951
23.8700
19.2251
6.4951
6.4951
6.4951
6.4951
34.9261
19.2251
43.5398
37.3604
....................
1.0887
7.4800
....................
43.5488
43.5488
6.4951
6.4951
19.2251
19.2251
19.2251
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,243.03
$1,852.70
$1,852.70
$261.15
$817.89
$817.89
$318.22
$144.98
$261.15
$46.32
$817.89
$817.89
....................
$817.89
$91.01
$318.22
$276.32
$817.89
$276.32
$1,015.50
$817.89
$276.32
$276.32
$276.32
$276.32
$1,485.86
$817.89
$1,852.31
$1,589.42
....................
$46.32
$318.22
....................
$1,852.70
$1,852.70
$276.32
$276.32
$817.89
$817.89
$817.89
$1,315.01
$783.26
$1,315.01
$1,057.01
$1,315.01
$783.26
$645.26
$848.51
$1,315.01
$848.51
$1,315.01
$783.26
$1,315.01
$783.26
$1,315.01
$1,057.01
$783.26
$1,315.01
$783.26
$1,315.01
$783.26
$1,315.01
$693.26
$783.26
$935.68
$1,209.43
$315.04
$817.89
$817.89
$318.22
$144.98
$315.04
$46.32
$454.22
$454.22
....................
$454.22
$121.38
$329.31
$318.83
$454.22
$318.83
$503.63
$454.22
$276.32
$276.32
$276.32
$276.32
$1,485.86
$817.89
$1,852.31
$1,589.42
....................
$46.32
$329.31
....................
$1,467.43
$1,467.43
$318.83
$318.83
$454.22
$454.22
$454.22
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00119
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42588
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Ureter endoscopy ..........................................
Ureter endoscopy & catheter .........................
Ureter endoscopy & biopsy ...........................
Ureter endoscopy & treatment ......................
Ureter endoscopy & treatment ......................
Drainage of bladder .......................................
Drainage of bladder .......................................
Drainage of bladder .......................................
Incise & treat bladder ....................................
Incise & treat bladder ....................................
Incise & drain bladder ....................................
Incise bladder/drain ureter .............................
Removal of bladder stone .............................
Remove ureter calculus .................................
Drainage of bladder abscess .........................
Removal of bladder cyst ................................
Removal of bladder lesion .............................
Injection for bladder x-ray ..............................
Preparation for bladder xray ..........................
Injection for bladder x-ray ..............................
Irrigation of bladder ........................................
Insert bladder catheter ...................................
Insert temp bladder cath ................................
Insert bladder cath, complex .........................
Change of bladder tube .................................
Change of bladder tube .................................
Endoscopic injection/implant .........................
Treatment of bladder lesion ...........................
Simple cystometrogram .................................
Complex cystometrogram ..............................
Urine flow measurement ................................
Electro-uroflowmetry, first ..............................
Urethra pressure profile .................................
Anal/urinary muscle study .............................
Anal/urinary muscle study .............................
Urinary reflex study ........................................
Urine voiding pressure study .........................
Intraabdominal pressure test .........................
Us urine capacity measure ............................
Repair of bladder opening .............................
Laparo sling operation ...................................
Cystoscopy ....................................................
Cystoscopy, removal of clots .........................
Cystoscopy & ureter catheter ........................
Cystoscopy and biopsy ..................................
Cystoscopy & duct catheter ...........................
Cystoscopy w/biopsy(s) .................................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy and radiotracer ...........................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy & revise urethra .........................
Cystoscopy & revise urethra .........................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy, implant stent ..............................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
..................
..................
Y ..............
N ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
50970
50972
50974
50976
50980
51000
51005
51010
51020
51030
51040
51045
51050
51065
51080
51500
51520
51600
51605
51610
51700
51701
51702
51703
51705
51710
51715
51720
51725
51726
51736
51741
51772
51784
51785
51792
51795
51797
51798
51880
51992
52000
52001
52005
52007
52010
52204
52214
52224
52234
52235
52240
52250
52260
52265
52270
52275
52276
52277
52281
52282
52283
52285
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
A2
A2
A2
P3
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
N1
N1
N1
P3
P2
P2
P2
P3
A2
A2
P3
P2
A2
P3
P3
A2
P2
A2
P2
P2
P2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$333.00
$333.00
$333.00
$333.00
$333.00
....................
....................
$333.00
$630.00
$630.00
$630.00
$399.24
$630.00
$630.00
$333.00
$630.00
$630.00
....................
....................
....................
....................
....................
....................
....................
....................
$333.00
$510.00
....................
....................
$209.48
....................
....................
$131.50
....................
$66.92
....................
....................
....................
....................
$333.00
$717.00
$333.00
$399.24
$446.00
$446.00
$399.24
$446.00
$446.00
$446.00
$446.00
$510.00
$510.00
$630.00
$446.00
....................
$446.00
$446.00
$510.00
$446.00
$446.00
$1,339.00
$446.00
$446.00
6.4951
6.4951
19.2251
19.2251
19.2251
1.1588
1.0887
18.1679
23.8700
23.8700
23.8700
6.4951
23.8700
23.8700
17.5086
29.2182
23.8700
....................
....................
....................
1.2554
0.6102
0.6102
1.0887
1.7302
7.4800
29.0253
1.3600
2.1393
3.4079
0.4264
0.4990
2.1393
1.0887
1.0887
1.0887
2.1393
2.1393
0.3702
23.8700
43.5488
6.4951
6.4951
19.2251
19.2251
6.4951
19.2251
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
19.2251
6.4951
19.2251
19.2251
19.2251
23.8700
19.2251
34.9261
19.2251
19.2251
$276.32
$276.32
$817.89
$817.89
$817.89
$49.30
$46.32
$772.92
$1,015.50
$1,015.50
$1,015.50
$276.32
$1,015.50
$1,015.50
$744.87
$1,243.03
$1,015.50
....................
....................
....................
$53.41
$25.96
$25.96
$46.32
$73.61
$318.22
$1,234.82
$57.86
$91.01
$144.98
$18.14
$21.23
$91.01
$46.32
$46.32
$46.32
$91.01
$91.01
$15.75
$1,015.50
$1,852.70
$276.32
$276.32
$817.89
$817.89
$276.32
$817.89
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$817.89
$276.32
$817.89
$817.89
$817.89
$1,015.50
$817.89
$1,485.86
$817.89
$817.89
$318.83
$318.83
$454.22
$454.22
$454.22
$49.30
$46.32
$442.98
$726.38
$726.38
$726.38
$368.51
$726.38
$726.38
$435.97
$783.26
$726.38
....................
....................
....................
$53.41
$25.96
$25.96
$46.32
$73.61
$329.31
$691.21
$57.86
$91.01
$193.36
$18.14
$21.23
$121.38
$46.32
$61.77
$46.32
$91.01
$91.01
$15.75
$503.63
$1,000.93
$318.83
$368.51
$538.97
$538.97
$368.51
$538.97
$588.38
$588.38
$588.38
$636.38
$636.38
$726.38
$538.97
$276.32
$538.97
$538.97
$586.97
$588.38
$538.97
$1,375.72
$538.97
$538.97
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00120
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42589
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
52290
52300
52301
52305
52310
52315
52317
52318
52320
52325
52327
52330
52332
52334
52341
52342
52343
52344
52345
52346
52351
52352
52353
52354
52355
52400
52402
52450
52500
52510
52601
52606
52612
52614
52620
52630
52640
52647
52648
52700
53000
53010
53020
53025
53040
53060
53080
53085
53200
53210
53215
53220
53230
53235
53240
53250
53260
53265
53270
53275
53400
53405
53410
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Remove bladder stone ..................................
Remove bladder stone ..................................
Cystoscopy and treatment .............................
Cystoscopy, stone removal ...........................
Cystoscopy, inject material ............................
Cystoscopy and treatment .............................
Cystoscopy and treatment .............................
Create passage to kidney ..............................
Cysto w/ureter stricture tx ..............................
Cysto w/up stricture tx ...................................
Cysto w/renal stricture tx ...............................
Cysto/uretero, stricture tx ..............................
Cysto/uretero w/up stricture ...........................
Cystouretero w/renal strict .............................
Cystouretero & or pyeloscope .......................
Cystouretero w/stone remove ........................
Cystouretero w/lithotripsy ..............................
Cystouretero w/biopsy ...................................
Cystouretero w/excise tumor .........................
Cystouretero w/congen repr ..........................
Cystourethro cut ejacul duct ..........................
Incision of prostate ........................................
Revision of bladder neck ...............................
Dilation prostatic urethra ................................
Prostatectomy (TURP) ...................................
Control postop bleeding .................................
Prostatectomy, first stage ..............................
Prostatectomy, second stage ........................
Remove residual prostate ..............................
Remove prostate regrowth ............................
Relieve bladder contracture ...........................
Laser surgery of prostate ..............................
Laser surgery of prostate ..............................
Drainage of prostate abscess ........................
Incision of urethra ..........................................
Incision of urethra ..........................................
Incision of urethra ..........................................
Incision of urethra ..........................................
Drainage of urethra abscess .........................
Drainage of urethra abscess .........................
Drainage of urinary leakage ..........................
Drainage of urinary leakage ..........................
Biopsy of urethra ...........................................
Removal of urethra ........................................
Removal of urethra ........................................
Treatment of urethra lesion ...........................
Removal of urethra lesion .............................
Removal of urethra lesion .............................
Surgery for urethra pouch .............................
Removal of urethra gland ..............................
Treatment of urethra lesion ...........................
Treatment of urethra lesion ...........................
Removal of urethra gland ..............................
Repair of urethra defect .................................
Revise urethra, stage 1 .................................
Revise urethra, stage 2 .................................
Reconstruction of urethra ..............................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
R2
A2
P3
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$446.00
$446.00
$510.00
$446.00
$399.24
$446.00
$333.00
$446.00
$717.00
$630.00
$446.00
$446.00
$446.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$630.00
$630.00
$630.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$333.00
$446.00
$333.00
$333.00
$446.00
$446.00
$1,339.00
$1,339.00
$446.00
$333.00
$333.00
$333.00
....................
$446.00
....................
$510.00
....................
$333.00
$717.00
$717.00
$446.00
$446.00
$510.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$510.00
$446.00
$446.00
19.2251
19.2251
19.2251
19.2251
6.4951
19.2251
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
19.2251
23.8700
34.9261
23.8700
23.8700
23.8700
23.8700
23.8700
23.8700
19.2251
34.9261
23.8700
34.9261
34.9261
34.9261
34.9261
23.8700
43.1004
43.1004
23.8700
18.3960
18.3960
18.3960
18.3960
18.3960
1.6416
18.3960
18.3960
18.3960
29.0253
18.3960
29.0253
29.0253
18.3960
29.0253
18.3960
18.3960
18.3960
18.3960
18.3960
29.0253
29.0253
29.0253
Estimated
CY 2008
fully implemented
payment
$817.89
$817.89
$817.89
$817.89
$276.32
$817.89
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$817.89
$1,015.50
$1,485.86
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$1,015.50
$817.89
$1,485.86
$1,015.50
$1,485.86
$1,485.86
$1,485.86
$1,485.86
$1,015.50
$1,833.62
$1,833.62
$1,015.50
$782.62
$782.62
$782.62
$782.62
$782.62
$69.84
$782.62
$782.62
$782.62
$1,234.82
$782.62
$1,234.82
$1,234.82
$782.62
$1,234.82
$782.62
$782.62
$782.62
$782.62
$782.62
$1,234.82
$1,234.82
$1,234.82
Estimated
CY 2008
first transition year
payment
$538.97
$538.97
$586.97
$538.97
$368.51
$538.97
$503.63
$588.38
$791.63
$726.38
$588.38
$588.38
$588.38
$636.38
$636.38
$636.38
$636.38
$636.38
$636.38
$636.38
$586.97
$726.38
$843.97
$726.38
$726.38
$636.38
$636.38
$636.38
$636.38
$586.97
$843.97
$503.63
$705.97
$621.22
$621.22
$705.97
$588.38
$1,462.66
$1,462.66
$588.38
$445.41
$445.41
$445.41
$782.62
$530.16
$69.84
$578.16
$782.62
$445.41
$846.46
$733.41
$643.21
$643.21
$578.16
$643.21
$530.16
$530.16
$530.16
$530.16
$530.16
$691.21
$643.21
$643.21
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00121
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42590
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Reconstruct urethra, stage 1 .........................
Reconstruct urethra, stage 2 .........................
Reconstruction of urethra ..............................
Reconstruct urethra/bladder ..........................
Male sling procedure .....................................
Remove/revise male sling .............................
Insert tandem cuff ..........................................
Insert uro/ves nck sphincter ..........................
Remove uro sphincter ...................................
Remove/replace ur sphincter .........................
Repair uro sphincter ......................................
Revision of urethra ........................................
Revision of urethra ........................................
Repair of urethra injury ..................................
Repair of urethra injury ..................................
Repair of urethra injury ..................................
Repair of urethra injury ..................................
Repair of urethra defect .................................
Dilate urethra stricture ...................................
Dilate urethra stricture ...................................
Dilate urethra stricture ...................................
Dilate urethra stricture ...................................
Dilate urethra stricture ...................................
Dilation of urethra ..........................................
Dilation of urethra ..........................................
Dilation of urethra ..........................................
Prostatic microwave thermotx .......................
Prostatic rf thermotx ......................................
Prostatic water thermother ............................
Slitting of prepuce ..........................................
Slitting of prepuce ..........................................
Drain penis lesion ..........................................
Destruction, penis lesion(s) ...........................
Destruction, penis lesion(s) ...........................
Cryosurgery, penis lesion(s) ..........................
Laser surg, penis lesion(s) ............................
Excision of penis lesion(s) .............................
Destruction, penis lesion(s) ...........................
Biopsy of penis ..............................................
Biopsy of penis ..............................................
Treatment of penis lesion ..............................
Treat penis lesion, graft .................................
Treat penis lesion, graft .................................
Treatment of penis lesion ..............................
Partial removal of penis .................................
Circumcision w/regionl block .........................
Circumcision, neonate ...................................
Circum 28 days or older ................................
Lysis penil circumic lesion .............................
Repair of circumcision ...................................
Frenulotomy of penis .....................................
Treatment of penis lesion ..............................
Treatment of penis lesion ..............................
Treatment of penis lesion ..............................
Prepare penis study .......................................
Dynamic cavernosometry ..............................
Penile injection ...............................................
Penis study ....................................................
Penis study ....................................................
Revision of penis ...........................................
Revision of penis ...........................................
Reconstruction of urethra ..............................
Reconstruction of urethra ..............................
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
Y ..............
N ..............
N ..............
Y ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
53420
53425
53430
53431
53440
53442
53444
53445
53446
53447
53449
53450
53460
53502
53505
53510
53515
53520
53600
53601
53605
53620
53621
53660
53661
53665
53850
53852
53853
54000
54001
54015
54050
54055
54056
54057
54060
54065
54100
54105
54110
54111
54112
54115
54120
54150
54160
54161
54162
54163
54164
54200
54205
54220
54230
54231
54235
54240
54250
54300
54304
54308
54312
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
H8
A2
H8
A2
A2
A2
A2
A2
A2
A2
A2
P3
P3
A2
P3
P3
P3
P3
A2
P2
P2
P2
A2
A2
A2
P2
P3
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
N1
P3
P3
P3
P3
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
$446.00
$446.00
$446.00
$446.00
$333.00
$446.00
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
$446.00
$446.00
$446.00
$446.00
$446.00
....................
....................
$446.00
....................
....................
....................
....................
$333.00
....................
....................
....................
$446.00
$446.00
$630.00
....................
....................
....................
$333.00
$333.00
$333.00
$333.00
$333.00
$446.00
$446.00
$446.00
$333.00
$446.00
$333.00
$446.00
$446.00
$446.00
$446.00
$446.00
....................
$630.00
$131.50
....................
....................
....................
....................
....................
$510.00
$510.00
$510.00
$510.00
29.0253
29.0253
29.0253
29.0253
79.2092
29.0253
79.2092
178.7754
29.0253
178.7754
29.0253
29.0253
18.3960
18.3960
29.0253
18.3960
29.0253
29.0253
0.9254
1.0702
19.2251
1.4888
1.5692
1.0542
1.0462
18.3960
41.1375
41.1375
23.8700
18.3960
18.3960
17.5086
1.0918
1.4404
0.8432
17.4423
17.4423
20.4276
15.1024
20.0656
32.9873
32.9873
32.9873
17.5086
32.9873
20.5513
20.5513
20.5513
20.5513
20.5513
20.5513
1.5370
32.9873
2.1393
....................
1.3036
0.9496
0.6518
0.2254
32.9873
32.9873
32.9873
32.9873
$1,234.82
$1,234.82
$1,234.82
$1,234.82
$3,369.80
$1,234.82
$3,369.80
$7,605.64
$1,234.82
$7,605.64
$1,234.82
$1,234.82
$782.62
$782.62
$1,234.82
$782.62
$1,234.82
$1,234.82
$39.37
$45.53
$817.89
$63.34
$66.76
$44.85
$44.51
$782.62
$1,750.11
$1,750.11
$1,015.50
$782.62
$782.62
$744.87
$46.45
$61.28
$35.87
$742.05
$742.05
$869.05
$642.50
$853.65
$1,403.38
$1,403.38
$1,403.38
$744.87
$1,403.38
$874.31
$874.31
$874.31
$874.31
$874.31
$874.31
$65.39
$1,403.38
$91.01
....................
$55.46
$40.40
$27.73
$9.59
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$691.21
$643.21
$643.21
$643.21
$1,176.95
$558.46
$1,176.95
$6,152.75
$558.46
$6,152.75
$558.46
$558.46
$445.41
$530.16
$643.21
$530.16
$643.21
$643.21
$39.37
$45.53
$538.97
$63.34
$66.76
$44.85
$44.51
$445.41
$1,750.11
$1,750.11
$1,015.50
$530.16
$530.16
$658.72
$46.45
$61.28
$35.87
$435.26
$435.26
$467.01
$410.38
$463.16
$685.35
$685.35
$685.35
$435.97
$685.35
$468.33
$553.08
$553.08
$553.08
$553.08
$553.08
$65.39
$823.35
$121.38
....................
$55.46
$40.40
$27.73
$9.59
$733.35
$733.35
$733.35
$733.35
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00122
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42591
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Reconstruction of urethra ..............................
Reconstruction of urethra ..............................
Reconstruction of urethra ..............................
Reconstruction of urethra ..............................
Reconstruction of urethra ..............................
Revise penis/urethra ......................................
Secondary urethral surgery ...........................
Secondary urethral surgery ...........................
Secondary urethral surgery ...........................
Reconstruct urethra/penis ..............................
Penis plastic surgery .....................................
Repair penis ...................................................
Repair penis ...................................................
Insert semi-rigid prosthesis ............................
Insert self-contd prosthesis ............................
Insert multi-comp penis pros .........................
Remove muti-comp penis pros ......................
Repair multi-comp penis pros ........................
Remove/replace penis prosth ........................
Remove self-contd penis pros .......................
Remv/repl penis contain pros ........................
Revision of penis ...........................................
Revision of penis ...........................................
Repair of penis ..............................................
Preputial stretching ........................................
Biopsy of testis ..............................................
Biopsy of testis ..............................................
Excise lesion testis ........................................
Removal of testis ...........................................
Orchiectomy, partial .......................................
Removal of testis ...........................................
Exploration for testis ......................................
Exploration for testis ......................................
Reduce testis torsion .....................................
Suspension of testis ......................................
Suspension of testis ......................................
Revision of testis ...........................................
Repair testis injury .........................................
Relocation of testis(es) ..................................
Laparoscopy, orchiectomy .............................
Laparoscopy, orchiopexy ...............................
Drainage of scrotum ......................................
Biopsy of epididymis ......................................
Remove epididymis lesion .............................
Remove epididymis lesion .............................
Removal of epididymis ..................................
Removal of epididymis ..................................
Explore epididymis .........................................
Fusion of spermatic ducts .............................
Fusion of spermatic ducts .............................
Drainage of hydrocele ...................................
Removal of hydrocele ....................................
Removal of hydroceles ..................................
Repair of hydrocele .......................................
Drainage of scrotum abscess ........................
Explore scrotum .............................................
Removal of scrotum lesion ............................
Removal of scrotum .......................................
Revision of scrotum .......................................
Revision of scrotum .......................................
Incision of sperm duct ...................................
Removal of sperm duct(s) .............................
Prepare, sperm duct x-ray .............................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
N ..............
N ..............
Y ..............
Y ..............
N ..............
Y ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
mstockstill on PROD1PC66 with RULES2
HCPCS
code
54316
54318
54322
54324
54326
54328
54340
54344
54348
54352
54360
54380
54385
54400
54401
54405
54406
54408
54410
54415
54416
54420
54435
54440
54450
54500
54505
54512
54520
54522
54530
54550
54560
54600
54620
54640
54660
54670
54680
54690
54692
54700
54800
54830
54840
54860
54861
54865
54900
54901
55000
55040
55041
55060
55100
55110
55120
55150
55175
55180
55200
55250
55300
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
H8
H8
A2
A2
H8
A2
H8
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
N1
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
$630.00
$630.00
$630.00
$209.48
$333.00
$333.00
$446.00
$510.00
$510.00
$630.00
$630.00
....................
$630.00
$510.00
$630.00
$446.00
$510.00
$510.00
$1,339.00
....................
$446.00
$127.16
$510.00
$630.00
$510.00
$630.00
$333.00
$630.00
$630.00
....................
$510.00
$717.00
$630.00
$333.00
$446.00
$446.00
$333.00
$333.00
$446.00
$446.00
$446.00
....................
32.9873
32.9873
32.9873
32.9873
32.9873
32.9873
32.9873
32.9873
32.9873
32.9873
32.9873
32.9873
32.9873
79.2092
178.7754
178.7754
32.9873
32.9873
178.7754
32.9873
178.7754
32.9873
32.9873
32.9873
3.4079
10.2655
23.5310
23.5310
23.5310
23.5310
29.2182
29.2182
23.5310
23.5310
23.5310
29.2182
23.5310
23.5310
23.5310
43.5488
70.5066
23.5310
2.0687
23.5310
23.5310
23.5310
23.5310
23.5310
23.5310
23.5310
1.5772
29.2182
29.2182
23.5310
11.1535
23.5310
23.5310
23.5310
23.5310
23.5310
23.5310
23.5310
....................
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$1,403.38
$3,369.80
$7,605.64
$7,605.64
$1,403.38
$1,403.38
$7,605.64
$1,403.38
$7,605.64
$1,403.38
$1,403.38
$1,403.38
$144.98
$436.73
$1,001.08
$1,001.08
$1,001.08
$1,001.08
$1,243.03
$1,243.03
$1,001.08
$1,001.08
$1,001.08
$1,243.03
$1,001.08
$1,001.08
$1,001.08
$1,852.70
$2,999.56
$1,001.08
$88.01
$1,001.08
$1,001.08
$1,001.08
$1,001.08
$1,001.08
$1,001.08
$1,001.08
$67.10
$1,243.03
$1,243.03
$1,001.08
$474.50
$1,001.08
$1,001.08
$1,001.08
$1,001.08
$1,001.08
$1,001.08
$1,001.08
....................
$733.35
$733.35
$733.35
$733.35
$733.35
$733.35
$733.35
$733.35
$733.35
$733.35
$733.35
$733.35
$733.35
$1,224.95
$6,285.50
$6,285.50
$733.35
$733.35
$6,285.50
$733.35
$6,285.50
$823.35
$823.35
$823.35
$193.36
$358.93
$500.02
$584.77
$632.77
$632.77
$783.26
$783.26
$1,001.08
$722.77
$632.77
$783.26
$584.77
$632.77
$632.77
$1,467.43
$2,999.56
$584.77
$117.37
$632.77
$722.77
$632.77
$722.77
$500.02
$722.77
$722.77
$67.10
$693.26
$848.51
$722.77
$368.38
$584.77
$584.77
$500.02
$500.02
$584.77
$584.77
$584.77
....................
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00123
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42592
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Subject to
multiple
procedure
discounting
mstockstill on PROD1PC66 with RULES2
HCPCS
code
Short descriptor
55400 .......
55450 .......
55500 .......
55520 .......
55530 .......
55535 .......
55540 .......
55550 .......
55600 .......
55680 .......
55700 .......
55705 .......
55720 .......
55725 .......
55860 .......
55870 .......
55873 .......
55875 .......
55876 * .....
56405 .......
56420 .......
56440 .......
56441 .......
56442 .......
56501 .......
56515 .......
56605 .......
56606 .......
56620 .......
56625 .......
56700 .......
56740 .......
56800 .......
56805 .......
56810 .......
56820 .......
56821 .......
57000 .......
57010 .......
57020 .......
57022 .......
57023 .......
57061 .......
57065 .......
57100 .......
57105 .......
57130 .......
57135 .......
57150 .......
57155 .......
57160 .......
57170 .......
57180 .......
57200 .......
57210 .......
57220 .......
57230 .......
57240 .......
57250 .......
57260 .......
57265 .......
57267 .......
57268 .......
Repair of sperm duct .....................................
Ligation of sperm duct ...................................
Removal of hydrocele ....................................
Removal of sperm cord lesion .......................
Revise spermatic cord veins .........................
Revise spermatic cord veins .........................
Revise hernia & sperm veins ........................
Laparo ligate spermatic vein .........................
Incise sperm duct pouch ...............................
Remove sperm pouch lesion .........................
Biopsy of prostate ..........................................
Biopsy of prostate ..........................................
Drainage of prostate abscess ........................
Drainage of prostate abscess ........................
Surgical exposure, prostate ...........................
Electroejaculation ...........................................
Cryoablate prostate .......................................
Transperi needle place, pros .........................
Place rt device/marker, pros ..........................
I & D of vulva/perineum .................................
Drainage of gland abscess ............................
Surgery for vulva lesion .................................
Lysis of labial lesion(s) ..................................
Hymenotomy ..................................................
Destroy, vulva lesions, sim ............................
Destroy vulva lesion/s compl .........................
Biopsy of vulva/perineum ..............................
Biopsy of vulva/perineum ..............................
Partial removal of vulva .................................
Complete removal of vulva ............................
Partial removal of hymen ...............................
Remove vagina gland lesion .........................
Repair of vagina ............................................
Repair clitoris .................................................
Repair of perineum ........................................
Exam of vulva w/scope ..................................
Exam/biopsy of vulva w/scope ......................
Exploration of vagina .....................................
Drainage of pelvic abscess ...........................
Drainage of pelvic fluid ..................................
I & d vaginal hematoma, pp ..........................
I & d vag hematoma, non-ob .........................
Destroy vag lesions, simple ...........................
Destroy vag lesions, complex ........................
Biopsy of vagina ............................................
Biopsy of vagina ............................................
Remove vagina lesion ...................................
Remove vagina lesion ...................................
Treat vagina infection ....................................
Insert uteri tandems/ovoids ...........................
Insert pessary/other device ...........................
Fitting of diaphragm/cap ................................
Treat vaginal bleeding ...................................
Repair of vagina ............................................
Repair vagina/perineum .................................
Revision of urethra ........................................
Repair of urethral lesion ................................
Repair bladder & vagina ................................
Repair rectum & vagina .................................
Repair of vagina ............................................
Extensive repair of vagina .............................
Insert mesh/pelvic flr addon ..........................
Repair of bowel bulge ....................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
P3
A2
A2
A2
A2
A2
A2
R2
A2
A2
A2
A2
A2
G2
P3
H8
A2
P3
P3
P2
A2
A2
A2
P3
A2
P3
P3
A2
A2
A2
A2
A2
G2
A2
P3
P3
A2
A2
A2
G2
A2
P3
A2
P3
A2
A2
A2
P2
A2
P3
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$333.00
....................
$510.00
$630.00
$630.00
$630.00
$717.00
$1,339.00
....................
$333.00
$345.83
$345.83
$333.00
$446.00
....................
....................
$1,339.00
$1,339.00
....................
....................
....................
$446.00
$333.00
$333.00
....................
$510.00
....................
....................
$717.00
$995.00
$333.00
$510.00
$510.00
....................
$717.00
....................
....................
$333.00
$446.00
$409.33
....................
$333.00
....................
$333.00
....................
$446.00
$446.00
$446.00
....................
$409.33
....................
....................
$178.05
$333.00
$446.00
$510.00
$510.00
$717.00
$717.00
$717.00
$995.00
$995.00
$510.00
23.5310
5.2227
23.5310
23.5310
23.5310
29.2182
29.2182
43.5488
23.5310
23.5310
5.6262
5.6262
23.8700
23.8700
18.1679
1.6094
137.5639
34.9261
1.6416
1.0058
1.2900
20.5081
14.8489
14.8489
1.3680
20.4276
0.7966
0.3460
28.5095
28.5095
20.5081
20.5081
20.5081
14.8489
20.5081
1.0058
1.3116
14.8489
14.8489
6.6592
11.1535
17.5086
1.2634
20.5081
0.8048
20.5081
20.5081
20.5081
0.1468
6.6592
0.8208
0.1468
2.8966
20.5081
20.5081
42.9896
28.5095
28.5095
28.5095
28.5095
42.9896
28.5095
28.5095
Estimated
CY 2008
fully implemented
payment
$1,001.08
$222.19
$1,001.08
$1,001.08
$1,001.08
$1,243.03
$1,243.03
$1,852.70
$1,001.08
$1,001.08
$239.36
$239.36
$1,015.50
$1,015.50
$772.92
$68.47
$5,852.38
$1,485.86
$69.84
$42.79
$54.88
$872.48
$631.72
$631.72
$58.20
$869.05
$33.89
$14.72
$1,212.88
$1,212.88
$872.48
$872.48
$872.48
$631.72
$872.48
$42.79
$55.80
$631.72
$631.72
$283.30
$474.50
$744.87
$53.75
$872.48
$34.24
$872.48
$872.48
$872.48
$6.25
$283.30
$34.92
$6.25
$123.23
$872.48
$872.48
$1,828.91
$1,212.88
$1,212.88
$1,212.88
$1,212.88
$1,828.91
$1,212.88
$1,212.88
Estimated
CY 2008
first transition year
payment
$500.02
$222.19
$632.77
$722.77
$722.77
$783.26
$848.51
$1,467.43
$1,001.08
$500.02
$319.21
$319.21
$503.63
$588.38
$772.92
$68.47
$5,252.74
$1,375.72
$69.84
$42.79
$54.88
$552.62
$407.68
$407.68
$58.20
$599.76
$33.89
$14.72
$840.97
$1,049.47
$467.87
$600.62
$600.62
$631.72
$755.87
$42.79
$55.80
$407.68
$492.43
$377.82
$474.50
$435.97
$53.75
$467.87
$34.24
$552.62
$552.62
$552.62
$6.25
$377.82
$34.92
$6.25
$164.35
$467.87
$552.62
$839.73
$685.72
$840.97
$840.97
$840.97
$1,203.48
$1,049.47
$685.72
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00124
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42593
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
Short descriptor
Subject to
multiple
procedure
discounting
57287 .......
57288 .......
57289 .......
57291 .......
57300 .......
57320 .......
57400 .......
57410 .......
57415 .......
57420 .......
57421 .......
57452 .......
57454 .......
57455 .......
57456 .......
57460 .......
57461 .......
57500 .......
57505 .......
57510 .......
57511 .......
57513 .......
57520 .......
57522 .......
57530 .......
57550 .......
57556 .......
57558 .......
57700 .......
57720 .......
57800 .......
58100 .......
58110 * .....
58120 .......
58145 .......
58301 .......
58321 .......
58322 .......
58323 .......
58340 .......
58345 .......
58346 .......
58350 .......
58353 .......
58356 .......
58545 .......
58546 .......
58550 .......
58552 .......
58555 .......
58558 .......
58559 .......
58560 .......
58561 .......
58562 .......
58563 .......
58565 .......
58600 .......
58615 .......
58660 .......
58661 .......
58662 .......
58670 .......
Revise/remove sling repair ............................
Repair bladder defect ....................................
Repair bladder & vagina ................................
Construction of vagina ...................................
Repair rectum-vagina fistula ..........................
Repair bladder-vagina lesion .........................
Dilation of vagina ...........................................
Pelvic examination .........................................
Remove vaginal foreign body ........................
Exam of vagina w/scope ...............................
Exam/biopsy of vag w/scope .........................
Exam of cervix w/scope .................................
Bx/curett of cervix w/scope ............................
Biopsy of cervix w/scope ...............................
Endocerv curettage w/scope .........................
Bx of cervix w/scope, leep .............................
Conz of cervix w/scope, leep ........................
Biopsy of cervix .............................................
Endocervical curettage ..................................
Cauterization of cervix ...................................
Cryocautery of cervix .....................................
Laser surgery of cervix ..................................
Conization of cervix .......................................
Conization of cervix .......................................
Removal of cervix ..........................................
Removal of residual cervix ............................
Remove cervix, repair bowel .........................
D&c of cervical stump ....................................
Revision of cervix ..........................................
Revision of cervix ..........................................
Dilation of cervical canal ................................
Biopsy of uterus lining ...................................
Bx done w/colposcopy add-on ......................
Dilation and curettage ....................................
Myomectomy vag method .............................
Remove intrauterine device ...........................
Artificial insemination .....................................
Artificial insemination .....................................
Sperm washing ..............................................
Catheter for hysterography ............................
Reopen fallopian tube ....................................
Insert heyman uteri capsule ..........................
Reopen fallopian tube ....................................
Endometr ablate, thermal ..............................
Endometrial cryoablation ...............................
Laparoscopic myomectomy ...........................
Laparo-myomectomy, complex ......................
Laparo-asst vag hysterectomy ......................
Laparo-vag hyst incl t/o .................................
Hysteroscopy, dx, sep proc ...........................
Hysteroscopy, biopsy .....................................
Hysteroscopy, lysis ........................................
Hysteroscopy, resect septum ........................
Hysteroscopy, remove myoma ......................
Hysteroscopy, remove fb ...............................
Hysteroscopy, ablation ..................................
Hysteroscopy, sterilization .............................
Division of fallopian tube ...............................
Occlude fallopian tube(s) ...............................
Laparoscopy, lysis .........................................
Laparoscopy, remove adnexa .......................
Laparoscopy, excise lesions ..........................
Laparoscopy, tubal cautery ...........................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Payment
indicator
G2
A2
A2
A2
A2
G2
A2
A2
A2
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P3
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
P3
P3
A2
A2
P3
P3
P3
P3
N1
R2
A2
A2
A2
P3
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
A2
A2
G2
G2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
....................
$717.00
$717.00
$717.00
$510.00
....................
$446.00
$446.00
$446.00
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$446.00
$446.00
$446.00
$510.00
$510.00
$717.00
$510.00
$333.00
$510.00
....................
....................
....................
$446.00
$717.00
....................
....................
....................
....................
....................
....................
$446.00
$510.00
$995.00
....................
$1,339.00
$1,339.00
$1,339.00
....................
$333.00
$510.00
$446.00
$510.00
$510.00
$510.00
$1,339.00
$1,339.00
....................
....................
$717.00
$717.00
$717.00
$510.00
28.5095
42.9896
28.5095
28.5095
28.5095
28.5095
20.5081
14.8489
20.5081
1.0380
1.3842
0.9818
1.2232
1.2876
1.2474
4.0639
4.2811
1.8186
1.1104
1.1508
1.2900
14.8489
20.5081
28.5095
28.5095
28.5095
42.9896
17.7499
20.5081
20.5081
0.5874
0.9818
0.3782
17.7499
28.5095
0.9496
0.8450
0.9012
0.2736
....................
14.8489
14.8489
28.5095
28.5095
41.9827
32.1241
43.5488
70.5066
43.5488
21.3586
21.3586
21.3586
34.0155
34.0155
21.3586
34.0155
42.9896
28.5095
20.5081
43.5488
43.5488
43.5488
43.5488
$1,212.88
$1,828.91
$1,212.88
$1,212.88
$1,212.88
$1,212.88
$872.48
$631.72
$872.48
$44.16
$58.89
$41.77
$52.04
$54.78
$53.07
$172.89
$182.13
$77.37
$47.24
$48.96
$54.88
$631.72
$872.48
$1,212.88
$1,212.88
$1,212.88
$1,828.91
$755.13
$872.48
$872.48
$24.99
$41.77
$16.09
$755.13
$1,212.88
$40.40
$35.95
$38.34
$11.64
....................
$631.72
$631.72
$1,212.88
$1,212.88
$1,786.07
$1,366.66
$1,852.70
$2,999.56
$1,852.70
$908.66
$908.66
$908.66
$1,447.12
$1,447.12
$908.66
$1,447.12
$1,828.91
$1,212.88
$872.48
$1,852.70
$1,852.70
$1,852.70
$1,852.70
$1,212.88
$994.98
$840.97
$840.97
$685.72
$1,212.88
$552.62
$492.43
$552.62
$44.16
$58.89
$41.77
$52.04
$54.78
$53.07
$172.89
$182.13
$77.37
$47.24
$48.96
$54.88
$492.43
$552.62
$637.72
$685.72
$685.72
$994.98
$571.28
$467.87
$600.62
$24.99
$41.77
$16.09
$523.28
$840.97
$40.40
$35.95
$38.34
$11.64
....................
$631.72
$492.43
$685.72
$1,049.47
$1,786.07
$1,345.92
$1,467.43
$1,754.14
$1,852.70
$476.92
$609.67
$561.67
$744.28
$744.28
$609.67
$1,366.03
$1,461.48
$1,212.88
$872.48
$1,000.93
$1,000.93
$1,000.93
$845.68
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00125
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42594
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
58671
58672
58673
58800
58820
58900
58970
58974
58976
59000
59001
59012
59015
59020
59025
59070
59072
59076
59100
59150
59151
59160
59200
59300
59320
59412
59414
59812
59820
59821
59840
59841
59866
59870
59871
60000
60001
60100
60200
60280
60281
61000
61001
61020
61026
61050
61055
61070
61215
61330
61334
61790
61791
61795
61880
61885
61886
61888
62194
62225
62230
62252
62263
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Laparoscopy, tubal block ...............................
Laparoscopy, fimbrioplasty ............................
Laparoscopy, salpingostomy .........................
Drainage of ovarian cyst(s) ...........................
Drain ovary abscess, open ............................
Biopsy of ovary(s) ..........................................
Retrieval of oocyte .........................................
Transfer of embryo ........................................
Transfer of embryo ........................................
Amniocentesis, diagnostic .............................
Amniocentesis, therapeutic ............................
Fetal cord puncture, prenatal ........................
Chorion biopsy ...............................................
Fetal contract stress test ...............................
Fetal non-stress test ......................................
Transabdom amnioinfus w/us ........................
Umbilical cord occlud w/us ............................
Fetal shunt placement, w/us ..........................
Remove uterus lesion ....................................
Treat ectopic pregnancy ................................
Treat ectopic pregnancy ................................
D& c after delivery .........................................
Insert cervical dilator ......................................
Episiotomy or vaginal repair ..........................
Revision of cervix ..........................................
Antepartum manipulation ...............................
Deliver placenta .............................................
Treatment of miscarriage ...............................
Care of miscarriage .......................................
Treatment of miscarriage ...............................
Abortion ..........................................................
Abortion ..........................................................
Abortion (mpr) ................................................
Evacuate mole of uterus ................................
Remove cerclage suture ................................
Drain thyroid/tongue cyst ...............................
Aspirate/inject thyriod cyst .............................
Biopsy of thyroid ............................................
Remove thyroid lesion ...................................
Remove thyroid duct lesion ...........................
Remove thyroid duct lesion ...........................
Remove cranial cavity fluid ............................
Remove cranial cavity fluid ............................
Remove brain cavity fluid ..............................
Injection into brain canal ................................
Remove brain canal fluid ...............................
Injection into brain canal ................................
Brain canal shunt procedure .........................
Insert brain-fluid device .................................
Decompress eye socket ................................
Explore orbit/remove object ...........................
Treat trigeminal nerve ....................................
Treat trigeminal tract ......................................
Brain surgery using computer .......................
Revise/remove neuroelectrode ......................
Insrt/redo neurostim 1 array ..........................
Implant neurostim arrays ...............................
Revise/remove neuroreceiver ........................
Replace/irrigate catheter ................................
Replace/irrigate catheter ................................
Replace/revise brain shunt ............................
Csf shunt reprogram ......................................
Epidural lysis mult sessions ..........................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
N
Y
Y
Y
Y
Y
N
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
P2
R2
G2
P3
P3
P3
G2
G2
G2
R2
G2
G2
A2
P3
P3
A2
G2
G2
A2
A2
A2
A2
A2
G2
A2
A2
A2
P3
P3
A2
A2
A2
R2
R2
A2
A2
A2
A2
A2
A2
G2
G2
A2
A2
A2
G2
H8
H8
A2
A2
A2
A2
P3
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$510.00
$717.00
$717.00
$510.00
$510.00
$510.00
$245.92
$245.92
$245.92
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$510.00
....................
....................
$333.00
....................
....................
$717.00
$717.00
$717.00
$717.00
$717.00
....................
$717.00
$717.00
$333.00
....................
....................
$446.00
$630.00
$630.00
....................
....................
$183.83
$183.83
$183.83
$183.83
$183.83
$510.00
....................
....................
$510.00
$351.92
$302.04
....................
$446.00
$510.00
$333.00
$333.00
$333.00
$446.00
....................
$333.00
43.5488
43.5488
43.5488
14.8489
28.5095
14.8489
4.0007
4.0007
4.0007
1.4222
6.6592
1.4222
1.1910
0.5632
0.2816
1.4222
1.4222
1.4222
28.5095
43.5488
43.5488
17.7499
0.8530
1.7542
20.5081
2.3864
14.8489
18.5201
18.5201
18.5201
16.9328
16.9328
1.4222
18.5201
20.5081
7.5511
1.3116
1.0462
37.7224
37.7224
37.7224
2.9907
2.9907
2.9907
2.9907
2.9907
2.9907
2.9907
47.0342
38.1991
38.1991
17.8499
5.7253
4.9138
17.8334
260.1530
342.4747
35.5702
11.6575
11.6575
47.0342
1.0462
12.1702
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$1,852.70
$1,852.70
$1,852.70
$631.72
$1,212.88
$631.72
$170.20
$170.20
$170.20
$60.50
$283.30
$60.50
$50.67
$23.96
$11.98
$60.50
$60.50
$60.50
$1,212.88
$1,852.70
$1,852.70
$755.13
$36.29
$74.63
$872.48
$101.52
$631.72
$787.90
$787.90
$787.90
$720.37
$720.37
$60.50
$787.90
$872.48
$321.25
$55.80
$44.51
$1,604.82
$1,604.82
$1,604.82
$127.23
$127.23
$127.23
$127.23
$127.23
$127.23
$127.23
$2,000.98
$1,625.10
$1,625.10
$759.39
$243.57
$209.05
$758.69
$11,067.69
$14,569.90
$1,513.26
$495.95
$495.95
$2,000.98
$44.51
$517.76
$845.68
$1,000.93
$1,000.93
$540.43
$685.72
$540.43
$226.99
$226.99
$226.99
$60.50
$283.30
$60.50
$50.67
$23.96
$11.98
$60.50
$60.50
$60.50
$1,212.88
$1,852.70
$1,852.70
$571.28
$36.29
$74.63
$467.87
$101.52
$631.72
$734.73
$734.73
$734.73
$717.84
$717.84
$60.50
$734.73
$755.87
$330.06
$55.80
$44.51
$735.71
$873.71
$873.71
$127.23
$127.23
$169.68
$169.68
$169.68
$169.68
$169.68
$882.75
$1,625.10
$1,625.10
$572.35
$324.83
$278.79
$758.69
$10,137.66
$13,649.39
$628.07
$373.74
$373.74
$834.75
$44.51
$379.19
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00126
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42595
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Payment
indicator
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
Epidural lysis on single day ...........................
Drain spinal cord cyst ....................................
Needle biopsy, spinal cord ............................
Spinal fluid tap, diagnostic .............................
Drain cerebro spinal fluid ...............................
Inject epidural patch ......................................
Treat spinal cord lesion .................................
Treat spinal cord lesion .................................
Treat spinal canal lesion ................................
Injection for myelogram .................................
Percutaneous diskectomy ..............................
Inject for spine disk x-ray ..............................
Inject for spine disk x-ray ..............................
Injection into disk lesion ................................
Injection into spinal artery ..............................
Inject spine c/t ................................................
Inject spine l/s (cd) ........................................
Inject spine w/cath, c/t ...................................
Inject spine w/cath l/s (cd) .............................
Implant spinal canal cath ...............................
Remove spinal canal catheter .......................
Insert spine infusion device ...........................
Implant spine infusion pump ..........................
Implant spine infusion pump ..........................
Remove spine infusion device .......................
Analyze spine infusion pump .........................
Analyze spine infusion pump .........................
Remove spinal cord lesion ............................
Stimulation of spinal cord ..............................
Remove lesion of spinal cord ........................
Implant neuroelectrodes ................................
Implant neuroelectrodes ................................
Revise/remove neuroelectrode ......................
Insrt/redo spine n generator ..........................
Revise/remove neuroreceiver ........................
Revision of spinal shunt ................................
Removal of spinal shunt ................................
Nblock inj, trigeminal .....................................
Nblock inj, facial .............................................
Nblock inj, occipital ........................................
Nblock inj, vagus ...........................................
Nblock inj, phrenic .........................................
Nblock inj, spinal accessor ............................
Nblock inj, cervical plexus .............................
Nblock inj, brachial plexus .............................
Nblock cont infuse, b plex .............................
Nblock inj, axillary ..........................................
Nblock inj, suprascapular ..............................
Nblock inj, intercost, sng ...............................
Nblock inj, intercost, mlt ................................
Nblock inj, ilio-ing/hypogi ...............................
Nblock inj, pudendal ......................................
Nblock inj, paracervical ..................................
Nblock inj, sciatic, sng ...................................
Nblk inj, sciatic, cont inf .................................
Nblock inj fem, single ....................................
Nblock, other peripheral ................................
Inj paravertebral c/t ........................................
Inj paravertebral c/t add-on ...........................
Inj paravertebral l/s ........................................
Inj paravertebral l/s add-on ............................
Inj foramen epidural c/t ..................................
Inj foramen epidural add-on ..........................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
..................
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
N ..............
Y ..............
Y ..............
Y ..............
N ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
N1 ............
A2 ............
N1 ............
N1 ............
G2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
H8 ............
H8 ............
A2 ............
P3 ............
P3 ............
A2 ............
A2 ............
R2 ............
H8 ............
J8 .............
A2 ............
H8 ............
A2 ............
A2 ............
A2 ............
P3 ............
P3 ............
P3 ............
P3 ............
A2 ............
P3 ............
P3 ............
A2 ............
G2 ............
A2 ............
P3 ............
A2 ............
A2 ............
P3 ............
A2 ............
P3 ............
P3 ............
G2 ............
G2 ............
P3 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
$333.00
$183.83
$333.00
$139.00
$139.00
$333.00
$333.00
$333.00
$333.00
....................
$1,339.00
....................
....................
....................
$183.83
$333.00
$333.00
$333.00
$333.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
....................
....................
$446.00
$333.00
....................
$446.00
....................
$333.00
$446.00
$333.00
$510.00
$446.00
....................
....................
....................
....................
$333.00
....................
....................
$139.00
....................
$139.00
....................
$139.00
$333.00
....................
$139.00
....................
....................
....................
....................
....................
$333.00
$333.00
$333.00
$333.00
$333.00
$333.00
12.1702
2.9907
6.1384
2.2614
2.2614
5.7253
6.3603
6.3603
6.3603
....................
33.1520
....................
....................
2.9907
2.9907
6.3603
6.3603
6.3603
6.3603
30.8394
12.1702
112.6322
243.3568
243.3568
33.1520
0.4104
0.5150
17.8499
17.8499
17.8499
71.6329
109.1028
17.8334
251.0862
35.5702
39.2633
10.9918
1.3198
1.2312
1.0542
1.2232
5.7253
1.8830
1.2554
2.2614
2.2614
2.2614
1.8026
2.2614
5.7253
1.1990
2.2614
1.8026
1.7382
5.7253
2.2614
1.0140
6.3603
5.7253
6.3603
5.7253
6.3603
6.3603
$517.76
$127.23
$261.15
$96.21
$96.21
$243.57
$270.59
$270.59
$270.59
....................
$1,410.39
....................
....................
$127.23
$127.23
$270.59
$270.59
$270.59
$270.59
$1,312.00
$517.76
$4,791.71
$10,353.13
$10,353.13
$1,410.39
$17.46
$21.91
$759.39
$759.39
$759.39
$3,047.48
$4,641.56
$758.69
$10,681.96
$1,513.26
$1,670.38
$467.62
$56.15
$52.38
$44.85
$52.04
$243.57
$80.11
$53.41
$96.21
$96.21
$96.21
$76.69
$96.21
$243.57
$51.01
$96.21
$76.69
$73.95
$243.57
$96.21
$43.14
$270.59
$243.57
$270.59
$243.57
$270.59
$270.59
$379.19
$169.68
$315.04
$128.30
$128.30
$310.64
$317.40
$317.40
$317.40
....................
$1,356.85
....................
....................
$127.23
$169.68
$317.40
$317.40
$317.40
$317.40
$662.50
$463.94
$1,532.43
$9,589.69
$9,589.69
$687.10
$17.46
$21.91
$524.35
$439.60
$759.39
$2,552.76
$4,641.56
$439.42
$9,721.25
$628.07
$800.10
$451.41
$56.15
$52.38
$44.85
$52.04
$310.64
$80.11
$53.41
$128.30
$96.21
$128.30
$76.69
$128.30
$310.64
$51.01
$128.30
$76.69
$73.95
$243.57
$96.21
$43.14
$317.40
$310.64
$317.40
$310.64
$317.40
$317.40
mstockstill on PROD1PC66 with RULES2
HCPCS
code
62264
62268
62269
62270
62272
62273
62280
62281
62282
62284
62287
62290
62291
62292
62294
62310
62311
62318
62319
62350
62355
62360
62361
62362
62365
62367
62368
63600
63610
63615
63650
63655
63660
63685
63688
63744
63746
64400
64402
64405
64408
64410
64412
64413
64415
64416
64417
64418
64420
64421
64425
64430
64435
64445
64446
64447
64450
64470
64472
64475
64476
64479
64480
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00127
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42596
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
64483
64484
64505
64508
64510
64517
64520
64530
64553
64555
64560
64561
64565
64573
64575
64577
64580
64581
64585
64590
64595
64600
64605
64610
64612
64613
64614
64620
64622
64623
64626
64627
64630
64640
64650
64653
64680
64681
64702
64704
64708
64712
64713
64714
64716
64718
64719
64721
64722
64726
64727
64732
64734
64736
64738
64740
64742
64744
64746
64761
64763
64766
64771
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Inj foramen epidural l/s ..................................
Inj foramen epidural add-on ..........................
Nblock, spenopalatine gangl .........................
Nblock, carotid sinus s/p ...............................
Nblock, stellate ganglion ................................
Nblock inj, hypogas plxs ................................
Nblock, lumbar/thoracic .................................
Nblock inj, celiac pelus ..................................
Implant neuroelectrodes ................................
Implant neuroelectrodes ................................
Implant neuroelectrodes ................................
Implant neuroelectrodes ................................
Implant neuroelectrodes ................................
Implant neuroelectrodes ................................
Implant neuroelectrodes ................................
Implant neuroelectrodes ................................
Implant neuroelectrodes ................................
Implant neuroelectrodes ................................
Revise/remove neuroelectrode ......................
Insrt/redo pn/gastr stimul ...............................
Revise/rmv pn/gastr stimul ............................
Injection treatment of nerve ...........................
Injection treatment of nerve ...........................
Injection treatment of nerve ...........................
Destroy nerve, face muscle ...........................
Destroy nerve, neck muscle ..........................
Destroy nerve, extrem musc .........................
Injection treatment of nerve ...........................
Destr paravertebrl nerve l/s ...........................
Destr paravertebral n add-on ........................
Destr paravertebrl nerve c/t ...........................
Destr paravertebral n add-on ........................
Injection treatment of nerve ...........................
Injection treatment of nerve ...........................
Chemodenerv eccrine glands ........................
Chemodenerv eccrine glands ........................
Injection treatment of nerve ...........................
Injection treatment of nerve ...........................
Revise finger/toe nerve ..................................
Revise hand/foot nerve ..................................
Revise arm/leg nerve .....................................
Revision of sciatic nerve ................................
Revision of arm nerve(s) ...............................
Revise low back nerve(s) ..............................
Revision of cranial nerve ...............................
Revise ulnar nerve at elbow ..........................
Revise ulnar nerve at wrist ............................
Carpal tunnel surgery ....................................
Relieve pressure on nerve(s) ........................
Release foot/toe nerve ..................................
Internal nerve revision ...................................
Incision of brow nerve ...................................
Incision of cheek nerve ..................................
Incision of chin nerve .....................................
Incision of jaw nerve ......................................
Incision of tongue nerve ................................
Incision of facial nerve ...................................
Incise nerve, back of head ............................
Incise diaphragm nerve .................................
Incision of pelvis nerve ..................................
Incise hip/thigh nerve .....................................
Incise hip/thigh nerve .....................................
Sever cranial nerve ........................................
Y
Y
Y
Y
Y
Y
Y
Y
N
N
N
N
N
N
N
N
N
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
CY 2007
ASC payment rate
A2 ............
A2 ............
P3 ............
P3 ............
A2 ............
A2 ............
A2 ............
A2 ............
H8 ............
J8 .............
J8 .............
H8 ............
J8 .............
H8 ............
H8 ............
H8 ............
H8 ............
H8 ............
A2 ............
H8 ............
A2 ............
A2 ............
A2 ............
A2 ............
P3 ............
P3 ............
P3 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
P3 ............
G2 ............
G2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
G2 ............
G2 ............
G2 ............
A2 ............
Estimated
fully implemented payment weight
$333.00
$333.00
....................
....................
$333.00
$139.00
$333.00
$333.00
$333.00
....................
....................
$510.00
....................
$333.00
$333.00
$333.00
$333.00
$510.00
$333.00
$446.00
$333.00
$333.00
$333.00
$333.00
....................
....................
....................
$333.00
$333.00
$333.00
$333.00
$333.00
$351.92
....................
....................
....................
$390.95
$446.00
$333.00
$333.00
$446.00
$446.00
$446.00
$446.00
$510.00
$446.00
$446.00
$446.00
$333.00
$333.00
$333.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
....................
....................
....................
$446.00
6.3603
6.3603
0.9416
2.0922
6.3603
2.2614
6.3603
6.3603
307.2433
71.6329
71.6329
71.6329
71.6329
307.2433
109.1028
109.1028
109.1028
109.1028
17.8334
251.0862
35.5702
12.1702
12.1702
12.1702
1.6579
1.7302
1.9474
12.1702
12.1702
6.3603
12.1702
6.3603
5.7253
2.6716
2.2614
2.2614
6.3603
12.1702
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
33.1520
17.8499
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$270.59
$270.59
$40.06
$89.01
$270.59
$96.21
$270.59
$270.59
$13,071.05
$3,047.48
$3,047.48
$3,047.48
$3,047.48
$13,071.05
$4,641.56
$4,641.56
$4,641.56
$4,641.56
$758.69
$10,681.96
$1,513.26
$517.76
$517.76
$517.76
$70.53
$73.61
$82.85
$517.76
$517.76
$270.59
$517.76
$270.59
$243.57
$113.66
$96.21
$96.21
$270.59
$517.76
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$1,410.39
$759.39
$317.40
$317.40
$40.06
$89.01
$317.40
$128.30
$317.40
$317.40
$11,841.79
$3,047.48
$3,047.48
$2,600.76
$3,047.48
$11,841.79
$3,818.33
$3,818.33
$3,818.33
$3,951.08
$439.42
$9,721.25
$628.07
$379.19
$379.19
$379.19
$70.53
$73.61
$82.85
$379.19
$379.19
$317.40
$379.19
$317.40
$324.83
$113.66
$96.21
$96.21
$360.86
$463.94
$439.60
$439.60
$524.35
$524.35
$524.35
$524.35
$572.35
$524.35
$524.35
$524.35
$439.60
$439.60
$439.60
$524.35
$524.35
$524.35
$524.35
$524.35
$524.35
$524.35
$524.35
$759.39
$759.39
$1,410.39
$524.35
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00128
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42597
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
64772
64774
64776
64778
64782
64783
64784
64786
64787
64788
64790
64792
64795
64802
64820
64821
64822
64823
64831
64832
64834
64835
64836
64837
64840
64856
64857
64858
64859
64861
64862
64864
64865
64870
64872
64874
64876
64885
64886
64890
64891
64892
64893
64895
64896
64897
64898
64901
64902
64905
64907
65091
65093
65101
65103
65105
65110
65112
65114
65125
65130
65135
65140
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Incision of spinal nerve ..................................
Remove skin nerve lesion .............................
Remove digit nerve lesion .............................
Digit nerve surgery add-on ............................
Remove limb nerve lesion .............................
Limb nerve surgery add-on ...........................
Remove nerve lesion .....................................
Remove sciatic nerve lesion ..........................
Implant nerve end ..........................................
Remove skin nerve lesion .............................
Removal of nerve lesion ................................
Removal of nerve lesion ................................
Biopsy of nerve ..............................................
Remove sympathetic nerves .........................
Remove sympathetic nerves .........................
Remove sympathetic nerves .........................
Remove sympathetic nerves .........................
Remove sympathetic nerves .........................
Repair of digit nerve ......................................
Repair nerve add-on ......................................
Repair of hand or foot nerve .........................
Repair of hand or foot nerve .........................
Repair of hand or foot nerve .........................
Repair nerve add-on ......................................
Repair of leg nerve ........................................
Repair/transpose nerve .................................
Repair arm/leg nerve .....................................
Repair sciatic nerve .......................................
Nerve surgery ................................................
Repair of arm nerves .....................................
Repair of low back nerves .............................
Repair of facial nerve ....................................
Repair of facial nerve ....................................
Fusion of facial/other nerve ...........................
Subsequent repair of nerve ...........................
Repair & revise nerve add-on .......................
Repair nerve/shorten bone ............................
Nerve graft, head or neck ..............................
Nerve graft, head or neck ..............................
Nerve graft, hand or foot ...............................
Nerve graft, hand or foot ...............................
Nerve graft, arm or leg ..................................
Nerve graft, arm or leg ..................................
Nerve graft, hand or foot ...............................
Nerve graft, hand or foot ...............................
Nerve graft, arm or leg ..................................
Nerve graft, arm or leg ..................................
Nerve graft add-on .........................................
Nerve graft add-on .........................................
Nerve pedicle transfer ...................................
Nerve pedicle transfer ...................................
Revise eye .....................................................
Revise eye with implant .................................
Removal of eye ..............................................
Remove eye/insert implant ............................
Remove eye/attach implant ...........................
Removal of eye ..............................................
Remove eye/revise socket ............................
Remove eye/revise socket ............................
Revise ocular implant ....................................
Insert ocular implant ......................................
Insert ocular implant ......................................
Attach ocular implant .....................................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
G2
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
G2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$446.00
$446.00
$510.00
$446.00
$510.00
$446.00
$510.00
$510.00
$446.00
$510.00
$510.00
$510.00
$446.00
$446.00
....................
$630.00
....................
....................
$630.00
$333.00
$446.00
$510.00
$510.00
$333.00
$446.00
$446.00
$446.00
$446.00
$333.00
$510.00
$510.00
$510.00
$630.00
$630.00
$446.00
$510.00
$510.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
$510.00
$510.00
$510.00
$510.00
$446.00
$446.00
$446.00
$333.00
$510.00
$510.00
$510.00
$510.00
$630.00
$717.00
$995.00
$995.00
....................
$510.00
$446.00
$510.00
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
17.8499
33.1520
17.8499
17.8499
17.8499
33.1520
17.8499
17.8499
17.8499
25.8758
25.8758
25.8758
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
33.1520
35.2292
35.2292
35.2292
35.2292
35.2292
35.2292
35.2292
35.2292
17.1243
25.2550
25.2550
35.2292
Estimated
CY 2008
fully implemented
payment
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$759.39
$1,410.39
$759.39
$759.39
$759.39
$1,410.39
$759.39
$759.39
$759.39
$1,100.83
$1,100.83
$1,100.83
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,410.39
$1,498.76
$1,498.76
$1,498.76
$1,498.76
$1,498.76
$1,498.76
$1,498.76
$1,498.76
$728.52
$1,074.42
$1,074.42
$1,498.76
Estimated
CY 2008
first transition year
payment
$524.35
$524.35
$572.35
$524.35
$572.35
$524.35
$572.35
$735.10
$524.35
$572.35
$572.35
$735.10
$524.35
$524.35
$759.39
$747.71
$1,100.83
$1,100.83
$825.10
$602.35
$687.10
$735.10
$735.10
$602.35
$687.10
$687.10
$687.10
$687.10
$602.35
$735.10
$735.10
$735.10
$825.10
$825.10
$687.10
$735.10
$735.10
$687.10
$687.10
$687.10
$687.10
$687.10
$687.10
$735.10
$735.10
$735.10
$735.10
$687.10
$687.10
$687.10
$602.35
$757.19
$757.19
$757.19
$757.19
$847.19
$912.44
$1,120.94
$1,120.94
$728.52
$651.11
$603.11
$757.19
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00129
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42598
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
65150
65155
65175
65205
65210
65220
65222
65235
65260
65265
65270
65272
65275
65280
65285
65286
65290
65400
65410
65420
65426
65430
65435
65436
65450
65600
65710
65730
65750
65755
65770
65772
65775
65780
65781
65782
65800
65805
65810
65815
65820
65850
65855
65860
65865
65870
65875
65880
65900
65920
65930
66020
66030
66130
66150
66155
66160
66165
66170
66172
66180
66185
66220
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Revise ocular implant ....................................
Reinsert ocular implant ..................................
Removal of ocular implant .............................
Remove foreign body from eye .....................
Remove foreign body from eye .....................
Remove foreign body from eye .....................
Remove foreign body from eye .....................
Remove foreign body from eye .....................
Remove foreign body from eye .....................
Remove foreign body from eye .....................
Repair of eye wound .....................................
Repair of eye wound .....................................
Repair of eye wound .....................................
Repair of eye wound .....................................
Repair of eye wound .....................................
Repair of eye wound .....................................
Repair of eye socket wound ..........................
Removal of eye lesion ...................................
Biopsy of cornea ............................................
Removal of eye lesion ...................................
Removal of eye lesion ...................................
Corneal smear ...............................................
Curette/treat cornea .......................................
Curette/treat cornea .......................................
Treatment of corneal lesion ...........................
Revision of cornea .........................................
Corneal transplant .........................................
Corneal transplant .........................................
Corneal transplant .........................................
Corneal transplant .........................................
Revise cornea with implant ...........................
Correction of astigmatism ..............................
Correction of astigmatism ..............................
Ocular reconst, transplant .............................
Ocular reconst, transplant .............................
Ocular reconst, transplant .............................
Drainage of eye .............................................
Drainage of eye .............................................
Drainage of eye .............................................
Drainage of eye .............................................
Relieve inner eye pressure ............................
Incision of eye ................................................
Laser surgery of eye ......................................
Incise inner eye adhesions ............................
Incise inner eye adhesions ............................
Incise inner eye adhesions ............................
Incise inner eye adhesions ............................
Incise inner eye adhesions ............................
Remove eye lesion ........................................
Remove implant of eye ..................................
Remove blood clot from eye .........................
Injection treatment of eye ..............................
Injection treatment of eye ..............................
Remove eye lesion ........................................
Glaucoma surgery .........................................
Glaucoma surgery .........................................
Glaucoma surgery .........................................
Glaucoma surgery .........................................
Glaucoma surgery .........................................
Incision of eye ................................................
Implant eye shunt ..........................................
Revise eye shunt ...........................................
Repair eye lesion ...........................................
Y
Y
Y
N
N
N
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
A2
A2
A2
P3
P3
G2
P3
A2
A2
A2
A2
A2
A2
A2
A2
P2
A2
A2
A2
A2
A2
P3
P3
G2
G2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
$446.00
$510.00
$333.00
....................
....................
....................
....................
$446.00
$510.00
$630.00
$446.00
$446.00
$630.00
$630.00
$630.00
....................
$510.00
$333.00
$446.00
$446.00
$717.00
....................
....................
....................
....................
....................
$995.00
$995.00
$995.00
$995.00
$995.00
$630.00
$630.00
$717.00
$717.00
$717.00
$333.00
$333.00
$510.00
$446.00
$333.00
$630.00
....................
....................
$333.00
$630.00
$630.00
$630.00
$717.00
$995.00
$717.00
$333.00
$333.00
$995.00
$630.00
$630.00
$446.00
$630.00
$630.00
$630.00
$717.00
$446.00
$510.00
25.2550
35.2292
17.1243
0.4990
0.6196
1.1607
0.6840
15.2259
16.5239
27.6020
17.1243
22.9970
22.9970
16.5239
37.4290
6.0673
21.2801
15.2259
15.2259
15.2259
22.9970
0.9736
0.7564
15.2259
2.1451
3.8707
38.2707
38.2707
38.2707
38.2707
51.9894
15.2259
15.2259
38.2707
38.2707
38.2707
15.2259
15.2259
22.9970
22.9970
6.0673
22.9970
3.1947
2.9855
15.2259
22.9970
22.9970
15.2259
15.2259
22.9970
22.9970
15.2259
6.0673
22.9970
22.9970
22.9970
22.9970
22.9970
22.9970
22.9970
37.8967
37.8967
37.4290
Estimated
CY 2008
fully implemented
payment
$1,074.42
$1,498.76
$728.52
$21.23
$26.36
$49.38
$29.10
$647.76
$702.98
$1,174.27
$728.52
$978.36
$978.36
$702.98
$1,592.34
$258.12
$905.32
$647.76
$647.76
$647.76
$978.36
$41.42
$32.18
$647.76
$91.26
$164.67
$1,628.15
$1,628.15
$1,628.15
$1,628.15
$2,211.78
$647.76
$647.76
$1,628.15
$1,628.15
$1,628.15
$647.76
$647.76
$978.36
$978.36
$258.12
$978.36
$135.91
$127.01
$647.76
$978.36
$978.36
$647.76
$647.76
$978.36
$978.36
$647.76
$258.12
$978.36
$978.36
$978.36
$978.36
$978.36
$978.36
$978.36
$1,612.24
$1,612.24
$1,592.34
Estimated
CY 2008
first transition year
payment
$603.11
$757.19
$431.88
$21.23
$26.36
$49.38
$29.10
$496.44
$558.25
$766.07
$516.63
$579.09
$717.09
$648.25
$870.59
$258.12
$608.83
$411.69
$496.44
$496.44
$782.34
$41.42
$32.18
$647.76
$91.26
$164.67
$1,153.29
$1,153.29
$1,153.29
$1,153.29
$1,299.20
$634.44
$634.44
$944.79
$944.79
$944.79
$411.69
$411.69
$627.09
$579.09
$314.28
$717.09
$135.91
$127.01
$411.69
$717.09
$717.09
$634.44
$699.69
$990.84
$782.34
$411.69
$314.28
$990.84
$717.09
$717.09
$579.09
$717.09
$717.09
$717.09
$940.81
$737.56
$780.59
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00130
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42599
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Repair/graft eye lesion ...................................
Follow-up surgery of eye ...............................
Incision of iris .................................................
Incision of iris .................................................
Remove iris and lesion ..................................
Removal of iris ...............................................
Removal of iris ...............................................
Removal of iris ...............................................
Removal of iris ...............................................
Repair iris & ciliary body ................................
Repair iris & ciliary body ................................
Destruction, ciliary body ................................
Ciliary transsleral therapy ..............................
Ciliary endoscopic ablation ............................
Destruction, ciliary body ................................
Destruction, ciliary body ................................
Revision of iris ...............................................
Revision of iris ...............................................
Removal of inner eye lesion ..........................
Incision, secondary cataract ..........................
After cataract laser surgery ...........................
Reposition intraocular lens ............................
Removal of lens lesion ..................................
Removal of lens material ...............................
Removal of lens material ...............................
Removal of lens material ...............................
Extraction of lens ...........................................
Extraction of lens ...........................................
Extraction of lens ...........................................
Cataract surgery, complex .............................
Cataract surg w/iol, 1 stage ...........................
Cataract surg w/iol, 1 stage ...........................
Insert lens prosthesis .....................................
Exchange lens prosthesis ..............................
Ophthalmic endoscope add-on ......................
Partial removal of eye fluid ............................
Partial removal of eye fluid ............................
Release of eye fluid .......................................
Replace eye fluid ...........................................
Implant eye drug system ...............................
Injection eye drug ..........................................
Incise inner eye strands ................................
Laser surgery, eye strands ............................
Removal of inner eye fluid .............................
Strip retinal membrane ..................................
Laser treatment of retina ...............................
Laser treatment of retina ...............................
Repair detached retina ..................................
Repair detached retina ..................................
Repair detached retina ..................................
Repair detached retina ..................................
Repair detached retina ..................................
Rerepair detached retina ...............................
Release encircling material ...........................
Remove eye implant material ........................
Remove eye implant material ........................
Treatment of retina ........................................
Treatment of retina ........................................
Treatment of retinal lesion .............................
Treatment of retinal lesion .............................
Treatment of retinal lesion .............................
Treatment of choroid lesion ...........................
Ocular photodynamic ther .............................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
66225
66250
66500
66505
66600
66605
66625
66630
66635
66680
66682
66700
66710
66711
66720
66740
66761
66762
66770
66820
66821
66825
66830
66840
66850
66852
66920
66930
66940
66982
66983
66984
66985
66986
66990
67005
67010
67015
67025
67027
67028
67030
67031
67036
67038
67039
67040
67101
67105
67107
67108
67110
67112
67115
67120
67121
67141
67145
67208
67210
67218
67220
67221
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
P3
P3
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
N1
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
P3
P2
A2
A2
P3
A2
A2
A2
A2
A2
P3
P3
P2
A2
P2
P3
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$630.00
$446.00
$333.00
$333.00
$510.00
$510.00
$372.94
$510.00
$510.00
$510.00
$446.00
$446.00
$446.00
$446.00
$446.00
$446.00
....................
....................
....................
....................
$312.50
$630.00
$372.94
$630.00
$995.00
$630.00
$630.00
$717.00
$717.00
$973.00
$973.00
$973.00
$826.00
$826.00
....................
$630.00
$630.00
$333.00
$333.00
$630.00
....................
$333.00
$312.50
$630.00
$717.00
$995.00
$995.00
....................
....................
$717.00
$995.00
....................
$995.00
$446.00
$446.00
$446.00
$241.77
....................
....................
....................
$717.00
....................
....................
37.8967
15.2259
6.0673
6.0673
22.9970
22.9970
6.0673
22.9970
22.9970
22.9970
22.9970
15.2259
15.2259
15.2259
15.2259
22.9970
4.3375
4.4019
4.7639
6.0673
5.0839
22.9970
6.0673
14.8702
29.2281
29.2281
29.2281
29.2281
14.8702
23.6313
23.6313
23.6313
23.6313
23.6313
....................
27.6020
27.6020
27.6020
27.6020
37.4290
1.9876
16.5239
5.0839
37.4290
37.4290
37.4290
37.4290
7.2104
5.0841
37.4290
37.4290
7.8462
37.4290
16.5239
16.5239
27.6020
3.9333
4.5387
4.8283
5.0841
16.5239
3.9333
2.9695
$1,612.24
$647.76
$258.12
$258.12
$978.36
$978.36
$258.12
$978.36
$978.36
$978.36
$978.36
$647.76
$647.76
$647.76
$647.76
$978.36
$184.53
$187.27
$202.67
$258.12
$216.28
$978.36
$258.12
$632.62
$1,243.45
$1,243.45
$1,243.45
$1,243.45
$632.62
$1,005.35
$1,005.35
$1,005.35
$1,005.35
$1,005.35
....................
$1,174.27
$1,174.27
$1,174.27
$1,174.27
$1,592.34
$84.56
$702.98
$216.28
$1,592.34
$1,592.34
$1,592.34
$1,592.34
$306.75
$216.29
$1,592.34
$1,592.34
$333.80
$1,592.34
$702.98
$702.98
$1,174.27
$167.33
$193.09
$205.41
$216.29
$702.98
$167.33
$126.33
$875.56
$496.44
$314.28
$314.28
$627.09
$627.09
$344.24
$627.09
$627.09
$627.09
$579.09
$496.44
$496.44
$496.44
$496.44
$579.09
$184.53
$187.27
$202.67
$258.12
$288.45
$717.09
$344.24
$630.66
$1,057.11
$783.36
$783.36
$848.61
$695.91
$981.09
$981.09
$981.09
$870.84
$870.84
....................
$766.07
$766.07
$543.32
$543.32
$870.59
$84.56
$425.50
$288.45
$870.59
$935.84
$1,144.34
$1,144.34
$306.75
$216.29
$935.84
$1,144.34
$333.80
$1,144.34
$510.25
$510.25
$628.07
$223.16
$193.09
$205.41
$216.29
$713.50
$167.33
$126.33
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00131
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42600
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
67225
67227
67228
67250
67255
67311
67312
67314
67316
67318
67320
67331
67332
67334
67335
67340
67343
67345
67346
67400
67405
67412
67413
67414
67415
67420
67430
67440
67445
67450
67500
67505
67515
67550
67560
67570
67700
67710
67715
67800
67801
67805
67808
67810
67820
67825
67830
67835
67840
67850
67875
67880
67882
67900
67901
67902
67903
67904
67906
67908
67909
67911
67912
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Eye photodynamic ther add-on .....................
Treatment of retinal lesion .............................
Treatment of retinal lesion .............................
Reinforce eye wall .........................................
Reinforce/graft eye wall .................................
Revise eye muscle ........................................
Revise two eye muscles ................................
Revise eye muscle ........................................
Revise two eye muscles ................................
Revise eye muscle(s) ....................................
Revise eye muscle(s) add-on ........................
Eye surgery follow-up add-on ........................
Rerevise eye muscles add-on .......................
Revise eye muscle w/suture ..........................
Eye suture during surgery .............................
Revise eye muscle add-on ............................
Release eye tissue ........................................
Destroy nerve of eye muscle .........................
Biopsy, eye muscle ........................................
Explore/biopsy eye socket .............................
Explore/drain eye socket ...............................
Explore/treat eye socket ................................
Explore/treat eye socket ................................
Explr/decompress eye socket ........................
Aspiration, orbital contents ............................
Explore/treat eye socket ................................
Explore/treat eye socket ................................
Explore/drain eye socket ...............................
Explr/decompress eye socket ........................
Explore/biopsy eye socket .............................
Inject/treat eye socket ....................................
Inject/treat eye socket ....................................
Inject/treat eye socket ....................................
Insert eye socket implant ...............................
Revise eye socket implant .............................
Decompress optic nerve ................................
Drainage of eyelid abscess ...........................
Incision of eyelid ............................................
Incision of eyelid fold .....................................
Remove eyelid lesion ....................................
Remove eyelid lesions ...................................
Remove eyelid lesions ...................................
Remove eyelid lesion(s) ................................
Biopsy of eyelid .............................................
Revise eyelashes ...........................................
Revise eyelashes ...........................................
Revise eyelashes ...........................................
Revise eyelashes ...........................................
Remove eyelid lesion ....................................
Treat eyelid lesion .........................................
Closure of eyelid by suture ............................
Revision of eyelid ..........................................
Revision of eyelid ..........................................
Repair brow defect ........................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Revise eyelid defect ......................................
Revise eyelid defect ......................................
Correction eyelid w/implant ...........................
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
P3
A2
P2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
G2
A2
A2
A2
A2
A2
A2
G2
G2
P3
A2
A2
A2
P2
P3
A2
P3
P3
P3
A2
P2
P3
P3
A2
A2
P3
P3
G2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
....................
$333.00
....................
$510.00
$510.00
$510.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$995.00
....................
$333.00
$510.00
$630.00
$717.00
$717.00
....................
$333.00
$717.00
$717.00
$717.00
$717.00
$717.00
....................
....................
....................
$630.00
$446.00
$630.00
....................
....................
$333.00
....................
....................
....................
$446.00
....................
....................
....................
$446.00
$446.00
....................
....................
....................
$510.00
$510.00
$630.00
$717.00
$717.00
$630.00
$630.00
$717.00
$630.00
$630.00
$510.00
$510.00
0.2012
27.6020
5.0841
17.1243
27.6020
21.2801
21.2801
21.2801
21.2801
21.2801
21.2801
21.2801
21.2801
21.2801
21.2801
21.2801
21.2801
1.9634
14.3845
25.2550
25.2550
25.2550
25.2550
35.2292
17.1243
35.2292
35.2292
35.2292
35.2292
35.2292
2.1451
2.8954
0.5714
35.2292
25.2550
35.2292
2.8954
3.6777
17.1243
1.2312
1.4888
1.9232
17.1243
2.8954
0.4264
1.2794
7.2819
17.1243
3.8063
2.6879
7.2819
15.2259
17.1243
17.1243
17.1243
17.1243
17.1243
17.1243
17.1243
17.1243
17.1243
17.1243
17.1243
Estimated
CY 2008
fully implemented
payment
$8.56
$1,174.27
$216.29
$728.52
$1,174.27
$905.32
$905.32
$905.32
$905.32
$905.32
$905.32
$905.32
$905.32
$905.32
$905.32
$905.32
$905.32
$83.53
$611.96
$1,074.42
$1,074.42
$1,074.42
$1,074.42
$1,498.76
$728.52
$1,498.76
$1,498.76
$1,498.76
$1,498.76
$1,498.76
$91.26
$123.18
$24.31
$1,498.76
$1,074.42
$1,498.76
$123.18
$156.46
$728.52
$52.38
$63.34
$81.82
$728.52
$123.18
$18.14
$54.43
$309.79
$728.52
$161.93
$114.35
$309.79
$647.76
$728.52
$728.52
$728.52
$728.52
$728.52
$728.52
$728.52
$728.52
$728.52
$728.52
$728.52
Estimated
CY 2008
first transition year
payment
$8.56
$543.32
$216.29
$564.63
$676.07
$608.83
$698.83
$698.83
$698.83
$698.83
$698.83
$698.83
$698.83
$698.83
$698.83
$698.83
$972.58
$83.53
$402.74
$651.11
$741.11
$806.36
$806.36
$1,498.76
$431.88
$912.44
$912.44
$912.44
$912.44
$912.44
$91.26
$123.18
$24.31
$847.19
$603.11
$847.19
$123.18
$156.46
$431.88
$52.38
$63.34
$81.82
$516.63
$123.18
$18.14
$54.43
$411.95
$516.63
$161.93
$114.35
$309.79
$544.44
$564.63
$654.63
$719.88
$719.88
$654.63
$654.63
$719.88
$654.63
$654.63
$564.63
$564.63
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00132
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42601
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
Short descriptor
Subject to
multiple
procedure
discounting
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid defect .......................................
Repair eyelid wound ......................................
Repair eyelid wound ......................................
Remove eyelid foreign body ..........................
Revision of eyelid ..........................................
Revision of eyelid ..........................................
Revision of eyelid ..........................................
Reconstruction of eyelid ................................
Reconstruction of eyelid ................................
Reconstruction of eyelid ................................
Reconstruction of eyelid ................................
Incise/drain eyelid lining ................................
Treatment of eyelid lesions ...........................
Biopsy of eyelid lining ....................................
Remove eyelid lining lesion ...........................
Remove eyelid lining lesion ...........................
Remove eyelid lining lesion ...........................
Remove eyelid lining lesion ...........................
Treat eyelid by injection .................................
Revise/graft eyelid lining ................................
Revise/graft eyelid lining ................................
Revise/graft eyelid lining ................................
Revise/graft eyelid lining ................................
Revise eyelid lining ........................................
Revise/graft eyelid lining ................................
Separate eyelid adhesions ............................
Revise eyelid lining ........................................
Revise eyelid lining ........................................
Harvest eye tissue, alograft ...........................
Incise/drain tear gland ...................................
Incise/drain tear sac ......................................
Incise tear duct opening ................................
Removal of tear gland ...................................
Partial removal, tear gland ............................
Biopsy of tear gland .......................................
Removal of tear sac ......................................
Biopsy of tear sac ..........................................
Clearance of tear duct ...................................
Remove tear gland lesion ..............................
Remove tear gland lesion ..............................
Repair tear ducts ...........................................
Revise tear duct opening ...............................
Create tear sac drain .....................................
Create tear duct drain ....................................
Create tear duct drain ....................................
Close tear duct opening ................................
Close tear duct opening ................................
Close tear system fistula ...............................
Dilate tear duct opening ................................
Probe nasolacrimal duct ................................
Probe nasolacrimal duct ................................
Probe nasolacrimal duct ................................
Explore/irrigate tear ducts ..............................
Injection for tear sac x-ray .............................
Drain external ear lesion ...............................
Drain external ear lesion ...............................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
N ..............
N ..............
Y ..............
N ..............
N ..............
Y ..............
Y ..............
N ..............
..................
Y ..............
Y ..............
mstockstill on PROD1PC66 with RULES2
HCPCS
code
67914
67915
67916
67917
67921
67922
67923
67924
67930
67935
67938
67950
67961
67966
67971
67973
67974
67975
68020
68040
68100
68110
68115
68130
68135
68200
68320
68325
68326
68328
68330
68335
68340
68360
68362
68371
68400
68420
68440
68500
68505
68510
68520
68525
68530
68540
68550
68700
68705
68720
68745
68750
68760
68761
68770
68801
68810
68811
68815
68840
68850
69000
69005
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
A2
P3
A2
A2
A2
P3
A2
A2
P3
A2
P2
A2
A2
A2
A2
A2
A2
A2
P3
P3
P3
P3
A2
A2
P3
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
P2
P3
P3
A2
A2
A2
A2
A2
P3
A2
A2
A2
P2
A2
A2
A2
P2
P3
A2
P2
A2
A2
A2
P2
N1
P2
P3
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
$510.00
....................
$630.00
$630.00
$510.00
....................
$630.00
$630.00
....................
$446.00
....................
$446.00
$510.00
$510.00
$510.00
$510.00
$510.00
$510.00
....................
....................
....................
....................
$446.00
$446.00
....................
....................
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$630.00
$446.00
$446.00
$446.00
....................
....................
....................
$510.00
$510.00
$333.00
$510.00
$333.00
....................
$510.00
$510.00
$446.00
....................
$630.00
$630.00
$630.00
....................
....................
$630.00
....................
$131.86
$446.00
$446.00
....................
....................
....................
....................
17.1243
4.2329
17.1243
17.1243
17.1243
4.1685
17.1243
17.1243
4.1121
17.1243
1.1607
17.1243
17.1243
17.1243
25.2550
25.2550
25.2550
17.1243
1.0864
0.5392
2.2775
2.9131
17.1243
15.2259
1.3922
0.4024
17.1243
25.2550
25.2550
25.2550
22.9970
25.2550
17.1243
22.9970
22.9970
15.2259
2.8954
4.3777
1.3520
25.2550
25.2550
17.1243
25.2550
17.1243
5.5929
25.2550
25.2550
25.2550
2.8954
25.2550
25.2550
25.2550
2.1451
1.6658
17.1243
1.1607
2.1451
17.1243
17.1243
1.1607
....................
1.4392
2.2934
$728.52
$180.08
$728.52
$728.52
$728.52
$177.34
$728.52
$728.52
$174.94
$728.52
$49.38
$728.52
$728.52
$728.52
$1,074.42
$1,074.42
$1,074.42
$728.52
$46.22
$22.94
$96.89
$123.93
$728.52
$647.76
$59.23
$17.12
$728.52
$1,074.42
$1,074.42
$1,074.42
$978.36
$1,074.42
$728.52
$978.36
$978.36
$647.76
$123.18
$186.24
$57.52
$1,074.42
$1,074.42
$728.52
$1,074.42
$728.52
$237.94
$1,074.42
$1,074.42
$1,074.42
$123.18
$1,074.42
$1,074.42
$1,074.42
$91.26
$70.87
$728.52
$49.38
$91.26
$728.52
$728.52
$49.38
....................
$61.23
$97.57
$564.63
$180.08
$654.63
$654.63
$564.63
$177.34
$654.63
$654.63
$174.94
$516.63
$49.38
$516.63
$564.63
$564.63
$651.11
$651.11
$651.11
$564.63
$46.22
$22.94
$96.89
$123.93
$516.63
$496.44
$59.23
$17.12
$654.63
$741.11
$741.11
$741.11
$717.09
$741.11
$654.63
$579.09
$579.09
$496.44
$123.18
$186.24
$57.52
$651.11
$651.11
$431.88
$651.11
$431.88
$237.94
$651.11
$651.11
$603.11
$123.18
$741.11
$741.11
$741.11
$91.26
$70.87
$654.63
$49.38
$121.71
$516.63
$516.63
$49.38
....................
$61.23
$97.57
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00133
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42602
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
mstockstill on PROD1PC66 with RULES2
HCPCS
code
69020
69100
69105
69110
69120
69140
69145
69150
69200
69205
69210
69220
69222
69300
69310
69320
69400
69401
69405
69420
69421
69424
69433
69436
69440
69450
69501
69502
69505
69511
69530
69540
69550
69552
69601
69602
69603
69604
69605
69610
69620
69631
69632
69633
69635
69636
69637
69641
69642
69643
69644
69645
69646
69650
69660
69661
69662
69666
69667
69670
69676
69700
69711
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Subject to
multiple
procedure
discounting
Short descriptor
Drain outer ear canal lesion ..........................
Biopsy of external ear ....................................
Biopsy of external ear canal ..........................
Remove external ear, partial .........................
Removal of external ear ................................
Remove ear canal lesion(s) ...........................
Remove ear canal lesion(s) ...........................
Extensive ear canal surgery ..........................
Clear outer ear canal .....................................
Clear outer ear canal .....................................
Remove impacted ear wax ............................
Clean out mastoid cavity ...............................
Clean out mastoid cavity ...............................
Revise external ear ........................................
Rebuild outer ear canal .................................
Rebuild outer ear canal .................................
Inflate middle ear canal .................................
Inflate middle ear canal .................................
Catheterize middle ear canal .........................
Incision of eardrum ........................................
Incision of eardrum ........................................
Remove ventilating tube ................................
Create eardrum opening ................................
Create eardrum opening ................................
Exploration of middle ear ...............................
Eardrum revision ............................................
Mastoidectomy ...............................................
Mastoidectomy ...............................................
Remove mastoid structures ...........................
Extensive mastoid surgery ............................
Extensive mastoid surgery ............................
Remove ear lesion .........................................
Remove ear lesion .........................................
Remove ear lesion .........................................
Mastoid surgery revision ................................
Mastoid surgery revision ................................
Mastoid surgery revision ................................
Mastoid surgery revision ................................
Mastoid surgery revision ................................
Repair of eardrum ..........................................
Repair of eardrum ..........................................
Repair eardrum structures .............................
Rebuild eardrum structures ...........................
Rebuild eardrum structures ...........................
Repair eardrum structures .............................
Rebuild eardrum structures ...........................
Rebuild eardrum structures ...........................
Revise middle ear & mastoid ........................
Revise middle ear & mastoid ........................
Revise middle ear & mastoid ........................
Revise middle ear & mastoid ........................
Revise middle ear & mastoid ........................
Revise middle ear & mastoid ........................
Release middle ear bone ..............................
Revise middle ear bone .................................
Revise middle ear bone .................................
Revise middle ear bone .................................
Repair middle ear structures .........................
Repair middle ear structures .........................
Remove mastoid air cells ..............................
Remove middle ear nerve .............................
Close mastoid fistula .....................................
Remove/repair hearing aid ............................
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
..............
Payment
indicator
P2
P3
P3
A2
A2
A2
A2
A2
P2
A2
P3
P2
P3
A2
A2
A2
P3
P3
P3
P2
A2
P3
P3
A2
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
P3
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
A2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
....................
....................
....................
$333.00
$446.00
$446.00
$446.00
$464.15
....................
$333.00
....................
....................
....................
$510.00
$510.00
$995.00
....................
....................
....................
....................
$510.00
....................
....................
$510.00
$510.00
$333.00
$995.00
$995.00
$995.00
$995.00
$995.00
....................
$717.00
$995.00
$995.00
$995.00
$995.00
$995.00
$995.00
....................
$446.00
$717.00
$717.00
$717.00
$995.00
$995.00
$995.00
$995.00
$995.00
$995.00
$995.00
$995.00
$995.00
$995.00
$717.00
$717.00
$717.00
$630.00
$630.00
$510.00
$510.00
$510.00
$333.00
1.4392
1.4404
1.9474
15.1024
23.3299
23.3299
15.1024
7.5511
0.6102
20.0656
0.4748
0.8432
3.0339
23.3299
38.1991
38.1991
1.9152
1.0944
2.7842
2.4520
16.4266
1.7542
2.4787
16.4266
23.3299
38.1991
38.1991
23.3299
38.1991
38.1991
38.1991
2.9615
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
4.0477
23.3299
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
23.3299
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
Estimated
CY 2008
fully implemented
payment
$61.23
$61.28
$82.85
$642.50
$992.52
$992.52
$642.50
$321.25
$25.96
$853.65
$20.20
$35.87
$129.07
$992.52
$1,625.10
$1,625.10
$81.48
$46.56
$118.45
$104.32
$698.84
$74.63
$105.45
$698.84
$992.52
$1,625.10
$1,625.10
$992.52
$1,625.10
$1,625.10
$1,625.10
$125.99
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$172.20
$992.52
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$992.52
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
Estimated
CY 2008
first transition year
payment
$61.23
$61.28
$82.85
$410.38
$582.63
$582.63
$495.13
$428.43
$25.96
$463.16
$20.20
$35.87
$129.07
$630.63
$788.78
$1,152.53
$81.48
$46.56
$118.45
$104.32
$557.21
$74.63
$105.45
$557.21
$630.63
$656.03
$1,152.53
$994.38
$1,152.53
$1,152.53
$1,152.53
$125.99
$944.03
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$172.20
$582.63
$944.03
$944.03
$944.03
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$1,152.53
$994.38
$944.03
$944.03
$944.03
$878.78
$878.78
$788.78
$788.78
$788.78
$656.03
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based’’, whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00134
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42603
ADDENDUM AA.—ILLUSTRATIVE ASC COVERED SURGICAL PROCEDURES FOR CY 2008—Continued
[Including surgical procedures for which payment is packaged]
HCPCS
code
69714 .......
69715 .......
69717 .......
69718 .......
69720 .......
69740 .......
69745 .......
69801 .......
69802 .......
69805 .......
69806 .......
69820 .......
69840 .......
69905 .......
69910 .......
69915 .......
69930 .......
69990 .......
C9716 ......
C9724 ......
C9725 ......
C9726 ......
C9727 ......
G0104 ......
G0105 ......
G0121 ......
G0127 ......
G0186 ......
G0247 ......
G0259 ......
G0260 ......
G0268 ......
G0269 ......
G0289 ......
G0297 ......
G0298 ......
G0299 ......
G0300 ......
G0364 ......
G0392 ......
G0393 ......
Short descriptor
Subject to
multiple
procedure
discounting
Payment
indicator
CY 2007
ASC payment rate
Estimated
fully implemented payment weight
Estimated
CY 2008
fully implemented
payment
Estimated
CY 2008
first transition year
payment
Implant temple bone w/stimul ........................
Temple bne implnt w/stimulat ........................
Temple bone implant revision .......................
Revise temple bone implant ..........................
Release facial nerve ......................................
Repair facial nerve .........................................
Repair facial nerve .........................................
Incise inner ear ..............................................
Incise inner ear ..............................................
Explore inner ear ...........................................
Explore inner ear ...........................................
Establish inner ear window ............................
Revise inner ear window ...............................
Remove inner ear ..........................................
Remove inner ear & mastoid .........................
Incise inner ear nerve ....................................
Implant cochlear device .................................
Microsurgery add-on ......................................
Radiofrequency energy to anu ......................
EPS gast cardia plic ......................................
Place endorectal app .....................................
Rxt breast appl place/remov ..........................
Insert palate implants ....................................
CA screen;flexi sigmoidscope .......................
Colorectal scrn; hi risk ind .............................
Colon ca scrn not hi rsk ind ..........................
Trim nail(s) .....................................................
Dstry eye lesn,fdr vssl tech ...........................
Routine footcare pt w lops .............................
Inject for sacroiliac joint .................................
Inj for sacroiliac jt anesth ...............................
Removal of impacted wax md .......................
Occlusive device in vein art ...........................
Arthro, loose body + chondro ........................
Insert single chamber/cd ...............................
Insert dual chamber/cd ..................................
Inser/repos single icd+leads ..........................
Insert reposit lead dual+gen ..........................
Bone marrow aspirate & biopsy ....................
AV fistula or graft arterial ...............................
AV fistula or graft venous ..............................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
Y ..............
N ..............
N ..............
N ..............
N ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
..................
Y ..............
N ..............
..................
..................
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
Y ..............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
A2 ............
H8 ............
N1 ............
G2 ............
G2 ............
G2 ............
G2 ............
G2 ............
P3 ............
A2 ............
A2 ............
P3 ............
R2 ............
P3 ............
N1 ............
A2 ............
P3 ............
N1 ............
N1 ............
J8 .............
J8 .............
J8 .............
J8 .............
P3 ............
A2 ............
A2 ............
$1,339.00
$1,339.00
$1,339.00
$1,339.00
$717.00
$717.00
$717.00
$717.00
$995.00
$995.00
$995.00
$717.00
$717.00
$995.00
$995.00
$995.00
$995.00
....................
....................
....................
....................
....................
....................
....................
$446.00
$446.00
....................
....................
....................
....................
$333.00
....................
....................
....................
....................
....................
....................
....................
....................
$1,339.00
$1,339.00
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
38.1991
587.7216
....................
29.6189
25.7552
8.9477
10.5746
13.8283
1.9152
7.8492
7.8492
0.2494
3.9333
0.4828
....................
5.7253
0.4990
....................
....................
440.1206
440.1206
546.9370
546.9370
0.1208
42.9360
42.9360
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$1,625.10
$25,003.44
....................
$1,260.08
$1,095.70
$380.66
$449.88
$588.30
$81.48
$333.93
$333.93
$10.61
$167.33
$20.54
....................
$243.57
$21.23
....................
....................
$18,724.05
$18,724.05
$23,268.34
$23,268.34
$5.14
$1,826.63
$1,826.63
$1,410.53
$1,410.53
$1,410.53
$1,410.53
$944.03
$944.03
$944.03
$944.03
$1,152.53
$1,152.53
$1,152.53
$944.03
$944.03
$1,152.53
$1,152.53
$1,152.53
$23,712.58
....................
$1,260.08
$1,095.70
$380.66
$449.88
$588.30
$81.48
$417.98
$417.98
$10.61
$167.33
$20.54
....................
$310.64
$21.23
....................
....................
$18,724.05
$18,724.05
$23,268.34
$23,268.34
$5.14
$1,460.91
$1,460.91
mstockstill on PROD1PC66 with RULES2
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
* Refers to codes designated as ‘‘office-based,’’ whose designation as office-based is temporary because we have insufficient claims data. We will reconsider this designation when new
claims data become available.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00135
Fmt 4701
Sfmt 4701
E:\FR\FM\02AUR2.SGM
02AUR2
42604
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)
mstockstill on PROD1PC66 with RULES2
HCPCS
code
Short descriptor
Payment
indicator
0028T ......
0042T ......
0054T ......
0055T ......
0056T ......
0067T ......
0071T ......
0072T ......
0073T ......
0126T ......
0144T ......
0145T ......
0146T ......
0147T ......
0148T ......
0149T ......
0150T ......
0151T ......
0159T ......
0174T ......
0175T ......
70010 .......
70015 .......
70030 .......
70100 .......
70110 .......
70120 .......
70130 .......
70134 .......
70140 .......
70150 .......
70160 .......
70170 .......
70190 .......
70200 .......
70210 .......
70220 .......
70240 .......
70250 .......
70260 .......
70300 .......
70310 .......
70320 .......
70328 .......
70330 .......
70332 .......
70336 .......
70350 .......
70355 .......
70360 .......
70370 .......
70371 .......
70373 .......
70380 .......
70390 .......
70450 .......
70460 .......
70470 .......
70480 .......
70481 .......
70482 .......
70486 .......
70487 .......
70488 .......
Dexa body composition study .............................................................................................
Ct perfusion w/contrast, cbf .................................................................................................
Bone surgery using computer .............................................................................................
Bone surgery using computer .............................................................................................
Bone surgery using computer .............................................................................................
Ct colonography;dx ..............................................................................................................
U/s leiomyomata ablate <200 ..............................................................................................
U/s leiomyomata ablate >200 ..............................................................................................
Delivery, comp imrt ..............................................................................................................
Chd risk imt study ................................................................................................................
CT heart wo dye; qual calc .................................................................................................
CT heart w/wo dye funct .....................................................................................................
CCTA w/wo dye ...................................................................................................................
CCTA w/wo, quan calcium ..................................................................................................
CCTA w/wo, strxr .................................................................................................................
CCTA w/wo, strxr quan calc ................................................................................................
CCTA w/wo, disease strxr ...................................................................................................
CT heart funct add-on .........................................................................................................
Cad breast mri .....................................................................................................................
Cad cxr with interp ...............................................................................................................
Cad cxr remote ....................................................................................................................
Contrast x-ray of brain .........................................................................................................
Contrast x-ray of brain .........................................................................................................
X-ray eye for foreign body ...................................................................................................
X-ray exam of jaw ................................................................................................................
X-ray exam of jaw ................................................................................................................
X-ray exam of mastoids .......................................................................................................
X-ray exam of mastoids .......................................................................................................
X-ray exam of middle ear ....................................................................................................
X-ray exam of facial bones ..................................................................................................
X-ray exam of facial bones ..................................................................................................
X-ray exam of nasal bones .................................................................................................
X-ray exam of tear duct .......................................................................................................
X-ray exam of eye sockets ..................................................................................................
X-ray exam of eye sockets ..................................................................................................
X-ray exam of sinuses .........................................................................................................
X-ray exam of sinuses .........................................................................................................
X-ray exam, pituitary saddle ................................................................................................
X-ray exam of skull ..............................................................................................................
X-ray exam of skull ..............................................................................................................
X-ray exam of teeth .............................................................................................................
X-ray exam of teeth .............................................................................................................
Full mouth x-ray of teeth .....................................................................................................
X-ray exam of jaw joint ........................................................................................................
X-ray exam of jaw joints ......................................................................................................
X-ray exam of jaw joint ........................................................................................................
Magnetic image, jaw joint ....................................................................................................
X-ray head for orthodontia ...................................................................................................
Panoramic x-ray of jaws ......................................................................................................
X-ray exam of neck .............................................................................................................
Throat x-ray & fluoroscopy ..................................................................................................
Speech evaluation, complex ................................................................................................
Contrast x-ray of larynx .......................................................................................................
X-ray exam of salivary gland ...............................................................................................
X-ray exam of salivary duct .................................................................................................
Ct head/brain w/o dye .........................................................................................................
Ct head/brain w/dye .............................................................................................................
Ct head/brain w/o & w/dye ..................................................................................................
Ct orbit/ear/fossa w/o dye ....................................................................................................
Ct orbit/ear/fossa w/dye .......................................................................................................
Ct orbit/ear/fossa w/o & w/dye ............................................................................................
Ct maxillofacial w/o dye .......................................................................................................
Ct maxillofacial w/dye ..........................................................................................................
Ct maxillofacial w/o & w/dye ................................................................................................
N1
N1
Z2
Z2
Z2
Z2
Z2
Z2
Z2
N1
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
N1
N1
N1
Z2
Z3
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
....................
....................
4.9138
4.9138
4.9138
4.8405
28.5095
42.9896
5.4731
....................
4.1265
4.9832
4.9832
4.9832
6.5012
6.5012
4.1265
1.5379
....................
....................
....................
2.5544
1.4806
0.3782
0.4346
0.5230
0.4990
0.7093
0.6036
0.4346
0.6116
0.4506
2.9586
0.4990
0.6116
0.4506
0.5632
0.3862
0.4908
0.6518
0.1932
0.4828
0.6550
0.4104
0.6920
1.3520
4.5523
0.2576
0.3218
0.3622
1.1346
1.2908
1.3036
0.5714
1.5612
3.0908
4.0825
4.8405
3.0908
4.0825
4.8405
3.0908
4.0825
4.8405
....................
....................
$209.05
$209.05
$209.05
$205.93
$1,212.88
$1,828.91
$232.84
....................
$175.55
$212.00
$212.00
$212.00
$276.58
$276.58
$175.55
$65.43
....................
....................
....................
$108.67
$62.99
$16.09
$18.49
$22.25
$21.23
$30.18
$25.68
$18.49
$26.02
$19.17
$125.87
$21.23
$26.02
$19.17
$23.96
$16.43
$20.88
$27.73
$8.22
$20.54
$27.87
$17.46
$29.44
$57.52
$193.67
$10.96
$13.69
$15.41
$48.27
$54.91
$55.46
$24.31
$66.42
$131.49
$173.68
$205.93
$131.49
$173.68
$205.93
$131.49
$173.68
$205.93
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00136
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42605
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
70490
70491
70492
70496
70498
70540
70542
70543
70544
70545
70546
70547
70548
70549
70551
70552
70553
70554
70555
70557
70558
70559
71010
71015
71020
71021
71022
71023
71030
71034
71035
71040
71060
71090
71100
71101
71110
71111
71120
71130
71250
71260
71270
71275
71550
71551
71552
72010
72020
72040
72050
72052
72069
72070
72072
72074
72080
72090
72100
72110
72114
72120
72125
72126
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Ct soft tissue neck w/o dye .................................................................................................
Ct soft tissue neck w/dye ....................................................................................................
Ct sft tsue nck w/o & w/dye .................................................................................................
Ct angiography, head ..........................................................................................................
Ct angiography, neck ...........................................................................................................
Mri orbit/face/neck w/o dye ..................................................................................................
Mri orbit/face/neck w/dye .....................................................................................................
Mri orbt/fac/nck w/o & w/dye ...............................................................................................
Mr angiography head w/o dye .............................................................................................
Mr angiography head w/dye ................................................................................................
Mr angiograph head w/o & w/dye .......................................................................................
Mr angiography neck w/o dye .............................................................................................
Mr angiography neck w/dye ................................................................................................
Mr angiograph neck w/o & w/dye ........................................................................................
Mri brain w/o dye .................................................................................................................
Mri brain w/dye ....................................................................................................................
Mri brain w/o & w/dye ..........................................................................................................
Fmri brain by tech ................................................................................................................
Fmri brain by phys/psych ....................................................................................................
Mri brain w/o dye .................................................................................................................
Mri brain w/dye ....................................................................................................................
Mri brain w/o & w/dye ..........................................................................................................
Chest x-ray ..........................................................................................................................
Chest x-ray ..........................................................................................................................
Chest x-ray ..........................................................................................................................
Chest x-ray ..........................................................................................................................
Chest x-ray ..........................................................................................................................
Chest x-ray and fluoroscopy ................................................................................................
Chest x-ray ..........................................................................................................................
Chest x-ray and fluoroscopy ................................................................................................
Chest x-ray ..........................................................................................................................
Contrast x-ray of bronchi .....................................................................................................
Contrast x-ray of bronchi .....................................................................................................
X-ray & pacemaker insertion ...............................................................................................
X-ray exam of ribs ...............................................................................................................
X-ray exam of ribs/chest ......................................................................................................
X-ray exam of ribs ...............................................................................................................
X-ray exam of ribs/chest ......................................................................................................
X-ray exam of breastbone ...................................................................................................
X-ray exam of breastbone ...................................................................................................
Ct thorax w/o dye ................................................................................................................
Ct thorax w/dye ....................................................................................................................
Ct thorax w/o & w/dye .........................................................................................................
Ct angiography, chest ..........................................................................................................
Mri chest w/o dye ................................................................................................................
Mri chest w/dye ....................................................................................................................
Mri chest w/o & w/dye .........................................................................................................
X-ray exam of spine ............................................................................................................
X-ray exam of spine ............................................................................................................
X-ray exam of neck spine ....................................................................................................
X-ray exam of neck spine ....................................................................................................
X-ray exam of neck spine ....................................................................................................
X-ray exam of trunk spine ...................................................................................................
X-ray exam of thoracic spine ...............................................................................................
X-ray exam of thoracic spine ...............................................................................................
X-ray exam of thoracic spine ...............................................................................................
X-ray exam of trunk spine ...................................................................................................
X-ray exam of trunk spine ...................................................................................................
X-ray exam of lower spine ...................................................................................................
X-ray exam of lower spine ...................................................................................................
X-ray exam of lower spine ...................................................................................................
X-ray exam of lower spine ...................................................................................................
Ct neck spine w/o dye .........................................................................................................
Ct neck spine w/dye ............................................................................................................
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z2
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
3.0908
4.0825
4.8405
4.8552
4.8552
5.6745
6.1231
8.1155
5.6745
6.1231
8.1155
5.6745
6.1231
8.1155
5.6745
6.1231
8.1155
5.6745
5.6745
5.6745
6.1231
8.1155
0.3300
0.4024
0.4426
0.5392
0.6036
0.8690
0.6276
1.2908
0.4828
1.3278
1.6956
1.2908
0.4426
0.5230
0.5794
0.7322
0.4748
0.5472
3.0908
4.0825
4.8405
4.8552
5.6745
6.1231
8.1155
0.7093
0.3218
0.5150
0.7322
0.9416
0.4586
0.4748
0.5552
0.7000
0.5070
0.6196
0.5552
0.7644
1.0380
0.7484
3.0908
4.0825
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00137
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
$131.49
$173.68
$205.93
$206.55
$206.55
$241.41
$260.50
$345.26
$241.41
$260.50
$345.26
$241.41
$260.50
$345.26
$241.41
$260.50
$345.26
$241.41
$241.41
$241.41
$260.50
$345.26
$14.04
$17.12
$18.83
$22.94
$25.68
$36.97
$26.70
$54.91
$20.54
$56.49
$72.14
$54.91
$18.83
$22.25
$24.65
$31.15
$20.20
$23.28
$131.49
$173.68
$205.93
$206.55
$241.41
$260.50
$345.26
$30.18
$13.69
$21.91
$31.15
$40.06
$19.51
$20.20
$23.62
$29.78
$21.57
$26.36
$23.62
$32.52
$44.16
$31.84
$131.49
$173.68
42606
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
72127
72128
72129
72130
72131
72132
72133
72141
72142
72146
72147
72148
72149
72156
72157
72158
72170
72190
72191
72192
72193
72194
72195
72196
72197
72200
72202
72220
72240
72255
72265
72270
72275
72285
72291
72292
72295
73000
73010
73020
73030
73040
73050
73060
73070
73080
73085
73090
73092
73100
73110
73115
73120
73130
73140
73200
73201
73202
73206
73218
73219
73220
73221
73222
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Ct neck spine w/o & w/dye ..................................................................................................
Ct chest spine w/o dye ........................................................................................................
Ct chest spine w/dye ...........................................................................................................
Ct chest spine w/o & w/dye .................................................................................................
Ct lumbar spine w/o dye ......................................................................................................
Ct lumbar spine w/dye .........................................................................................................
Ct lumbar spine w/o & w/dye ..............................................................................................
Mri neck spine w/o dye ........................................................................................................
Mri neck spine w/dye ...........................................................................................................
Mri chest spine w/o dye .......................................................................................................
Mri chest spine w/dye ..........................................................................................................
Mri lumbar spine w/o dye ....................................................................................................
Mri lumbar spine w/dye .......................................................................................................
Mri neck spine w/o & w/dye ................................................................................................
Mri chest spine w/o & w/dye ...............................................................................................
Mri lumbar spine w/o & w/dye .............................................................................................
X-ray exam of pelvis ............................................................................................................
X-ray exam of pelvis ............................................................................................................
Ct angiograph pelv w/o & w/dye .........................................................................................
Ct pelvis w/o dye .................................................................................................................
Ct pelvis w/dye ....................................................................................................................
Ct pelvis w/o & w/dye ..........................................................................................................
Mri pelvis w/o dye ................................................................................................................
Mri pelvis w/dye ...................................................................................................................
Mri pelvis w/o & w/dye .........................................................................................................
X-ray exam sacroiliac joints .................................................................................................
X-ray exam sacroiliac joints .................................................................................................
X-ray exam of tailbone ........................................................................................................
Contrast x-ray of neck spine ...............................................................................................
Contrast x-ray, thorax spine ................................................................................................
Contrast x-ray, lower spine ..................................................................................................
Contrast x-ray, spine ...........................................................................................................
Epidurography ......................................................................................................................
X-ray c/t spine disk ..............................................................................................................
Perq vertebroplasty, fluor ....................................................................................................
Perq vertebroplasty, ct .........................................................................................................
X-ray of lower spine disk .....................................................................................................
X-ray exam of collar bone ...................................................................................................
X-ray exam of shoulder blade .............................................................................................
X-ray exam of shoulder .......................................................................................................
X-ray exam of shoulder .......................................................................................................
Contrast x-ray of shoulder ...................................................................................................
X-ray exam of shoulders .....................................................................................................
X-ray exam of humerus .......................................................................................................
X-ray exam of elbow ............................................................................................................
X-ray exam of elbow ............................................................................................................
Contrast x-ray of elbow .......................................................................................................
X-ray exam of forearm .........................................................................................................
X-ray exam of arm, infant ....................................................................................................
X-ray exam of wrist ..............................................................................................................
X-ray exam of wrist ..............................................................................................................
Contrast x-ray of wrist .........................................................................................................
X-ray exam of hand .............................................................................................................
X-ray exam of hand .............................................................................................................
X-ray exam of finger(s) ........................................................................................................
Ct upper extremity w/o dye .................................................................................................
Ct upper extremity w/dye .....................................................................................................
Ct uppr extremity w/o & w/dye ............................................................................................
Ct angio upr extrm w/o & w/dye ..........................................................................................
Mri upper extremity w/o dye ................................................................................................
Mri upper extremity w/dye ...................................................................................................
Mri uppr extremity w/o & w/dye ...........................................................................................
Mri joint upr extrem w/o dye ................................................................................................
Mri joint upr extrem w/dye ...................................................................................................
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z2
Z3
Z3
Z2
Z3
Z3
Z2
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
4.8405
3.0908
4.0825
4.8405
3.0908
4.0825
4.8405
5.6745
6.1231
5.6745
6.1231
5.6745
6.1231
8.1155
8.1155
8.1155
0.3782
0.5714
4.8552
3.0908
4.0825
4.8405
5.6745
6.1231
8.1155
0.4184
0.5070
0.4264
2.5544
2.5026
2.4867
2.5544
1.4404
3.8145
2.5544
2.5544
3.6213
0.4024
0.4184
0.3460
0.4264
1.6256
0.5230
0.4264
0.4024
0.4990
1.4806
0.4024
0.4024
0.4104
0.4908
1.4806
0.3944
0.4426
0.4184
3.0908
4.0825
4.8405
4.8552
5.6745
6.1231
8.1155
5.6745
6.1231
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00138
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
$205.93
$131.49
$173.68
$205.93
$131.49
$173.68
$205.93
$241.41
$260.50
$241.41
$260.50
$241.41
$260.50
$345.26
$345.26
$345.26
$16.09
$24.31
$206.55
$131.49
$173.68
$205.93
$241.41
$260.50
$345.26
$17.80
$21.57
$18.14
$108.67
$106.47
$105.79
$108.67
$61.28
$162.28
$108.67
$108.67
$154.06
$17.12
$17.80
$14.72
$18.14
$69.16
$22.25
$18.14
$17.12
$21.23
$62.99
$17.12
$17.12
$17.46
$20.88
$62.99
$16.78
$18.83
$17.80
$131.49
$173.68
$205.93
$206.55
$241.41
$260.50
$345.26
$241.41
$260.50
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42607
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
73223
73500
73510
73520
73525
73530
73540
73542
73550
73560
73562
73564
73565
73580
73590
73592
73600
73610
73615
73620
73630
73650
73660
73700
73701
73702
73706
73718
73719
73720
73721
73722
73723
74000
74010
74020
74022
74150
74160
74170
74175
74181
74182
74183
74190
74210
74220
74230
74235
74240
74241
74245
74246
74247
74249
74250
74251
74260
74270
74280
74283
74290
74291
74300
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Mri joint upr extr w/o & w/dye ..............................................................................................
X-ray exam of hip ................................................................................................................
X-ray exam of hip ................................................................................................................
X-ray exam of hips ..............................................................................................................
Contrast x-ray of hip ............................................................................................................
X-ray exam of hip ................................................................................................................
X-ray exam of pelvis & hips ................................................................................................
X-ray exam, sacroiliac joint .................................................................................................
X-ray exam of thigh .............................................................................................................
X-ray exam of knee, 1 or 2 .................................................................................................
X-ray exam of knee, 3 .........................................................................................................
X-ray exam, knee, 4 or more ..............................................................................................
X-ray exam of knees ...........................................................................................................
Contrast x-ray of knee joint .................................................................................................
X-ray exam of lower leg ......................................................................................................
X-ray exam of leg, infant .....................................................................................................
X-ray exam of ankle ............................................................................................................
X-ray exam of ankle ............................................................................................................
Contrast x-ray of ankle ........................................................................................................
X-ray exam of foot ...............................................................................................................
X-ray exam of foot ...............................................................................................................
X-ray exam of heel ..............................................................................................................
X-ray exam of toe(s) ............................................................................................................
Ct lower extremity w/o dye ..................................................................................................
Ct lower extremity w/dye .....................................................................................................
Ct lwr extremity w/o & w/dye ...............................................................................................
Ct angio lwr extr w/o & w/dye .............................................................................................
Mri lower extremity w/o dye .................................................................................................
Mri lower extremity w/dye ....................................................................................................
Mri lwr extremity w/o & w/dye .............................................................................................
Mri jnt of lwr extre w/o dye ..................................................................................................
Mri joint of lwr extr w/dye ....................................................................................................
Mri joint lwr extr w/o & w/dye ..............................................................................................
X-ray exam of abdomen ......................................................................................................
X-ray exam of abdomen ......................................................................................................
X-ray exam of abdomen ......................................................................................................
X-ray exam series, abdomen ..............................................................................................
Ct abdomen w/o dye ...........................................................................................................
Ct abdomen w/dye ...............................................................................................................
Ct abdomen w/o & w/dye ....................................................................................................
Ct angio abdom w/o & w/dye ..............................................................................................
Mri abdomen w/o dye ..........................................................................................................
Mri abdomen w/dye .............................................................................................................
Mri abdomen w/o & w/dye ...................................................................................................
X-ray exam of peritoneum ...................................................................................................
Contrst x-ray exam of throat ................................................................................................
Contrast x-ray, esophagus ..................................................................................................
Cine/vid x-ray, throat/esoph .................................................................................................
Remove esophagus obstruction ..........................................................................................
X-ray exam, upper gi tract ...................................................................................................
X-ray exam, upper gi tract ...................................................................................................
X-ray exam, upper gi tract ...................................................................................................
Contrst x-ray uppr gi tract ....................................................................................................
Contrst x-ray uppr gi tract ....................................................................................................
Contrst x-ray uppr gi tract ....................................................................................................
X-ray exam of small bowel ..................................................................................................
X-ray exam of small bowel ..................................................................................................
X-ray exam of small bowel ..................................................................................................
Contrast x-ray exam of colon ..............................................................................................
Contrast x-ray exam of colon ..............................................................................................
Contrast x-ray exam of colon ..............................................................................................
Contrast x-ray, gallbladder ..................................................................................................
Contrast x-rays, gallbladder .................................................................................................
X-ray bile ducts/pancreas ....................................................................................................
Z2
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z2
Z3
Z2
Z2
Z2
Z2
Z2
Z3
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
8.1155
0.3540
0.5070
0.5392
1.4726
1.2224
0.5150
1.2312
0.4184
0.4184
0.4908
0.5552
0.4264
1.9152
0.3944
0.4104
0.3944
0.4506
1.5128
0.3944
0.4426
0.3862
0.4024
3.0908
4.0825
4.8405
4.8552
5.6745
6.1231
8.1155
5.6745
6.1231
8.1155
0.3622
0.5070
0.5150
0.6196
3.0908
4.0825
4.8405
4.8552
5.6745
6.1231
8.1155
2.9586
1.1024
1.1830
1.1990
1.0974
1.3680
1.4294
2.2176
1.4294
1.4294
2.2176
1.4082
2.2176
1.4294
1.4294
2.2176
1.4294
0.8450
0.7726
1.6956
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00139
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
$345.26
$15.06
$21.57
$22.94
$62.65
$52.00
$21.91
$52.38
$17.80
$17.80
$20.88
$23.62
$18.14
$81.48
$16.78
$17.46
$16.78
$19.17
$64.36
$16.78
$18.83
$16.43
$17.12
$131.49
$173.68
$205.93
$206.55
$241.41
$260.50
$345.26
$241.41
$260.50
$345.26
$15.41
$21.57
$21.91
$26.36
$131.49
$173.68
$205.93
$206.55
$241.41
$260.50
$345.26
$125.87
$46.90
$50.33
$51.01
$46.69
$58.20
$60.81
$94.34
$60.81
$60.81
$94.34
$59.91
$94.34
$60.81
$60.81
$94.34
$60.81
$35.95
$32.87
$72.14
42608
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
74301
74305
74320
74327
74328
74329
74330
74340
74350
74355
74360
74363
74400
74410
74415
74420
74425
74430
74440
74445
74450
74455
74470
74475
74480
74485
74710
74740
74742
74775
75552
75553
75554
75555
75600
75605
75625
75630
75635
75650
75658
75660
75662
75665
75671
75676
75680
75685
75705
75710
75716
75722
75724
75726
75731
75733
75736
75741
75743
75746
75756
75774
75790
75801
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
X-rays at surgery add-on .....................................................................................................
X-ray bile ducts/pancreas ....................................................................................................
Contrast x-ray of bile ducts .................................................................................................
X-ray bile stone removal ......................................................................................................
X-ray bile duct endoscopy ...................................................................................................
X-ray for pancreas endoscopy ............................................................................................
X-ray bile/panc endoscopy ..................................................................................................
X-ray guide for GI tube ........................................................................................................
X-ray guide, stomach tube ..................................................................................................
X-ray guide, intestinal tube ..................................................................................................
X-ray guide, GI dilation ........................................................................................................
X-ray, bile duct dilation ........................................................................................................
Contrst x-ray, urinary tract ...................................................................................................
Contrst x-ray, urinary tract ...................................................................................................
Contrst x-ray, urinary tract ...................................................................................................
Contrst x-ray, urinary tract ...................................................................................................
Contrst x-ray, urinary tract ...................................................................................................
Contrast x-ray, bladder ........................................................................................................
X-ray, male genital tract ......................................................................................................
X-ray exam of penis ............................................................................................................
X-ray, urethra/bladder ..........................................................................................................
X-ray, urethra/bladder ..........................................................................................................
X-ray exam of kidney lesion ................................................................................................
X-ray control, cath insert .....................................................................................................
X-ray control, cath insert .....................................................................................................
X-ray guide, GU dilation ......................................................................................................
X-ray measurement of pelvis ...............................................................................................
X-ray, female genital tract ...................................................................................................
X-ray, fallopian tube .............................................................................................................
X-ray exam of perineum ......................................................................................................
Heart mri for morph w/o dye ...............................................................................................
Heart mri for morph w/dye ...................................................................................................
Cardiac MRI/function ...........................................................................................................
Cardiac MRI/limited study ....................................................................................................
Contrast x-ray exam of aorta ...............................................................................................
Contrast x-ray exam of aorta ...............................................................................................
Contrast x-ray exam of aorta ...............................................................................................
X-ray aorta, leg arteries .......................................................................................................
Ct angio abdominal arteries ................................................................................................
Artery x-rays, head & neck ..................................................................................................
Artery x-rays, arm ................................................................................................................
Artery x-rays, head & neck ..................................................................................................
Artery x-rays, head & neck ..................................................................................................
Artery x-rays, head & neck ..................................................................................................
Artery x-rays, head & neck ..................................................................................................
Artery x-rays, neck ...............................................................................................................
Artery x-rays, neck ...............................................................................................................
Artery x-rays, spine ..............................................................................................................
Artery x-rays, spine ..............................................................................................................
Artery x-rays, arm/leg ..........................................................................................................
Artery x-rays, arms/legs .......................................................................................................
Artery x-rays, kidney ............................................................................................................
Artery x-rays, kidneys ..........................................................................................................
Artery x-rays, abdomen .......................................................................................................
Artery x-rays, adrenal gland ................................................................................................
Artery x-rays, adrenals ........................................................................................................
Artery x-rays, pelvis .............................................................................................................
Artery x-rays, lung ...............................................................................................................
Artery x-rays, lungs ..............................................................................................................
Artery x-rays, lung ...............................................................................................................
Artery x-rays, chest ..............................................................................................................
Artery x-ray, each vessel .....................................................................................................
Visualize A-V shunt .............................................................................................................
Lymph vessel x-ray, arm/leg ...............................................................................................
Z2
Z2
Z3
Z3
N1
N1
N1
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z2
Z2
Z3
Z3
Z2
Z2
Z3
Z2
Z3
Z3
Z3
Z3
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
1.6956
1.6956
2.0039
1.7462
....................
....................
....................
1.2908
1.6956
1.6956
1.0974
3.6392
1.6094
1.7625
2.0440
2.4159
2.4159
1.1346
1.2634
2.4159
2.4159
1.4324
1.6956
2.3738
2.3738
2.0683
0.6276
1.1508
2.9586
2.4159
5.6745
6.1231
5.6745
5.6745
7.5404
6.2929
6.2125
6.4941
4.8552
6.2125
6.3815
6.2463
6.7840
6.4699
6.7920
6.3815
6.5987
6.3736
6.2463
6.4619
6.7920
6.4055
6.8242
6.3413
6.4055
6.2463
6.3975
6.0999
6.1963
6.2607
6.5828
6.0033
1.5210
2.9586
$72.14
$72.14
$85.25
$74.29
....................
....................
....................
$54.91
$72.14
$ 72.14
$46.69
$154.82
$68.47
$74.98
$86.96
$102.78
$102.78
$48.27
$53.75
$102.78
$102.78
$60.94
$72.14
$100.99
$100.99
$87.99
$26.70
$48.96
$125.87
$102.78
$241.41
$260.50
$241.41
$241.41
$320.79
$267.72
$264.30
$276.28
$206.55
$264.30
$271.49
$265.74
$288.61
$275.25
$288.95
$271.49
$280.73
$271.15
$265.74
$274.91
$288.95
$272.51
$290.32
$269.78
$272.51
$265.74
$272.17
$259.51
$263.61
$266.35
$280.05
$255.40
$64.71
$125.87
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00140
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42609
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
75803
75805
75807
75809
75810
75820
75822
75825
75827
75831
75833
75840
75842
75860
75870
75872
75880
75885
75887
75889
75891
75893
75894
75896
75898
75901
75902
75940
75945
75946
75960
75961
75962
75964
75966
75968
75970
75978
75980
75982
75984
75989
75992
75993
75994
75995
75996
76000
76001
76010
76080
76098
76100
76101
76102
76120
76125
76150
76350
76376
76377
76380
76496
76497
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Lymph vessel x-ray, arms/legs ............................................................................................
Lymph vessel x-ray, trunk ...................................................................................................
Lymph vessel x-ray, trunk ...................................................................................................
Nonvascular shunt, x-ray .....................................................................................................
Vein x-ray, spleen/liver ........................................................................................................
Vein x-ray, arm/leg ..............................................................................................................
Vein x-ray, arms/legs ...........................................................................................................
Vein x-ray, trunk ..................................................................................................................
Vein x-ray, chest ..................................................................................................................
Vein x-ray, kidney ................................................................................................................
Vein x-ray, kidneys ..............................................................................................................
Vein x-ray, adrenal gland ....................................................................................................
Vein x-ray, adrenal glands ...................................................................................................
Vein x-ray, neck ...................................................................................................................
Vein x-ray, skull ...................................................................................................................
Vein x-ray, skull ...................................................................................................................
Vein x-ray, eye socket .........................................................................................................
Vein x-ray, liver ....................................................................................................................
Vein x-ray, liver ....................................................................................................................
Vein x-ray, liver ....................................................................................................................
Vein x-ray, liver ....................................................................................................................
Venous sampling by catheter ..............................................................................................
X-rays, transcath therapy ....................................................................................................
X-rays, transcath therapy ....................................................................................................
Follow-up angiography ........................................................................................................
Remove cva device obstruct ...............................................................................................
Remove cva lumen obstruct ................................................................................................
X-ray placement, vein filter ..................................................................................................
Intravascular us ...................................................................................................................
Intravascular us add-on .......................................................................................................
Transcath iv stent rs&i .........................................................................................................
Retrieval, broken catheter ...................................................................................................
Repair arterial blockage .......................................................................................................
Repair artery blockage, each ..............................................................................................
Repair arterial blockage .......................................................................................................
Repair artery blockage, each ..............................................................................................
Vascular biopsy ...................................................................................................................
Repair venous blockage ......................................................................................................
Contrast xray exam bile duct ...............................................................................................
Contrast xray exam bile duct ...............................................................................................
Xray control catheter change ..............................................................................................
Abscess drainage under x-ray .............................................................................................
Atherectomy, x-ray exam .....................................................................................................
Atherectomy, x-ray exam .....................................................................................................
Atherectomy, x-ray exam .....................................................................................................
Atherectomy, x-ray exam .....................................................................................................
Atherectomy, x-ray exam .....................................................................................................
Fluoroscope examination .....................................................................................................
Fluoroscope exam, extensive ..............................................................................................
X-ray, nose to rectum ..........................................................................................................
X-ray exam of fistula ............................................................................................................
X-ray exam, breast specimen ..............................................................................................
X-ray exam of body section .................................................................................................
Complex body section x-ray ................................................................................................
Complex body section x-rays ..............................................................................................
Cine/video x-rays .................................................................................................................
Cine/video x-rays add-on .....................................................................................................
X-ray exam, dry process .....................................................................................................
Special x-ray contrast study ................................................................................................
3d render w/o postprocess ..................................................................................................
3d rendering w/postprocess ................................................................................................
CAT scan follow-up study ....................................................................................................
Fluoroscopic procedure .......................................................................................................
Ct procedure ........................................................................................................................
Z2
Z2
Z2
Z3
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
N1
Z2
Z2
Z2
Z2
Z3
Z2
Z2
Z2
Z2
Z3
Z2
Z3
Z2
Z3
Z2
Z2
Z2
Z2
Z3
N1
Z2
Z2
Z2
Z2
Z2
Z2
N1
Z3
Z3
Z3
Z2
Z2
Z2
Z3
Z2
Z3
N1
Z2
Z2
Z2
Z2
Z2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
2.9586
2.9586
2.9586
1.0864
9.5061
1.4484
1.6738
6.0515
6.0677
6.0999
6.3009
6.1723
6.2769
6.2285
6.1641
6.4459
1.4484
6.0837
6.1561
6.0837
6.0837
....................
8.3906
8.3906
1.6956
1.6956
1.1024
8.3906
2.4606
1.5607
6.2463
5.4399
6.2463
4.2571
6.2463
4.2731
6.2463
6.2463
3.6392
3.6392
1.5692
....................
6.2463
6.2463
6.2463
6.2463
6.2463
1.2908
....................
0.3944
0.7644
0.2736
1.2224
1.6956
2.9586
1.1024
0.7093
0.4346
....................
0.6102
1.5379
1.5379
1.2908
1.5379
$125.87
$125.87
$125.87
$46.22
$404.42
$61.62
$71.21
$257.45
$258.14
$259.51
$268.06
$262.59
$267.04
$264.98
$262.24
$274.23
$61.62
$258.82
$261.90
$258.82
$258.82
....................
$356.96
$356.96
$72.14
$72.14
$46.90
$356.96
$104.68
$66.40
$265.74
$231.43
$265.74
$181.11
$265.74
$181.79
$265.74
$265.74
$154.82
$154.82
$66.76
....................
$265.74
$265.74
$265.74
$265.74
$265.74
$54.91
....................
$16.78
$32.52
$11.64
$52.00
$72.14
$125.87
$46.90
$30.18
$18.49
....................
$25.96
$65.43
$65.43
$54.91
$65.43
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00141
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42610
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
76498
76499
76506
76510
76511
76512
76513
76514
76516
76519
76529
76536
76604
76645
76700
76705
76770
76775
76776
76800
76801
76802
76805
76810
76811
76812
76813
76814
76815
76816
76817
76818
76819
76820
76821
76825
76826
76827
76828
76830
76831
76856
76857
76870
76872
76873
76880
76885
76886
76930
76932
76936
76937
76940
76941
76942
76945
76946
76948
76950
76965
76970
76975
76977
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Mri procedure .......................................................................................................................
Radiographic procedure ......................................................................................................
Echo exam of head .............................................................................................................
Ophth us, b & quant a .........................................................................................................
Ophth us, quant a only ........................................................................................................
Ophth us, b w/non-quant a ..................................................................................................
Echo exam of eye, water bath ............................................................................................
Echo exam of eye, thickness ..............................................................................................
Echo exam of eye ................................................................................................................
Echo exam of eye ................................................................................................................
Echo exam of eye ................................................................................................................
Us exam of head and neck .................................................................................................
Us exam, chest ....................................................................................................................
Us exam, breast(s) ..............................................................................................................
Us exam, abdom, complete .................................................................................................
Echo exam of abdomen ......................................................................................................
Us exam abdo back wall, comp ..........................................................................................
Us exam abdo back wall, lim ..............................................................................................
Us exam k transpl w/doppler ...............................................................................................
Us exam, spinal canal .........................................................................................................
Ob us < 14 wks, single fetus ...............................................................................................
Ob us < 14 wks, add’l fetus .................................................................................................
Ob us >/= 14 wks, sngl fetus ..............................................................................................
Ob us >/= 14 wks, addl fetus ..............................................................................................
Ob us, detailed, sngl fetus ...................................................................................................
Ob us, detailed, addl fetus ..................................................................................................
Ob us nuchal meas, 1 gest .................................................................................................
Ob us nuchal meas, add-on ................................................................................................
Ob us, limited, fetus(s) ........................................................................................................
Ob us, follow-up, per fetus ..................................................................................................
Transvaginal us, obstetric ....................................................................................................
Fetal biophys profile w/nst ...................................................................................................
Fetal biophys profil w/o nst ..................................................................................................
Umbilical artery echo ...........................................................................................................
Middle cerebral artery echo .................................................................................................
Echo exam of fetal heart .....................................................................................................
Echo exam of fetal heart .....................................................................................................
Echo exam of fetal heart .....................................................................................................
Echo exam of fetal heart .....................................................................................................
Transvaginal us, non-ob ......................................................................................................
Echo exam, uterus ...............................................................................................................
Us exam, pelvic, complete ..................................................................................................
Us exam, pelvic, limited .......................................................................................................
Us exam, scrotum ................................................................................................................
Us, transrectal ......................................................................................................................
Echograp trans r, pros study ...............................................................................................
Us exam, extremity ..............................................................................................................
Us exam infant hips, dynamic .............................................................................................
Us exam infant hips, static ..................................................................................................
Echo guide, cardiocentesis ..................................................................................................
Echo guide for heart biopsy ................................................................................................
Echo guide for artery repair .................................................................................................
Us guide, vascular access ...................................................................................................
Us guide, tissue ablation .....................................................................................................
Echo guide for transfusion ...................................................................................................
Echo guide for biopsy ..........................................................................................................
Echo guide, villus sampling .................................................................................................
Echo guide for amniocentesis .............................................................................................
Echo guide, ova aspiration ..................................................................................................
Echo guidance radiotherapy ................................................................................................
Echo guidance radiotherapy ................................................................................................
Ultrasound exam follow-up ..................................................................................................
GI endoscopic ultrasound ....................................................................................................
Us bone density measure ....................................................................................................
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z2
Z2
Z3
Z2
Z3
Z2
Z3
Z2
Z3
Z2
Z3
Z3
Z2
Z3
Z3
Z2
Z2
Z2
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z2
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
N1
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z2
Z2
Z2
Z3
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
4.5523
0.7093
0.9923
1.5607
1.2312
1.0702
1.1426
0.0644
0.8852
0.9736
0.8450
1.5290
0.9923
0.9923
1.5607
1.3922
1.5607
1.4002
1.5607
1.3680
1.5607
0.7000
1.5607
0.9576
2.4060
0.9923
1.3922
0.6760
0.9923
0.9923
0.9923
1.3922
1.1990
0.8128
1.3036
1.5973
1.2794
1.0462
0.6358
1.5607
1.6094
1.5607
0.9923
1.5607
1.5607
1.5607
1.5607
0.9923
0.9923
1.1882
2.1012
2.1012
....................
1.1882
1.1882
1.1882
1.1882
0.7404
0.7404
0.9416
2.1012
0.9923
1.5607
0.3702
$193.67
$30.18
$42.22
$66.40
$52.38
$45.53
$48.61
$2.74
$37.66
$41.42
$35.95
$65.05
$42.22
$42.22
$66.40
$59.23
$66.40
$59.57
$66.40
$58.20
$66.40
$29.78
$66.40
$40.74
$102.36
$42.22
$59.23
$28.76
$42.22
$42.22
$42.22
$59.23
$51.01
$34.58
$55.46
$67.95
$54.43
$44.51
$27.05
$66.40
$68.47
$66.40
$42.22
$66.40
$66.40
$66.40
$66.40
$42.22
$42.22
$50.55
$89.39
$89.39
....................
$50.55
$50.55
$50.55
$50.55
$31.50
$31.50
$40.06
$89.39
$42.22
$66.40
$15.75
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00142
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42611
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
76998
76999
77001
77002
77003
77011
77012
77013
77014
77021
77022
77031
77032
77053
77054
77071
77072
77073
77074
77075
77076
77077
77078
77079
77080
77081
77082
77083
77084
77280
77285
77290
77295
77299
77300
77301
77305
77310
77315
77321
77326
77327
77328
77331
77332
77333
77334
77336
77370
77371
77399
77401
77402
77403
77404
77406
77407
77408
77409
77411
77412
77413
77414
77416
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Us guide, intraop .................................................................................................................
Echo examination procedure ...............................................................................................
Fluoroguide for vein device .................................................................................................
Needle localization by xray ..................................................................................................
Fluoroguide for spine inject .................................................................................................
Ct scan for localization ........................................................................................................
Ct scan for needle biopsy ....................................................................................................
Ct guide for tissue ablation ..................................................................................................
Ct scan for therapy guide ....................................................................................................
Mr guidance for needle place ..............................................................................................
Mri for tissue ablation ..........................................................................................................
Stereotact guide for brst bx .................................................................................................
Guidance for needle, breast ................................................................................................
X-ray of mammary duct .......................................................................................................
X-ray of mammary ducts .....................................................................................................
X-ray stress view .................................................................................................................
X-rays for bone age .............................................................................................................
X-rays, bone length studies .................................................................................................
X-rays, bone survey, limited ................................................................................................
X-rays, bone survey complete .............................................................................................
X-rays, bone survey, infant ..................................................................................................
Joint survey, single view ......................................................................................................
Ct bone density, axial ..........................................................................................................
Ct bone density, peripheral .................................................................................................
Dxa bone density, axial .......................................................................................................
Dxa bone density/peripheral ................................................................................................
Dxa bone density, vert fx .....................................................................................................
Radiographic absorptiometry ...............................................................................................
Magnetic image, bone marrow ............................................................................................
Sbrt management ................................................................................................................
Set radiation therapy field ....................................................................................................
Set radiation therapy field ....................................................................................................
Set radiation therapy field ....................................................................................................
Radiation therapy planning ..................................................................................................
Radiation therapy dose plan ................................................................................................
Radiotherapy dose plan, imrt ..............................................................................................
Teletx isodose plan simple ..................................................................................................
Teletx isodose plan intermed ..............................................................................................
Teletx isodose plan complex ...............................................................................................
Special teletx port plan ........................................................................................................
Brachytx isodose calc simp .................................................................................................
Brachytx isodose calc interm ...............................................................................................
Brachytx isodose plan compl ...............................................................................................
Special radiation dosimetry .................................................................................................
Radiation treatment aid(s) ...................................................................................................
Radiation treatment aid(s) ...................................................................................................
Radiation treatment aid(s) ...................................................................................................
Radiation physics consult ....................................................................................................
Radiation physics consult ....................................................................................................
Srs, multisource ...................................................................................................................
External radiation dosimetry ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Radiation treatment delivery ................................................................................................
Z2
Z2
N1
N1
N1
Z2
Z3
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z2
Z2
Z3
Z2
Z3
Z2
Z2
Z3
Z3
Z2
Z2
Z2
Z2
Z3
Z2
Z3
Z2
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z2
Z3
Z2
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
1.5607
0.9923
....................
....................
....................
4.0825
4.0559
4.8405
1.5379
4.5523
4.5523
2.9586
0.6840
1.2554
1.6956
0.3782
0.2736
0.5312
0.8852
1.2224
0.7093
0.6598
1.1755
1.4566
1.1755
0.5497
0.4426
0.4264
4.5523
1.5735
3.9723
3.9723
13.6401
1.5735
0.9334
13.8081
1.0140
1.3036
1.7060
2.1085
1.5735
2.8649
3.8305
0.4104
1.0944
0.8610
2.2453
1.5735
1.5735
24.3429
1.5735
0.9094
1.4826
1.4826
1.4826
1.4826
1.4826
1.4826
1.4826
2.2295
2.2295
2.2295
2.2295
2.2295
$66.40
$42.22
....................
....................
....................
$173.68
$172.55
$205.93
$65.43
$193.67
$193.67
$125.87
$29.10
$53.41
$72.14
$16.09
$11.64
$22.60
$37.66
$52.00
$30.18
$28.07
$50.01
$61.97
$50.01
$23.39
$18.83
$18.14
$193.67
$66.94
$168.99
$168.99
$580.29
$66.94
$39.71
$587.44
$43.14
$55.46
$72.58
$89.70
$66.94
$121.88
$162.96
$17.46
$46.56
$36.63
$95.52
$66.94
$66.94
$1,035.62
$66.94
$38.69
$63.07
$63.07
$63.07
$63.07
$63.07
$63.07
$63.07
$94.85
$94.85
$94.85
$94.85
$94.85
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00143
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42612
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
77417
77418
77421
77422
77423
77435
77470
77520
77522
77523
77525
77600
77605
77610
77615
77620
77750
77761
77762
77763
77776
77777
77778
77781
77782
77783
77784
77789
77790
77799
78000
78001
78003
78006
78007
78010
78011
78015
78016
78018
78020
78070
78075
78099
78102
78103
78104
78110
78111
78120
78121
78122
78130
78135
78140
78185
78190
78191
78195
78199
78201
78202
78205
78206
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Radiology port film(s) ...........................................................................................................
Radiation tx delivery, imrt ....................................................................................................
Stereoscopic x-ray guidance ...............................................................................................
Neutron beam tx, simple .....................................................................................................
Neutron beam tx, complex ..................................................................................................
Sbrt management ................................................................................................................
Special radiation treatment ..................................................................................................
Proton trmt, simple w/o comp ..............................................................................................
Proton trmt, simple w/comp .................................................................................................
Proton trmt, intermediate .....................................................................................................
Proton treatment, complex ..................................................................................................
Hyperthermia treatment .......................................................................................................
Hyperthermia treatment .......................................................................................................
Hyperthermia treatment .......................................................................................................
Hyperthermia treatment .......................................................................................................
Hyperthermia treatment .......................................................................................................
Infuse radioactive materials .................................................................................................
Apply intrcav radiat simple ..................................................................................................
Apply intrcav radiat interm ...................................................................................................
Apply intrcav radiat compl ...................................................................................................
Apply interstit radiat simpl ...................................................................................................
Apply interstit radiat inter .....................................................................................................
Apply interstit radiat compl ..................................................................................................
High intensity brachytherapy ...............................................................................................
High intensity brachytherapy ...............................................................................................
High intensity brachytherapy ...............................................................................................
High intensity brachytherapy ...............................................................................................
Apply surface radiation ........................................................................................................
Radiation handling ...............................................................................................................
Radium/radioisotope therapy ...............................................................................................
Thyroid, single uptake .........................................................................................................
Thyroid, multiple uptakes .....................................................................................................
Thyroid suppress/stimul .......................................................................................................
Thyroid imaging with uptake ................................................................................................
Thyroid image, mult uptakes ...............................................................................................
Thyroid imaging ...................................................................................................................
Thyroid imaging with flow ....................................................................................................
Thyroid met imaging ............................................................................................................
Thyroid met imaging/studies ................................................................................................
Thyroid met imaging, body ..................................................................................................
Thyroid met uptake ..............................................................................................................
Parathyroid nuclear imaging ................................................................................................
Adrenal nuclear imaging ......................................................................................................
Endocrine nuclear procedure ..............................................................................................
Bone marrow imaging, ltd ....................................................................................................
Bone marrow imaging, mult .................................................................................................
Bone marrow imaging, body ................................................................................................
Plasma volume, single .........................................................................................................
Plasma volume, multiple ......................................................................................................
Red cell mass, single ..........................................................................................................
Red cell mass, multiple .......................................................................................................
Blood volume .......................................................................................................................
Red cell survival study .........................................................................................................
Red cell survival kinetics .....................................................................................................
Red cell sequestration .........................................................................................................
Spleen imaging ....................................................................................................................
Platelet survival, kinetics .....................................................................................................
Platelet survival ....................................................................................................................
Lymph system imaging ........................................................................................................
Blood/lymph nuclear exam ..................................................................................................
Liver imaging .......................................................................................................................
Liver imaging with flow ........................................................................................................
Liver imaging (3D) ...............................................................................................................
Liver image (3d) with flow ...................................................................................................
Z3
Z2
Z2
Z2
Z2
N1
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z2
Z2
Z3
N1
Z2
Z3
Z3
Z3
Z2
Z3
Z3
Z2
Z3
Z2
Z2
Z3
Z2
Z2
Z2
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z3
Z3
Z2
Z3
Z3
Z2
Z2
Z2
Z2
Z3
Z3
Z3
Z2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
0.3782
5.4731
1.0974
2.2295
2.2295
....................
4.9813
18.8926
18.8926
22.6031
22.6031
3.3461
3.3461
3.3461
3.3461
3.3461
1.7140
3.0419
3.7741
4.8283
3.2109
3.8707
5.1261
9.7854
12.8473
12.8473
12.8473
0.8530
....................
4.8569
1.0622
1.3520
1.0622
2.3432
2.1085
2.2692
2.3432
3.0097
3.9934
3.9934
1.1346
2.7146
2.7146
2.3432
2.3336
3.2431
3.9073
1.1830
1.8266
1.4566
1.9634
2.6394
2.4060
3.7562
2.5913
2.8808
2.0057
2.0057
3.9073
3.9073
2.7039
3.1385
4.2811
4.3774
$16.09
$232.84
$46.69
$94.85
$94.85
....................
$211.92
$803.75
$803.75
$961.60
$961.60
$142.35
$142.35
$142.35
$142.35
$142.35
$72.92
$129.41
$160.56
$205.41
$136.60
$164.67
$218.08
$416.30
$546.56
$546.56
$546.56
$36.29
....................
$206.63
$45.19
$57.52
$45.19
$99.69
$89.70
$96.54
$99.69
$128.04
$169.89
$169.89
$48.27
$115.49
$115.49
$99.69
$99.28
$137.97
$166.23
$50.33
$77.71
$61.97
$83.53
$112.29
$102.36
$159.80
$110.24
$122.56
$85.33
$85.33
$166.23
$166.23
$115.03
$133.52
$182.13
$186.23
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00144
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42613
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
78215
78216
78220
78223
78230
78231
78232
78258
78261
78262
78264
78270
78271
78272
78278
78282
78290
78291
78299
78300
78305
78306
78315
78320
78399
78414
78428
78445
78456
78457
78458
78459
78460
78461
78464
78465
78466
78468
78469
78472
78473
78478
78480
78481
78483
78491
78492
78494
78496
78499
78580
78584
78585
78586
78587
78588
78591
78593
78594
78596
78599
78600
78601
78605
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Liver and spleen imaging ....................................................................................................
Liver & spleen image/flow ...................................................................................................
Liver function study ..............................................................................................................
Hepatobiliary imaging ..........................................................................................................
Salivary gland imaging ........................................................................................................
Serial salivary imaging .........................................................................................................
Salivary gland function exam ..............................................................................................
Esophageal motility study ....................................................................................................
Gastric mucosa imaging ......................................................................................................
Gastroesophageal reflux exam ............................................................................................
Gastric emptying study ........................................................................................................
Vit B–12 absorption exam ...................................................................................................
Vit B–12 absrp exam, int fac ...............................................................................................
Vit B–12 absorp, combined .................................................................................................
Acute GI blood loss imaging ...............................................................................................
GI protein loss exam ...........................................................................................................
Meckel’s divert exam ...........................................................................................................
Leveen/shunt patency exam ................................................................................................
GI nuclear procedure ...........................................................................................................
Bone imaging, limited area ..................................................................................................
Bone imaging, multiple areas ..............................................................................................
Bone imaging, whole body ..................................................................................................
Bone imaging, 3 phase ........................................................................................................
Bone imaging (3D) ...............................................................................................................
Musculoskeletal nuclear exam ............................................................................................
Non-imaging heart function .................................................................................................
Cardiac shunt imaging .........................................................................................................
Vascular flow imaging ..........................................................................................................
Acute venous thrombus image ............................................................................................
Venous thrombosis imaging ................................................................................................
Ven thrombosis images, bilat ..............................................................................................
Heart muscle imaging (PET) ...............................................................................................
Heart muscle blood, single ..................................................................................................
Heart muscle blood, multiple ...............................................................................................
Heart image (3d), single ......................................................................................................
Heart image (3d), multiple ...................................................................................................
Heart infarct image ..............................................................................................................
Heart infarct image (ef) ........................................................................................................
Heart infarct image (3D) ......................................................................................................
Gated heart, planar, single ..................................................................................................
Gated heart, multiple ...........................................................................................................
Heart wall motion add-on ....................................................................................................
Heart function add-on ..........................................................................................................
Heart first pass, single .........................................................................................................
Heart first pass, multiple ......................................................................................................
Heart image (pet), single .....................................................................................................
Heart image (pet), multiple ..................................................................................................
Heart image, spect ..............................................................................................................
Heart first pass add-on ........................................................................................................
Cardiovascular nuclear exam ..............................................................................................
Lung perfusion imaging .......................................................................................................
Lung V/Q image single breath .............................................................................................
Lung V/Q imaging ................................................................................................................
Aerosol lung image, single ..................................................................................................
Aerosol lung image, multiple ...............................................................................................
Perfusion lung image ...........................................................................................................
Vent image, 1 breath, 1 proj ................................................................................................
Vent image, 1 proj, gas .......................................................................................................
Vent image, mult proj, gas ..................................................................................................
Lung differential function .....................................................................................................
Respiratory nuclear exam ....................................................................................................
Brain imaging, ltd static .......................................................................................................
Brain imaging, ltd w/flow ......................................................................................................
Brain imaging, complete ......................................................................................................
Z3
Z3
Z3
Z2
Z3
Z3
Z3
Z3
Z2
Z2
Z2
Z3
Z3
Z3
Z2
Z2
Z2
Z3
Z2
Z3
Z3
Z3
Z2
Z2
Z2
Z2
Z3
Z2
Z2
Z2
Z2
Z2
Z3
Z3
Z2
Z2
Z3
Z3
Z2
Z2
Z2
Z3
Z3
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z3
Z2
Z3
Z3
Z3
Z3
Z3
Z2
Z2
Z2
Z3
Z3
Z3
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
2.9453
2.3980
2.5833
4.3774
2.3980
2.2775
2.4143
3.2995
3.6526
3.6526
3.6526
1.3278
1.3760
1.6898
3.6526
3.6526
3.6526
3.4765
3.6526
2.5106
3.4443
3.9029
3.9174
3.9174
3.9174
4.1265
2.8729
2.4204
2.4204
2.4204
2.4204
11.8963
2.6235
3.2673
4.1265
6.5012
2.7039
3.7099
4.1265
4.1265
4.9832
0.8530
0.8530
3.9431
4.9832
11.8963
11.8963
4.1265
1.5054
4.1265
3.1802
2.2775
5.0975
2.5670
3.1305
4.4261
2.6637
3.1465
3.1802
5.0975
3.1802
3.8627
3.3315
3.1063
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00145
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
$125.30
$102.02
$109.90
$186.23
$102.02
$96.89
$102.71
$140.37
$155.39
$155.39
$155.39
$56.49
$58.54
$71.89
$155.39
$155.39
$155.39
$147.90
$155.39
$106.81
$146.53
$166.04
$166.66
$166.66
$166.66
$175.55
$122.22
$102.97
$102.97
$102.97
$102.97
$506.10
$111.61
$139.00
$175.55
$276.58
$115.03
$157.83
$175.55
$175.55
$212.00
$36.29
$36.29
$167.75
$212.00
$506.10
$506.10
$175.55
$64.04
$175.55
$135.30
$96.89
$216.86
$109.21
$133.18
$188.30
$113.32
$133.86
$135.30
$216.86
$135.30
$164.33
$141.73
$132.15
42614
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
Short descriptor
Payment
indicator
78606 .......
78607 .......
78608 .......
78610 .......
78615 .......
78630 .......
78635 .......
78645 .......
78647 .......
78650 .......
78660 .......
78699 .......
78700 .......
78701 .......
78707 .......
78708 .......
78709 .......
78710 .......
78725 .......
78730 .......
78740 .......
78761 .......
78799 .......
78800 .......
78801 .......
78802 .......
78803 .......
78804 .......
78805 .......
78806 .......
78807 .......
78811 .......
78812 .......
78813 .......
78814 .......
78815 .......
78816 .......
78890 .......
78891 .......
78999 .......
79005 .......
79101 .......
79200 .......
79300 .......
79403 .......
79440 .......
79445 .......
79999 .......
90371 .......
90375 .......
90376 .......
90396 .......
90585 .......
90675 .......
90676 .......
90708 .......
90720 .......
90727 .......
90733 .......
90734 .......
90735 .......
A4218 ......
A4220 ......
A4248 ......
Brain imaging, compl w/flow ................................................................................................
Brain imaging (3D) ...............................................................................................................
Brain imaging (PET) ............................................................................................................
Brain flow imaging only .......................................................................................................
Cerebral vascular flow image ..............................................................................................
Cerebrospinal fluid scan ......................................................................................................
CSF ventriculography ..........................................................................................................
CSF shunt evaluation ..........................................................................................................
Cerebrospinal fluid scan ......................................................................................................
CSF leakage imaging ..........................................................................................................
Nuclear exam of tear flow ...................................................................................................
Nervous system nuclear exam ............................................................................................
Kidney imaging, morphol .....................................................................................................
Kidney imaging with flow .....................................................................................................
Kflow/funct image w/o drug .................................................................................................
Kflow/funct image w/drug ....................................................................................................
Kflow/funct image, multiple ..................................................................................................
Kidney imaging (3D) ............................................................................................................
Kidney function study ..........................................................................................................
Urinary bladder retention .....................................................................................................
Ureteral reflux study ............................................................................................................
Testicular imaging w/flow ....................................................................................................
Genitourinary nuclear exam ................................................................................................
Tumor imaging, limited area ................................................................................................
Tumor imaging, mult areas ..................................................................................................
Tumor imaging, whole body ................................................................................................
Tumor imaging (3D) .............................................................................................................
Tumor imaging, whole body ................................................................................................
Abscess imaging, ltd area ...................................................................................................
Abscess imaging, whole body .............................................................................................
Nuclear localization/abscess ...............................................................................................
Tumor imaging (pet), limited ................................................................................................
Tumor image (pet)/skul-thigh ...............................................................................................
Tumor image (pet) full body ................................................................................................
Tumor image pet/ct, limited .................................................................................................
Tumorimage pet/ct skul-thigh ..............................................................................................
Tumor image pet/ct full body ...............................................................................................
Nuclear medicine data proc .................................................................................................
Nuclear med data proc ........................................................................................................
Nuclear diagnostic exam .....................................................................................................
Nuclear rx, oral admin .........................................................................................................
Nuclear rx, iv admin .............................................................................................................
Nuclear rx, intracav admin ...................................................................................................
Nuclr rx, interstit colloid .......................................................................................................
Hematopoietic nuclear tx .....................................................................................................
Nuclear rx, intra-articular .....................................................................................................
Nuclear rx, intra-arterial .......................................................................................................
Nuclear medicine therapy ....................................................................................................
Hep b ig, im .........................................................................................................................
Rabies ig, im/sc ...................................................................................................................
Rabies ig, heat treated ........................................................................................................
Varicella-zoster ig, im ..........................................................................................................
Bcg vaccine, precut .............................................................................................................
Rabies vaccine, im ..............................................................................................................
Rabies vaccine, id ...............................................................................................................
Measles-rubella vaccine, sc ................................................................................................
Dtp/hib vaccine, im ..............................................................................................................
Plague vaccine, im ..............................................................................................................
Meningococcal vaccine, sc ..................................................................................................
Meningococcal vaccine, im ..................................................................................................
Encephalitis vaccine, sc ......................................................................................................
Sterile saline or water ..........................................................................................................
Infusion pump refill kit ..........................................................................................................
Chlorhexidine antisept .........................................................................................................
Z2
Z2
Z2
Z3
Z3
Z2
Z2
Z2
Z2
Z2
Z3
Z2
Z3
Z3
Z2
Z3
Z2
Z2
Z2
Z2
Z3
Z3
Z2
Z3
Z3
Z2
Z2
Z2
Z3
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
N1
N1
Z2
Z3
Z3
Z3
Z2
Z3
Z3
Z2
Z2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
N1
N1
N1
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
4.6418
4.6418
13.9166
2.2855
3.5327
3.4923
3.4923
3.4923
3.4923
3.4923
2.4143
4.6418
2.8891
3.4041
3.4209
2.9373
4.0378
3.4209
1.3754
0.6102
2.8649
3.0499
3.4209
2.9293
3.9271
3.9934
3.9934
5.9245
2.8729
3.9934
3.9934
13.9166
13.9166
13.9166
15.4552
15.4552
15.4552
....................
....................
1.3754
1.5370
1.6094
1.6738
3.1779
2.5591
1.4968
3.1779
3.1779
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$197.48
$197.48
$592.05
$97.23
$150.29
$148.57
$148.57
$148.57
$148.57
$148.57
$102.71
$197.48
$122.91
$144.82
$145.54
$124.96
$171.78
$145.54
$58.51
$25.96
$121.88
$129.75
$145.54
$124.62
$167.07
$169.89
$169.89
$252.05
$122.22
$169.89
$169.89
$592.05
$592.05
$592.05
$657.51
$657.51
$657.51
....................
....................
$58.51
$65.39
$68.47
$71.21
$135.20
$108.87
$63.68
$135.20
$135.20
$133.69
$65.44
$70.06
$122.74
$113.63
$146.91
$119.86
$45.53
$58.70
$7.13
$89.43
$82.00
$99.11
....................
....................
....................
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00146
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42615
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
A4262
A4263
A4270
A4300
A4301
A4305
A4306
A9527
A9698
C1713
C1714
C1715
C1716
C1717
C1718
C1719
C1720
C1721
C1722
C1724
C1725
C1726
C1727
C1728
C1729
C1730
C1731
C1732
C1733
C1750
C1751
C1752
C1753
C1754
C1755
C1756
C1757
C1758
C1759
C1760
C1762
C1763
C1764
C1765
C1766
C1767
C1768
C1769
C1770
C1771
C1772
C1773
C1776
C1777
C1778
C1779
C1780
C1781
C1782
C1783
C1784
C1785
C1786
C1787
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
Payment
indicator
Short descriptor
Temporary tear duct plug ....................................................................................................
Permanent tear duct plug ....................................................................................................
Disposable endoscope sheath ............................................................................................
Cath impl vasc access portal ..............................................................................................
Implantable access syst perc ..............................................................................................
Drug delivery system ´50 ML .............................................................................................
Drug delivery system ™50 ml ..............................................................................................
Iodine I-125 sodium iodide ..................................................................................................
Non-rad contrast materialNOC ............................................................................................
Anchor/screw bn/bn,tis/bn ...................................................................................................
Cath, trans atherectomy, dir ................................................................................................
Brachytherapy needle ..........................................................................................................
Brachytx source, Gold 198 ..................................................................................................
Brachytx source, HDR Ir-192 ..............................................................................................
Brachytx source, Iodine 125 ................................................................................................
Brachytx sour, Non-HDR Ir-192 ..........................................................................................
Brachytx sour, Palladium 103 ..............................................................................................
AICD, dual chamber ............................................................................................................
AICD, single chamber ..........................................................................................................
Cath, trans atherec, rotation ................................................................................................
Cath, translumin non-laser ..................................................................................................
Cath, bal dil, non-vascular ...................................................................................................
Cath, bal tis dis, non-vas .....................................................................................................
Cath, brachytx seed adm ....................................................................................................
Cath, drainage .....................................................................................................................
Cath, EP, 19 or few elect ....................................................................................................
Cath, EP, 20 or more elec ...................................................................................................
Cath, EP, diag/abl, 3D/vect .................................................................................................
Cath, EP, othr than cool-tip .................................................................................................
Cath, hemodialysis, long-term .............................................................................................
Cath, inf, per/cent/midline ....................................................................................................
Cath, hemodialysis, short-term ............................................................................................
Cath, intravas ultrasound .....................................................................................................
Catheter, intradiscal .............................................................................................................
Catheter, intraspinal .............................................................................................................
Cath, pacing, transesoph .....................................................................................................
Cath, thrombectomy/embolect .............................................................................................
Catheter, ureteral .................................................................................................................
Cath, intra echocardiography ..............................................................................................
Closure dev, vasc ................................................................................................................
Conn tiss, human (inc fascia) ..............................................................................................
Conn tiss, non-human .........................................................................................................
Event recorder, cardiac .......................................................................................................
Adhesion barrier ..................................................................................................................
Intro/sheath, strble, non-peel ...............................................................................................
Generator, neuro non-recharg .............................................................................................
Graft, vascular .....................................................................................................................
Guide wire ............................................................................................................................
Imaging coil, MR, insertable ................................................................................................
Rep dev, urinary, w/sling .....................................................................................................
Infusion pump, programmable .............................................................................................
Ret dev, insertable ...............................................................................................................
Joint device (implantable) ....................................................................................................
Lead, AICD, endo single coil ...............................................................................................
Lead, neurostimulator ..........................................................................................................
Lead, pmkr, transvenous VDD ............................................................................................
Lens, intraocular (new tech) ................................................................................................
Mesh (implantable) ..............................................................................................................
Morcellator ...........................................................................................................................
Ocular imp, aqueous drain de .............................................................................................
Ocular dev, intraop, det ret ..................................................................................................
Pmkr, dual, rate-resp ...........................................................................................................
Pmkr, single, rate-resp ........................................................................................................
Patient progr, neurostim ......................................................................................................
N1
N1
N1
N1
N1
N1
N1
H7
N1
N1
N1
N1
H7
H7
H7
H7
H7
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00147
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42616
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
Short descriptor
Payment
indicator
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
Port, indwelling, imp ............................................................................................................
Prosthesis, breast, imp ........................................................................................................
Prosthesis, penile, inflatab ...................................................................................................
Retinal tamp, silicone oil ......................................................................................................
Pros, urinary sph, imp .........................................................................................................
Receiver/transmitter, neuro .................................................................................................
Septal defect imp sys ..........................................................................................................
Integrated keratoprosthesis .................................................................................................
Tissue localization-excision .................................................................................................
Generator neuro rechg bat sy .............................................................................................
Interspinous implant .............................................................................................................
Stent, coated/cov w/del sys .................................................................................................
Stent, coated/cov w/o del sy ...............................................................................................
Stent, non-coa/non-cov w/del ..............................................................................................
Stent, non-coat/cov w/o del .................................................................................................
Matrl for vocal cord ..............................................................................................................
Tissue marker, implantable .................................................................................................
Vena cava filter ....................................................................................................................
Dialysis access system ........................................................................................................
AICD, other than sing/dual ..................................................................................................
Adapt/ext, pacing/neuro lead ...............................................................................................
Embolization Protect syst ....................................................................................................
Cath, translumin angio laser ................................................................................................
Catheter, guiding .................................................................................................................
Endovas non-cardiac abl cath .............................................................................................
Infusion pump, non-prog, perm ...........................................................................................
Intro/sheath, fixed, peel-away ..............................................................................................
Intro/sheath, fixed, non-peel ................................................................................................
Intro/sheath, non-laser .........................................................................................................
Lead, AICD, endo dual coil .................................................................................................
Lead, AICD, non sing/dual ..................................................................................................
Lead, neurostim test kit .......................................................................................................
Lead, pmkr, other than trans ...............................................................................................
Lead, pmkr/AICD combination .............................................................................................
Lead, coronary venous ........................................................................................................
Probe, perc lumb disc ..........................................................................................................
Sealant, pulmonary, liquid ...................................................................................................
Brachytx source, Yttrium-90 ................................................................................................
Stent, non-cor, tem w/o del .................................................................................................
Probe, cryoablation ..............................................................................................................
Pmkr, dual, non rate-resp ....................................................................................................
Pmkr, single, non rate-resp .................................................................................................
Pmkr, other than sing/dual ..................................................................................................
Prosthesis, penile, non-inf ...................................................................................................
Stent, non-cor, tem w/del sy ................................................................................................
Infusion pump, non-prog, temp ...........................................................................................
Cath, suprapubic/cystoscopic ..............................................................................................
Catheter, occlusion ..............................................................................................................
Intro/sheath, laser ................................................................................................................
Cath, EP, cool-tip .................................................................................................................
Rep dev, urinary, w/o sling ..................................................................................................
Brachytx source, Cesium-131 .............................................................................................
Brachytx source, HA, I-125 .................................................................................................
Brachytx source, HA, P-103 ................................................................................................
Brachytx linear source, P-103 .............................................................................................
Brachytx, Ytterbium–169 .....................................................................................................
MRA w/cont, abd .................................................................................................................
MRA w/o cont, abd ..............................................................................................................
MRA w/o fol w/cont, abd .....................................................................................................
MRI w/cont, breast, uni ........................................................................................................
MRI w/o cont, breast, uni ....................................................................................................
MRI w/o fol w/cont, brst, un .................................................................................................
MRI w/cont, breast, bi ..........................................................................................................
MRI w/o cont, breast, bi ......................................................................................................
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
J7 .............
J7 .............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
H7 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
H7 ............
H7 ............
H7 ............
H7 ............
H7 ............
Z2 ............
Z2 ............
Z2 ............
Z2 ............
Z2 ............
Z2 ............
Z2 ............
Z2 ............
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
6.1231
5.6745
8.1155
6.1231
5.6745
8.1155
6.1231
5.6745
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$260.50
$241.41
$345.26
$260.50
$241.41
$345.26
$260.50
$241.41
mstockstill on PROD1PC66 with RULES2
HCPCS
code
C1788
C1789
C1813
C1814
C1815
C1816
C1817
C1818
C1819
C1820
C1821
C1874
C1875
C1876
C1877
C1878
C1879
C1880
C1881
C1882
C1883
C1884
C1885
C1887
C1888
C1891
C1892
C1893
C1894
C1895
C1896
C1897
C1898
C1899
C1900
C2614
C2615
C2616
C2617
C2618
C2619
C2620
C2621
C2622
C2625
C2626
C2627
C2628
C2629
C2630
C2631
C2633
C2634
C2635
C2636
C2637
C8900
C8901
C8902
C8903
C8904
C8905
C8906
C8907
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
......
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00148
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42617
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
Short descriptor
Payment
indicator
C8908 ......
C8909 ......
C8910 ......
C8911 ......
C8912 ......
C8913 ......
C8914 ......
C8918 ......
C8919 ......
C8920 ......
C9003 ......
C9113 ......
C9121 ......
C9232 ......
C9233 ......
C9234 ......
C9235 ......
C9350 ......
C9351 ......
C9399 ......
E0616 ......
E0749 ......
E0782 ......
E0783 ......
E0785 ......
E0786 ......
G0130 ......
G0173 ......
G0251 ......
G0288 ......
G0339 ......
G0340 ......
J0120 .......
J0128 .......
J0129 .......
J0130 .......
J0132 .......
J0133 .......
J0135 .......
J0150 .......
J0152 .......
J0170 .......
J0180 .......
J0190 .......
J0200 .......
J0205 .......
J0207 .......
J0210 .......
J0215 .......
J0256 .......
J0278 .......
J0280 .......
J0282 .......
J0285 .......
J0287 .......
J0288 .......
J0289 .......
J0290 .......
J0295 .......
J0300 .......
J0330 .......
J0348 .......
J0350 .......
J0360 .......
MRI w/o fol w/cont, breast, ..................................................................................................
MRA w/cont, chest ...............................................................................................................
MRA w/o cont, chest ...........................................................................................................
MRA w/o fol w/cont, chest ...................................................................................................
MRA w/cont, lwr ext .............................................................................................................
MRA w/o cont, lwr ext .........................................................................................................
MRA w/o fol w/cont, lwr ext .................................................................................................
MRA w/cont, pelvis ..............................................................................................................
MRA w/o cont, pelvis ...........................................................................................................
MRA w/o fol w/cont, pelvis ..................................................................................................
Palivizumab, per 50 mg .......................................................................................................
Inj pantoprazole sodium, via ................................................................................................
Injection, argatroban ............................................................................................................
Injection, idursulfase ............................................................................................................
Injection, ranibizumab ..........................................................................................................
Inj, alglucosidase alfa ..........................................................................................................
Injection, panitumumab ........................................................................................................
Porous collagen tube per cm ..............................................................................................
Acellular derm tissue percm2 ..............................................................................................
Unclassified drugs or biolog ................................................................................................
Cardiac event recorder ........................................................................................................
Elec osteogen stim implanted .............................................................................................
Non-programble infusion pump ...........................................................................................
Programmable infusion pump ..............................................................................................
Replacement impl pump cathet ...........................................................................................
Implantable pump replacement ...........................................................................................
Single energy x-ray study ....................................................................................................
Linear acc stereo radsur com ..............................................................................................
Linear acc based stero radio ...............................................................................................
Recon, CTA for surg plan ....................................................................................................
Robot lin-radsurg com, first .................................................................................................
Robt lin-radsurg fractx 2–5 ..................................................................................................
Tetracyclin injection .............................................................................................................
Abarelix injection ..................................................................................................................
Abatacept injection ..............................................................................................................
Abciximab injection ..............................................................................................................
Acetylcysteine injection ........................................................................................................
Acyclovir injection ................................................................................................................
Adalimumab injection ...........................................................................................................
Injection adenosine 6 MG ....................................................................................................
Adenosine injection ..............................................................................................................
Adrenalin epinephrin inject ..................................................................................................
Agalsidase beta injection .....................................................................................................
Inj biperiden lactate/5 mg ....................................................................................................
Alatrofloxacin mesylate ........................................................................................................
Alglucerase injection ............................................................................................................
Amifostine ............................................................................................................................
Methyldopate hcl injection ...................................................................................................
Alefacept ..............................................................................................................................
Alpha 1 proteinase inhibitor .................................................................................................
Amikacin sulfate injection ....................................................................................................
Aminophyllin 250 MG inj ......................................................................................................
Amiodarone HCl ..................................................................................................................
Amphotericin B ....................................................................................................................
Amphotericin b lipid complex ...............................................................................................
Ampho b cholesteryl sulfate ................................................................................................
Amphotericin b liposome inj ................................................................................................
Ampicillin 500 MG inj ...........................................................................................................
Ampicillin sodium per 1.5 gm ..............................................................................................
Amobarbital 125 MG inj .......................................................................................................
Succinycholine chloride inj ..................................................................................................
Anadulafungin injection ........................................................................................................
Injection anistreplase 30 u ...................................................................................................
Hydralazine hcl injection ......................................................................................................
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
Z2
K2
N1
K2
K2
K2
K2
K2
K2
K2
K7
N1
N1
N1
N1
N1
N1
Z3
Z2
Z2
Z2
Z2
Z2
N1
K2
K2
K2
K2
N1
K2
K2
K2
N1
K2
K2
N1
K2
K2
K2
K2
K2
N1
N1
N1
N1
K2
K2
K2
N1
N1
N1
N1
K2
K2
N1
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
8.1155
6.1231
5.6745
8.1155
6.1231
5.6745
8.1155
6.1231
5.6745
8.1155
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
0.5150
63.3759
20.3224
3.2393
63.3759
43.0297
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$345.26
$260.50
$241.41
$345.26
$260.50
$241.41
$345.26
$260.50
$241.41
$345.26
$684.43
....................
$18.04
$455.03
$2,030.92
$127.20
$84.80
$485.91
$41.59
....................
....................
....................
....................
....................
....................
....................
$21.91
$2,696.20
$864.58
$137.81
$2,696.20
$1,830.61
....................
$68.62
$18.69
$413.16
$1.95
....................
$319.03
$22.86
$69.16
....................
$127.20
$88.15
....................
$39.22
$480.64
$10.11
$26.07
$3.28
....................
....................
....................
....................
$10.38
$12.00
$17.24
....................
....................
....................
....................
$1.91
$2,693.80
....................
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00149
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42618
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
J0364
J0365
J0380
J0390
J0395
J0456
J0460
J0470
J0475
J0476
J0480
J0500
J0515
J0520
J0530
J0540
J0550
J0560
J0570
J0580
J0583
J0585
J0587
J0592
J0594
J0595
J0600
J0610
J0620
J0630
J0636
J0637
J0640
J0670
J0690
J0692
J0694
J0696
J0697
J0698
J0702
J0704
J0706
J0710
J0713
J0715
J0720
J0725
J0735
J0740
J0743
J0744
J0745
J0760
J0770
J0780
J0795
J0800
J0835
J0850
J0878
J0881
J0885
J0894
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Apomorphine hydrochloride .................................................................................................
Aprotonin, 10,000 kiu ...........................................................................................................
Inj metaraminol bitartrate .....................................................................................................
Chloroquine injection ...........................................................................................................
Arbutamine HCl injection .....................................................................................................
Azithromycin ........................................................................................................................
Atropine sulfate injection .....................................................................................................
Dimecaprol injection ............................................................................................................
Baclofen 10 MG injection ....................................................................................................
Baclofen intrathecal trial ......................................................................................................
Basiliximab ...........................................................................................................................
Dicyclomine injection ...........................................................................................................
Inj benztropine mesylate ......................................................................................................
Bethanechol chloride inject ..................................................................................................
Penicillin g benzathine inj ....................................................................................................
Penicillin g benzathine inj ....................................................................................................
Penicillin g benzathine inj ....................................................................................................
Penicillin g benzathine inj ....................................................................................................
Penicillin g benzathine inj ....................................................................................................
Penicillin g benzathine inj ....................................................................................................
Bivalirudin ............................................................................................................................
Botulinum toxin a per unit ....................................................................................................
Botulinum toxin type B .........................................................................................................
Buprenorphine hydrochloride ...............................................................................................
Busulfan injection .................................................................................................................
Butorphanol tartrate 1 mg ....................................................................................................
Edetate calcium disodium inj ...............................................................................................
Calcium gluconate injection .................................................................................................
Calcium glycer & lact/10 ML ................................................................................................
Calcitonin salmon injection ..................................................................................................
Inj calcitriol per 0.1 mcg ......................................................................................................
Caspofungin acetate ............................................................................................................
Leucovorin calcium injection ................................................................................................
Inj mepivacaine HCL/10 ml .................................................................................................
Cefazolin sodium injection ...................................................................................................
Cefepime HCl for injection ...................................................................................................
Cefoxitin sodium injection ....................................................................................................
Ceftriaxone sodium injection ...............................................................................................
Sterile cefuroxime injection ..................................................................................................
Cefotaxime sodium injection ................................................................................................
Betamethasone acet&sod phosp .........................................................................................
Betamethasone sod phosp/4 MG ........................................................................................
Caffeine citrate injection ......................................................................................................
Cephapirin sodium injection ................................................................................................
Inj ceftazidime per 500 mg ..................................................................................................
Ceftizoxime sodium/500 MG ...............................................................................................
Chloramphenicol sodium injec .............................................................................................
Chorionic gonadotropin/1000u .............................................................................................
Clonidine hydrochloride .......................................................................................................
Cidofovir injection ................................................................................................................
Cilastatin sodium injection ...................................................................................................
Ciprofloxacin iv ....................................................................................................................
Inj codeine phosphate /30 MG ............................................................................................
Colchicine injection ..............................................................................................................
Colistimethate sodium inj .....................................................................................................
Prochlorperazine injection ...................................................................................................
Corticorelin ovine triflutal .....................................................................................................
Corticotropin injection ..........................................................................................................
Inj cosyntropin per 0.25 MG ................................................................................................
Cytomegalovirus imm IV /vial ..............................................................................................
Daptomycin injection ............................................................................................................
Darbepoetin alfa, non-esrd ..................................................................................................
Epoetin alfa, non-esrd .........................................................................................................
Decitabine injection ..............................................................................................................
K2
K2
K2
N1
K2
N1
N1
N1
K2
K2
K2
N1
N1
N1
N1
N1
N1
N1
N1
N1
K2
K2
K2
N1
K2
N1
K2
N1
N1
N1
N1
K2
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
K2
N1
N1
N1
N1
N1
K2
K2
N1
N1
N1
N1
N1
N1
K2
K2
K2
K2
K2
K2
K2
K2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$2.99
$2.52
$15.67
....................
$182.40
....................
....................
....................
$197.04
$71.59
$1,359.97
....................
....................
....................
....................
....................
....................
....................
....................
....................
$1.74
$5.10
$8.37
....................
$8.89
....................
$40.19
....................
....................
....................
....................
$30.35
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$3.36
....................
....................
....................
....................
....................
$63.46
$761.81
....................
....................
....................
....................
....................
....................
$4.31
$127.73
$63.85
$868.05
$0.33
$3.14
$9.45
$26.48
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00150
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42619
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
J0895
J0900
J0945
J0970
J1000
J1020
J1030
J1040
J1051
J1060
J1070
J1080
J1094
J1100
J1110
J1120
J1160
J1162
J1165
J1170
J1180
J1190
J1200
J1205
J1212
J1230
J1240
J1245
J1250
J1260
J1265
J1270
J1320
J1324
J1325
J1327
J1330
J1335
J1364
J1380
J1390
J1410
J1430
J1435
J1436
J1438
J1440
J1441
J1450
J1451
J1452
J1455
J1457
J1458
J1460
J1562
J1565
J1566
J1567
J1570
J1580
J1590
J1595
J1600
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Deferoxamine mesylate inj ..................................................................................................
Testosterone enanthate inj ..................................................................................................
Brompheniramine maleate inj ..............................................................................................
Estradiol valerate injection ...................................................................................................
Depo-estradiol cypionate inj ................................................................................................
Methylprednisolone 20 MG inj .............................................................................................
Methylprednisolone 40 MG inj .............................................................................................
Methylprednisolone 80 MG inj .............................................................................................
Medroxyprogesterone inj .....................................................................................................
Testosterone cypionate 1 ML ..............................................................................................
Testosterone cypionat 100 MG ...........................................................................................
Testosterone cypionat 200 MG ...........................................................................................
Inj dexamethasone acetate .................................................................................................
Dexamethasone sodium phos .............................................................................................
Inj dihydroergotamine mesylt ...............................................................................................
Acetazolamid sodium injectio ..............................................................................................
Digoxin injection ...................................................................................................................
Digoxin immune fab (ovine) .................................................................................................
Phenytoin sodium injection ..................................................................................................
Hydromorphone injection .....................................................................................................
Dyphylline injection ..............................................................................................................
Dexrazoxane HCl injection ..................................................................................................
Diphenhydramine hcl injectio ...............................................................................................
Chlorothiazide sodium inj ....................................................................................................
Dimethyl sulfoxide 50% 50 ML ............................................................................................
Methadone injection .............................................................................................................
Dimenhydrinate injection .....................................................................................................
Dipyridamole injection ..........................................................................................................
Inj dobutamine HCL/250 mg ................................................................................................
Dolasetron mesylate ............................................................................................................
Dopamine injection ..............................................................................................................
Injection, doxercalciferol ......................................................................................................
Amitriptyline injection ...........................................................................................................
Enfuvirtide injection ..............................................................................................................
Epoprostenol injection .........................................................................................................
Eptifibatide injection .............................................................................................................
Ergonovine maleate injection ..............................................................................................
Ertapenem injection .............................................................................................................
Erythro lactobionate /500 MG ..............................................................................................
Estradiol valerate 10 MG inj ................................................................................................
Estradiol valerate 20 MG inj ................................................................................................
Inj estrogen conjugate 25 MG .............................................................................................
Ethanolamine oleate 100 mg ...............................................................................................
Injection estrone per 1 MG ..................................................................................................
Etidronate disodium inj ........................................................................................................
Etanercept injection .............................................................................................................
Filgrastim 300 mcg injection ................................................................................................
Filgrastim 480 mcg injection ................................................................................................
Fluconazole ..........................................................................................................................
Fomepizole, 15 mg ..............................................................................................................
Intraocular Fomivirsen na ....................................................................................................
Foscarnet sodium injection ..................................................................................................
Gallium nitrate injection .......................................................................................................
Galsulfase injection ..............................................................................................................
Gamma globulin 1 CC inj ....................................................................................................
Immune globulin subcutaneous ...........................................................................................
RSV-ivig ...............................................................................................................................
Immune globulin, powder ....................................................................................................
Immune globulin, liquid ........................................................................................................
Ganciclovir sodium injection ................................................................................................
Garamycin gentamicin inj ....................................................................................................
Gatifloxacin injection ............................................................................................................
Injection glatiramer acetate .................................................................................................
Gold sodium thiomaleate inj ................................................................................................
K2
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
K2
N1
N1
N1
K2
N1
K2
N1
N1
N1
N1
N1
K2
N1
N1
N1
K2
N1
K2
K2
N1
N1
N1
N1
K2
K2
N1
K2
K2
K2
K2
N1
K2
K2
K2
N1
K2
K2
K2
K2
K2
K2
N1
N1
N1
N1
N1
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$14.52
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$516.35
....................
....................
....................
$174.07
....................
$123.84
....................
....................
....................
....................
....................
$6.11
....................
....................
....................
$22.91
....................
$16.05
$4.00
....................
....................
....................
....................
$60.90
$79.01
....................
$71.41
$161.55
$189.47
$300.58
....................
$12.39
$237.50
$10.20
....................
$299.92
$11.42
$12.72
$16.18
$25.72
$30.57
....................
....................
....................
....................
....................
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00151
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42620
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
J1610
J1620
J1626
J1630
J1631
J1640
J1642
J1644
J1645
J1650
J1652
J1655
J1670
J1700
J1710
J1720
J1730
J1740
J1742
J1745
J1751
J1752
J1756
J1785
J1790
J1800
J1815
J1817
J1830
J1835
J1840
J1850
J1885
J1890
J1931
J1940
J1945
J1950
J1956
J1960
J1980
J1990
J2001
J2010
J2020
J2060
J2150
J2170
J2175
J2180
J2185
J2210
J2248
J2250
J2260
J2270
J2271
J2275
J2278
J2280
J2300
J2310
J2315
J2320
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Glucagon hydrochloride/1 MG .............................................................................................
Gonadorelin hydroch/ 100 mcg ...........................................................................................
Granisetron HCl injection .....................................................................................................
Haloperidol injection ............................................................................................................
Haloperidol decanoate inj ....................................................................................................
Hemin, 1 mg ........................................................................................................................
Inj heparin sodium per 10 u ................................................................................................
Inj heparin sodium per 1000u ..............................................................................................
Dalteparin sodium ................................................................................................................
Inj enoxaparin sodium .........................................................................................................
Fondaparinux sodium ..........................................................................................................
Tinzaparin sodium injection .................................................................................................
Tetanus immune globulin inj ................................................................................................
Hydrocortisone acetate inj ...................................................................................................
Hydrocortisone sodium ph inj ..............................................................................................
Hydrocortisone sodium succ i .............................................................................................
Diazoxide injection ...............................................................................................................
Ibandronate sodium injection ...............................................................................................
Ibutilide fumarate injection ...................................................................................................
Infliximab injection ...............................................................................................................
Iron dextran 165 injection ....................................................................................................
Iron dextran 267 injection ....................................................................................................
Iron sucrose injection ...........................................................................................................
Injection imiglucerase /unit ..................................................................................................
Droperidol injection ..............................................................................................................
Propranolol injection ............................................................................................................
Insulin injection ....................................................................................................................
Insulin for insulin pump use .................................................................................................
Interferon beta-1b /.25 MG ..................................................................................................
Itraconazole injection ...........................................................................................................
Kanamycin sulfate 500 MG inj ............................................................................................
Kanamycin sulfate 75 MG inj ..............................................................................................
Ketorolac tromethamine inj ..................................................................................................
Cephalothin sodium injection ...............................................................................................
Laronidase injection .............................................................................................................
Furosemide injection ............................................................................................................
Lepirudin ..............................................................................................................................
Leuprolide acetate /3.75 MG ...............................................................................................
Levofloxacin injection ...........................................................................................................
Levorphanol tartrate inj ........................................................................................................
Hyoscyamine sulfate inj .......................................................................................................
Chlordiazepoxide injection ...................................................................................................
Lidocaine injection ...............................................................................................................
Lincomycin injection .............................................................................................................
Linezolid injection ................................................................................................................
Lorazepam injection .............................................................................................................
Mannitol injection .................................................................................................................
Mecasermin injection ...........................................................................................................
Meperidine hydrochl /100 MG .............................................................................................
Meperidine/promethazine inj ................................................................................................
Meropenem ..........................................................................................................................
Methylergonovin maleate inj ................................................................................................
Micafungin sodium injection ................................................................................................
Inj midazolam hydrochloride ................................................................................................
Inj milrinone lactate/5 MG ....................................................................................................
Morphine sulfate injection ....................................................................................................
Morphine so4 injection 100 mg ...........................................................................................
Morphine sulfate injection ....................................................................................................
Ziconotide injection ..............................................................................................................
Inj, moxifloxacin 100 mg ......................................................................................................
Inj nalbuphine hydrochloride ................................................................................................
Inj naloxone hydrochloride ...................................................................................................
Naltrexone, depot form ........................................................................................................
Nandrolone decanoate 50 MG ............................................................................................
K2
K2
K2
N1
N1
K2
N1
N1
N1
N1
N1
K2
K2
N1
N1
N1
K2
K2
K2
K2
K2
K2
K2
K2
N1
N1
N1
N1
K2
K2
N1
N1
N1
N1
K2
N1
K2
K2
N1
N1
N1
N1
N1
N1
K2
N1
N1
K2
N1
N1
K2
N1
K2
N1
N1
N1
N1
N1
K2
N1
N1
N1
K2
N1
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$66.27
$180.30
$7.50
....................
....................
$6.80
....................
....................
....................
....................
....................
$2.45
$97.26
....................
....................
....................
$114.32
$138.71
$266.92
$53.76
$11.72
$10.42
$0.37
$3.92
....................
....................
....................
....................
$84.92
$38.41
....................
....................
....................
....................
$23.87
....................
$154.89
$433.92
....................
....................
....................
....................
....................
....................
$25.17
....................
....................
$11.93
....................
....................
$3.71
....................
$1.71
....................
....................
....................
....................
....................
$6.52
....................
....................
....................
$1.90
....................
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00152
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42621
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
J2321
J2322
J2325
J2353
J2354
J2355
J2357
J2360
J2370
J2400
J2405
J2410
J2425
J2430
J2440
J2460
J2469
J2501
J2503
J2504
J2505
J2510
J2513
J2515
J2540
J2543
J2550
J2560
J2590
J2597
J2650
J2670
J2675
J2680
J2690
J2700
J2710
J2720
J2725
J2730
J2760
J2765
J2770
J2780
J2783
J2788
J2790
J2792
J2794
J2795
J2800
J2805
J2810
J2820
J2850
J2910
J2916
J2920
J2930
J2940
J2941
J2950
J2993
J2995
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Nandrolone decanoate 100 MG ..........................................................................................
Nandrolone decanoate 200 MG ..........................................................................................
Nesiritide injection ................................................................................................................
Octreotide injection, depot ...................................................................................................
Octreotide inj, non-depot .....................................................................................................
Oprelvekin injection .............................................................................................................
Omalizumab injection ..........................................................................................................
Orphenadrine injection .........................................................................................................
Phenylephrine hcl injection ..................................................................................................
Chloroprocaine hcl injection ................................................................................................
Ondansetron hcl injection ....................................................................................................
Oxymorphone hcl injection ..................................................................................................
Palifermin injection ...............................................................................................................
Pamidronate disodium/30 MG .............................................................................................
Papaverin hcl injection .........................................................................................................
Oxytetracycline injection ......................................................................................................
Palonosetron HCl .................................................................................................................
Paricalcitol ............................................................................................................................
Pegaptanib sodium injection ................................................................................................
Pegademase bovine, 25 iu ..................................................................................................
Injection, pegfilgrastim 6mg .................................................................................................
Penicillin g procaine inj ........................................................................................................
Pentastarch 10% solution ....................................................................................................
Pentobarbital sodium inj ......................................................................................................
Penicillin g potassium inj .....................................................................................................
Piperacillin/tazobactam ........................................................................................................
Promethazine hcl injection ...................................................................................................
Phenobarbital sodium inj .....................................................................................................
Oxytocin injection .................................................................................................................
Inj desmopressin acetate .....................................................................................................
Prednisolone acetate inj ......................................................................................................
Totazoline hcl injection ........................................................................................................
Inj progesterone per 50 MG ................................................................................................
Fluphenazine decanoate 25 MG .........................................................................................
Procainamide hcl injection ...................................................................................................
Oxacillin sodium injection ....................................................................................................
Neostigmine methylslfte inj ..................................................................................................
Inj protamine sulfate/10 MG ................................................................................................
Inj protirelin per 250 mcg .....................................................................................................
Pralidoxime chloride inj ........................................................................................................
Phentolaine mesylate inj ......................................................................................................
Metoclopramide hcl injection ...............................................................................................
Quinupristin/dalfopristin .......................................................................................................
Ranitidine hydrochloride inj .................................................................................................
Rasburicase .........................................................................................................................
Rho d immune globulin 50 mcg ..........................................................................................
Rho d immune globulin inj ...................................................................................................
Rho(D) immune globulin h, sd .............................................................................................
Risperidone, long acting ......................................................................................................
Ropivacaine HCl injection ....................................................................................................
Methocarbamol injection ......................................................................................................
Sincalide injection ................................................................................................................
Inj theophylline per 40 MG ..................................................................................................
Sargramostim injection ........................................................................................................
Inj secretin synthetic human ................................................................................................
Aurothioglucose injection .....................................................................................................
Na ferric gluconate complex ................................................................................................
Methylprednisolone injection ...............................................................................................
Methylprednisolone injection ...............................................................................................
Somatrem injection ..............................................................................................................
Somatropin injection ............................................................................................................
Promazine hcl injection ........................................................................................................
Reteplase injection ..............................................................................................................
Inj streptokinase /250000 IU ................................................................................................
N1
N1
K2
K2
N1
K2
K2
N1
N1
N1
K2
N1
K2
K2
N1
N1
K2
N1
K2
K2
K2
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
K2
N1
K2
K2
K2
K2
K2
N1
N1
N1
N1
K2
K2
N1
N1
N1
N1
K2
K2
N1
K2
K2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$31.66
$96.77
....................
$247.31
$16.95
....................
....................
....................
$3.40
....................
$11.43
$30.78
....................
....................
$16.00
....................
$1,054.70
$177.83
$2,163.33
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$117.81
....................
$132.53
$26.66
$81.48
$15.91
$4.85
....................
....................
....................
....................
$25.31
$20.31
....................
....................
....................
....................
$168.90
$47.19
....................
$899.51
$129.75
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00153
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42622
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
J2997
J3000
J3010
J3030
J3070
J3100
J3105
J3120
J3130
J3140
J3150
J3230
J3240
J3243
J3246
J3250
J3260
J3265
J3280
J3285
J3301
J3302
J3303
J3305
J3310
J3315
J3320
J3350
J3355
J3360
J3364
J3365
J3370
J3396
J3400
J3410
J3411
J3415
J3420
J3430
J3465
J3470
J3471
J3472
J3473
J3475
J3480
J3485
J3486
J3487
J3490
J3530
J3590
J7030
J7040
J7042
J7050
J7060
J7070
J7100
J7110
J7120
J7130
J7187
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Alteplase recombinant .........................................................................................................
Streptomycin injection ..........................................................................................................
Fentanyl citrate injeciton ......................................................................................................
Sumatriptan succinate / 6 MG .............................................................................................
Pentazocine injection ...........................................................................................................
Tenecteplase injection .........................................................................................................
Terbutaline sulfate inj ..........................................................................................................
Testosterone enanthate inj ..................................................................................................
Testosterone enanthate inj ..................................................................................................
Testosterone suspension inj ................................................................................................
Testosterone propionate inj .................................................................................................
Chlorpromazine hcl injection ...............................................................................................
Thyrotropin injection ............................................................................................................
Tigecycline injection .............................................................................................................
Tirofiban HCl ........................................................................................................................
Trimethobenzamide hcl inj ...................................................................................................
Tobramycin sulfate injection ................................................................................................
Injection torsemide 10 mg/ml ..............................................................................................
Thiethylperazine maleate inj ................................................................................................
Treprostinil injection .............................................................................................................
Triamcinolone acetonide inj .................................................................................................
Triamcinolone diacetate inj ..................................................................................................
Triamcinolone hexacetonl inj ...............................................................................................
Inj trimetrexate glucoronate .................................................................................................
Perphenazine injection ........................................................................................................
Triptorelin pamoate ..............................................................................................................
Spectinomycn di-hcl inj ........................................................................................................
Urea injection .......................................................................................................................
Urofollitropin, 75 iu ...............................................................................................................
Diazepam injection ..............................................................................................................
Urokinase 5000 IU injection ................................................................................................
Urokinase 250,000 IU inj .....................................................................................................
Vancomycin hcl injection .....................................................................................................
Verteporfin injection .............................................................................................................
Triflupromazine hcl inj ..........................................................................................................
Hydroxyzine hcl injection .....................................................................................................
Thiamine hcl 100 mg ...........................................................................................................
Pyridoxine hcl 100 mg .........................................................................................................
Vitamin b12 injection ...........................................................................................................
Vitamin k phytonadione inj ..................................................................................................
Injection, voriconazole .........................................................................................................
Hyaluronidase injection ........................................................................................................
Ovine, up to 999 USP units .................................................................................................
Ovine, 1000 USP units ........................................................................................................
Hyaluronidase recombinant .................................................................................................
Inj magnesium sulfate ..........................................................................................................
Inj potassium chloride ..........................................................................................................
Zidovudine ...........................................................................................................................
Ziprasidone mesylate ...........................................................................................................
Zoledronic acid ....................................................................................................................
Drugs unclassified injection .................................................................................................
Nasal vaccine inhalation ......................................................................................................
Unclassified biologics ..........................................................................................................
Normal saline solution infus ................................................................................................
Normal saline solution infus ................................................................................................
5% dextrose/normal saline ..................................................................................................
Normal saline solution infus ................................................................................................
5% dextrose/water ...............................................................................................................
D5w infusion ........................................................................................................................
Dextran 40 infusion ..............................................................................................................
Dextran 75 infusion ..............................................................................................................
Ringers lactate infusion .......................................................................................................
Hypertonic saline solution ....................................................................................................
Inj Vonwillebrand factor IU ..................................................................................................
K2
N1
N1
K2
N1
K2
N1
N1
N1
N1
N1
N1
K2
K2
K2
N1
N1
N1
N1
K2
N1
N1
N1
K2
N1
K2
K2
K2
K2
N1
N1
K2
N1
K2
N1
N1
N1
N1
N1
N1
K2
N1
N1
K2
K2
N1
N1
N1
N1
K2
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
N1
K2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$32.79
....................
....................
$59.38
....................
$2,043.40
....................
....................
....................
....................
....................
....................
$765.38
$0.91
$7.73
....................
....................
....................
....................
$55.89
....................
....................
....................
$145.26
....................
$155.44
$30.08
$74.16
$50.70
....................
....................
$457.73
....................
$8.92
....................
....................
....................
....................
....................
....................
$4.99
....................
....................
$135.04
$0.40
....................
....................
....................
....................
$206.04
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$0.88
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00154
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42623
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
J7189
J7190
J7191
J7192
J7193
J7194
J7195
J7197
J7198
J7308
J7310
J7311
J7340
J7341
J7342
J7343
J7344
J7345
J7346
J7500
J7501
J7502
J7504
J7505
J7506
J7507
J7509
J7510
J7511
J7513
J7515
J7516
J7517
J7518
J7520
J7525
J7599
J7674
J7799
J8501
J8510
J8520
J8530
J8540
J8560
J8597
J8600
J8610
J8650
J8700
J9000
J9001
J9010
J9015
J9017
J9020
J9025
J9027
J9031
J9035
J9040
J9041
J9045
J9050
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Factor viia ............................................................................................................................
Factor viii .............................................................................................................................
Factor VIII (porcine) .............................................................................................................
Factor viii recombinant ........................................................................................................
Factor IX non-recombinant ..................................................................................................
Factor ix complex ................................................................................................................
Factor IX recombinant .........................................................................................................
Antithrombin iii injection .......................................................................................................
Anti-inhibitor .........................................................................................................................
Aminolevulinic acid hcl top ..................................................................................................
Ganciclovir long act implant ................................................................................................
Fluocinolone acetonide implt ...............................................................................................
Metabolic active D/E tissue .................................................................................................
Non-human, metabolic tissue ..............................................................................................
Metabolically active tissue ...................................................................................................
Nonmetabolic act d/e tissue ................................................................................................
Nonmetabolic active tissue ..................................................................................................
Non-human, non-metab tissue ............................................................................................
Injectable human tissue .......................................................................................................
Azathioprine oral 50 mg ......................................................................................................
Azathioprine parenteral ........................................................................................................
Cyclosporine oral 100 mg ....................................................................................................
Lymphocyte immune globulin ..............................................................................................
Monoclonal antibodies .........................................................................................................
Prednisone oral ....................................................................................................................
Tacrolimus oral per 1 MG ....................................................................................................
Methylprednisolone oral .......................................................................................................
Prednisolone oral per 5 mg .................................................................................................
Antithymocyte globuln rabbit ...............................................................................................
Daclizumab, parenteral ........................................................................................................
Cyclosporine oral 25 mg ......................................................................................................
Cyclosporin parenteral 250 mg ...........................................................................................
Mycophenolate mofetil oral ..................................................................................................
Mycophenolic acid ...............................................................................................................
Sirolimus, oral ......................................................................................................................
Tacrolimus injection .............................................................................................................
Immunosuppressive drug noc .............................................................................................
Methacholine chloride, neb ..................................................................................................
Non-inhalation drug for DME ...............................................................................................
Oral aprepitant .....................................................................................................................
Oral busulfan .......................................................................................................................
Capecitabine, oral, 150 mg .................................................................................................
Cyclophosphamide oral 25 MG ...........................................................................................
Oral dexamethasone ...........................................................................................................
Etoposide oral 50 MG ..........................................................................................................
Antiemetic drug oral NOS ....................................................................................................
Melphalan oral 2 MG ...........................................................................................................
Methotrexate oral 2.5 MG ....................................................................................................
Nabilone oral ........................................................................................................................
Temozolomide .....................................................................................................................
Doxorubic hcl 10 MG vl chemo ...........................................................................................
Doxorubicin hcl liposome inj ................................................................................................
Alemtuzumab injection .........................................................................................................
Aldesleukin/single use vial ...................................................................................................
Arsenic trioxide ....................................................................................................................
Asparaginase injection .........................................................................................................
Azacitidine injection .............................................................................................................
Clofarabine injection ............................................................................................................
Bcg live intravesical vac ......................................................................................................
Bevacizumab injection .........................................................................................................
Bleomycin sulfate injection ..................................................................................................
Bortezomib injection ............................................................................................................
Carboplatin injection ............................................................................................................
Carmus bischl nitro inj .........................................................................................................
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
N1
K2
K2
K2
K2
N1
K2
N1
N1
K2
K2
N1
N1
K2
K2
K2
K2
N1
N1
N1
K2
K2
K2
N1
N1
K2
N1
N1
N1
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$1.12
$0.70
$0.75
$1.07
$0.89
$0.75
$0.99
$1.64
$1.36
$105.43
$4,752.26
$19,345.00
$28.78
$1.82
$31.66
$18.30
$89.21
$36.10
$735.38
....................
$48.44
$3.60
$317.18
$895.15
....................
$3.66
....................
....................
$327.75
$299.86
....................
....................
$2.62
$2.27
$7.22
$140.44
....................
....................
....................
$5.07
$2.14
$3.97
....................
....................
$29.60
....................
....................
....................
$16.96
$7.41
$6.31
$389.48
$541.20
$762.98
$34.17
$54.72
$4.30
$116.75
$110.67
$57.53
$35.85
$32.68
$8.46
$139.84
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00155
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42624
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
J9055
J9060
J9065
J9070
J9093
J9098
J9100
J9120
J9130
J9150
J9151
J9160
J9165
J9170
J9175
J9178
J9181
J9185
J9190
J9200
J9201
J9202
J9206
J9208
J9209
J9211
J9212
J9213
J9214
J9215
J9216
J9217
J9218
J9219
J9225
J9230
J9245
J9250
J9261
J9263
J9264
J9265
J9266
J9268
J9270
J9280
J9293
J9300
J9305
J9310
J9320
J9340
J9350
J9355
J9357
J9360
J9370
J9390
J9395
J9600
J9999
L8600
L8603
L8606
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
.......
Payment
indicator
Short descriptor
Cetuximab injection .............................................................................................................
Cisplatin 10 MG injection .....................................................................................................
Inj cladribine per 1 MG ........................................................................................................
Cyclophosphamide 100 MG inj ...........................................................................................
Cyclophosphamide lyophilized ............................................................................................
Cytarabine liposome ............................................................................................................
Cytarabine hcl 100 MG inj ...................................................................................................
Dactinomycin actinomycin d ................................................................................................
Dacarbazine 100 mg inj .......................................................................................................
Daunorubicin ........................................................................................................................
Daunorubicin citrate liposom ...............................................................................................
Denileukin diftitox, 300 mcg ................................................................................................
Diethylstilbestrol injection ....................................................................................................
Docetaxel .............................................................................................................................
Elliotts b solution per ml ......................................................................................................
Inj, epirubicin hcl, 2 mg .......................................................................................................
Etoposide 10 MG inj ............................................................................................................
Fludarabine phosphate inj ...................................................................................................
Fluorouracil injection ............................................................................................................
Floxuridine injection .............................................................................................................
Gemcitabine HCl ..................................................................................................................
Goserelin acetate implant ....................................................................................................
Irinotecan injection ...............................................................................................................
Ifosfomide injection ..............................................................................................................
Mesna injection ....................................................................................................................
Idarubicin hcl injection .........................................................................................................
Interferon alfacon–1 .............................................................................................................
Interferon alfa–2a inj ............................................................................................................
Interferon alfa–2b inj ............................................................................................................
Interferon alfa–n3 inj ............................................................................................................
Interferon gamma 1–b inj ....................................................................................................
Leuprolide acetate suspnsion ..............................................................................................
Leuprolide acetate injeciton .................................................................................................
Leuprolide acetate implant ..................................................................................................
Histrelin implant ...................................................................................................................
Mechlorethamine hcl inj .......................................................................................................
Inj melphalan hydrochl 50 MG ............................................................................................
Methotrexate sodium inj ......................................................................................................
Nelarabine injection .............................................................................................................
Oxaliplatin ............................................................................................................................
Paclitaxel protein bound ......................................................................................................
Paclitaxel injection ...............................................................................................................
Pegaspargase/singl dose vial ..............................................................................................
Pentostatin injection .............................................................................................................
Plicamycin (mithramycin) inj ................................................................................................
Mitomycin 5 MG inj ..............................................................................................................
Mitoxantrone hydrochl / 5 MG .............................................................................................
Gemtuzumab ozogamicin ....................................................................................................
Pemetrexed injection ...........................................................................................................
Rituximab cancer treatment .................................................................................................
Streptozocin injection ...........................................................................................................
Thiotepa injection .................................................................................................................
Topotecan ............................................................................................................................
Trastuzumab ........................................................................................................................
Valrubicin, 200 mg ...............................................................................................................
Vinblastine sulfate inj ...........................................................................................................
Vincristine sulfate 1 MG inj ..................................................................................................
Vinorelbine tartrate/10 mg ...................................................................................................
Injection, Fulvestrant ............................................................................................................
Porfimer sodium ...................................................................................................................
Chemotherapy drug .............................................................................................................
Implant breast silicone/eq ....................................................................................................
Collagen imp urinary 2.5 ml ................................................................................................
Synthetic implnt urinary 1ml ................................................................................................
K2
N1
K2
N1
K2
K2
N1
K2
K2
K2
K2
K2
N1
K2
N1
K2
N1
K2
N1
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
N1
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
K2
N1
N1
K2
K2
K2
N1
N1
N1
N1
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
............
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$49.81
....................
$36.12
....................
$1.99
$395.04
....................
$493.43
$5.25
$20.47
$55.92
$1,406.59
....................
$306.81
....................
$21.21
....................
$236.44
....................
$51.31
$125.16
$198.68
$126.00
$46.59
$8.97
$304.61
$4.65
$37.89
$13.88
$9.12
$289.87
$229.50
$8.88
$1,713.12
$1,460.77
$141.61
$1,284.12
....................
$83.33
$8.97
$8.73
$12.59
$1,683.49
$1,934.91
$172.41
$16.13
$168.23
$2,356.98
$43.79
$496.22
$153.73
$40.70
$830.74
$57.87
$77.96
....................
....................
$20.07
$80.56
$2,563.31
....................
....................
....................
....................
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00156
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
42625
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
mstockstill on PROD1PC66 with RULES2
HCPCS
code
Short descriptor
Payment
indicator
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
L8609 .......
L8610 .......
L8612 .......
L8613 .......
L8614 .......
L8630 .......
L8631 .......
L8641 .......
L8642 .......
L8658 .......
L8659 .......
L8670 .......
L8682 .......
L8690 .......
L8699 .......
Q0163 ......
Q0164 ......
Q0166 ......
Q0167 ......
Q0169 ......
Q0171 ......
Q0173 ......
Q0174 ......
Q0175 ......
Q0177 ......
Q0179 ......
Q0180 ......
Q0515 ......
Q1003 ......
Q2004 ......
Q2009 ......
Q2017 ......
Q3025 ......
Q4079 ......
Q4083 ......
Q4084 ......
Q4085 ......
Q4086 ......
Q9945 ......
Q9946 ......
Q9947 ......
Q9948 ......
Q9949 ......
Q9950 ......
Q9951 ......
Q9952 ......
Q9953 ......
Q9954 ......
Q9955 ......
Q9956 ......
Q9957 ......
Q9958 ......
Q9959 ......
Q9960 ......
Q9961 ......
Q9962 ......
Q9963 ......
Q9964 ......
V2630 ......
V2631 ......
V2632 ......
V2785 ......
Artificial cornea ....................................................................................................................
Ocular implant ......................................................................................................................
Aqueous shunt prosthesis ...................................................................................................
Ossicular implant .................................................................................................................
Cochlear device ...................................................................................................................
Metacarpophalangeal implant ..............................................................................................
MCP joint repl 2 pc or more ................................................................................................
Metatarsal joint implant ........................................................................................................
Hallux implant ......................................................................................................................
Interphalangeal joint spacer ................................................................................................
Interphalangeal joint repl .....................................................................................................
Vascular graft, synthetic ......................................................................................................
Implt neurostim radiofq rec ..................................................................................................
Aud osseo dev, int/ext comp ...............................................................................................
Prosthetic implant NOS .......................................................................................................
Diphenhydramine HCl 50mg ...............................................................................................
Prochlorperazine maleate 5mg ............................................................................................
Granisetron HCl 1 mg oral ..................................................................................................
Dronabinol 2.5 mg oral ........................................................................................................
Promethazine HCl 12.5 mg oral ..........................................................................................
Chlorpromazine HCl 10 mg oral ..........................................................................................
Trimethobenzamide HCl 250 mg .........................................................................................
Thiethylperazine maleate 10 mg .........................................................................................
Perphenazine 4 mg oral ......................................................................................................
Hydroxyzine pamoate 25 mg ...............................................................................................
Ondansetron HCl 8 mg oral ................................................................................................
Dolasetron mesylate oral .....................................................................................................
Sermorelin acetate injection ................................................................................................
Ntiol category 3 ....................................................................................................................
Bladder calculi irrig sol ........................................................................................................
Fosphenytoin, 50 mg ...........................................................................................................
Teniposide, 50 mg ...............................................................................................................
IM inj interferon beta 1–a ....................................................................................................
Natalizumab injection ...........................................................................................................
Hyalgan/supartz inj per dose ...............................................................................................
Synvisc inj per dose ............................................................................................................
Euflexxa inj per dose ...........................................................................................................
Orthovisc inj per dose ..........................................................................................................
LOCM ™149 mg/ml iodine, 1 ml .........................................................................................
LOCM 150–199 mg/ml iodine,1 ml ......................................................................................
LOCM 200–249 mg/ml iodine,1 ml ......................................................................................
LOCM 250–299 mg/ml iodine,1 ml ......................................................................................
LOCM 300–349 mg/ml iodine,1 ml ......................................................................................
LOCM 350–399 mg/ml iodine,1 ml ......................................................................................
LOCM ´ 400 mg/ml iodine,1 ml .........................................................................................
Inj Gad-base MR contrast,1 ml ...........................................................................................
Inj Fe-based MR contrast,1 ml ............................................................................................
Oral MR contrast, 100 ml ....................................................................................................
Inj perflexane lip micros, ml .................................................................................................
Inj octafluoropropane mic, ml ..............................................................................................
Inj perflutren lip micros, ml ..................................................................................................
HOCM ™149 mg/ml iodine, 1ml ..........................................................................................
HOCM 150–199 mg/ml iodine, 1ml .....................................................................................
HOCM 200–249 mg/ml iodine, 1 ml ....................................................................................
HOCM 250–299 mg/ml iodine, 1ml .....................................................................................
HOCM 300–349 mg/ml iodine, 1 ml ....................................................................................
HOCM 350–399 mg/ml iodine, 1ml .....................................................................................
HOCM´ 400 mg/ml iodine, 1 ml .........................................................................................
Anter chamber intraocul lens ...............................................................................................
Iris support intraoclr lens .....................................................................................................
Post chmbr intraocular lens .................................................................................................
Corneal tissue processing ...................................................................................................
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
J7 .............
N1 ............
N1 ............
N1 ............
K2 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
K2 ............
K2 ............
K2 ............
L6 ............
N1 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
K2 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
N1 ............
F4 ............
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
$44.87
....................
....................
....................
....................
....................
....................
....................
$36.55
$47.52
$1.75
$50.00
....................
$5.66
$264.09
$114.57
$7.52
$104.85
$186.66
$115.16
$198.34
$0.42
$1.95
$1.33
$0.36
$0.37
$0.22
$0.22
$2.82
$30.41
$8.82
$12.96
$49.61
$61.55
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
....................
——————————
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00157
Fmt 4742
Sfmt 4742
E:\FR\FM\02AUR2.SGM
02AUR2
42626
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 / Rules and Regulations
ADDENDUM BB.—ILLUSTRATIVE ASC COVERED ANCILLARYSERVICES INTEGRAL TO COVERED SURGICAL PROCEDURES
FOR CY 2008 (INCLUDING ANCILLARY SERVICES FOR WHICH PAYMENT IS PACKAGED)—Continued
HCPCS
code
Short descriptor
Payment
indicator
Estimated
CY 2008
payment
weights
Estimated
CY 2008
payment
V2790 ......
Amniotic membrane .............................................................................................................
N1 ............
....................
....................
Note: The Medicare program payment is 80 percent of the total payment amount and beneficiary coinsurance is 20 percent of the total payment amount, except for screening flexible
sigmoidoscopies and screening colonoscopies for which the program payment is 75 percent and the beneficiary coinsurance is 25 percent.
ADDENDUM DD1.—ILLUSTRATIVE ASC PAYMENT INDICATORS
Indicator
Payment indicator definition
A2 ............
F4 ............
G2 ............
H7 ............
H8 ............
J7 .............
J8 .............
K2 ............
K7 ............
L6 .............
N1 ............
P2 ............
Surgical procedure on ASC list in CY 2007; payment based on OPPS relative payment weight.
Corneal tissue acquisition; paid at reasonable cost.
Non office-based surgical procedure added to ASC list in CY 2008 or later; payment based on OPPS relative payment weight.
Brachytherapy source paid separately when provided integral to a surgical procedure on ASC list; payment contractor-priced.
Device-intensive procedure on ASC list in CY 2007; paid at adjusted rate.
OPPS pass-through device paid separately when provided integral to a surgical procedure on ASC list; payment contractor-priced.
Device-intensive procedure added to ASC list in CY 2008 or later; paid at adjusted rate.
Drugs and biologicals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate.
Unclassified drugs and biologicals; payment contractor-priced.
New Technology Intraocular Lens (NTIOL); special payment.
Packaged procedure/item; no separate payment made.
Office-based surgical procedure added to ASC list in CY 2008 or later with MPFS nonfacility PE RVUs; payment based on OPPS
relative payment weight.
Office-based surgical procedure added to ASC list in CY 2008 or later with MPFS nonfacility PE RVUs; payment based on MPFS
nonfacility PE RVUs.
Office-based surgical procedure added to ASC list in CY 2008 or later without MPFS nonfacility PE RVUs; payment based on
OPPS relative payment weight.
Radiology service paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS relative
payment weight.
Radiology service paid separately when provided integral to a surgical procedure on ASC list; payment based on MPFS nonfacility
PE RVUs.
P3 ............
R2 ............
Z2 ............
Z3 ............
[FR Doc. 07–3490 Filed 7–16–07; 4:00 pm]
mstockstill on PROD1PC66 with RULES2
BILLING CODE 4120–01–P
VerDate Aug<31>2005
16:08 Aug 01, 2007
Jkt 211001
PO 00000
Frm 00158
Fmt 4701
Sfmt 4701
E:\FR\FM\02AUR2.SGM
02AUR2
Agencies
[Federal Register Volume 72, Number 148 (Thursday, August 2, 2007)]
[Rules and Regulations]
[Pages 42470-42626]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-3490]
[[Page 42469]]
-----------------------------------------------------------------------
Part II
Department of Health and Human Services
-----------------------------------------------------------------------
Centers for Medicare & Medicaid Services
-----------------------------------------------------------------------
42 CFR Parts 410 and 416
Medicare Program; Revised Payment System Policies for Services
Furnished in Ambulatory Surgical Centers (ASCs) Beginning in CY 2008;
Final Rule
Federal Register / Vol. 72, No. 148 / Thursday, August 2, 2007 /
Rules and Regulations
[[Page 42470]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Parts 410 and 416
[CMS-1517-F]
RIN 0938-AO73
Medicare Program; Revised Payment System Policies for Services
Furnished in Ambulatory Surgical Centers (ASCs) Beginning in CY 2008
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This final rule revises the Medicare ambulatory surgical
center (ASC) payment system to implement certain related provisions of
the Medicare Prescription Drug, Improvement, and Modernization Act of
2003 (MMA). This final rule establishes the ASC list of covered
surgical procedures, identifies covered ancillary services under the
revised ASC payment system, and sets forth the amounts and factors that
will be used to determine the ASC payment rates for calendar year (CY)
2008. The changes to the ASC payment system and ratesetting methodology
in this final rule are applicable to services furnished on or after
January 1, 2008.
DATES: Effective Date: This final rule is effective on January 1, 2008.
FOR FURTHER INFORMATION, CONTACT: Alberta Dwivedi, (410) 786-0378. Dana
Burley, (410) 786-0378.
SUPPLEMENTARY INFORMATION:
Electronic Access
This Federal Register document is also available from the Federal
Register online database through GPO Access, a service of the U.S.
Government Printing Office. Free public access is available on a Wide
Area Information Server (WAIS) through the Internet and via
asynchronous dial-in. Internet users can access the database by using
the World Wide Web; the Superintendent of Documents' home page address
is https://www.gpoaccess.gov/, by using local WAIS client
software, or by telnet to swais.access.gpo.gov, then login as guest (no
password required). Dial-in users should use communications software
and modem to call (202) 512-1661; type swais, then login as guest (no
password required).
Alphabetical List of Acronyms Appearing in This Final Rule
AHA American Hospital Association
AMA American Medical Association
APC Ambulatory payment classification
ASC Ambulatory surgical center
BESS [Medicare] Part B Extract Summary System
CAH Critical access hospital
CBSA Core-Based Statistical Area
CMS Centers for Medicare & Medicaid Services
CPI-U Consumer Price Index for All Urban Consumers
CPT [Physicians'] Current Procedural Terminology, Fourth Edition,
2007, copyrighted by the American Medical Association. CPT[supreg]
is a trademark of the American Medical Association.
CY Calendar year
DRA Deficit Reduction Act of 2005, Public Law 109-171
FY Federal fiscal year
GAO Government Accountability Office
HCPCS Healthcare Common Procedure Coding System
HOPD Hospital outpatient department
HQA Hospital Quality Alliance
IOL Intraocular lens
IPPS [Hospital] Inpatient prospective payment system
MAC Medicare administrative contractor
MedPAC Medicare Payment Advisory Commission
MMA Medicare Prescription Drug, Improvement, and Modernization Act
of 2003, Public Law 108-173
MPFS Medicare Physician Fee Schedule
MSA Metropolitan Statistical Area
NTIOL New technology intraocular lens
OCE Outpatient Code Editor
OMB Office of Management and Budget
OPPS [Hospital] Outpatient prospective payment system
PM Program memorandum
PPAC Practicing Physicians Advisory Council
PPS Prospective payment system
PRA Paperwork Reduction Act of 1995
RFA Regulatory Flexibility Act
RVU Relative value unit
To assist readers in referencing sections contained in this
document, we are providing the following table of contents:
Table of Contents
I. Background
A. Legislative and Regulatory History
B. ASC Payment Method
C. Provisions of Public Law 108-173 (MMA)
D. Issuance of Proposed Rule
E. Changes to the ASC List for CY 2007
II. Revisions to the ASC Payment System Effective January 1, 2008
A. General
B. Factors Considered in the Development of the Revised ASC
Payment System
C. Rulemaking for the Revised ASC Payment System in CY 2008
III. Covered Surgical Procedures Paid in ASCs On or After January 1,
2008
A. Payable Procedures
1. Definition of Surgical Procedure
2. Procedures Excluded From Payment Under the Revised ASC
Payment System
a. Significant Safety Risk
b. Overnight Stay
B. Treatment of Unlisted Procedure Codes and Procedures That Are
Not Paid Separately Under the OPPS
C. Treatment of Office-Based Procedures
D. Specific Surgical Procedures Excluded From Payment Under the
Revised ASC Payment System
IV. Ratesetting Methodology for the Revised ASC Payment System
A. Overview of Current ASC Payment System
B. ASC Relative Payment Weights Based on APC Groups and Relative
Payment Weights Established Under the OPPS
C. Packaging Policy
1. General Policy
2. Policies for Specific Items and Services
a. Radiology Services
b. Brachytherapy Sources
c. Drugs and Biologicals
d. Implantable Devices With Pass-Through Status Under the OPPS
e. Implantable Devices Without Pass-Through Status Under the
OPPS
D. Payment for Corneal Tissue Under the Revised ASC Payment
System
E. Payment for Office-Based Procedures
F. Payment Policies for Multiple and Interrupted Procedures
1. Multiple Procedure Discounting Policy
2. Interrupted Procedure Policies
G. Geographic Adjustment
H. Adjustment for Inflation
I. Beneficiary Coinsurance
J. Phase-In of Full Implementation of Payment Rates Calculated
Under the Revised ASC Payment System Methodology
V. Calculation of ASC Conversion Factor and ASC Payment Rates for CY
2008
A. Overview
B. Budget Neutrality Requirement
C. Calculation of the ASC Payment Rates for CY 2008
1. Proposed Method for Calculation of the ASC Payment Rates for
CY 2008 in the August 2006 Proposed Rule
a. Estimated Medicare Program Payments (Excluding Beneficiary
Coinsurnace) Under the Current ASC Payment System in the August 2006
Proposed Rule
b. Estimated Medicare Program Payments (Excluding Beneficiary
Coinsurance) Under the Proposed Revised ASC Payment System in the
August 2006 Proposed Rule
c. Calculation of the Proposed CY 2008 Budget Neutrality
Adjustment in the August 2006 Proposed Rule
d. Application of the Budget Neutrality Adjustment To Determine
the Proposed CY 2008 ASC Conversion Factor in the August 2006
Proposed Rule
e. Calculation of the Proposed CY 2008 ASC Payment Rates Under
the Revised ASC Payment System in the August 2006 Proposed Rule
f. Calculation of the Proposed CY 2008 ASC Payment Rates Under
the Transition in the August 2006 Proposed Rule
2. Alternative Option for Calculating the Proposed Budget
Neutrality Adjustment in the August 2006 Proposed Rule
a. Estimated Medicare Program Payments (Excluding Beneficiary
Coinsurance)
[[Page 42471]]
Under the Existing ASC Payment System in the August 2006 Proposed
Rule
b. Estimated Medicare Program Payments (Excluding Beneficiary
Coinsurance) Under the Proposed Revised ASC Payment System in the
August 2006 Proposed Rule
c. Calculation of the Proposed CY 2008 Budget Neutrality
Adjustment in the August 2006 Proposed Rule
d. Discussion of the Alternative Calculation of the Budget
Neutrality Adjustment
3. Calculation of the Estimated CY 2008 Budget Neutrality
Adjustment According to the Final Policy
4. Final Calculation of the Estimated ASC Payment Rates for CY
2008
a. Estimated CY 2008 Medicare Program Payments (Excluding
Beneficiary Coinsurance) Under the Existing ASC Payment System
b. Estimated Medicare Program Payments (Excluding Beneficiary
Coinsurance) Under the Revised ASC Payment System
c. Calculation of the Final Estimated CY 2008 Budget Neutrality
Adjustment
d. Calculation of the Final Estimated CY 2008 ASC Payment Rates
D. Calculation of the ASC Payment Rates for CY 2009 and Future
Years
1. Updating the ASC Relative Payment Weights
2. Updating the ASC Conversion Factor
E. Annual Updates
VI. Information in Addenda Related to the Revised CY 2008 ASC
Payment System
VII. ASC Regulatory Changes
A. Regulatory Changes That Were Finalized in the CY 2007 OPPS/
ASC Final Rule With Comment Period
B. Regulatory Changes Included in This Final Rule
VIII. Files Available to the Public Via the Internet
IX. Collection of Information Requirements
X. Regulatory Impact Analysis
A. Overall Impact
1. Executive Order 12866
2. Regulatory Flexibility Act
3. Small Rural Hospitals
4. Unfunded Mandates
5. Federalism
B. Effects of the Revisions to the ASC Payment System for CY
2008
1. Alternatives Considered
2. Limitations of Our Analysis
3. Estimated Effects of This Final Rule on ASCs
4. Estimated Effects of This Final Rule on Beneficiaries
5. Conclusion
6. Accounting Statement
C. Executive Order 12866
Regulation Text
Addendum AA.--Illustrative ASC Covered Surgical Procedures for CY
2008 (Including Surgical Procedures for Which Payment Is Packaged)
Addendum BB.--Illustrative ASC Covered Ancillary Services Integral
to Covered Surgical Procedures for CY 2008 (Including Ancillary
Services for Which Payment Is Packaged)
Addendum DD1.--Illustrative ASC Payment Indicators
I. Background
A. Legislative and Regulatory History
Section 1832(a)(2)(F)(i) of the Social Security Act (the Act)
provides that benefits under the Medicare Supplementary Medical
Insurance program (Part B) include payment for facility services
furnished in connection with surgical procedures specified by the
Secretary that are performed in an ambulatory surgical center (ASC). To
participate in the Medicare program as an ASC, a facility must meet the
standards specified in section 1832(a)(2)(F)(i) of the Act, which are
implemented in 42 CFR Part 416, Subpart B and Subpart C of our
regulations. The regulations at 42 CFR 416, Subpart B set forth general
conditions and requirements for ASCs, and the regulations at Subpart C
provide specific conditions for coverage for ASCs.
The ASC services benefit was enacted by Congress through the
Omnibus Reconciliation Act of 1980 (Pub. L. 96-499). For a detailed
discussion of the legislative history related to ASCs, we refer readers
to the June 12, 1998 proposed rule (63 FR 32291).
Section 1833(i)(1)(A) of the Act requires the Secretary to specify
surgical procedures that, although appropriately performed in an
inpatient hospital setting, also can be performed safely on an
ambulatory basis in an ASC, critical access hospital (CAH), or a
hospital outpatient department (HOPD). The report accompanying the
legislation explained that Congress intended procedures currently
performed on an ambulatory basis in a physician's office that do not
generally require the more elaborate facilities of an ASC not be
included in the list of ASC covered procedures (H.R. Rep. No. 96-1167,
at 390-91, reprinted in 1980 U.S.C.C.A.N. 5526, 5753-54). In a final
rule published on August 5, 1982, in the Federal Register (47 FR
34082), we established regulations that included criteria for
specifying which surgical procedures were to be included for purposes
of implementing the ASC facility benefit. Medicare only allows payment
to ASCs for procedures that are specified on the ASC list.
Section 626(b) of the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003, Public Law 108-173, repealed the requirement
formerly found in section 1833(i)(2)(A) of the Act that the Secretary
conduct a survey of ASC costs for purposes of updating ASC payment
rates and, instead, requires the Secretary to implement a revised ASC
payment system, to be effective not later than January 1, 2008. Section
5103 of the Deficit Reduction Act of 2005 (DRA), Public Law 109-171,
amended section 1833(i)(2) of the Act by adding a new subparagraph (E)
to place a limitation on payments for surgical procedures in ASCs.
Section 1833(i)(2) of the Act provides that if the standard overhead
amount under section 1833(i)(2)(A) of the Act for a facility service
for such procedure, without application of any geographic adjustment,
exceeds the Medicare payment amount under the hospital outpatient
prospective payment system (OPPS) for the service for that year,
without application of any geographic adjustment, the Secretary shall
substitute the OPPS payment amount for the ASC standard overhead
amount. This provision applies to surgical procedures furnished in ASCs
on or after January 1, 2007, and before the effective date of the
revised ASC payment system implemented in this final rule.
In the November 24, 2006 final rule with comment period for the CY
2007 OPPS and ASC payment systems (71 FR 67960), we addressed the
changes in payment to ASCs mandated by section 5103 of Public Law 109-
171 and finalized Sec. 416.1(a)(5) of the regulations to implement
this provision. (Hereinafter, the November 24, 2006 final rule with
comment period is referred to as the CY 2007 OPPS/ASC final rule with
comment period.) We also addressed additions to and deletions from the
ASC list of covered surgical procedures that were implemented on
January 1, 2007. In addition, we made changes in the process to review
payment adjustments for insertion of new technology intraocular lenses
(NTIOLs) under section 1833(i)(2)(A)(iii) of the Act.
Section 416.65(a) of the regulations specifies general standards
for procedures on the ASC list. ASC procedures are those surgical and
other medical procedures that are--
Commonly performed on an inpatient basis but may be safely
performed in an ASC;
Not of a type that are commonly performed or that may be
safely performed in physicians' offices;
Limited to procedures requiring a dedicated operating room
or suite and generally requiring a postoperative recovery room or
short-term (not overnight) convalescent room; and
Not otherwise excluded from Medicare coverage.
Specific standards in Sec. 416.65(b) limit covered ASC procedures
to those that do not generally exceed 90 minutes operating time and a
total of 4 hours recovery or convalescent time. If
[[Page 42472]]
anesthesia is required, the anesthesia must be local or regional
anesthesia, or general anesthesia of not more than 90 minutes duration.
Section 416.65(b)(3) of the regulations excludes from the ASC list
procedures that generally result in extensive blood loss, that require
major or prolonged invasion of body cavities, that directly involve
major blood vessels, or that are generally emergency or life-
threatening in nature.
A detailed history of published changes to the ASC list and ASC
payment rates can be found in the June 12, 1998 proposed rule (63 FR
32291). Subsequently, in accordance with Sec. 416.65(c), we published
updates of the ASC list in the Federal Register on March 28, 2003 (68
FR 15268), May 4, 2005 (70 FR 23690), and in the CY 2007 OPPS/ASC final
rule with comment period (71 FR 67960).
During years when we have not updated the ASC list in the Federal
Register, we have revised the list to be consistent with annual
calendar year changes to the Healthcare Common Procedure Coding System
(HCPCS) and Current Procedural Terminology (CPT) codes. These annual
coding updates have been implemented through program instructions to
the carriers that process ASC claims. (We note that Medicare Part B
carriers are transitioning to Medicare Administrative Contractors
(MACs) through 2011, as described in a final rule with comment period
published in the Federal Register on November 24, 2006 (71 FR 68229).)
We last issued program instructions to update the list only to conform
to CPT and HCPCS coding changes on December 20, 2006, via Transmittal
1134, Change Request 5211. This transmittal can be found on the CMS Web
site at: https://www.cms.hhs.gov/Transmittals/).
B. ASC Payment Method
On August 23, 2006, we proposed in the Federal Register (71 FR
49635) a revised payment system for ASCs to be implemented effective
January 1, 2008, in accordance with section 626(b) of Public Law 108-
173, including revisions to the ratesetting methodology and the
applicable ASC regulations to incorporate the requirements and payments
for ASC services under the revised ASC payment system. We also proposed
a new ``exclusionary'' approach for revising the ASC list of covered
surgical procedures beginning CY 2008. We proposed to evaluate surgical
procedures to identify those that could pose a significant safety risk
or that would be expected to require an overnight stay when performed
in ASCs, and that would, therefore, be excluded from Medicare payment
under the revised ASC payment system. Using that exclusionary method,
we developed a list of surgical procedures that we believed were safe
for Medicare beneficiaries in ASCs and that were appropriate for
Medicare payment. We proposed to adopt an exclusionary approach for
identifying surgical procedures that were appropriate for payment under
the revised ASC payment system, and the result of that process was a
proposed list of surgical procedures for which separate payment would
be made. We refer to that list of payable procedures hereinafter as the
ASC ``list of covered surgical procedures.''
There are two primary elements in the total cost of performing a
surgical procedure: (a) The cost of the physician's professional
services to perform the procedure; and (b) the cost of items and
services furnished by the facility where the procedure is performed
(for example, surgical supplies, equipment, and nursing services).
Payment for the first element is made under the Medicare Physician Fee
Schedule (MPFS). The August 2006 OPPS/ASC proposed rule addressed the
second element, payment for the cost of items and services furnished by
the facility.
Under the current ASC payment system, the ASC payment rate is a
standard overhead amount established on the basis of our estimate of a
fee that takes into account the costs incurred by ASCs generally in
providing facility services in connection with performing a specific
procedure. The report of the Conference Committee accompanying section
934 of the Omnibus Reconciliation Act of 1980 states that this overhead
amount is expected to be calculated on a prospective basis using sample
survey data and similar techniques to establish reasonable estimated
overhead allowances, which take into account volume (within reasonable
limits), for each of the listed procedures (H.R. Rept. No. 96-1479, at
134-35 (1980)).
As stated earlier, to establish those reasonable estimated
allowances for services furnished prior to implementation of the
revised ASC payment system, section 626(b)(1) of Public Law 108-73
amended section 1833(i)(2)(A)(i) of the Act that required us to take
into account the audited costs incurred by ASCs to perform a procedure
in accordance with a survey. Further, beginning January 1, 2007, and
prior to implementation of a revised ASC payment system, in accordance
with section 5103 of Pub. L. 109-171, no ASC standard overhead amount
may be greater than the OPPS payment rate for a given service for that
year. Except for screening colonoscopies and flexible sigmoidoscopies,
payment for ASC services is subject to the usual Medicare Part B
deductible and coinsurance requirements, and the amounts paid by
Medicare must be 80 percent of the standard overhead amount. As
required by section 1834(d) of the Act and implemented in regulations
at 42 CFR 410.152(i), the amount paid by Medicare must be 75 percent of
the fee schedule payment amount for screening colonoscopies and
flexible sigmoidoscopies.
Section 1833(i)(1) of the Act requires us to specify, in
consultation with appropriate medical organizations, surgical
procedures that are appropriately performed on an inpatient basis in a
hospital but that can be safely performed in an ASC, a CAH, or an HOPD
and to review and update the list of ASC procedures at least every 2
years.
Section 141(b) of the Social Security Act Amendments of 1994,
Public Law 103-432, requires us to establish a process for reviewing
the appropriateness of the payment amount provided under section
1833(i)(2)(A)(iii) of the Act for intraocular lenses (IOLs) that belong
to a class of NTIOLs. That process was the subject of a separate final
rule entitled ``Adjustment in Payment Amounts for New Technology
Intraocular Lenses Furnished by Ambulatory Surgical Centers,''
published on June 16, 1999, in the Federal Register (64 FR 32198). We
proposed changes to the NTIOL request for review process in the CY 2007
OPPS/ASC proposed rule published in the Federal Register on August 23,
2006 (71 FR 49631 through 49635) and finalized changes to that process
in the CY 2007 OPPS/ASC final rule with comment period (71 FR 68175
through 68181).
C. Provisions of Public Law 108-173 (MMA)
Section 626(a) of Public Law 108-173 (MMA) amended section
1833(i)(2)(C) of the Act, which requires the Secretary to update ASC
payment rates using the Consumer Price Index for All Urban Consumers
(CPI-U) (U.S. city average) if the Secretary has not otherwise updated
the amounts under the revised ASC payment system. As amended by Pub. L.
108-173, section 1833(i)(2)(C) of the Act requires that, if the
Secretary is required to apply the CPI-U increase, the CPI-U percentage
increase is to be applied on a fiscal year (FY) basis beginning with FY
1986 through FY 2005 and on a
[[Page 42473]]
calendar year (CY) basis beginning with CY 2006.
Section 626(a) of Public Law 108-173 further amended section
1833(i)(2)(C) of the Act to require us in FY 2004, beginning April 1,
2004, to increase the ASC payment rates using the CPI-U as estimated
for the 12-month period ending March 31, 2003, minus 3.0 percentage
points. Section 626(a) of Public Law 108-173 also requires that the
CPI-U adjustment factor equal zero percent in FY 2005, the last quarter
of CY 2005, and each calendar year from CY 2006 through CY 2009.
Section 626(b) of Public Law 108-173 repealed the requirement that
CMS conduct a survey of ASC costs upon which to base a standard
overhead payment amount for surgical services performed in ASCs, and
added section 1833(i)(2)(D) of the Act. Section 1833(i)(2)(D)(iii) of
the Act requires us to implement by no earlier than January 1, 2006,
and not later than January 1, 2008, a revised ASC payment system. The
revised payment system under section 1833(i)(2)(D)(i) of the Act is to
take into account the recommendations contained in a Report to Congress
that the Government Accountability Office (GAO) was required to submit
by January 1, 2005. Section 1833(i)(2)(D)(ii) of the Act requires that
the revised ASC payment system be designed to result in the same
aggregate amount of expenditures for surgical services furnished in
ASCs the year the system is implemented as would be made if the new
system did not apply as estimated by the Secretary. This requirement is
to take into account the limitation in ASC expenditures resulting from
implementation of section 5103 of Public Law 109-171 beginning January
1, 2007, as we described in sections XVII.A.1. and XVII.E. of the
preamble to the CY 2007 OPPS/ASC final rule with comment period (71 FR
68165 and 68174, respectively).
Section 1833(i)(2)(D)(iv) of the Act exempts the classification
system, relative weights, payment amounts, and geographic adjustment
factor (if any) under the revised ASC payment system from
administrative and judicial review.
Section 626(c) of Public Law 108-173 added a conforming amendment
to section 1833(a)(1) of the Act, which provides that the amounts paid
under the revised ASC payment system shall equal 80 percent of the
lesser of the actual charge for the services or the payment amount that
we determine under the revised ASC payment system.
D. Issuance of Proposed Rule
As stated earlier, in the August 23, 2006 Federal Register (71 FR
49635), we proposed to implement revisions to the ASC payment system so
that the revised system is first effective on January 1, 2008.
In addition, we set forth an analysis of the impact that the
proposed revised ASC payment system would have on affected entities and
Medicare beneficiaries.
We received over 8,900 pieces of correspondence in response to our
August 23, 2006 proposal for the revised ASC payment system, which
included some comments recommending various changes to how CMS pays for
ASC services and processes ASC claims that we did not propose in the
August 23, 2006 Federal Register. While we read those comments with
interest, we generally do not address them, nor have we made any
changes in this final rule based on them. We summarize the numerous
comments and recommendations that are pertinent to what we proposed,
and we respond to them in the appropriate sections of this final rule.
E. Changes to the ASC List for CY 2007
As part of the CY 2007 OPPS/ASC final rule with comment period, we
finalized additions to and deletions from the ASC list of covered
surgical procedures, effective January 1, 2007 (71 FR 68166). We did
not change the criteria for adding or deleting items from the ASC list
effective January 1, 2007. However, in the August 2006 proposed rule
(71 FR 49628), we discussed changes to the criteria in the context of
developing the proposed revised ASC payment system to be effective
January 1, 2008. The changes to the criteria that we proposed resulted
in the proposed addition for CY 2008 of many procedures that do not
meet the current criteria for addition to the list.
II. Revisions to the ASC Payment System Effective January 1, 2008
A. General
As we discussed earlier, generally, there are two primary elements
in the total cost of performing a surgical procedure: (a) The cost of
the physician's professional services for performing the procedure; and
(b) the cost of services furnished by the facility where the procedure
is performed (for example, surgical supplies, equipment, nursing
services, and overhead). The former is covered by the MPFS. The latter
is covered by a Medicare benefit enacted in 1980 that authorized
payment of a fee to ASCs for services furnished in connection with
performing certain surgical procedures.
Section 1833(i)(1) of the Act requires us to specify surgical
procedures that are appropriately and safely performed on an ambulatory
basis in an ASC. Moreover, we are required to review and update the
list of these procedures not less often than every 2 years, in
consultation with appropriate trade and professional associations. The
ASC list of covered surgical procedures was limited in 1982 to
approximately 100 procedures. Currently, the list consists of more than
2,500 CPT codes encompassing a cross-section of surgical services,
although 150 of these codes account for more than 90 percent of the
approximately 4.5 million procedures paid for each year under the ASC
Part B benefit. Eye, pain management, and gastrointestinal endoscopic
procedures are the highest volume ASC surgeries performed under the
present ASC payment system.
In CY 2007, Medicare only allows payment to ASCs for procedures on
the ASC list of covered surgical procedures. Except for screening
colonoscopy services, payment for ASC facility services is subject to
the usual Medicare Part B deductible and coinsurance requirements, and
the amounts paid by Medicare must be 80 percent of the standard
overhead amount. As discussed earlier, under section 626(b) of Public
Law 108-173, Congress mandated implementation of a revised payment
system for ASC surgical services by no later than January 1, 2008.
Public Law 108-173 set forth several requirements for the revised
payment system, but did not amend those provisions of the statute
pertaining to the ASC list.
As we proposed in the August 2006 proposed rule (71 FR 49635), in
this final rule, we address two components of the ASC payment system
that will go into effect January 1, 2008. First, we are establishing
the ASC list of covered surgical procedures for which an ASC may
receive Medicare payment for facility services under the revised ASC
payment system, as well as those covered ancillary services that may be
separately paid if they are provided integral to a covered surgical
procedure. Second, we are specifying the method we will use to set
payment rates for ASC services furnished in association with covered
surgical procedures. In this final rule, we also specify the regulatory
changes that we are making to 42 CFR Parts 410 and 416 to incorporate
the rules governing ASC payments that will be applicable beginning in
CY 2008.
[[Page 42474]]
B. Factors Considered in the Development of the Revised ASC Payment
System
On August 2, 2005, we convened a listening session teleconference
on revising the Medicare ASC payment system. Over 450 callers
participated, including ASC staff, physicians, and representatives of
industry trade associations. The listening session provided an
opportunity for participants to identify the issues and concerns that
they wanted us to address as we developed the revised ASC payment
system.
Callers encouraged us to foster beneficiary access to ASCs by
creating incentives for physicians to use ASCs. The issues raised by
participants included suggestions to expand or eliminate altogether the
ASC list, recommendations to model payment on the OPPS, and concerns
about how we would propose to treat the geographic wage index
adjustment and the annual ASC payment rate update. Several callers also
raised concerns about ensuring adequate payment for supplies, ancillary
services, and implantable devices under the revised payment system, as
well as developing a process to allow special payment for new
technology.
We also met with representatives of the ASC industry over the past
several years to discuss options for ratesetting other than conducting
a survey, to discuss timely updates to the ASC list, and to listen to
industry concerns related to the implementation of a revised payment
system. We appreciate the thoughtful suggestions that were presented.
We considered the concerns and issues brought to our attention, the
proposals for revising the ASC list of covered surgical procedures, and
the suggested methods by which we could set ASC payment rates in
developing the policies in this final rule.
In the August 23, 2006 Federal Register (71 FR 49506), we proposed
the policies for the revised ASC payment system to be effective
beginning in CY 2008. In response to those proposed policies, we
received over 8,900 pieces of correspondence from the public that we
are addressing in this final rule.
Subsequent to publication of the August 2006 proposed rule for the
revised ASC payment system, the GAO published the statutorily mandated
report entitled, ``Medicare: Payment for Ambulatory Surgical Centers
Should Be Based on the Hospital Outpatient Payment System'' (GAO-07-86)
on November 30, 2006. We considered the report's methodology, findings,
and recommendations in the development of this CY 2008 final rule for
the revised ASC payment system. The GAO methodology, results, and
recommendations are summarized below.
The GAO was directed to conduct a study comparing the relative
costs of procedures furnished in ASCs to those furnished in HOPDs paid
under the OPPS, including examining the accuracy of the ambulatory
payment classifications (APC) with respect to surgical procedures
furnished in ASCs. Section 626(d) of Pub. L. 108-173 indicated that the
report should include recommendations on the following matters:
1. Appropriateness of using groups of covered services and relative
weights established for the OPPS as the basis of payment for ASCs.
2. If the OPPS relative weights are appropriate for this purpose,
whether the ASC payments should be based on a uniform percentage of the
payment rates or weights under the OPPS, or should vary, or the weights
should be revised based on specific procedures or types of services.
3. Whether a geographic adjustment should be used for ASC payment
and, if so, the labor and nonlabor shares of such payment.
To compare the relative costs of procedures performed in ASCs and
HOPDs, the GAO first compiled information on ASCs' costs and the
surgical procedures performed. It conducted a survey of 600 randomly
selected ASCs from the universe of all ASCs to obtain their CY 2004
cost and procedure data. The GAO received 397 responses from facilities
and, through data reliability testing, determined that data from 290
responding facilities were sufficiently reliable and geographically
representative of ASCs. Furthermore, to compare the delivery of
surgical procedures and their relative costs between ASC and HOPD
settings, the GAO analyzed OPPS claims data from CY 2003. It also
interviewed officials at CMS, representatives from ASC industry
organizations and physician specialty societies, and representatives
from nine ASCs.
In order to allocate ASCs' total costs among the individual
procedures they performed, the GAO developed a specific methodology to
allocate the portion of an ASC's costs accounted for by each procedure.
It constructed a relative weight scale for Medicare's covered ASC
procedures that captured the general variation in resources associated
with performing different procedures. Primarily, it used data that CMS
collects for the purpose of setting the practice expense component of
physician payment rates, supplemented by information from specialty
societies and physicians who work for CMS for those procedures for
which CMS had no data on the resources used.
To calculate per-procedure costs based upon data gathered through
its survey of ASCs, the GAO deducted costs that Medicare considers
unallowable, that is, advertising and entertainment costs. In addition,
it also removed costs for services that Medicare pays for separately,
such as physician and nonphysician practitioner services. The remaining
facility costs were then divided into direct and indirect costs. The
GAO defined direct costs as those associated with the clinical staff,
equipment, and supplies utilized during the procedure. Indirect costs
included all remaining costs. Next, to allocate each facility's direct
costs across the procedures it performed, the GAO applied its relative
weight scale. It allocated indirect costs equally across all procedures
performed by the facility. For each procedure performed by a responding
ASC facility, it summed the allocated direct and indirect costs to
determine a total cost for the procedure. To obtain a per-procedure
cost across all ASCs, the GAO arrayed the calculated costs for all ASCs
performing that procedure and identified the median cost.
To compare per-procedure costs for ASCs and HOPDs, the GAO obtained
the list of OPPS APCs and their assigned procedures, along with the
OPPS median cost of each procedure and its related APC group. It then
calculated a ratio between each procedure's ASC median cost as
determined by the survey and the median cost of the procedure's
corresponding APC group under the OPPS, referred to as the ASC-to-APC
cost ratio. It calculated a corresponding ratio between each ASC
procedure's median cost under the OPPS and the median cost of the
procedure's APC group using CMS data, referred to as the OPPS-to-APC
cost ratio. In order to evaluate the difference in procedure costs
between the two settings, the GAO compared the ASC-to-APC cost ratio to
the OPPS-to-APC cost ratio. Next, to assess how well the relative costs
of procedures in the OPPS, defined by their assignment to APC groups,
reflect the relative costs of procedures in the ASC setting, it
evaluated the distribution of both the ASC-to-APC cost ratios and the
OPPS-to-APC cost ratios.
The GAO also analyzed Medicare claims data for the top 20
procedures with the highest Medicare ASC claims volume in CY 2004 to
examine the delivery of additional services with
[[Page 42475]]
surgical procedures in ASCs and HOPDs. Last, to calculate the
percentage of labor-related costs among the responding ASCs, for each
ASC, the GAO divided total labor costs by total costs and then
determined the range of the percentage of labor-related costs among all
of the ASCs between the 25th and the 75th percentile, as well as the
mean and median percentage of labor-related costs.
Based on its extensive analyses, the GAO determined that the APC
groups in the OPPS accurately reflect the relative costs of the
procedures performed in ASCs. GAO's analysis of the cost ratios showed
that the ASC-to-APC cost ratios were more tightly distributed around
their median cost ratio than were the OPPS-to-APC cost ratios. These
patterns demonstrated that the APC groups reflect the relative costs of
procedures performed by ASCs and, therefore, that the APC groups could
be used as the basis for an ASC payment system. The GAO determined, in
fact, that there was less variation in the ASC setting between
individual procedures' costs and the costs of their assigned APC groups
than there is in the HOPD setting. It concluded that, as a group, the
costs of procedures performed in ASCs have a relatively consistent
relationship with the costs of the APC groups to which they would be
assigned under the OPPS. The GAO's analysis also found that procedures
in the ASC setting had substantially lower costs than those same
procedures in the HOPD. While ASC costs for individual procedures
varied, in general, the median costs for procedures were lower in ASCs,
relative to the median costs of their APC groups, than the median costs
for the same procedures in the HOPD setting. The median cost ratio
among all ASC procedures was 0.39 (0.84 when weighted by Medicare
volume based on CY 2004 claims), whereas the median cost ratio among
all OPPS procedures was 1.04.
The GAO found many similarities in the additional items and
services provided by ASCs and HOPDs for the top 20 ASC procedures.
However, of these additional items and services, few resulted in
additional payment in one setting but not the other. HOPDs were paid
for some of the related services separately, while in the ASC setting,
other Part B suppliers billed Medicare and received payment for many of
the related services.
Finally, in its analysis of labor-related costs, the GAO determined
that the mean labor-related proportion of costs was 50 percent. The
range of the labor-related costs for the middle 50 percent of
responding ASCs was 43 percent to 57 percent of total costs.
Based on its findings from the study, the GAO recommended that CMS
implement a payment system for procedures performed in ASCs based on
the OPPS, taking into account the lower relative costs of procedures
performed in ASCs compared to HOPDs in determining ASC payment rates.
Comment: A number of commenters noted that, by the close of the
public comment period for the August 2006 proposed rule for the revised
ASC payment system, the GAO had not yet provided recommendations
regarding ASC payment in a report to Congress that it was required to
submit by January 1, 2005. Some commenters recommended that, although
CMS was directed to take into account these recommendations in
implementing the revised ASC payment system, should the GAO's
recommendations be provided before publication of the final rule
establishing the policies of the revised ASC payment system, CMS should
not take them into consideration, given the public's inability to
provide input to CMS during the comment period regarding the GAO's
methodology, findings, and recommendations. Other commenters
recommended that, if the GAO Report was forthcoming shortly, CMS should
provide another opportunity for public comment prior to finalizing the
policies of the revised ASC payment system in order to allow the public
to provide CMS with their perspectives on those recommendations.
Response: As described earlier, the GAO published its report (GAO-
07-86) on November 30, 2006. In accordance with section
1833(i)(2)(D)(i) of the Act, we did take into account the
recommendations made in the GAO Report in developing the final policies
for the revised ASC payment system. The GAO's findings and
recommendations are summarized above, and its specific recommendations
are further discussed in the particular sections of this final rule
that address the related topics. We appreciate the public's interest in
providing us with detailed input regarding the revised ASC payment
system from a variety of perspectives. In regard to the commenters'
recommendation for a second opportunity for public comment prior to
finalizing the policies of the revised ASC payment system after the GAO
Report was published, we note that the GAO's recommendations are in
complete accord with our August 2006 proposal for the revised ASC
payment system. Therefore, we are not providing another opportunity for
public comment prior to finalizing the policies of the revised ASC
payment system, because the proposed revised system is fully consistent
with the recommendations of the GAO Report and we already provided a
90-day comment period regarding our proposal for CY 2008. We believe
that the comment period for the August 2006 proposed rule provided the
public with ample opportunity to comment on the policies that were
recommended by the GAO. The considerable operational changes required
to implement the revised ASC payment system necessitate significant
lead time that would not be possible if we were to provide another
comment period prior to finalizing the policies. We also believe that
our consideration of the recent GAO study, as well as other available
information regarding HOPD and ASC costs and payments, in addition to
our prior discussions with stakeholders and the many public comments on
the proposed rule, provide us with the necessary breadth and depth of
information and viewpoints to finalize our payment policies for the
revised ASC payment system in this final rule.
At its December 2006 meeting, the Practicing Physicians Advisory
Council (PPAC) made two recommendations to CMS regarding the final rule
for the revised ASC payment system. First, the PPAC recommended that
CMS establish a process to consult with national medical specialty
societies and the ASC community to develop and adopt a systematic and
adaptable means of fairly reimbursing ASCs for all safe and appropriate
services, allowing for changes in technology and current day practice.
Second, the PPAC recommended that CMS apply any payment policies
uniformly to both ASCs and HOPDs, as appropriate.
We have considered the GAO Report, in addition to the
recommendations of the PPAC, all public comments received on the
proposed rule, and other concerns and issues brought to our attention
by interested parties over the past several years, in developing this
final rule for the CY 2008 revised ASC payment system. Specific
policies are discussed, comments summarized and responses provided, and
policies finalized in subsequent sections of this final rule.
C. Rulemaking for the Revised ASC Payment System in CY 2008
In response to comments submitted timely regarding the proposals
set forth in the proposed rule for the revised ASC payment system
published on August 23, 2006, this final rule establishes the final
policies and regulations of the
[[Page 42476]]
revised ASC payment system for initial implementation in CY 2008. All
tables included in this final rule listing HCPCS codes subject to
pertinent final policies of the revised ASC payment system, as well as
estimated payment rates, are illustrative only, based on CY 2007 HCPCS
codes and final CY 2007 OPPS and MPFS information, with application of
the most current update estimates for CY 2008. The information in the
Addenda to this final rule is also only illustrative, to provide
examples of the results of applying the final policies of the revised
ASC payment system, based on the most recent information available for
CY 2007. As further discussed in sections V.E. and VI. of this final
rule, we will propose the CY 2008 relative payment weights, payment
amounts, specific HCPCS codes to which the final policies of the
revised ASC payment system would apply, and other pertinent ratesetting
information for the CY 2008 revised ASC payment system in the proposed
OPPS/ASC rule to update the payment systems for CY 2008 to be issued in
mid-summer of CY 2007. We will then publish final relative payment
weights, payment amounts, specific CY 2008 HCPCS codes to which the
final policies will apply, and other pertinent ratesetting information
for the CY 2008 revised ASC payment system in the final OPPS/ASC rule
to update the payment systems for CY 2008. The ASC payment system
treatment of new CY 2008 HCPCS codes published in the CY 2008 OPPS/ASC
final rule will provide interim determinations, open to public comment
on that final rule, and we will respond to comments about those
determinations in the OPPS/ASC final rule for CY 2009.
III. Covered Surgical Procedures Paid in ASCs On or After January 1,
2008
A. Payable Procedures
In its March 2004 Report to the Congress, the Medicare Payment
Advisory Commission (MedPAC) recommended replacing the current
``inclusive'' list of procedures, which are the only surgical
procedures for which Medicare allows payment to an ASC, with an
``exclusionary'' list. That is, rather than limiting payment to ASCs to
a list of procedures that CMS specifies, Medicare would allow payment
to ASCs for any surgical procedure except those that CMS explicitly
excludes from payment. MedPAC further recommended that clinical safety
standards and the need for an overnight stay be the only criteria for
excluding a procedure from eligibility for Medicare ASC payment. MedPAC
suggested that some of the criteria, such as site-of-service volume and
time limits, which we have used in the past to identify procedures for
the ASC list of covered surgical procedures, are probably no longer
clinically relevant.
In the August 2006 proposed rule for the revised ASC payment
system, we noted that we had given careful consideration to MedPAC's
recommendations and participated in considerable discussion and
consultation with members of ASC trade associations and physicians, who
represent a variety of surgical specialties, regarding the criteria
that we would use to identify procedures for payment under the revised
ASC payment system. We agreed that adoption of a policy similar to that
recommended by MedPAC would serve both to protect beneficiary safety
and increase beneficiary access to procedures in appropriate clinical
settings, recognizing the ASC industry's interest in obtaining Medicare
payment for a much wider spectrum of services than is now allowed.
Therefore, in the August 2006 proposed rule (71 FR 49636), we proposed
that, under the revised ASC payment system for services furnished on or
after January 1, 2008, Medicare would allow payment to ASCs for any
surgical procedure performed in an ASC, except those surgical
procedures that we determine are not payable under the ASC benefit.
Further, we proposed to establish beneficiary safety and the
expected need for an overnight stay as the principal clinical
considerations and decisive factors in determining whether ASC payment
would be allowed for a particular surgical procedure. As discussed in
section XVIII.B.2. of the preamble of the proposed rule, we also
proposed to exclude from separate payment under the revised ASC payment
system those surgical procedures that are on the OPPS inpatient list,
that are not eligible for separate payment under the OPPS, and that are
CPT surgical unlisted procedure codes.
We discuss below the criteria that we proposed as the basis for
identifying procedures that would pose a significant safety risk to a
Medicare beneficiary when performed in an ASC, or procedures following
which we would expect a Medicare beneficiary to require overnight care.
1. Definition of Surgical Procedure
In order to delineate the scope of procedures that constitute
``outpatient surgical procedures'' in the August 2006 proposed rule, we
first proposed to clarify what we considered to be a ``surgical''
procedure. Under the existing ASC payment system, we define a surgical
procedure as any procedure described within the range of Category I CPT
codes that the CPT Editorial Panel of the American Medical Association
(AMA) defines as ``surgery'' (CPT codes 10000 through 69999). Under the
revised payment system, we proposed to continue to define surgery using
that standard. The CPT Editorial Panel is responsible for maintaining
the CPT nomenclature, with authority to revise, update, or modify the
CPT codes. A larger body of CPT advisors, the CPT Advisory Committee,
supports the work of the CPT Editorial Panel. Members of the CPT
Editorial Panel include individuals nominated by physician and hospital
associations and insurers, providing for diverse specialty input.
In addition, in the August 2006 proposed rule for the revised ASC
payment system, we proposed to include within the scope of surgical
procedures payable in an ASC those procedures that are described by
Level II HCPCS codes or by Category III CPT codes that directly
crosswalk to or are clinically similar to procedures in the CPT
surgical range. We proposed to include all three types of codes in our
definition of surgical procedures because they all may be eligible for
separate payment under the OPPS and, to the extent it is reasonable to
do so, we proposed that the revised ASC payment system parallel the
OPPS in its policies.
In the August 2006 proposed rule, we provided an example of a Level
II HCPCS code that we believe represents a procedure that could be
safely and appropriately performed in an ASC, specifically HCPCS code
G0297 (Insertion of single chamber pacing cardioverter-defibrillator
pulse generator). We developed this Level II HCPCS code for use in the
OPPS because CPT code 33240 (Insertion of single or dual chamber pacing
cardioverter-defibrillator pulse generator), which describes the
surgical insertion of a cardioverter-defibrillator pulse generator,
does not distinguish insertion of a single chamber cardioverter-
defibrillator generator from insertion of a dual chamber cardioverter-
defibrillator generator. Under the OPPS, we were concerned that
different facility resources could be required for the insertion of
these two types of cardioverter-defibrillator pulse generators, so we
developed Level II HCPCS codes to permit HOPDs to more accurately
report the resources required when these surgical procedures are
performed. In instances such as this, when a Level II HCPCS code is
[[Page 42477]]
established as a substitute for a CPT surgical procedure code which
does not adequately describe, from a facility perspective, the nature
of a surgical service, we proposed to allow payment for the Level II
HCPCS code under the proposed revised ASC payment system. We proposed
not to allow ASC payment for Level II HCPCS codes or Category III CPT
codes that describe services that fall outside the scope of, that is,
that do not correspond to, surgical procedures described by CPT codes
10000 through 69999.
We recognized in the proposed rule that continuing to use this
definition of surgery would exclude from ASC payment certain invasive,
``surgery-like'' procedures, such as cardiac catheterization or certain
radiation treatment services which are assigned codes outside the CPT
surgical range. However, we believed that continuing to rely on the CPT
definition of surgery would be administratively straightforward,
logically related to the categorization of services by physician
experts who both establish the codes and perform the procedures, and
consistent with our proposal to allow ASC payment for all outpatient
surgical procedures. Given the number of other changes that we expected
to implement as part of the revised payment system, along with the
significant expansion of ASC covered surgical procedures that we
proposed, we explained that we believed it would be prudent at the
outset to continue to define surgery as it is defined by the CPT code
set, which is used to report services for payment under both the MPFS
and the OPPS. During the development of the August 2006 proposed rule,
we reviewed thousands of CPT codes in the surgical range (CPT codes
10000 through 69999), and we proposed to not exclude from payment over
750 surgical procedures previously excluded, in addition to providing
ASC payment for the more than 2,500 CPT codes on the CY 2007 ASC list
of covered surgical procedures.
However, we are cognizant of the dynamic nature of ambulatory
surgery, which has resulted in a dramatic shift of services from the
inpatient setting to the outpatient setting over the past two decades.
Therefore, in the proposed rule, we solicited comments regarding other
services that are invasive and ``surgery-like,'' which could safely and
appropriately be performed in an ASC, and which require the resources
typical of an ASC, even though the procedures are described by codes
that fall outside the range of CPT surgical codes. In particular, we
were interested in considering commenters' views regarding what
constitutes a ``surgical'' procedure.
We received many public comments about our August 2006 proposal to
define the surgical procedures for which we would make payment to ASCs
as those falling within the surgical code range specified by the CPT
Editorial Panel.
Comment: While, in general, hospital associations and device
manufacturers supported the proposal to maintain the definition of a
surgical procedure used under the existing ASC payment system, many ASC
industry representatives provided a broad range of suggestions about
how the definition should be expanded. Some of the commenters requested
that CMS place no limit on the procedures that would be payable in ASCs
because there is no such limit on Medicare payments to HOPDs. Other
commenters suggested a more limited expansion of procedures eligible
for payment under the revised ASC payment system. These commenters
specifically recommended that CMS expand its definition of a surgical
procedure to include:
(a) Medical procedures that are invasive and require general
anesthesia or that are specifically designated as intraoperative
procedures;
(b) X-ray, fluoroscopy, and ultrasound procedures that require
insertion of a needle, catheter, tube, or probe via a natural orifice
or through the skin;
(c) Radiology procedures integral to performance of nonradiologic
procedures, performed either during or immediately following the
surgical procedure; and
(d) Level II HCPCS and Category III CPT codes that describe
procedures that crosswalk directly or are clinically similar to those
listed in suggestions (a) through (c) above.
Response: We have given consideration to the many recommendations
of the commenters. In general, we continue to believe it is appropriate
to provide payments to ASCs for the resources associated with
performing those services that are surgical procedures as defined by
the CPT Editorial Panel. From the Panel's broad experience in regularly
addressing the complex issues associated with new and emerging health
care technologies, as well as the difficulties encountered with
obsolete procedures, we believe its members are well-positioned to
maintain and refine the existing coding taxonomy, which defines certain
procedures as surgery, to appropriately reflect medical practice in an
evolving health care delivery system. In addition, we believe that our
proposal to pay for surgical procedures in ASCs that are reported by
Level II HCPCS and Category III CPT codes that directly crosswalk or
are clinically similar to procedures in the surgical range of CPT codes
that are payable in ASCs is consistent with our definition of surgery
according to the CPT surgical code range, while providing ASC payment
for some procedures that have not yet been categorized by the CPT
Editorial Panel or for which Medicare recognizes alternative HCPCS
codes for payment.
Although we are not changing our definition of surgery as suggested
by commenters, we did review procedures that are coded by specific
Level II HCPCS or Category III CPT codes that were identified by
commenters as surgical procedures that should be payable in ASCs. We
assessed those procedures using the same final criteria discussed in
section III.A.2. of this final rule that we used to evaluate all
surgical procedures for their safety or the expected need for an
overnight stay in making decisions about their exclusion from ASC
payment. As we proposed, we also evaluated the codes in the context of
whether they directly crosswalk or are clinically similar to procedures
in the CPT surgical range that we have determined do not pose a
significant safety risk or for which an overnight stay is not expected
when performed in ASCs. As a result of that review, 14 additional Level
II HCPCS codes and 15 Category III CPT codes beyond those we proposed
for CY 2008 payment will be payable as covered surgical procedures when
performed in ASCs beginning in CY 2008.
Furthermore, as discussed in section IV. of this final rule,
although we are not expanding our definition of surgical procedures, we
will provide separate ASC payment for a number of covered ancillary
services when they are furnished on the same day as a covered surgical
procedure and are integral to the performance of that procedure in the
ASC setting. Those services include certain radiology procedures, such
as some fluoroscopy and ultrasound services, that some commenters
recommended we define as surgical procedures for addition to the ASC
list of covered surgical procedures.
Comment: Several commenters expressed concern regarding CMS'
proposed exclusion from ASC payment of all procedures described within
the range of Category I CPT codes defined as ``radiology'' in
accordance with the CPT Editorial Panel designation. The commenters
asserted that regulations regarding the Federal physician self-referral
prohibition (section 1877 of the Act) exclude interventional and
[[Page 42478]]
intraoperative radiology services from the definition of ``radiology''
services subject to the law's self-referral prohibition, and that CMS
should, therefore, treat those services as surgical services that are
eligible for payment as covered surgical procedures under the revised
ASC payment system. They believed that interventional radiology and
intraoperative radiology services that require insertion of a needle,
catheter, tube, probe, or similar device are appropriately considered
surgical in nature for purposes of ASC payment.
Response: The commenters' statements with respect to the treatment
of interventional radiology procedures under the physician self-
referral regulations seem overly broad. The physician self-referral
regulations provide that the following services (which may include
some, but not all, interventional radiology procedures) are not
``radiology and certain other imaging services'' for purposes of
section 1877 of the Act: (i) X-ray, fluoroscopy, or ultrasound
procedures that require the insertion of a needle, catheter, tube, or
probe through the skin or into a body orifice; and (ii) radiology
procedures that are integral to the performance of a nonradiological
medical procedure and performed either during the nonradiological
medical procedure or immediately following the nonradiological medical
procedure when necessary to confirm placement of an item inserted
during the nonradiological medical procedure. We do not believe that
Medicare's exclusion of specific services from the definition of
``radiology and certain other imaging services'' for purposes of the
physician self-referral prohibition should result in such services
being considered ``surgical services'' for purposes of the revised ASC
payment system.
Further, as we explain above, we believe that the characterization
of procedures as surgery for purposes of their performance in ASCs is
best left to the expertise of the CPT Editorial Panel. We do not
believe that services designated as radiology services by the CPT
Editorial Panel are appropriately classified as covered surgical
procedures in ASCs, facilities that specialize in the delivery of
ambulatory surgical services. However, as discussed further in section
IV.C.2. of this final rule, we do believe that it is appropriate to
provide separate ASC payment for certain ancillary services that are
integral to the covered surgical procedures. Thus, we will provide
separate payment to ASCs under the revised payment system for radiology
services that are integral to the performance of an ASC covered
surgical procedure when that radiology procedure is one of those for
which separate payment is made under the OPPS. That is, separate
payment will be made for covered ancillary radiology services integral
to covered surgical procedures that are provided in the ASC immediately
before, during, or immediately following the surgical procedure.
After consideration of the public comments we received, we are
finalizing our proposal to define surgery as those procedures described
by CPT codes within the surgical range of 10000 through 69999, without
modification. In addition, we are including within our definition of a
covered surgical procedure payable in the ASC setting those Level II
HCPCS codes or Category III CPT codes that directly crosswalk or are
clinically similar to procedures in the CPT surgical range that we have
determined do not pose a significant safety risk, that we would not
expect to require an overnight stay when performed in ASCs, and that
are separately paid under the OPPS. An illustrative list of covered
surgical procedures under the revised ASC payment system, including
Category I and Category III CPT codes and Level II HCPCS codes, can be
found in Addendum AA to this final rule. An illustrative list of
radiology services and other covered ancillary services that are
eligible for separate ASC payment when provided integral to an ASC
covered surgical procedure on the same day is located in Addendum BB to
this final rule.
2. Procedures Excluded From Payment Under the Revised ASC Payment
System
As stated above, in the August 2006 proposed rule for the revised
ASC payment system, we proposed to allow payment to ASCs for all
procedures described by CPT codes within the surgical range of 10000
through 69999, or by Level II HCPCS codes or Category III CPT codes
that directly crosswalk or are clinically similar to procedures in the
CPT surgical range, that do not pose a significant safety risk to
Medicare beneficiaries and that are not expected to require an
overnight stay. Having established what we consider to be a ``surgical
procedure,'' we next considered criteria that would enable us to
identify procedures that could pose a significant safety risk when
performed in an ASC or that we expect would require an overnight stay
within the bounds of prevailing medical practice. We discuss in the
next section how we proposed to identify procedures that could pose a
significant safety risk.
a. Significant Safety Risk
First, we proposed to exclude from ASC payment any procedure that
is included on the current OPPS inpatient list, that is, those
procedures designated as requiring inpatient care under Sec.
419.22(n). (S